pmid,year,mesh,meshTreeNumber
19124948,2009-01-06T00:00:00,Algorithms,G17.035
19124948,2009-01-06T00:00:00,Algorithms,L01.224.050
19124948,2009-01-06T00:00:00,Animals,B01.050
19124948,2009-01-06T00:00:00,Computer Simulation,L01.224.160
19124948,2009-01-06T00:00:00,Finite Element Analysis,E05.355
19124948,2009-01-06T00:00:00,Hepatectomy,E04.210.556
19124948,2009-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19124948,2009-01-06T00:00:00,Liver,A03.620
19124948,2009-01-06T00:00:00,"Models, Biological",E05.599.395
19124948,2009-01-06T00:00:00,"Models, Statistical",E05.318.740.500
19124948,2009-01-06T00:00:00,"Models, Statistical",E05.599.835
19124948,2009-01-06T00:00:00,"Models, Statistical",N05.715.360.750.530
19124948,2009-01-06T00:00:00,"Models, Statistical",N06.850.520.830.500
19124948,2009-01-06T00:00:00,"Surgery, Computer-Assisted",E02.950.875
19124948,2009-01-06T00:00:00,"Surgery, Computer-Assisted",E04.749
19124948,2009-01-06T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
19185566,2009-01-06T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19185566,2009-01-06T00:00:00,Cell Line,A11.251.210
19185566,2009-01-06T00:00:00,Genetic Variation,G05.365
19185566,2009-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19185566,2009-01-06T00:00:00,Mutation,G05.365.590
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C10.228.140.163.100.680.100
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C10.314.400.250
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C10.597.606.643.455.124
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C16.320.322.500.124
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C16.320.400.525.124
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C16.320.565.189.680.100
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C16.320.565.663.112
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C18.452.132.100.680.100
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C18.452.648.189.680.100
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C18.452.648.663.112
19127062,2009-01-07T00:00:00,Adrenoleukodystrophy,C19.053.500.270
19127062,2009-01-07T00:00:00,Cell Line,A11.251.210
19127062,2009-01-07T00:00:00,Child,M01.060.406
19127062,2009-01-07T00:00:00,Fatty Acids,D10.251
19127062,2009-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19127062,2009-01-07T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
19127062,2009-01-07T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
19127062,2009-01-07T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
19127062,2009-01-07T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
19127062,2009-01-07T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
19127062,2009-01-07T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
19127062,2009-01-07T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
19127062,2009-01-07T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
19127062,2009-01-07T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
19127062,2009-01-07T00:00:00,Lovastatin,D02.455.426.559.847.638.400
19127062,2009-01-07T00:00:00,Lovastatin,D04.615.638.400
19127062,2009-01-07T00:00:00,Lymphocytes,A11.118.637.555.567
19127062,2009-01-07T00:00:00,Lymphocytes,A15.145.229.637.555.567
19127062,2009-01-07T00:00:00,Lymphocytes,A15.382.490.555.567
19127062,2009-01-07T00:00:00,Membrane Glycoproteins,D12.776.395.550
19127062,2009-01-07T00:00:00,Membrane Glycoproteins,D12.776.543.550
19127062,2009-01-07T00:00:00,Nitric Oxide,D01.339.387
19127062,2009-01-07T00:00:00,Nitric Oxide,D01.625.550.500
19127062,2009-01-07T00:00:00,Nitric Oxide,D01.625.700.500
19127062,2009-01-07T00:00:00,Nitric Oxide,D01.650.550.587.600
19127062,2009-01-07T00:00:00,Phosphoproteins,D12.776.744
19127062,2009-01-07T00:00:00,Reactive Oxygen Species,D01.339.431
19127062,2009-01-07T00:00:00,Reactive Oxygen Species,D01.650.775
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19127062,2009-01-07T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19166836,2009-01-07T00:00:00,Adult Stem Cells,A11.872.040
19166836,2009-01-07T00:00:00,Animals,B01.050
19166836,2009-01-07T00:00:00,Antineoplastic Agents,D27.505.954.248
19166836,2009-01-07T00:00:00,Cell Differentiation,G04.299.151
19166836,2009-01-07T00:00:00,Cell Survival,G04.299.316
19166836,2009-01-07T00:00:00,Nerve Tissue Proteins,D12.776.641
19166836,2009-01-07T00:00:00,Neurons,A08.663
19166836,2009-01-07T00:00:00,Neurons,A11.671
19166836,2009-01-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19166836,2009-01-07T00:00:00,Time Factors,G01.910.857
19195794,2009-01-07T00:00:00,Adult,M01.060.116
19195794,2009-01-07T00:00:00,Alcoholism,C21.739.100.250
19195794,2009-01-07T00:00:00,Alcoholism,F03.900.100.350
19195794,2009-01-07T00:00:00,Ambulatory Care,E02.760.106
19195794,2009-01-07T00:00:00,Ambulatory Care,N02.421.585.106
19195794,2009-01-07T00:00:00,Anxiety,F01.470.132
19195794,2009-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19195794,2009-01-07T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
19195794,2009-01-07T00:00:00,Substance-Related Disorders,C21.739
19195794,2009-01-07T00:00:00,Substance-Related Disorders,F03.900
19072163,2009-01-08T00:00:00,Amino Acid Sequence,G02.111.570.060
19072163,2009-01-08T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19072163,2009-01-08T00:00:00,Animals,B01.050
19072163,2009-01-08T00:00:00,Calpain,D08.811.277.656.262.500.120
19072163,2009-01-08T00:00:00,Calpain,D08.811.277.656.300.200.120
19072163,2009-01-08T00:00:00,Cell Line,A11.251.210
19072163,2009-01-08T00:00:00,Enzyme Inhibitors,D27.505.519.389
19072163,2009-01-08T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19072163,2009-01-08T00:00:00,Mitochondria,A11.284.835.626
19072163,2009-01-08T00:00:00,Peptides,D12.644
19072163,2009-01-08T00:00:00,Rabbits,B01.050.150.900.649.521.700
19131940,2009-01-08T00:00:00,Adolescent,M01.060.057
19131940,2009-01-08T00:00:00,Adult,M01.060.116
19131940,2009-01-08T00:00:00,Aged,M01.060.116.100
19131940,2009-01-08T00:00:00,Blood Glucose,D09.546.359.448.500
19131940,2009-01-08T00:00:00,Cardiovascular Diseases,C14
19131940,2009-01-08T00:00:00,Coronary Disease,C14.280.647.250
19131940,2009-01-08T00:00:00,Coronary Disease,C14.907.585.250
19131940,2009-01-08T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
19131940,2009-01-08T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
19131940,2009-01-08T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
19131940,2009-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19131940,2009-01-08T00:00:00,Incidence,E05.318.308.985.525.375
19131940,2009-01-08T00:00:00,Incidence,L01.280.975.525.375
19131940,2009-01-08T00:00:00,Incidence,N01.224.935.597.500
19131940,2009-01-08T00:00:00,Incidence,N06.850.505.400.975.525.375
19131940,2009-01-08T00:00:00,Incidence,N06.850.520.308.985.525.375
19131940,2009-01-08T00:00:00,Middle Aged,M01.060.116.630
19131940,2009-01-08T00:00:00,Risk Factors,E05.318.740.600.800.725
19131940,2009-01-08T00:00:00,Risk Factors,N05.715.350.200.700
19131940,2009-01-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19131940,2009-01-08T00:00:00,Risk Factors,N06.850.490.625.750
19131940,2009-01-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19131940,2009-01-08T00:00:00,Stroke,C10.228.140.300.775
19131940,2009-01-08T00:00:00,Stroke,C14.907.253.855
19131940,2009-01-08T00:00:00,Young Adult,M01.060.116.815
19132495,2009-01-08T00:00:00,Adult,M01.060.116
19132495,2009-01-08T00:00:00,Graft Rejection,G12.425.901.545.328
19132495,2009-01-08T00:00:00,Heart Transplantation,E04.100.376.475
19132495,2009-01-08T00:00:00,Heart Transplantation,E04.928.220.390
19132495,2009-01-08T00:00:00,Heart Transplantation,E04.936.450.475
19132495,2009-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19132495,2009-01-08T00:00:00,Radiation Dosage,E05.799.513
19132495,2009-01-08T00:00:00,Radiation Dosage,G01.201.875.740
19132495,2009-01-08T00:00:00,Radiation Dosage,N06.850.810.250
19132495,2009-01-08T00:00:00,"Radiotherapy, Intensity-Modulated",E02.815.635.700.700
19132495,2009-01-08T00:00:00,"Radiotherapy, Intensity-Modulated",L01.700.508.100.710.600.550.700
19132495,2009-01-08T00:00:00,"Tomography, Spiral Computed",E01.370.350.350.810.800
19132495,2009-01-08T00:00:00,"Tomography, Spiral Computed",E01.370.350.600.350.700.810.800
19132495,2009-01-08T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.700.810.800
19132495,2009-01-08T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.810.810.800
19132495,2009-01-08T00:00:00,"Tomography, Spiral Computed",E01.370.350.825.810.810.800
19132495,2009-01-08T00:00:00,Transplantation Conditioning,E02.095.465.425.450.800
19132495,2009-01-08T00:00:00,Transplantation Conditioning,E05.478.610.800
19133135,2009-01-08T00:00:00,Animals,B01.050
19133135,2009-01-08T00:00:00,Cell Line,A11.251.210
19133135,2009-01-08T00:00:00,Clonal Anergy,G12.425.746.425.100
19133135,2009-01-08T00:00:00,Gene Expression Regulation,G05.355.315
19133135,2009-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19133135,2009-01-08T00:00:00,Immune Tolerance,G12.425.746.425
19133135,2009-01-08T00:00:00,Vaccines,D20.215.894
19479009,2009-01-09T00:00:00,Animals,B01.050
19479009,2009-01-09T00:00:00,Autoimmune Diseases,C20.111
19479009,2009-01-09T00:00:00,Environmental Exposure,N06.850.460.350
19479009,2009-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19479009,2009-01-09T00:00:00,Immune System,A15.382
19479009,2009-01-09T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19479009,2009-01-09T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19479009,2009-01-09T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19479009,2009-01-09T00:00:00,Interferon-gamma,D12.644.276.718.550
19479009,2009-01-09T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19479009,2009-01-09T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19479009,2009-01-09T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19479009,2009-01-09T00:00:00,Interferon-gamma,D12.776.467.718.550
19479009,2009-01-09T00:00:00,Interferon-gamma,D23.529.374.440.893
19479009,2009-01-09T00:00:00,Interferon-gamma,D23.529.374.480.350
19479009,2009-01-09T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19479009,2009-01-09T00:00:00,Interferon-gamma,D23.529.718.550
19479009,2009-01-09T00:00:00,Interleukin-4,D12.644.276.374.465.504
19479009,2009-01-09T00:00:00,Interleukin-4,D12.776.467.374.465.504
19479009,2009-01-09T00:00:00,Interleukin-4,D23.529.374.465.504
19479009,2009-01-09T00:00:00,"Scleroderma, Systemic",C17.300.799
19479009,2009-01-09T00:00:00,"Scleroderma, Systemic",C17.800.784
19479009,2009-01-09T00:00:00,Trichloroethylene,D02.455.526.439.939
19479009,2009-01-09T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
19136111,2009-01-10T00:00:00,Adult,M01.060.116
19136111,2009-01-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
19136111,2009-01-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
19136111,2009-01-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
19136111,2009-01-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
19136111,2009-01-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
19136111,2009-01-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
19136111,2009-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19136111,2009-01-10T00:00:00,Pregnancy,G08.686.785.760.769
19136111,2009-01-10T00:00:00,Pregnancy Complications,C13.703
19136971,2009-01-11T00:00:00,Acetylcysteine,D02.886.030.230.259
19136971,2009-01-11T00:00:00,Acetylcysteine,D12.125.166.230.259
19136971,2009-01-11T00:00:00,Animals,B01.050
19136971,2009-01-11T00:00:00,"Behavior, Animal",F01.145.113
19136971,2009-01-11T00:00:00,Cocaine-Related Disorders,C21.739.300
19136971,2009-01-11T00:00:00,Cocaine-Related Disorders,F03.900.300
19136971,2009-01-11T00:00:00,"Disease Models, Animal",C22.232
19136971,2009-01-11T00:00:00,"Disease Models, Animal",E05.598.500
19136971,2009-01-11T00:00:00,"Disease Models, Animal",E05.599.395.080
19136971,2009-01-11T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
19136971,2009-01-11T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
19136971,2009-01-11T00:00:00,Long-Term Synaptic Depression,G11.561.600.635.355
19136971,2009-01-11T00:00:00,Neuronal Plasticity,G11.561.600.635
19136971,2009-01-11T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19136971,2009-01-11T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19136971,2009-01-11T00:00:00,Pyridines,D03.383.725
19136971,2009-01-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19136971,2009-01-11T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19136971,2009-01-11T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
19136971,2009-01-11T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
19136971,2009-01-11T00:00:00,Self Administration,E02.319.890
19136971,2009-01-11T00:00:00,Self Administration,E02.900.890
19136971,2009-01-11T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19136971,2009-01-11T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19137010,2009-01-12T00:00:00,Apoptosis,G04.299.139.160
19137010,2009-01-12T00:00:00,Ceramides,D02.065.313
19137010,2009-01-12T00:00:00,Ceramides,D09.400.410.420.525.200
19137010,2009-01-12T00:00:00,Ceramides,D10.390.470.675.200
19137010,2009-01-12T00:00:00,Ceramides,D10.570.877.360.612.200
19137010,2009-01-12T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19137010,2009-01-12T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19137010,2009-01-12T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19137010,2009-01-12T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19137010,2009-01-12T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19137010,2009-01-12T00:00:00,Enzyme Inhibitors,D27.505.519.389
19137010,2009-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19137010,2009-01-12T00:00:00,Oxidoreductases,D08.811.682
19137010,2009-01-12T00:00:00,Protein Transport,G03.495.166.700
19137010,2009-01-12T00:00:00,Sphingosine,D02.033.100.700
19137010,2009-01-12T00:00:00,Sphingosine,D02.033.455.843
19137010,2009-01-12T00:00:00,Sphingosine,D02.092.063.700
19137010,2009-01-12T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
19137010,2009-01-12T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
19137010,2009-01-12T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
19137010,2009-01-12T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
19137010,2009-01-12T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
19137010,2009-01-12T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
19139096,2009-01-12T00:00:00,Lipid Metabolism,G03.495.520
19139096,2009-01-12T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
19139096,2009-01-12T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
19139096,2009-01-12T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
19139096,2009-01-12T00:00:00,Signal Transduction,G02.111.087.800
19139096,2009-01-12T00:00:00,Signal Transduction,G02.149.115.800
19139096,2009-01-12T00:00:00,Signal Transduction,G04.299.880
19139096,2009-01-12T00:00:00,Sphingolipids,D10.570.877
19139096,2009-01-12T00:00:00,Sphingolipids,D10.808
19139797,2009-01-12T00:00:00,Child,M01.060.406
19139797,2009-01-12T00:00:00,Child Behavior,F01.145.179
19139797,2009-01-12T00:00:00,Child Development,F01.525.200
19139797,2009-01-12T00:00:00,Child Development,G07.700.320.374.750
19139797,2009-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19139797,2009-01-12T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19139797,2009-01-12T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19139797,2009-01-12T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19139797,2009-01-12T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19139797,2009-01-12T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19139797,2009-01-12T00:00:00,United States,Z01.107.567.875
19139797,2009-01-12T00:00:00,Wounds and Injuries,C21.866
19139797,2009-01-12T00:00:00,Young Adult,M01.060.116.815
19141526,2009-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19141526,2009-01-13T00:00:00,Lung Neoplasms,C04.588.894.797.520
19141526,2009-01-13T00:00:00,Lung Neoplasms,C08.381.540
19141526,2009-01-13T00:00:00,Lung Neoplasms,C08.785.520
19141526,2009-01-13T00:00:00,"Pattern Recognition, Automated",L01.725
19141526,2009-01-13T00:00:00,"Phantoms, Imaging",E07.671
19141526,2009-01-13T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19141526,2009-01-13T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19141526,2009-01-13T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19141526,2009-01-13T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19141526,2009-01-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19141526,2009-01-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19141526,2009-01-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19141526,2009-01-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19141526,2009-01-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19141786,2009-01-13T00:00:00,Animals,B01.050
19141786,2009-01-13T00:00:00,B-Lymphocytes,A11.063.438
19141786,2009-01-13T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
19141786,2009-01-13T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
19141786,2009-01-13T00:00:00,B-Lymphocytes,A15.382.032.438
19141786,2009-01-13T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
19141786,2009-01-13T00:00:00,Biological Availability,G03.787.151
19141786,2009-01-13T00:00:00,Biological Availability,G07.690.725.129
19141786,2009-01-13T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
19141786,2009-01-13T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
19141786,2009-01-13T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
19141786,2009-01-13T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
19141786,2009-01-13T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
19141786,2009-01-13T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
19141786,2009-01-13T00:00:00,Cell Proliferation,G04.299.233.750
19141786,2009-01-13T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19141786,2009-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19141786,2009-01-13T00:00:00,Immune Tolerance,G12.425.746.425
19141786,2009-01-13T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
19141786,2009-01-13T00:00:00,"Models, Animal",E05.598
19141786,2009-01-13T00:00:00,Spleen,A10.549.700
19141786,2009-01-13T00:00:00,Spleen,A15.382.520.604.700
19141786,2009-01-13T00:00:00,Thymus Gland,A10.549.750
19141786,2009-01-13T00:00:00,Thymus Gland,A15.382.520.604.750
19192459,2009-01-13T00:00:00,Adult,M01.060.116
19192459,2009-01-13T00:00:00,Aged,M01.060.116.100
19192459,2009-01-13T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
19192459,2009-01-13T00:00:00,Combined Modality Therapy,E02.186
19192459,2009-01-13T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19192459,2009-01-13T00:00:00,Drug Resistance,G07.690.320
19192459,2009-01-13T00:00:00,Electroconvulsive Therapy,F04.570.200.583
19192459,2009-01-13T00:00:00,Electroconvulsive Therapy,F04.669.224.300
19192459,2009-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19192459,2009-01-13T00:00:00,Middle Aged,M01.060.116.630
19192459,2009-01-13T00:00:00,Nortriptyline,D02.455.426.559.847.181.384.535
19192459,2009-01-13T00:00:00,Nortriptyline,D04.615.181.384.535
19192459,2009-01-13T00:00:00,Personality Inventory,F04.711.647.513
19192459,2009-01-13T00:00:00,Psychometrics,F04.711.780
19192459,2009-01-13T00:00:00,Risk Factors,E05.318.740.600.800.725
19192459,2009-01-13T00:00:00,Risk Factors,N05.715.350.200.700
19192459,2009-01-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19192459,2009-01-13T00:00:00,Risk Factors,N06.850.490.625.750
19192459,2009-01-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19142584,2009-01-14T00:00:00,Adolescent,M01.060.057
19142584,2009-01-14T00:00:00,Adult,M01.060.116
19142584,2009-01-14T00:00:00,Aged,M01.060.116.100
19142584,2009-01-14T00:00:00,Brain Neoplasms,C04.588.614.250.195
19142584,2009-01-14T00:00:00,Brain Neoplasms,C10.228.140.211
19142584,2009-01-14T00:00:00,Brain Neoplasms,C10.551.240.250
19142584,2009-01-14T00:00:00,Combined Modality Therapy,E02.186
19142584,2009-01-14T00:00:00,Glioma,C04.557.465.625.600.380
19142584,2009-01-14T00:00:00,Glioma,C04.557.470.670.380
19142584,2009-01-14T00:00:00,Glioma,C04.557.580.625.600.380
19142584,2009-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19142584,2009-01-14T00:00:00,Middle Aged,M01.060.116.630
19142584,2009-01-14T00:00:00,Radiation Dosage,E05.799.513
19142584,2009-01-14T00:00:00,Radiation Dosage,G01.201.875.740
19142584,2009-01-14T00:00:00,Radiation Dosage,N06.850.810.250
19142584,2009-01-14T00:00:00,Young Adult,M01.060.116.815
19144693,2009-01-14T00:00:00,Adenoviridae,B04.280.030
19144693,2009-01-14T00:00:00,Adenoviridae,B04.909.204.097
19144693,2009-01-14T00:00:00,Aging,G07.700.320.124
19144693,2009-01-14T00:00:00,Animals,B01.050
19144693,2009-01-14T00:00:00,Calpain,D08.811.277.656.262.500.120
19144693,2009-01-14T00:00:00,Calpain,D08.811.277.656.300.200.120
19144693,2009-01-14T00:00:00,Cell Survival,G04.299.316
19144693,2009-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19144693,2009-01-14T00:00:00,Kidney,A05.810.453
19144693,2009-01-14T00:00:00,Liver,A03.620
19144693,2009-01-14T00:00:00,Rabbits,B01.050.150.900.649.521.700
19144693,2009-01-14T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19150341,2009-01-14T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
19150341,2009-01-14T00:00:00,ADAM Proteins,D09.400.430.500
19150341,2009-01-14T00:00:00,ADAM Proteins,D12.776.395.033
19150341,2009-01-14T00:00:00,Cell Proliferation,G04.299.233.750
19150341,2009-01-14T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19150341,2009-01-14T00:00:00,Endothelial Cells,A11.436.275
19150341,2009-01-14T00:00:00,Gene Silencing,G05.355.315.203.374
19150341,2009-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19150341,2009-01-14T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
19150341,2009-01-14T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
19150341,2009-01-14T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
19150341,2009-01-14T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
19150341,2009-01-14T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
19150341,2009-01-14T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
19150341,2009-01-14T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
19150341,2009-01-14T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19150341,2009-01-14T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19150341,2009-01-14T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20559964,2009-01-14T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20559964,2009-01-14T00:00:00,Coronary Angiography,E01.370.370.050.200
20559964,2009-01-14T00:00:00,Coronary Angiography,E01.370.370.380.200
20559964,2009-01-14T00:00:00,Diagnostic Imaging,E01.370.350
20559964,2009-01-14T00:00:00,Disease Progression,C23.550.291.656
20559964,2009-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20559964,2009-01-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20559964,2009-01-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20559964,2009-01-14T00:00:00,Myocardial Infarction,C14.280.647.500
20559964,2009-01-14T00:00:00,Myocardial Infarction,C14.907.585.500
20559964,2009-01-14T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
20559964,2009-01-14T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
20559964,2009-01-14T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
20559964,2009-01-14T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
20559964,2009-01-14T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
20559964,2009-01-14T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
20559964,2009-01-14T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
20559964,2009-01-14T00:00:00,"Tomography, Optical Coherence",E01.370.350.825.805.500
20559964,2009-01-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20559964,2009-01-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20559964,2009-01-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20559964,2009-01-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20559964,2009-01-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20559964,2009-01-14T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
18720408,2009-01-15T00:00:00,Animals,B01.050
18720408,2009-01-15T00:00:00,Central Nervous System,A08.186
18720408,2009-01-15T00:00:00,Cyclic AMP,D03.438.759.646.138.395
18720408,2009-01-15T00:00:00,Cyclic AMP,D13.695.462.200
18720408,2009-01-15T00:00:00,Cyclic AMP,D13.695.667.138.395
18720408,2009-01-15T00:00:00,Cyclic AMP,D13.695.827.068.395
18720408,2009-01-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
18720408,2009-01-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
18720408,2009-01-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
18720408,2009-01-15T00:00:00,"Disease Models, Animal",C22.232
18720408,2009-01-15T00:00:00,"Disease Models, Animal",E05.598.500
18720408,2009-01-15T00:00:00,"Disease Models, Animal",E05.599.395.080
18720408,2009-01-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
18720408,2009-01-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
18720408,2009-01-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
18720408,2009-01-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
18720408,2009-01-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
18720408,2009-01-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
18720408,2009-01-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
18720408,2009-01-15T00:00:00,Immunologic Factors,D27.505.696.477
18720408,2009-01-15T00:00:00,Lovastatin,D02.455.426.559.847.638.400
18720408,2009-01-15T00:00:00,Lovastatin,D04.615.638.400
18720408,2009-01-15T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
18720408,2009-01-15T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
18720408,2009-01-15T00:00:00,Nerve Regeneration,G11.561.600.615
18720408,2009-01-15T00:00:00,Nerve Regeneration,G16.100.856.611
18720408,2009-01-15T00:00:00,Neuroprotective Agents,D27.505.696.706.548
18720408,2009-01-15T00:00:00,Neuroprotective Agents,D27.505.954.427.575
18720408,2009-01-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18720408,2009-01-15T00:00:00,Treatment Outcome,E01.789.800
18720408,2009-01-15T00:00:00,Treatment Outcome,N04.761.559.590.800
18720408,2009-01-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19115983,2009-01-15T00:00:00,Animals,B01.050
19115983,2009-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19145440,2009-01-15T00:00:00,Disease Progression,C23.550.291.656
19145440,2009-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19145440,2009-01-15T00:00:00,Interleukin-10,D12.644.276.374.465.510
19145440,2009-01-15T00:00:00,Interleukin-10,D12.776.467.374.465.510
19145440,2009-01-15T00:00:00,Interleukin-10,D23.529.374.465.510
19145440,2009-01-15T00:00:00,Middle Aged,M01.060.116.630
19145440,2009-01-15T00:00:00,"Polymorphism, Genetic",G05.365.795
19145440,2009-01-15T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19145440,2009-01-15T00:00:00,Prostatic Neoplasms,C12.294.260.750
19145440,2009-01-15T00:00:00,Prostatic Neoplasms,C12.294.565.625
19145440,2009-01-15T00:00:00,Prostatic Neoplasms,C12.758.409.750
19145440,2009-01-15T00:00:00,Risk Factors,E05.318.740.600.800.725
19145440,2009-01-15T00:00:00,Risk Factors,N05.715.350.200.700
19145440,2009-01-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19145440,2009-01-15T00:00:00,Risk Factors,N06.850.490.625.750
19145440,2009-01-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19145477,2009-01-15T00:00:00,Aminoglycosides,D09.408.051
19145477,2009-01-15T00:00:00,Animals,B01.050
19145477,2009-01-15T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19145477,2009-01-15T00:00:00,Caspases,D08.811.277.656.262.500.126
19145477,2009-01-15T00:00:00,Caspases,D08.811.277.656.300.200.126
19145477,2009-01-15T00:00:00,Caspases,D12.644.360.075.405
19145477,2009-01-15T00:00:00,Caspases,D12.776.476.075.405
19145477,2009-01-15T00:00:00,Cell Death,G04.299.139
19145477,2009-01-15T00:00:00,"Hair Cells, Auditory",A08.663.650.250
19145477,2009-01-15T00:00:00,"Hair Cells, Auditory",A08.663.650.915.750.600.350
19145477,2009-01-15T00:00:00,"Hair Cells, Auditory",A08.800.950.750.600.350
19145477,2009-01-15T00:00:00,"Hair Cells, Auditory",A09.246.631.246.577.325
19145477,2009-01-15T00:00:00,"Hair Cells, Auditory",A11.671.650.250
19145477,2009-01-15T00:00:00,"Hair Cells, Auditory",A11.671.650.915.750.600.350
19145477,2009-01-15T00:00:00,Hearing Loss,C09.218.458.341
19145477,2009-01-15T00:00:00,Hearing Loss,C10.597.751.418.341
19145477,2009-01-15T00:00:00,Hearing Loss,C23.888.592.763.393.341
19147617,2009-01-15T00:00:00,Evidence-Based Medicine,H02.249.750
19147617,2009-01-15T00:00:00,Evidence-Based Medicine,H02.403.200.400
19147617,2009-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19147617,2009-01-15T00:00:00,"Hypertension, Pulmonary",C08.381.423
19147617,2009-01-15T00:00:00,Kidney Diseases,C12.777.419
19147617,2009-01-15T00:00:00,Kidney Diseases,C13.351.968.419
19147617,2009-01-15T00:00:00,"Lung Diseases, Interstitial",C08.381.483
19147617,2009-01-15T00:00:00,"Scleroderma, Systemic",C17.300.799
19147617,2009-01-15T00:00:00,"Scleroderma, Systemic",C17.800.784
19147617,2009-01-15T00:00:00,Treatment Outcome,E01.789.800
19147617,2009-01-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19147617,2009-01-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19148123,2009-01-15T00:00:00,Adult,M01.060.116
19148123,2009-01-15T00:00:00,Case-Control Studies,E05.318.760.500.500
19148123,2009-01-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19148123,2009-01-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19148123,2009-01-15T00:00:00,Gastric Bypass,E02.065.062.249
19148123,2009-01-15T00:00:00,Gastric Bypass,E04.035.398.385
19148123,2009-01-15T00:00:00,Gastric Bypass,E04.062.249
19148123,2009-01-15T00:00:00,Gastric Bypass,E04.210.457.430
19148123,2009-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19148123,2009-01-15T00:00:00,Incidence,E05.318.308.985.525.375
19148123,2009-01-15T00:00:00,Incidence,L01.280.975.525.375
19148123,2009-01-15T00:00:00,Incidence,N01.224.935.597.500
19148123,2009-01-15T00:00:00,Incidence,N06.850.505.400.975.525.375
19148123,2009-01-15T00:00:00,Incidence,N06.850.520.308.985.525.375
19148123,2009-01-15T00:00:00,Middle Aged,M01.060.116.630
19148123,2009-01-15T00:00:00,Neoplasms,C04
19148123,2009-01-15T00:00:00,"Obesity, Morbid",C18.654.726.500.700
19148123,2009-01-15T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
19148123,2009-01-15T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
19148123,2009-01-15T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
19148123,2009-01-15T00:00:00,Risk Factors,E05.318.740.600.800.725
19148123,2009-01-15T00:00:00,Risk Factors,N05.715.350.200.700
19148123,2009-01-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19148123,2009-01-15T00:00:00,Risk Factors,N06.850.490.625.750
19148123,2009-01-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19148126,2009-01-15T00:00:00,Adult,M01.060.116
19148126,2009-01-15T00:00:00,Bariatric Surgery,E02.065.062
19148126,2009-01-15T00:00:00,Bariatric Surgery,E04.062
19148126,2009-01-15T00:00:00,Feeding Behavior,F01.145.113.547
19148126,2009-01-15T00:00:00,Feeding Behavior,F01.145.407
19148126,2009-01-15T00:00:00,Health Surveys,E05.318.308.250
19148126,2009-01-15T00:00:00,Health Surveys,N05.715.360.300.375
19148126,2009-01-15T00:00:00,Health Surveys,N06.850.520.308.250
19148126,2009-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19148126,2009-01-15T00:00:00,Middle Aged,M01.060.116.630
19148126,2009-01-15T00:00:00,Motivation,F01.658
19148126,2009-01-15T00:00:00,Motivation,F01.752.543.500.750
19148126,2009-01-15T00:00:00,Obesity,C18.654.726.500
19148126,2009-01-15T00:00:00,Obesity,C23.888.144.699.500
19148126,2009-01-15T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19148126,2009-01-15T00:00:00,Obesity,G07.100.100.160.120.699.500
19148126,2009-01-15T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19148126,2009-01-15T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19148126,2009-01-15T00:00:00,Patient Compliance,F01.145.488.500
19148126,2009-01-15T00:00:00,Patient Compliance,N05.300.150.600.600
19148126,2009-01-15T00:00:00,Satiety Response,F02.830.749.658
19148126,2009-01-15T00:00:00,Weight Loss,C23.888.144.243.963
19148126,2009-01-15T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19150094,2009-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19150094,2009-01-15T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19150094,2009-01-15T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19150094,2009-01-15T00:00:00,Postoperative Complications,C23.550.767
19150094,2009-01-15T00:00:00,Preoperative Care,E02.760.795
19150094,2009-01-15T00:00:00,Preoperative Care,E04.641
19150094,2009-01-15T00:00:00,Preoperative Care,N02.421.585.795
19150094,2009-01-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
19150094,2009-01-15T00:00:00,Risk Assessment,N04.452.871.715
19150094,2009-01-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19150094,2009-01-15T00:00:00,Risk Assessment,N06.850.505.715
19150094,2009-01-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19150094,2009-01-15T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
19150094,2009-01-15T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
19150094,2009-01-15T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
19150094,2009-01-15T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
19150094,2009-01-15T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
20643329,2009-01-15T00:00:00,Aged,M01.060.116.100
20643329,2009-01-15T00:00:00,Chronic Disease,C23.550.291.500
20643329,2009-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20643329,2009-01-15T00:00:00,Mass Screening,E01.370.500
20643329,2009-01-15T00:00:00,Mass Screening,E05.318.308.250.580
20643329,2009-01-15T00:00:00,Mass Screening,N02.421.143.827.233.443
20643329,2009-01-15T00:00:00,Mass Screening,N02.421.726.233.443
20643329,2009-01-15T00:00:00,Mass Screening,N05.715.360.300.375.500
20643329,2009-01-15T00:00:00,Mass Screening,N06.850.520.308.250.580
20643329,2009-01-15T00:00:00,Mass Screening,N06.850.780.500
20643329,2009-01-15T00:00:00,Pilot Projects,E05.318.760.750
20643329,2009-01-15T00:00:00,Pilot Projects,E05.337.737
20643329,2009-01-15T00:00:00,Pilot Projects,N05.715.360.775.625
20643329,2009-01-15T00:00:00,Pilot Projects,N06.850.520.450.720
20643329,2009-01-15T00:00:00,Venous Insufficiency,C14.907.952
19151105,2009-01-16T00:00:00,Adolescent,M01.060.057
19151105,2009-01-16T00:00:00,Adult,M01.060.116
19151105,2009-01-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19151105,2009-01-16T00:00:00,Interviews as Topic,E05.318.308.420
19151105,2009-01-16T00:00:00,Interviews as Topic,L01.280.520
19151105,2009-01-16T00:00:00,Interviews as Topic,N05.715.360.300.400
19151105,2009-01-16T00:00:00,Interviews as Topic,N06.850.520.308.420
19151105,2009-01-16T00:00:00,Middle Aged,M01.060.116.630
19151105,2009-01-16T00:00:00,Program Evaluation,E05.337.820
19151105,2009-01-16T00:00:00,Program Evaluation,N04.761.685
19151105,2009-01-16T00:00:00,Program Evaluation,N05.715.360.650
19151105,2009-01-16T00:00:00,Smoking,F01.145.466.753
19151105,2009-01-16T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19151105,2009-01-16T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19151105,2009-01-16T00:00:00,Young Adult,M01.060.116.815
19840594,2009-01-16T00:00:00,Adult,M01.060.116
19840594,2009-01-16T00:00:00,Age Factors,N05.715.350.075
19840594,2009-01-16T00:00:00,Age Factors,N06.850.490.250
19840594,2009-01-16T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19840594,2009-01-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19840594,2009-01-16T00:00:00,Personality,F01.752
19840594,2009-01-16T00:00:00,Psychiatric Status Rating Scales,F04.586
19840594,2009-01-16T00:00:00,Regression Analysis,E05.318.740.750
19840594,2009-01-16T00:00:00,Regression Analysis,N05.715.360.750.695
19840594,2009-01-16T00:00:00,Regression Analysis,N06.850.520.830.750
19231328,2009-01-17T00:00:00,African Americans,M01.686.508.100.100
19231328,2009-01-17T00:00:00,African Americans,M01.686.754.100
19231328,2009-01-17T00:00:00,Aged,M01.060.116.100
19231328,2009-01-17T00:00:00,Drug-Eluting Stents,E07.695.750.500
19231328,2009-01-17T00:00:00,Healthcare Disparities,N04.590.374.380
19231328,2009-01-17T00:00:00,Healthcare Disparities,N05.300.493
19231328,2009-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19231328,2009-01-17T00:00:00,Middle Aged,M01.060.116.630
19231328,2009-01-17T00:00:00,Myocardial Ischemia,C14.280.647
19231328,2009-01-17T00:00:00,Myocardial Ischemia,C14.907.585
19231328,2009-01-17T00:00:00,Risk Factors,E05.318.740.600.800.725
19231328,2009-01-17T00:00:00,Risk Factors,N05.715.350.200.700
19231328,2009-01-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19231328,2009-01-17T00:00:00,Risk Factors,N06.850.490.625.750
19231328,2009-01-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19231328,2009-01-17T00:00:00,Treatment Outcome,E01.789.800
19231328,2009-01-17T00:00:00,Treatment Outcome,N04.761.559.590.800
19231328,2009-01-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19327304,2009-01-17T00:00:00,Critical Illness,C23.550.291.625
19327304,2009-01-17T00:00:00,Echocardiography,E01.370.350.850.220
19327304,2009-01-17T00:00:00,Echocardiography,E01.370.370.380.220
19327304,2009-01-17T00:00:00,Heart Ventricles,A07.541.560
19327304,2009-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19327304,2009-01-17T00:00:00,Intensive Care Units,N02.278.388.493
19327304,2009-01-17T00:00:00,Middle Aged,M01.060.116.630
19327304,2009-01-17T00:00:00,Stroke Volume,E01.370.370.380.150.700
19327304,2009-01-17T00:00:00,Stroke Volume,G09.330.380.124.882
19327304,2009-01-17T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
19152959,2009-01-18T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
19152959,2009-01-18T00:00:00,"Diagnosis, Differential",E01.171
19152959,2009-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19152959,2009-01-18T00:00:00,"Lung Diseases, Interstitial",C08.381.483
19152959,2009-01-18T00:00:00,"Scleroderma, Systemic",C17.300.799
19152959,2009-01-18T00:00:00,"Scleroderma, Systemic",C17.800.784
19155049,2009-01-19T00:00:00,Child,M01.060.406
19155049,2009-01-19T00:00:00,"Databases, Factual",L01.470.750.750
19155049,2009-01-19T00:00:00,"Databases, Factual",L01.700.508.300.188.400
19155049,2009-01-19T00:00:00,Developmental Disabilities,F03.550.362
19155049,2009-01-19T00:00:00,Environmental Monitoring,N06.850.460.350.080
19155049,2009-01-19T00:00:00,Environmental Monitoring,N06.850.780.375
19155049,2009-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19155049,2009-01-19T00:00:00,Industrial Waste,D20.944.420
19155049,2009-01-19T00:00:00,Industrial Waste,D27.888.284.404
19155049,2009-01-19T00:00:00,Industrial Waste,N06.850.460.710.420
19155049,2009-01-19T00:00:00,Metals,D01.552
19155049,2009-01-19T00:00:00,Soil Pollutants,D27.888.284.756
19158958,2009-01-19T00:00:00,Apoptosis,G04.299.139.160
19158958,2009-01-19T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
19158958,2009-01-19T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
19158958,2009-01-19T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
19158958,2009-01-19T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
19158958,2009-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19158958,2009-01-19T00:00:00,"Lipoproteins, LDL",D10.532.515
19158958,2009-01-19T00:00:00,"Lipoproteins, LDL",D12.776.521.550
19158958,2009-01-19T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
19158958,2009-01-19T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
19158958,2009-01-19T00:00:00,MAP Kinase Signaling System,G03.495.553.560
19158958,2009-01-19T00:00:00,MAP Kinase Signaling System,G04.299.880.560
19158958,2009-01-19T00:00:00,Phosphorylation,G02.111.087.677
19158958,2009-01-19T00:00:00,Phosphorylation,G02.149.115.677
19158958,2009-01-19T00:00:00,Phosphorylation,G02.149.465.700
19158958,2009-01-19T00:00:00,Phosphorylation,G02.607.750.700
19158958,2009-01-19T00:00:00,Phosphorylation,G03.495.790
19158958,2009-01-19T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19158958,2009-01-19T00:00:00,Pyridines,D03.383.725
19158958,2009-01-19T00:00:00,Retinal Vessels,A07.231.611
19158958,2009-01-19T00:00:00,Time Factors,G01.910.857
19158958,2009-01-19T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
19158958,2009-01-19T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
19158958,2009-01-19T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
19158958,2009-01-19T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
19153477,2009-01-20T00:00:00,African Americans,M01.686.508.100.100
19153477,2009-01-20T00:00:00,African Americans,M01.686.754.100
19153477,2009-01-20T00:00:00,Albuminuria,C12.777.934.734.269
19153477,2009-01-20T00:00:00,Albuminuria,C13.351.968.934.734.269
19153477,2009-01-20T00:00:00,Albuminuria,C23.888.942.750.269
19153477,2009-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19153477,2009-01-20T00:00:00,Hypertension,C14.907.489
19153477,2009-01-20T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19153477,2009-01-20T00:00:00,United States,Z01.107.567.875
19154609,2009-01-20T00:00:00,Bias (Epidemiology),N05.715.350.150
19154609,2009-01-20T00:00:00,Bias (Epidemiology),N06.850.490.500
19154609,2009-01-20T00:00:00,Decision Support Techniques,E05.245
19154609,2009-01-20T00:00:00,Decision Support Techniques,L01.700.508.190
19154609,2009-01-20T00:00:00,Early Detection of Cancer,E01.390.500
19154609,2009-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19154609,2009-01-20T00:00:00,Mass Screening,E01.370.500
19154609,2009-01-20T00:00:00,Mass Screening,E05.318.308.250.580
19154609,2009-01-20T00:00:00,Mass Screening,N02.421.143.827.233.443
19154609,2009-01-20T00:00:00,Mass Screening,N02.421.726.233.443
19154609,2009-01-20T00:00:00,Mass Screening,N05.715.360.300.375.500
19154609,2009-01-20T00:00:00,Mass Screening,N06.850.520.308.250.580
19154609,2009-01-20T00:00:00,Mass Screening,N06.850.780.500
19154609,2009-01-20T00:00:00,"Models, Statistical",E05.318.740.500
19154609,2009-01-20T00:00:00,"Models, Statistical",E05.599.835
19154609,2009-01-20T00:00:00,"Models, Statistical",N05.715.360.750.530
19154609,2009-01-20T00:00:00,"Models, Statistical",N06.850.520.830.500
19157986,2009-01-20T00:00:00,Animals,B01.050
19157986,2009-01-20T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19157986,2009-01-20T00:00:00,Brain,A08.186.211
19157986,2009-01-20T00:00:00,Cocaine,D02.145.074.722.388
19157986,2009-01-20T00:00:00,Cocaine,D03.132.889.354
19157986,2009-01-20T00:00:00,Cocaine,D03.605.869.388
19157986,2009-01-20T00:00:00,Cocaine,D04.075.080.875.099.722.388
19157986,2009-01-20T00:00:00,Ethanol,D02.033.375
19157986,2009-01-20T00:00:00,Glutamic Acid,D12.125.067.750
19157986,2009-01-20T00:00:00,Glutamic Acid,D12.125.119.450
19157986,2009-01-20T00:00:00,Glutamic Acid,D12.125.427.300
19157986,2009-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19157986,2009-01-20T00:00:00,Nicotine,D03.132.760.570
19157986,2009-01-20T00:00:00,Nicotine,D03.383.725.518
19157986,2009-01-20T00:00:00,Substance-Related Disorders,C21.739
19157986,2009-01-20T00:00:00,Substance-Related Disorders,F03.900
19157986,2009-01-20T00:00:00,Synaptic Transmission,G02.111.087.800.850
19157986,2009-01-20T00:00:00,Synaptic Transmission,G02.149.115.800.850
19157986,2009-01-20T00:00:00,Synaptic Transmission,G04.299.880.850
19157986,2009-01-20T00:00:00,Synaptic Transmission,G07.265.337.900
19157986,2009-01-20T00:00:00,Synaptic Transmission,G07.700.240.900
19157986,2009-01-20T00:00:00,Synaptic Transmission,G11.561.600.835
19457353,2009-01-20T00:00:00,Biological Markers,D23.101
19457353,2009-01-20T00:00:00,Body Fluids,A12.207
19457353,2009-01-20T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
19457353,2009-01-20T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
19457353,2009-01-20T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
19457353,2009-01-20T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
19457353,2009-01-20T00:00:00,Epithelial Cells,A11.436
19457353,2009-01-20T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19457353,2009-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19457353,2009-01-20T00:00:00,Prostatic Diseases,C12.294.565
19457353,2009-01-20T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19457353,2009-01-20T00:00:00,Prostatic Neoplasms,C12.294.260.750
19457353,2009-01-20T00:00:00,Prostatic Neoplasms,C12.294.565.625
19457353,2009-01-20T00:00:00,Prostatic Neoplasms,C12.758.409.750
19457353,2009-01-20T00:00:00,Proteomics,H01.158.201.843
19457353,2009-01-20T00:00:00,Proteomics,H01.158.273.180.350.700
19457353,2009-01-20T00:00:00,Proteomics,H01.158.273.343.350.700
19457353,2009-01-20T00:00:00,Proteomics,H01.181.122.738
19457353,2009-01-20T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19457353,2009-01-20T00:00:00,Time Factors,G01.910.857
19158081,2009-01-21T00:00:00,Antineoplastic Agents,D27.505.954.248
19158081,2009-01-21T00:00:00,Cell Cycle Proteins,D12.776.167
19158081,2009-01-21T00:00:00,Cell Division,G04.299.134.220
19158081,2009-01-21T00:00:00,Cell Division,G04.299.233.750.500
19158081,2009-01-21T00:00:00,Cell Division,G05.355.105
19158081,2009-01-21T00:00:00,Cell Division,G07.700.320.249.410.750.500
19158081,2009-01-21T00:00:00,DNA Damage,C21.111
19158081,2009-01-21T00:00:00,DNA Damage,G05.355.180
19158081,2009-01-21T00:00:00,Mutation,G05.365.590
19158081,2009-01-21T00:00:00,Phosphorylation,G02.111.087.677
19158081,2009-01-21T00:00:00,Phosphorylation,G02.149.115.677
19158081,2009-01-21T00:00:00,Phosphorylation,G02.149.465.700
19158081,2009-01-21T00:00:00,Phosphorylation,G02.607.750.700
19158081,2009-01-21T00:00:00,Phosphorylation,G03.495.790
19158081,2009-01-21T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
19158081,2009-01-21T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
19158081,2009-01-21T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
19158081,2009-01-21T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
19158081,2009-01-21T00:00:00,Signal Transduction,G02.111.087.800
19158081,2009-01-21T00:00:00,Signal Transduction,G02.149.115.800
19158081,2009-01-21T00:00:00,Signal Transduction,G04.299.880
19158226,2009-01-21T00:00:00,Adult,M01.060.116
19158226,2009-01-21T00:00:00,Cholecalciferol,D04.808.247.222.159
19158226,2009-01-21T00:00:00,Cholecalciferol,D04.808.247.808.146
19158226,2009-01-21T00:00:00,Cholecalciferol,D04.808.812.768.196
19158226,2009-01-21T00:00:00,Cholecalciferol,D10.570.938.146
19158226,2009-01-21T00:00:00,Dietary Supplements,J02.500.456
19158226,2009-01-21T00:00:00,Double-Blind Method,E05.318.780.300
19158226,2009-01-21T00:00:00,Double-Blind Method,E05.581.500.300
19158226,2009-01-21T00:00:00,Double-Blind Method,N05.715.360.780.320
19158226,2009-01-21T00:00:00,Double-Blind Method,N06.850.520.445.300
19158226,2009-01-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19158226,2009-01-21T00:00:00,Vitamin D,D04.808.812.768
19158226,2009-01-21T00:00:00,Young Adult,M01.060.116.815
19158677,2009-01-21T00:00:00,Animals,B01.050
19158677,2009-01-21T00:00:00,"Animals, Newborn",B01.050.050.282
19158677,2009-01-21T00:00:00,Calcium Signaling,G02.111.087.800.800.100
19158677,2009-01-21T00:00:00,Calcium Signaling,G02.149.115.800.800.100
19158677,2009-01-21T00:00:00,Calcium Signaling,G03.495.166.500.100
19158677,2009-01-21T00:00:00,Calcium Signaling,G04.299.880.800.100
19158677,2009-01-21T00:00:00,"Models, Neurological",E05.599.395.642
19158677,2009-01-21T00:00:00,Photic Stimulation,E05.723.729
19158677,2009-01-21T00:00:00,Visual Cortex,A08.186.211.730.885.287.500.571.735
19158677,2009-01-21T00:00:00,Visual Pathways,A08.612.220.860
19164583,2009-01-21T00:00:00,Animals,B01.050
19164583,2009-01-21T00:00:00,Brain Infarction,C10.228.140.300.150.477
19164583,2009-01-21T00:00:00,Brain Infarction,C10.228.140.300.775.200
19164583,2009-01-21T00:00:00,Brain Infarction,C14.907.253.092.477
19164583,2009-01-21T00:00:00,Brain Infarction,C14.907.253.855.200
19164583,2009-01-21T00:00:00,Cell Death,G04.299.139
19164583,2009-01-21T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
19164583,2009-01-21T00:00:00,"Disease Models, Animal",C22.232
19164583,2009-01-21T00:00:00,"Disease Models, Animal",E05.598.500
19164583,2009-01-21T00:00:00,"Disease Models, Animal",E05.599.395.080
19164583,2009-01-21T00:00:00,Dopamine,D02.092.211.215.311.342
19164583,2009-01-21T00:00:00,Dopamine,D02.092.311.342
19164583,2009-01-21T00:00:00,Gene Expression Regulation,G05.355.315
19164583,2009-01-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19164583,2009-01-21T00:00:00,Mesencephalon,A08.186.211.132.659
19164583,2009-01-21T00:00:00,Mesencephalon,A08.186.211.653
19164583,2009-01-21T00:00:00,Neurons,A08.663
19164583,2009-01-21T00:00:00,Neurons,A11.671
19164583,2009-01-21T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19164583,2009-01-21T00:00:00,Parkinson Disease,C10.228.662.600.400
19164583,2009-01-21T00:00:00,Parkinson Disease,C10.574.812
19164583,2009-01-21T00:00:00,Peptides,D12.644
19164583,2009-01-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19164583,2009-01-21T00:00:00,Stroke,C10.228.140.300.775
19164583,2009-01-21T00:00:00,Stroke,C14.907.253.855
19164583,2009-01-21T00:00:00,Treatment Outcome,E01.789.800
19164583,2009-01-21T00:00:00,Treatment Outcome,N04.761.559.590.800
19164583,2009-01-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19160043,2009-01-22T00:00:00,Adolescent,M01.060.057
19160043,2009-01-22T00:00:00,Adult,M01.060.116
19160043,2009-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19160043,2009-01-22T00:00:00,Life Style,F01.829.458
19160043,2009-01-22T00:00:00,Middle Aged,M01.060.116.630
19160043,2009-01-22T00:00:00,Peptic Ulcer,C06.405.469.275.800
19160043,2009-01-22T00:00:00,Peptic Ulcer,C06.405.608
19160043,2009-01-22T00:00:00,Peptic Ulcer,C06.405.748.586
19160043,2009-01-22T00:00:00,Risk Factors,E05.318.740.600.800.725
19160043,2009-01-22T00:00:00,Risk Factors,N05.715.350.200.700
19160043,2009-01-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19160043,2009-01-22T00:00:00,Risk Factors,N06.850.490.625.750
19160043,2009-01-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19160043,2009-01-22T00:00:00,United States,Z01.107.567.875
19160043,2009-01-22T00:00:00,Young Adult,M01.060.116.815
19160049,2009-01-22T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
19160049,2009-01-22T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
19160049,2009-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19160049,2009-01-22T00:00:00,Questionnaires,E05.318.308.750
19160049,2009-01-22T00:00:00,Questionnaires,L01.280.800
19160049,2009-01-22T00:00:00,Questionnaires,N05.715.360.300.695
19160049,2009-01-22T00:00:00,Questionnaires,N06.850.520.308.750
19160049,2009-01-22T00:00:00,United States,Z01.107.567.875
19167178,2009-01-22T00:00:00,Adult,M01.060.116
19167178,2009-01-22T00:00:00,Aged,M01.060.116.100
19167178,2009-01-22T00:00:00,Contrast Media,D27.720.259
19167178,2009-01-22T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19167178,2009-01-22T00:00:00,Coronary Angiography,E01.370.370.050.200
19167178,2009-01-22T00:00:00,Coronary Angiography,E01.370.370.380.200
19167178,2009-01-22T00:00:00,Coronary Disease,C14.280.647.250
19167178,2009-01-22T00:00:00,Coronary Disease,C14.907.585.250
19167178,2009-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19167178,2009-01-22T00:00:00,Middle Aged,M01.060.116.630
19167178,2009-01-22T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19167178,2009-01-22T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19167178,2009-01-22T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19167178,2009-01-22T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19167178,2009-01-22T00:00:00,Regression Analysis,E05.318.740.750
19167178,2009-01-22T00:00:00,Regression Analysis,N05.715.360.750.695
19167178,2009-01-22T00:00:00,Regression Analysis,N06.850.520.830.750
19167178,2009-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19167178,2009-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19167178,2009-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19167178,2009-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19167178,2009-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19208563,2009-01-22T00:00:00,Adult,M01.060.116
19208563,2009-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19208563,2009-01-22T00:00:00,"Hypertension, Pulmonary",C08.381.423
19208563,2009-01-22T00:00:00,Ischemia,C23.550.513
19208563,2009-01-22T00:00:00,"Lung Diseases, Interstitial",C08.381.483
19208563,2009-01-22T00:00:00,Middle Aged,M01.060.116.630
19208563,2009-01-22T00:00:00,Pain,C10.597.617
19208563,2009-01-22T00:00:00,Pain,C23.888.592.612
19208563,2009-01-22T00:00:00,Pain,C23.888.646
19208563,2009-01-22T00:00:00,Pain,F02.830.816.444
19208563,2009-01-22T00:00:00,Pain,G11.561.600.810.444
19208563,2009-01-22T00:00:00,Physical Endurance,G11.427.680
19208563,2009-01-22T00:00:00,Physical Endurance,I03.450.642.845.054.600
19208563,2009-01-22T00:00:00,Respiratory Physiological Phenomena,G09.772
19208563,2009-01-22T00:00:00,"Scleroderma, Systemic",C17.300.799
19208563,2009-01-22T00:00:00,"Scleroderma, Systemic",C17.800.784
19208563,2009-01-22T00:00:00,Time Factors,G01.910.857
19208563,2009-01-22T00:00:00,Walking,G11.427.590.530.568.900
19208563,2009-01-22T00:00:00,Walking,G11.427.590.530.698.940
19208563,2009-01-22T00:00:00,Walking,I03.450.642.845.940
19167799,2009-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19167799,2009-01-23T00:00:00,Hypertension,C14.907.489
19167799,2009-01-23T00:00:00,Kidney,A05.810.453
19167799,2009-01-23T00:00:00,Kidney Diseases,C12.777.419
19167799,2009-01-23T00:00:00,Kidney Diseases,C13.351.968.419
19167799,2009-01-23T00:00:00,Middle Aged,M01.060.116.630
19168701,2009-01-23T00:00:00,Animals,B01.050
19168701,2009-01-23T00:00:00,Apoptosis,G04.299.139.160
19168701,2009-01-23T00:00:00,Cell Line,A11.251.210
19168701,2009-01-23T00:00:00,Cystic Fibrosis,C06.689.202
19168701,2009-01-23T00:00:00,Cystic Fibrosis,C08.381.187
19168701,2009-01-23T00:00:00,Cystic Fibrosis,C16.320.190
19168701,2009-01-23T00:00:00,Cystic Fibrosis,C16.614.213
19168701,2009-01-23T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.157.530.400.175.125
19168701,2009-01-23T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.550.425.175.125
19168701,2009-01-23T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.585.400.175.125
19168701,2009-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19168701,2009-01-23T00:00:00,Pseudomonas Infections,C01.252.400.739
19168701,2009-01-23T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
19168701,2009-01-23T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
19168701,2009-01-23T00:00:00,RNA Interference,G05.355.315.203.374.790
19168701,2009-01-23T00:00:00,Signal Transduction,G02.111.087.800
19168701,2009-01-23T00:00:00,Signal Transduction,G02.149.115.800
19168701,2009-01-23T00:00:00,Signal Transduction,G04.299.880
19168701,2009-01-23T00:00:00,Sphingolipids,D10.570.877
19168701,2009-01-23T00:00:00,Sphingolipids,D10.808
19168701,2009-01-23T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
19660318,2009-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19660318,2009-01-23T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
19660318,2009-01-23T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
19660318,2009-01-23T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
19660318,2009-01-23T00:00:00,"Infant, Newborn",M01.060.703.520
19168204,2009-01-24T00:00:00,Animals,B01.050
19168204,2009-01-24T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
19168204,2009-01-24T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
19168204,2009-01-24T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
19168204,2009-01-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19168204,2009-01-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19168204,2009-01-24T00:00:00,Urinary Bladder,A05.810.890
19268735,2009-01-24T00:00:00,Aged,M01.060.116.100
19268735,2009-01-24T00:00:00,Drug-Eluting Stents,E07.695.750.500
19268735,2009-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19268735,2009-01-24T00:00:00,Middle Aged,M01.060.116.630
19268735,2009-01-24T00:00:00,Myocardial Infarction,C14.280.647.500
19268735,2009-01-24T00:00:00,Myocardial Infarction,C14.907.585.500
19268735,2009-01-24T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19268735,2009-01-24T00:00:00,Risk Factors,E05.318.740.600.800.725
19268735,2009-01-24T00:00:00,Risk Factors,N05.715.350.200.700
19268735,2009-01-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19268735,2009-01-24T00:00:00,Risk Factors,N06.850.490.625.750
19268735,2009-01-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19268735,2009-01-24T00:00:00,Ticlopidine,D02.886.778.834
19268735,2009-01-24T00:00:00,Ticlopidine,D03.383.903.834
19268735,2009-01-24T00:00:00,Time Factors,G01.910.857
19268735,2009-01-24T00:00:00,Treatment Outcome,E01.789.800
19268735,2009-01-24T00:00:00,Treatment Outcome,N04.761.559.590.800
19268735,2009-01-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19375723,2009-01-24T00:00:00,Animals,B01.050
19375723,2009-01-24T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
19375723,2009-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
19375723,2009-01-24T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19375723,2009-01-24T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19375723,2009-01-24T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19375723,2009-01-24T00:00:00,"RNA, Messenger",D13.444.735.544
19375723,2009-01-24T00:00:00,Rabbits,B01.050.150.900.649.521.700
19375723,2009-01-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19375723,2009-01-24T00:00:00,"Stress, Mechanical",G01.374.676.830
19375723,2009-01-24T00:00:00,"Stress, Mechanical",G01.595.540.830
19171720,2009-01-26T00:00:00,Aged,M01.060.116.100
19171720,2009-01-26T00:00:00,Bariatric Surgery,E02.065.062
19171720,2009-01-26T00:00:00,Bariatric Surgery,E04.062
19171720,2009-01-26T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19171720,2009-01-26T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19171720,2009-01-26T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19171720,2009-01-26T00:00:00,Health Care Costs,N03.219.151.400
19171720,2009-01-26T00:00:00,Health Care Costs,N05.300.375
19171720,2009-01-26T00:00:00,Health Status,I01.240.425
19171720,2009-01-26T00:00:00,Health Status,N01.224.425
19171720,2009-01-26T00:00:00,Health Status,N06.850.505.400.425
19171720,2009-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19171720,2009-01-26T00:00:00,Middle Aged,M01.060.116.630
19171720,2009-01-26T00:00:00,"Obesity, Morbid",C18.654.726.500.700
19171720,2009-01-26T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
19171720,2009-01-26T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
19171720,2009-01-26T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
19171720,2009-01-26T00:00:00,Questionnaires,E05.318.308.750
19171720,2009-01-26T00:00:00,Questionnaires,L01.280.800
19171720,2009-01-26T00:00:00,Questionnaires,N05.715.360.300.695
19171720,2009-01-26T00:00:00,Questionnaires,N06.850.520.308.750
19171720,2009-01-26T00:00:00,Weight Loss,C23.888.144.243.963
19171720,2009-01-26T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19171726,2009-01-26T00:00:00,Bariatric Surgery,E02.065.062
19171726,2009-01-26T00:00:00,Bariatric Surgery,E04.062
19171726,2009-01-26T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19171726,2009-01-26T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19171726,2009-01-26T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19171726,2009-01-26T00:00:00,Drug Therapy,E02.319
19171726,2009-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19171726,2009-01-26T00:00:00,Obesity,C18.654.726.500
19171726,2009-01-26T00:00:00,Obesity,C23.888.144.699.500
19171726,2009-01-26T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19171726,2009-01-26T00:00:00,Obesity,G07.100.100.160.120.699.500
19171726,2009-01-26T00:00:00,Time Factors,G01.910.857
19171726,2009-01-26T00:00:00,Weight Loss,C23.888.144.243.963
19171726,2009-01-26T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19176247,2009-01-26T00:00:00,Animals,B01.050
19176247,2009-01-26T00:00:00,Computer Simulation,L01.224.160
19176247,2009-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19176247,2009-01-26T00:00:00,Prostheses and Implants,E07.695
19176247,2009-01-26T00:00:00,"Spheroids, Cellular",A11.251.800
19176247,2009-01-26T00:00:00,Tissue Engineering,E05.200.249.750
19171871,2009-01-27T00:00:00,Heart Diseases,C14.280
19171871,2009-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19171871,2009-01-27T00:00:00,Stroke,C10.228.140.300.775
19171871,2009-01-27T00:00:00,Stroke,C14.907.253.855
19171871,2009-01-27T00:00:00,United States,Z01.107.567.875
19174499,2009-01-27T00:00:00,Body Mass Index,E01.370.600.115.100.125
19174499,2009-01-27T00:00:00,Body Mass Index,E05.041.124.125
19174499,2009-01-27T00:00:00,Body Mass Index,G07.100.100.125
19174499,2009-01-27T00:00:00,Body Mass Index,N06.850.505.200.100.175
19174499,2009-01-27T00:00:00,C-Reactive Protein,D12.776.034.145
19174499,2009-01-27T00:00:00,C-Reactive Protein,D12.776.124.050.120
19174499,2009-01-27T00:00:00,C-Reactive Protein,D12.776.124.486.157
19174499,2009-01-27T00:00:00,Estradiol,D04.808.365.415.248
19174499,2009-01-27T00:00:00,Estradiol,D06.472.334.851.437.500
19174499,2009-01-27T00:00:00,Gastric Bypass,E02.065.062.249
19174499,2009-01-27T00:00:00,Gastric Bypass,E04.035.398.385
19174499,2009-01-27T00:00:00,Gastric Bypass,E04.062.249
19174499,2009-01-27T00:00:00,Gastric Bypass,E04.210.457.430
19174499,2009-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19174499,2009-01-27T00:00:00,Luteinizing Hormone,D06.472.699.322.576.463
19174499,2009-01-27T00:00:00,Luteinizing Hormone,D06.472.699.631.525.343.463
19174499,2009-01-27T00:00:00,Luteinizing Hormone,D12.644.548.691.525.343.463
19174499,2009-01-27T00:00:00,"Obesity, Morbid",C18.654.726.500.700
19174499,2009-01-27T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
19174499,2009-01-27T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
19174499,2009-01-27T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
19174499,2009-01-27T00:00:00,Sexual Behavior,F01.145.802
19174499,2009-01-27T00:00:00,Testosterone,D04.808.054.079.429.824
19174499,2009-01-27T00:00:00,Testosterone,D06.472.334.851.968.984
19174499,2009-01-27T00:00:00,Weight Loss,C23.888.144.243.963
19174499,2009-01-27T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19176383,2009-01-27T00:00:00,Adenocarcinoma,C04.557.470.200.025
19176383,2009-01-27T00:00:00,"Antigens, CD",D23.050.301.264.035
19176383,2009-01-27T00:00:00,"Antigens, CD",D23.101.100.110
19176383,2009-01-27T00:00:00,"Antigens, CD147",D12.776.395.550.045
19176383,2009-01-27T00:00:00,"Antigens, CD147",D12.776.543.550.188
19176383,2009-01-27T00:00:00,"Antigens, CD147",D23.050.285.040
19176383,2009-01-27T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
19176383,2009-01-27T00:00:00,"Antigens, CD147",D23.101.100.110.247
19176383,2009-01-27T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
19176383,2009-01-27T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
19176383,2009-01-27T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
19176383,2009-01-27T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
19176383,2009-01-27T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
19176383,2009-01-27T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
19176383,2009-01-27T00:00:00,Biological Transport,G03.495.166
19176383,2009-01-27T00:00:00,Breast Neoplasms,C04.588.180
19176383,2009-01-27T00:00:00,Breast Neoplasms,C17.800.090.500
19176383,2009-01-27T00:00:00,Cell Membrane,A11.284.149
19176383,2009-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19176383,2009-01-27T00:00:00,Hyaluronic Acid,D09.698.373.475
19176383,2009-01-27T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19176383,2009-01-27T00:00:00,"Microscopy, Confocal",E05.595.395
19176383,2009-01-27T00:00:00,Neoplasm Proteins,D12.776.624
19184557,2009-01-28T00:00:00,Adolescent,M01.060.057
19184557,2009-01-28T00:00:00,Adult,M01.060.116
19184557,2009-01-28T00:00:00,Aged,M01.060.116.100
19184557,2009-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19184557,2009-01-28T00:00:00,Intensive Care,E02.760.190.400
19184557,2009-01-28T00:00:00,Intensive Care,N02.421.585.190.400
19184557,2009-01-28T00:00:00,Middle Aged,M01.060.116.630
19184557,2009-01-28T00:00:00,Risk Factors,E05.318.740.600.800.725
19184557,2009-01-28T00:00:00,Risk Factors,N05.715.350.200.700
19184557,2009-01-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19184557,2009-01-28T00:00:00,Risk Factors,N06.850.490.625.750
19184557,2009-01-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19184557,2009-01-28T00:00:00,Ventilator Weaning,E02.880.820.950
19184557,2009-01-28T00:00:00,Young Adult,M01.060.116.815
19127121,2009-01-29T00:00:00,Animals,B01.050
19127121,2009-01-29T00:00:00,Antineoplastic Agents,D27.505.954.248
19127121,2009-01-29T00:00:00,Apoptosis,G04.299.139.160
19127121,2009-01-29T00:00:00,Cell Division,G04.299.134.220
19127121,2009-01-29T00:00:00,Cell Division,G04.299.233.750.500
19127121,2009-01-29T00:00:00,Cell Division,G05.355.105
19127121,2009-01-29T00:00:00,Cell Division,G07.700.320.249.410.750.500
19127121,2009-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19127121,2009-01-29T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19127121,2009-01-29T00:00:00,Prostatic Neoplasms,C12.294.260.750
19127121,2009-01-29T00:00:00,Prostatic Neoplasms,C12.294.565.625
19127121,2009-01-29T00:00:00,Prostatic Neoplasms,C12.758.409.750
19127121,2009-01-29T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
19127121,2009-01-29T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
19127121,2009-01-29T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
19127121,2009-01-29T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
19127121,2009-01-29T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
19127121,2009-01-29T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
19179331,2009-01-29T00:00:00,Animals,B01.050
19179331,2009-01-29T00:00:00,Carbon,D01.268.150
19179331,2009-01-29T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
19179331,2009-01-29T00:00:00,Ethanol,D02.033.375
19179331,2009-01-29T00:00:00,"Gene Expression Regulation, Fungal",G05.355.315.330
19179331,2009-01-29T00:00:00,Glucose,D09.546.359.448
19179331,2009-01-29T00:00:00,Microarray Analysis,E05.196.630.570
19179331,2009-01-29T00:00:00,Microarray Analysis,E05.588.570
19179331,2009-01-29T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19179331,2009-01-29T00:00:00,Mitochondria,A11.284.835.626
19179331,2009-01-29T00:00:00,Molecular Sequence Data,L01.453.245.667
19179331,2009-01-29T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
19179331,2009-01-29T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
19179331,2009-01-29T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
19179486,2009-01-29T00:00:00,Adolescent,M01.060.057
19179486,2009-01-29T00:00:00,Asthma,C08.127.108
19179486,2009-01-29T00:00:00,Asthma,C08.381.495.108
19179486,2009-01-29T00:00:00,Asthma,C08.674.095
19179486,2009-01-29T00:00:00,Asthma,C20.543.480.680.095
19179486,2009-01-29T00:00:00,Biological Markers,D23.101
19179486,2009-01-29T00:00:00,Child,M01.060.406
19179486,2009-01-29T00:00:00,Hospitalization,E02.760.400
19179486,2009-01-29T00:00:00,Hospitalization,N02.421.585.400
19179486,2009-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19179486,2009-01-29T00:00:00,Vitamin D,D04.808.812.768
19217788,2009-01-31T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
19217788,2009-01-31T00:00:00,Amides,D02.065
19217788,2009-01-31T00:00:00,Antineoplastic Agents,D27.505.954.248
19217788,2009-01-31T00:00:00,Enzyme Inhibitors,D27.505.519.389
19217788,2009-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19217788,2009-01-31T00:00:00,Propanolamines,D02.033.100.624
19217788,2009-01-31T00:00:00,Propanolamines,D02.033.755.624
19217788,2009-01-31T00:00:00,Propanolamines,D02.092.063.624
19306822,2009-01-31T00:00:00,Gastric Bypass,E02.065.062.249
19306822,2009-01-31T00:00:00,Gastric Bypass,E04.035.398.385
19306822,2009-01-31T00:00:00,Gastric Bypass,E04.062.249
19306822,2009-01-31T00:00:00,Gastric Bypass,E04.210.457.430
19306822,2009-01-31T00:00:00,Health Status,I01.240.425
19306822,2009-01-31T00:00:00,Health Status,N01.224.425
19306822,2009-01-31T00:00:00,Health Status,N06.850.505.400.425
19306822,2009-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19306822,2009-01-31T00:00:00,Middle Aged,M01.060.116.630
19306822,2009-01-31T00:00:00,"Obesity, Morbid",C18.654.726.500.700
19306822,2009-01-31T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
19306822,2009-01-31T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
19306822,2009-01-31T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
19306822,2009-01-31T00:00:00,Quality of Life,I01.800
19306822,2009-01-31T00:00:00,Quality of Life,K01.752.400.750
19306822,2009-01-31T00:00:00,Questionnaires,E05.318.308.750
19306822,2009-01-31T00:00:00,Questionnaires,L01.280.800
19306822,2009-01-31T00:00:00,Questionnaires,N05.715.360.300.695
19306822,2009-01-31T00:00:00,Questionnaires,N06.850.520.308.750
19306822,2009-01-31T00:00:00,Time Factors,G01.910.857
19306822,2009-01-31T00:00:00,Treatment Outcome,E01.789.800
19306822,2009-01-31T00:00:00,Treatment Outcome,N04.761.559.590.800
19306822,2009-01-31T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19306822,2009-01-31T00:00:00,Weight Loss,C23.888.144.243.963
19306822,2009-01-31T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18792848,2009-02-01T00:00:00,Adult,M01.060.116
18792848,2009-02-01T00:00:00,Age of Onset,N05.715.350.075.100
18792848,2009-02-01T00:00:00,Age of Onset,N06.850.490.250.100
18792848,2009-02-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
18792848,2009-02-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
18792848,2009-02-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
18792848,2009-02-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
18792848,2009-02-01T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
18792848,2009-02-01T00:00:00,Ethnic Groups,M01.686.754
18792848,2009-02-01T00:00:00,Ethnic Groups,N01.224.317
18792848,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18792848,2009-02-01T00:00:00,Military Personnel,M01.526.625
18792848,2009-02-01T00:00:00,Veterans,M01.930
19128049,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19128049,2009-02-01T00:00:00,Molecular Sequence Data,L01.453.245.667
19128049,2009-02-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
19128049,2009-02-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
19128049,2009-02-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
19128049,2009-02-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
19128049,2009-02-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
19128049,2009-02-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19128049,2009-02-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
19128049,2009-02-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
19128049,2009-02-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
19128049,2009-02-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19128049,2009-02-01T00:00:00,"Tumor Markers, Biological",D23.101.840
19131739,2009-02-01T00:00:00,Animals,B01.050
19131739,2009-02-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
19131739,2009-02-01T00:00:00,Fibrosis,C23.550.355
19131739,2009-02-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19131739,2009-02-01T00:00:00,Lung Neoplasms,C08.381.540
19131739,2009-02-01T00:00:00,Lung Neoplasms,C08.785.520
19131739,2009-02-01T00:00:00,Plutonium,D01.268.033.700
19131739,2009-02-01T00:00:00,Plutonium,D01.268.271.100.700
19131739,2009-02-01T00:00:00,Plutonium,D01.268.556.700
19131739,2009-02-01T00:00:00,Plutonium,D01.552.020.734
19131739,2009-02-01T00:00:00,Plutonium,D01.552.544.700
19131739,2009-02-01T00:00:00,Probability,E05.318.740.600
19131739,2009-02-01T00:00:00,Probability,G17.680
19131739,2009-02-01T00:00:00,Probability,N05.715.360.750.625
19131739,2009-02-01T00:00:00,Probability,N06.850.520.830.600
19131739,2009-02-01T00:00:00,Radiation Dosage,E05.799.513
19131739,2009-02-01T00:00:00,Radiation Dosage,G01.201.875.740
19131739,2009-02-01T00:00:00,Radiation Dosage,N06.850.810.250
19131739,2009-02-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19131739,2009-02-01T00:00:00,Risk Assessment,N04.452.871.715
19131739,2009-02-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19131739,2009-02-01T00:00:00,Risk Assessment,N06.850.505.715
19131739,2009-02-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19131739,2009-02-01T00:00:00,Time Factors,G01.910.857
19151263,2009-02-01T00:00:00,Animals,B01.050
19151263,2009-02-01T00:00:00,Aprotinin,D12.776.083
19151263,2009-02-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
19151263,2009-02-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
19151263,2009-02-01T00:00:00,Cytokines,D12.644.276.374
19151263,2009-02-01T00:00:00,Cytokines,D12.776.467.374
19151263,2009-02-01T00:00:00,Cytokines,D23.529.374
19151263,2009-02-01T00:00:00,Hemodynamics,G09.330.190.400
19151263,2009-02-01T00:00:00,Hemodynamics,G09.330.380
19151263,2009-02-01T00:00:00,Myocardial Contraction,G09.330.190.541
19151263,2009-02-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19151263,2009-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19151263,2009-02-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
19155409,2009-02-01T00:00:00,Adult,M01.060.116
19155409,2009-02-01T00:00:00,Aged,M01.060.116.100
19155409,2009-02-01T00:00:00,Catecholamines,D02.092.211.215.311
19155409,2009-02-01T00:00:00,Catecholamines,D02.092.311
19155409,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19155409,2009-02-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19155409,2009-02-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19155409,2009-02-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19155409,2009-02-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
19155409,2009-02-01T00:00:00,Middle Aged,M01.060.116.630
19155409,2009-02-01T00:00:00,Protons,D01.248.497.300.459.700
19155409,2009-02-01T00:00:00,Protons,D01.435.550
19155409,2009-02-01T00:00:00,Protons,G01.249.765
19161168,2009-02-01T00:00:00,Adult,M01.060.116
19161168,2009-02-01T00:00:00,Brain,A08.186.211
19161168,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19161168,2009-02-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19161168,2009-02-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19161168,2009-02-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19161168,2009-02-01T00:00:00,Iron,D01.268.556.412
19161168,2009-02-01T00:00:00,Iron,D01.268.956.287
19161168,2009-02-01T00:00:00,Iron,D01.552.544.412
19161168,2009-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19161168,2009-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19161168,2009-02-01T00:00:00,Magnetics,H01.671.493
19161168,2009-02-01T00:00:00,Middle Aged,M01.060.116.630
19161222,2009-02-01T00:00:00,Animals,B01.050
19161222,2009-02-01T00:00:00,Cell Proliferation,G04.299.233.750
19161222,2009-02-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19161222,2009-02-01T00:00:00,Chickens,B01.050.150.900.248.350.150
19161222,2009-02-01T00:00:00,Chickens,B01.050.150.900.248.617.192
19161222,2009-02-01T00:00:00,Collagen,D05.750.078.280
19161222,2009-02-01T00:00:00,Collagen,D12.776.860.300.250
19161222,2009-02-01T00:00:00,Coronary Vessels,A07.231.114.269
19161222,2009-02-01T00:00:00,Coronary Vessels,A07.231.908.194
19161222,2009-02-01T00:00:00,"Endothelium, Vascular",A07.231.330
19161222,2009-02-01T00:00:00,"Endothelium, Vascular",A10.272.491.355
19161222,2009-02-01T00:00:00,Morphogenesis,G07.700.320.500
19161222,2009-02-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19161222,2009-02-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19161222,2009-02-01T00:00:00,"Myocytes, Cardiac",A11.620.500
19161222,2009-02-01T00:00:00,Pericardium,A07.541.795
19161222,2009-02-01T00:00:00,Pericardium,A10.615.789.470
19161222,2009-02-01T00:00:00,Protein Isoforms,D12.776.800
19161222,2009-02-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19161222,2009-02-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19161222,2009-02-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19170451,2009-02-01T00:00:00,Adolescent,M01.060.057
19170451,2009-02-01T00:00:00,Antisocial Personality Disorder,F03.675.050
19170451,2009-02-01T00:00:00,Cognitive Therapy,F04.754.137.428
19170451,2009-02-01T00:00:00,Combined Modality Therapy,E02.186
19170451,2009-02-01T00:00:00,Counseling,F02.784.176
19170451,2009-02-01T00:00:00,Counseling,F04.408.413
19170451,2009-02-01T00:00:00,Counseling,N02.421.143.303
19170451,2009-02-01T00:00:00,Counseling,N02.421.461.363
19170451,2009-02-01T00:00:00,Family Therapy,F04.754.864.581.273
19170451,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19170451,2009-02-01T00:00:00,Juvenile Delinquency,I01.880.735.479
19170451,2009-02-01T00:00:00,Peer Group,F01.829.316.483
19170451,2009-02-01T00:00:00,Sex Offenses,I01.198.240.748
19170451,2009-02-01T00:00:00,Social Environment,I01.880.656
19177200,2009-02-01T00:00:00,Binding Sites,G02.111.570.120
19177200,2009-02-01T00:00:00,Down-Regulation,G02.111.087.225
19177200,2009-02-01T00:00:00,Down-Regulation,G02.149.115.225
19177200,2009-02-01T00:00:00,Down-Regulation,G05.355.315.200
19177200,2009-02-01T00:00:00,Down-Regulation,G07.690.812.230
19177200,2009-02-01T00:00:00,Down-Regulation,G07.700.680.230
19177200,2009-02-01T00:00:00,Gene Expression Profiling,E05.393.332
19177200,2009-02-01T00:00:00,Homeodomain Proteins,D12.776.260.400
19177200,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19177200,2009-02-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19177200,2009-02-01T00:00:00,Lung Neoplasms,C08.381.540
19177200,2009-02-01T00:00:00,Lung Neoplasms,C08.785.520
19177200,2009-02-01T00:00:00,Membrane Proteins,D12.776.543
19177200,2009-02-01T00:00:00,Nerve Tissue Proteins,D12.776.641
19177200,2009-02-01T00:00:00,"RNA, Messenger",D13.444.735.544
19177200,2009-02-01T00:00:00,Transcription Factors,D12.776.930
19177200,2009-02-01T00:00:00,"Transcription, Genetic",G02.111.087.847
19177200,2009-02-01T00:00:00,"Transcription, Genetic",G02.149.115.847
19177200,2009-02-01T00:00:00,"Transcription, Genetic",G05.355.310.700
19185209,2009-02-01T00:00:00,Animals,B01.050
19185209,2009-02-01T00:00:00,Astrocytes,A08.637.200
19185209,2009-02-01T00:00:00,Astrocytes,A11.650.200
19185209,2009-02-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
19185209,2009-02-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
19185209,2009-02-01T00:00:00,Ethanol,D02.033.375
19185209,2009-02-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
19185209,2009-02-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
19185209,2009-02-01T00:00:00,Hippocampus,A08.186.211.464.405
19185209,2009-02-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
19185209,2009-02-01T00:00:00,Phosphorylation,G02.111.087.677
19185209,2009-02-01T00:00:00,Phosphorylation,G02.149.115.677
19185209,2009-02-01T00:00:00,Phosphorylation,G02.149.465.700
19185209,2009-02-01T00:00:00,Phosphorylation,G02.607.750.700
19185209,2009-02-01T00:00:00,Phosphorylation,G03.495.790
19185209,2009-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19185209,2009-02-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19185209,2009-02-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
19185235,2009-02-01T00:00:00,Cataract,C11.510.245
19185235,2009-02-01T00:00:00,"Child, Preschool",M01.060.406.448
19185235,2009-02-01T00:00:00,Eye Diseases,C11
19185235,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19185235,2009-02-01T00:00:00,Infant,M01.060.703
19185235,2009-02-01T00:00:00,Intraoperative Complications,C23.550.505
19185235,2009-02-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
19187706,2009-02-01T00:00:00,"Affective Disorders, Psychotic",F03.600.150
19187706,2009-02-01T00:00:00,Aged,M01.060.116.100
19187706,2009-02-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
19187706,2009-02-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
19187706,2009-02-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
19187706,2009-02-01T00:00:00,Cardiovascular Diseases,C14
19187706,2009-02-01T00:00:00,Combined Modality Therapy,E02.186
19187706,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19187706,2009-02-01T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
19187706,2009-02-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
19187706,2009-02-01T00:00:00,Life Style,F01.829.458
19187706,2009-02-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
19187706,2009-02-01T00:00:00,Metabolic Syndrome X,C18.452.625
19187706,2009-02-01T00:00:00,Psychotic Disorders,F03.700.675
19187706,2009-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19187706,2009-02-01T00:00:00,Risk Factors,N05.715.350.200.700
19187706,2009-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19187706,2009-02-01T00:00:00,Risk Factors,N06.850.490.625.750
19187706,2009-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19187706,2009-02-01T00:00:00,Weight Gain,C23.888.144.243.926
19187706,2009-02-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
19194346,2009-02-01T00:00:00,Adolescent,M01.060.057
19194346,2009-02-01T00:00:00,Ambulatory Care,E02.760.106
19194346,2009-02-01T00:00:00,Ambulatory Care,N02.421.585.106
19194346,2009-02-01T00:00:00,Child,M01.060.406
19194346,2009-02-01T00:00:00,"Child, Preschool",M01.060.406.448
19194346,2009-02-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19194346,2009-02-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19194346,2009-02-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19194346,2009-02-01T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
19194346,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19194346,2009-02-01T00:00:00,Infant,M01.060.703
19194346,2009-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
19194346,2009-02-01T00:00:00,Length of Stay,E02.760.400.480
19194346,2009-02-01T00:00:00,Length of Stay,N02.421.585.400.480
19197960,2009-02-01T00:00:00,Biometry,E05.318.740.225
19197960,2009-02-01T00:00:00,Biometry,N06.850.505.200
19197960,2009-02-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
19197960,2009-02-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19197960,2009-02-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19197960,2009-02-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19197960,2009-02-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19197960,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19197960,2009-02-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19197960,2009-02-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19201295,2009-02-01T00:00:00,Adult,M01.060.116
19201295,2009-02-01T00:00:00,Aged,M01.060.116.100
19201295,2009-02-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19201295,2009-02-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19201295,2009-02-01T00:00:00,Cell Differentiation,G04.299.151
19201295,2009-02-01T00:00:00,Dendritic Cells,A11.066.270
19201295,2009-02-01T00:00:00,Dendritic Cells,A11.436.270
19201295,2009-02-01T00:00:00,Dendritic Cells,A15.382.066.270
19201295,2009-02-01T00:00:00,Dendritic Cells,A15.382.812.260
19201295,2009-02-01T00:00:00,Head and Neck Neoplasms,C04.588.443
19201295,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19201295,2009-02-01T00:00:00,Middle Aged,M01.060.116.630
19201295,2009-02-01T00:00:00,Pilot Projects,E05.318.760.750
19201295,2009-02-01T00:00:00,Pilot Projects,E05.337.737
19201295,2009-02-01T00:00:00,Pilot Projects,N05.715.360.775.625
19201295,2009-02-01T00:00:00,Pilot Projects,N06.850.520.450.720
19201295,2009-02-01T00:00:00,Stem Cells,A11.872
19203163,2009-02-01T00:00:00,Adolescent,M01.060.057
19203163,2009-02-01T00:00:00,Cognitive Therapy,F04.754.137.428
19203163,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19203163,2009-02-01T00:00:00,Sex Offenses,I01.198.240.748
19203163,2009-02-01T00:00:00,Sexual Behavior,F01.145.802
19203163,2009-02-01T00:00:00,Treatment Outcome,E01.789.800
19203163,2009-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19203163,2009-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19222814,2009-02-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
19222814,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19222814,2009-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19222814,2009-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19222814,2009-02-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19222814,2009-02-01T00:00:00,Questionnaires,E05.318.308.750
19222814,2009-02-01T00:00:00,Questionnaires,L01.280.800
19222814,2009-02-01T00:00:00,Questionnaires,N05.715.360.300.695
19222814,2009-02-01T00:00:00,Questionnaires,N06.850.520.308.750
19222814,2009-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19222814,2009-02-01T00:00:00,Risk Factors,N05.715.350.200.700
19222814,2009-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19222814,2009-02-01T00:00:00,Risk Factors,N06.850.490.625.750
19222814,2009-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19222814,2009-02-01T00:00:00,Substance-Related Disorders,C21.739
19222814,2009-02-01T00:00:00,Substance-Related Disorders,F03.900
19230006,2009-02-01T00:00:00,Adolescent,M01.060.057
19230006,2009-02-01T00:00:00,Adult,M01.060.116
19230006,2009-02-01T00:00:00,Alcoholism,C21.739.100.250
19230006,2009-02-01T00:00:00,Alcoholism,F03.900.100.350
19230006,2009-02-01T00:00:00,Crime Victims,M01.135
19230006,2009-02-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19230006,2009-02-01T00:00:00,Homicide,I01.198.240.470
19230006,2009-02-01T00:00:00,Homicide,I01.880.735.344
19230006,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19230006,2009-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19230006,2009-02-01T00:00:00,Risk Factors,N05.715.350.200.700
19230006,2009-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19230006,2009-02-01T00:00:00,Risk Factors,N06.850.490.625.750
19230006,2009-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19230006,2009-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19230006,2009-02-01T00:00:00,Substance-Related Disorders,C21.739
19230006,2009-02-01T00:00:00,Substance-Related Disorders,F03.900
19230006,2009-02-01T00:00:00,Survivors,M01.643.836
19230006,2009-02-01T00:00:00,Survivors,M01.860
19230006,2009-02-01T00:00:00,United States,Z01.107.567.875
19244152,2009-02-01T00:00:00,Adult,M01.060.116
19244152,2009-02-01T00:00:00,Biological Markers,D23.101
19244152,2009-02-01T00:00:00,Dietary Supplements,J02.500.456
19244152,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19244152,2009-02-01T00:00:00,Inflammation,C23.550.470
19244152,2009-02-01T00:00:00,Middle Aged,M01.060.116.630
19244152,2009-02-01T00:00:00,Obesity,C18.654.726.500
19244152,2009-02-01T00:00:00,Obesity,C23.888.144.699.500
19244152,2009-02-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19244152,2009-02-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19244152,2009-02-01T00:00:00,Seeds,A18.024.500.750
19244152,2009-02-01T00:00:00,Seeds,J02.500.775
19252536,2009-02-01T00:00:00,Animals,B01.050
19252536,2009-02-01T00:00:00,Drug Resistance,G07.690.320
19252536,2009-02-01T00:00:00,Treatment Outcome,E01.789.800
19252536,2009-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19252536,2009-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19281522,2009-02-01T00:00:00,Anticoagulants,D27.505.954.502.119
19281522,2009-02-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19281522,2009-02-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19281522,2009-02-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19281522,2009-02-01T00:00:00,Heparin,D09.698.373.400
19281522,2009-02-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
19281522,2009-02-01T00:00:00,Hospital Mortality,L01.280.975.550.400
19281522,2009-02-01T00:00:00,Hospital Mortality,N01.224.935.698.400
19281522,2009-02-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
19281522,2009-02-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
19281522,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19281522,2009-02-01T00:00:00,Peptide Fragments,D12.644.541
19281522,2009-02-01T00:00:00,Recombinant Proteins,D12.776.828
19281522,2009-02-01T00:00:00,Stents,E07.695.750
19281522,2009-02-01T00:00:00,Treatment Outcome,E01.789.800
19281522,2009-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19281522,2009-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19301566,2009-02-01T00:00:00,Adult,M01.060.116
19301566,2009-02-01T00:00:00,Gestonorone Caproate,D04.808.668.651.693.362
19301566,2009-02-01T00:00:00,Gestonorone Caproate,D04.808.745.745.654.527
19301566,2009-02-01T00:00:00,Home Care Services,N02.421.143.524
19301566,2009-02-01T00:00:00,Home Care Services,N02.421.539.089
19301566,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19301566,2009-02-01T00:00:00,"Obstetric Labor, Premature",C13.703.420.491
19301566,2009-02-01T00:00:00,Pregnancy,G08.686.785.760.769
19301566,2009-02-01T00:00:00,Premature Birth,C13.703.420.491.500
19301566,2009-02-01T00:00:00,Progestins,D27.505.696.399.472.858
19301566,2009-02-01T00:00:00,Young Adult,M01.060.116.815
19322953,2009-02-01T00:00:00,Animals,B01.050
19322953,2009-02-01T00:00:00,CHO Cells,A11.251.210.200
19322953,2009-02-01T00:00:00,CHO Cells,A11.436.155
19322953,2009-02-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
19322953,2009-02-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
19322953,2009-02-01T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
19322953,2009-02-01T00:00:00,Methylphenidate,D02.241.223.601.600
19322953,2009-02-01T00:00:00,Methylphenidate,D03.383.621.460
19322953,2009-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19342324,2009-02-01T00:00:00,Artifacts,E05.047
19342324,2009-02-01T00:00:00,Electrodes,E07.305.250
19342324,2009-02-01T00:00:00,Electroencephalography,E01.370.376.300
19342324,2009-02-01T00:00:00,Electroencephalography,E01.370.405.245
19342324,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19342324,2009-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19342324,2009-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19342324,2009-02-01T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
19371519,2009-02-01T00:00:00,Adolescent,M01.060.057
19371519,2009-02-01T00:00:00,Adult,M01.060.116
19371519,2009-02-01T00:00:00,Aged,M01.060.116.100
19371519,2009-02-01T00:00:00,Emergency Medical Services,N02.421.297
19371519,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19371519,2009-02-01T00:00:00,Middle Aged,M01.060.116.630
19371519,2009-02-01T00:00:00,Stroke,C10.228.140.300.775
19371519,2009-02-01T00:00:00,Stroke,C14.907.253.855
19618702,2009-02-01T00:00:00,Activities of Daily Living,E02.831.067
19618702,2009-02-01T00:00:00,Activities of Daily Living,I03.050
19618702,2009-02-01T00:00:00,Activities of Daily Living,N02.421.784.110
19618702,2009-02-01T00:00:00,"Adaptation, Psychological",F01.058
19618702,2009-02-01T00:00:00,Adolescent,M01.060.057
19618702,2009-02-01T00:00:00,Age Factors,N05.715.350.075
19618702,2009-02-01T00:00:00,Age Factors,N06.850.490.250
19618702,2009-02-01T00:00:00,Caregivers,M01.085
19618702,2009-02-01T00:00:00,Caregivers,M01.526.485.200
19618702,2009-02-01T00:00:00,Caregivers,N02.360.200
19618702,2009-02-01T00:00:00,Child,M01.060.406
19618702,2009-02-01T00:00:00,Cost of Illness,I01.137
19618702,2009-02-01T00:00:00,Cost of Illness,N03.219.151.165
19618702,2009-02-01T00:00:00,Depression,F01.145.126.350
19618702,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19618702,2009-02-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19618702,2009-02-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19618702,2009-02-01T00:00:00,Parents,F01.829.263.500.320
19618702,2009-02-01T00:00:00,Parents,I01.880.225.500.340
19618702,2009-02-01T00:00:00,Parents,M01.620
19618702,2009-02-01T00:00:00,Personality Inventory,F04.711.647.513
19618702,2009-02-01T00:00:00,Psychometrics,F04.711.780
19618702,2009-02-01T00:00:00,Quality of Life,I01.800
19618702,2009-02-01T00:00:00,Quality of Life,K01.752.400.750
19618702,2009-02-01T00:00:00,"Spondylitis, Ankylosing",C05.116.900.853.625.800.850
19618702,2009-02-01T00:00:00,"Spondylitis, Ankylosing",C05.550.069.680
19618702,2009-02-01T00:00:00,"Spondylitis, Ankylosing",C05.550.114.865.800.850
20377366,2009-02-01T00:00:00,Adenoviridae,B04.280.030
20377366,2009-02-01T00:00:00,Adenoviridae,B04.909.204.097
20377366,2009-02-01T00:00:00,Animals,B01.050
20377366,2009-02-01T00:00:00,Anterior Cruciate Ligament,A02.513.514.100
20377366,2009-02-01T00:00:00,Anterior Cruciate Ligament,A02.835.583.512.100
20377366,2009-02-01T00:00:00,"Disease Models, Animal",C22.232
20377366,2009-02-01T00:00:00,"Disease Models, Animal",E05.598.500
20377366,2009-02-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20377366,2009-02-01T00:00:00,Disease Progression,C23.550.291.656
20377366,2009-02-01T00:00:00,Genetic Vectors,G05.360.337
20377366,2009-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20377366,2009-02-01T00:00:00,Knee Joint,A02.835.583.475
20377366,2009-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20377366,2009-02-01T00:00:00,Serpins,D12.644.822.750
20377366,2009-02-01T00:00:00,Serpins,D12.644.861
20377366,2009-02-01T00:00:00,Serpins,D12.776.645.750
20377366,2009-02-01T00:00:00,Serpins,D12.776.872
19187532,2009-02-02T00:00:00,Cell Line,A11.251.210
19187532,2009-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19187532,2009-02-02T00:00:00,MicroRNAs,D13.150.650.319
19187532,2009-02-02T00:00:00,MicroRNAs,D13.444.735.150.319
19187532,2009-02-02T00:00:00,MicroRNAs,D13.444.735.790.099
19187532,2009-02-02T00:00:00,Molecular Sequence Data,L01.453.245.667
19187532,2009-02-02T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19187532,2009-02-02T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19187532,2009-02-02T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19187532,2009-02-02T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19187532,2009-02-02T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19187532,2009-02-02T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19187532,2009-02-02T00:00:00,RNA Interference,G05.355.315.203.374.790
19187532,2009-02-02T00:00:00,"RNA, Messenger",D13.444.735.544
19187532,2009-02-02T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
19187532,2009-02-02T00:00:00,Telomerase,D12.776.157.725.500.921
19187532,2009-02-02T00:00:00,Telomerase,D12.776.664.962.500.921
19187535,2009-02-02T00:00:00,Aged,M01.060.116.100
19187535,2009-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19187535,2009-02-02T00:00:00,Middle Aged,M01.060.116.630
19187535,2009-02-02T00:00:00,Neurilemmoma,C04.557.465.625.650.595
19187535,2009-02-02T00:00:00,Neurilemmoma,C04.557.580.600.290
19187535,2009-02-02T00:00:00,Neurilemmoma,C04.557.580.600.610.595
19187535,2009-02-02T00:00:00,Neurilemmoma,C04.557.580.625.650.595
19187535,2009-02-02T00:00:00,Neurilemmoma,C10.551.775.500.500
19187535,2009-02-02T00:00:00,Neurilemmoma,C10.668.829.725.500.500
19187535,2009-02-02T00:00:00,Retroperitoneal Neoplasms,C04.588.033.731
19187535,2009-02-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19187535,2009-02-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19187535,2009-02-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19187535,2009-02-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19187535,2009-02-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19187535,2009-02-02T00:00:00,Treatment Outcome,E01.789.800
19187535,2009-02-02T00:00:00,Treatment Outcome,N04.761.559.590.800
19187535,2009-02-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19189859,2009-02-02T00:00:00,Adult,M01.060.116
19189859,2009-02-02T00:00:00,Biological Markers,D23.101
19189859,2009-02-02T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19189859,2009-02-02T00:00:00,Genetic Predisposition to Disease,G05.380.355
19189859,2009-02-02T00:00:00,Graft Rejection,G12.425.901.545.328
19189859,2009-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19189859,2009-02-02T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
19189859,2009-02-02T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19189859,2009-02-02T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19189859,2009-02-02T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19189859,2009-02-02T00:00:00,Interferon-gamma,D12.644.276.718.550
19189859,2009-02-02T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19189859,2009-02-02T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19189859,2009-02-02T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19189859,2009-02-02T00:00:00,Interferon-gamma,D12.776.467.718.550
19189859,2009-02-02T00:00:00,Interferon-gamma,D23.529.374.440.893
19189859,2009-02-02T00:00:00,Interferon-gamma,D23.529.374.480.350
19189859,2009-02-02T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19189859,2009-02-02T00:00:00,Interferon-gamma,D23.529.718.550
19189859,2009-02-02T00:00:00,Kidney Transplantation,E02.870.500
19189859,2009-02-02T00:00:00,Kidney Transplantation,E04.936.450.485
19189859,2009-02-02T00:00:00,Kidney Transplantation,E04.950.774.400
19189859,2009-02-02T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19189859,2009-02-02T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19207187,2009-02-02T00:00:00,Age Factors,N05.715.350.075
19207187,2009-02-02T00:00:00,Age Factors,N06.850.490.250
19207187,2009-02-02T00:00:00,BK Virus,B04.280.640.615.100
19207187,2009-02-02T00:00:00,BK Virus,B04.909.204.210.620.615.100
19207187,2009-02-02T00:00:00,BK Virus,B04.909.574.204.670.615.100
19207187,2009-02-02T00:00:00,BK Virus,B04.909.675.615.100
19207187,2009-02-02T00:00:00,Child,M01.060.406
19207187,2009-02-02T00:00:00,Graft Rejection,G12.425.901.545.328
19207187,2009-02-02T00:00:00,Graft Survival,G12.425.901.545.340
19207187,2009-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19207187,2009-02-02T00:00:00,Incidence,E05.318.308.985.525.375
19207187,2009-02-02T00:00:00,Incidence,L01.280.975.525.375
19207187,2009-02-02T00:00:00,Incidence,N01.224.935.597.500
19207187,2009-02-02T00:00:00,Incidence,N06.850.505.400.975.525.375
19207187,2009-02-02T00:00:00,Incidence,N06.850.520.308.985.525.375
19207187,2009-02-02T00:00:00,Kidney Transplantation,E02.870.500
19207187,2009-02-02T00:00:00,Kidney Transplantation,E04.936.450.485
19207187,2009-02-02T00:00:00,Kidney Transplantation,E04.950.774.400
19207187,2009-02-02T00:00:00,Risk Factors,E05.318.740.600.800.725
19207187,2009-02-02T00:00:00,Risk Factors,N05.715.350.200.700
19207187,2009-02-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19207187,2009-02-02T00:00:00,Risk Factors,N06.850.490.625.750
19207187,2009-02-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19207187,2009-02-02T00:00:00,Tissue Donors,M01.898
19207187,2009-02-02T00:00:00,Treatment Outcome,E01.789.800
19207187,2009-02-02T00:00:00,Treatment Outcome,N04.761.559.590.800
19207187,2009-02-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19207187,2009-02-02T00:00:00,United States,Z01.107.567.875
21274396,2009-02-02T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.033
21274396,2009-02-02T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.565.925.249
21274396,2009-02-02T00:00:00,"Adrenal Hyperplasia, Congenital",C18.452.648.925.249
21274396,2009-02-02T00:00:00,"Adrenal Hyperplasia, Congenital",C19.053.440
21274396,2009-02-02T00:00:00,Child,M01.060.406
21274396,2009-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21274396,2009-02-02T00:00:00,Mutation,G05.365.590
21274396,2009-02-02T00:00:00,Steroid 21-Hydroxylase,D08.244.453.915.760
21274396,2009-02-02T00:00:00,Steroid 21-Hydroxylase,D08.811.682.690.708.170.915.760
21274396,2009-02-02T00:00:00,Steroid 21-Hydroxylase,D08.811.682.690.708.783.760
21274396,2009-02-02T00:00:00,Steroid 21-Hydroxylase,D12.776.422.220.453.915.760
19193586,2009-02-03T00:00:00,African Americans,M01.686.508.100.100
19193586,2009-02-03T00:00:00,African Americans,M01.686.754.100
19193586,2009-02-03T00:00:00,Aged,M01.060.116.100
19193586,2009-02-03T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19193586,2009-02-03T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
19193586,2009-02-03T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
19193586,2009-02-03T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
19193586,2009-02-03T00:00:00,Dementia,C10.228.140.380
19193586,2009-02-03T00:00:00,Dementia,F03.087.400
19193586,2009-02-03T00:00:00,Ethnic Groups,M01.686.754
19193586,2009-02-03T00:00:00,Ethnic Groups,N01.224.317
19193586,2009-02-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
19193586,2009-02-03T00:00:00,Healthcare Disparities,N04.590.374.380
19193586,2009-02-03T00:00:00,Healthcare Disparities,N05.300.493
19193586,2009-02-03T00:00:00,Hispanic Americans,M01.686.754.441
19193586,2009-02-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19193586,2009-02-03T00:00:00,Hypertension,C14.907.489
19193586,2009-02-03T00:00:00,Medication Adherence,F01.145.488.500.500
19193586,2009-02-03T00:00:00,Medication Adherence,N05.300.150.600.600.500
19193586,2009-02-03T00:00:00,Veterans,M01.930
19193589,2009-02-03T00:00:00,Adult,M01.060.116
19193589,2009-02-03T00:00:00,Cardiovascular Diseases,C14
19193589,2009-02-03T00:00:00,Drug-Eluting Stents,E07.695.750.500
19193589,2009-02-03T00:00:00,Exanthema,C17.800.257
19193589,2009-02-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19193589,2009-02-03T00:00:00,Medication Adherence,F01.145.488.500.500
19193589,2009-02-03T00:00:00,Medication Adherence,N05.300.150.600.600.500
19193589,2009-02-03T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19193589,2009-02-03T00:00:00,Ticlopidine,D02.886.778.834
19193589,2009-02-03T00:00:00,Ticlopidine,D03.383.903.834
19193905,2009-02-04T00:00:00,Animals,B01.050
19193905,2009-02-04T00:00:00,Cataplexy,C10.886.425.800.200.750.500
19193905,2009-02-04T00:00:00,Cataplexy,F03.870.400.800.200.750.500
19193905,2009-02-04T00:00:00,Electroencephalography,E01.370.376.300
19193905,2009-02-04T00:00:00,Electroencephalography,E01.370.405.245
19193905,2009-02-04T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19193905,2009-02-04T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19193905,2009-02-04T00:00:00,Neurons,A08.663
19193905,2009-02-04T00:00:00,Neurons,A11.671
19193905,2009-02-04T00:00:00,Neuropeptides,D12.644.400
19193905,2009-02-04T00:00:00,Neuropeptides,D12.776.641.650
19193905,2009-02-04T00:00:00,Sleep,F02.830.855
19193905,2009-02-04T00:00:00,Sleep,G11.561.600.815
19193905,2009-02-04T00:00:00,"Sleep, REM",F02.830.855.796.671
19193905,2009-02-04T00:00:00,"Sleep, REM",G11.561.600.815.754.671
19194378,2009-02-04T00:00:00,Animals,B01.050
19194378,2009-02-04T00:00:00,Cocaine-Related Disorders,C21.739.300
19194378,2009-02-04T00:00:00,Cocaine-Related Disorders,F03.900.300
19194378,2009-02-04T00:00:00,Dopamine,D02.092.211.215.311.342
19194378,2009-02-04T00:00:00,Dopamine,D02.092.311.342
19194378,2009-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19194378,2009-02-04T00:00:00,Neurons,A08.663
19194378,2009-02-04T00:00:00,Neurons,A11.671
19435580,2009-02-04T00:00:00,Adolescent,M01.060.057
19435580,2009-02-04T00:00:00,Adult,M01.060.116
19435580,2009-02-04T00:00:00,Aged,M01.060.116.100
19435580,2009-02-04T00:00:00,Anticonvulsants,D27.505.954.427.080
19435580,2009-02-04T00:00:00,Child,M01.060.406
19435580,2009-02-04T00:00:00,Complementary Therapies,E02.190
19435580,2009-02-04T00:00:00,Epilepsy,C10.228.140.490
19435580,2009-02-04T00:00:00,Ethnic Groups,M01.686.754
19435580,2009-02-04T00:00:00,Ethnic Groups,N01.224.317
19435580,2009-02-04T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19435580,2009-02-04T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19435580,2009-02-04T00:00:00,Health Surveys,E05.318.308.250
19435580,2009-02-04T00:00:00,Health Surveys,N05.715.360.300.375
19435580,2009-02-04T00:00:00,Health Surveys,N06.850.520.308.250
19435580,2009-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19435580,2009-02-04T00:00:00,Medication Adherence,F01.145.488.500.500
19435580,2009-02-04T00:00:00,Medication Adherence,N05.300.150.600.600.500
19435580,2009-02-04T00:00:00,Middle Aged,M01.060.116.630
19435580,2009-02-04T00:00:00,Outpatients,M01.643.630
19435580,2009-02-04T00:00:00,Questionnaires,E05.318.308.750
19435580,2009-02-04T00:00:00,Questionnaires,L01.280.800
19435580,2009-02-04T00:00:00,Questionnaires,N05.715.360.300.695
19435580,2009-02-04T00:00:00,Questionnaires,N06.850.520.308.750
19435580,2009-02-04T00:00:00,Young Adult,M01.060.116.815
19196838,2009-02-05T00:00:00,Aged,M01.060.116.100
19196838,2009-02-05T00:00:00,Bone Density Conservation Agents,D27.505.696.242
19196838,2009-02-05T00:00:00,Calcium,D01.268.552.100
19196838,2009-02-05T00:00:00,Calcium,D01.552.539.288
19196838,2009-02-05T00:00:00,Calcium,D23.119.100
19196838,2009-02-05T00:00:00,Dietary Supplements,J02.500.456
19196838,2009-02-05T00:00:00,"Fractures, Bone",C21.866.404
19196838,2009-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19196838,2009-02-05T00:00:00,Patient Compliance,F01.145.488.500
19196838,2009-02-05T00:00:00,Patient Compliance,N05.300.150.600.600
19196838,2009-02-05T00:00:00,Patient Education as Topic,I02.233.332.500
19196838,2009-02-05T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19196838,2009-02-05T00:00:00,Patient Education as Topic,N02.421.726.407.680
19196838,2009-02-05T00:00:00,Physician's Practice Patterns,N04.590.748
19196838,2009-02-05T00:00:00,Physician's Practice Patterns,N05.300.625
19196838,2009-02-05T00:00:00,"Physicians, Family",M01.526.485.810.770
19196838,2009-02-05T00:00:00,"Physicians, Family",N02.360.810.770
19196838,2009-02-05T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19196838,2009-02-05T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19196838,2009-02-05T00:00:00,Vitamin D,D04.808.812.768
19196989,2009-02-05T00:00:00,Animals,B01.050
19196989,2009-02-05T00:00:00,Astrocytes,A08.637.200
19196989,2009-02-05T00:00:00,Astrocytes,A11.650.200
19196989,2009-02-05T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
19196989,2009-02-05T00:00:00,"Disease Models, Animal",C22.232
19196989,2009-02-05T00:00:00,"Disease Models, Animal",E05.598.500
19196989,2009-02-05T00:00:00,"Disease Models, Animal",E05.599.395.080
19196989,2009-02-05T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
19196989,2009-02-05T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
19196989,2009-02-05T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19196989,2009-02-05T00:00:00,Parkinson Disease,C10.228.662.600.400
19196989,2009-02-05T00:00:00,Parkinson Disease,C10.574.812
19196989,2009-02-05T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
19196989,2009-02-05T00:00:00,Substantia Nigra,A08.186.211.653.822.731
19208192,2009-02-05T00:00:00,Algorithms,G17.035
19208192,2009-02-05T00:00:00,Algorithms,L01.224.050
19208192,2009-02-05T00:00:00,Computational Biology,H01.158.273.180
19208192,2009-02-05T00:00:00,"Databases, Factual",L01.470.750.750
19208192,2009-02-05T00:00:00,"Databases, Factual",L01.700.508.300.188.400
19208192,2009-02-05T00:00:00,Medical Informatics,L01.313.500
19208192,2009-02-05T00:00:00,Medical Informatics,L01.700
19208192,2009-02-05T00:00:00,Software,L01.224.900
19208192,2009-02-05T00:00:00,User-Computer Interface,L01.224.900.910
19223841,2009-02-05T00:00:00,Head and Neck Neoplasms,C04.588.443
19223841,2009-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19223841,2009-02-05T00:00:00,"Quality Assurance, Health Care",N04.761.700
19223841,2009-02-05T00:00:00,"Quality Assurance, Health Care",N05.700
19223841,2009-02-05T00:00:00,"Radiotherapy, Intensity-Modulated",E02.815.635.700.700
19223841,2009-02-05T00:00:00,"Radiotherapy, Intensity-Modulated",L01.700.508.100.710.600.550.700
19200937,2009-02-06T00:00:00,Animals,B01.050
19200937,2009-02-06T00:00:00,Cervix Uteri,A05.360.319.679.256
19200937,2009-02-06T00:00:00,Postpartum Period,G08.686.702
19200937,2009-02-06T00:00:00,Time Factors,G01.910.857
19201042,2009-02-06T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19201042,2009-02-06T00:00:00,Coronary Angiography,E01.370.370.050.200
19201042,2009-02-06T00:00:00,Coronary Angiography,E01.370.370.380.200
19201042,2009-02-06T00:00:00,Drug-Eluting Stents,E07.695.750.500
19201042,2009-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19201042,2009-02-06T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
19201042,2009-02-06T00:00:00,Middle Aged,M01.060.116.630
19201042,2009-02-06T00:00:00,Myocardial Infarction,C14.280.647.500
19201042,2009-02-06T00:00:00,Myocardial Infarction,C14.907.585.500
19201042,2009-02-06T00:00:00,Prosthesis Design,E05.320.550
19201042,2009-02-06T00:00:00,Prosthesis Design,E07.695.680
19201042,2009-02-06T00:00:00,Treatment Outcome,E01.789.800
19201042,2009-02-06T00:00:00,Treatment Outcome,N04.761.559.590.800
19201042,2009-02-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19720247,2009-02-06T00:00:00,Adolescent,M01.060.057
19720247,2009-02-06T00:00:00,Adult,M01.060.116
19720247,2009-02-06T00:00:00,Aged,M01.060.116.100
19720247,2009-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19720247,2009-02-06T00:00:00,Middle Aged,M01.060.116.630
19720247,2009-02-06T00:00:00,Quality of Life,I01.800
19720247,2009-02-06T00:00:00,Quality of Life,K01.752.400.750
19720247,2009-02-06T00:00:00,Questionnaires,E05.318.308.750
19720247,2009-02-06T00:00:00,Questionnaires,L01.280.800
19720247,2009-02-06T00:00:00,Questionnaires,N05.715.360.300.695
19720247,2009-02-06T00:00:00,Questionnaires,N06.850.520.308.750
19720247,2009-02-06T00:00:00,Rhinitis,C08.460.799
19720247,2009-02-06T00:00:00,Rhinitis,C08.730.674
19720247,2009-02-06T00:00:00,Rhinitis,C09.603.799
19720247,2009-02-06T00:00:00,Treatment Outcome,E01.789.800
19720247,2009-02-06T00:00:00,Treatment Outcome,N04.761.559.590.800
19720247,2009-02-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19720247,2009-02-06T00:00:00,Young Adult,M01.060.116.815
19198960,2009-02-07T00:00:00,Adult,M01.060.116
19198960,2009-02-07T00:00:00,Aged,M01.060.116.100
19198960,2009-02-07T00:00:00,Duodenal Diseases,C06.405.469.275
19198960,2009-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19198960,2009-02-07T00:00:00,Length of Stay,E02.760.400.480
19198960,2009-02-07T00:00:00,Length of Stay,N02.421.585.400.480
19198960,2009-02-07T00:00:00,Middle Aged,M01.060.116.630
19198960,2009-02-07T00:00:00,Pancreaticoduodenectomy,E04.210.760
19198960,2009-02-07T00:00:00,Risk Factors,E05.318.740.600.800.725
19198960,2009-02-07T00:00:00,Risk Factors,N05.715.350.200.700
19198960,2009-02-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19198960,2009-02-07T00:00:00,Risk Factors,N06.850.490.625.750
19198960,2009-02-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19198960,2009-02-07T00:00:00,Treatment Outcome,E01.789.800
19198960,2009-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
19198960,2009-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19198960,2009-02-07T00:00:00,Young Adult,M01.060.116.815
19201064,2009-02-07T00:00:00,Adolescent,M01.060.057
19201064,2009-02-07T00:00:00,Age Factors,N05.715.350.075
19201064,2009-02-07T00:00:00,Age Factors,N06.850.490.250
19201064,2009-02-07T00:00:00,Child,M01.060.406
19201064,2009-02-07T00:00:00,"Child, Preschool",M01.060.406.448
19201064,2009-02-07T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19201064,2009-02-07T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19201064,2009-02-07T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19201064,2009-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19201064,2009-02-07T00:00:00,Incidence,E05.318.308.985.525.375
19201064,2009-02-07T00:00:00,Incidence,L01.280.975.525.375
19201064,2009-02-07T00:00:00,Incidence,N01.224.935.597.500
19201064,2009-02-07T00:00:00,Incidence,N06.850.505.400.975.525.375
19201064,2009-02-07T00:00:00,Incidence,N06.850.520.308.985.525.375
19201064,2009-02-07T00:00:00,Infant,M01.060.703
19201064,2009-02-07T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19201064,2009-02-07T00:00:00,Ketamine,D02.455.426.392.368.367.652
19201064,2009-02-07T00:00:00,Respiratory System,A04
19201064,2009-02-07T00:00:00,Risk Factors,E05.318.740.600.800.725
19201064,2009-02-07T00:00:00,Risk Factors,N05.715.350.200.700
19201064,2009-02-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19201064,2009-02-07T00:00:00,Risk Factors,N06.850.490.625.750
19201064,2009-02-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19303582,2009-02-07T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19303582,2009-02-07T00:00:00,Coronary Angiography,E01.370.370.050.200
19303582,2009-02-07T00:00:00,Coronary Angiography,E01.370.370.380.200
19303582,2009-02-07T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19303582,2009-02-07T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19303582,2009-02-07T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19303582,2009-02-07T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
19303582,2009-02-07T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
19303582,2009-02-07T00:00:00,Drug-Eluting Stents,E07.695.750.500
19303582,2009-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19303582,2009-02-07T00:00:00,Metals,D01.552
19303582,2009-02-07T00:00:00,Patient Selection,E05.581.500.653
19303582,2009-02-07T00:00:00,Patient Selection,N04.590.731
19303582,2009-02-07T00:00:00,Prosthesis Design,E05.320.550
19303582,2009-02-07T00:00:00,Prosthesis Design,E07.695.680
19303582,2009-02-07T00:00:00,Stents,E07.695.750
19303582,2009-02-07T00:00:00,Thrombosis,C14.907.355.830
19303582,2009-02-07T00:00:00,Treatment Outcome,E01.789.800
19303582,2009-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
19303582,2009-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19303582,2009-02-07T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
19220522,2009-02-09T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19220522,2009-02-09T00:00:00,Cardiovascular Diseases,C14
19220522,2009-02-09T00:00:00,Clinical Trials as Topic,E05.318.760.535
19220522,2009-02-09T00:00:00,Clinical Trials as Topic,E05.337.250
19220522,2009-02-09T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19220522,2009-02-09T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19220522,2009-02-09T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19220522,2009-02-09T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19220522,2009-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19220522,2009-02-09T00:00:00,Life Style,F01.829.458
19220522,2009-02-09T00:00:00,Obesity,C18.654.726.500
19220522,2009-02-09T00:00:00,Obesity,C23.888.144.699.500
19220522,2009-02-09T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19220522,2009-02-09T00:00:00,Obesity,G07.100.100.160.120.699.500
19220522,2009-02-09T00:00:00,Renin-Angiotensin System,G03.495.805
19220522,2009-02-09T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
19220522,2009-02-09T00:00:00,Risk Factors,E05.318.740.600.800.725
19220522,2009-02-09T00:00:00,Risk Factors,N05.715.350.200.700
19220522,2009-02-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19220522,2009-02-09T00:00:00,Risk Factors,N06.850.490.625.750
19220522,2009-02-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19220522,2009-02-09T00:00:00,Treatment Outcome,E01.789.800
19220522,2009-02-09T00:00:00,Treatment Outcome,N04.761.559.590.800
19220522,2009-02-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19208839,2009-02-10T00:00:00,Animals,B01.050
19208839,2009-02-10T00:00:00,Cell Division,G04.299.134.220
19208839,2009-02-10T00:00:00,Cell Division,G04.299.233.750.500
19208839,2009-02-10T00:00:00,Cell Division,G05.355.105
19208839,2009-02-10T00:00:00,Cell Division,G07.700.320.249.410.750.500
19208839,2009-02-10T00:00:00,Lung Neoplasms,C04.588.894.797.520
19208839,2009-02-10T00:00:00,Lung Neoplasms,C08.381.540
19208839,2009-02-10T00:00:00,Lung Neoplasms,C08.785.520
19208839,2009-02-10T00:00:00,Microcirculation,G09.330.190.163.645
19208839,2009-02-10T00:00:00,Neoplasm Staging,E01.370.550
19208839,2009-02-10T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
19208839,2009-02-10T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19208839,2009-02-10T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19208839,2009-02-10T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19208842,2009-02-10T00:00:00,Adenocarcinoma,C04.557.470.200.025
19208842,2009-02-10T00:00:00,Aged,M01.060.116.100
19208842,2009-02-10T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19208842,2009-02-10T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19208842,2009-02-10T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19208842,2009-02-10T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19208842,2009-02-10T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19208842,2009-02-10T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19208842,2009-02-10T00:00:00,Dietary Supplements,J02.500.456
19208842,2009-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19208842,2009-02-10T00:00:00,Incidence,E05.318.308.985.525.375
19208842,2009-02-10T00:00:00,Incidence,L01.280.975.525.375
19208842,2009-02-10T00:00:00,Incidence,N01.224.935.597.500
19208842,2009-02-10T00:00:00,Incidence,N06.850.505.400.975.525.375
19208842,2009-02-10T00:00:00,Incidence,N06.850.520.308.985.525.375
19208842,2009-02-10T00:00:00,Lung Neoplasms,C04.588.894.797.520
19208842,2009-02-10T00:00:00,Lung Neoplasms,C08.381.540
19208842,2009-02-10T00:00:00,Lung Neoplasms,C08.785.520
19208842,2009-02-10T00:00:00,Middle Aged,M01.060.116.630
19208842,2009-02-10T00:00:00,Ovarian Neoplasms,C04.588.322.455
19208842,2009-02-10T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
19208842,2009-02-10T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
19208842,2009-02-10T00:00:00,Ovarian Neoplasms,C19.344.410
19208842,2009-02-10T00:00:00,Ovarian Neoplasms,C19.391.630.705
19208842,2009-02-10T00:00:00,Pancreatic Neoplasms,C04.588.274.761
19208842,2009-02-10T00:00:00,Pancreatic Neoplasms,C04.588.322.421
19208842,2009-02-10T00:00:00,Pancreatic Neoplasms,C06.301.761
19208842,2009-02-10T00:00:00,Pancreatic Neoplasms,C06.689.667
19208842,2009-02-10T00:00:00,Pancreatic Neoplasms,C19.344.421
19208842,2009-02-10T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19208842,2009-02-10T00:00:00,Prostatic Neoplasms,C12.294.260.750
19208842,2009-02-10T00:00:00,Prostatic Neoplasms,C12.294.565.625
19208842,2009-02-10T00:00:00,Prostatic Neoplasms,C12.758.409.750
19208842,2009-02-10T00:00:00,Risk Factors,E05.318.740.600.800.725
19208842,2009-02-10T00:00:00,Risk Factors,N05.715.350.200.700
19208842,2009-02-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19208842,2009-02-10T00:00:00,Risk Factors,N06.850.490.625.750
19208842,2009-02-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19208842,2009-02-10T00:00:00,Vitamin D,D04.808.812.768
19208842,2009-02-10T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19210946,2009-02-10T00:00:00,Adult,M01.060.116
19210946,2009-02-10T00:00:00,Anticonvulsants,D27.505.954.427.080
19210946,2009-02-10T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
19210946,2009-02-10T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
19210946,2009-02-10T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
19210946,2009-02-10T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
19210946,2009-02-10T00:00:00,Bipolar Disorder,F03.600.150.150
19210946,2009-02-10T00:00:00,Cost of Illness,I01.137
19210946,2009-02-10T00:00:00,Cost of Illness,N03.219.151.165
19210946,2009-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19210946,2009-02-10T00:00:00,Middle Aged,M01.060.116.630
19210946,2009-02-10T00:00:00,Psychiatric Status Rating Scales,F04.586
19210946,2009-02-10T00:00:00,Psychotic Disorders,F03.700.675
19210946,2009-02-10T00:00:00,Risk Factors,E05.318.740.600.800.725
19210946,2009-02-10T00:00:00,Risk Factors,N05.715.350.200.700
19210946,2009-02-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19210946,2009-02-10T00:00:00,Risk Factors,N06.850.490.625.750
19210946,2009-02-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19211486,2009-02-10T00:00:00,Aged,M01.060.116.100
19211486,2009-02-10T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
19211486,2009-02-10T00:00:00,Carotid Artery Diseases,C14.907.253.123
19211486,2009-02-10T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
19211486,2009-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19211486,2009-02-10T00:00:00,Postoperative Complications,C23.550.767
19211486,2009-02-10T00:00:00,Risk Factors,E05.318.740.600.800.725
19211486,2009-02-10T00:00:00,Risk Factors,N05.715.350.200.700
19211486,2009-02-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19211486,2009-02-10T00:00:00,Risk Factors,N06.850.490.625.750
19211486,2009-02-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19211486,2009-02-10T00:00:00,Stents,E07.695.750
19211486,2009-02-10T00:00:00,Stroke,C10.228.140.300.775
19211486,2009-02-10T00:00:00,Stroke,C14.907.253.855
19215595,2009-02-10T00:00:00,Adult,M01.060.116
19215595,2009-02-10T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19215595,2009-02-10T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19215595,2009-02-10T00:00:00,Health Policy,I01.880.604.825.608.400
19215595,2009-02-10T00:00:00,Health Policy,N03.706.825.608.428
19215595,2009-02-10T00:00:00,Health Promotion,N02.370
19215595,2009-02-10T00:00:00,Health Promotion,N02.421.726.507
19215595,2009-02-10T00:00:00,Health Surveys,E05.318.308.250
19215595,2009-02-10T00:00:00,Health Surveys,N05.715.360.300.375
19215595,2009-02-10T00:00:00,Health Surveys,N06.850.520.308.250
19215595,2009-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19215595,2009-02-10T00:00:00,Middle Aged,M01.060.116.630
19215595,2009-02-10T00:00:00,Motivation,F01.658
19215595,2009-02-10T00:00:00,Motivation,F01.752.543.500.750
19215595,2009-02-10T00:00:00,Smoking,F01.145.466.753
19215595,2009-02-10T00:00:00,Smoking Cessation,F01.145.940.700
19215595,2009-02-10T00:00:00,United States,Z01.107.567.875
19419669,2009-02-10T00:00:00,Adult,M01.060.116
19419669,2009-02-10T00:00:00,Environmental Monitoring,N06.850.460.350.080
19419669,2009-02-10T00:00:00,Environmental Monitoring,N06.850.780.375
19419669,2009-02-10T00:00:00,Environmental Pollutants,D27.888.284
19419669,2009-02-10T00:00:00,Fluorocarbons,D02.455.526.510.435
19419669,2009-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19419669,2009-02-10T00:00:00,Middle Aged,M01.060.116.630
19419669,2009-02-10T00:00:00,New York,Z01.107.567.875.075.437
19419669,2009-02-10T00:00:00,New York,Z01.107.567.875.350.530
19419669,2009-02-10T00:00:00,New York,Z01.107.567.875.500.530
19419669,2009-02-10T00:00:00,Regression Analysis,E05.318.740.750
19419669,2009-02-10T00:00:00,Regression Analysis,N05.715.360.750.695
19419669,2009-02-10T00:00:00,Regression Analysis,N06.850.520.830.750
19211681,2009-02-11T00:00:00,Animals,B01.050
19211681,2009-02-11T00:00:00,Cell Cycle Proteins,D12.776.167
19211681,2009-02-11T00:00:00,Cilia,A11.284.180.165
19211681,2009-02-11T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19211681,2009-02-11T00:00:00,Membrane Proteins,D12.776.543
19211681,2009-02-11T00:00:00,Mutation,G05.365.590
19211681,2009-02-11T00:00:00,Phenotype,G05.695
19212414,2009-02-11T00:00:00,Adult,M01.060.116
19212414,2009-02-11T00:00:00,African Americans,M01.686.508.100.100
19212414,2009-02-11T00:00:00,African Americans,M01.686.754.100
19212414,2009-02-11T00:00:00,Age Factors,N05.715.350.075
19212414,2009-02-11T00:00:00,Age Factors,N06.850.490.250
19212414,2009-02-11T00:00:00,European Continental Ancestry Group,M01.686.508.400
19212414,2009-02-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19212414,2009-02-11T00:00:00,Kidney Transplantation,E02.870.500
19212414,2009-02-11T00:00:00,Kidney Transplantation,E04.936.450.485
19212414,2009-02-11T00:00:00,Kidney Transplantation,E04.950.774.400
19212414,2009-02-11T00:00:00,Living Donors,M01.898.656
19212414,2009-02-11T00:00:00,Middle Aged,M01.060.116.630
19212414,2009-02-11T00:00:00,Sex Factors,N05.715.350.675
19212414,2009-02-11T00:00:00,Sex Factors,N06.850.490.875
19217079,2009-02-12T00:00:00,Adult,M01.060.116
19217079,2009-02-12T00:00:00,African Americans,M01.686.508.100.100
19217079,2009-02-12T00:00:00,African Americans,M01.686.754.100
19217079,2009-02-12T00:00:00,Alcoholism,C21.739.100.250
19217079,2009-02-12T00:00:00,Alcoholism,F03.900.100.350
19217079,2009-02-12T00:00:00,Case-Control Studies,E05.318.760.500.500
19217079,2009-02-12T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19217079,2009-02-12T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19217079,2009-02-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
19217079,2009-02-12T00:00:00,Genetic Variation,G05.365
19217079,2009-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19217079,2009-02-12T00:00:00,Substance-Related Disorders,C21.739
19217079,2009-02-12T00:00:00,Substance-Related Disorders,F03.900
19217079,2009-02-12T00:00:00,United States,Z01.107.567.875
19480853,2009-02-12T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19480853,2009-02-12T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19480853,2009-02-12T00:00:00,Cell Proliferation,G04.299.233.750
19480853,2009-02-12T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19480853,2009-02-12T00:00:00,Dinoprostone,D10.251.355.255.100.637.250.200
19480853,2009-02-12T00:00:00,Dinoprostone,D10.251.355.255.550.250.200
19480853,2009-02-12T00:00:00,Dinoprostone,D23.469.050.175.725.780.200
19480853,2009-02-12T00:00:00,Down-Regulation,G02.111.087.225
19480853,2009-02-12T00:00:00,Down-Regulation,G02.149.115.225
19480853,2009-02-12T00:00:00,Down-Regulation,G05.355.315.200
19480853,2009-02-12T00:00:00,Down-Regulation,G07.690.812.230
19480853,2009-02-12T00:00:00,Down-Regulation,G07.700.680.230
19480853,2009-02-12T00:00:00,Endothelial Cells,A11.436.275
19480853,2009-02-12T00:00:00,"Endothelium, Vascular",A07.231.330
19480853,2009-02-12T00:00:00,"Endothelium, Vascular",A10.272.491.355
19480853,2009-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19480853,2009-02-12T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19480853,2009-02-12T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19480853,2009-02-12T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19480853,2009-02-12T00:00:00,Interferon-gamma,D12.644.276.718.550
19480853,2009-02-12T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19480853,2009-02-12T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19480853,2009-02-12T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19480853,2009-02-12T00:00:00,Interferon-gamma,D12.776.467.718.550
19480853,2009-02-12T00:00:00,Interferon-gamma,D23.529.374.440.893
19480853,2009-02-12T00:00:00,Interferon-gamma,D23.529.374.480.350
19480853,2009-02-12T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19480853,2009-02-12T00:00:00,Interferon-gamma,D23.529.718.550
19480853,2009-02-12T00:00:00,Lymphocyte Activation,E01.450.495.482
19480853,2009-02-12T00:00:00,Lymphocyte Activation,E05.478.594.530
19480853,2009-02-12T00:00:00,Lymphocyte Activation,G12.425.747
19480853,2009-02-12T00:00:00,Lymphocyte Activation,G12.450.050.400.545
19480853,2009-02-12T00:00:00,Microcirculation,G09.330.190.163.645
19480853,2009-02-12T00:00:00,Mouth Neoplasms,C04.588.443.591
19480853,2009-02-12T00:00:00,Mouth Neoplasms,C07.465.565
19480853,2009-02-12T00:00:00,Recombinant Proteins,D12.776.828
19480853,2009-02-12T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
19480853,2009-02-12T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
19480853,2009-02-12T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19480853,2009-02-12T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19480853,2009-02-12T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19480853,2009-02-12T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19222535,2009-02-13T00:00:00,Adolescent,M01.060.057
19222535,2009-02-13T00:00:00,Adult,M01.060.116
19222535,2009-02-13T00:00:00,Aged,M01.060.116.100
19222535,2009-02-13T00:00:00,Catheterization,E02.148
19222535,2009-02-13T00:00:00,Catheterization,E05.157
19222535,2009-02-13T00:00:00,Cough,C08.618.248
19222535,2009-02-13T00:00:00,Cough,C23.888.852.293
19222535,2009-02-13T00:00:00,Gastric Acid,A12.200.307.603
19222535,2009-02-13T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
19222535,2009-02-13T00:00:00,Heartburn,C23.888.821.525
19222535,2009-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19222535,2009-02-13T00:00:00,Middle Aged,M01.060.116.630
19222535,2009-02-13T00:00:00,Time Factors,G01.910.857
19222535,2009-02-13T00:00:00,Young Adult,M01.060.116.815
19219410,2009-02-14T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
19219410,2009-02-14T00:00:00,Budgets,N03.219.463.060
19219410,2009-02-14T00:00:00,CD4 Lymphocyte Count,E01.450.375.107.595.500.150
19219410,2009-02-14T00:00:00,CD4 Lymphocyte Count,E05.200.500.195.107.595.500.150
19219410,2009-02-14T00:00:00,CD4 Lymphocyte Count,G04.170.107.595.500.150
19219410,2009-02-14T00:00:00,CD4 Lymphocyte Count,G09.188.105.595.500.150
19219410,2009-02-14T00:00:00,Coronary Disease,C14.280.647.250
19219410,2009-02-14T00:00:00,Coronary Disease,C14.907.585.250
19219410,2009-02-14T00:00:00,Cost Savings,N03.219.151.160.200
19219410,2009-02-14T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19219410,2009-02-14T00:00:00,Decision Support Techniques,E05.245
19219410,2009-02-14T00:00:00,Decision Support Techniques,L01.700.508.190
19219410,2009-02-14T00:00:00,HIV Infections,C02.782.815.616.400
19219410,2009-02-14T00:00:00,HIV Infections,C02.800.801.400
19219410,2009-02-14T00:00:00,HIV Infections,C20.673.480
19219410,2009-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19219410,2009-02-14T00:00:00,Markov Chains,E05.318.740.600.500
19219410,2009-02-14T00:00:00,Markov Chains,E05.318.740.996.500
19219410,2009-02-14T00:00:00,Markov Chains,G17.830.500
19219410,2009-02-14T00:00:00,Markov Chains,N05.715.360.750.625.500
19219410,2009-02-14T00:00:00,Markov Chains,N05.715.360.750.770.500
19219410,2009-02-14T00:00:00,Markov Chains,N06.850.520.830.600.500
19219410,2009-02-14T00:00:00,Markov Chains,N06.850.520.830.996.500
19219410,2009-02-14T00:00:00,Oligopeptides,D12.644.456
19219410,2009-02-14T00:00:00,Pyridines,D03.383.725
19219410,2009-02-14T00:00:00,Ritonavir,D02.886.675.653
19219410,2009-02-14T00:00:00,Ritonavir,D03.383.129.708.653
19219410,2009-02-14T00:00:00,Smoking,F01.145.466.753
19219410,2009-02-14T00:00:00,United States,Z01.107.567.875
19342194,2009-02-14T00:00:00,Adult,M01.060.116
19342194,2009-02-14T00:00:00,Cognitive Therapy,F04.754.137.428
19342194,2009-02-14T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19342194,2009-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19342194,2009-02-14T00:00:00,International Classification of Diseases,L01.453.245.945.400
19342194,2009-02-14T00:00:00,"Interview, Psychological",F04.669.599
19342194,2009-02-14T00:00:00,Pilot Projects,E05.318.760.750
19342194,2009-02-14T00:00:00,Pilot Projects,E05.337.737
19342194,2009-02-14T00:00:00,Pilot Projects,N05.715.360.775.625
19342194,2009-02-14T00:00:00,Pilot Projects,N06.850.520.450.720
19342194,2009-02-14T00:00:00,Psychotic Disorders,F03.700.675
19342194,2009-02-14T00:00:00,Schizophrenia,F03.700.750
19342194,2009-02-14T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18831007,2009-02-15T00:00:00,Calcium,D01.268.552.100
18831007,2009-02-15T00:00:00,Calcium,D01.552.539.288
18831007,2009-02-15T00:00:00,Calcium,D23.119.100
18831007,2009-02-15T00:00:00,Calpain,D08.811.277.656.262.500.120
18831007,2009-02-15T00:00:00,Calpain,D08.811.277.656.300.200.120
18831007,2009-02-15T00:00:00,Glycoproteins,D09.400.430
18831007,2009-02-15T00:00:00,Glycoproteins,D12.776.395
18831007,2009-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18831007,2009-02-15T00:00:00,Signal Transduction,G02.111.087.800
18831007,2009-02-15T00:00:00,Signal Transduction,G02.149.115.800
18831007,2009-02-15T00:00:00,Signal Transduction,G04.299.880
18831007,2009-02-15T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18831007,2009-02-15T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18831007,2009-02-15T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19035445,2009-02-15T00:00:00,Aged,M01.060.116.100
19035445,2009-02-15T00:00:00,Case-Control Studies,E05.318.760.500.500
19035445,2009-02-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19035445,2009-02-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19035445,2009-02-15T00:00:00,Diet,E05.272
19035445,2009-02-15T00:00:00,Diet,G07.610.240
19035445,2009-02-15T00:00:00,Double-Blind Method,E05.318.780.300
19035445,2009-02-15T00:00:00,Double-Blind Method,E05.581.500.300
19035445,2009-02-15T00:00:00,Double-Blind Method,N05.715.360.780.320
19035445,2009-02-15T00:00:00,Double-Blind Method,N06.850.520.445.300
19035445,2009-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19035445,2009-02-15T00:00:00,Middle Aged,M01.060.116.630
19035445,2009-02-15T00:00:00,Regression Analysis,E05.318.740.750
19035445,2009-02-15T00:00:00,Regression Analysis,N05.715.360.750.695
19035445,2009-02-15T00:00:00,Regression Analysis,N06.850.520.830.750
19035445,2009-02-15T00:00:00,Vitamin D,D04.808.812.768
19195508,2009-02-15T00:00:00,Aged,M01.060.116.100
19195508,2009-02-15T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19195508,2009-02-15T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19195508,2009-02-15T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19195508,2009-02-15T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
19195508,2009-02-15T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
19195508,2009-02-15T00:00:00,Drug-Eluting Stents,E07.695.750.500
19195508,2009-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19195508,2009-02-15T00:00:00,Middle Aged,M01.060.116.630
19195508,2009-02-15T00:00:00,Stents,E07.695.750
19195508,2009-02-15T00:00:00,Time Factors,G01.910.857
19195508,2009-02-15T00:00:00,Treatment Outcome,E01.789.800
19195508,2009-02-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19195508,2009-02-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19195509,2009-02-15T00:00:00,Aged,M01.060.116.100
19195509,2009-02-15T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19195509,2009-02-15T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19195509,2009-02-15T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19195509,2009-02-15T00:00:00,Coronary Vessels,A07.231.114.269
19195509,2009-02-15T00:00:00,Coronary Vessels,A07.231.908.194
19195509,2009-02-15T00:00:00,Drug-Eluting Stents,E07.695.750.500
19195509,2009-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19195509,2009-02-15T00:00:00,Middle Aged,M01.060.116.630
19195509,2009-02-15T00:00:00,Stents,E07.695.750
19195509,2009-02-15T00:00:00,Treatment Outcome,E01.789.800
19195509,2009-02-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19195509,2009-02-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19201856,2009-02-15T00:00:00,Animals,B01.050
19201856,2009-02-15T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
19201856,2009-02-15T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
19201856,2009-02-15T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
19201856,2009-02-15T00:00:00,Cancer Vaccines,D20.215.894.200
19201856,2009-02-15T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
19201856,2009-02-15T00:00:00,Cyclophosphamide,D02.705.670.243
19201856,2009-02-15T00:00:00,Dendritic Cells,A11.066.270
19201856,2009-02-15T00:00:00,Dendritic Cells,A11.436.270
19201856,2009-02-15T00:00:00,Dendritic Cells,A15.382.066.270
19201856,2009-02-15T00:00:00,Dendritic Cells,A15.382.812.260
19201856,2009-02-15T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19201856,2009-02-15T00:00:00,Flow Cytometry,E05.200.500.386.350
19201856,2009-02-15T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
19201856,2009-02-15T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
19201856,2009-02-15T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
19201856,2009-02-15T00:00:00,Membrane Glycoproteins,D12.776.395.550
19201856,2009-02-15T00:00:00,Membrane Glycoproteins,D12.776.543.550
19201856,2009-02-15T00:00:00,Poly I-C,D13.695.578.550.560.600
19201856,2009-02-15T00:00:00,Poly I-C,D13.695.578.550.650.600
19201856,2009-02-15T00:00:00,Transplantation Conditioning,E02.095.465.425.450.800
19201856,2009-02-15T00:00:00,Transplantation Conditioning,E05.478.610.800
19201903,2009-02-15T00:00:00,Antioxidants,D27.505.519.217
19201903,2009-02-15T00:00:00,Antioxidants,D27.505.696.706.125
19201903,2009-02-15T00:00:00,Antioxidants,D27.720.799.047
19201903,2009-02-15T00:00:00,Gene Expression Regulation,G05.355.315
19201903,2009-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19201903,2009-02-15T00:00:00,Lactic Acid,D02.241.511.459.450
19201903,2009-02-15T00:00:00,Lipopolysaccharides,D09.400.500
19201903,2009-02-15T00:00:00,Lipopolysaccharides,D09.698.718.450
19201903,2009-02-15T00:00:00,Lipopolysaccharides,D10.494
19201903,2009-02-15T00:00:00,Lipopolysaccharides,D23.050.161.616.525
19201903,2009-02-15T00:00:00,Lipopolysaccharides,D23.946.123.329.500
19201903,2009-02-15T00:00:00,Macrophages,A11.329.372
19201903,2009-02-15T00:00:00,Macrophages,A11.627.482
19201903,2009-02-15T00:00:00,Macrophages,A11.733.397
19201903,2009-02-15T00:00:00,Macrophages,A15.382.680.397
19201903,2009-02-15T00:00:00,Macrophages,A15.382.812.522
19201903,2009-02-15T00:00:00,NF-kappa B,D12.776.260.600
19201903,2009-02-15T00:00:00,NF-kappa B,D12.776.660.600
19201903,2009-02-15T00:00:00,NF-kappa B,D12.776.930.600
19201903,2009-02-15T00:00:00,Signal Transduction,G02.111.087.800
19201903,2009-02-15T00:00:00,Signal Transduction,G02.149.115.800
19201903,2009-02-15T00:00:00,Signal Transduction,G04.299.880
19201903,2009-02-15T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
19201903,2009-02-15T00:00:00,"Transcription, Genetic",G02.111.087.847
19201903,2009-02-15T00:00:00,"Transcription, Genetic",G02.149.115.847
19201903,2009-02-15T00:00:00,"Transcription, Genetic",G05.355.310.700
19221370,2009-02-16T00:00:00,Adult,M01.060.116
19221370,2009-02-16T00:00:00,Aged,M01.060.116.100
19221370,2009-02-16T00:00:00,Combined Modality Therapy,E02.186
19221370,2009-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19221370,2009-02-16T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19221370,2009-02-16T00:00:00,Middle Aged,M01.060.116.630
19221370,2009-02-16T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
19223636,2009-02-17T00:00:00,Animals,B01.050
19223636,2009-02-17T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
19223636,2009-02-17T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
19223636,2009-02-17T00:00:00,Polyamines,D02.092.782
19223636,2009-02-17T00:00:00,Rabbits,B01.050.150.900.649.521.700
19224864,2009-02-17T00:00:00,Diffusion of Innovation,L01.143.320
19224864,2009-02-17T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
19224864,2009-02-17T00:00:00,"Hospitals, Teaching",N02.278.020.300
19224864,2009-02-17T00:00:00,"Hospitals, Teaching",N02.278.421.639
19224864,2009-02-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19224864,2009-02-17T00:00:00,Medical Order Entry Systems,L01.700.508.300.408.600
19224864,2009-02-17T00:00:00,Medical Order Entry Systems,L01.700.508.300.680.360.450
19224864,2009-02-17T00:00:00,Medical Order Entry Systems,L01.700.508.300.695.600
19224864,2009-02-17T00:00:00,Medical Order Entry Systems,N04.452.442.452.500
19224864,2009-02-17T00:00:00,Medical Order Entry Systems,N04.452.515.360.500
19224864,2009-02-17T00:00:00,Medical Order Entry Systems,N04.452.859.564.650.500
19224864,2009-02-17T00:00:00,Quality of Health Care,N04.761
19224864,2009-02-17T00:00:00,Quality of Health Care,N05.715
19224864,2009-02-17T00:00:00,Time Factors,G01.910.857
19224864,2009-02-17T00:00:00,United States,Z01.107.567.875
19226307,2009-02-17T00:00:00,Adolescent,M01.060.057
19226307,2009-02-17T00:00:00,Adult,M01.060.116
19226307,2009-02-17T00:00:00,Child,M01.060.406
19226307,2009-02-17T00:00:00,Ethnic Groups,M01.686.754
19226307,2009-02-17T00:00:00,Ethnic Groups,N01.224.317
19226307,2009-02-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19226307,2009-02-17T00:00:00,"Models, Genetic",E05.599.395.397
19226307,2009-02-17T00:00:00,Sex Characteristics,G08.686.815
19226307,2009-02-17T00:00:00,"Stress, Psychological",F01.145.126.990
19226307,2009-02-17T00:00:00,"Stress, Psychological",F02.830.900
19226307,2009-02-17T00:00:00,Young Adult,M01.060.116.815
19224380,2009-02-18T00:00:00,Diffusion of Innovation,L01.143.320
19224380,2009-02-18T00:00:00,Evidence-Based Medicine,H02.249.750
19224380,2009-02-18T00:00:00,Evidence-Based Medicine,H02.403.200.400
19224380,2009-02-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19224380,2009-02-18T00:00:00,Information Dissemination,F01.145.209.364
19224380,2009-02-18T00:00:00,Information Dissemination,L01.143.443
19224380,2009-02-18T00:00:00,"Models, Theoretical",E05.599
19224380,2009-02-18T00:00:00,Neoplasms,C04
19224380,2009-02-18T00:00:00,Preventive Medicine,H02.403.720.750
19224380,2009-02-18T00:00:00,Research Design,E05.581.500
19224380,2009-02-18T00:00:00,Research Design,H01.770.644.728
19224380,2009-02-18T00:00:00,United States,Z01.107.567.875
19225761,2009-02-19T00:00:00,Animals,B01.050
19225761,2009-02-19T00:00:00,Central Nervous System Depressants,D27.505.696.277
19225761,2009-02-19T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
19225761,2009-02-19T00:00:00,Ethanol,D02.033.375
19225761,2009-02-19T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
19225761,2009-02-19T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
19225761,2009-02-19T00:00:00,Feeding Behavior,F01.145.113.547
19225761,2009-02-19T00:00:00,Feeding Behavior,F01.145.407
19225761,2009-02-19T00:00:00,Motor Activity,F01.145.632
19225761,2009-02-19T00:00:00,Motor Activity,G11.427.590.530.698
19225761,2009-02-19T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19225761,2009-02-19T00:00:00,Piperidines,D03.383.621
19225761,2009-02-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19225761,2009-02-19T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
19225761,2009-02-19T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
19225761,2009-02-19T00:00:00,Signal Transduction,G02.111.087.800
19225761,2009-02-19T00:00:00,Signal Transduction,G02.149.115.800
19225761,2009-02-19T00:00:00,Signal Transduction,G04.299.880
19225761,2009-02-19T00:00:00,Thiazoles,D02.886.675
19225761,2009-02-19T00:00:00,Thiazoles,D03.383.129.708
19228621,2009-02-19T00:00:00,"Embolization, Therapeutic",E02.520.360
19228621,2009-02-19T00:00:00,Epistaxis,C08.460.261
19228621,2009-02-19T00:00:00,Epistaxis,C09.603.261
19228621,2009-02-19T00:00:00,Epistaxis,C23.550.414.712
19228621,2009-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19228621,2009-02-19T00:00:00,Middle Aged,M01.060.116.630
19228621,2009-02-19T00:00:00,Nasal Septum,A04.531.591
19228621,2009-02-19T00:00:00,Pressure,G01.374.715
19228812,2009-02-19T00:00:00,Aged,M01.060.116.100
19228812,2009-02-19T00:00:00,Cyclonic Storms,G16.500.240.135.500
19228812,2009-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19228812,2009-02-19T00:00:00,Interviews as Topic,E05.318.308.420
19228812,2009-02-19T00:00:00,Interviews as Topic,L01.280.520
19228812,2009-02-19T00:00:00,Interviews as Topic,N05.715.360.300.400
19228812,2009-02-19T00:00:00,Interviews as Topic,N06.850.520.308.420
19228812,2009-02-19T00:00:00,Life Change Events,F01.829.458.410
19228812,2009-02-19T00:00:00,Middle Aged,M01.060.116.630
19228812,2009-02-19T00:00:00,"Polymorphism, Genetic",G05.365.795
19228812,2009-02-19T00:00:00,Risk Factors,E05.318.740.600.800.725
19228812,2009-02-19T00:00:00,Risk Factors,N05.715.350.200.700
19228812,2009-02-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19228812,2009-02-19T00:00:00,Risk Factors,N06.850.490.625.750
19228812,2009-02-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19228812,2009-02-19T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.450.625.311
19228812,2009-02-19T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.562.374.875
19228812,2009-02-19T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.450.625.374
19228812,2009-02-19T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.562.374.875
19228812,2009-02-19T00:00:00,Social Environment,I01.880.656
19228812,2009-02-19T00:00:00,Social Support,I01.880.656.600
19228812,2009-02-19T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19236436,2009-02-19T00:00:00,Adult,M01.060.116
19236436,2009-02-19T00:00:00,African Americans,M01.686.508.100.100
19236436,2009-02-19T00:00:00,African Americans,M01.686.754.100
19236436,2009-02-19T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
19236436,2009-02-19T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
19236436,2009-02-19T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
19236436,2009-02-19T00:00:00,Antilymphocyte Serum,A12.207.152.846.500.203
19236436,2009-02-19T00:00:00,Antilymphocyte Serum,D12.776.124.486.485.114.573.203
19236436,2009-02-19T00:00:00,Antilymphocyte Serum,D12.776.124.790.651.114.573.203
19236436,2009-02-19T00:00:00,Antilymphocyte Serum,D12.776.377.715.548.114.573.203
19236436,2009-02-19T00:00:00,Antilymphocyte Serum,D20.215.401.203
19236436,2009-02-19T00:00:00,Graft Rejection,G12.425.901.545.328
19236436,2009-02-19T00:00:00,Graft Survival,G12.425.901.545.340
19236436,2009-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19236436,2009-02-19T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
19236436,2009-02-19T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
19236436,2009-02-19T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
19236436,2009-02-19T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
19236436,2009-02-19T00:00:00,Kidney Diseases,C12.777.419
19236436,2009-02-19T00:00:00,Kidney Diseases,C13.351.968.419
19236436,2009-02-19T00:00:00,Kidney Transplantation,E02.870.500
19236436,2009-02-19T00:00:00,Kidney Transplantation,E04.936.450.485
19236436,2009-02-19T00:00:00,Kidney Transplantation,E04.950.774.400
19236436,2009-02-19T00:00:00,Middle Aged,M01.060.116.630
19236436,2009-02-19T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19236436,2009-02-19T00:00:00,Treatment Outcome,E01.789.800
19236436,2009-02-19T00:00:00,Treatment Outcome,N04.761.559.590.800
19236436,2009-02-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19513140,2009-02-19T00:00:00,"Education, Pharmacy",I02.358.525
19513140,2009-02-19T00:00:00,Faculty,I02.463
19513140,2009-02-19T00:00:00,Faculty,M01.526.339
19513140,2009-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19513140,2009-02-19T00:00:00,Motivation,F01.658
19513140,2009-02-19T00:00:00,Motivation,F01.752.543.500.750
19513140,2009-02-19T00:00:00,Pharmacists,M01.526.485.780
19513140,2009-02-19T00:00:00,Pharmacists,N02.360.780
19513140,2009-02-19T00:00:00,Professional Competence,I02.399.630
19513140,2009-02-19T00:00:00,Professional Role,F01.829.316.616.625
19513140,2009-02-19T00:00:00,"Students, Pharmacy",I02.851.686.768
19513140,2009-02-19T00:00:00,"Students, Pharmacy",M01.848.769.768
19229019,2009-02-20T00:00:00,Biomedical Research,H01.770.644.145
19229019,2009-02-20T00:00:00,Clinical Trials as Topic,E05.318.760.535
19229019,2009-02-20T00:00:00,Clinical Trials as Topic,E05.337.250
19229019,2009-02-20T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19229019,2009-02-20T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19229019,2009-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19229019,2009-02-20T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
19229019,2009-02-20T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
19229019,2009-02-20T00:00:00,United States,Z01.107.567.875
19234097,2009-02-20T00:00:00,Cell Cycle Proteins,D12.776.167
19234097,2009-02-20T00:00:00,DNA Replication,G02.111.087.222
19234097,2009-02-20T00:00:00,DNA Replication,G02.149.115.222
19234097,2009-02-20T00:00:00,DNA Replication,G05.355.200
19234097,2009-02-20T00:00:00,DNA-Binding Proteins,D12.776.260
19234097,2009-02-20T00:00:00,"Recombination, Genetic",G05.355.760
19234097,2009-02-20T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
19234097,2009-02-20T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
19234097,2009-02-20T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
19236840,2009-02-21T00:00:00,Animals,B01.050
19236840,2009-02-21T00:00:00,Cell Line,A11.251.210
19236840,2009-02-21T00:00:00,Enzyme Inhibitors,D27.505.519.389
19236840,2009-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19236840,2009-02-21T00:00:00,Liposomes,D25.479.517
19236840,2009-02-21T00:00:00,Liposomes,D26.255.260.517
19236840,2009-02-21T00:00:00,Liposomes,D27.720.280.260.517
19236840,2009-02-21T00:00:00,Liposomes,J01.637.051.479.517
19236840,2009-02-21T00:00:00,Liposomes,J01.637.087.500.517
19236840,2009-02-21T00:00:00,Peroxidases,D08.811.682.732
19236840,2009-02-21T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.300.500
19236840,2009-02-21T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.625.624
19236840,2009-02-21T00:00:00,Peroxiredoxin VI,D08.811.682.732.850.500
19236840,2009-02-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19236840,2009-02-21T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
19236840,2009-02-21T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
19356993,2009-02-21T00:00:00,Gastric Bypass,E02.065.062.249
19356993,2009-02-21T00:00:00,Gastric Bypass,E04.035.398.385
19356993,2009-02-21T00:00:00,Gastric Bypass,E04.062.249
19356993,2009-02-21T00:00:00,Gastric Bypass,E04.210.457.430
19356993,2009-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19356993,2009-02-21T00:00:00,Middle Aged,M01.060.116.630
19356993,2009-02-21T00:00:00,"Obesity, Morbid",C18.654.726.500.700
19356993,2009-02-21T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
19356993,2009-02-21T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
19356993,2009-02-21T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
19233596,2009-02-23T00:00:00,Angiography,E01.370.350.700.060
19233596,2009-02-23T00:00:00,Angiography,E01.370.370.050
19233596,2009-02-23T00:00:00,Blood Pressure,E01.370.600.875.249
19233596,2009-02-23T00:00:00,Blood Pressure,G09.330.380.076
19233596,2009-02-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19233596,2009-02-23T00:00:00,Ischemia,C23.550.513
19233596,2009-02-23T00:00:00,"Mesenteric Artery, Superior",A07.231.114.565.755
19233596,2009-02-23T00:00:00,Risk Factors,E05.318.740.600.800.725
19233596,2009-02-23T00:00:00,Risk Factors,N05.715.350.200.700
19233596,2009-02-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19233596,2009-02-23T00:00:00,Risk Factors,N06.850.490.625.750
19233596,2009-02-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19233596,2009-02-23T00:00:00,Stents,E07.695.750
19237663,2009-02-23T00:00:00,Adenosine Triphosphatases,D08.811.277.040.025
19237663,2009-02-23T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
19237663,2009-02-23T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
19237663,2009-02-23T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
19237663,2009-02-23T00:00:00,Animals,B01.050
19237663,2009-02-23T00:00:00,Carrier Proteins,D12.776.157
19237663,2009-02-23T00:00:00,Echocardiography,E01.370.350.850.220
19237663,2009-02-23T00:00:00,Echocardiography,E01.370.370.380.220
19237663,2009-02-23T00:00:00,Gene Expression,G05.355.310
19237663,2009-02-23T00:00:00,Membrane Proteins,D12.776.543
19237663,2009-02-23T00:00:00,Mitochondrial Diseases,C18.452.660
19237663,2009-02-23T00:00:00,Myocardium,A02.633.580
19237663,2009-02-23T00:00:00,Myocardium,A07.541.704
19237663,2009-02-23T00:00:00,Myocardium,A10.690.552.750
19237663,2009-02-23T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19237663,2009-02-23T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19237663,2009-02-23T00:00:00,"Myocytes, Cardiac",A11.620.500
19237663,2009-02-23T00:00:00,Oxidative Stress,G03.495.710
19237663,2009-02-23T00:00:00,Oxidative Stress,G07.700.830.750
19237663,2009-02-23T00:00:00,Oxygen Consumption,G03.730
19237663,2009-02-23T00:00:00,Phenotype,G05.695
19237663,2009-02-23T00:00:00,Proteomics,H01.158.201.843
19237663,2009-02-23T00:00:00,Proteomics,H01.158.273.180.350.700
19237663,2009-02-23T00:00:00,Proteomics,H01.158.273.343.350.700
19237663,2009-02-23T00:00:00,Proteomics,H01.181.122.738
19237663,2009-02-23T00:00:00,Signal Transduction,G02.111.087.800
19237663,2009-02-23T00:00:00,Signal Transduction,G02.149.115.800
19237663,2009-02-23T00:00:00,Signal Transduction,G04.299.880
19237663,2009-02-23T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
19239981,2009-02-23T00:00:00,Animals,B01.050
19239981,2009-02-23T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
19239981,2009-02-23T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
19239981,2009-02-23T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
19239981,2009-02-23T00:00:00,Brain,A08.186.211
19239981,2009-02-23T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
19239981,2009-02-23T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
19239981,2009-02-23T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
19239981,2009-02-23T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
19239981,2009-02-23T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
19239981,2009-02-23T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
19239981,2009-02-23T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
19239981,2009-02-23T00:00:00,Piperazines,D03.383.606
19239981,2009-02-23T00:00:00,Quinolones,D03.438.810.835
19239981,2009-02-23T00:00:00,Time Factors,G01.910.857
19173594,2009-02-24T00:00:00,Cell Line,A11.251.210
19173594,2009-02-24T00:00:00,Endocytosis,G04.299.482
19173594,2009-02-24T00:00:00,Glycoproteins,D09.400.430
19173594,2009-02-24T00:00:00,Glycoproteins,D12.776.395
19173594,2009-02-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19173594,2009-02-24T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
19173594,2009-02-24T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
19173594,2009-02-24T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
19173594,2009-02-24T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19173594,2009-02-24T00:00:00,"Microscopy, Confocal",E05.595.395
19173594,2009-02-24T00:00:00,Phosphorylation,G02.111.087.677
19173594,2009-02-24T00:00:00,Phosphorylation,G02.149.115.677
19173594,2009-02-24T00:00:00,Phosphorylation,G02.149.465.700
19173594,2009-02-24T00:00:00,Phosphorylation,G02.607.750.700
19173594,2009-02-24T00:00:00,Phosphorylation,G03.495.790
19173594,2009-02-24T00:00:00,RNA Interference,G05.355.315.203.374.790
19173594,2009-02-24T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
19173594,2009-02-24T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
19173594,2009-02-24T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
19173594,2009-02-24T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
19173594,2009-02-24T00:00:00,Signal Transduction,G02.111.087.800
19173594,2009-02-24T00:00:00,Signal Transduction,G02.149.115.800
19173594,2009-02-24T00:00:00,Signal Transduction,G04.299.880
19238517,2009-02-24T00:00:00,Adolescent,M01.060.057
19238517,2009-02-24T00:00:00,Adult,M01.060.116
19238517,2009-02-24T00:00:00,Electromyography,E01.370.405.255
19238517,2009-02-24T00:00:00,Electromyography,E01.370.530.255
19238517,2009-02-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19238517,2009-02-24T00:00:00,Motor Activity,F01.145.632
19238517,2009-02-24T00:00:00,Motor Activity,G11.427.590.530.698
19238517,2009-02-24T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
19238517,2009-02-24T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19238517,2009-02-24T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19238517,2009-02-24T00:00:00,Triazines,D03.383.931
19238517,2009-02-24T00:00:00,Valproic Acid,D02.241.081.944.509.900
19238517,2009-02-24T00:00:00,Valproic Acid,D10.251.400.895.593.900
19238517,2009-02-24T00:00:00,Young Adult,M01.060.116.815
19243859,2009-02-25T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19243859,2009-02-25T00:00:00,Bacterial Toxins,D23.946.123
19243859,2009-02-25T00:00:00,Clostridium difficile,B03.300.390.400.200.250
19243859,2009-02-25T00:00:00,Clostridium difficile,B03.510.415.400.200.250
19243859,2009-02-25T00:00:00,Cross Infection,C01.539.248
19243859,2009-02-25T00:00:00,Disease Outbreaks,N06.850.290
19243859,2009-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19243859,2009-02-25T00:00:00,Infection Control,N06.850.780.200.450
19243859,2009-02-25T00:00:00,Patient Isolation,E02.770
19243859,2009-02-25T00:00:00,Patient Isolation,N06.850.780.200.450.650
19244188,2009-02-25T00:00:00,African Continental Ancestry Group,M01.686.508.100
19244188,2009-02-25T00:00:00,Colonic Polyps,C23.300.825.411.235
19244188,2009-02-25T00:00:00,Colonoscopy,E01.370.372.250.250.200
19244188,2009-02-25T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
19244188,2009-02-25T00:00:00,Colonoscopy,E04.210.240.250.160
19244188,2009-02-25T00:00:00,Colonoscopy,E04.800.250.250.250.160
19244188,2009-02-25T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19244188,2009-02-25T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19244188,2009-02-25T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19244188,2009-02-25T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19244188,2009-02-25T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19244188,2009-02-25T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19244188,2009-02-25T00:00:00,European Continental Ancestry Group,M01.686.508.400
19244188,2009-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19244188,2009-02-25T00:00:00,Mass Screening,E01.370.500
19244188,2009-02-25T00:00:00,Mass Screening,E05.318.308.250.580
19244188,2009-02-25T00:00:00,Mass Screening,N02.421.143.827.233.443
19244188,2009-02-25T00:00:00,Mass Screening,N02.421.726.233.443
19244188,2009-02-25T00:00:00,Mass Screening,N05.715.360.300.375.500
19244188,2009-02-25T00:00:00,Mass Screening,N06.850.520.308.250.580
19244188,2009-02-25T00:00:00,Mass Screening,N06.850.780.500
19244188,2009-02-25T00:00:00,Risk Factors,E05.318.740.600.800.725
19244188,2009-02-25T00:00:00,Risk Factors,N05.715.350.200.700
19244188,2009-02-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19244188,2009-02-25T00:00:00,Risk Factors,N06.850.490.625.750
19244188,2009-02-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19244188,2009-02-25T00:00:00,United States,Z01.107.567.875
19246037,2009-02-25T00:00:00,Adolescent,M01.060.057
19246037,2009-02-25T00:00:00,Adult,M01.060.116
19246037,2009-02-25T00:00:00,Aged,M01.060.116.100
19246037,2009-02-25T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
19246037,2009-02-25T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
19246037,2009-02-25T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
19246037,2009-02-25T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
19246037,2009-02-25T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
19246037,2009-02-25T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
19246037,2009-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19246037,2009-02-25T00:00:00,Incidence,E05.318.308.985.525.375
19246037,2009-02-25T00:00:00,Incidence,L01.280.975.525.375
19246037,2009-02-25T00:00:00,Incidence,N01.224.935.597.500
19246037,2009-02-25T00:00:00,Incidence,N06.850.505.400.975.525.375
19246037,2009-02-25T00:00:00,Incidence,N06.850.520.308.985.525.375
19246037,2009-02-25T00:00:00,Middle Aged,M01.060.116.630
19246037,2009-02-25T00:00:00,Pancreatitis,C06.689.750
19246037,2009-02-25T00:00:00,South Carolina,Z01.107.567.875.075.662
19246037,2009-02-25T00:00:00,South Carolina,Z01.107.567.875.750.700
19246037,2009-02-25T00:00:00,Young Adult,M01.060.116.815
19242796,2009-02-26T00:00:00,Aged,M01.060.116.100
19242796,2009-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19242796,2009-02-26T00:00:00,Liver Transplantation,E04.210.650
19242796,2009-02-26T00:00:00,Liver Transplantation,E04.936.450.490
19242796,2009-02-26T00:00:00,Liver Transplantation,E04.936.580.490
19242796,2009-02-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19242796,2009-02-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19242796,2009-02-26T00:00:00,Middle Aged,M01.060.116.630
19242796,2009-02-26T00:00:00,Portal Vein,A07.231.908.670.567
19242796,2009-02-26T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.035.760.795
19242796,2009-02-26T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.100.814.790.830
19242796,2009-02-26T00:00:00,Postoperative Complications,C23.550.767
19242796,2009-02-26T00:00:00,Thrombectomy,E04.100.814.842
19242796,2009-02-26T00:00:00,Venous Thrombosis,C14.907.355.830.925
19246453,2009-02-26T00:00:00,Animals,B01.050
19246453,2009-02-26T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
19246453,2009-02-26T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
19246453,2009-02-26T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
19246453,2009-02-26T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
19246453,2009-02-26T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
19246453,2009-02-26T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
19246453,2009-02-26T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19246453,2009-02-26T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19246453,2009-02-26T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19246453,2009-02-26T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19246453,2009-02-26T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19246453,2009-02-26T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
19246453,2009-02-26T00:00:00,Gene Expression,G05.355.310
19246453,2009-02-26T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19246453,2009-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19246453,2009-02-26T00:00:00,Hyaluronic Acid,D09.698.373.475
19246453,2009-02-26T00:00:00,Nanoparticles,J01.637.512.600
19246453,2009-02-26T00:00:00,RNA,D13.444.735
19246453,2009-02-26T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
19246453,2009-02-26T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
19246453,2009-02-26T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
19246453,2009-02-26T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
19246453,2009-02-26T00:00:00,"Receptor, erbB-2",D23.101.840.642
19246453,2009-02-26T00:00:00,Signal Transduction,G02.111.087.800
19246453,2009-02-26T00:00:00,Signal Transduction,G02.149.115.800
19246453,2009-02-26T00:00:00,Signal Transduction,G04.299.880
19246453,2009-02-26T00:00:00,Transferrin,D12.776.124.050.800
19246453,2009-02-26T00:00:00,Transferrin,D12.776.124.790.223.839
19246453,2009-02-26T00:00:00,Transferrin,D12.776.157.427.500
19246453,2009-02-26T00:00:00,Transferrin,D12.776.377.715.182.839
19246453,2009-02-26T00:00:00,Transferrin,D12.776.556.579.500
19246557,2009-02-26T00:00:00,Adolescent,M01.060.057
19246557,2009-02-26T00:00:00,Adult,M01.060.116
19246557,2009-02-26T00:00:00,Child,M01.060.406
19246557,2009-02-26T00:00:00,Chronic Disease,C23.550.291.500
19246557,2009-02-26T00:00:00,Epilepsy,C10.228.140.490
19246557,2009-02-26T00:00:00,Exercise Therapy,E02.779.483
19246557,2009-02-26T00:00:00,Exercise Therapy,E02.831.387
19246557,2009-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19246557,2009-02-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19246557,2009-02-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19246557,2009-02-26T00:00:00,Movement,G07.700.560
19246557,2009-02-26T00:00:00,Movement,G11.427.590.530
19246557,2009-02-26T00:00:00,Paresis,C10.597.636
19246557,2009-02-26T00:00:00,Paresis,C23.888.592.643
19246557,2009-02-26T00:00:00,"Restraint, Physical",E02.085.700
19246557,2009-02-26T00:00:00,"Restraint, Physical",E05.472.760
19246557,2009-02-26T00:00:00,Treatment Outcome,E01.789.800
19246557,2009-02-26T00:00:00,Treatment Outcome,N04.761.559.590.800
19246557,2009-02-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19246557,2009-02-26T00:00:00,Young Adult,M01.060.116.815
19249310,2009-02-26T00:00:00,Animals,B01.050
19249310,2009-02-26T00:00:00,Echocardiography,E01.370.350.850.220
19249310,2009-02-26T00:00:00,Echocardiography,E01.370.370.380.220
19249310,2009-02-26T00:00:00,Fatty Acids,D10.251
19249310,2009-02-26T00:00:00,Lipid Metabolism,G03.495.520
19249310,2009-02-26T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
19249310,2009-02-26T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
19249310,2009-02-26T00:00:00,Myocardial Infarction,C14.280.647.500
19249310,2009-02-26T00:00:00,Myocardial Infarction,C14.907.585.500
19249310,2009-02-26T00:00:00,Oxygen Consumption,G03.730
19249310,2009-02-26T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19249310,2009-02-26T00:00:00,Signal Transduction,G02.111.087.800
19249310,2009-02-26T00:00:00,Signal Transduction,G02.149.115.800
19249310,2009-02-26T00:00:00,Signal Transduction,G04.299.880
19273454,2009-02-27T00:00:00,Adolescent,M01.060.057
19273454,2009-02-27T00:00:00,Adult,M01.060.116
19273454,2009-02-27T00:00:00,Aged,M01.060.116.100
19273454,2009-02-27T00:00:00,Cost of Illness,I01.137
19273454,2009-02-27T00:00:00,Cost of Illness,N03.219.151.165
19273454,2009-02-27T00:00:00,Employment,N01.824.245
19273454,2009-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19273454,2009-02-27T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19273454,2009-02-27T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19273454,2009-02-27T00:00:00,Middle Aged,M01.060.116.630
19273454,2009-02-27T00:00:00,Questionnaires,E05.318.308.750
19273454,2009-02-27T00:00:00,Questionnaires,L01.280.800
19273454,2009-02-27T00:00:00,Questionnaires,N05.715.360.300.695
19273454,2009-02-27T00:00:00,Questionnaires,N06.850.520.308.750
19273454,2009-02-27T00:00:00,Risk Factors,E05.318.740.600.800.725
19273454,2009-02-27T00:00:00,Risk Factors,N05.715.350.200.700
19273454,2009-02-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19273454,2009-02-27T00:00:00,Risk Factors,N06.850.490.625.750
19273454,2009-02-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19273454,2009-02-27T00:00:00,Young Adult,M01.060.116.815
19590674,2009-02-27T00:00:00,Environmental Health,H02.229
19590674,2009-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19590674,2009-02-27T00:00:00,United States,Z01.107.567.875
20633405,2009-02-28T00:00:00,Brain Mapping,E01.370.350.086
20633405,2009-02-28T00:00:00,Brain Mapping,E01.370.376.149
20633405,2009-02-28T00:00:00,Brain Mapping,E05.132
20633405,2009-02-28T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20633405,2009-02-28T00:00:00,Electroencephalography,E01.370.376.300
20633405,2009-02-28T00:00:00,Electroencephalography,E01.370.405.245
20633405,2009-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633405,2009-02-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20633405,2009-02-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20633405,2009-02-28T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20633405,2009-02-28T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
18717629,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18717629,2009-03-01T00:00:00,"Models, Theoretical",E05.599
18717629,2009-03-01T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
18717629,2009-03-01T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
18717629,2009-03-01T00:00:00,Neurodegenerative Diseases,C10.574
18987553,2009-03-01T00:00:00,Adult,M01.060.116
18987553,2009-03-01T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
18987553,2009-03-01T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
18987553,2009-03-01T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
18987553,2009-03-01T00:00:00,Deglutition,G10.261.326.215
18987553,2009-03-01T00:00:00,Double-Blind Method,E05.318.780.300
18987553,2009-03-01T00:00:00,Double-Blind Method,E05.581.500.300
18987553,2009-03-01T00:00:00,Double-Blind Method,N05.715.360.780.320
18987553,2009-03-01T00:00:00,Double-Blind Method,N06.850.520.445.300
18987553,2009-03-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
18987553,2009-03-01T00:00:00,Esophagus,A03.556.875.500
18987553,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18987553,2009-03-01T00:00:00,Manometry,E05.559
18987553,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
18987553,2009-03-01T00:00:00,Young Adult,M01.060.116.815
19144876,2009-03-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
19144876,2009-03-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
19144876,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19144876,2009-03-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
19144876,2009-03-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
19144876,2009-03-01T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
19144876,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19144876,2009-03-01T00:00:00,Myocardial Infarction,C14.280.647.500
19144876,2009-03-01T00:00:00,Myocardial Infarction,C14.907.585.500
19144876,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19144876,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19144876,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19144876,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19144876,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19194974,2009-03-01T00:00:00,"Membranes, Artificial",D25.479
19194974,2009-03-01T00:00:00,"Membranes, Artificial",J01.637.051.479
19194974,2009-03-01T00:00:00,"Membranes, Artificial",J01.637.087.500
19194974,2009-03-01T00:00:00,Polymers,D05.750
19194974,2009-03-01T00:00:00,Polymers,D25.720
19194974,2009-03-01T00:00:00,Polymers,J01.637.051.720
19194974,2009-03-01T00:00:00,Proteins,D12.776
19194974,2009-03-01T00:00:00,Surface Properties,G02.842.850
19196035,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19196035,2009-03-01T00:00:00,Infant Formula,J02.200.700.249
19196035,2009-03-01T00:00:00,Infant Formula,J02.200.712.249
19196035,2009-03-01T00:00:00,Infant Formula,J02.500.350.525.332
19196035,2009-03-01T00:00:00,Infant Formula,J02.500.525.350.500
19196035,2009-03-01T00:00:00,Infant Formula,J02.500.525.500.500
19196035,2009-03-01T00:00:00,Infant Nutritional Physiological Phenomena,G07.610.220.500
19196035,2009-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
19196035,2009-03-01T00:00:00,"Infant, Premature",M01.060.703.520.520
19196035,2009-03-01T00:00:00,"Milk, Human",A12.200.467
19196035,2009-03-01T00:00:00,"Milk, Human",J02.200.700.500
19196035,2009-03-01T00:00:00,"Milk, Human",J02.500.350.525.500
19202395,2009-03-01T00:00:00,Civil Defense,I01.451.227
19202395,2009-03-01T00:00:00,Community Networks,I01.880.656.300
19202395,2009-03-01T00:00:00,Community Networks,L01.700.508.300.184
19202395,2009-03-01T00:00:00,Community Networks,N02.421.143.202
19202395,2009-03-01T00:00:00,Disaster Planning,N06.230.100.035
19202395,2009-03-01T00:00:00,Health Personnel,M01.526.485
19202395,2009-03-01T00:00:00,Health Personnel,N02.360
19202395,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19202395,2009-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19202395,2009-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19207482,2009-03-01T00:00:00,Animals,B01.050
19207482,2009-03-01T00:00:00,Biological Markers,D23.101
19207482,2009-03-01T00:00:00,Cell Cycle,G04.299.134
19207482,2009-03-01T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
19207482,2009-03-01T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
19207482,2009-03-01T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
19207482,2009-03-01T00:00:00,Trypanosoma brucei brucei,B01.268.475.868.887.080
19211526,2009-03-01T00:00:00,Aging,G07.700.320.124
19211526,2009-03-01T00:00:00,Animals,B01.050
19211526,2009-03-01T00:00:00,Chickens,B01.050.150.900.248.350.150
19211526,2009-03-01T00:00:00,Chickens,B01.050.150.900.248.617.192
19211526,2009-03-01T00:00:00,Gastrointestinal Tract,A03.556
19211526,2009-03-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
19211526,2009-03-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
19211526,2009-03-01T00:00:00,Poultry Diseases,C22.131.728
19212680,2009-03-01T00:00:00,Apoptosis,G04.299.139.160
19212680,2009-03-01T00:00:00,Calcium,D01.268.552.100
19212680,2009-03-01T00:00:00,Calcium,D01.552.539.288
19212680,2009-03-01T00:00:00,Calcium,D23.119.100
19212680,2009-03-01T00:00:00,Calpain,D08.811.277.656.262.500.120
19212680,2009-03-01T00:00:00,Calpain,D08.811.277.656.300.200.120
19212680,2009-03-01T00:00:00,Cell Differentiation,G04.299.151
19212680,2009-03-01T00:00:00,Down-Regulation,G02.111.087.225
19212680,2009-03-01T00:00:00,Down-Regulation,G02.149.115.225
19212680,2009-03-01T00:00:00,Down-Regulation,G05.355.315.200
19212680,2009-03-01T00:00:00,Down-Regulation,G07.690.812.230
19212680,2009-03-01T00:00:00,Down-Regulation,G07.700.680.230
19212680,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19212680,2009-03-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19212680,2009-03-01T00:00:00,Mitochondria,A11.284.835.626
19212680,2009-03-01T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
19212680,2009-03-01T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
19212680,2009-03-01T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
19212680,2009-03-01T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
19212680,2009-03-01T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
19212680,2009-03-01T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
19212680,2009-03-01T00:00:00,Retinoids,D02.455.326.271.665.202.495
19212680,2009-03-01T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
19212680,2009-03-01T00:00:00,Retinoids,D02.455.849.131.495
19212680,2009-03-01T00:00:00,Retinoids,D23.767.261.700
19212680,2009-03-01T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
19212680,2009-03-01T00:00:00,Telomerase,D12.776.157.725.500.921
19212680,2009-03-01T00:00:00,Telomerase,D12.776.664.962.500.921
19218526,2009-03-01T00:00:00,Computer Simulation,L01.224.160
19218526,2009-03-01T00:00:00,Gait,E01.370.600.250
19218526,2009-03-01T00:00:00,Gait,G11.427.590.530.389
19218526,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19218526,2009-03-01T00:00:00,Joints,A02.835.583
19218526,2009-03-01T00:00:00,"Muscle, Skeletal",A02.633.567
19218526,2009-03-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
19218526,2009-03-01T00:00:00,Walking,G11.427.590.530.568.900
19218526,2009-03-01T00:00:00,Walking,G11.427.590.530.698.940
19218526,2009-03-01T00:00:00,Walking,I03.450.642.845.940
19225134,2009-03-01T00:00:00,Cytomegalovirus,B04.280.382.150.150
19225134,2009-03-01T00:00:00,Cytomegalovirus,B04.909.204.382.150.150
19225134,2009-03-01T00:00:00,DNA,D13.444.308
19225134,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19225134,2009-03-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19225956,2009-03-01T00:00:00,Adolescent,M01.060.057
19225956,2009-03-01T00:00:00,Adult,M01.060.116
19225956,2009-03-01T00:00:00,Cooperative Behavior,F01.145.813.115
19225956,2009-03-01T00:00:00,Data Collection,E05.318.308
19225956,2009-03-01T00:00:00,Data Collection,L01.280
19225956,2009-03-01T00:00:00,Data Collection,N05.715.360.300
19225956,2009-03-01T00:00:00,Data Collection,N06.850.520.308
19225956,2009-03-01T00:00:00,Health Personnel,M01.526.485
19225956,2009-03-01T00:00:00,Health Personnel,N02.360
19225956,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19225956,2009-03-01T00:00:00,Interdisciplinary Communication,F01.145.209.381
19225956,2009-03-01T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
19225956,2009-03-01T00:00:00,Interdisciplinary Communication,L01.143.474
19225956,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19225956,2009-03-01T00:00:00,"Schools, Medical",I02.783.660.552
19225956,2009-03-01T00:00:00,"Schools, Medical",N02.278.020.578
19225956,2009-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19225956,2009-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19225956,2009-03-01T00:00:00,Young Adult,M01.060.116.815
19231369,2009-03-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
19231369,2009-03-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
19231369,2009-03-01T00:00:00,Publishing,L01.737
19231369,2009-03-01T00:00:00,Thoracic Surgical Procedures,E04.928
19231369,2009-03-01T00:00:00,Treatment Outcome,E01.789.800
19231369,2009-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19231369,2009-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19231388,2009-03-01T00:00:00,Adult,M01.060.116
19231388,2009-03-01T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
19231388,2009-03-01T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
19231388,2009-03-01T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
19231388,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19231388,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19231388,2009-03-01T00:00:00,Treatment Outcome,E01.789.800
19231388,2009-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19231388,2009-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19231394,2009-03-01T00:00:00,Hemodynamics,G09.330.190.400
19231394,2009-03-01T00:00:00,Hemodynamics,G09.330.380
19231394,2009-03-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
19231394,2009-03-01T00:00:00,Myocardial Infarction,C14.280.647.500
19231394,2009-03-01T00:00:00,Myocardial Infarction,C14.907.585.500
19231394,2009-03-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
19243014,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19243014,2009-03-01T00:00:00,Liver,A03.620
19243014,2009-03-01T00:00:00,Liver Diseases,C06.552
19247196,2009-03-01T00:00:00,Animals,B01.050
19247196,2009-03-01T00:00:00,Brain,A08.186.211
19247196,2009-03-01T00:00:00,Cell Death,G04.299.139
19247196,2009-03-01T00:00:00,Ceramides,D02.065.313
19247196,2009-03-01T00:00:00,Ceramides,D09.400.410.420.525.200
19247196,2009-03-01T00:00:00,Ceramides,D10.390.470.675.200
19247196,2009-03-01T00:00:00,Ceramides,D10.570.877.360.612.200
19247196,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19247196,2009-03-01T00:00:00,Kidney,A05.810.453
19247196,2009-03-01T00:00:00,Liver,A03.620
19247196,2009-03-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19247196,2009-03-01T00:00:00,Mitochondria,A11.284.835.626
19247196,2009-03-01T00:00:00,Myocardium,A02.633.580
19247196,2009-03-01T00:00:00,Myocardium,A07.541.704
19247196,2009-03-01T00:00:00,Myocardium,A10.690.552.750
19247196,2009-03-01T00:00:00,Reperfusion Injury,C14.907.725
19247196,2009-03-01T00:00:00,Reperfusion Injury,C23.550.767.877
19247196,2009-03-01T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
19248944,2009-03-01T00:00:00,Adult,M01.060.116
19248944,2009-03-01T00:00:00,Aged,M01.060.116.100
19248944,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19248944,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19248944,2009-03-01T00:00:00,Prostheses and Implants,E07.695
19248944,2009-03-01T00:00:00,Prosthesis Implantation,E04.650
19248944,2009-03-01T00:00:00,Treatment Outcome,E01.789.800
19248944,2009-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19248944,2009-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19251147,2009-03-01T00:00:00,Cataract,C11.510.245
19251147,2009-03-01T00:00:00,Cataract Extraction,E04.540.825.249
19251147,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19251147,2009-03-01T00:00:00,Infant,M01.060.703
19251147,2009-03-01T00:00:00,Intraoperative Complications,C23.550.505
19251147,2009-03-01T00:00:00,Postoperative Complications,C23.550.767
19251147,2009-03-01T00:00:00,Treatment Outcome,E01.789.800
19251147,2009-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19251147,2009-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19251147,2009-03-01T00:00:00,Visual Acuity,E01.370.380.850.950
19251147,2009-03-01T00:00:00,Visual Acuity,F02.463.593.932.901
19251147,2009-03-01T00:00:00,Visual Acuity,G14.940
19251910,2009-03-01T00:00:00,Adult,M01.060.116
19251910,2009-03-01T00:00:00,Aged,M01.060.116.100
19251910,2009-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19251910,2009-03-01T00:00:00,Body Mass Index,E05.041.124.125
19251910,2009-03-01T00:00:00,Body Mass Index,G07.100.100.125
19251910,2009-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19251910,2009-03-01T00:00:00,Energy Intake,G07.610.240.340
19251910,2009-03-01T00:00:00,Energy Metabolism,G03.495.335
19251910,2009-03-01T00:00:00,Hospitalization,E02.760.400
19251910,2009-03-01T00:00:00,Hospitalization,N02.421.585.400
19251910,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19251910,2009-03-01T00:00:00,Mathematics,H01.548
19251910,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19251910,2009-03-01T00:00:00,Obesity,C18.654.726.500
19251910,2009-03-01T00:00:00,Obesity,C23.888.144.699.500
19251910,2009-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19251910,2009-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19251910,2009-03-01T00:00:00,"Respiration, Artificial",E02.365.647.729
19251910,2009-03-01T00:00:00,"Respiration, Artificial",E02.880.820
19251910,2009-03-01T00:00:00,Young Adult,M01.060.116.815
19255048,2009-03-01T00:00:00,Conflict of Interest,K01.316.130
19255048,2009-03-01T00:00:00,Conflict of Interest,N05.350.225
19255048,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19255048,2009-03-01T00:00:00,Psychiatry,F04.096.544
19255048,2009-03-01T00:00:00,Psychiatry,H02.403.690
19255233,2009-03-01T00:00:00,Adolescent,M01.060.057
19255233,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19255233,2009-03-01T00:00:00,Scoliosis,C05.116.900.800.875
19255233,2009-03-01T00:00:00,Spinal Fusion,E04.555.100.700
19255233,2009-03-01T00:00:00,Superior Vena Cava Syndrome,C14.907.800
19255233,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19255233,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19255233,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19255233,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19255233,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19255376,2009-03-01T00:00:00,Adult,M01.060.116
19255376,2009-03-01T00:00:00,Alleles,G05.360.340.024.340.030
19255376,2009-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19255376,2009-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19255376,2009-03-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19255376,2009-03-01T00:00:00,Gene Expression,G05.355.310
19255376,2009-03-01T00:00:00,Genetic Variation,G05.365
19255376,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19255376,2009-03-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19261230,2009-03-01T00:00:00,Adult,M01.060.116
19261230,2009-03-01T00:00:00,Alcohol Drinking,F01.145.317.269
19261230,2009-03-01T00:00:00,Alcoholism,C21.739.100.250
19261230,2009-03-01T00:00:00,Alcoholism,F03.900.100.350
19261230,2009-03-01T00:00:00,Combined Modality Therapy,E02.186
19261230,2009-03-01T00:00:00,Employment,N01.824.245
19261230,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19261230,2009-03-01T00:00:00,Life Style,F01.829.458
19261230,2009-03-01T00:00:00,Quality of Life,I01.800
19261230,2009-03-01T00:00:00,Quality of Life,K01.752.400.750
19261230,2009-03-01T00:00:00,Treatment Outcome,E01.789.800
19261230,2009-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19261230,2009-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19263283,2009-03-01T00:00:00,Animals,B01.050
19263283,2009-03-01T00:00:00,Epithelial Cells,A11.436
19263283,2009-03-01T00:00:00,Pulmonary Alveoli,A04.411.715
19264711,2009-03-01T00:00:00,Anticoagulants,D27.505.954.502.119
19264711,2009-03-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
19264711,2009-03-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
19264711,2009-03-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
19264711,2009-03-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
19264711,2009-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
19264711,2009-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19264711,2009-03-01T00:00:00,"Heparin, Low-Molecular-Weight",D09.698.373.400.300
19264711,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19264711,2009-03-01T00:00:00,Inpatients,M01.643.470
19264711,2009-03-01T00:00:00,Patient Discharge,E02.760.400.610
19264711,2009-03-01T00:00:00,Patient Discharge,N02.421.585.400.610
19264711,2009-03-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19264711,2009-03-01T00:00:00,Postoperative Care,E02.760.722.700
19264711,2009-03-01T00:00:00,Postoperative Care,E04.624
19264711,2009-03-01T00:00:00,Postoperative Care,N02.421.585.722.700
19264711,2009-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19264711,2009-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19264711,2009-03-01T00:00:00,Preoperative Care,E02.760.795
19264711,2009-03-01T00:00:00,Preoperative Care,E04.641
19264711,2009-03-01T00:00:00,Preoperative Care,N02.421.585.795
19264711,2009-03-01T00:00:00,Pulmonary Embolism,C08.381.746
19264711,2009-03-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
19264711,2009-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19264711,2009-03-01T00:00:00,Risk Assessment,N04.452.871.715
19264711,2009-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19264711,2009-03-01T00:00:00,Risk Assessment,N06.850.505.715
19264711,2009-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19264711,2009-03-01T00:00:00,Warfarin,D03.438.150.446.520.914
19264711,2009-03-01T00:00:00,Warfarin,D03.830.219.446.520.914
19264937,2009-03-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19264937,2009-03-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19264937,2009-03-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19264937,2009-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19264937,2009-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19264937,2009-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19264937,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19264937,2009-03-01T00:00:00,Mass Screening,E01.370.500
19264937,2009-03-01T00:00:00,Mass Screening,E05.318.308.250.580
19264937,2009-03-01T00:00:00,Mass Screening,N02.421.143.827.233.443
19264937,2009-03-01T00:00:00,Mass Screening,N02.421.726.233.443
19264937,2009-03-01T00:00:00,Mass Screening,N05.715.360.300.375.500
19264937,2009-03-01T00:00:00,Mass Screening,N06.850.520.308.250.580
19264937,2009-03-01T00:00:00,Mass Screening,N06.850.780.500
19264937,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19264937,2009-03-01T00:00:00,"Models, Organizational",E05.599.670
19264937,2009-03-01T00:00:00,"Models, Organizational",N04.452.534
19264937,2009-03-01T00:00:00,Organizational Case Studies,N03.349.380.710
19264937,2009-03-01T00:00:00,Organizational Case Studies,N05.715.360.455
19264937,2009-03-01T00:00:00,Primary Health Care,N04.590.233.727
19264937,2009-03-01T00:00:00,United States,Z01.107.567.875
19265592,2009-03-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
19265592,2009-03-01T00:00:00,Heart Failure,C14.280.434
19265592,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19265592,2009-03-01T00:00:00,"Pacemaker, Artificial",E07.858.082.748
19265592,2009-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19265592,2009-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19265592,2009-03-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19265592,2009-03-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19265592,2009-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19265592,2009-03-01T00:00:00,Risk Assessment,N04.452.871.715
19265592,2009-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19265592,2009-03-01T00:00:00,Risk Assessment,N06.850.505.715
19265592,2009-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19265592,2009-03-01T00:00:00,Time Factors,G01.910.857
19265592,2009-03-01T00:00:00,Treatment Outcome,E01.789.800
19265592,2009-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19265592,2009-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19265592,2009-03-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
19265592,2009-03-01T00:00:00,Ventricular Remodeling,C23.300.985
19265592,2009-03-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
19272070,2009-03-01T00:00:00,Adult,M01.060.116
19272070,2009-03-01T00:00:00,Aged,M01.060.116.100
19272070,2009-03-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
19272070,2009-03-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
19272070,2009-03-01T00:00:00,"Defibrillators, Implantable",E07.695.175
19272070,2009-03-01T00:00:00,Heart Failure,C14.280.434
19272070,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19272070,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19272070,2009-03-01T00:00:00,Patient Education as Topic,I02.233.332.500
19272070,2009-03-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19272070,2009-03-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
19272070,2009-03-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
19272070,2009-03-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
19272070,2009-03-01T00:00:00,Patient Satisfaction,N05.715.360.600
19273805,2009-03-01T00:00:00,Aged,M01.060.116.100
19273805,2009-03-01T00:00:00,Blood Pressure,E01.370.600.875.249
19273805,2009-03-01T00:00:00,Blood Pressure,G09.330.380.076
19273805,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19273805,2009-03-01T00:00:00,Macular Degeneration,C11.768.585.439
19273805,2009-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19273805,2009-03-01T00:00:00,Risk Factors,N05.715.350.200.700
19273805,2009-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19273805,2009-03-01T00:00:00,Risk Factors,N06.850.490.625.750
19273805,2009-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19273880,2009-03-01T00:00:00,Family Practice,H02.403.280
19273880,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19273880,2009-03-01T00:00:00,Leadership,F01.752.609
19274681,2009-03-01T00:00:00,Contrast Media,D27.720.259
19274681,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19274681,2009-03-01T00:00:00,Kidney,A05.810.453
19274681,2009-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19274681,2009-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19276732,2009-03-01T00:00:00,Adolescent,M01.060.057
19276732,2009-03-01T00:00:00,Adult,M01.060.116
19276732,2009-03-01T00:00:00,Contrast Media,D27.720.259
19276732,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19276732,2009-03-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19276732,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19276732,2009-03-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.350.810.800
19276732,2009-03-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.600.350.700.810.800
19276732,2009-03-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.700.810.800
19276732,2009-03-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.810.810.800
19276732,2009-03-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.825.810.810.800
19276732,2009-03-01T00:00:00,United States,Z01.107.567.875
19276732,2009-03-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
19276732,2009-03-01T00:00:00,"Wounds, Penetrating",C21.866.986
19276732,2009-03-01T00:00:00,Young Adult,M01.060.116.815
19283565,2009-03-01T00:00:00,Chronic Disease,C23.550.291.500
19283565,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19283565,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19283565,2009-03-01T00:00:00,Opioid-Related Disorders,C21.739.675
19283565,2009-03-01T00:00:00,Opioid-Related Disorders,F03.900.675
19283565,2009-03-01T00:00:00,Pain,C10.597.617
19283565,2009-03-01T00:00:00,Pain,C23.888.592.612
19283565,2009-03-01T00:00:00,Pain,C23.888.646
19283565,2009-03-01T00:00:00,Pain,F02.830.816.444
19283565,2009-03-01T00:00:00,Pain,G11.561.600.810.444
19283565,2009-03-01T00:00:00,Patient Discharge,E02.760.400.610
19283565,2009-03-01T00:00:00,Patient Discharge,N02.421.585.400.610
19283565,2009-03-01T00:00:00,Time Factors,G01.910.857
19283565,2009-03-01T00:00:00,Treatment Outcome,E01.789.800
19283565,2009-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19283565,2009-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19283572,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19283572,2009-03-01T00:00:00,Marijuana Abuse,C21.739.635
19283572,2009-03-01T00:00:00,Marijuana Abuse,F03.900.635
19283572,2009-03-01T00:00:00,Substance Abuse Detection,E05.885
19283572,2009-03-01T00:00:00,Substance Abuse Detection,N06.850.780.500.765
19283607,2009-03-01T00:00:00,Adolescent,M01.060.057
19283607,2009-03-01T00:00:00,Child,M01.060.406
19283607,2009-03-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19283607,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19283607,2009-03-01T00:00:00,Questionnaires,E05.318.308.750
19283607,2009-03-01T00:00:00,Questionnaires,L01.280.800
19283607,2009-03-01T00:00:00,Questionnaires,N05.715.360.300.695
19283607,2009-03-01T00:00:00,Questionnaires,N06.850.520.308.750
19283607,2009-03-01T00:00:00,Rape,I01.198.240.748.640
19283607,2009-03-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19283607,2009-03-01T00:00:00,Substance-Related Disorders,C21.739
19283607,2009-03-01T00:00:00,Substance-Related Disorders,F03.900
19283607,2009-03-01T00:00:00,United States,Z01.107.567.875
19283607,2009-03-01T00:00:00,Violence,I01.198.240.856
19283607,2009-03-01T00:00:00,Violence,I01.880.735.900
19287279,2009-03-01T00:00:00,"Accidents, Traffic",N06.850.135.392
19287279,2009-03-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
19287279,2009-03-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
19287279,2009-03-01T00:00:00,Cardiac Tamponade,C14.280.155
19287279,2009-03-01T00:00:00,"Child, Preschool",M01.060.406.448
19287279,2009-03-01T00:00:00,"Diagnosis, Differential",E01.171
19287279,2009-03-01T00:00:00,Drainage,E02.309
19287279,2009-03-01T00:00:00,Drainage,E04.237
19287279,2009-03-01T00:00:00,Echocardiography,E01.370.350.850.220
19287279,2009-03-01T00:00:00,Echocardiography,E01.370.370.380.220
19287279,2009-03-01T00:00:00,Heart Atria,A07.541.358
19287279,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19287279,2009-03-01T00:00:00,Thoracic Injuries,C21.866.891
19287279,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19287279,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19287279,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19287279,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19287279,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19287279,2009-03-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
19289658,2009-03-01T00:00:00,Adult,M01.060.116
19289658,2009-03-01T00:00:00,Aged,M01.060.116.100
19289658,2009-03-01T00:00:00,Biocompatible Materials,D25.130
19289658,2009-03-01T00:00:00,Biocompatible Materials,D27.720.102.130
19289658,2009-03-01T00:00:00,Biocompatible Materials,J01.637.051.130
19289658,2009-03-01T00:00:00,Collagen,D05.750.078.280
19289658,2009-03-01T00:00:00,Collagen,D12.776.860.300.250
19289658,2009-03-01T00:00:00,"Hernia, Ventral",C23.300.707.374.937
19289658,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19289658,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19289658,2009-03-01T00:00:00,"Skin, Artificial",E07.858.082.800
19289658,2009-03-01T00:00:00,Surgical Wound Infection,C01.539.947.692
19289658,2009-03-01T00:00:00,Surgical Wound Infection,C23.550.767.925
19289726,2009-03-01T00:00:00,Employment,N01.824.245
19289726,2009-03-01T00:00:00,"Faculty, Dental",I02.463.273
19289726,2009-03-01T00:00:00,"Faculty, Dental",M01.526.339.273
19289726,2009-03-01T00:00:00,"Faculty, Dental",M01.526.485.360
19289726,2009-03-01T00:00:00,"Faculty, Dental",N02.360.360
19289726,2009-03-01T00:00:00,Guidelines as Topic,N04.761.700.350
19289726,2009-03-01T00:00:00,Guidelines as Topic,N05.700.350
19289726,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19289726,2009-03-01T00:00:00,Publishing,L01.737
19289726,2009-03-01T00:00:00,Salaries and Fringe Benefits,N01.824.417.700
19289726,2009-03-01T00:00:00,Salaries and Fringe Benefits,N04.452.677.800
19289726,2009-03-01T00:00:00,"Schools, Dental",I02.783.660.481
19289726,2009-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19289726,2009-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19289726,2009-03-01T00:00:00,Staff Development,I02.574.700
19289726,2009-03-01T00:00:00,Staff Development,N04.452.677.822
19289726,2009-03-01T00:00:00,United States,Z01.107.567.875
19329105,2009-03-01T00:00:00,Curriculum,I02.158
19329105,2009-03-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
19329105,2009-03-01T00:00:00,Environmental Health,H02.229
19329105,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19329105,2009-03-01T00:00:00,Pediatrics,H02.403.670
19329105,2009-03-01T00:00:00,Questionnaires,E05.318.308.750
19329105,2009-03-01T00:00:00,Questionnaires,L01.280.800
19329105,2009-03-01T00:00:00,Questionnaires,N05.715.360.300.695
19329105,2009-03-01T00:00:00,Questionnaires,N06.850.520.308.750
19329105,2009-03-01T00:00:00,Teaching,I02.903
19329105,2009-03-01T00:00:00,United States,Z01.107.567.875
19337910,2009-03-01T00:00:00,Algorithms,G17.035
19337910,2009-03-01T00:00:00,Algorithms,L01.224.050
19337910,2009-03-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
19337910,2009-03-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
19337910,2009-03-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
19337910,2009-03-01T00:00:00,Catheter Ablation,E02.148.110
19337910,2009-03-01T00:00:00,Catheter Ablation,E02.148.442.110
19337910,2009-03-01T00:00:00,Catheter Ablation,E02.154.402.110
19337910,2009-03-01T00:00:00,Catheter Ablation,E04.014.170.402.110
19337910,2009-03-01T00:00:00,Computer Simulation,L01.224.160
19337910,2009-03-01T00:00:00,Copper,D01.268.556.195
19337910,2009-03-01T00:00:00,Copper,D01.268.956.170
19337910,2009-03-01T00:00:00,Copper,D01.552.544.195
19337910,2009-03-01T00:00:00,Electrodes,E07.305.250
19337910,2009-03-01T00:00:00,Finite Element Analysis,E05.355
19337910,2009-03-01T00:00:00,Gold,D01.268.556.322
19337910,2009-03-01T00:00:00,Gold,D01.268.956.186
19337910,2009-03-01T00:00:00,Gold,D01.552.544.322
19347072,2009-03-01T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
19347072,2009-03-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
19347072,2009-03-01T00:00:00,Environmental Monitoring,N06.850.780.375
19347072,2009-03-01T00:00:00,Smoking,F01.145.466.753
19347072,2009-03-01T00:00:00,Workplace,N01.824.245.925
19347072,2009-03-01T00:00:00,Workplace,N04.452.677.975
19399309,2009-03-01T00:00:00,Bronchoscopy,E01.370.386.105
19399309,2009-03-01T00:00:00,Bronchoscopy,E01.370.388.250.100
19399309,2009-03-01T00:00:00,Bronchoscopy,E04.800.250.100
19399309,2009-03-01T00:00:00,Bronchoscopy,E04.928.600.080
19399309,2009-03-01T00:00:00,Clinical Competence,I02.399.630.210
19399309,2009-03-01T00:00:00,Clinical Competence,N04.761.210
19399309,2009-03-01T00:00:00,Data Collection,E05.318.308
19399309,2009-03-01T00:00:00,Data Collection,L01.280
19399309,2009-03-01T00:00:00,Data Collection,N05.715.360.300
19399309,2009-03-01T00:00:00,Data Collection,N06.850.520.308
19399309,2009-03-01T00:00:00,Fellowships and Scholarships,N03.219.483.838.276
19399309,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19399309,2009-03-01T00:00:00,Program Evaluation,E05.337.820
19399309,2009-03-01T00:00:00,Program Evaluation,N04.761.685
19399309,2009-03-01T00:00:00,Program Evaluation,N05.715.360.650
19399309,2009-03-01T00:00:00,"Students, Medical",I02.851.686.602
19399309,2009-03-01T00:00:00,"Students, Medical",M01.848.769.602
19401047,2009-03-01T00:00:00,Adolescent,M01.060.057
19401047,2009-03-01T00:00:00,Adult,M01.060.116
19401047,2009-03-01T00:00:00,Aged,M01.060.116.100
19401047,2009-03-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
19401047,2009-03-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
19401047,2009-03-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
19401047,2009-03-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
19401047,2009-03-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
19401047,2009-03-01T00:00:00,Child,M01.060.406
19401047,2009-03-01T00:00:00,"Child, Preschool",M01.060.406.448
19401047,2009-03-01T00:00:00,Endoscopy,E01.370.388.250
19401047,2009-03-01T00:00:00,Endoscopy,E04.800.250
19401047,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19401047,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19401047,2009-03-01T00:00:00,Skull Base,A01.456.830
19401047,2009-03-01T00:00:00,Skull Base,A02.835.232.781.750
19401053,2009-03-01T00:00:00,Cadaver,C23.550.260.224
19401053,2009-03-01T00:00:00,Education,I02
19401053,2009-03-01T00:00:00,"Education, Professional",I02.358
19401053,2009-03-01T00:00:00,Endoscopy,E01.370.388.250
19401053,2009-03-01T00:00:00,Endoscopy,E04.800.250
19401053,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19401053,2009-03-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19401053,2009-03-01T00:00:00,Paranasal Sinuses,A04.531.621
19401053,2009-03-01T00:00:00,Quality of Health Care,N04.761
19401053,2009-03-01T00:00:00,Quality of Health Care,N05.715
19401053,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19401053,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19401053,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19401053,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19401053,2009-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19426643,2009-03-01T00:00:00,"Accidents, Traffic",N06.850.135.392
19426643,2009-03-01T00:00:00,Catheterization,E02.148
19426643,2009-03-01T00:00:00,Catheterization,E05.157
19426643,2009-03-01T00:00:00,Emergencies,C23.550.291.781
19426643,2009-03-01T00:00:00,Emergencies,N06.230.100.083
19426643,2009-03-01T00:00:00,Emergencies,N06.850.376
19426643,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19426643,2009-03-01T00:00:00,Leg,A01.378.610.500
19426643,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19426643,2009-03-01T00:00:00,Thrombectomy,E04.100.814.842
19426643,2009-03-01T00:00:00,Treatment Outcome,E01.789.800
19426643,2009-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19426643,2009-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19426643,2009-03-01T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
19426643,2009-03-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
19455869,2009-03-01T00:00:00,"Adaptation, Psychological",F01.058
19455869,2009-03-01T00:00:00,Data Collection,E05.318.308
19455869,2009-03-01T00:00:00,Data Collection,L01.280
19455869,2009-03-01T00:00:00,Data Collection,N05.715.360.300
19455869,2009-03-01T00:00:00,Data Collection,N06.850.520.308
19455869,2009-03-01T00:00:00,Gynecology,H02.403.810.310
19455869,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19455869,2009-03-01T00:00:00,Middle Aged,M01.060.116.630
19455869,2009-03-01T00:00:00,Obstetrics,H02.403.810.450
19455869,2009-03-01T00:00:00,Office Visits,N04.452.758.635
19455869,2009-03-01T00:00:00,Physicians,M01.526.485.810
19455869,2009-03-01T00:00:00,Physicians,N02.360.810
19455869,2009-03-01T00:00:00,Psychometrics,F04.711.780
19455869,2009-03-01T00:00:00,Time Factors,G01.910.857
19455869,2009-03-01T00:00:00,United States,Z01.107.567.875
19528883,2009-03-01T00:00:00,Adolescent,M01.060.057
19528883,2009-03-01T00:00:00,Adult,M01.060.116
19528883,2009-03-01T00:00:00,Child,M01.060.406
19528883,2009-03-01T00:00:00,"Child, Preschool",M01.060.406.448
19528883,2009-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
19528883,2009-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
19528883,2009-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
19528883,2009-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
19528883,2009-03-01T00:00:00,Hernia,C23.300.707
19528883,2009-03-01T00:00:00,Hernia,C23.300.842.500.374
19528883,2009-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19528883,2009-03-01T00:00:00,Jejunostomy,E04.210.338.523
19528883,2009-03-01T00:00:00,Jejunostomy,E04.579.338.523
19528883,2009-03-01T00:00:00,Obesity,C18.654.726.500
19528883,2009-03-01T00:00:00,Obesity,C23.888.144.699.500
19528883,2009-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19528883,2009-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19528883,2009-03-01T00:00:00,Pancreatitis,C06.689.750
19528883,2009-03-01T00:00:00,"Pneumonia, Aspiration",C08.381.677.529
19528883,2009-03-01T00:00:00,"Pneumonia, Aspiration",C08.730.610.529
19528883,2009-03-01T00:00:00,Short Bowel Syndrome,C06.405.469.637.832
19528883,2009-03-01T00:00:00,Short Bowel Syndrome,C23.550.767.882
19255585,2009-03-03T00:00:00,Adult,M01.060.116
19255585,2009-03-03T00:00:00,Alcohol Drinking,F01.145.317.269
19255585,2009-03-03T00:00:00,Demography,I01.240
19255585,2009-03-03T00:00:00,Demography,N01.224
19255585,2009-03-03T00:00:00,Demography,N06.850.505.400
19255585,2009-03-03T00:00:00,Health Behavior,F01.145.488
19255585,2009-03-03T00:00:00,Hospitalization,E02.760.400
19255585,2009-03-03T00:00:00,Hospitalization,N02.421.585.400
19255585,2009-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19255585,2009-03-03T00:00:00,Middle Aged,M01.060.116.630
19255585,2009-03-03T00:00:00,Risk Factors,E05.318.740.600.800.725
19255585,2009-03-03T00:00:00,Risk Factors,N05.715.350.200.700
19255585,2009-03-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19255585,2009-03-03T00:00:00,Risk Factors,N06.850.490.625.750
19255585,2009-03-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19255585,2009-03-03T00:00:00,Smoking,F01.145.466.753
19255585,2009-03-03T00:00:00,Spinal Cord Injuries,C10.228.854.770
19255585,2009-03-03T00:00:00,Spinal Cord Injuries,C10.900.850
19255585,2009-03-03T00:00:00,Spinal Cord Injuries,C21.866.819
19255585,2009-03-03T00:00:00,United States,Z01.107.567.875
19255586,2009-03-03T00:00:00,Adult,M01.060.116
19255586,2009-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19255586,2009-03-03T00:00:00,Income,N01.824.417
19255586,2009-03-03T00:00:00,Middle Aged,M01.060.116.630
19255586,2009-03-03T00:00:00,Risk Factors,E05.318.740.600.800.725
19255586,2009-03-03T00:00:00,Risk Factors,N05.715.350.200.700
19255586,2009-03-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19255586,2009-03-03T00:00:00,Risk Factors,N06.850.490.625.750
19255586,2009-03-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19255586,2009-03-03T00:00:00,Social Support,I01.880.656.600
19255586,2009-03-03T00:00:00,Spinal Cord Injuries,C10.228.854.770
19255586,2009-03-03T00:00:00,Spinal Cord Injuries,C10.900.850
19255586,2009-03-03T00:00:00,Spinal Cord Injuries,C21.866.819
19255782,2009-03-03T00:00:00,Birth Weight,C23.888.144.186
19255782,2009-03-03T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
19255782,2009-03-03T00:00:00,Birth Weight,E05.041.124.160.750.149
19255782,2009-03-03T00:00:00,Birth Weight,G07.100.100.160.120.186
19255782,2009-03-03T00:00:00,Birth Weight,G07.700.320.249.314.120.186
19255782,2009-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19255782,2009-03-03T00:00:00,"Infant, Newborn",M01.060.703.520
19255782,2009-03-03T00:00:00,Risk Factors,E05.318.740.600.800.725
19255782,2009-03-03T00:00:00,Risk Factors,N05.715.350.200.700
19255782,2009-03-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19255782,2009-03-03T00:00:00,Risk Factors,N06.850.490.625.750
19255782,2009-03-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19258383,2009-03-03T00:00:00,Creatinine,D03.383.129.308.207
19258383,2009-03-03T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19258383,2009-03-03T00:00:00,Genetic Predisposition to Disease,G05.380.355
19258383,2009-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19258383,2009-03-03T00:00:00,Hypertension,C14.907.489
19258383,2009-03-03T00:00:00,Insulin Resistance,C18.452.394.968.500
19258383,2009-03-03T00:00:00,Insulin Resistance,G07.690.320.617
19258383,2009-03-03T00:00:00,Middle Aged,M01.060.116.630
19258383,2009-03-03T00:00:00,Phenotype,G05.695
19258383,2009-03-03T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
19258446,2009-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19258446,2009-03-03T00:00:00,Neoplasms,C04
19258446,2009-03-03T00:00:00,Skin Diseases,C17.800
19437712,2009-03-03T00:00:00,Adsorption,G02.149.047
19437712,2009-03-03T00:00:00,Adsorption,G02.149.767.029
19437712,2009-03-03T00:00:00,Adsorption,G02.842.750.029
19437712,2009-03-03T00:00:00,Albumins,D12.776.034
19437712,2009-03-03T00:00:00,Biocompatible Materials,D25.130
19437712,2009-03-03T00:00:00,Biocompatible Materials,D27.720.102.130
19437712,2009-03-03T00:00:00,Biocompatible Materials,J01.637.051.130
19437712,2009-03-03T00:00:00,Fibrinogen,D12.776.124.050.250
19437712,2009-03-03T00:00:00,Fibrinogen,D12.776.124.125.500
19437712,2009-03-03T00:00:00,Fibrinogen,D12.776.811.300
19437712,2009-03-03T00:00:00,Fibrinogen,D23.119.490
19437712,2009-03-03T00:00:00,Gold,D01.268.556.322
19437712,2009-03-03T00:00:00,Gold,D01.268.956.186
19437712,2009-03-03T00:00:00,Gold,D01.552.544.322
19437712,2009-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19437712,2009-03-03T00:00:00,Materials Testing,E05.570
19437712,2009-03-03T00:00:00,Proteins,D12.776
19437712,2009-03-03T00:00:00,Surface Properties,G02.842.850
19437712,2009-03-03T00:00:00,Time Factors,G01.910.857
19261738,2009-03-04T00:00:00,Animals,B01.050
19261738,2009-03-04T00:00:00,Cardiomyopathies,C14.280.238
19261738,2009-03-04T00:00:00,Enzyme Inhibitors,D27.505.519.389
19261738,2009-03-04T00:00:00,Fibroblasts,A11.329.228
19261738,2009-03-04T00:00:00,Fibroblasts,A11.872.228
19261738,2009-03-04T00:00:00,Fibrosis,C23.550.355
19261738,2009-03-04T00:00:00,Gene Expression,G05.355.310
19261738,2009-03-04T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
19261738,2009-03-04T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
19261738,2009-03-04T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
19261738,2009-03-04T00:00:00,Myocardium,A02.633.580
19261738,2009-03-04T00:00:00,Myocardium,A07.541.704
19261738,2009-03-04T00:00:00,Myocardium,A10.690.552.750
19261738,2009-03-04T00:00:00,Nephrectomy,E04.950.774.435
19261738,2009-03-04T00:00:00,Procollagen,D12.776.811.690
19261738,2009-03-04T00:00:00,Procollagen,D12.776.860.300.250.600
19261738,2009-03-04T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
19261738,2009-03-04T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
19261738,2009-03-04T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
19261883,2009-03-04T00:00:00,Actins,D05.750.078.730.250
19261883,2009-03-04T00:00:00,Actins,D12.776.210.500.100
19261883,2009-03-04T00:00:00,Actins,D12.776.220.525.255
19261883,2009-03-04T00:00:00,Animals,B01.050
19261883,2009-03-04T00:00:00,Cocaine,D02.145.074.722.388
19261883,2009-03-04T00:00:00,Cocaine,D03.132.889.354
19261883,2009-03-04T00:00:00,Cocaine,D03.605.869.388
19261883,2009-03-04T00:00:00,Cocaine,D04.075.080.875.099.722.388
19261883,2009-03-04T00:00:00,Electric Stimulation,E05.723.402
19261883,2009-03-04T00:00:00,Evoked Potentials,G07.265.500
19261883,2009-03-04T00:00:00,Evoked Potentials,G11.561.270
19261883,2009-03-04T00:00:00,Extracellular Space,A10.082.500
19261883,2009-03-04T00:00:00,Extracellular Space,A11.284.295
19261883,2009-03-04T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19261883,2009-03-04T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19261883,2009-03-04T00:00:00,"Microscopy, Confocal",E05.595.395
19261883,2009-03-04T00:00:00,Neuronal Plasticity,G11.561.600.635
19261883,2009-03-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19261883,2009-03-04T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19261883,2009-03-04T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19261883,2009-03-04T00:00:00,Synapses,A08.850
19261883,2009-03-04T00:00:00,Synapses,A11.284.149.165.420.780
19264428,2009-03-04T00:00:00,Adult,M01.060.116
19264428,2009-03-04T00:00:00,Cocaine-Related Disorders,C21.739.300
19264428,2009-03-04T00:00:00,Cocaine-Related Disorders,F03.900.300
19264428,2009-03-04T00:00:00,Cues,F02.463.425.234
19264428,2009-03-04T00:00:00,Functional Laterality,F02.830.297.425
19264428,2009-03-04T00:00:00,Functional Laterality,G11.561.225.425
19264428,2009-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19264428,2009-03-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19264428,2009-03-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19264428,2009-03-04T00:00:00,Middle Aged,M01.060.116.630
19264428,2009-03-04T00:00:00,Psychiatric Status Rating Scales,F04.586
19264428,2009-03-04T00:00:00,Psychomotor Performance,F02.808
19264428,2009-03-04T00:00:00,Psychomotor Performance,G11.427.700
19264428,2009-03-04T00:00:00,Psychomotor Performance,G11.561.623
19264428,2009-03-04T00:00:00,Reaction Time,F02.830.650
19264428,2009-03-04T00:00:00,Reaction Time,F04.669.817
19264428,2009-03-04T00:00:00,Reaction Time,G11.561.677
19268469,2009-03-04T00:00:00,Bradykinin,D12.644.276.812.169
19268469,2009-03-04T00:00:00,Bradykinin,D12.644.400.090
19268469,2009-03-04T00:00:00,Bradykinin,D12.644.456.193
19268469,2009-03-04T00:00:00,Bradykinin,D12.776.467.812.169
19268469,2009-03-04T00:00:00,Bradykinin,D12.776.641.650.090
19268469,2009-03-04T00:00:00,Bradykinin,D23.469.050.375.110
19268469,2009-03-04T00:00:00,Bradykinin,D23.529.812.169
19268469,2009-03-04T00:00:00,Gene Expression,G05.355.310
19268469,2009-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19268469,2009-03-04T00:00:00,Kallikreins,D08.811.277.656.300.760.442
19268469,2009-03-04T00:00:00,Kallikreins,D08.811.277.656.959.350.442
19268469,2009-03-04T00:00:00,Kallikreins,D12.776.124.125.597
19268469,2009-03-04T00:00:00,Kallikreins,D23.119.597
19268469,2009-03-04T00:00:00,Kinins,D12.644.276.812
19268469,2009-03-04T00:00:00,Kinins,D12.776.467.812
19268469,2009-03-04T00:00:00,Kinins,D23.469.050.375
19268469,2009-03-04T00:00:00,Kinins,D23.529.812
19268469,2009-03-04T00:00:00,"RNA, Messenger",D13.444.735.544
19268469,2009-03-04T00:00:00,Trabecular Meshwork,A09.371.060.932
19298368,2009-03-04T00:00:00,Bacillus subtilis,B03.300.390.400.158.218.725
19298368,2009-03-04T00:00:00,Bacillus subtilis,B03.510.100.100.218.725
19298368,2009-03-04T00:00:00,Bacillus subtilis,B03.510.415.400.158.218.725
19298368,2009-03-04T00:00:00,Bacillus subtilis,B03.510.460.410.158.218.725
19298368,2009-03-04T00:00:00,DNA Replication,G02.111.087.222
19298368,2009-03-04T00:00:00,DNA Replication,G02.149.115.222
19298368,2009-03-04T00:00:00,DNA Replication,G05.355.200
19298368,2009-03-04T00:00:00,Escherichia coli,B03.440.450.425.325.300
19298368,2009-03-04T00:00:00,Escherichia coli,B03.660.250.150.180.100
19298368,2009-03-04T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
19298368,2009-03-04T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
19298368,2009-03-04T00:00:00,Schizosaccharomyces,B01.300.107.797
19298368,2009-03-04T00:00:00,Schizosaccharomyces,B01.300.930.720
19264882,2009-03-05T00:00:00,Animals,B01.050
19264882,2009-03-05T00:00:00,Choroidal Neovascularization,C11.941.160.244
19264882,2009-03-05T00:00:00,Choroidal Neovascularization,C23.550.589.500.145
19264882,2009-03-05T00:00:00,Complement Activation,G12.425.255
19264882,2009-03-05T00:00:00,Complement C3,D12.776.124.050.140
19264882,2009-03-05T00:00:00,Complement C3,D12.776.124.486.274.250
19264882,2009-03-05T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
19264882,2009-03-05T00:00:00,"Disease Models, Animal",C22.232
19264882,2009-03-05T00:00:00,"Disease Models, Animal",E05.598.500
19264882,2009-03-05T00:00:00,"Disease Models, Animal",E05.599.395.080
19264882,2009-03-05T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19264882,2009-03-05T00:00:00,Macular Degeneration,C11.768.585.439
19264882,2009-03-05T00:00:00,"RNA, Messenger",D13.444.735.544
19264882,2009-03-05T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19264882,2009-03-05T00:00:00,Retina,A09.371.729
19264882,2009-03-05T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
19264882,2009-03-05T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
19264882,2009-03-05T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19264882,2009-03-05T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19264882,2009-03-05T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19265784,2009-03-05T00:00:00,Adult,M01.060.116
19265784,2009-03-05T00:00:00,African Americans,M01.686.508.100.100
19265784,2009-03-05T00:00:00,African Americans,M01.686.754.100
19265784,2009-03-05T00:00:00,Aged,M01.060.116.100
19265784,2009-03-05T00:00:00,Blood Pressure,E01.370.600.875.249
19265784,2009-03-05T00:00:00,Blood Pressure,G09.330.380.076
19265784,2009-03-05T00:00:00,DNA Damage,C21.111
19265784,2009-03-05T00:00:00,DNA Damage,G05.355.180
19265784,2009-03-05T00:00:00,European Continental Ancestry Group,M01.686.508.400
19265784,2009-03-05T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19265784,2009-03-05T00:00:00,Genetic Predisposition to Disease,G05.380.355
19265784,2009-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19265784,2009-03-05T00:00:00,Hypertension,C14.907.489
19265784,2009-03-05T00:00:00,Kidney Diseases,C12.777.419
19265784,2009-03-05T00:00:00,Kidney Diseases,C13.351.968.419
19265784,2009-03-05T00:00:00,Middle Aged,M01.060.116.630
19265784,2009-03-05T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19265784,2009-03-05T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
19269192,2009-03-06T00:00:00,Animals,B01.050
19269192,2009-03-06T00:00:00,Apoptosis,G04.299.139.160
19269192,2009-03-06T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
19269192,2009-03-06T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
19269192,2009-03-06T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
19269192,2009-03-06T00:00:00,Cell Differentiation,G04.299.151
19269192,2009-03-06T00:00:00,Cytokines,D12.644.276.374
19269192,2009-03-06T00:00:00,Cytokines,D12.776.467.374
19269192,2009-03-06T00:00:00,Cytokines,D23.529.374
19269192,2009-03-06T00:00:00,DNA-Binding Proteins,D12.776.260
19269192,2009-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19269192,2009-03-06T00:00:00,Repressor Proteins,D12.776.260.703
19269192,2009-03-06T00:00:00,Repressor Proteins,D12.776.930.700
19269192,2009-03-06T00:00:00,Signal Transduction,G02.111.087.800
19269192,2009-03-06T00:00:00,Signal Transduction,G02.149.115.800
19269192,2009-03-06T00:00:00,Signal Transduction,G04.299.880
19272854,2009-03-06T00:00:00,Acoustic Stimulation,E02.037
19272854,2009-03-06T00:00:00,Acoustic Stimulation,E02.190.888.030
19272854,2009-03-06T00:00:00,Acoustic Stimulation,E05.723.136
19272854,2009-03-06T00:00:00,Anxiety,F01.470.132
19272854,2009-03-06T00:00:00,Electromyography,E01.370.405.255
19272854,2009-03-06T00:00:00,Electromyography,E01.370.530.255
19272854,2009-03-06T00:00:00,Emotions,F01.470
19272854,2009-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19272854,2009-03-06T00:00:00,Interpersonal Relations,F01.829.401
19272854,2009-03-06T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
19272854,2009-03-06T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
19272854,2009-03-06T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
19272854,2009-03-06T00:00:00,Photic Stimulation,E05.723.729
19272854,2009-03-06T00:00:00,Questionnaires,E05.318.308.750
19272854,2009-03-06T00:00:00,Questionnaires,L01.280.800
19272854,2009-03-06T00:00:00,Questionnaires,N05.715.360.300.695
19272854,2009-03-06T00:00:00,Questionnaires,N06.850.520.308.750
19272854,2009-03-06T00:00:00,Self Concept,F01.752.747.792
19272854,2009-03-06T00:00:00,Startle Reaction,E01.370.376.550.650.800
19272854,2009-03-06T00:00:00,Startle Reaction,E01.370.600.550.650.800
19272854,2009-03-06T00:00:00,Startle Reaction,F02.830.702.807
19272854,2009-03-06T00:00:00,Startle Reaction,G11.561.600.765.869
19269855,2009-03-09T00:00:00,Adult,M01.060.116
19269855,2009-03-09T00:00:00,African Americans,M01.686.508.100.100
19269855,2009-03-09T00:00:00,African Americans,M01.686.754.100
19269855,2009-03-09T00:00:00,Aged,M01.060.116.100
19269855,2009-03-09T00:00:00,Body Mass Index,E01.370.600.115.100.125
19269855,2009-03-09T00:00:00,Body Mass Index,E05.041.124.125
19269855,2009-03-09T00:00:00,Body Mass Index,G07.100.100.125
19269855,2009-03-09T00:00:00,Body Mass Index,N06.850.505.200.100.175
19269855,2009-03-09T00:00:00,European Continental Ancestry Group,M01.686.508.400
19269855,2009-03-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19269855,2009-03-09T00:00:00,Hypertension,C14.907.489
19269855,2009-03-09T00:00:00,Lung Neoplasms,C04.588.894.797.520
19269855,2009-03-09T00:00:00,Lung Neoplasms,C08.381.540
19269855,2009-03-09T00:00:00,Lung Neoplasms,C08.785.520
19269855,2009-03-09T00:00:00,Middle Aged,M01.060.116.630
19269855,2009-03-09T00:00:00,Smoking,F01.145.466.753
19269855,2009-03-09T00:00:00,South Carolina,Z01.107.567.875.075.662
19269855,2009-03-09T00:00:00,South Carolina,Z01.107.567.875.750.700
19269855,2009-03-09T00:00:00,Young Adult,M01.060.116.815
19287111,2009-03-09T00:00:00,Aged,M01.060.116.100
19287111,2009-03-09T00:00:00,"Constriction, Pathologic",C23.300.287
19287111,2009-03-09T00:00:00,Gastric Bypass,E02.065.062.249
19287111,2009-03-09T00:00:00,Gastric Bypass,E04.035.398.385
19287111,2009-03-09T00:00:00,Gastric Bypass,E04.062.249
19287111,2009-03-09T00:00:00,Gastric Bypass,E04.210.457.430
19287111,2009-03-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19287111,2009-03-09T00:00:00,Middle Aged,M01.060.116.630
19287111,2009-03-09T00:00:00,Pancreaticoduodenectomy,E04.210.760
19287111,2009-03-09T00:00:00,Time Factors,G01.910.857
19287111,2009-03-09T00:00:00,Treatment Outcome,E01.789.800
19287111,2009-03-09T00:00:00,Treatment Outcome,N04.761.559.590.800
19287111,2009-03-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19393421,2009-03-09T00:00:00,Adolescent,M01.060.057
19393421,2009-03-09T00:00:00,Adult,M01.060.116
19393421,2009-03-09T00:00:00,Aged,M01.060.116.100
19393421,2009-03-09T00:00:00,Child,M01.060.406
19393421,2009-03-09T00:00:00,"Diagnosis, Differential",E01.171
19393421,2009-03-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19393421,2009-03-09T00:00:00,Middle Aged,M01.060.116.630
19393421,2009-03-09T00:00:00,Paranasal Sinuses,A04.531.621
19393421,2009-03-09T00:00:00,Sinusitis,C08.460.692.752
19393421,2009-03-09T00:00:00,Sinusitis,C08.730.749
19393421,2009-03-09T00:00:00,Sinusitis,C09.603.692.752
19393421,2009-03-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19393421,2009-03-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19393421,2009-03-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19393421,2009-03-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19393421,2009-03-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19276078,2009-03-10T00:00:00,Bacterial Proteins,D12.776.097
19276078,2009-03-10T00:00:00,Blood Proteins,D12.776.124
19276078,2009-03-10T00:00:00,Calcium-Binding Proteins,D12.776.157.125
19276078,2009-03-10T00:00:00,Carrier Proteins,D12.776.157
19276078,2009-03-10T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
19276078,2009-03-10T00:00:00,Fibronectins,D12.776.377.715.390
19276078,2009-03-10T00:00:00,Fibronectins,D12.776.395.550.350
19276078,2009-03-10T00:00:00,Fibronectins,D12.776.543.550.350
19276078,2009-03-10T00:00:00,Fibronectins,D12.776.860.300.450
19276078,2009-03-10T00:00:00,Recombinant Proteins,D12.776.828
19276078,2009-03-10T00:00:00,Streptococcus pyogenes,B03.510.400.800.872.575
19276625,2009-03-10T00:00:00,African Americans,M01.686.508.100.100
19276625,2009-03-10T00:00:00,African Americans,M01.686.754.100
19276625,2009-03-10T00:00:00,Aged,M01.060.116.100
19276625,2009-03-10T00:00:00,Alzheimer Disease,C10.228.140.380.100
19276625,2009-03-10T00:00:00,Alzheimer Disease,C10.574.945.249
19276625,2009-03-10T00:00:00,Alzheimer Disease,F03.087.400.100
19276625,2009-03-10T00:00:00,Cognition Disorders,F03.087.250
19276625,2009-03-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
19276625,2009-03-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19276625,2009-03-10T00:00:00,Middle Aged,M01.060.116.630
19276625,2009-03-10T00:00:00,Patient Selection,E05.581.500.653
19276625,2009-03-10T00:00:00,Patient Selection,N04.590.731
19276625,2009-03-10T00:00:00,Questionnaires,E05.318.308.750
19276625,2009-03-10T00:00:00,Questionnaires,L01.280.800
19276625,2009-03-10T00:00:00,Questionnaires,N05.715.360.300.695
19276625,2009-03-10T00:00:00,Questionnaires,N06.850.520.308.750
19276625,2009-03-10T00:00:00,South Carolina,Z01.107.567.875.075.662
19276625,2009-03-10T00:00:00,South Carolina,Z01.107.567.875.750.700
19285047,2009-03-10T00:00:00,Animals,B01.050
19285047,2009-03-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19285047,2009-03-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19285047,2009-03-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19285047,2009-03-10T00:00:00,Apoptosis,G04.299.139.160
19285047,2009-03-10T00:00:00,Astrocytes,A08.637.200
19285047,2009-03-10T00:00:00,Astrocytes,A11.650.200
19285047,2009-03-10T00:00:00,Calpain,D08.811.277.656.262.500.120
19285047,2009-03-10T00:00:00,Calpain,D08.811.277.656.300.200.120
19285047,2009-03-10T00:00:00,Cell Cycle,G04.299.134
19285047,2009-03-10T00:00:00,Cell Differentiation,G04.299.151
19285047,2009-03-10T00:00:00,Cell Survival,G04.299.316
19285047,2009-03-10T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
19285047,2009-03-10T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
19285047,2009-03-10T00:00:00,Fenretinide,D02.455.849.131.495.270
19285047,2009-03-10T00:00:00,Fenretinide,D23.767.261.700.270
19285047,2009-03-10T00:00:00,Gene Expression,G05.355.310
19285047,2009-03-10T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
19285047,2009-03-10T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
19285047,2009-03-10T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
19285047,2009-03-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19285047,2009-03-10T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
19285047,2009-03-10T00:00:00,Telomerase,D12.776.157.725.500.921
19285047,2009-03-10T00:00:00,Telomerase,D12.776.664.962.500.921
19285047,2009-03-10T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
19285108,2009-03-10T00:00:00,Adult,M01.060.116
19285108,2009-03-10T00:00:00,African Americans,M01.686.508.100.100
19285108,2009-03-10T00:00:00,African Americans,M01.686.754.100
19285108,2009-03-10T00:00:00,Ethnic Groups,M01.686.754
19285108,2009-03-10T00:00:00,Ethnic Groups,N01.224.317
19285108,2009-03-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
19285108,2009-03-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19285108,2009-03-10T00:00:00,Sex Factors,N05.715.350.675
19285108,2009-03-10T00:00:00,Sex Factors,N06.850.490.875
19285108,2009-03-10T00:00:00,"Stress, Psychological",F01.145.126.990
19285108,2009-03-10T00:00:00,"Stress, Psychological",F02.830.900
19285108,2009-03-10T00:00:00,Young Adult,M01.060.116.815
19428909,2009-03-10T00:00:00,Amphetamine-Related Disorders,C21.739.225
19428909,2009-03-10T00:00:00,Amphetamine-Related Disorders,F03.900.225
19428909,2009-03-10T00:00:00,Animals,B01.050
19428909,2009-03-10T00:00:00,Antibodies,D12.776.124.486.485.114
19428909,2009-03-10T00:00:00,Antibodies,D12.776.124.790.651.114
19428909,2009-03-10T00:00:00,Antibodies,D12.776.377.715.548.114
19428909,2009-03-10T00:00:00,Methamphetamine,D02.092.471.683.152.619
19428909,2009-03-10T00:00:00,Peptide Fragments,D12.644.541
19428909,2009-03-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19428909,2009-03-10T00:00:00,Self Administration,E02.319.890
19428909,2009-03-10T00:00:00,Self Administration,E02.900.890
19428909,2009-03-10T00:00:00,Substance-Related Disorders,C21.739
19428909,2009-03-10T00:00:00,Substance-Related Disorders,F03.900
19277670,2009-03-11T00:00:00,Algorithms,G17.035
19277670,2009-03-11T00:00:00,Algorithms,L01.224.050
19277670,2009-03-11T00:00:00,Artifacts,E05.047
19277670,2009-03-11T00:00:00,Artificial Intelligence,L01.224.065
19277670,2009-03-11T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19277670,2009-03-11T00:00:00,Coronary Angiography,E01.370.370.050.200
19277670,2009-03-11T00:00:00,Coronary Angiography,E01.370.370.380.200
19277670,2009-03-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19277670,2009-03-11T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
19277670,2009-03-11T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
19277670,2009-03-11T00:00:00,Middle Aged,M01.060.116.630
19277670,2009-03-11T00:00:00,Movement,G07.700.560
19277670,2009-03-11T00:00:00,Movement,G11.427.590.530
19277670,2009-03-11T00:00:00,"Pattern Recognition, Automated",L01.725
19277670,2009-03-11T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19277670,2009-03-11T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19277670,2009-03-11T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19277670,2009-03-11T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19277670,2009-03-11T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19277670,2009-03-11T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19277670,2009-03-11T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19277670,2009-03-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19277670,2009-03-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19277670,2009-03-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19277670,2009-03-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19277670,2009-03-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19285474,2009-03-12T00:00:00,Action Potentials,G04.580.100
19285474,2009-03-12T00:00:00,Action Potentials,G07.265.750.100
19285474,2009-03-12T00:00:00,Action Potentials,G11.561.570.100
19285474,2009-03-12T00:00:00,Animals,B01.050
19285474,2009-03-12T00:00:00,Avoidance Learning,F02.463.425.097
19285474,2009-03-12T00:00:00,Cues,F02.463.425.234
19285474,2009-03-12T00:00:00,Dopamine,D02.092.211.215.311.342
19285474,2009-03-12T00:00:00,Dopamine,D02.092.311.342
19285474,2009-03-12T00:00:00,Maze Learning,F02.463.425.507
19285474,2009-03-12T00:00:00,Mesencephalon,A08.186.211.132.659
19285474,2009-03-12T00:00:00,Mesencephalon,A08.186.211.653
19285474,2009-03-12T00:00:00,Motor Activity,F01.145.632
19285474,2009-03-12T00:00:00,Motor Activity,G11.427.590.530.698
19285474,2009-03-12T00:00:00,Neurons,A08.663
19285474,2009-03-12T00:00:00,Neurons,A11.671
19285474,2009-03-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19285474,2009-03-12T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19285474,2009-03-12T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19285474,2009-03-12T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
19286849,2009-03-13T00:00:00,Adult,M01.060.116
19286849,2009-03-13T00:00:00,Biological Markers,D23.101
19286849,2009-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19286849,2009-03-13T00:00:00,"Lung Diseases, Interstitial",C08.381.483
19286849,2009-03-13T00:00:00,Middle Aged,M01.060.116.630
19286849,2009-03-13T00:00:00,"Scleroderma, Systemic",C17.300.799
19286849,2009-03-13T00:00:00,"Scleroderma, Systemic",C17.800.784
19286178,2009-03-14T00:00:00,Adolescent,M01.060.057
19286178,2009-03-14T00:00:00,Adult,M01.060.116
19286178,2009-03-14T00:00:00,Aged,M01.060.116.100
19286178,2009-03-14T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
19286178,2009-03-14T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
19286178,2009-03-14T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
19286178,2009-03-14T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
19286178,2009-03-14T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
19286178,2009-03-14T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
19286178,2009-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19286178,2009-03-14T00:00:00,Incidence,E05.318.308.985.525.375
19286178,2009-03-14T00:00:00,Incidence,L01.280.975.525.375
19286178,2009-03-14T00:00:00,Incidence,N01.224.935.597.500
19286178,2009-03-14T00:00:00,Incidence,N06.850.505.400.975.525.375
19286178,2009-03-14T00:00:00,Incidence,N06.850.520.308.985.525.375
19286178,2009-03-14T00:00:00,Middle Aged,M01.060.116.630
19286178,2009-03-14T00:00:00,Postoperative Complications,C23.550.767
19286178,2009-03-14T00:00:00,Risk Factors,E05.318.740.600.800.725
19286178,2009-03-14T00:00:00,Risk Factors,N05.715.350.200.700
19286178,2009-03-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19286178,2009-03-14T00:00:00,Risk Factors,N06.850.490.625.750
19286178,2009-03-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19286178,2009-03-14T00:00:00,Time Factors,G01.910.857
19286178,2009-03-14T00:00:00,United States,Z01.107.567.875
19286178,2009-03-14T00:00:00,Young Adult,M01.060.116.815
19286181,2009-03-14T00:00:00,Aged,M01.060.116.100
19286181,2009-03-14T00:00:00,Device Removal,E04.199
19286181,2009-03-14T00:00:00,Esophageal Perforation,C06.405.117.468
19286181,2009-03-14T00:00:00,Esophageal Perforation,C21.866.348
19286181,2009-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19286181,2009-03-14T00:00:00,Prosthesis Design,E05.320.550
19286181,2009-03-14T00:00:00,Prosthesis Design,E07.695.680
19286181,2009-03-14T00:00:00,Stents,E07.695.750
18428981,2009-03-15T00:00:00,Biocompatible Materials,D25.130
18428981,2009-03-15T00:00:00,Biocompatible Materials,D27.720.102.130
18428981,2009-03-15T00:00:00,Biocompatible Materials,J01.637.051.130
18428981,2009-03-15T00:00:00,Lactic Acid,D02.241.511.459.450
18428981,2009-03-15T00:00:00,Materials Testing,E05.570
18428981,2009-03-15T00:00:00,Polymers,D05.750
18428981,2009-03-15T00:00:00,Polymers,D25.720
18428981,2009-03-15T00:00:00,Polymers,J01.637.051.720
18428981,2009-03-15T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
18428981,2009-03-15T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
18428981,2009-03-15T00:00:00,"Stress, Mechanical",G01.374.676.830
18428981,2009-03-15T00:00:00,"Stress, Mechanical",G01.595.540.830
18428981,2009-03-15T00:00:00,Surface Properties,G02.842.850
19289651,2009-03-16T00:00:00,Angiotensin I,D06.472.699.094.075
19289651,2009-03-16T00:00:00,Angiotensin I,D12.644.400.070.075
19289651,2009-03-16T00:00:00,Angiotensin I,D12.644.456.073.021
19289651,2009-03-16T00:00:00,Angiotensin I,D12.644.548.058.075
19289651,2009-03-16T00:00:00,Angiotensin I,D12.776.641.650.070.075
19289651,2009-03-16T00:00:00,Angiotensin I,D23.469.050.050.025
19289651,2009-03-16T00:00:00,Animals,B01.050
19289651,2009-03-16T00:00:00,Kidney Glomerulus,A05.810.453.324.359
19289651,2009-03-16T00:00:00,Kidney Glomerulus,A05.810.453.736.520
19289651,2009-03-16T00:00:00,Peptide Fragments,D12.644.541
19289651,2009-03-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19289651,2009-03-16T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19289651,2009-03-16T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19375675,2009-03-17T00:00:00,Aged,M01.060.116.100
19375675,2009-03-17T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19375675,2009-03-17T00:00:00,Coronary Angiography,E01.370.370.050.200
19375675,2009-03-17T00:00:00,Coronary Angiography,E01.370.370.380.200
19375675,2009-03-17T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
19375675,2009-03-17T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
19375675,2009-03-17T00:00:00,Drug-Eluting Stents,E07.695.750.500
19375675,2009-03-17T00:00:00,Hospitalization,E02.760.400
19375675,2009-03-17T00:00:00,Hospitalization,N02.421.585.400
19375675,2009-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19375675,2009-03-17T00:00:00,Metals,D01.552
19375675,2009-03-17T00:00:00,Middle Aged,M01.060.116.630
19375675,2009-03-17T00:00:00,Myocardial Infarction,C14.280.647.500
19375675,2009-03-17T00:00:00,Myocardial Infarction,C14.907.585.500
19375675,2009-03-17T00:00:00,Prosthesis Design,E05.320.550
19375675,2009-03-17T00:00:00,Prosthesis Design,E07.695.680
19375675,2009-03-17T00:00:00,Risk Assessment,E05.318.740.600.800.715
19375675,2009-03-17T00:00:00,Risk Assessment,N04.452.871.715
19375675,2009-03-17T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19375675,2009-03-17T00:00:00,Risk Assessment,N06.850.505.715
19375675,2009-03-17T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19375675,2009-03-17T00:00:00,Stents,E07.695.750
19375675,2009-03-17T00:00:00,Thrombosis,C14.907.355.830
19375675,2009-03-17T00:00:00,Time Factors,G01.910.857
19375675,2009-03-17T00:00:00,Treatment Outcome,E01.789.800
19375675,2009-03-17T00:00:00,Treatment Outcome,N04.761.559.590.800
19375675,2009-03-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19410114,2009-03-17T00:00:00,Aged,M01.060.116.100
19410114,2009-03-17T00:00:00,Depression,F01.145.126.350
19410114,2009-03-17T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19410114,2009-03-17T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19410114,2009-03-17T00:00:00,Health Behavior,F01.145.488
19410114,2009-03-17T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
19410114,2009-03-17T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
19410114,2009-03-17T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
19410114,2009-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19410114,2009-03-17T00:00:00,Hypoglycemic Agents,D27.505.696.422
19410114,2009-03-17T00:00:00,Motor Activity,F01.145.632
19410114,2009-03-17T00:00:00,Motor Activity,G11.427.590.530.698
19289044,2009-03-18T00:00:00,Algorithms,G17.035
19289044,2009-03-18T00:00:00,Algorithms,L01.224.050
19289044,2009-03-18T00:00:00,Amino Acid Sequence,G02.111.570.060
19289044,2009-03-18T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19289044,2009-03-18T00:00:00,"Databases, Genetic",L01.470.750.750.325
19289044,2009-03-18T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
19289044,2009-03-18T00:00:00,Glutathione Transferase,D08.811.913.225.500
19289044,2009-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19289044,2009-03-18T00:00:00,"Models, Molecular",E05.599.595
19289044,2009-03-18T00:00:00,Molecular Sequence Data,L01.453.245.667
19289044,2009-03-18T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19289044,2009-03-18T00:00:00,Protein Conformation,G02.111.570.790.709
19289044,2009-03-18T00:00:00,Protein Interaction Mapping,E05.601.690
19289044,2009-03-18T00:00:00,Proteins,D12.776
19289044,2009-03-18T00:00:00,Static Electricity,G01.201.249.820
19297657,2009-03-18T00:00:00,Age Factors,N05.715.350.075
19297657,2009-03-18T00:00:00,Age Factors,N06.850.490.250
19297657,2009-03-18T00:00:00,Aged,M01.060.116.100
19297657,2009-03-18T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19297657,2009-03-18T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19297657,2009-03-18T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19297657,2009-03-18T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19297657,2009-03-18T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19297657,2009-03-18T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19297657,2009-03-18T00:00:00,Early Detection of Cancer,E01.390.500
19297657,2009-03-18T00:00:00,Health Promotion,N02.370
19297657,2009-03-18T00:00:00,Health Promotion,N02.421.726.507
19297657,2009-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19297657,2009-03-18T00:00:00,Middle Aged,M01.060.116.630
19297657,2009-03-18T00:00:00,Primary Health Care,N04.590.233.727
19297657,2009-03-18T00:00:00,Sex Factors,N05.715.350.675
19297657,2009-03-18T00:00:00,Sex Factors,N06.850.490.875
19299309,2009-03-18T00:00:00,Academic Medical Centers,N02.278.020
19299309,2009-03-18T00:00:00,Aged,M01.060.116.100
19299309,2009-03-18T00:00:00,Brain Infarction,C10.228.140.300.150.477
19299309,2009-03-18T00:00:00,Brain Infarction,C10.228.140.300.775.200
19299309,2009-03-18T00:00:00,Brain Infarction,C14.907.253.092.477
19299309,2009-03-18T00:00:00,Brain Infarction,C14.907.253.855.200
19299309,2009-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19299309,2009-03-18T00:00:00,Middle Aged,M01.060.116.630
19299309,2009-03-18T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19299309,2009-03-18T00:00:00,Postoperative Complications,C23.550.767
19299309,2009-03-18T00:00:00,Professional Competence,I02.399.630
19299309,2009-03-18T00:00:00,Risk Factors,E05.318.740.600.800.725
19299309,2009-03-18T00:00:00,Risk Factors,N05.715.350.200.700
19299309,2009-03-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19299309,2009-03-18T00:00:00,Risk Factors,N06.850.490.625.750
19299309,2009-03-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19299309,2009-03-18T00:00:00,Stents,E07.695.750
19299309,2009-03-18T00:00:00,Stroke,C10.228.140.300.775
19299309,2009-03-18T00:00:00,Stroke,C14.907.253.855
19299309,2009-03-18T00:00:00,Vascular Surgical Procedures,E04.100.814
19299309,2009-03-18T00:00:00,Vertebrobasilar Insufficiency,C10.228.140.300.150.956
19299309,2009-03-18T00:00:00,Vertebrobasilar Insufficiency,C14.907.253.092.956
19299309,2009-03-18T00:00:00,Vertebrobasilar Insufficiency,C14.907.253.956
19299580,2009-03-19T00:00:00,Animals,B01.050
19299580,2009-03-19T00:00:00,"Hypertension, Portal",C06.552.494
19299580,2009-03-19T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19299580,2009-03-19T00:00:00,Liver,A03.620
19299580,2009-03-19T00:00:00,"Receptor, Endothelin A",D12.776.543.750.100.220.100
19299580,2009-03-19T00:00:00,"Receptor, Endothelin A",D12.776.543.750.750.320.100
19299580,2009-03-19T00:00:00,Time Factors,G01.910.857
19302480,2009-03-19T00:00:00,Aged,M01.060.116.100
19302480,2009-03-19T00:00:00,"Cardiac Pacing, Artificial",E02.145
19302480,2009-03-19T00:00:00,Heart Failure,C14.280.434
19302480,2009-03-19T00:00:00,Hemodynamics,G09.330.190.400
19302480,2009-03-19T00:00:00,Hemodynamics,G09.330.380
19302480,2009-03-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19302480,2009-03-19T00:00:00,Middle Aged,M01.060.116.630
19302480,2009-03-19T00:00:00,Time Factors,G01.910.857
19303447,2009-03-19T00:00:00,Alzheimer Disease,C10.228.140.380.100
19303447,2009-03-19T00:00:00,Alzheimer Disease,C10.574.945.249
19303447,2009-03-19T00:00:00,Alzheimer Disease,F03.087.400.100
19303447,2009-03-19T00:00:00,Animals,B01.050
19303447,2009-03-19T00:00:00,Brain,A08.186.211
19303447,2009-03-19T00:00:00,"Disease Models, Animal",C22.232
19303447,2009-03-19T00:00:00,"Disease Models, Animal",E05.598.500
19303447,2009-03-19T00:00:00,"Disease Models, Animal",E05.599.395.080
19303447,2009-03-19T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19303447,2009-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19303447,2009-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19303447,2009-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19303447,2009-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19303447,2009-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19389676,2009-03-19T00:00:00,Adult,M01.060.116
19389676,2009-03-19T00:00:00,Genome-Wide Association Study,E05.318.416.249
19389676,2009-03-19T00:00:00,Genome-Wide Association Study,E05.318.780.392
19389676,2009-03-19T00:00:00,Genome-Wide Association Study,E05.393.385.500
19389676,2009-03-19T00:00:00,Genome-Wide Association Study,E05.393.522.500
19389676,2009-03-19T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19389676,2009-03-19T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19389676,2009-03-19T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19389676,2009-03-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19389676,2009-03-19T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19478501,2009-03-19T00:00:00,Clinical Trials as Topic,E05.318.760.535
19478501,2009-03-19T00:00:00,Clinical Trials as Topic,E05.337.250
19478501,2009-03-19T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19478501,2009-03-19T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19478501,2009-03-19T00:00:00,Research Design,E05.581.500
19478501,2009-03-19T00:00:00,Research Design,H01.770.644.728
19300490,2009-03-20T00:00:00,Adult,M01.060.116
19300490,2009-03-20T00:00:00,African Americans,M01.686.508.100.100
19300490,2009-03-20T00:00:00,African Americans,M01.686.754.100
19300490,2009-03-20T00:00:00,African Continental Ancestry Group,M01.686.508.100
19300490,2009-03-20T00:00:00,Alleles,G05.360.340.024.340.030
19300490,2009-03-20T00:00:00,"Antigens, CD",D23.050.301.264.035
19300490,2009-03-20T00:00:00,"Antigens, CD",D23.101.100.110
19300490,2009-03-20T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
19300490,2009-03-20T00:00:00,"Arthritis, Rheumatoid",C05.799.114
19300490,2009-03-20T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
19300490,2009-03-20T00:00:00,"Arthritis, Rheumatoid",C20.111.199
19300490,2009-03-20T00:00:00,Case-Control Studies,E05.318.760.500.500
19300490,2009-03-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19300490,2009-03-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19300490,2009-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19300490,2009-03-20T00:00:00,Middle Aged,M01.060.116.630
19300490,2009-03-20T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19304906,2009-03-20T00:00:00,Animals,B01.050
19304906,2009-03-20T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
19304906,2009-03-20T00:00:00,Cell Line,A11.251.210
19304906,2009-03-20T00:00:00,"Disease Models, Animal",C22.232
19304906,2009-03-20T00:00:00,"Disease Models, Animal",E05.598.500
19304906,2009-03-20T00:00:00,"Disease Models, Animal",E05.599.395.080
19304906,2009-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19304906,2009-03-20T00:00:00,Lung,A04.411
19304906,2009-03-20T00:00:00,Time Factors,G01.910.857
20811098,2009-03-20T00:00:00,Animals,B01.050
20811098,2009-03-20T00:00:00,Calcium,D01.268.552.100
20811098,2009-03-20T00:00:00,Calcium,D01.552.539.288
20811098,2009-03-20T00:00:00,Calcium,D23.119.100
20811098,2009-03-20T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20811098,2009-03-20T00:00:00,Cell Differentiation,G04.299.151
20811098,2009-03-20T00:00:00,Compressive Strength,G01.374.180
20811098,2009-03-20T00:00:00,Osteoblasts,A11.329.629
20811098,2009-03-20T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
20811098,2009-03-20T00:00:00,Osteogenesis,G11.427.590.560.100.729
20811098,2009-03-20T00:00:00,Polyesters,D05.750.728
20811098,2009-03-20T00:00:00,Polyesters,D25.720.728
20811098,2009-03-20T00:00:00,Polyesters,J01.637.051.720.728
20811098,2009-03-20T00:00:00,Tissue Engineering,E05.200.249.750
20811098,2009-03-20T00:00:00,Tissue Scaffolds,E07.206.627
20811098,2009-03-20T00:00:00,Tissue Scaffolds,E07.695.825
20811098,2009-03-20T00:00:00,X-Ray Microtomography,E01.370.350.700.810.810.900
20811098,2009-03-20T00:00:00,X-Ray Microtomography,E01.370.350.825.810.810.900
19346614,2009-03-21T00:00:00,Crystallization,E05.196.300
19346614,2009-03-21T00:00:00,Crystallization,G02.149.767.505
19346614,2009-03-21T00:00:00,Crystallization,G02.842.750.505
19346614,2009-03-21T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
19346614,2009-03-21T00:00:00,Hydrogen Bonding,G02.149.767.620
19346614,2009-03-21T00:00:00,Hydrogen Bonding,G02.842.750.620
19346614,2009-03-21T00:00:00,Molecular Structure,G02.111.570
19346614,2009-03-21T00:00:00,Molecular Structure,G02.575
19346614,2009-03-21T00:00:00,Molecular Structure,G02.842.575
19346614,2009-03-21T00:00:00,Phenylpropionates,D02.241.223.701
19346614,2009-03-21T00:00:00,Pyrazoles,D03.383.129.539
19454332,2009-03-21T00:00:00,Animals,B01.050
19454332,2009-03-21T00:00:00,Apoptosis,G04.299.139.160
19454332,2009-03-21T00:00:00,Cell Proliferation,G04.299.233.750
19454332,2009-03-21T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19454332,2009-03-21T00:00:00,Gene Expression Profiling,E05.393.332
19454332,2009-03-21T00:00:00,Gene Expression Regulation,G05.355.315
19454332,2009-03-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19454332,2009-03-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19454332,2009-03-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19454332,2009-03-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19454332,2009-03-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19454332,2009-03-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19454332,2009-03-21T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19454332,2009-03-21T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19454332,2009-03-21T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19454332,2009-03-21T00:00:00,Skin,A17.815
19306106,2009-03-22T00:00:00,Adolescent,M01.060.057
19306106,2009-03-22T00:00:00,Adult,M01.060.116
19306106,2009-03-22T00:00:00,African Continental Ancestry Group,M01.686.508.100
19306106,2009-03-22T00:00:00,Alcoholism,C21.739.100.250
19306106,2009-03-22T00:00:00,Alcoholism,F03.900.100.350
19306106,2009-03-22T00:00:00,Case-Control Studies,E05.318.760.500.500
19306106,2009-03-22T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19306106,2009-03-22T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19306106,2009-03-22T00:00:00,European Continental Ancestry Group,M01.686.508.400
19306106,2009-03-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19306106,2009-03-22T00:00:00,Middle Aged,M01.060.116.630
19306106,2009-03-22T00:00:00,"Models, Genetic",E05.599.395.397
19306106,2009-03-22T00:00:00,Risk Factors,E05.318.740.600.800.725
19306106,2009-03-22T00:00:00,Risk Factors,N05.715.350.200.700
19306106,2009-03-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19306106,2009-03-22T00:00:00,Risk Factors,N06.850.490.625.750
19306106,2009-03-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19306106,2009-03-22T00:00:00,United States,Z01.107.567.875
19306106,2009-03-22T00:00:00,Young Adult,M01.060.116.815
19307187,2009-03-23T00:00:00,Fibroblasts,A11.329.228
19307187,2009-03-23T00:00:00,Fibroblasts,A11.872.228
19307187,2009-03-23T00:00:00,Glucose,D09.546.359.448
19307187,2009-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19307187,2009-03-23T00:00:00,Interleukin-6,D12.644.276.374.465.506
19307187,2009-03-23T00:00:00,Interleukin-6,D12.776.467.374.465.506
19307187,2009-03-23T00:00:00,Interleukin-6,D23.529.374.465.506
19307187,2009-03-23T00:00:00,Lipopolysaccharides,D09.400.500
19307187,2009-03-23T00:00:00,Lipopolysaccharides,D09.698.718.450
19307187,2009-03-23T00:00:00,Lipopolysaccharides,D10.494
19307187,2009-03-23T00:00:00,Lipopolysaccharides,D23.050.161.616.525
19307187,2009-03-23T00:00:00,Lipopolysaccharides,D23.946.123.329.500
19307187,2009-03-23T00:00:00,Macrophages,A11.329.372
19307187,2009-03-23T00:00:00,Macrophages,A11.627.482
19307187,2009-03-23T00:00:00,Macrophages,A11.733.397
19307187,2009-03-23T00:00:00,Macrophages,A15.382.680.397
19307187,2009-03-23T00:00:00,Macrophages,A15.382.812.522
19307187,2009-03-23T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
19307187,2009-03-23T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
19307187,2009-03-23T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
19307187,2009-03-23T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
19307187,2009-03-23T00:00:00,Sweetening Agents,D27.720.364.609
19307187,2009-03-23T00:00:00,Sweetening Agents,D27.720.888
19307187,2009-03-23T00:00:00,Sweetening Agents,J02.500.512.400.700
19318137,2009-03-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19318137,2009-03-24T00:00:00,Medical Informatics,L01.313.500
19318137,2009-03-24T00:00:00,Medical Informatics,L01.700
19318137,2009-03-24T00:00:00,Terminology as Topic,L01.143.506.598.400
19318137,2009-03-24T00:00:00,"Vocabulary, Controlled",L01.453.245.945
19238107,2009-03-25T00:00:00,Adult,M01.060.116
19238107,2009-03-25T00:00:00,Brain Mapping,E01.370.350.086
19238107,2009-03-25T00:00:00,Brain Mapping,E01.370.376.149
19238107,2009-03-25T00:00:00,Brain Mapping,E05.132
19238107,2009-03-25T00:00:00,Face,A01.456.505
19238107,2009-03-25T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
19238107,2009-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19238107,2009-03-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19238107,2009-03-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19238107,2009-03-25T00:00:00,Motor Activity,F01.145.632
19238107,2009-03-25T00:00:00,Motor Activity,G11.427.590.530.698
19238107,2009-03-25T00:00:00,Photic Stimulation,E05.723.729
19238107,2009-03-25T00:00:00,Speech Perception,F02.463.593.071.875
19238107,2009-03-25T00:00:00,Visual Perception,F02.463.593.932
19238107,2009-03-25T00:00:00,Young Adult,M01.060.116.815
19321768,2009-03-25T00:00:00,Animals,B01.050
19321768,2009-03-25T00:00:00,Cocaine,D02.145.074.722.388
19321768,2009-03-25T00:00:00,Cocaine,D03.132.889.354
19321768,2009-03-25T00:00:00,Cocaine,D03.605.869.388
19321768,2009-03-25T00:00:00,Cocaine,D04.075.080.875.099.722.388
19321768,2009-03-25T00:00:00,Cocaine-Related Disorders,C21.739.300
19321768,2009-03-25T00:00:00,Cocaine-Related Disorders,F03.900.300
19321768,2009-03-25T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19321768,2009-03-25T00:00:00,Extracellular Space,A10.082.500
19321768,2009-03-25T00:00:00,Extracellular Space,A11.284.295
19321768,2009-03-25T00:00:00,Glutamic Acid,D12.125.067.750
19321768,2009-03-25T00:00:00,Glutamic Acid,D12.125.119.450
19321768,2009-03-25T00:00:00,Glutamic Acid,D12.125.427.300
19321768,2009-03-25T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19321768,2009-03-25T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19321768,2009-03-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19321768,2009-03-25T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19321768,2009-03-25T00:00:00,Self Administration,E02.319.890
19321768,2009-03-25T00:00:00,Self Administration,E02.900.890
19321768,2009-03-25T00:00:00,Synaptic Transmission,G02.111.087.800.850
19321768,2009-03-25T00:00:00,Synaptic Transmission,G02.149.115.800.850
19321768,2009-03-25T00:00:00,Synaptic Transmission,G04.299.880.850
19321768,2009-03-25T00:00:00,Synaptic Transmission,G07.265.337.900
19321768,2009-03-25T00:00:00,Synaptic Transmission,G07.700.240.900
19321768,2009-03-25T00:00:00,Synaptic Transmission,G11.561.600.835
19321791,2009-03-25T00:00:00,Animals,B01.050
19321791,2009-03-25T00:00:00,"Animals, Newborn",B01.050.050.282
19321791,2009-03-25T00:00:00,Antibodies,D12.776.124.486.485.114
19321791,2009-03-25T00:00:00,Antibodies,D12.776.124.790.651.114
19321791,2009-03-25T00:00:00,Antibodies,D12.776.377.715.548.114
19321791,2009-03-25T00:00:00,Dendritic Cells,A11.066.270
19321791,2009-03-25T00:00:00,Dendritic Cells,A11.436.270
19321791,2009-03-25T00:00:00,Dendritic Cells,A15.382.066.270
19321791,2009-03-25T00:00:00,Dendritic Cells,A15.382.812.260
19321791,2009-03-25T00:00:00,HIV-1,B04.820.650.589.650.350.400
19321791,2009-03-25T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
19321791,2009-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19321791,2009-03-25T00:00:00,Interferon-alpha,D12.644.276.374.440.890.250
19321791,2009-03-25T00:00:00,Interferon-alpha,D12.644.276.718.500.250
19321791,2009-03-25T00:00:00,Interferon-alpha,D12.776.467.374.440.890.250
19321791,2009-03-25T00:00:00,Interferon-alpha,D12.776.467.718.500.250
19321791,2009-03-25T00:00:00,Interferon-alpha,D23.529.374.440.890.250
19321791,2009-03-25T00:00:00,Interferon-alpha,D23.529.718.500.250
19321791,2009-03-25T00:00:00,Maze Learning,F02.463.425.507
19321791,2009-03-25T00:00:00,Neurons,A08.663
19321791,2009-03-25T00:00:00,Neurons,A11.671
19321791,2009-03-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19321791,2009-03-25T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19321791,2009-03-25T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
19324534,2009-03-25T00:00:00,Aged,M01.060.116.100
19324534,2009-03-25T00:00:00,Brain,A08.186.211
19324534,2009-03-25T00:00:00,Brain Ischemia,C10.228.140.300.150
19324534,2009-03-25T00:00:00,Brain Ischemia,C14.907.253.092
19324534,2009-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19324534,2009-03-25T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19324534,2009-03-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19324534,2009-03-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19324534,2009-03-25T00:00:00,Middle Aged,M01.060.116.630
19324855,2009-03-25T00:00:00,Animals,B01.050
19324855,2009-03-25T00:00:00,Morphine,D03.132.577.249.547
19324855,2009-03-25T00:00:00,Morphine,D03.549.686.575
19324855,2009-03-25T00:00:00,Morphine,D03.605.497.575
19324855,2009-03-25T00:00:00,Morphine,D04.615.723.795.547
19324855,2009-03-25T00:00:00,Narcotic Antagonists,D27.505.696.543
19324855,2009-03-25T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
19324855,2009-03-25T00:00:00,Narcotic Antagonists,D27.505.954.427.550
19324855,2009-03-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19324855,2009-03-25T00:00:00,"Receptors, Opioid",D12.776.543.750.100.620
19324855,2009-03-25T00:00:00,"Receptors, Opioid",D12.776.543.750.720.600.610
19324855,2009-03-25T00:00:00,"Receptors, Opioid",D12.776.543.750.750.555.610
19324855,2009-03-25T00:00:00,Reperfusion Injury,C14.907.725
19324855,2009-03-25T00:00:00,Reperfusion Injury,C23.550.767.877
19324855,2009-03-25T00:00:00,Retinal Degeneration,C11.768.585
19324855,2009-03-25T00:00:00,Retinal Vessels,A07.231.611
19362838,2009-03-25T00:00:00,Enzyme Inhibitors,D27.505.519.389
19362838,2009-03-25T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
19362838,2009-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19362838,2009-03-25T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19362838,2009-03-25T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19362838,2009-03-25T00:00:00,Peptides,D12.644
19395178,2009-03-25T00:00:00,Adolescent,M01.060.057
19395178,2009-03-25T00:00:00,Adult,M01.060.116
19395178,2009-03-25T00:00:00,Cues,F02.463.425.234
19395178,2009-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19395178,2009-03-25T00:00:00,Psychometrics,F04.711.780
19395178,2009-03-25T00:00:00,Smoking,F01.145.466.753
19395178,2009-03-25T00:00:00,"Stress, Psychological",F01.145.126.990
19395178,2009-03-25T00:00:00,"Stress, Psychological",F02.830.900
19395178,2009-03-25T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19395178,2009-03-25T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19395178,2009-03-25T00:00:00,Tobacco Use Disorder,C21.739.912
19395178,2009-03-25T00:00:00,Tobacco Use Disorder,F03.900.912
19395178,2009-03-25T00:00:00,Young Adult,M01.060.116.815
19324870,2009-03-26T00:00:00,Alleles,G05.360.340.024.340.030
19324870,2009-03-26T00:00:00,Breast Neoplasms,C04.588.180
19324870,2009-03-26T00:00:00,Breast Neoplasms,C17.800.090.500
19324870,2009-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19324870,2009-03-26T00:00:00,Molecular Sequence Data,L01.453.245.667
19324870,2009-03-26T00:00:00,Phosphoprotein Phosphatases,D08.811.277.352.650.625
19324870,2009-03-26T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19324870,2009-03-26T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
19324870,2009-03-26T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
19324870,2009-03-26T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
19324870,2009-03-26T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
19324870,2009-03-26T00:00:00,Serine,D12.125.154.800
19324870,2009-03-26T00:00:00,Serine,D12.125.837
19325134,2009-03-26T00:00:00,Adolescent,M01.060.057
19325134,2009-03-26T00:00:00,Adult,M01.060.116
19325134,2009-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19325134,2009-03-26T00:00:00,Interviews as Topic,E05.318.308.420
19325134,2009-03-26T00:00:00,Interviews as Topic,L01.280.520
19325134,2009-03-26T00:00:00,Interviews as Topic,N05.715.360.300.400
19325134,2009-03-26T00:00:00,Interviews as Topic,N06.850.520.308.420
19325134,2009-03-26T00:00:00,Middle Aged,M01.060.116.630
19325134,2009-03-26T00:00:00,New York,Z01.107.567.875.075.437
19325134,2009-03-26T00:00:00,New York,Z01.107.567.875.350.530
19325134,2009-03-26T00:00:00,New York,Z01.107.567.875.500.530
19325134,2009-03-26T00:00:00,Nicotine,D03.132.760.570
19325134,2009-03-26T00:00:00,Nicotine,D03.383.725.518
19325134,2009-03-26T00:00:00,Smoking,F01.145.466.753
19325134,2009-03-26T00:00:00,Young Adult,M01.060.116.815
19476843,2009-03-26T00:00:00,Adolescent,M01.060.057
19476843,2009-03-26T00:00:00,Algorithms,G17.035
19476843,2009-03-26T00:00:00,Algorithms,L01.224.050
19476843,2009-03-26T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19476843,2009-03-26T00:00:00,Appendectomy,E04.210.078
19476843,2009-03-26T00:00:00,Appendicitis,C06.405.205.099
19476843,2009-03-26T00:00:00,Appendicitis,C06.405.469.110.207
19476843,2009-03-26T00:00:00,Child,M01.060.406
19476843,2009-03-26T00:00:00,"Child, Preschool",M01.060.406.448
19476843,2009-03-26T00:00:00,Combined Modality Therapy,E02.186
19476843,2009-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19476843,2009-03-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19476843,2009-03-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19476843,2009-03-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19476843,2009-03-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19476843,2009-03-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19476873,2009-03-26T00:00:00,Breast Neoplasms,C04.588.180
19476873,2009-03-26T00:00:00,Breast Neoplasms,C17.800.090.500
19476873,2009-03-26T00:00:00,Gene Expression Profiling,E05.393.332
19476873,2009-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19476873,2009-03-26T00:00:00,Lymph Nodes,A10.549.400
19476873,2009-03-26T00:00:00,Lymph Nodes,A15.382.520.604.412
19476873,2009-03-26T00:00:00,Middle Aged,M01.060.116.630
19476873,2009-03-26T00:00:00,Neoplasm Proteins,D12.776.624
19476873,2009-03-26T00:00:00,Neoplasm Staging,E01.370.550
19476873,2009-03-26T00:00:00,Obesity,C18.654.726.500
19476873,2009-03-26T00:00:00,Obesity,C23.888.144.699.500
19476873,2009-03-26T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19476873,2009-03-26T00:00:00,Obesity,G07.100.100.160.120.699.500
19476873,2009-03-26T00:00:00,Peptide Fragments,D12.644.541
19476873,2009-03-26T00:00:00,Proteomics,H01.158.201.843
19476873,2009-03-26T00:00:00,Proteomics,H01.158.273.180.350.700
19476873,2009-03-26T00:00:00,Proteomics,H01.158.273.343.350.700
19476873,2009-03-26T00:00:00,Proteomics,H01.181.122.738
19476873,2009-03-26T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19476873,2009-03-26T00:00:00,"Tumor Markers, Biological",D23.101.840
19197194,2009-03-27T00:00:00,Adolescent,M01.060.057
19197194,2009-03-27T00:00:00,Adult,M01.060.116
19197194,2009-03-27T00:00:00,Age Factors,N05.715.350.075
19197194,2009-03-27T00:00:00,Age Factors,N06.850.490.250
19197194,2009-03-27T00:00:00,HIV Infections,C02.782.815.616.400
19197194,2009-03-27T00:00:00,HIV Infections,C02.800.801.400
19197194,2009-03-27T00:00:00,HIV Infections,C20.673.480
19197194,2009-03-27T00:00:00,Health Services,N02.421
19197194,2009-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19197194,2009-03-27T00:00:00,Middle Aged,M01.060.116.630
19197194,2009-03-27T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
19197194,2009-03-27T00:00:00,Sex Factors,N05.715.350.675
19197194,2009-03-27T00:00:00,Sex Factors,N06.850.490.875
19197194,2009-03-27T00:00:00,South Carolina,Z01.107.567.875.075.662
19197194,2009-03-27T00:00:00,South Carolina,Z01.107.567.875.750.700
19197194,2009-03-27T00:00:00,Young Adult,M01.060.116.815
19325561,2009-03-27T00:00:00,Adolescent,M01.060.057
19325561,2009-03-27T00:00:00,African Americans,M01.686.508.100.100
19325561,2009-03-27T00:00:00,African Americans,M01.686.754.100
19325561,2009-03-27T00:00:00,Age Factors,N05.715.350.075
19325561,2009-03-27T00:00:00,Age Factors,N06.850.490.250
19325561,2009-03-27T00:00:00,Blood Pressure,E01.370.600.875.249
19325561,2009-03-27T00:00:00,Blood Pressure,G09.330.380.076
19325561,2009-03-27T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
19325561,2009-03-27T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
19325561,2009-03-27T00:00:00,Child,M01.060.406
19325561,2009-03-27T00:00:00,Circadian Rhythm,G07.180.562.190
19325561,2009-03-27T00:00:00,European Continental Ancestry Group,M01.686.508.400
19325561,2009-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19325561,2009-03-27T00:00:00,Hypertension,C14.907.489
19325561,2009-03-27T00:00:00,Sex Factors,N05.715.350.675
19325561,2009-03-27T00:00:00,Sex Factors,N06.850.490.875
19325561,2009-03-27T00:00:00,United States,Z01.107.567.875
19325561,2009-03-27T00:00:00,Young Adult,M01.060.116.815
19326210,2009-03-27T00:00:00,"Adaptation, Psychological",F01.058
19326210,2009-03-27T00:00:00,Adolescent,M01.060.057
19326210,2009-03-27T00:00:00,Child,M01.060.406
19326210,2009-03-27T00:00:00,"Child, Preschool",M01.060.406.448
19326210,2009-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19326210,2009-03-27T00:00:00,Life Change Events,F01.829.458.410
19326210,2009-03-27T00:00:00,Needs Assessment,I02.594
19326210,2009-03-27T00:00:00,Needs Assessment,N03.349.380.565
19326210,2009-03-27T00:00:00,Needs Assessment,N05.300.537
19326210,2009-03-27T00:00:00,Parents,F01.829.263.500.320
19326210,2009-03-27T00:00:00,Parents,I01.880.225.500.340
19326210,2009-03-27T00:00:00,Parents,M01.620
19326210,2009-03-27T00:00:00,Psychiatric Status Rating Scales,F04.586
19326210,2009-03-27T00:00:00,Schools,I02.233.659
19326210,2009-03-27T00:00:00,Schools,I02.783
19326210,2009-03-27T00:00:00,Social Support,I01.880.656.600
19326210,2009-03-27T00:00:00,"Stress, Psychological",F01.145.126.990
19326210,2009-03-27T00:00:00,"Stress, Psychological",F02.830.900
19326210,2009-03-27T00:00:00,Students,I02.233.748
19326210,2009-03-27T00:00:00,Students,I02.851
19326210,2009-03-27T00:00:00,Students,M01.848
19326210,2009-03-27T00:00:00,United States,Z01.107.567.875
19329491,2009-03-27T00:00:00,Animals,B01.050
19329491,2009-03-27T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
19329491,2009-03-27T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
19329491,2009-03-27T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
19329491,2009-03-27T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19329491,2009-03-27T00:00:00,Genetic Predisposition to Disease,G05.380.355
19329491,2009-03-27T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19329491,2009-03-27T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19329491,2009-03-27T00:00:00,Phenotype,G05.695
19329491,2009-03-27T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19329491,2009-03-27T00:00:00,Risk Factors,E05.318.740.600.800.725
19329491,2009-03-27T00:00:00,Risk Factors,N05.715.350.200.700
19329491,2009-03-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19329491,2009-03-27T00:00:00,Risk Factors,N06.850.490.625.750
19329491,2009-03-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19322918,2009-03-28T00:00:00,Aged,M01.060.116.100
19322918,2009-03-28T00:00:00,Contrast Media,D27.720.259
19322918,2009-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19322918,2009-03-28T00:00:00,Incidence,E05.318.308.985.525.375
19322918,2009-03-28T00:00:00,Incidence,L01.280.975.525.375
19322918,2009-03-28T00:00:00,Incidence,N01.224.935.597.500
19322918,2009-03-28T00:00:00,Incidence,N06.850.505.400.975.525.375
19322918,2009-03-28T00:00:00,Incidence,N06.850.520.308.985.525.375
19322918,2009-03-28T00:00:00,Inpatients,M01.643.470
19322918,2009-03-28T00:00:00,Kidney Diseases,C12.777.419
19322918,2009-03-28T00:00:00,Kidney Diseases,C13.351.968.419
19322918,2009-03-28T00:00:00,Liver Cirrhosis,C06.552.630
19322918,2009-03-28T00:00:00,Middle Aged,M01.060.116.630
19322918,2009-03-28T00:00:00,Risk Factors,E05.318.740.600.800.725
19322918,2009-03-28T00:00:00,Risk Factors,N05.715.350.200.700
19322918,2009-03-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19322918,2009-03-28T00:00:00,Risk Factors,N06.850.490.625.750
19322918,2009-03-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19330495,2009-03-28T00:00:00,Adult,M01.060.116
19330495,2009-03-28T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
19330495,2009-03-28T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19330495,2009-03-28T00:00:00,Decision Support Techniques,E05.245
19330495,2009-03-28T00:00:00,Decision Support Techniques,L01.700.508.190
19330495,2009-03-28T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19330495,2009-03-28T00:00:00,Drug Resistance,G07.690.320
19330495,2009-03-28T00:00:00,Employment,N01.824.245
19330495,2009-03-28T00:00:00,Health Care Costs,N03.219.151.400
19330495,2009-03-28T00:00:00,Health Care Costs,N05.300.375
19330495,2009-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19330495,2009-03-28T00:00:00,Markov Chains,E05.318.740.600.500
19330495,2009-03-28T00:00:00,Markov Chains,E05.318.740.996.500
19330495,2009-03-28T00:00:00,Markov Chains,G17.830.500
19330495,2009-03-28T00:00:00,Markov Chains,N05.715.360.750.625.500
19330495,2009-03-28T00:00:00,Markov Chains,N05.715.360.750.770.500
19330495,2009-03-28T00:00:00,Markov Chains,N06.850.520.830.600.500
19330495,2009-03-28T00:00:00,Markov Chains,N06.850.520.830.996.500
19330495,2009-03-28T00:00:00,Middle Aged,M01.060.116.630
19330495,2009-03-28T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19330495,2009-03-28T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19330495,2009-03-28T00:00:00,Treatment Outcome,E01.789.800
19330495,2009-03-28T00:00:00,Treatment Outcome,N04.761.559.590.800
19330495,2009-03-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19346594,2009-03-28T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
19346594,2009-03-28T00:00:00,Fluorine Compounds,D01.303
19346594,2009-03-28T00:00:00,Molecular Structure,G02.111.570
19346594,2009-03-28T00:00:00,Molecular Structure,G02.575
19346594,2009-03-28T00:00:00,Molecular Structure,G02.842.575
19346594,2009-03-28T00:00:00,Titanium,D01.268.557.800
19346594,2009-03-28T00:00:00,Titanium,D01.268.956.878
19346594,2009-03-28T00:00:00,Titanium,D01.552.547.800
19329191,2009-03-29T00:00:00,Adult,M01.060.116
19329191,2009-03-29T00:00:00,Aged,M01.060.116.100
19329191,2009-03-29T00:00:00,Brain,A08.186.211
19329191,2009-03-29T00:00:00,Disease Progression,C23.550.291.656
19329191,2009-03-29T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
19329191,2009-03-29T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
19329191,2009-03-29T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
19329191,2009-03-29T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
19329191,2009-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19329191,2009-03-29T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
19329191,2009-03-29T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
19329191,2009-03-29T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
19329191,2009-03-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19329191,2009-03-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19329191,2009-03-29T00:00:00,Middle Aged,M01.060.116.630
19329191,2009-03-29T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
19329191,2009-03-29T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
19329191,2009-03-29T00:00:00,Pilot Projects,E05.318.760.750
19329191,2009-03-29T00:00:00,Pilot Projects,E05.337.737
19329191,2009-03-29T00:00:00,Pilot Projects,N05.715.360.775.625
19329191,2009-03-29T00:00:00,Pilot Projects,N06.850.520.450.720
19329191,2009-03-29T00:00:00,Proteomics,H01.158.201.843
19329191,2009-03-29T00:00:00,Proteomics,H01.158.273.180.350.700
19329191,2009-03-29T00:00:00,Proteomics,H01.158.273.343.350.700
19329191,2009-03-29T00:00:00,Proteomics,H01.181.122.738
19329191,2009-03-29T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19329191,2009-03-29T00:00:00,Young Adult,M01.060.116.815
19332718,2009-03-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19332718,2009-03-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19332718,2009-03-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19332718,2009-03-30T00:00:00,Breast Neoplasms,C04.588.180
19332718,2009-03-30T00:00:00,Breast Neoplasms,C17.800.090.500
19332718,2009-03-30T00:00:00,Combined Modality Therapy,E02.186
19332718,2009-03-30T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
19332718,2009-03-30T00:00:00,Cyclophosphamide,D02.705.670.243
19332718,2009-03-30T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
19332718,2009-03-30T00:00:00,Doxorubicin,D04.615.562.050.200.175
19332718,2009-03-30T00:00:00,Doxorubicin,D09.408.051.059.200.175
19332718,2009-03-30T00:00:00,Early Detection of Cancer,E01.390.500
19332718,2009-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19332718,2009-03-30T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
19332718,2009-03-30T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
19332718,2009-03-30T00:00:00,Treatment Outcome,E01.789.800
19332718,2009-03-30T00:00:00,Treatment Outcome,N04.761.559.590.800
19332718,2009-03-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19333663,2009-03-31T00:00:00,"Anastomosis, Surgical",E04.035
19333663,2009-03-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19333663,2009-03-31T00:00:00,Incidence,E05.318.308.985.525.375
19333663,2009-03-31T00:00:00,Incidence,L01.280.975.525.375
19333663,2009-03-31T00:00:00,Incidence,N01.224.935.597.500
19333663,2009-03-31T00:00:00,Incidence,N06.850.505.400.975.525.375
19333663,2009-03-31T00:00:00,Incidence,N06.850.520.308.985.525.375
19333663,2009-03-31T00:00:00,Pancreatectomy,E04.210.752
19333663,2009-03-31T00:00:00,Pancreatic Neoplasms,C04.588.274.761
19333663,2009-03-31T00:00:00,Pancreatic Neoplasms,C04.588.322.421
19333663,2009-03-31T00:00:00,Pancreatic Neoplasms,C06.301.761
19333663,2009-03-31T00:00:00,Pancreatic Neoplasms,C06.689.667
19333663,2009-03-31T00:00:00,Pancreatic Neoplasms,C19.344.421
19333663,2009-03-31T00:00:00,Pancreaticoduodenectomy,E04.210.760
19333663,2009-03-31T00:00:00,Postoperative Complications,C23.550.767
19333663,2009-03-31T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19333663,2009-03-31T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19333663,2009-03-31T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19333663,2009-03-31T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19333663,2009-03-31T00:00:00,Risk Assessment,E05.318.740.600.800.715
19333663,2009-03-31T00:00:00,Risk Assessment,N04.452.871.715
19333663,2009-03-31T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19333663,2009-03-31T00:00:00,Risk Assessment,N06.850.505.715
19333663,2009-03-31T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19333663,2009-03-31T00:00:00,Suture Techniques,E04.901
19333663,2009-03-31T00:00:00,Treatment Outcome,E01.789.800
19333663,2009-03-31T00:00:00,Treatment Outcome,N04.761.559.590.800
19333663,2009-03-31T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19336548,2009-03-31T00:00:00,Biomedical Research,H01.770.644.145
19336548,2009-03-31T00:00:00,Communication,F01.145.209
19336548,2009-03-31T00:00:00,Communication,L01.143
19336548,2009-03-31T00:00:00,Community-Based Participatory Research,N05.425.104
19336548,2009-03-31T00:00:00,Consumer Participation,N02.421.143.262
19336548,2009-03-31T00:00:00,Consumer Participation,N03.540.245.360
19336548,2009-03-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19336548,2009-03-31T00:00:00,Language,F01.145.209.399
19336548,2009-03-31T00:00:00,Language,L01.143.506
19336548,2009-03-31T00:00:00,Neoplasms,C04
19338536,2009-03-31T00:00:00,Aged,M01.060.116.100
19338536,2009-03-31T00:00:00,Antineoplastic Agents,D27.505.954.248
19338536,2009-03-31T00:00:00,Case-Control Studies,E05.318.760.500.500
19338536,2009-03-31T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19338536,2009-03-31T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19338536,2009-03-31T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19338536,2009-03-31T00:00:00,Genetic Predisposition to Disease,G05.380.355
19338536,2009-03-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19338536,2009-03-31T00:00:00,Middle Aged,M01.060.116.630
19338536,2009-03-31T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
19338536,2009-03-31T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
19338536,2009-03-31T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19338536,2009-03-31T00:00:00,"Polymorphism, Genetic",G05.365.795
19338536,2009-03-31T00:00:00,Risk Factors,E05.318.740.600.800.725
19338536,2009-03-31T00:00:00,Risk Factors,N05.715.350.200.700
19338536,2009-03-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19338536,2009-03-31T00:00:00,Risk Factors,N06.850.490.625.750
19338536,2009-03-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19338536,2009-03-31T00:00:00,Treatment Outcome,E01.789.800
19338536,2009-03-31T00:00:00,Treatment Outcome,N04.761.559.590.800
19338536,2009-03-31T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19338536,2009-03-31T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19338536,2009-03-31T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
19338536,2009-03-31T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
19338536,2009-03-31T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
19338536,2009-03-31T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
19338536,2009-03-31T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
19341767,2009-03-31T00:00:00,Calmodulin,D12.644.360.381.249
19341767,2009-03-31T00:00:00,Calmodulin,D12.776.157.125.412.249
19341767,2009-03-31T00:00:00,Calmodulin,D12.776.476.387.249
19341767,2009-03-31T00:00:00,Cell Differentiation,G04.299.151
19341767,2009-03-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19341767,2009-03-31T00:00:00,Phosphorylation,G02.111.087.677
19341767,2009-03-31T00:00:00,Phosphorylation,G02.149.115.677
19341767,2009-03-31T00:00:00,Phosphorylation,G02.149.465.700
19341767,2009-03-31T00:00:00,Phosphorylation,G02.607.750.700
19341767,2009-03-31T00:00:00,Phosphorylation,G03.495.790
19341767,2009-03-31T00:00:00,Podocytes,A05.810.453.324.359.720
19341767,2009-03-31T00:00:00,Podocytes,A05.810.453.736.520.720
19341767,2009-03-31T00:00:00,Podocytes,A11.436.720
19341767,2009-03-31T00:00:00,"RNA, Messenger",D13.444.735.544
19341767,2009-03-31T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
19341767,2009-03-31T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
19341767,2009-03-31T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
19341767,2009-03-31T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
19341767,2009-03-31T00:00:00,Sodium-Hydrogen Antiporter,D12.776.157.530.450.162.775
19341767,2009-03-31T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.550.190.775
19341767,2009-03-31T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.585.450.162.775
18465750,2009-04-01T00:00:00,Acoustic Stimulation,E02.037
18465750,2009-04-01T00:00:00,Acoustic Stimulation,E02.190.888.030
18465750,2009-04-01T00:00:00,Acoustic Stimulation,E05.723.136
18465750,2009-04-01T00:00:00,Adolescent,M01.060.057
18465750,2009-04-01T00:00:00,Adult,M01.060.116
18465750,2009-04-01T00:00:00,Auditory Perception,F02.463.593.071
18465750,2009-04-01T00:00:00,Brain,A08.186.211
18465750,2009-04-01T00:00:00,Brain Mapping,E01.370.350.086
18465750,2009-04-01T00:00:00,Brain Mapping,E01.370.376.149
18465750,2009-04-01T00:00:00,Brain Mapping,E05.132
18465750,2009-04-01T00:00:00,Discrimination (Psychology),F02.463.593.257
18465750,2009-04-01T00:00:00,Electroencephalography,E01.370.376.300
18465750,2009-04-01T00:00:00,Electroencephalography,E01.370.405.245
18465750,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18465750,2009-04-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18465750,2009-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18465750,2009-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18465750,2009-04-01T00:00:00,Oxygen,D01.268.185.550
18465750,2009-04-01T00:00:00,Oxygen,D01.362.670
18465750,2009-04-01T00:00:00,Young Adult,M01.060.116.815
18847385,2009-04-01T00:00:00,Adolescent,M01.060.057
18847385,2009-04-01T00:00:00,Age Factors,N05.715.350.075
18847385,2009-04-01T00:00:00,Age Factors,N06.850.490.250
18847385,2009-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
18847385,2009-04-01T00:00:00,Blood Pressure,G09.330.380.076
18847385,2009-04-01T00:00:00,Cardiovascular Diseases,C14
18847385,2009-04-01T00:00:00,Child,M01.060.406
18847385,2009-04-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18847385,2009-04-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18847385,2009-04-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18847385,2009-04-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18847385,2009-04-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18847385,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18847385,2009-04-01T00:00:00,Lipids,D10
18847385,2009-04-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
18847385,2009-04-01T00:00:00,Metabolic Syndrome X,C18.452.625
18847385,2009-04-01T00:00:00,"Models, Biological",E05.599.395
18847385,2009-04-01T00:00:00,Obesity,C18.654.726.500
18847385,2009-04-01T00:00:00,Obesity,C23.888.144.699.500
18847385,2009-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18847385,2009-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18847385,2009-04-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18847385,2009-04-01T00:00:00,Risk Assessment,N04.452.871.715
18847385,2009-04-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18847385,2009-04-01T00:00:00,Risk Assessment,N06.850.505.715
18847385,2009-04-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18847385,2009-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18847385,2009-04-01T00:00:00,Risk Factors,N05.715.350.200.700
18847385,2009-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18847385,2009-04-01T00:00:00,Risk Factors,N06.850.490.625.750
18847385,2009-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18847385,2009-04-01T00:00:00,United States,Z01.107.567.875
18847385,2009-04-01T00:00:00,Young Adult,M01.060.116.815
18932244,2009-04-01T00:00:00,Adult,M01.060.116
18932244,2009-04-01T00:00:00,Aged,M01.060.116.100
18932244,2009-04-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
18932244,2009-04-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
18932244,2009-04-01T00:00:00,Equipment Failure Analysis,E05.325.192
18932244,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18932244,2009-04-01T00:00:00,Knee Joint,A02.835.583.475
18932244,2009-04-01T00:00:00,Knee Prosthesis,E07.695.400.410
18932244,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
18932244,2009-04-01T00:00:00,Polyethylene,D02.455.326.271.665.550.500
18932244,2009-04-01T00:00:00,Polyethylene,D05.750.716.507.500
18932244,2009-04-01T00:00:00,Polyethylene,D25.720.716.507.500
18932244,2009-04-01T00:00:00,Polyethylene,J01.637.051.720.716.507.500
19107856,2009-04-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
19107856,2009-04-01T00:00:00,Animals,B01.050
19107856,2009-04-01T00:00:00,Contrast Media,D27.720.259
19107856,2009-04-01T00:00:00,"Diagnosis, Differential",E01.171
19107856,2009-04-01T00:00:00,"Disease Models, Animal",C22.232
19107856,2009-04-01T00:00:00,"Disease Models, Animal",E05.598.500
19107856,2009-04-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19107856,2009-04-01T00:00:00,Disease Progression,C23.550.291.656
19107856,2009-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19107856,2009-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19107856,2009-04-01T00:00:00,Organometallic Compounds,D01.632
19107856,2009-04-01T00:00:00,Organometallic Compounds,D02.691
19107856,2009-04-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19107856,2009-04-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
19107856,2009-04-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
19107856,2009-04-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
19107856,2009-04-01T00:00:00,User-Computer Interface,L01.224.900.910
19127211,2009-04-01T00:00:00,Adolescent,M01.060.057
19127211,2009-04-01T00:00:00,African Americans,M01.686.508.100.100
19127211,2009-04-01T00:00:00,African Americans,M01.686.754.100
19127211,2009-04-01T00:00:00,Biological Markers,D23.101
19127211,2009-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
19127211,2009-04-01T00:00:00,Blood Pressure,G09.330.380.076
19127211,2009-04-01T00:00:00,Creatinine,D03.383.129.308.207
19127211,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19127211,2009-04-01T00:00:00,Sodium,D01.268.549.750
19127211,2009-04-01T00:00:00,Sodium,D01.552.528.850
19127211,2009-04-01T00:00:00,"Stress, Psychological",F01.145.126.990
19127211,2009-04-01T00:00:00,"Stress, Psychological",F02.830.900
19127211,2009-04-01T00:00:00,Time Factors,G01.910.857
19156831,2009-04-01T00:00:00,Antineoplastic Agents,D27.505.954.248
19156831,2009-04-01T00:00:00,Combined Modality Therapy,E02.186
19156831,2009-04-01T00:00:00,Head and Neck Neoplasms,C04.588.443
19156831,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19156831,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19156831,2009-04-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
19156831,2009-04-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
19156831,2009-04-01T00:00:00,Radiation Injuries,C21.866.733
19156831,2009-04-01T00:00:00,Radiation Injuries,N06.850.810.300.360
19194292,2009-04-01T00:00:00,Acoustic Stimulation,E02.037
19194292,2009-04-01T00:00:00,Acoustic Stimulation,E02.190.888.030
19194292,2009-04-01T00:00:00,Acoustic Stimulation,E05.723.136
19194292,2009-04-01T00:00:00,"Adaptation, Physiological",G07.700.062
19194292,2009-04-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
19194292,2009-04-01T00:00:00,Aged,M01.060.116.100
19194292,2009-04-01T00:00:00,Auditory Threshold,F02.463.593.071.173
19194292,2009-04-01T00:00:00,Auditory Threshold,F02.463.593.710.190
19194292,2009-04-01T00:00:00,Hearing Aids,E07.814.458
19194292,2009-04-01T00:00:00,"Hearing Loss, Sensorineural",C09.218.458.341.887
19194292,2009-04-01T00:00:00,"Hearing Loss, Sensorineural",C10.597.751.418.341.887
19194292,2009-04-01T00:00:00,"Hearing Loss, Sensorineural",C23.888.592.763.393.341.887
19194292,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19194292,2009-04-01T00:00:00,Noise,G01.595.907.567
19194292,2009-04-01T00:00:00,Noise,G16.500.275.600
19194292,2009-04-01T00:00:00,Noise,N06.230.400
19194292,2009-04-01T00:00:00,Noise,N06.850.460.610
19194292,2009-04-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
19194292,2009-04-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
19194292,2009-04-01T00:00:00,Patient Satisfaction,N05.715.360.600
19194292,2009-04-01T00:00:00,Questionnaires,E05.318.308.750
19194292,2009-04-01T00:00:00,Questionnaires,L01.280.800
19194292,2009-04-01T00:00:00,Questionnaires,N05.715.360.300.695
19194292,2009-04-01T00:00:00,Questionnaires,N06.850.520.308.750
19194292,2009-04-01T00:00:00,Speech Perception,F02.463.593.071.875
19197987,2009-04-01T00:00:00,Amines,D02.092
19197987,2009-04-01T00:00:00,Animals,B01.050
19197987,2009-04-01T00:00:00,Anticarcinogenic Agents,D27.505.696.706.018
19197987,2009-04-01T00:00:00,Anticarcinogenic Agents,D27.505.954.248.125
19197987,2009-04-01T00:00:00,Anticarcinogenic Agents,D27.720.799.018
19197987,2009-04-01T00:00:00,Eating,G07.610.593.260
19197987,2009-04-01T00:00:00,Eating,G07.700.620.260
19197987,2009-04-01T00:00:00,Eating,G10.261.326.240
19197987,2009-04-01T00:00:00,Glutathione Transferase,D08.811.913.225.500
19197987,2009-04-01T00:00:00,Heterocyclic Compounds,D03
19197987,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19197987,2009-04-01T00:00:00,Isothiocyanates,D02.500.375
19197987,2009-04-01T00:00:00,Isothiocyanates,D02.886.250
19197987,2009-04-01T00:00:00,"Polymorphism, Genetic",G05.365.795
19204574,2009-04-01T00:00:00,Adult,M01.060.116
19204574,2009-04-01T00:00:00,Aged,M01.060.116.100
19204574,2009-04-01T00:00:00,Antineoplastic Agents,D27.505.954.248
19204574,2009-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
19204574,2009-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
19204574,2009-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
19204574,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19204574,2009-04-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19204574,2009-04-01T00:00:00,Lung Neoplasms,C08.381.540
19204574,2009-04-01T00:00:00,Lung Neoplasms,C08.785.520
19204574,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19204574,2009-04-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19204574,2009-04-01T00:00:00,Quinazolines,D03.438.786
19215218,2009-04-01T00:00:00,Child,M01.060.406
19215218,2009-04-01T00:00:00,"Diagnosis, Differential",E01.171
19215218,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19215218,2009-04-01T00:00:00,Intestinal Volvulus,C06.405.469.531.568
19215218,2009-04-01T00:00:00,Intestinal Volvulus,C23.300.970.500
19215218,2009-04-01T00:00:00,Laparoscopy,E01.370.388.250.520
19215218,2009-04-01T00:00:00,Laparoscopy,E04.800.250.520
19215218,2009-04-01T00:00:00,Meckel Diverticulum,A03.556.124.684.249.612
19215218,2009-04-01T00:00:00,Meckel Diverticulum,A03.556.249.124.612
19215218,2009-04-01T00:00:00,Meckel Diverticulum,C06.198.859
19215218,2009-04-01T00:00:00,Meckel Diverticulum,C16.131.314.556
19215218,2009-04-01T00:00:00,Meckel Diverticulum,C23.300.415.750
19215218,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19215218,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19215218,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19215218,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19215218,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19241258,2009-04-01T00:00:00,Animals,B01.050
19241258,2009-04-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
19241258,2009-04-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
19241258,2009-04-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
19241258,2009-04-01T00:00:00,Body Weight,C23.888.144
19241258,2009-04-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
19241258,2009-04-01T00:00:00,Body Weight,E05.041.124.160.750
19241258,2009-04-01T00:00:00,Body Weight,G07.100.100.160.120
19241258,2009-04-01T00:00:00,Body Weight,G07.700.320.249.314.120
19241258,2009-04-01T00:00:00,Cell Proliferation,G04.299.233.750
19241258,2009-04-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19241258,2009-04-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19241258,2009-04-01T00:00:00,Flow Cytometry,E05.200.500.386.350
19241258,2009-04-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19241258,2009-04-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19241258,2009-04-01T00:00:00,Trichloroethylene,D02.455.526.439.939
19242833,2009-04-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
19242833,2009-04-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
19242833,2009-04-01T00:00:00,Biocompatible Materials,D25.130
19242833,2009-04-01T00:00:00,Biocompatible Materials,D27.720.102.130
19242833,2009-04-01T00:00:00,Biocompatible Materials,J01.637.051.130
19242833,2009-04-01T00:00:00,"Coated Materials, Biocompatible",D25.130.420
19242833,2009-04-01T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
19242833,2009-04-01T00:00:00,Finite Element Analysis,E05.355
19242833,2009-04-01T00:00:00,Hip Prosthesis,E07.695.400.400
19242833,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19242833,2009-04-01T00:00:00,Materials Testing,E05.570
19242833,2009-04-01T00:00:00,"Models, Biological",E05.599.395
19242833,2009-04-01T00:00:00,Prosthesis Design,E05.320.550
19242833,2009-04-01T00:00:00,Prosthesis Design,E07.695.680
19275430,2009-04-01T00:00:00,Actins,D05.750.078.730.250
19275430,2009-04-01T00:00:00,Actins,D12.776.210.500.100
19275430,2009-04-01T00:00:00,Actins,D12.776.220.525.255
19275430,2009-04-01T00:00:00,Animals,B01.050
19275430,2009-04-01T00:00:00,Cell Adhesion,G04.299.117
19275430,2009-04-01T00:00:00,"Endothelium, Vascular",A07.231.330
19275430,2009-04-01T00:00:00,"Endothelium, Vascular",A10.272.491.355
19275430,2009-04-01T00:00:00,"Models, Biological",E05.599.395
19275430,2009-04-01T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
19275430,2009-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19275430,2009-04-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19275430,2009-04-01T00:00:00,"Stress, Mechanical",G01.374.676.830
19275430,2009-04-01T00:00:00,"Stress, Mechanical",G01.595.540.830
19280755,2009-04-01T00:00:00,Animals,B01.050
19280755,2009-04-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
19280755,2009-04-01T00:00:00,Incidence,E05.318.308.985.525.375
19280755,2009-04-01T00:00:00,Incidence,L01.280.975.525.375
19280755,2009-04-01T00:00:00,Incidence,N01.224.935.597.500
19280755,2009-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19280755,2009-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19280755,2009-04-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19280755,2009-04-01T00:00:00,Lung Neoplasms,C08.381.540
19280755,2009-04-01T00:00:00,Lung Neoplasms,C08.785.520
19280755,2009-04-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
19280755,2009-04-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
19280755,2009-04-01T00:00:00,Plutonium,D01.268.033.700
19280755,2009-04-01T00:00:00,Plutonium,D01.268.271.100.700
19280755,2009-04-01T00:00:00,Plutonium,D01.268.556.700
19280755,2009-04-01T00:00:00,Plutonium,D01.552.020.734
19280755,2009-04-01T00:00:00,Plutonium,D01.552.544.700
19280755,2009-04-01T00:00:00,Pulmonary Fibrosis,C08.381.765
19309700,2009-04-01T00:00:00,Aged,M01.060.116.100
19309700,2009-04-01T00:00:00,Cardiovascular Diseases,C14
19309700,2009-04-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19309700,2009-04-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19309700,2009-04-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19309700,2009-04-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19309700,2009-04-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19309700,2009-04-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19309700,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19309700,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19309700,2009-04-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19309700,2009-04-01T00:00:00,Risk Assessment,N04.452.871.715
19309700,2009-04-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19309700,2009-04-01T00:00:00,Risk Assessment,N06.850.505.715
19309700,2009-04-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19309700,2009-04-01T00:00:00,Time Factors,G01.910.857
19309700,2009-04-01T00:00:00,Treatment Outcome,E01.789.800
19309700,2009-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19309700,2009-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19317746,2009-04-01T00:00:00,Adolescent,M01.060.057
19317746,2009-04-01T00:00:00,Adult,M01.060.116
19317746,2009-04-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19317746,2009-04-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19317746,2009-04-01T00:00:00,Helicobacter Infections,C01.252.400.466
19317746,2009-04-01T00:00:00,Helicobacter pylori,B03.440.500.550
19317746,2009-04-01T00:00:00,Helicobacter pylori,B03.660.150.280.550
19317746,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19317746,2009-04-01T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
19317746,2009-04-01T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
19317746,2009-04-01T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
19317746,2009-04-01T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
19317746,2009-04-01T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
19317746,2009-04-01T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
19317746,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19317746,2009-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19317746,2009-04-01T00:00:00,"Purpura, Thrombocytopenic, Idiopathic",C15.378.100.805.600
19317746,2009-04-01T00:00:00,"Purpura, Thrombocytopenic, Idiopathic",C15.378.140.855.925.750.600
19317746,2009-04-01T00:00:00,"Purpura, Thrombocytopenic, Idiopathic",C15.378.463.740
19317746,2009-04-01T00:00:00,"Purpura, Thrombocytopenic, Idiopathic",C20.111.759
19317746,2009-04-01T00:00:00,"Purpura, Thrombocytopenic, Idiopathic",C20.841.600
19317746,2009-04-01T00:00:00,Young Adult,M01.060.116.815
19318769,2009-04-01T00:00:00,Biomedical Research,H01.770.644.145
19318769,2009-04-01T00:00:00,Cooperative Behavior,F01.145.813.115
19318769,2009-04-01T00:00:00,"Education, Graduate",I02.358.337
19318769,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19318769,2009-04-01T00:00:00,United States,Z01.107.567.875
19318858,2009-04-01T00:00:00,Critical Illness,C23.550.291.625
19318858,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19318858,2009-04-01T00:00:00,Ventilator Weaning,E02.880.820.950
19319918,2009-04-01T00:00:00,Adolescent,M01.060.057
19319918,2009-04-01T00:00:00,Child,M01.060.406
19319918,2009-04-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19319918,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19319918,2009-04-01T00:00:00,Interviews as Topic,E05.318.308.420
19319918,2009-04-01T00:00:00,Interviews as Topic,L01.280.520
19319918,2009-04-01T00:00:00,Interviews as Topic,N05.715.360.300.400
19319918,2009-04-01T00:00:00,Interviews as Topic,N06.850.520.308.420
19319918,2009-04-01T00:00:00,"Models, Psychological",E05.599.695
19319918,2009-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19321895,2009-04-01T00:00:00,Aged,M01.060.116.100
19321895,2009-04-01T00:00:00,Decision Making,F02.463.785.373
19321895,2009-04-01T00:00:00,Dementia,C10.228.140.380
19321895,2009-04-01T00:00:00,Dementia,F03.087.400
19321895,2009-04-01T00:00:00,Enteral Nutrition,E02.421.360
19321895,2009-04-01T00:00:00,Enteral Nutrition,E02.642.500.360
19321895,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19321895,2009-04-01T00:00:00,Palliative Care,E02.760.666
19321895,2009-04-01T00:00:00,Palliative Care,N02.421.585.666
19323625,2009-04-01T00:00:00,Certification,N03.706.110.120
19323625,2009-04-01T00:00:00,Certification,N05.700.200.190
19323625,2009-04-01T00:00:00,Clinical Competence,I02.399.630.210
19323625,2009-04-01T00:00:00,Clinical Competence,N04.761.210
19323625,2009-04-01T00:00:00,Communicable Diseases,C01.539.221
19323625,2009-04-01T00:00:00,"Education, Pharmacy",I02.358.525
19323625,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19323625,2009-04-01T00:00:00,Internship and Residency,I02.358.399.644
19323625,2009-04-01T00:00:00,Teaching,I02.903
19324158,2009-04-01T00:00:00,Adolescent,M01.060.057
19324158,2009-04-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
19324158,2009-04-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
19324158,2009-04-01T00:00:00,Child,M01.060.406
19324158,2009-04-01T00:00:00,"Child, Preschool",M01.060.406.448
19324158,2009-04-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
19324158,2009-04-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
19324158,2009-04-01T00:00:00,"Defibrillators, Implantable",E07.695.175
19324158,2009-04-01T00:00:00,"Electrodes, Implanted",E07.305.250.319
19324158,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19324158,2009-04-01T00:00:00,Infant,M01.060.703
19324158,2009-04-01T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
19326402,2009-04-01T00:00:00,Adolescent,M01.060.057
19326402,2009-04-01T00:00:00,Adult,M01.060.116
19326402,2009-04-01T00:00:00,Child,M01.060.406
19326402,2009-04-01T00:00:00,"Child, Preschool",M01.060.406.448
19326402,2009-04-01T00:00:00,Heart Failure,C14.280.434
19326402,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19326402,2009-04-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
19326402,2009-04-01T00:00:00,Liver Cirrhosis,C06.552.630
19326402,2009-04-01T00:00:00,Liver Transplantation,E04.210.650
19326402,2009-04-01T00:00:00,Liver Transplantation,E04.936.450.490
19326402,2009-04-01T00:00:00,Liver Transplantation,E04.936.580.490
19326402,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19326402,2009-04-01T00:00:00,Multiple Organ Failure,C23.550.835.525
19326402,2009-04-01T00:00:00,Treatment Outcome,E01.789.800
19326402,2009-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19326402,2009-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19326402,2009-04-01T00:00:00,Young Adult,M01.060.116.815
19326567,2009-04-01T00:00:00,Animals,B01.050
19326567,2009-04-01T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
19326567,2009-04-01T00:00:00,Dopamine,D02.092.211.215.311.342
19326567,2009-04-01T00:00:00,Dopamine,D02.092.311.342
19326567,2009-04-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
19326567,2009-04-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
19326567,2009-04-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
19326567,2009-04-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
19326567,2009-04-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
19326567,2009-04-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
19326567,2009-04-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
19326567,2009-04-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
19326567,2009-04-01T00:00:00,Drug Resistance,G07.690.320
19326567,2009-04-01T00:00:00,Methamphetamine,D02.092.471.683.152.619
19326567,2009-04-01T00:00:00,Neurons,A08.663
19326567,2009-04-01T00:00:00,Neurons,A11.671
19326567,2009-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19326567,2009-04-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19326567,2009-04-01T00:00:00,Time Factors,G01.910.857
19326567,2009-04-01T00:00:00,Vesicular Monoamine Transport Proteins,D12.776.157.530.450.162.887.500.500
19326567,2009-04-01T00:00:00,Vesicular Monoamine Transport Proteins,D12.776.157.530.562.750.500.500
19326567,2009-04-01T00:00:00,Vesicular Monoamine Transport Proteins,D12.776.543.585.450.162.887.500.500
19326567,2009-04-01T00:00:00,Vesicular Monoamine Transport Proteins,D12.776.543.585.562.750.500.500
19327189,2009-04-01T00:00:00,Cystic Fibrosis,C06.689.202
19327189,2009-04-01T00:00:00,Cystic Fibrosis,C08.381.187
19327189,2009-04-01T00:00:00,Cystic Fibrosis,C16.320.190
19327189,2009-04-01T00:00:00,Cystic Fibrosis,C16.614.213
19327189,2009-04-01T00:00:00,Disease Progression,C23.550.291.656
19327189,2009-04-01T00:00:00,Evidence-Based Medicine,H02.249.750
19327189,2009-04-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19327189,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19327189,2009-04-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19327189,2009-04-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19327189,2009-04-01T00:00:00,Oxygen Consumption,G03.730
19327189,2009-04-01T00:00:00,Quality of Life,I01.800
19327189,2009-04-01T00:00:00,Quality of Life,K01.752.400.750
19327421,2009-04-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19327421,2009-04-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19327421,2009-04-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19327421,2009-04-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19327421,2009-04-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19327421,2009-04-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19327421,2009-04-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
19327421,2009-04-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
19327421,2009-04-01T00:00:00,Emergencies,C23.550.291.781
19327421,2009-04-01T00:00:00,Emergencies,N06.230.100.083
19327421,2009-04-01T00:00:00,Emergencies,N06.850.376
19327421,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19327421,2009-04-01T00:00:00,Incidence,E05.318.308.985.525.375
19327421,2009-04-01T00:00:00,Incidence,L01.280.975.525.375
19327421,2009-04-01T00:00:00,Incidence,N01.224.935.597.500
19327421,2009-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19327421,2009-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19327421,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19327421,2009-04-01T00:00:00,Reoperation,E04.690
19327421,2009-04-01T00:00:00,Stents,E07.695.750
19327435,2009-04-01T00:00:00,Adolescent,M01.060.057
19327435,2009-04-01T00:00:00,Adult,M01.060.116
19327435,2009-04-01T00:00:00,Aged,M01.060.116.100
19327435,2009-04-01T00:00:00,Child,M01.060.406
19327435,2009-04-01T00:00:00,"Diagnosis, Differential",E01.171
19327435,2009-04-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
19327435,2009-04-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
19327435,2009-04-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
19327435,2009-04-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
19327435,2009-04-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
19327435,2009-04-01T00:00:00,"Heart Defects, Congenital",C14.240.400
19327435,2009-04-01T00:00:00,"Heart Defects, Congenital",C14.280.400
19327435,2009-04-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19327435,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19327435,2009-04-01T00:00:00,Intensive Care Units,N02.278.388.493
19327435,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19327435,2009-04-01T00:00:00,Young Adult,M01.060.116.815
19328898,2009-04-01T00:00:00,Child,M01.060.406
19328898,2009-04-01T00:00:00,Endoscopy,E01.370.388.250
19328898,2009-04-01T00:00:00,Endoscopy,E04.800.250
19328898,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19328898,2009-04-01T00:00:00,Nasal Obstruction,C08.460.525
19328898,2009-04-01T00:00:00,Nasal Obstruction,C08.618.846.185.525
19328898,2009-04-01T00:00:00,Nasal Obstruction,C09.603.525
19328898,2009-04-01T00:00:00,Paranasal Sinuses,A04.531.621
19332845,2009-04-01T00:00:00,Breast Neoplasms,C04.588.180
19332845,2009-04-01T00:00:00,Breast Neoplasms,C17.800.090.500
19332845,2009-04-01T00:00:00,Data Display,F02.784.412.221
19332845,2009-04-01T00:00:00,Data Display,L01.296
19332845,2009-04-01T00:00:00,Equipment Failure Analysis,E05.325.192
19332845,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19332845,2009-04-01T00:00:00,Mammography,E01.370.350.700.500
19332845,2009-04-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19332845,2009-04-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19332845,2009-04-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19332845,2009-04-01T00:00:00,United States,Z01.107.567.875
19333917,2009-04-01T00:00:00,B-Lymphocytes,A11.063.438
19333917,2009-04-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
19333917,2009-04-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
19333917,2009-04-01T00:00:00,B-Lymphocytes,A15.382.032.438
19333917,2009-04-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
19333917,2009-04-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19333917,2009-04-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19333917,2009-04-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19333917,2009-04-01T00:00:00,Genetic Variation,G05.365
19333917,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19333917,2009-04-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19333917,2009-04-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19333917,2009-04-01T00:00:00,Phenotype,G05.695
19333917,2009-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19333917,2009-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19333917,2009-04-01T00:00:00,Risk Factors,N05.715.350.200.700
19333917,2009-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19333917,2009-04-01T00:00:00,Risk Factors,N06.850.490.625.750
19333917,2009-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19333948,2009-04-01T00:00:00,Adult,M01.060.116
19333948,2009-04-01T00:00:00,Creatinine,D03.383.129.308.207
19333948,2009-04-01T00:00:00,Double-Blind Method,E05.318.780.300
19333948,2009-04-01T00:00:00,Double-Blind Method,E05.581.500.300
19333948,2009-04-01T00:00:00,Double-Blind Method,N05.715.360.780.320
19333948,2009-04-01T00:00:00,Double-Blind Method,N06.850.520.445.300
19333948,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19333948,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19333948,2009-04-01T00:00:00,Recombinant Proteins,D12.776.828
19333948,2009-04-01T00:00:00,Relaxin,D06.472.334.734.769
19333948,2009-04-01T00:00:00,Relaxin,D06.472.699.715
19333948,2009-04-01T00:00:00,Relaxin,D12.644.548.762
19333948,2009-04-01T00:00:00,"Scleroderma, Systemic",C17.300.799
19333948,2009-04-01T00:00:00,"Scleroderma, Systemic",C17.800.784
19333948,2009-04-01T00:00:00,Skin,A17.815
19333948,2009-04-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19333948,2009-04-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19333953,2009-04-01T00:00:00,African Americans,M01.686.508.100.100
19333953,2009-04-01T00:00:00,African Americans,M01.686.754.100
19333953,2009-04-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19333953,2009-04-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19333953,2009-04-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19333953,2009-04-01T00:00:00,Hispanic Americans,M01.686.754.441
19333953,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19333953,2009-04-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19333953,2009-04-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19333953,2009-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19333953,2009-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19333953,2009-04-01T00:00:00,Risk Factors,N05.715.350.200.700
19333953,2009-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19333953,2009-04-01T00:00:00,Risk Factors,N06.850.490.625.750
19333953,2009-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.644.360.024.303.500.500
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.644.360.024.342.100
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.776.157.057.061.500.500
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.776.157.057.186.100
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.776.260.513.249.500
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.776.476.024.387.500.500
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.776.476.024.421.100
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.776.930.354.249.500
19333953,2009-04-01T00:00:00,STAT1 Transcription Factor,D12.776.930.840.100
19333953,2009-04-01T00:00:00,United States,Z01.107.567.875
19335093,2009-04-01T00:00:00,"Esthetics, Dental",E06.420
19335093,2009-04-01T00:00:00,Evaluation Studies as Topic,E05.337
19335093,2009-04-01T00:00:00,Evaluation Studies as Topic,N05.715.360.335
19335093,2009-04-01T00:00:00,Gingival Recession,C07.465.714.258.447
19335093,2009-04-01T00:00:00,Gingival Recession,C07.465.714.354.625
19335093,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19335093,2009-04-01T00:00:00,Surgical Flaps,A10.850.710
19335093,2009-04-01T00:00:00,Surgical Flaps,E07.862.710
19335329,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19335329,2009-04-01T00:00:00,Kidney,A05.810.453
19335329,2009-04-01T00:00:00,Laparoscopy,E01.370.388.250.520
19335329,2009-04-01T00:00:00,Laparoscopy,E04.800.250.520
19335329,2009-04-01T00:00:00,Length of Stay,E02.760.400.480
19335329,2009-04-01T00:00:00,Length of Stay,N02.421.585.400.480
19335329,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19342086,2009-04-01T00:00:00,Bradykinin,D12.644.276.812.169
19342086,2009-04-01T00:00:00,Bradykinin,D12.644.400.090
19342086,2009-04-01T00:00:00,Bradykinin,D12.644.456.193
19342086,2009-04-01T00:00:00,Bradykinin,D12.776.467.812.169
19342086,2009-04-01T00:00:00,Bradykinin,D12.776.641.650.090
19342086,2009-04-01T00:00:00,Bradykinin,D23.469.050.375.110
19342086,2009-04-01T00:00:00,Bradykinin,D23.529.812.169
19342086,2009-04-01T00:00:00,Factor XII,D12.776.124.125.450
19342086,2009-04-01T00:00:00,Factor XII,D23.119.450
19342086,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19342086,2009-04-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.644.276.812.654.350
19342086,2009-04-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.124.125.635.480
19342086,2009-04-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.467.812.654.350
19342086,2009-04-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.811.420.350
19342086,2009-04-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.119.630.480
19342086,2009-04-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.469.050.375.425.350
19342086,2009-04-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.529.812.654.350
19342086,2009-04-01T00:00:00,Prekallikrein,D08.811.277.656.300.760.442.725
19342086,2009-04-01T00:00:00,Prekallikrein,D08.811.277.656.959.350.442.725
19342086,2009-04-01T00:00:00,Prekallikrein,D12.776.124.125.597.712
19342086,2009-04-01T00:00:00,Prekallikrein,D23.119.597.712
19343554,2009-04-01T00:00:00,Family Practice,H02.403.280
19343554,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19343554,2009-04-01T00:00:00,Internship and Residency,I02.358.399.644
19343554,2009-04-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19343554,2009-04-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19343554,2009-04-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
19343554,2009-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19343554,2009-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19343554,2009-04-01T00:00:00,Teaching,I02.903
19345779,2009-04-01T00:00:00,Adult,M01.060.116
19345779,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19345779,2009-04-01T00:00:00,"Models, Statistical",E05.318.740.500
19345779,2009-04-01T00:00:00,"Models, Statistical",E05.599.835
19345779,2009-04-01T00:00:00,"Models, Statistical",N05.715.360.750.530
19345779,2009-04-01T00:00:00,"Models, Statistical",N06.850.520.830.500
19345779,2009-04-01T00:00:00,Personality,F01.752
19345779,2009-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19345779,2009-04-01T00:00:00,Risk Factors,N05.715.350.200.700
19345779,2009-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19345779,2009-04-01T00:00:00,Risk Factors,N06.850.490.625.750
19345779,2009-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19345779,2009-04-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19345779,2009-04-01T00:00:00,Spinal Cord Injuries,C10.900.850
19345779,2009-04-01T00:00:00,Spinal Cord Injuries,C21.866.819
19349312,2009-04-01T00:00:00,Adult,M01.060.116
19349312,2009-04-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19349312,2009-04-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19349312,2009-04-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19349312,2009-04-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19349312,2009-04-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19349312,2009-04-01T00:00:00,Corticotropin-Releasing Hormone,D06.472.699.327.740.140
19349312,2009-04-01T00:00:00,Corticotropin-Releasing Hormone,D12.644.400.400.740.140
19349312,2009-04-01T00:00:00,Corticotropin-Releasing Hormone,D12.644.548.365.740.140
19349312,2009-04-01T00:00:00,Corticotropin-Releasing Hormone,D12.776.641.650.405.740.140
19349312,2009-04-01T00:00:00,Cues,F02.463.425.234
19349312,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19349312,2009-04-01T00:00:00,Hydrocortisone,D04.808.745.745.654.600
19349312,2009-04-01T00:00:00,Hydrocortisone,D06.472.040.585.353.476
19349312,2009-04-01T00:00:00,Hydrocortisone,D06.472.040.585.478.392
19349312,2009-04-01T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
19349312,2009-04-01T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
19349312,2009-04-01T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
19349312,2009-04-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19349312,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19349312,2009-04-01T00:00:00,Motivation,F01.658
19349312,2009-04-01T00:00:00,Motivation,F01.752.543.500.750
19349312,2009-04-01T00:00:00,Pituitary-Adrenal System,A06.407.691
19349312,2009-04-01T00:00:00,Sex Factors,N05.715.350.675
19349312,2009-04-01T00:00:00,Sex Factors,N06.850.490.875
19349312,2009-04-01T00:00:00,Young Adult,M01.060.116.815
19359942,2009-04-01T00:00:00,Adult,M01.060.116
19359942,2009-04-01T00:00:00,Biocompatible Materials,D25.130
19359942,2009-04-01T00:00:00,Biocompatible Materials,D27.720.102.130
19359942,2009-04-01T00:00:00,Biocompatible Materials,J01.637.051.130
19359942,2009-04-01T00:00:00,Collagen,D05.750.078.280
19359942,2009-04-01T00:00:00,Collagen,D12.776.860.300.250
19359942,2009-04-01T00:00:00,"Hernia, Ventral",C23.300.707.374.937
19359942,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19359942,2009-04-01T00:00:00,Prostheses and Implants,E07.695
19359942,2009-04-01T00:00:00,Reconstructive Surgical Procedures,E04.680
19359942,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19359942,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19359942,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19359942,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19359942,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19361650,2009-04-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
19361650,2009-04-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
19361650,2009-04-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
19361650,2009-04-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
19361650,2009-04-01T00:00:00,"Biopsy, Needle",E04.074.119
19361650,2009-04-01T00:00:00,Child,M01.060.406
19361650,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19361650,2009-04-01T00:00:00,Length of Stay,E02.760.400.480
19361650,2009-04-01T00:00:00,Length of Stay,N02.421.585.400.480
19361650,2009-04-01T00:00:00,Postoperative Complications,C23.550.767
19361650,2009-04-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
19361650,2009-04-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.840.830
19361650,2009-04-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.950.830
19361650,2009-04-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.840.830
19361650,2009-04-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.950.830
19361650,2009-04-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.928.752.830
19361650,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19361650,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19361650,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19361650,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19361650,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19361650,2009-04-01T00:00:00,Treatment Outcome,E01.789.800
19361650,2009-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19361650,2009-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19368588,2009-04-01T00:00:00,Adult,M01.060.116
19368588,2009-04-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19368588,2009-04-01T00:00:00,Clinical Trials as Topic,E05.337.250
19368588,2009-04-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19368588,2009-04-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19368588,2009-04-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19368588,2009-04-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19368588,2009-04-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19368588,2009-04-01T00:00:00,Dietary Supplements,J02.500.456
19368588,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19368588,2009-04-01T00:00:00,Hypertension,C14.907.489
19368588,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19368588,2009-04-01T00:00:00,Questionnaires,E05.318.308.750
19368588,2009-04-01T00:00:00,Questionnaires,L01.280.800
19368588,2009-04-01T00:00:00,Questionnaires,N05.715.360.300.695
19368588,2009-04-01T00:00:00,Questionnaires,N06.850.520.308.750
19368588,2009-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19368588,2009-04-01T00:00:00,Risk Factors,N05.715.350.200.700
19368588,2009-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19368588,2009-04-01T00:00:00,Risk Factors,N06.850.490.625.750
19368588,2009-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19368588,2009-04-01T00:00:00,Sodium,D01.268.549.750
19368588,2009-04-01T00:00:00,Sodium,D01.552.528.850
19368588,2009-04-01T00:00:00,Stroke,C10.228.140.300.775
19368588,2009-04-01T00:00:00,Stroke,C14.907.253.855
19370699,2009-04-01T00:00:00,Adolescent,M01.060.057
19370699,2009-04-01T00:00:00,Adult,M01.060.116
19370699,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19370699,2009-04-01T00:00:00,Interviews as Topic,E05.318.308.420
19370699,2009-04-01T00:00:00,Interviews as Topic,L01.280.520
19370699,2009-04-01T00:00:00,Interviews as Topic,N05.715.360.300.400
19370699,2009-04-01T00:00:00,Interviews as Topic,N06.850.520.308.420
19370699,2009-04-01T00:00:00,Rape,I01.198.240.748.640
19370699,2009-04-01T00:00:00,Smoking,F01.145.466.753
19370699,2009-04-01T00:00:00,United States,Z01.107.567.875
19370699,2009-04-01T00:00:00,Young Adult,M01.060.116.815
19373660,2009-04-01T00:00:00,Adult,M01.060.116
19373660,2009-04-01T00:00:00,Aged,M01.060.116.100
19373660,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19373660,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19373660,2009-04-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19373660,2009-04-01T00:00:00,Young Adult,M01.060.116.815
19375238,2009-04-01T00:00:00,Adolescent,M01.060.057
19375238,2009-04-01T00:00:00,Adult,M01.060.116
19375238,2009-04-01T00:00:00,Aged,M01.060.116.100
19375238,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19375238,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19375238,2009-04-01T00:00:00,Prescription Drugs,D26.670
19375238,2009-04-01T00:00:00,Rape,I01.198.240.748.640
19375238,2009-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19375238,2009-04-01T00:00:00,Substance-Related Disorders,C21.739
19375238,2009-04-01T00:00:00,Substance-Related Disorders,F03.900
19375238,2009-04-01T00:00:00,United States,Z01.107.567.875
19375238,2009-04-01T00:00:00,Young Adult,M01.060.116.815
19379064,2009-04-01T00:00:00,Ethnic Groups,M01.686.754
19379064,2009-04-01T00:00:00,Ethnic Groups,N01.224.317
19379064,2009-04-01T00:00:00,Health Services Accessibility,N04.590.374.350
19379064,2009-04-01T00:00:00,Health Services Accessibility,N05.300.430
19379064,2009-04-01T00:00:00,Healthcare Disparities,N04.590.374.380
19379064,2009-04-01T00:00:00,Healthcare Disparities,N05.300.493
19379064,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19379064,2009-04-01T00:00:00,Length of Stay,E02.760.400.480
19379064,2009-04-01T00:00:00,Length of Stay,N02.421.585.400.480
19379064,2009-04-01T00:00:00,Occupational Therapy,E02.831.489
19379064,2009-04-01T00:00:00,Occupational Therapy,H02.010.500
19379064,2009-04-01T00:00:00,Physical Therapy Modalities,E02.779
19379064,2009-04-01T00:00:00,Stroke,C10.228.140.300.775
19379064,2009-04-01T00:00:00,Stroke,C14.907.253.855
19379064,2009-04-01T00:00:00,United States,Z01.107.567.875
19380651,2009-04-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
19380651,2009-04-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
19380651,2009-04-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
19380651,2009-04-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
19380651,2009-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.557.470.200.025.232.750
19380651,2009-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.557.470.615.132.750
19380651,2009-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.588.274.761.750
19380651,2009-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.588.322.421.750
19380651,2009-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C06.301.761.750
19380651,2009-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C06.689.667.625
19380651,2009-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C19.344.421.750
19380651,2009-04-01T00:00:00,Clostridium Infections,C01.252.410.222
19380651,2009-04-01T00:00:00,Clostridium perfringens,B03.300.390.400.200.575
19380651,2009-04-01T00:00:00,Clostridium perfringens,B03.510.415.400.200.575
19380651,2009-04-01T00:00:00,Endosonography,E01.370.350.850.280
19380651,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19380651,2009-04-01T00:00:00,Pancreatectomy,E04.210.752
19380651,2009-04-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
19380651,2009-04-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
19380651,2009-04-01T00:00:00,Pancreatic Neoplasms,C06.301.761
19380651,2009-04-01T00:00:00,Pancreatic Neoplasms,C06.689.667
19380651,2009-04-01T00:00:00,Pancreatic Neoplasms,C19.344.421
19380651,2009-04-01T00:00:00,Pancreatitis,C06.689.750
19380651,2009-04-01T00:00:00,Sepsis,C01.539.757
19380651,2009-04-01T00:00:00,Sepsis,C23.550.470.790.500
19380651,2009-04-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
19390284,2009-04-01T00:00:00,Adult,M01.060.116
19390284,2009-04-01T00:00:00,Health Status,I01.240.425
19390284,2009-04-01T00:00:00,Health Status,N01.224.425
19390284,2009-04-01T00:00:00,Health Status,N06.850.505.400.425
19390284,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19390284,2009-04-01T00:00:00,Kidney Transplantation,E02.870.500
19390284,2009-04-01T00:00:00,Kidney Transplantation,E04.936.450.485
19390284,2009-04-01T00:00:00,Kidney Transplantation,E04.950.774.400
19390284,2009-04-01T00:00:00,Length of Stay,E02.760.400.480
19390284,2009-04-01T00:00:00,Length of Stay,N02.421.585.400.480
19390284,2009-04-01T00:00:00,Living Donors,M01.898.656
19390284,2009-04-01T00:00:00,Nephrectomy,E04.950.774.435
19390284,2009-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19390284,2009-04-01T00:00:00,Risk Factors,N05.715.350.200.700
19390284,2009-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19390284,2009-04-01T00:00:00,Risk Factors,N06.850.490.625.750
19390284,2009-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19390284,2009-04-01T00:00:00,Smoking,F01.145.466.753
19390284,2009-04-01T00:00:00,Treatment Outcome,E01.789.800
19390284,2009-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19390284,2009-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19416166,2009-04-01T00:00:00,Amino Acid Sequence,G02.111.570.060
19416166,2009-04-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19416166,2009-04-01T00:00:00,Cell Line,A11.251.210
19416166,2009-04-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
19416166,2009-04-01T00:00:00,Cyclic AMP,D03.438.759.646.138.395
19416166,2009-04-01T00:00:00,Cyclic AMP,D13.695.462.200
19416166,2009-04-01T00:00:00,Cyclic AMP,D13.695.667.138.395
19416166,2009-04-01T00:00:00,Cyclic AMP,D13.695.827.068.395
19416166,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19416166,2009-04-01T00:00:00,Insulin,D06.472.699.587.740.625
19416166,2009-04-01T00:00:00,Insulin,D12.644.548.586.740.625
19416166,2009-04-01T00:00:00,"Models, Molecular",E05.599.595
19416166,2009-04-01T00:00:00,Proteins,D12.776
19416166,2009-04-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
19416166,2009-04-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19425211,2009-04-01T00:00:00,Adult,M01.060.116
19425211,2009-04-01T00:00:00,Aged,M01.060.116.100
19425211,2009-04-01T00:00:00,Chronic Disease,C23.550.291.500
19425211,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19425211,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19425211,2009-04-01T00:00:00,Pain,C10.597.617
19425211,2009-04-01T00:00:00,Pain,C23.888.592.612
19425211,2009-04-01T00:00:00,Pain,C23.888.646
19425211,2009-04-01T00:00:00,Pain,F02.830.816.444
19425211,2009-04-01T00:00:00,Pain,G11.561.600.810.444
19425211,2009-04-01T00:00:00,Prescription Drugs,D26.670
19425211,2009-04-01T00:00:00,Questionnaires,E05.318.308.750
19425211,2009-04-01T00:00:00,Questionnaires,L01.280.800
19425211,2009-04-01T00:00:00,Questionnaires,N05.715.360.300.695
19425211,2009-04-01T00:00:00,Questionnaires,N06.850.520.308.750
19425211,2009-04-01T00:00:00,Substance-Related Disorders,C21.739
19425211,2009-04-01T00:00:00,Substance-Related Disorders,F03.900
19425211,2009-04-01T00:00:00,Veterans,M01.930
19425432,2009-04-01T00:00:00,Droughts,G16.500.240.135.781
19425432,2009-04-01T00:00:00,Droughts,G16.500.750.775.154
19425432,2009-04-01T00:00:00,"Models, Biological",E05.599.395
19425432,2009-04-01T00:00:00,Trees,B01.650.915
19425432,2009-04-01T00:00:00,Virginia,Z01.107.567.875.075.837
19425432,2009-04-01T00:00:00,Virginia,Z01.107.567.875.750.870
19430351,2009-04-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
19430351,2009-04-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
19430351,2009-04-01T00:00:00,Heart Failure,C14.280.434
19430351,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19430351,2009-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19430351,2009-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19430351,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19430351,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19430351,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19430351,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19430351,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19430351,2009-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19439158,2009-04-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
19439158,2009-04-01T00:00:00,Chronic Disease,C23.550.291.500
19439158,2009-04-01T00:00:00,Double-Blind Method,E05.318.780.300
19439158,2009-04-01T00:00:00,Double-Blind Method,E05.581.500.300
19439158,2009-04-01T00:00:00,Double-Blind Method,N05.715.360.780.320
19439158,2009-04-01T00:00:00,Double-Blind Method,N06.850.520.445.300
19439158,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19439158,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19439158,2009-04-01T00:00:00,Questionnaires,E05.318.308.750
19439158,2009-04-01T00:00:00,Questionnaires,L01.280.800
19439158,2009-04-01T00:00:00,Questionnaires,N05.715.360.300.695
19439158,2009-04-01T00:00:00,Questionnaires,N06.850.520.308.750
19439158,2009-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19439158,2009-04-01T00:00:00,Valproic Acid,D02.241.081.944.509.900
19439158,2009-04-01T00:00:00,Valproic Acid,D10.251.400.895.593.900
19452880,2009-04-01T00:00:00,"Chromatography, Gel",E05.196.181.400.250
19452880,2009-04-01T00:00:00,Organic Chemicals,D02
19452880,2009-04-01T00:00:00,Plant Leaves,A18.024.812
19452880,2009-04-01T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
19452880,2009-04-01T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
19476790,2009-04-01T00:00:00,Aged,M01.060.116.100
19476790,2009-04-01T00:00:00,Amputation,E04.555.080
19476790,2009-04-01T00:00:00,Blood Vessel Prosthesis,E07.695.110
19476790,2009-04-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
19476790,2009-04-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
19476790,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19476790,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19476790,2009-04-01T00:00:00,Polytetrafluoroethylene,D05.750.395.616
19476790,2009-04-01T00:00:00,Polytetrafluoroethylene,D25.720.395.616
19476790,2009-04-01T00:00:00,Polytetrafluoroethylene,J01.637.051.720.395.616
19476790,2009-04-01T00:00:00,Prosthesis-Related Infections,C01.539.685
19476790,2009-04-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
19476790,2009-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19476790,2009-04-01T00:00:00,Risk Factors,N05.715.350.200.700
19476790,2009-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19476790,2009-04-01T00:00:00,Risk Factors,N06.850.490.625.750
19476790,2009-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19476790,2009-04-01T00:00:00,Time Factors,G01.910.857
19476790,2009-04-01T00:00:00,Vascular Patency,G09.330.920
19480125,2009-04-01T00:00:00,Adolescent,M01.060.057
19480125,2009-04-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19480125,2009-04-01T00:00:00,Body Mass Index,E05.041.124.125
19480125,2009-04-01T00:00:00,Body Mass Index,G07.100.100.125
19480125,2009-04-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19480125,2009-04-01T00:00:00,Child,M01.060.406
19480125,2009-04-01T00:00:00,Health Behavior,F01.145.488
19480125,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19480125,2009-04-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
19480125,2009-04-01T00:00:00,Metabolic Syndrome X,C18.452.625
19480125,2009-04-01T00:00:00,Obesity,C18.654.726.500
19480125,2009-04-01T00:00:00,Obesity,C23.888.144.699.500
19480125,2009-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19480125,2009-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19480128,2009-04-01T00:00:00,Adolescent,M01.060.057
19480128,2009-04-01T00:00:00,Child,M01.060.406
19480128,2009-04-01T00:00:00,Child Welfare,I01.880.787.293
19480128,2009-04-01T00:00:00,Health Promotion,N02.370
19480128,2009-04-01T00:00:00,Health Promotion,N02.421.726.507
19480128,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19480128,2009-04-01T00:00:00,Obesity,C18.654.726.500
19480128,2009-04-01T00:00:00,Obesity,C23.888.144.699.500
19480128,2009-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19480128,2009-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19480128,2009-04-01T00:00:00,School Health Services,N02.421.143.827.809
19480128,2009-04-01T00:00:00,School Health Services,N02.421.726.809
19615617,2009-04-01T00:00:00,Animals,B01.050
19615617,2009-04-01T00:00:00,Columbidae,B01.050.150.900.248.165.150
19615617,2009-04-01T00:00:00,Discrimination (Psychology),F02.463.593.257
19615617,2009-04-01T00:00:00,Motivation,F01.658
19615617,2009-04-01T00:00:00,Motivation,F01.752.543.500.750
19615617,2009-04-01T00:00:00,Neuropsychological Tests,F04.711.513
19615617,2009-04-01T00:00:00,Time Factors,G01.910.857
19679265,2009-04-01T00:00:00,Anoxia,C23.888.852.079
19679265,2009-04-01T00:00:00,"Diagnosis, Differential",E01.171
19679265,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19679265,2009-04-01T00:00:00,Macrophages,A11.329.372
19679265,2009-04-01T00:00:00,Macrophages,A11.627.482
19679265,2009-04-01T00:00:00,Macrophages,A11.733.397
19679265,2009-04-01T00:00:00,Macrophages,A15.382.680.397
19679265,2009-04-01T00:00:00,Macrophages,A15.382.812.522
19679265,2009-04-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
19679265,2009-04-01T00:00:00,Terminology as Topic,L01.143.506.598.400
19828900,2009-04-01T00:00:00,Biological Markers,D23.101
19828900,2009-04-01T00:00:00,Cardiovascular Diseases,C14
19828900,2009-04-01T00:00:00,"Cholesterol, HDL",D10.532.432.400
19828900,2009-04-01T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
19828900,2009-04-01T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
19828900,2009-04-01T00:00:00,Diet,E05.272
19828900,2009-04-01T00:00:00,Diet,G07.610.240
19828900,2009-04-01T00:00:00,Dietary Carbohydrates,D09.301
19828900,2009-04-01T00:00:00,Dietary Carbohydrates,J02.500.362
19828900,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19828900,2009-04-01T00:00:00,Insulin,D06.472.699.587.740.625
19828900,2009-04-01T00:00:00,Insulin,D12.644.548.586.740.625
19828900,2009-04-01T00:00:00,Insulin Resistance,C18.452.394.968.500
19828900,2009-04-01T00:00:00,Insulin Resistance,G07.690.320.617
19828900,2009-04-01T00:00:00,Middle Aged,M01.060.116.630
19828900,2009-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19828900,2009-04-01T00:00:00,Risk Factors,N05.715.350.200.700
19828900,2009-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19828900,2009-04-01T00:00:00,Risk Factors,N06.850.490.625.750
19828900,2009-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20161310,2009-04-01T00:00:00,Depressive Disorder,F03.600.300
20161310,2009-04-01T00:00:00,Double-Blind Method,E05.318.780.300
20161310,2009-04-01T00:00:00,Double-Blind Method,E05.581.500.300
20161310,2009-04-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20161310,2009-04-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20161310,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20161310,2009-04-01T00:00:00,Pain,C10.597.617
20161310,2009-04-01T00:00:00,Pain,C23.888.592.612
20161310,2009-04-01T00:00:00,Pain,C23.888.646
20161310,2009-04-01T00:00:00,Pain,F02.830.816.444
20161310,2009-04-01T00:00:00,Pain,G11.561.600.810.444
20161310,2009-04-01T00:00:00,Pain Measurement,E01.370.376.550.600
20161310,2009-04-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20161310,2009-04-01T00:00:00,Psychiatric Status Rating Scales,F04.586
20161310,2009-04-01T00:00:00,Questionnaires,E05.318.308.750
20161310,2009-04-01T00:00:00,Questionnaires,L01.280.800
20161310,2009-04-01T00:00:00,Questionnaires,N05.715.360.300.695
20161310,2009-04-01T00:00:00,Questionnaires,N06.850.520.308.750
20161310,2009-04-01T00:00:00,Time Factors,G01.910.857
20161310,2009-04-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20161310,2009-04-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20161310,2009-04-01T00:00:00,Treatment Outcome,E01.789.800
20161310,2009-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20161310,2009-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20205006,2009-04-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
20205006,2009-04-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
20205006,2009-04-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
20205006,2009-04-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
20205006,2009-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20205006,2009-04-01T00:00:00,Perception,F02.463.593
20205006,2009-04-01T00:00:00,Questionnaires,E05.318.308.750
20205006,2009-04-01T00:00:00,Questionnaires,L01.280.800
20205006,2009-04-01T00:00:00,Questionnaires,N05.715.360.300.695
20205006,2009-04-01T00:00:00,Questionnaires,N06.850.520.308.750
20205006,2009-04-01T00:00:00,Spouses,F01.829.263.500.660
20205006,2009-04-01T00:00:00,Spouses,I01.880.225.500.670
20205006,2009-04-01T00:00:00,Spouses,M01.816
19339986,2009-04-02T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
19339986,2009-04-02T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
19339986,2009-04-02T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
19339986,2009-04-02T00:00:00,Case-Control Studies,E05.318.760.500.500
19339986,2009-04-02T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19339986,2009-04-02T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19339986,2009-04-02T00:00:00,European Continental Ancestry Group,M01.686.508.400
19339986,2009-04-02T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19339986,2009-04-02T00:00:00,Genetic Predisposition to Disease,G05.380.355
19339986,2009-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19339986,2009-04-02T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19339986,2009-04-02T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19339986,2009-04-02T00:00:00,Membrane Proteins,D12.776.543
19339986,2009-04-02T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19344885,2009-04-02T00:00:00,Adult,M01.060.116
19344885,2009-04-02T00:00:00,Aged,M01.060.116.100
19344885,2009-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19344885,2009-04-02T00:00:00,Middle Aged,M01.060.116.630
19344885,2009-04-02T00:00:00,Pressure,G01.374.715
19344885,2009-04-02T00:00:00,Surgical Wound Infection,C01.539.947.692
19344885,2009-04-02T00:00:00,Surgical Wound Infection,C23.550.767.925
19344885,2009-04-02T00:00:00,Time Factors,G01.910.857
19344885,2009-04-02T00:00:00,Treatment Outcome,E01.789.800
19344885,2009-04-02T00:00:00,Treatment Outcome,N04.761.559.590.800
19344885,2009-04-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19344885,2009-04-02T00:00:00,Wound Healing,G16.100.856.891
19345734,2009-04-02T00:00:00,Acoustic Stimulation,E02.037
19345734,2009-04-02T00:00:00,Acoustic Stimulation,E02.190.888.030
19345734,2009-04-02T00:00:00,Acoustic Stimulation,E05.723.136
19345734,2009-04-02T00:00:00,Adult,M01.060.116
19345734,2009-04-02T00:00:00,Algorithms,G17.035
19345734,2009-04-02T00:00:00,Algorithms,L01.224.050
19345734,2009-04-02T00:00:00,Auditory Perception,F02.463.593.071
19345734,2009-04-02T00:00:00,Brain,A08.186.211
19345734,2009-04-02T00:00:00,Brain Mapping,E01.370.350.086
19345734,2009-04-02T00:00:00,Brain Mapping,E01.370.376.149
19345734,2009-04-02T00:00:00,Brain Mapping,E05.132
19345734,2009-04-02T00:00:00,Electroencephalography,E01.370.376.300
19345734,2009-04-02T00:00:00,Electroencephalography,E01.370.405.245
19345734,2009-04-02T00:00:00,Evoked Potentials,G07.265.500
19345734,2009-04-02T00:00:00,Evoked Potentials,G11.561.270
19345734,2009-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19345734,2009-04-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19345734,2009-04-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19345734,2009-04-02T00:00:00,Neuropsychological Tests,F04.711.513
19345734,2009-04-02T00:00:00,Reaction Time,F02.830.650
19345734,2009-04-02T00:00:00,Reaction Time,F04.669.817
19345734,2009-04-02T00:00:00,Reaction Time,G11.561.677
19345734,2009-04-02T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
19342830,2009-04-03T00:00:00,Biological Markers,D23.101
19342830,2009-04-03T00:00:00,Brain Ischemia,C10.228.140.300.150
19342830,2009-04-03T00:00:00,Brain Ischemia,C14.907.253.092
19342830,2009-04-03T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
19342830,2009-04-03T00:00:00,Carotid Stenosis,C14.907.137.230
19342830,2009-04-03T00:00:00,Carotid Stenosis,C14.907.253.123.360
19342830,2009-04-03T00:00:00,Diagnostic Imaging,E01.370.350
19342830,2009-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19342830,2009-04-03T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
19342830,2009-04-03T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
19342830,2009-04-03T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
19342830,2009-04-03T00:00:00,Risk Assessment,E05.318.740.600.800.715
19342830,2009-04-03T00:00:00,Risk Assessment,N04.452.871.715
19342830,2009-04-03T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19342830,2009-04-03T00:00:00,Risk Assessment,N06.850.505.715
19342830,2009-04-03T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19342830,2009-04-03T00:00:00,Stroke,C10.228.140.300.775
19342830,2009-04-03T00:00:00,Stroke,C14.907.253.855
19342830,2009-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19342830,2009-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19342830,2009-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19342830,2009-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19342830,2009-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19342830,2009-04-03T00:00:00,Ultrasonography,E01.370.350.850
19345353,2009-04-03T00:00:00,Carcinoma,C04.557.470.200
19345353,2009-04-03T00:00:00,Endometrial Neoplasms,C04.588.945.418.948.585
19345353,2009-04-03T00:00:00,Endometrial Neoplasms,C13.351.500.852.762.200
19345353,2009-04-03T00:00:00,Endometrial Neoplasms,C13.351.937.418.875.200
19345353,2009-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19345353,2009-04-03T00:00:00,Neoplasm Staging,E01.370.550
19345353,2009-04-03T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19345353,2009-04-03T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19345569,2009-04-03T00:00:00,Animals,B01.050
19346505,2009-04-03T00:00:00,Adult,M01.060.116
19346505,2009-04-03T00:00:00,Aged,M01.060.116.100
19346505,2009-04-03T00:00:00,Health Behavior,F01.145.488
19346505,2009-04-03T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19346505,2009-04-03T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19346505,2009-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19346505,2009-04-03T00:00:00,Middle Aged,M01.060.116.630
19346505,2009-04-03T00:00:00,Motivation,F01.658
19346505,2009-04-03T00:00:00,Motivation,F01.752.543.500.750
19346505,2009-04-03T00:00:00,Smoking,F01.145.466.753
19346505,2009-04-03T00:00:00,Smoking Cessation,F01.145.940.700
19346505,2009-04-03T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19346505,2009-04-03T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19346505,2009-04-03T00:00:00,United States,Z01.107.567.875
19343331,2009-04-04T00:00:00,Bacteria,B03
19343331,2009-04-04T00:00:00,DNA,D13.444.308
19343331,2009-04-04T00:00:00,RNA,D13.444.735
19343331,2009-04-04T00:00:00,"Spectrum Analysis, Raman",E05.196.822.860
19343331,2009-04-04T00:00:00,"Spectrum Analysis, Raman",E05.196.867.890
19343331,2009-04-04T00:00:00,Surface Properties,G02.842.850
19426195,2009-04-04T00:00:00,Aged,M01.060.116.100
19426195,2009-04-04T00:00:00,Body Mass Index,E01.370.600.115.100.125
19426195,2009-04-04T00:00:00,Body Mass Index,E05.041.124.125
19426195,2009-04-04T00:00:00,Body Mass Index,G07.100.100.125
19426195,2009-04-04T00:00:00,Body Mass Index,N06.850.505.200.100.175
19426195,2009-04-04T00:00:00,Case-Control Studies,E05.318.760.500.500
19426195,2009-04-04T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19426195,2009-04-04T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19426195,2009-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19426195,2009-04-04T00:00:00,Middle Aged,M01.060.116.630
19426195,2009-04-04T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
19426195,2009-04-04T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
19426195,2009-04-04T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19426195,2009-04-04T00:00:00,Prostatic Neoplasms,C12.294.260.750
19426195,2009-04-04T00:00:00,Prostatic Neoplasms,C12.294.565.625
19426195,2009-04-04T00:00:00,Prostatic Neoplasms,C12.758.409.750
19426195,2009-04-04T00:00:00,Vitamin D,D04.808.812.768
19426195,2009-04-04T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19345545,2009-04-05T00:00:00,Adolescent,M01.060.057
19345545,2009-04-05T00:00:00,Ankle Injuries,C21.866.558.100
19345545,2009-04-05T00:00:00,Ankle Joint,A02.835.583.378.062
19345545,2009-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19345545,2009-04-05T00:00:00,Pain,C10.597.617
19345545,2009-04-05T00:00:00,Pain,C23.888.592.612
19345545,2009-04-05T00:00:00,Pain,C23.888.646
19345545,2009-04-05T00:00:00,Pain,F02.830.816.444
19345545,2009-04-05T00:00:00,Pain,G11.561.600.810.444
19345545,2009-04-05T00:00:00,Weight-Bearing,G01.374.676.965
19345545,2009-04-05T00:00:00,Weight-Bearing,G01.595.540.965
19349285,2009-04-05T00:00:00,Genome-Wide Association Study,E05.318.416.249
19349285,2009-04-05T00:00:00,Genome-Wide Association Study,E05.318.780.392
19349285,2009-04-05T00:00:00,Genome-Wide Association Study,E05.393.385.500
19349285,2009-04-05T00:00:00,Genome-Wide Association Study,E05.393.522.500
19349285,2009-04-05T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19349285,2009-04-05T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19349285,2009-04-05T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19349285,2009-04-05T00:00:00,Linkage Disequilibrium,G05.540.500
19349285,2009-04-05T00:00:00,Lipid Metabolism,G03.495.520
19349285,2009-04-05T00:00:00,Phenotype,G05.695
19349285,2009-04-05T00:00:00,Proteins,D12.776
19351579,2009-04-05T00:00:00,Adult,M01.060.116
19351579,2009-04-05T00:00:00,Bipolar Disorder,F03.600.150.150
19351579,2009-04-05T00:00:00,Case-Control Studies,E05.318.760.500.500
19351579,2009-04-05T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19351579,2009-04-05T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19351579,2009-04-05T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19351579,2009-04-05T00:00:00,Functional Laterality,F02.830.297.425
19351579,2009-04-05T00:00:00,Functional Laterality,G11.561.225.425
19351579,2009-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19351579,2009-04-05T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19351579,2009-04-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19351579,2009-04-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19351579,2009-04-05T00:00:00,Middle Aged,M01.060.116.630
19351579,2009-04-05T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
19351579,2009-04-05T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19351579,2009-04-05T00:00:00,Psychiatric Status Rating Scales,F04.586
19351579,2009-04-05T00:00:00,Young Adult,M01.060.116.815
20633404,2009-04-05T00:00:00,Animals,B01.050
20633404,2009-04-05T00:00:00,Deep Brain Stimulation,E02.342.250
20633404,2009-04-05T00:00:00,Deep Brain Stimulation,E04.190
20633404,2009-04-05T00:00:00,Diagnostic Imaging,E01.370.350
20633404,2009-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633404,2009-04-05T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20633404,2009-04-05T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19349647,2009-04-06T00:00:00,Aged,M01.060.116.100
19349647,2009-04-06T00:00:00,Electric Conductivity,G01.201.249.277
19349647,2009-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19349647,2009-04-06T00:00:00,Liver,A03.620
19349647,2009-04-06T00:00:00,Liver Neoplasms,C04.588.274.623
19349647,2009-04-06T00:00:00,Liver Neoplasms,C06.301.623
19349647,2009-04-06T00:00:00,Liver Neoplasms,C06.552.697
19349647,2009-04-06T00:00:00,Middle Aged,M01.060.116.630
19508642,2009-04-06T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
19508642,2009-04-06T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
19508642,2009-04-06T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19508642,2009-04-06T00:00:00,Mitochondria,A11.284.835.626
19508642,2009-04-06T00:00:00,Photochemotherapy,E02.186.500
19508642,2009-04-06T00:00:00,Photochemotherapy,E02.319.685
19508642,2009-04-06T00:00:00,Photochemotherapy,E02.774.722
19508642,2009-04-06T00:00:00,Photosensitizing Agents,D27.505.696.750.710
19508642,2009-04-06T00:00:00,Photosensitizing Agents,D27.505.954.444.600
19351784,2009-04-07T00:00:00,Air Pollutants,D27.888.284.101
19351784,2009-04-07T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
19351784,2009-04-07T00:00:00,Environmental Monitoring,N06.850.460.350.080
19351784,2009-04-07T00:00:00,Environmental Monitoring,N06.850.780.375
19351784,2009-04-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19351784,2009-04-07T00:00:00,Risk Assessment,E05.318.740.600.800.715
19351784,2009-04-07T00:00:00,Risk Assessment,N04.452.871.715
19351784,2009-04-07T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19351784,2009-04-07T00:00:00,Risk Assessment,N06.850.505.715
19351784,2009-04-07T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19351784,2009-04-07T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19351784,2009-04-07T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19351787,2009-04-07T00:00:00,Adult,M01.060.116
19351787,2009-04-07T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
19351787,2009-04-07T00:00:00,Alcohol Drinking,F01.145.317.269
19351787,2009-04-07T00:00:00,Attitude to Health,F01.100.150
19351787,2009-04-07T00:00:00,Attitude to Health,N05.300.150
19351787,2009-04-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19351787,2009-04-07T00:00:00,Middle Aged,M01.060.116.630
19351787,2009-04-07T00:00:00,Questionnaires,E05.318.308.750
19351787,2009-04-07T00:00:00,Questionnaires,L01.280.800
19351787,2009-04-07T00:00:00,Questionnaires,N05.715.360.300.695
19351787,2009-04-07T00:00:00,Questionnaires,N06.850.520.308.750
19351787,2009-04-07T00:00:00,Smoking,F01.145.466.753
19351787,2009-04-07T00:00:00,Smoking Cessation,F01.145.940.700
19351787,2009-04-07T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19351787,2009-04-07T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19351865,2009-04-07T00:00:00,Angiotensin II,D06.472.699.094.078
19351865,2009-04-07T00:00:00,Angiotensin II,D12.644.400.070.078
19351865,2009-04-07T00:00:00,Angiotensin II,D12.644.456.073.041
19351865,2009-04-07T00:00:00,Angiotensin II,D12.644.548.058.078
19351865,2009-04-07T00:00:00,Angiotensin II,D12.776.641.650.070.078
19351865,2009-04-07T00:00:00,Angiotensin II,D23.469.050.050.050
19351865,2009-04-07T00:00:00,Animals,B01.050
19351865,2009-04-07T00:00:00,Cell Line,A11.251.210
19351865,2009-04-07T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
19351865,2009-04-07T00:00:00,Heterotrimeric GTP-Binding Proteins,D08.811.277.040.330.300.200
19351865,2009-04-07T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.644.360.375
19351865,2009-04-07T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.157.325.332
19351865,2009-04-07T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.476.375
19351865,2009-04-07T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.543.325
19351865,2009-04-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19351865,2009-04-07T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
19351865,2009-04-07T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
19351865,2009-04-07T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
19351865,2009-04-07T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
19351865,2009-04-07T00:00:00,Peptides,D12.644
19351865,2009-04-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19403215,2009-04-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19403215,2009-04-07T00:00:00,Internet,L01.224.230.110.500
19403215,2009-04-07T00:00:00,Mental Disorders,F03
19403215,2009-04-07T00:00:00,Psychotherapy,F04.754
19403215,2009-04-07T00:00:00,"Stress, Psychological",F01.145.126.990
19403215,2009-04-07T00:00:00,"Stress, Psychological",F02.830.900
19357286,2009-04-08T00:00:00,Animals,B01.050
19357286,2009-04-08T00:00:00,Eye Proteins,D12.776.306
19357286,2009-04-08T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
19357286,2009-04-08T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
19357286,2009-04-08T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
19357286,2009-04-08T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
19357286,2009-04-08T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
19357286,2009-04-08T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
19357286,2009-04-08T00:00:00,Visual Perception,F02.463.593.932
19290594,2009-04-09T00:00:00,Animals,B01.050
19290594,2009-04-09T00:00:00,Calcium,D01.268.552.100
19290594,2009-04-09T00:00:00,Calcium,D01.552.539.288
19290594,2009-04-09T00:00:00,Calcium,D23.119.100
19290594,2009-04-09T00:00:00,Cell Line,A11.251.210
19290594,2009-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19290594,2009-04-09T00:00:00,Neurotensin,D12.644.400.550
19290594,2009-04-09T00:00:00,Neurotensin,D12.776.641.650.550
19290594,2009-04-09T00:00:00,Peptide Fragments,D12.644.541
19290594,2009-04-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19290594,2009-04-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19290594,2009-04-09T00:00:00,"Receptors, Neurotensin",D12.776.543.750.100.550
19290594,2009-04-09T00:00:00,"Receptors, Neurotensin",D12.776.543.750.720.600.560
19290594,2009-04-09T00:00:00,"Receptors, Neurotensin",D12.776.543.750.750.555.560
19359651,2009-04-09T00:00:00,Aged,M01.060.116.100
19359651,2009-04-09T00:00:00,Blood Pressure,E01.370.600.875.249
19359651,2009-04-09T00:00:00,Blood Pressure,G09.330.380.076
19359651,2009-04-09T00:00:00,Brain Ischemia,C10.228.140.300.150
19359651,2009-04-09T00:00:00,Brain Ischemia,C14.907.253.092
19359651,2009-04-09T00:00:00,Case-Control Studies,E05.318.760.500.500
19359651,2009-04-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19359651,2009-04-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19359651,2009-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19359651,2009-04-09T00:00:00,Middle Aged,M01.060.116.630
19359651,2009-04-09T00:00:00,Risk Factors,E05.318.740.600.800.725
19359651,2009-04-09T00:00:00,Risk Factors,N05.715.350.200.700
19359651,2009-04-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19359651,2009-04-09T00:00:00,Risk Factors,N06.850.490.625.750
19359651,2009-04-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19359651,2009-04-09T00:00:00,Stroke,C10.228.140.300.775
19359651,2009-04-09T00:00:00,Stroke,C14.907.253.855
19389201,2009-04-09T00:00:00,Alcoholism,C21.739.100.250
19389201,2009-04-09T00:00:00,Alcoholism,F03.900.100.350
19389201,2009-04-09T00:00:00,Animals,B01.050
19389201,2009-04-09T00:00:00,Ethanol,D02.033.375
19389201,2009-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19389201,2009-04-09T00:00:00,Neuronal Plasticity,G11.561.600.635
19361902,2009-04-10T00:00:00,Environmental Monitoring,N06.850.460.350.080
19361902,2009-04-10T00:00:00,Environmental Monitoring,N06.850.780.375
19361902,2009-04-10T00:00:00,Geographic Information Systems,L01.470.750.750.462
19361902,2009-04-10T00:00:00,Geographic Information Systems,L01.700.508.300.314
19361902,2009-04-10T00:00:00,Soil Pollutants,D27.888.284.756
19271753,2009-04-13T00:00:00,Animals,B01.050
19271753,2009-04-13T00:00:00,Cell Adhesion,G04.299.117
19271753,2009-04-13T00:00:00,Osteoblasts,A11.329.629
19271753,2009-04-13T00:00:00,Peptide Fragments,D12.644.541
19271753,2009-04-13T00:00:00,Polymers,D05.750
19271753,2009-04-13T00:00:00,Polymers,D25.720
19271753,2009-04-13T00:00:00,Polymers,J01.637.051.720
19271753,2009-04-13T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
19271753,2009-04-13T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
19271753,2009-04-13T00:00:00,Surface Plasmon Resonance,E05.196.890
19271753,2009-04-13T00:00:00,Surface Plasmon Resonance,E05.601.123.700
19271753,2009-04-13T00:00:00,Surface Properties,G02.842.850
19271753,2009-04-13T00:00:00,Titanium,D01.268.557.800
19271753,2009-04-13T00:00:00,Titanium,D01.268.956.878
19271753,2009-04-13T00:00:00,Titanium,D01.552.547.800
19364763,2009-04-13T00:00:00,Animals,B01.050
19364763,2009-04-13T00:00:00,Cardiomegaly,C14.280.195
19364763,2009-04-13T00:00:00,Cardiomegaly,C23.300.775.250
19364763,2009-04-13T00:00:00,Cell Survival,G04.299.316
19364763,2009-04-13T00:00:00,Integrin beta3,D12.776.543.750.705.408.200.750
19364763,2009-04-13T00:00:00,Integrin beta3,D23.050.301.264.035.302
19364763,2009-04-13T00:00:00,Integrin beta3,D23.101.100.110.299
19364763,2009-04-13T00:00:00,"Models, Cardiovascular",E05.599.395.161
19364763,2009-04-13T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19364763,2009-04-13T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19364763,2009-04-13T00:00:00,"Myocytes, Cardiac",A11.620.500
19364763,2009-04-13T00:00:00,NF-kappa B,D12.776.260.600
19364763,2009-04-13T00:00:00,NF-kappa B,D12.776.660.600
19364763,2009-04-13T00:00:00,NF-kappa B,D12.776.930.600
19364763,2009-04-13T00:00:00,Oligopeptides,D12.644.456
19364763,2009-04-13T00:00:00,Signal Transduction,G02.111.087.800
19364763,2009-04-13T00:00:00,Signal Transduction,G02.149.115.800
19364763,2009-04-13T00:00:00,Signal Transduction,G04.299.880
19365052,2009-04-14T00:00:00,Adolescent,M01.060.057
19365052,2009-04-14T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
19365052,2009-04-14T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
19365052,2009-04-14T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
19365052,2009-04-14T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
19365052,2009-04-14T00:00:00,Blood Transfusion,E02.095.135
19365052,2009-04-14T00:00:00,Child,M01.060.406
19365052,2009-04-14T00:00:00,"Child, Preschool",M01.060.406.448
19365052,2009-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19365052,2009-04-14T00:00:00,Regression Analysis,E05.318.740.750
19365052,2009-04-14T00:00:00,Regression Analysis,N05.715.360.750.695
19365052,2009-04-14T00:00:00,Regression Analysis,N06.850.520.830.750
19365052,2009-04-14T00:00:00,Stroke,C10.228.140.300.775
19365052,2009-04-14T00:00:00,Stroke,C14.907.253.855
19365052,2009-04-14T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
19365052,2009-04-14T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
19365052,2009-04-14T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
19365052,2009-04-14T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
19365631,2009-04-14T00:00:00,Adult,M01.060.116
19365631,2009-04-14T00:00:00,Aged,M01.060.116.100
19365631,2009-04-14T00:00:00,Antibodies,D12.776.124.486.485.114
19365631,2009-04-14T00:00:00,Antibodies,D12.776.124.790.651.114
19365631,2009-04-14T00:00:00,Antibodies,D12.776.377.715.548.114
19365631,2009-04-14T00:00:00,Breast Neoplasms,C04.588.180
19365631,2009-04-14T00:00:00,Breast Neoplasms,C17.800.090.500
19365631,2009-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19365631,2009-04-14T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
19365631,2009-04-14T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
19365631,2009-04-14T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
19365631,2009-04-14T00:00:00,Middle Aged,M01.060.116.630
19366985,2009-04-14T00:00:00,Adolescent,M01.060.057
19366985,2009-04-14T00:00:00,Adolescent Behavior,F01.145.022
19366985,2009-04-14T00:00:00,Attitude to Health,F01.100.150
19366985,2009-04-14T00:00:00,Attitude to Health,N05.300.150
19366985,2009-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19366985,2009-04-14T00:00:00,Motivation,F01.658
19366985,2009-04-14T00:00:00,Motivation,F01.752.543.500.750
19366985,2009-04-14T00:00:00,Smoking,F01.145.466.753
19366985,2009-04-14T00:00:00,Smoking Cessation,F01.145.940.700
19366985,2009-04-14T00:00:00,South Carolina,Z01.107.567.875.075.662
19366985,2009-04-14T00:00:00,South Carolina,Z01.107.567.875.750.700
19522984,2009-04-14T00:00:00,Alleles,G05.360.340.024.340.030
19522984,2009-04-14T00:00:00,Animals,B01.050
19522984,2009-04-14T00:00:00,Hair,A17.360
19522984,2009-04-14T00:00:00,Mutation,G05.365.590
19522984,2009-04-14T00:00:00,Phenotype,G05.695
19205066,2009-04-15T00:00:00,Constipation,C23.888.821.150
19205066,2009-04-15T00:00:00,Deglutition Disorders,C06.405.117.119
19205066,2009-04-15T00:00:00,Deglutition Disorders,C09.775.174
19205066,2009-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19205066,2009-04-15T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19205066,2009-04-15T00:00:00,Parkinson Disease,C10.228.662.600.400
19205066,2009-04-15T00:00:00,Parkinson Disease,C10.574.812
19342619,2009-04-15T00:00:00,Animals,B01.050
19342619,2009-04-15T00:00:00,Cell Cycle Proteins,D12.776.167
19342619,2009-04-15T00:00:00,DNA-Binding Proteins,D12.776.260
19342619,2009-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19342619,2009-04-15T00:00:00,Spleen,A10.549.700
19342619,2009-04-15T00:00:00,Spleen,A15.382.520.604.700
19349486,2009-04-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
19349486,2009-04-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
19349486,2009-04-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
19349486,2009-04-15T00:00:00,Endosonography,E01.370.350.850.280
19349486,2009-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19349486,2009-04-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
19349486,2009-04-15T00:00:00,Lung Neoplasms,C08.381.540
19349486,2009-04-15T00:00:00,Lung Neoplasms,C08.785.520
19349486,2009-04-15T00:00:00,Neoplasm Staging,E01.370.550
19369694,2009-04-15T00:00:00,Animals,B01.050
19369694,2009-04-15T00:00:00,Cell Line,A11.251.210
19369694,2009-04-15T00:00:00,Ceramides,D02.065.313
19369694,2009-04-15T00:00:00,Ceramides,D09.400.410.420.525.200
19369694,2009-04-15T00:00:00,Ceramides,D10.390.470.675.200
19369694,2009-04-15T00:00:00,Ceramides,D10.570.877.360.612.200
19369694,2009-04-15T00:00:00,Diet,E05.272
19369694,2009-04-15T00:00:00,Diet,G07.610.240
19369694,2009-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19369694,2009-04-15T00:00:00,Lysophospholipids,D10.570.755.375.760.550
19369694,2009-04-15T00:00:00,Obesity,C18.654.726.500
19369694,2009-04-15T00:00:00,Obesity,C23.888.144.699.500
19369694,2009-04-15T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19369694,2009-04-15T00:00:00,Obesity,G07.100.100.160.120.699.500
19369694,2009-04-15T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
19369694,2009-04-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19369694,2009-04-15T00:00:00,Signal Transduction,G02.111.087.800
19369694,2009-04-15T00:00:00,Signal Transduction,G02.149.115.800
19369694,2009-04-15T00:00:00,Signal Transduction,G04.299.880
19369694,2009-04-15T00:00:00,Sphingosine,D02.033.100.700
19369694,2009-04-15T00:00:00,Sphingosine,D02.033.455.843
19369694,2009-04-15T00:00:00,Sphingosine,D02.092.063.700
19369943,2009-04-16T00:00:00,Animals,B01.050
19369943,2009-04-16T00:00:00,Epithelial Cells,A11.436
19369943,2009-04-16T00:00:00,Fibroblasts,A11.329.228
19369943,2009-04-16T00:00:00,Fibroblasts,A11.872.228
19369943,2009-04-16T00:00:00,Neoplasms,C04
19369943,2009-04-16T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
19369943,2009-04-16T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
19369943,2009-04-16T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
19369943,2009-04-16T00:00:00,Peroxiredoxins,D08.811.682.732.850
19369943,2009-04-16T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
19369943,2009-04-16T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
19369943,2009-04-16T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
19369943,2009-04-16T00:00:00,Reactive Oxygen Species,D01.339.431
19369943,2009-04-16T00:00:00,Reactive Oxygen Species,D01.650.775
19369946,2009-04-16T00:00:00,Age Factors,N05.715.350.075
19369946,2009-04-16T00:00:00,Age Factors,N06.850.490.250
19369946,2009-04-16T00:00:00,Case-Control Studies,E05.318.760.500.500
19369946,2009-04-16T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19369946,2009-04-16T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19369946,2009-04-16T00:00:00,Genome-Wide Association Study,E05.318.416.249
19369946,2009-04-16T00:00:00,Genome-Wide Association Study,E05.318.780.392
19369946,2009-04-16T00:00:00,Genome-Wide Association Study,E05.393.385.500
19369946,2009-04-16T00:00:00,Genome-Wide Association Study,E05.393.522.500
19369946,2009-04-16T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19369946,2009-04-16T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19369946,2009-04-16T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19369946,2009-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19369946,2009-04-16T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19369946,2009-04-16T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19369946,2009-04-16T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19369946,2009-04-16T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
19373213,2009-04-16T00:00:00,Aged,M01.060.116.100
19373213,2009-04-16T00:00:00,Algorithms,G17.035
19373213,2009-04-16T00:00:00,Algorithms,L01.224.050
19373213,2009-04-16T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19373213,2009-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19373213,2009-04-16T00:00:00,Hypertension,C14.907.489
19373213,2009-04-16T00:00:00,Middle Aged,M01.060.116.630
19373213,2009-04-16T00:00:00,Renin,D08.811.277.656.074.500.780
19373213,2009-04-16T00:00:00,Renin,D08.811.277.656.300.048.780
19373213,2009-04-16T00:00:00,Renin,D08.811.277.656.837.750
19375948,2009-04-17T00:00:00,Aged,M01.060.116.100
19375948,2009-04-17T00:00:00,Breast Neoplasms,C04.588.180
19375948,2009-04-17T00:00:00,Breast Neoplasms,C17.800.090.500
19375948,2009-04-17T00:00:00,Combined Modality Therapy,E02.186
19375948,2009-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19375948,2009-04-17T00:00:00,Mammography,E01.370.350.700.500
19375948,2009-04-17T00:00:00,Middle Aged,M01.060.116.630
19375948,2009-04-17T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
19375948,2009-04-17T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
19375948,2009-04-17T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
19375948,2009-04-17T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
19375948,2009-04-17T00:00:00,Treatment Outcome,E01.789.800
19375948,2009-04-17T00:00:00,Treatment Outcome,N04.761.559.590.800
19375948,2009-04-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19375952,2009-04-17T00:00:00,Body Burden,E05.799.638.231
19375952,2009-04-17T00:00:00,Body Burden,N06.850.460.200
19375952,2009-04-17T00:00:00,Equipment Failure Analysis,E05.325.192
19375952,2009-04-17T00:00:00,Radiation Dosage,E05.799.513
19375952,2009-04-17T00:00:00,Radiation Dosage,G01.201.875.740
19375952,2009-04-17T00:00:00,Radiation Dosage,N06.850.810.250
19375952,2009-04-17T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19375952,2009-04-17T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19375952,2009-04-17T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19375952,2009-04-17T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19375952,2009-04-17T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19375952,2009-04-17T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19375952,2009-04-17T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19375952,2009-04-17T00:00:00,"Technology Assessment, Biomedical",N03.880
19375952,2009-04-17T00:00:00,"Technology Assessment, Biomedical",N05.715.360.825
19375952,2009-04-17T00:00:00,X-Ray Diffraction,E05.196.309.742
19375952,2009-04-17T00:00:00,X-Ray Diffraction,E05.196.822.950
19375952,2009-04-17T00:00:00,X-Ray Diffraction,G01.595.861.950
19375952,2009-04-17T00:00:00,X-Ray Diffraction,G02.149.767.915
19375952,2009-04-17T00:00:00,X-Ray Diffraction,G02.842.750.915
19486347,2009-04-17T00:00:00,Adult,M01.060.116
19486347,2009-04-17T00:00:00,Case-Control Studies,E05.318.760.500.500
19486347,2009-04-17T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19486347,2009-04-17T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19486347,2009-04-17T00:00:00,Glutathione Transferase,D08.811.913.225.500
19486347,2009-04-17T00:00:00,Graft Rejection,G12.425.901.545.328
19486347,2009-04-17T00:00:00,Graft Survival,G12.425.901.545.340
19486347,2009-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19486347,2009-04-17T00:00:00,Kidney Transplantation,E02.870.500
19486347,2009-04-17T00:00:00,Kidney Transplantation,E04.936.450.485
19486347,2009-04-17T00:00:00,Kidney Transplantation,E04.950.774.400
19486347,2009-04-17T00:00:00,Living Donors,M01.898.656
19486347,2009-04-17T00:00:00,Middle Aged,M01.060.116.630
19486347,2009-04-17T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19235216,2009-04-20T00:00:00,Animals,B01.050
19235216,2009-04-20T00:00:00,Cocaine,D02.145.074.722.388
19235216,2009-04-20T00:00:00,Cocaine,D03.132.889.354
19235216,2009-04-20T00:00:00,Cocaine,D03.605.869.388
19235216,2009-04-20T00:00:00,Cocaine,D04.075.080.875.099.722.388
19235216,2009-04-20T00:00:00,Gene Expression,G05.355.310
19235216,2009-04-20T00:00:00,Habenula,A08.186.211.464.200.360
19235216,2009-04-20T00:00:00,Habenula,A08.186.211.730.317.200.360
19235216,2009-04-20T00:00:00,Methamphetamine,D02.092.471.683.152.619
19235216,2009-04-20T00:00:00,Neural Pathways,A08.612
19235216,2009-04-20T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.260.108.765
19235216,2009-04-20T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.624.664.700.179
19235216,2009-04-20T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.660.760
19235216,2009-04-20T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.930.127.765
19235216,2009-04-20T00:00:00,"RNA, Messenger",D13.444.735.544
19235216,2009-04-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19235216,2009-04-20T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19235216,2009-04-20T00:00:00,Self Administration,E02.319.890
19235216,2009-04-20T00:00:00,Self Administration,E02.900.890
19235216,2009-04-20T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
19235216,2009-04-20T00:00:00,Substantia Nigra,A08.186.211.653.822.731
19235216,2009-04-20T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
19235216,2009-04-20T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
19379517,2009-04-20T00:00:00,Age Factors,N05.715.350.075
19379517,2009-04-20T00:00:00,Age Factors,N06.850.490.250
19379517,2009-04-20T00:00:00,Behavior Therapy,F04.754.137
19379517,2009-04-20T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19379517,2009-04-20T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19379517,2009-04-20T00:00:00,Health Services Accessibility,N04.590.374.350
19379517,2009-04-20T00:00:00,Health Services Accessibility,N05.300.430
19379517,2009-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19379517,2009-04-20T00:00:00,Middle Aged,M01.060.116.630
19379517,2009-04-20T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
19379517,2009-04-20T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
19379517,2009-04-20T00:00:00,Research Design,E05.581.500
19379517,2009-04-20T00:00:00,Research Design,H01.770.644.728
19379517,2009-04-20T00:00:00,Telemedicine,H02.403.840
19379517,2009-04-20T00:00:00,Telemedicine,L01.178.847.652
19379517,2009-04-20T00:00:00,Telemedicine,N04.590.374.800
19379517,2009-04-20T00:00:00,Time Factors,G01.910.857
19379517,2009-04-20T00:00:00,Treatment Outcome,E01.789.800
19379517,2009-04-20T00:00:00,Treatment Outcome,N04.761.559.590.800
19379517,2009-04-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19379517,2009-04-20T00:00:00,Veterans,M01.930
19379536,2009-04-20T00:00:00,Adolescent,M01.060.057
19379536,2009-04-20T00:00:00,Adult,M01.060.116
19379536,2009-04-20T00:00:00,Age Factors,N05.715.350.075
19379536,2009-04-20T00:00:00,Age Factors,N06.850.490.250
19379536,2009-04-20T00:00:00,Alcoholism,C21.739.100.250
19379536,2009-04-20T00:00:00,Alcoholism,F03.900.100.350
19379536,2009-04-20T00:00:00,Anxiety Disorders,F03.080
19379536,2009-04-20T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19379536,2009-04-20T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19379536,2009-04-20T00:00:00,Health Surveys,E05.318.308.250
19379536,2009-04-20T00:00:00,Health Surveys,N05.715.360.300.375
19379536,2009-04-20T00:00:00,Health Surveys,N06.850.520.308.250
19379536,2009-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19379536,2009-04-20T00:00:00,Life Change Events,F01.829.458.410
19379536,2009-04-20T00:00:00,"Models, Psychological",E05.599.695
19379536,2009-04-20T00:00:00,Phobic Disorders,F03.080.725
19379536,2009-04-20T00:00:00,Psychometrics,F04.711.780
19379536,2009-04-20T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19379536,2009-04-20T00:00:00,United States,Z01.107.567.875
19379536,2009-04-20T00:00:00,Young Adult,M01.060.116.815
19380381,2009-04-20T00:00:00,Air Movements,G16.500.240.135.249
19380381,2009-04-20T00:00:00,Air Movements,G16.500.275.063.725.154
19380381,2009-04-20T00:00:00,Air Movements,N06.230.300.100.150.185
19380381,2009-04-20T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
19380381,2009-04-20T00:00:00,Environmental Monitoring,N06.850.460.350.080
19380381,2009-04-20T00:00:00,Environmental Monitoring,N06.850.780.375
19380381,2009-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19380381,2009-04-20T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D02.455.426.559.847
19380381,2009-04-20T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D04.615
19380381,2009-04-20T00:00:00,Risk Assessment,E05.318.740.600.800.715
19380381,2009-04-20T00:00:00,Risk Assessment,N04.452.871.715
19380381,2009-04-20T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19380381,2009-04-20T00:00:00,Risk Assessment,N06.850.505.715
19380381,2009-04-20T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19380381,2009-04-20T00:00:00,Smoking,F01.145.466.753
19380381,2009-04-20T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19380381,2009-04-20T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19380710,2009-04-20T00:00:00,Animals,B01.050
19380710,2009-04-20T00:00:00,Brain Mapping,E01.370.350.086
19380710,2009-04-20T00:00:00,Brain Mapping,E01.370.376.149
19380710,2009-04-20T00:00:00,Brain Mapping,E05.132
19380710,2009-04-20T00:00:00,Fear,F01.470.361
19380710,2009-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19380710,2009-04-20T00:00:00,Neural Pathways,A08.612
19380710,2009-04-20T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19380710,2009-04-20T00:00:00,Substance-Related Disorders,C21.739
19380710,2009-04-20T00:00:00,Substance-Related Disorders,F03.900
19392728,2009-04-20T00:00:00,Adult,M01.060.116
19392728,2009-04-20T00:00:00,Aged,M01.060.116.100
19392728,2009-04-20T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19392728,2009-04-20T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19392728,2009-04-20T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19392728,2009-04-20T00:00:00,Hemorrhage,C23.550.414
19392728,2009-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19392728,2009-04-20T00:00:00,Incidence,E05.318.308.985.525.375
19392728,2009-04-20T00:00:00,Incidence,L01.280.975.525.375
19392728,2009-04-20T00:00:00,Incidence,N01.224.935.597.500
19392728,2009-04-20T00:00:00,Incidence,N06.850.505.400.975.525.375
19392728,2009-04-20T00:00:00,Incidence,N06.850.520.308.985.525.375
19392728,2009-04-20T00:00:00,Middle Aged,M01.060.116.630
19392728,2009-04-20T00:00:00,Organ Transplantation,E04.936.450
19392728,2009-04-20T00:00:00,Recombinant Proteins,D12.776.828
19392728,2009-04-20T00:00:00,Sepsis,C01.539.757
19392728,2009-04-20T00:00:00,Sepsis,C23.550.470.790.500
19392728,2009-04-20T00:00:00,Treatment Outcome,E01.789.800
19392728,2009-04-20T00:00:00,Treatment Outcome,N04.761.559.590.800
19392728,2009-04-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19381300,2009-04-21T00:00:00,Animals,B01.050
19381300,2009-04-21T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19381300,2009-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19381300,2009-04-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19381300,2009-04-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19381300,2009-04-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19381300,2009-04-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19381300,2009-04-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19381300,2009-04-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19381300,2009-04-21T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19381300,2009-04-21T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
19386604,2009-04-21T00:00:00,Cell Line,A11.251.210
19386604,2009-04-21T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
19386604,2009-04-21T00:00:00,Complement System Proteins,D12.776.124.486.274
19386604,2009-04-21T00:00:00,Epithelial Cells,A11.436
19386604,2009-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19386604,2009-04-21T00:00:00,Macular Degeneration,C11.768.585.439
19386604,2009-04-21T00:00:00,Oxidative Stress,G03.495.710
19386604,2009-04-21T00:00:00,Oxidative Stress,G07.700.830.750
19386604,2009-04-21T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
19386604,2009-04-21T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
19386604,2009-04-21T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19386604,2009-04-21T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19386604,2009-04-21T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19389332,2009-04-21T00:00:00,Adult,M01.060.116
19389332,2009-04-21T00:00:00,Bipolar Disorder,F03.600.150.150
19389332,2009-04-21T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19389332,2009-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19389332,2009-04-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19389332,2009-04-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19389332,2009-04-21T00:00:00,Middle Aged,M01.060.116.630
19389332,2009-04-21T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19389332,2009-04-21T00:00:00,Questionnaires,E05.318.308.750
19389332,2009-04-21T00:00:00,Questionnaires,L01.280.800
19389332,2009-04-21T00:00:00,Questionnaires,N05.715.360.300.695
19389332,2009-04-21T00:00:00,Questionnaires,N06.850.520.308.750
19389332,2009-04-21T00:00:00,Young Adult,M01.060.116.815
19389388,2009-04-21T00:00:00,Animals,B01.050
19389388,2009-04-21T00:00:00,Apoptosis,G04.299.139.160
19389388,2009-04-21T00:00:00,Calcium,D01.268.552.100
19389388,2009-04-21T00:00:00,Calcium,D01.552.539.288
19389388,2009-04-21T00:00:00,Calcium,D23.119.100
19389388,2009-04-21T00:00:00,"Calcium Channels, L-Type",D12.776.157.530.400.150.400
19389388,2009-04-21T00:00:00,"Calcium Channels, L-Type",D12.776.543.550.425.150.400
19389388,2009-04-21T00:00:00,"Calcium Channels, L-Type",D12.776.543.585.400.150.400
19389388,2009-04-21T00:00:00,Calpain,D08.811.277.656.262.500.120
19389388,2009-04-21T00:00:00,Calpain,D08.811.277.656.300.200.120
19389388,2009-04-21T00:00:00,Cell Line,A11.251.210
19389388,2009-04-21T00:00:00,Estradiol,D04.808.365.415.248
19389388,2009-04-21T00:00:00,Estradiol,D06.472.334.851.437.500
19389388,2009-04-21T00:00:00,Estrogens,D27.505.696.399.472.277
19389388,2009-04-21T00:00:00,Glutamic Acid,D12.125.067.750
19389388,2009-04-21T00:00:00,Glutamic Acid,D12.125.119.450
19389388,2009-04-21T00:00:00,Glutamic Acid,D12.125.427.300
19389388,2009-04-21T00:00:00,Neurons,A08.663
19389388,2009-04-21T00:00:00,Neurons,A11.671
19389388,2009-04-21T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19389388,2009-04-21T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19389388,2009-04-21T00:00:00,Pyrroles,D03.383.129.578
19389388,2009-04-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19389403,2009-04-21T00:00:00,Bioreactors,E07.115
19389403,2009-04-21T00:00:00,Bioreactors,J01.897.120.115
19389403,2009-04-21T00:00:00,Cell Survival,G04.299.316
19389403,2009-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19389403,2009-04-21T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
19389403,2009-04-21T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
19389403,2009-04-21T00:00:00,"Lymphocytes, Tumor-Infiltrating",A11.118.637.555.567.650
19389403,2009-04-21T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.145.229.637.555.567.650
19389403,2009-04-21T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.382.490.555.567.650
19389403,2009-04-21T00:00:00,Perfusion,E05.680
19389403,2009-04-21T00:00:00,Phenotype,G05.695
19386593,2009-04-22T00:00:00,Animals,B01.050
19386593,2009-04-22T00:00:00,Cone Opsins,D12.776.306.466.249
19386593,2009-04-22T00:00:00,Cone Opsins,D23.767.930.750.249
19386593,2009-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19386593,2009-04-22T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
19386593,2009-04-22T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
19386593,2009-04-22T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
19386593,2009-04-22T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
19386593,2009-04-22T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
19386593,2009-04-22T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
19386593,2009-04-22T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
19386593,2009-04-22T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
19386593,2009-04-22T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
19386593,2009-04-22T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
19386593,2009-04-22T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
19386593,2009-04-22T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
19386593,2009-04-22T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
19386593,2009-04-22T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
19290588,2009-04-23T00:00:00,Adsorption,G02.149.047
19290588,2009-04-23T00:00:00,Adsorption,G02.149.767.029
19290588,2009-04-23T00:00:00,Adsorption,G02.842.750.029
19290588,2009-04-23T00:00:00,Probability,E05.318.740.600
19290588,2009-04-23T00:00:00,Probability,G17.680
19290588,2009-04-23T00:00:00,Probability,N05.715.360.750.625
19290588,2009-04-23T00:00:00,Probability,N06.850.520.830.600
19290588,2009-04-23T00:00:00,Silver,D01.268.556.812
19290588,2009-04-23T00:00:00,Silver,D01.268.956.843
19290588,2009-04-23T00:00:00,Silver,D01.552.544.812
19290588,2009-04-23T00:00:00,"Spectrum Analysis, Raman",E05.196.822.860
19290588,2009-04-23T00:00:00,"Spectrum Analysis, Raman",E05.196.867.890
19290588,2009-04-23T00:00:00,Surface Properties,G02.842.850
19290588,2009-04-23T00:00:00,Temperature,G01.906.595
19290588,2009-04-23T00:00:00,Temperature,G16.500.275.063.725.710
19290588,2009-04-23T00:00:00,Temperature,G16.500.750.775.710
19290588,2009-04-23T00:00:00,Temperature,N06.230.150.450
19290588,2009-04-23T00:00:00,Temperature,N06.230.300.100.725.710
19290588,2009-04-23T00:00:00,Time Factors,G01.910.857
19387456,2009-04-23T00:00:00,DNA-Binding Proteins,D12.776.260
19387456,2009-04-23T00:00:00,Genome-Wide Association Study,E05.318.416.249
19387456,2009-04-23T00:00:00,Genome-Wide Association Study,E05.318.780.392
19387456,2009-04-23T00:00:00,Genome-Wide Association Study,E05.393.385.500
19387456,2009-04-23T00:00:00,Genome-Wide Association Study,E05.393.522.500
19387456,2009-04-23T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19387456,2009-04-23T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19387456,2009-04-23T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19387456,2009-04-23T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19387456,2009-04-23T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19387456,2009-04-23T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
19387456,2009-04-23T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
19387456,2009-04-23T00:00:00,Lupus Nephritis,C17.300.480.680
19387456,2009-04-23T00:00:00,Lupus Nephritis,C20.111.590.560
19387456,2009-04-23T00:00:00,Nuclear Proteins,D12.776.660
19387456,2009-04-23T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19387458,2009-04-23T00:00:00,Alternative Splicing,G02.111.087.750.700.100
19387458,2009-04-23T00:00:00,Alternative Splicing,G02.149.115.750.700.100
19387458,2009-04-23T00:00:00,Alternative Splicing,G03.495.839.700.100
19387458,2009-04-23T00:00:00,Alternative Splicing,G05.355.315.700.700.100
19387458,2009-04-23T00:00:00,Case-Control Studies,E05.318.760.500.500
19387458,2009-04-23T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19387458,2009-04-23T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19387458,2009-04-23T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19387458,2009-04-23T00:00:00,Genetic Predisposition to Disease,G05.380.355
19387458,2009-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19387458,2009-04-23T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19387458,2009-04-23T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19387458,2009-04-23T00:00:00,Molecular Sequence Data,L01.453.245.667
19394044,2009-04-24T00:00:00,Child Development,F01.525.200
19394044,2009-04-24T00:00:00,Child Development,G07.700.320.374.750
19394044,2009-04-24T00:00:00,"Child, Preschool",M01.060.406.448
19394044,2009-04-24T00:00:00,Depression,F01.145.126.350
19394044,2009-04-24T00:00:00,Health Status,I01.240.425
19394044,2009-04-24T00:00:00,Health Status,N01.224.425
19394044,2009-04-24T00:00:00,Health Status,N06.850.505.400.425
19394044,2009-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19394044,2009-04-24T00:00:00,Infant,M01.060.703
19394044,2009-04-24T00:00:00,"Infant, Newborn",M01.060.703.520
19394044,2009-04-24T00:00:00,Mass Screening,E01.370.500
19394044,2009-04-24T00:00:00,Mass Screening,E05.318.308.250.580
19394044,2009-04-24T00:00:00,Mass Screening,N02.421.143.827.233.443
19394044,2009-04-24T00:00:00,Mass Screening,N02.421.726.233.443
19394044,2009-04-24T00:00:00,Mass Screening,N05.715.360.300.375.500
19394044,2009-04-24T00:00:00,Mass Screening,N06.850.520.308.250.580
19394044,2009-04-24T00:00:00,Mass Screening,N06.850.780.500
19394044,2009-04-24T00:00:00,Parent-Child Relations,F01.829.263.370.290
19394044,2009-04-24T00:00:00,Parenting,F01.829.263.370.310
19394044,2009-04-24T00:00:00,Parents,F01.829.263.500.320
19394044,2009-04-24T00:00:00,Parents,I01.880.225.500.340
19394044,2009-04-24T00:00:00,Parents,M01.620
19394044,2009-04-24T00:00:00,Psychiatric Status Rating Scales,F04.586
19395557,2009-04-24T00:00:00,Amino Acid Sequence,G02.111.570.060
19395557,2009-04-24T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19395557,2009-04-24T00:00:00,Animals,B01.050
19395557,2009-04-24T00:00:00,Calcium,D01.268.552.100
19395557,2009-04-24T00:00:00,Calcium,D01.552.539.288
19395557,2009-04-24T00:00:00,Calcium,D23.119.100
19395557,2009-04-24T00:00:00,Cell Line,A11.251.210
19395557,2009-04-24T00:00:00,Gene Expression,G05.355.310
19395557,2009-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19395557,2009-04-24T00:00:00,Kidney,A05.810.453
19395557,2009-04-24T00:00:00,Molecular Sequence Data,L01.453.245.667
19395557,2009-04-24T00:00:00,Myocardium,A02.633.580
19395557,2009-04-24T00:00:00,Myocardium,A07.541.704
19395557,2009-04-24T00:00:00,Myocardium,A10.690.552.750
19395557,2009-04-24T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19395557,2009-04-24T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19395557,2009-04-24T00:00:00,"Myocytes, Cardiac",A11.620.500
19395557,2009-04-24T00:00:00,Phylogeny,G05.697
19395557,2009-04-24T00:00:00,Phylogeny,G16.100.275.605
19395557,2009-04-24T00:00:00,Phylogeny,L01.100.697
19395557,2009-04-24T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
19395557,2009-04-24T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
19395557,2009-04-24T00:00:00,Superoxide Dismutase,D08.811.682.881
19426264,2009-04-24T00:00:00,Bacterial Proteins,D12.776.097
19426264,2009-04-24T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19426264,2009-04-24T00:00:00,"Recombination, Genetic",G05.355.760
19393994,2009-04-25T00:00:00,Abdominal Pain,C23.888.646.100
19393994,2009-04-25T00:00:00,Abdominal Pain,C23.888.821.030
19393994,2009-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19393994,2009-04-25T00:00:00,Hysterectomy,E04.950.300.399
19393994,2009-04-25T00:00:00,Pregnancy,G08.686.785.760.769
19393994,2009-04-25T00:00:00,"Pregnancy, Ectopic",C13.703.733
19394023,2009-04-25T00:00:00,Computer Simulation,L01.224.160
19394023,2009-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19394023,2009-04-25T00:00:00,"Models, Biological",E05.599.395
19394023,2009-04-25T00:00:00,Walking,G11.427.590.530.568.900
19394023,2009-04-25T00:00:00,Walking,G11.427.590.530.698.940
19394023,2009-04-25T00:00:00,Walking,I03.450.642.845.940
19394790,2009-04-25T00:00:00,Adult,M01.060.116
19394790,2009-04-25T00:00:00,Attention,F02.830.104.214
19394790,2009-04-25T00:00:00,Cocaine-Related Disorders,C21.739.300
19394790,2009-04-25T00:00:00,Cocaine-Related Disorders,F03.900.300
19394790,2009-04-25T00:00:00,Cognition,F02.463.188
19394790,2009-04-25T00:00:00,Double-Blind Method,E05.318.780.300
19394790,2009-04-25T00:00:00,Double-Blind Method,E05.581.500.300
19394790,2009-04-25T00:00:00,Double-Blind Method,N05.715.360.780.320
19394790,2009-04-25T00:00:00,Double-Blind Method,N06.850.520.445.300
19394790,2009-04-25T00:00:00,Executive Function,F02.463.217
19394790,2009-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19394790,2009-04-25T00:00:00,Middle Aged,M01.060.116.630
19394790,2009-04-25T00:00:00,Neuropsychological Tests,F04.711.513
19394790,2009-04-25T00:00:00,Time Factors,G01.910.857
19394790,2009-04-25T00:00:00,Treatment Outcome,E01.789.800
19394790,2009-04-25T00:00:00,Treatment Outcome,N04.761.559.590.800
19394790,2009-04-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19394866,2009-04-25T00:00:00,Adult,M01.060.116
19394866,2009-04-25T00:00:00,Age Factors,N05.715.350.075
19394866,2009-04-25T00:00:00,Age Factors,N06.850.490.250
19394866,2009-04-25T00:00:00,Aged,M01.060.116.100
19394866,2009-04-25T00:00:00,Body Mass Index,E01.370.600.115.100.125
19394866,2009-04-25T00:00:00,Body Mass Index,E05.041.124.125
19394866,2009-04-25T00:00:00,Body Mass Index,G07.100.100.125
19394866,2009-04-25T00:00:00,Body Mass Index,N06.850.505.200.100.175
19394866,2009-04-25T00:00:00,Case-Control Studies,E05.318.760.500.500
19394866,2009-04-25T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19394866,2009-04-25T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19394866,2009-04-25T00:00:00,Glutathione Transferase,D08.811.913.225.500
19394866,2009-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19394866,2009-04-25T00:00:00,Incidence,E05.318.308.985.525.375
19394866,2009-04-25T00:00:00,Incidence,L01.280.975.525.375
19394866,2009-04-25T00:00:00,Incidence,N01.224.935.597.500
19394866,2009-04-25T00:00:00,Incidence,N06.850.505.400.975.525.375
19394866,2009-04-25T00:00:00,Incidence,N06.850.520.308.985.525.375
19394866,2009-04-25T00:00:00,Lung Neoplasms,C04.588.894.797.520
19394866,2009-04-25T00:00:00,Lung Neoplasms,C08.381.540
19394866,2009-04-25T00:00:00,Lung Neoplasms,C08.785.520
19394866,2009-04-25T00:00:00,Middle Aged,M01.060.116.630
19394866,2009-04-25T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19394866,2009-04-25T00:00:00,Risk Factors,E05.318.740.600.800.725
19394866,2009-04-25T00:00:00,Risk Factors,N05.715.350.200.700
19394866,2009-04-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19394866,2009-04-25T00:00:00,Risk Factors,N06.850.490.625.750
19394866,2009-04-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19394866,2009-04-25T00:00:00,Sex Factors,N05.715.350.675
19394866,2009-04-25T00:00:00,Sex Factors,N06.850.490.875
19394866,2009-04-25T00:00:00,Smoking,F01.145.466.753
19398095,2009-04-26T00:00:00,Adenocarcinoma,C04.557.470.200.025
19398095,2009-04-26T00:00:00,Adult,M01.060.116
19398095,2009-04-26T00:00:00,Brachytherapy,E02.815.150
19398095,2009-04-26T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19398095,2009-04-26T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19398095,2009-04-26T00:00:00,Cisplatin,D01.210.375
19398095,2009-04-26T00:00:00,Cisplatin,D01.625.125
19398095,2009-04-26T00:00:00,Cisplatin,D01.710.100
19398095,2009-04-26T00:00:00,Combined Modality Therapy,E02.186
19398095,2009-04-26T00:00:00,Disease Progression,C23.550.291.656
19398095,2009-04-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19398095,2009-04-26T00:00:00,Middle Aged,M01.060.116.630
19398095,2009-04-26T00:00:00,Neoplasm Staging,E01.370.550
19398095,2009-04-26T00:00:00,Radiotherapy Dosage,E02.815.639
19398095,2009-04-26T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
19398095,2009-04-26T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
19398095,2009-04-26T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
19398095,2009-04-26T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
19398095,2009-04-26T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
19398095,2009-04-26T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
19398095,2009-04-26T00:00:00,Young Adult,M01.060.116.815
19398114,2009-04-26T00:00:00,Adolescent,M01.060.057
19398114,2009-04-26T00:00:00,Adult,M01.060.116
19398114,2009-04-26T00:00:00,African Americans,M01.686.508.100.100
19398114,2009-04-26T00:00:00,African Americans,M01.686.754.100
19398114,2009-04-26T00:00:00,Aged,M01.060.116.100
19398114,2009-04-26T00:00:00,Brain Ischemia,C10.228.140.300.150
19398114,2009-04-26T00:00:00,Brain Ischemia,C14.907.253.092
19398114,2009-04-26T00:00:00,Cardiovascular Diseases,C14
19398114,2009-04-26T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
19398114,2009-04-26T00:00:00,Carotid Artery Diseases,C14.907.253.123
19398114,2009-04-26T00:00:00,European Continental Ancestry Group,M01.686.508.400
19398114,2009-04-26T00:00:00,Hispanic Americans,M01.686.754.441
19398114,2009-04-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19398114,2009-04-26T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
19398114,2009-04-26T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
19398114,2009-04-26T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
19398114,2009-04-26T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
19398114,2009-04-26T00:00:00,Metabolic Syndrome X,C18.452.625
19398114,2009-04-26T00:00:00,Middle Aged,M01.060.116.630
19398114,2009-04-26T00:00:00,Risk Factors,E05.318.740.600.800.725
19398114,2009-04-26T00:00:00,Risk Factors,N05.715.350.200.700
19398114,2009-04-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19398114,2009-04-26T00:00:00,Risk Factors,N06.850.490.625.750
19398114,2009-04-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19398114,2009-04-26T00:00:00,Smoking,F01.145.466.753
19398114,2009-04-26T00:00:00,Young Adult,M01.060.116.815
19444533,2009-04-27T00:00:00,Adult,M01.060.116
19444533,2009-04-27T00:00:00,Age Factors,N05.715.350.075
19444533,2009-04-27T00:00:00,Age Factors,N06.850.490.250
19444533,2009-04-27T00:00:00,Aged,M01.060.116.100
19444533,2009-04-27T00:00:00,Brain,A08.186.211
19444533,2009-04-27T00:00:00,Brain Infarction,C10.228.140.300.150.477
19444533,2009-04-27T00:00:00,Brain Infarction,C10.228.140.300.775.200
19444533,2009-04-27T00:00:00,Brain Infarction,C14.907.253.092.477
19444533,2009-04-27T00:00:00,Brain Infarction,C14.907.253.855.200
19444533,2009-04-27T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
19444533,2009-04-27T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
19444533,2009-04-27T00:00:00,Glucose,D09.546.359.448
19444533,2009-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19444533,2009-04-27T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
19444533,2009-04-27T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
19444533,2009-04-27T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
19444533,2009-04-27T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
19444533,2009-04-27T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
19444533,2009-04-27T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
19444533,2009-04-27T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
19444533,2009-04-27T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
19444533,2009-04-27T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
19444533,2009-04-27T00:00:00,Middle Aged,M01.060.116.630
19444533,2009-04-27T00:00:00,Phenotype,G05.695
19444533,2009-04-27T00:00:00,Risk Factors,E05.318.740.600.800.725
19444533,2009-04-27T00:00:00,Risk Factors,N05.715.350.200.700
19444533,2009-04-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19444533,2009-04-27T00:00:00,Risk Factors,N06.850.490.625.750
19444533,2009-04-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19444533,2009-04-27T00:00:00,Stroke,C10.228.140.300.775
19444533,2009-04-27T00:00:00,Stroke,C14.907.253.855
19426456,2009-04-29T00:00:00,Algorithms,G17.035
19426456,2009-04-29T00:00:00,Algorithms,L01.224.050
19426456,2009-04-29T00:00:00,Computational Biology,H01.158.273.180
19426456,2009-04-29T00:00:00,Protein Interaction Mapping,E05.601.690
19426456,2009-04-29T00:00:00,Proteins,D12.776
19407011,2009-04-30T00:00:00,Animals,B01.050
19407011,2009-04-30T00:00:00,Apoptosis,G04.299.139.160
19407011,2009-04-30T00:00:00,Carrier Proteins,D12.776.157
19407011,2009-04-30T00:00:00,Eye Proteins,D12.776.306
19407011,2009-04-30T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
19407011,2009-04-30T00:00:00,"Microscopy, Fluorescence",E05.595.458
19407011,2009-04-30T00:00:00,Photic Stimulation,E05.723.729
19407011,2009-04-30T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
19407011,2009-04-30T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
19407011,2009-04-30T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
19407011,2009-04-30T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
19407011,2009-04-30T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
19407011,2009-04-30T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
19407011,2009-04-30T00:00:00,Retinal Degeneration,C11.768.585
19407011,2009-04-30T00:00:00,Retinaldehyde,D02.047.850
19407011,2009-04-30T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
19407011,2009-04-30T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
19407011,2009-04-30T00:00:00,Retinaldehyde,D02.455.849.131.495.690
19407011,2009-04-30T00:00:00,Retinaldehyde,D23.767.261.700.690
19407228,2009-04-30T00:00:00,Anticoagulants,D27.505.954.502.119
19407228,2009-04-30T00:00:00,Brain Ischemia,C10.228.140.300.150
19407228,2009-04-30T00:00:00,Brain Ischemia,C14.907.253.092
19407228,2009-04-30T00:00:00,Cerebrovascular Disorders,C10.228.140.300
19407228,2009-04-30T00:00:00,Cerebrovascular Disorders,C14.907.253
19407228,2009-04-30T00:00:00,"Constriction, Pathologic",C23.300.287
19407228,2009-04-30T00:00:00,Double-Blind Method,E05.318.780.300
19407228,2009-04-30T00:00:00,Double-Blind Method,E05.581.500.300
19407228,2009-04-30T00:00:00,Double-Blind Method,N05.715.360.780.320
19407228,2009-04-30T00:00:00,Double-Blind Method,N06.850.520.445.300
19407228,2009-04-30T00:00:00,Embolism,C14.907.355.350
19407228,2009-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19407228,2009-04-30T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19407228,2009-04-30T00:00:00,Stents,E07.695.750
19407228,2009-04-30T00:00:00,Stroke,C10.228.140.300.775
19407228,2009-04-30T00:00:00,Stroke,C14.907.253.855
19407228,2009-04-30T00:00:00,Warfarin,D03.438.150.446.520.914
19407228,2009-04-30T00:00:00,Warfarin,D03.830.219.446.520.914
19407238,2009-04-30T00:00:00,Angioplasty,E02.148.050
19407238,2009-04-30T00:00:00,Angioplasty,E04.100.814.050
19407238,2009-04-30T00:00:00,Cerebral Arterial Diseases,C10.228.140.300.510.200
19407238,2009-04-30T00:00:00,Cerebral Arterial Diseases,C14.907.253.560.200
19407238,2009-04-30T00:00:00,"Constriction, Pathologic",C23.300.287
19407238,2009-04-30T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19407238,2009-04-30T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19407238,2009-04-30T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19407238,2009-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19407238,2009-04-30T00:00:00,Risk Factors,E05.318.740.600.800.725
19407238,2009-04-30T00:00:00,Risk Factors,N05.715.350.200.700
19407238,2009-04-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19407238,2009-04-30T00:00:00,Risk Factors,N06.850.490.625.750
19407238,2009-04-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19407238,2009-04-30T00:00:00,Stents,E07.695.750
19407238,2009-04-30T00:00:00,Stroke,C10.228.140.300.775
19407238,2009-04-30T00:00:00,Stroke,C14.907.253.855
19407238,2009-04-30T00:00:00,Thrombolytic Therapy,E02.319.913
19438630,2009-04-30T00:00:00,Animals,B01.050
19438630,2009-04-30T00:00:00,Dog Diseases,C22.268
19438630,2009-04-30T00:00:00,Dogs,B01.050.150.900.649.147.153.200
19438630,2009-04-30T00:00:00,Ehrlichia canis,B03.440.040.287.090
19438630,2009-04-30T00:00:00,Ehrlichia canis,B03.660.050.020.287.090
19438630,2009-04-30T00:00:00,Ehrlichiosis,C01.252.400.054.160
19438630,2009-04-30T00:00:00,Ehrlichiosis,C01.252.400.825.200
19438630,2009-04-30T00:00:00,Mass Screening,E01.370.500
19438630,2009-04-30T00:00:00,Mass Screening,E05.318.308.250.580
19438630,2009-04-30T00:00:00,Mass Screening,N02.421.143.827.233.443
19438630,2009-04-30T00:00:00,Mass Screening,N02.421.726.233.443
19438630,2009-04-30T00:00:00,Mass Screening,N05.715.360.300.375.500
19438630,2009-04-30T00:00:00,Mass Screening,N06.850.520.308.250.580
19438630,2009-04-30T00:00:00,Mass Screening,N06.850.780.500
19438630,2009-04-30T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19045935,2009-05-01T00:00:00,Animals,B01.050
19045935,2009-05-01T00:00:00,Corticosterone,D04.808.745.745.654.237
19045935,2009-05-01T00:00:00,Corticosterone,D06.472.040.585.353.237
19045935,2009-05-01T00:00:00,Environmental Pollutants,D27.888.284
19045935,2009-05-01T00:00:00,Estradiol,D04.808.365.415.248
19045935,2009-05-01T00:00:00,Estradiol,D06.472.334.851.437.500
19045935,2009-05-01T00:00:00,Methylmercury Compounds,D01.632.750.100.738
19045935,2009-05-01T00:00:00,Methylmercury Compounds,D02.691.750.100.738
19045935,2009-05-01T00:00:00,Testosterone,D04.808.054.079.429.824
19045935,2009-05-01T00:00:00,Testosterone,D06.472.334.851.968.984
19140803,2009-05-01T00:00:00,Animals,B01.050
19140803,2009-05-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
19140803,2009-05-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
19140803,2009-05-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
19140803,2009-05-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
19140803,2009-05-01T00:00:00,Endocytosis,G04.299.482
19140803,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19140803,2009-05-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
19140803,2009-05-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
19140803,2009-05-01T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
19140803,2009-05-01T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
19140803,2009-05-01T00:00:00,Mutation,G05.365.590
19140803,2009-05-01T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.300.500
19140803,2009-05-01T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.625.624
19140803,2009-05-01T00:00:00,Peroxiredoxin VI,D08.811.682.732.850.500
19140803,2009-05-01T00:00:00,Phosphorylation,G02.111.087.677
19140803,2009-05-01T00:00:00,Phosphorylation,G02.149.115.677
19140803,2009-05-01T00:00:00,Phosphorylation,G02.149.465.700
19140803,2009-05-01T00:00:00,Phosphorylation,G02.607.750.700
19140803,2009-05-01T00:00:00,Phosphorylation,G03.495.790
19140803,2009-05-01T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
19140803,2009-05-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19140803,2009-05-01T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
19140803,2009-05-01T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
19140803,2009-05-01T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
19140803,2009-05-01T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
19140803,2009-05-01T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
19140803,2009-05-01T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
19140803,2009-05-01T00:00:00,Pulmonary Alveoli,A04.411.715
19140803,2009-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19140803,2009-05-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19140803,2009-05-01T00:00:00,Threonine,D12.125.142.815
19140803,2009-05-01T00:00:00,Threonine,D12.125.154.900
19140803,2009-05-01T00:00:00,Threonine,D12.125.901
19197196,2009-05-01T00:00:00,Adult,M01.060.116
19197196,2009-05-01T00:00:00,Aged,M01.060.116.100
19197196,2009-05-01T00:00:00,Asthma,C08.127.108
19197196,2009-05-01T00:00:00,Asthma,C08.381.495.108
19197196,2009-05-01T00:00:00,Asthma,C08.674.095
19197196,2009-05-01T00:00:00,Asthma,C20.543.480.680.095
19197196,2009-05-01T00:00:00,Chronic Disease,C23.550.291.500
19197196,2009-05-01T00:00:00,Cough,C08.618.248
19197196,2009-05-01T00:00:00,Cough,C23.888.852.293
19197196,2009-05-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
19197196,2009-05-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
19197196,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19197196,2009-05-01T00:00:00,Manometry,E05.559
19197196,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19197196,2009-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19197196,2009-05-01T00:00:00,Risk Factors,N05.715.350.200.700
19197196,2009-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19197196,2009-05-01T00:00:00,Risk Factors,N06.850.490.625.750
19197196,2009-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19210291,2009-05-01T00:00:00,Adult,M01.060.116
19210291,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19210291,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19210291,2009-05-01T00:00:00,Young Adult,M01.060.116.815
19235197,2009-05-01T00:00:00,Biological Transport,G03.495.166
19235197,2009-05-01T00:00:00,Carbon,D01.268.150
19235197,2009-05-01T00:00:00,Nanostructures,J01.637.512
19235197,2009-05-01T00:00:00,Plant Leaves,A18.024.812
19259951,2009-05-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
19259951,2009-05-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
19259951,2009-05-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
19259951,2009-05-01T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
19259951,2009-05-01T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
19259951,2009-05-01T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
19259951,2009-05-01T00:00:00,Gene Expression,G05.355.310
19259951,2009-05-01T00:00:00,Gene Expression Regulation,G05.355.315
19259951,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19259951,2009-05-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19259951,2009-05-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19259951,2009-05-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19259951,2009-05-01T00:00:00,Interferon-gamma,D12.644.276.718.550
19259951,2009-05-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19259951,2009-05-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19259951,2009-05-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19259951,2009-05-01T00:00:00,Interferon-gamma,D12.776.467.718.550
19259951,2009-05-01T00:00:00,Interferon-gamma,D23.529.374.440.893
19259951,2009-05-01T00:00:00,Interferon-gamma,D23.529.374.480.350
19259951,2009-05-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19259951,2009-05-01T00:00:00,Interferon-gamma,D23.529.718.550
19259951,2009-05-01T00:00:00,Interleukin-12,D12.644.276.374.465.512
19259951,2009-05-01T00:00:00,Interleukin-12,D12.776.467.374.465.512
19259951,2009-05-01T00:00:00,Interleukin-12,D23.529.374.465.512
19259951,2009-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19259951,2009-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19259951,2009-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19259951,2009-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19259951,2009-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19259951,2009-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19259951,2009-05-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19259951,2009-05-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19259951,2009-05-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19259951,2009-05-01T00:00:00,"RNA, Messenger",D13.444.735.544
19259951,2009-05-01T00:00:00,Transcription Factors,D12.776.930
19320573,2009-05-01T00:00:00,Adult,M01.060.116
19320573,2009-05-01T00:00:00,Aged,M01.060.116.100
19320573,2009-05-01T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
19320573,2009-05-01T00:00:00,Cross Infection,C01.539.248
19320573,2009-05-01T00:00:00,Disease Outbreaks,N06.850.290
19320573,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19320573,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19320626,2009-05-01T00:00:00,Adult,M01.060.116
19320626,2009-05-01T00:00:00,Alcoholism,C21.739.100.250
19320626,2009-05-01T00:00:00,Alcoholism,F03.900.100.350
19320626,2009-05-01T00:00:00,Genetic Variation,G05.365
19320626,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19320626,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19320626,2009-05-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19320626,2009-05-01T00:00:00,Young Adult,M01.060.116.815
19334280,2009-05-01T00:00:00,Animals,B01.050
19334280,2009-05-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
19334280,2009-05-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
19334280,2009-05-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
19334280,2009-05-01T00:00:00,Cell Lineage,G04.172
19334280,2009-05-01T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
19334280,2009-05-01T00:00:00,Cell Lineage,G08.686.155
19334280,2009-05-01T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
19334280,2009-05-01T00:00:00,Chick Embryo,A13.350.150
19334280,2009-05-01T00:00:00,Chick Embryo,A16.331.200
19334280,2009-05-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
19334280,2009-05-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
19334280,2009-05-01T00:00:00,Fibroblasts,A11.329.228
19334280,2009-05-01T00:00:00,Fibroblasts,A11.872.228
19334280,2009-05-01T00:00:00,Heart Atria,A07.541.358
19334280,2009-05-01T00:00:00,Heart Valves,A07.541.510
19334280,2009-05-01T00:00:00,Heart Ventricles,A07.541.560
19334280,2009-05-01T00:00:00,Mesoderm,A16.504.660
19334280,2009-05-01T00:00:00,Stem Cells,A11.872
19346976,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19346976,2009-05-01T00:00:00,Vitamin D,D04.808.812.768
19359676,2009-05-01T00:00:00,Animals,B01.050
19359676,2009-05-01T00:00:00,Chickens,B01.050.150.900.248.350.150
19359676,2009-05-01T00:00:00,Chickens,B01.050.150.900.248.617.192
19359676,2009-05-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
19359676,2009-05-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
19359676,2009-05-01T00:00:00,Poultry Diseases,C22.131.728
19359686,2009-05-01T00:00:00,Animals,B01.050
19359686,2009-05-01T00:00:00,Chickens,B01.050.150.900.248.350.150
19359686,2009-05-01T00:00:00,Chickens,B01.050.150.900.248.617.192
19359686,2009-05-01T00:00:00,Gastrointestinal Tract,A03.556
19359686,2009-05-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
19359686,2009-05-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
19363398,2009-05-01T00:00:00,Adolescent,M01.060.057
19363398,2009-05-01T00:00:00,Child,M01.060.406
19363398,2009-05-01T00:00:00,Child Welfare,I01.880.787.293
19363398,2009-05-01T00:00:00,"Child, Preschool",M01.060.406.448
19363398,2009-05-01T00:00:00,Dental Care,E06.170
19363398,2009-05-01T00:00:00,Dental Care,N02.421.240.190
19363398,2009-05-01T00:00:00,Health Personnel,M01.526.485
19363398,2009-05-01T00:00:00,Health Personnel,N02.360
19363398,2009-05-01T00:00:00,Health Services Accessibility,N04.590.374.350
19363398,2009-05-01T00:00:00,Health Services Accessibility,N05.300.430
19363398,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19363398,2009-05-01T00:00:00,Infant,M01.060.703
19363398,2009-05-01T00:00:00,Rural Population,N01.600.725
19363398,2009-05-01T00:00:00,United States,Z01.107.567.875
19376318,2009-05-01T00:00:00,Aged,M01.060.116.100
19376318,2009-05-01T00:00:00,Biological Markers,D23.101
19376318,2009-05-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19376318,2009-05-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19376318,2009-05-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19376318,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19376318,2009-05-01T00:00:00,Myocardial Infarction,C14.280.647.500
19376318,2009-05-01T00:00:00,Myocardial Infarction,C14.907.585.500
19376318,2009-05-01T00:00:00,Preoperative Care,E02.760.795
19376318,2009-05-01T00:00:00,Preoperative Care,E04.641
19376318,2009-05-01T00:00:00,Preoperative Care,N02.421.585.795
19379857,2009-05-01T00:00:00,Adult,M01.060.116
19379857,2009-05-01T00:00:00,Anticoagulants,D27.505.954.502.119
19379857,2009-05-01T00:00:00,Heart Valve Diseases,C14.280.484
19379857,2009-05-01T00:00:00,Heart Valve Prosthesis,E07.695.310
19379857,2009-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
19379857,2009-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
19379857,2009-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
19379857,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19379857,2009-05-01T00:00:00,Thrombolytic Therapy,E02.319.913
19379857,2009-05-01T00:00:00,Thrombosis,C14.907.355.830
19379857,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19379857,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19379857,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19379857,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19379857,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19379857,2009-05-01T00:00:00,Treatment Outcome,E01.789.800
19379857,2009-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19379857,2009-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19379857,2009-05-01T00:00:00,Warfarin,D03.438.150.446.520.914
19379857,2009-05-01T00:00:00,Warfarin,D03.830.219.446.520.914
19379860,2009-05-01T00:00:00,Conflict of Interest,K01.316.130
19379860,2009-05-01T00:00:00,Conflict of Interest,N05.350.225
19379860,2009-05-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
19379860,2009-05-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
19379860,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19379860,2009-05-01T00:00:00,Interprofessional Relations,F01.829.401.205
19379860,2009-05-01T00:00:00,Physicians,M01.526.485.810
19379860,2009-05-01T00:00:00,Physicians,N02.360.810
19379860,2009-05-01T00:00:00,Thoracic Surgery,H02.403.810.803
19379860,2009-05-01T00:00:00,United States,Z01.107.567.875
19379964,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19379964,2009-05-01T00:00:00,Interprofessional Relations,F01.829.401.205
19379964,2009-05-01T00:00:00,Physician's Practice Patterns,N04.590.748
19379964,2009-05-01T00:00:00,Physician's Practice Patterns,N05.300.625
19379964,2009-05-01T00:00:00,Thoracic Surgery,H02.403.810.803
19379964,2009-05-01T00:00:00,Total Quality Management,N04.452.955
19379964,2009-05-01T00:00:00,Total Quality Management,N04.761.700.675
19379964,2009-05-01T00:00:00,Total Quality Management,N05.700.792
19389336,2009-05-01T00:00:00,Adolescent,M01.060.057
19389336,2009-05-01T00:00:00,Child,M01.060.406
19389336,2009-05-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19389336,2009-05-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19389336,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19389336,2009-05-01T00:00:00,Questionnaires,E05.318.308.750
19389336,2009-05-01T00:00:00,Questionnaires,L01.280.800
19389336,2009-05-01T00:00:00,Questionnaires,N05.715.360.300.695
19389336,2009-05-01T00:00:00,Questionnaires,N06.850.520.308.750
19389336,2009-05-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19389336,2009-05-01T00:00:00,United States,Z01.107.567.875
19393106,2009-05-01T00:00:00,Cystic Fibrosis,C06.689.202
19393106,2009-05-01T00:00:00,Cystic Fibrosis,C08.381.187
19393106,2009-05-01T00:00:00,Cystic Fibrosis,C16.320.190
19393106,2009-05-01T00:00:00,Cystic Fibrosis,C16.614.213
19393106,2009-05-01T00:00:00,Disease Progression,C23.550.291.656
19393106,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19393106,2009-05-01T00:00:00,Incidence,E05.318.308.985.525.375
19393106,2009-05-01T00:00:00,Incidence,L01.280.975.525.375
19393106,2009-05-01T00:00:00,Incidence,N01.224.935.597.500
19393106,2009-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19393106,2009-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19393106,2009-05-01T00:00:00,Respiratory Tract Diseases,C08
19393106,2009-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19393106,2009-05-01T00:00:00,Risk Factors,N05.715.350.200.700
19393106,2009-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19393106,2009-05-01T00:00:00,Risk Factors,N06.850.490.625.750
19393106,2009-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19404953,2009-05-01T00:00:00,Adolescent,M01.060.057
19404953,2009-05-01T00:00:00,Azathioprine,D02.886.759.111
19404953,2009-05-01T00:00:00,Azathioprine,D03.438.759.534.090
19404953,2009-05-01T00:00:00,Azathioprine,D13.570.900.111
19404953,2009-05-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19404953,2009-05-01T00:00:00,Body Mass Index,E05.041.124.125
19404953,2009-05-01T00:00:00,Body Mass Index,G07.100.100.125
19404953,2009-05-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19404953,2009-05-01T00:00:00,Child,M01.060.406
19404953,2009-05-01T00:00:00,Creatinine,D03.383.129.308.207
19404953,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19404953,2009-05-01T00:00:00,Lipoproteins,D10.532
19404953,2009-05-01T00:00:00,Lipoproteins,D12.776.521
19404953,2009-05-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19404953,2009-05-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19404953,2009-05-01T00:00:00,Prednisone,D04.808.745.432.719.702
19404953,2009-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19404953,2009-05-01T00:00:00,Risk Factors,N05.715.350.200.700
19404953,2009-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19404953,2009-05-01T00:00:00,Risk Factors,N06.850.490.625.750
19404953,2009-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19404953,2009-05-01T00:00:00,Sex Factors,N05.715.350.675
19404953,2009-05-01T00:00:00,Sex Factors,N06.850.490.875
19404953,2009-05-01T00:00:00,Young Adult,M01.060.116.815
19407614,2009-05-01T00:00:00,Animals,B01.050
19407614,2009-05-01T00:00:00,Biocompatible Materials,D25.130
19407614,2009-05-01T00:00:00,Biocompatible Materials,D27.720.102.130
19407614,2009-05-01T00:00:00,Biocompatible Materials,J01.637.051.130
19407614,2009-05-01T00:00:00,Breast Implants,E07.695.140
19407614,2009-05-01T00:00:00,Connexin 43,D12.776.543.585.250.200
19407614,2009-05-01T00:00:00,"Disease Models, Animal",C22.232
19407614,2009-05-01T00:00:00,"Disease Models, Animal",E05.598.500
19407614,2009-05-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19407614,2009-05-01T00:00:00,Immunologic Factors,D27.505.696.477
19407614,2009-05-01T00:00:00,Peptide Fragments,D12.644.541
19407614,2009-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19407614,2009-05-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19407614,2009-05-01T00:00:00,Wound Healing,G16.100.856.891
19411720,2009-05-01T00:00:00,Aged,M01.060.116.100
19411720,2009-05-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
19411720,2009-05-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
19411720,2009-05-01T00:00:00,Drug-Eluting Stents,E07.695.750.500
19411720,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19411720,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19411720,2009-05-01T00:00:00,Myocardial Infarction,C14.280.647.500
19411720,2009-05-01T00:00:00,Myocardial Infarction,C14.907.585.500
19411720,2009-05-01T00:00:00,Suction,E04.237.890
19411720,2009-05-01T00:00:00,Thrombectomy,E04.100.814.842
19413414,2009-05-01T00:00:00,Adolescent,M01.060.057
19413414,2009-05-01T00:00:00,Adult,M01.060.116
19413414,2009-05-01T00:00:00,Crime Victims,M01.135
19413414,2009-05-01T00:00:00,Depression,F01.145.126.350
19413414,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19413414,2009-05-01T00:00:00,Interpersonal Relations,F01.829.401
19413414,2009-05-01T00:00:00,Life Change Events,F01.829.458.410
19413414,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19413414,2009-05-01T00:00:00,Questionnaires,E05.318.308.750
19413414,2009-05-01T00:00:00,Questionnaires,L01.280.800
19413414,2009-05-01T00:00:00,Questionnaires,N05.715.360.300.695
19413414,2009-05-01T00:00:00,Questionnaires,N06.850.520.308.750
19413414,2009-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19413414,2009-05-01T00:00:00,Risk Assessment,N04.452.871.715
19413414,2009-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19413414,2009-05-01T00:00:00,Risk Assessment,N06.850.505.715
19413414,2009-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19413414,2009-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19413414,2009-05-01T00:00:00,Risk Factors,N05.715.350.200.700
19413414,2009-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19413414,2009-05-01T00:00:00,Risk Factors,N06.850.490.625.750
19413414,2009-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19413414,2009-05-01T00:00:00,Sex Factors,N05.715.350.675
19413414,2009-05-01T00:00:00,Sex Factors,N06.850.490.875
19413414,2009-05-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19413414,2009-05-01T00:00:00,"Stress, Psychological",F01.145.126.990
19413414,2009-05-01T00:00:00,"Stress, Psychological",F02.830.900
19413414,2009-05-01T00:00:00,Substance-Related Disorders,C21.739
19413414,2009-05-01T00:00:00,Substance-Related Disorders,F03.900
19413414,2009-05-01T00:00:00,Violence,I01.198.240.856
19413414,2009-05-01T00:00:00,Violence,I01.880.735.900
19413414,2009-05-01T00:00:00,Young Adult,M01.060.116.815
19418287,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19418287,2009-05-01T00:00:00,"Physicians, Family",M01.526.485.810.770
19418287,2009-05-01T00:00:00,"Physicians, Family",N02.360.810.770
19418287,2009-05-01T00:00:00,Voluntary Health Agencies,N03.540.630.780
19419456,2009-05-01T00:00:00,Adolescent,M01.060.057
19419456,2009-05-01T00:00:00,Adult,M01.060.116
19419456,2009-05-01T00:00:00,Alleles,G05.360.340.024.340.030
19419456,2009-05-01T00:00:00,Child,M01.060.406
19419456,2009-05-01T00:00:00,Gingival Crevicular Fluid,A12.383.500
19419456,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19419456,2009-05-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19419456,2009-05-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
19419456,2009-05-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
19419456,2009-05-01T00:00:00,Interleukin-1,D12.644.276.374.465.501
19419456,2009-05-01T00:00:00,Interleukin-1,D12.644.276.374.500.400
19419456,2009-05-01T00:00:00,Interleukin-1,D12.776.467.374.465.501
19419456,2009-05-01T00:00:00,Interleukin-1,D12.776.467.374.500.400
19419456,2009-05-01T00:00:00,Interleukin-1,D23.529.374.465.501
19419456,2009-05-01T00:00:00,Interleukin-1,D23.529.374.500.400
19419456,2009-05-01T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
19419456,2009-05-01T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
19419456,2009-05-01T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
19419456,2009-05-01T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
19419456,2009-05-01T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
19419456,2009-05-01T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
19419456,2009-05-01T00:00:00,"Polymorphism, Genetic",G05.365.795
19419456,2009-05-01T00:00:00,Proteins,D12.776
19419456,2009-05-01T00:00:00,"Stress, Mechanical",G01.374.676.830
19419456,2009-05-01T00:00:00,"Stress, Mechanical",G01.595.540.830
19419456,2009-05-01T00:00:00,Time Factors,G01.910.857
19419456,2009-05-01T00:00:00,Young Adult,M01.060.116.815
19420209,2009-05-01T00:00:00,Aged,M01.060.116.100
19420209,2009-05-01T00:00:00,Bronchoscopy,E01.370.386.105
19420209,2009-05-01T00:00:00,Bronchoscopy,E01.370.388.250.100
19420209,2009-05-01T00:00:00,Bronchoscopy,E04.800.250.100
19420209,2009-05-01T00:00:00,Bronchoscopy,E04.928.600.080
19420209,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19420209,2009-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
19420209,2009-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
19420209,2009-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
19420209,2009-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
19420209,2009-05-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
19420209,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19420209,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19420209,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19420209,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19420209,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19422575,2009-05-01T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
19422575,2009-05-01T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
19422575,2009-05-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
19422575,2009-05-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
19422575,2009-05-01T00:00:00,"Defibrillators, Implantable",E07.695.175
19422575,2009-05-01T00:00:00,Equipment Failure Analysis,E05.325.192
19422575,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19422575,2009-05-01T00:00:00,Prosthesis Implantation,E04.650
19430253,2009-05-01T00:00:00,Adolescent,M01.060.057
19430253,2009-05-01T00:00:00,Adult,M01.060.116
19430253,2009-05-01T00:00:00,Delivery of Health Care,N04.590.374
19430253,2009-05-01T00:00:00,Delivery of Health Care,N05.300
19430253,2009-05-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19430253,2009-05-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19430253,2009-05-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19430253,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19430253,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19430253,2009-05-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19430253,2009-05-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19430253,2009-05-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19430253,2009-05-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19430253,2009-05-01T00:00:00,Probability,E05.318.740.600
19430253,2009-05-01T00:00:00,Probability,G17.680
19430253,2009-05-01T00:00:00,Probability,N05.715.360.750.625
19430253,2009-05-01T00:00:00,Probability,N06.850.520.830.600
19430253,2009-05-01T00:00:00,Questionnaires,E05.318.308.750
19430253,2009-05-01T00:00:00,Questionnaires,L01.280.800
19430253,2009-05-01T00:00:00,Questionnaires,N05.715.360.300.695
19430253,2009-05-01T00:00:00,Questionnaires,N06.850.520.308.750
19430253,2009-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19430253,2009-05-01T00:00:00,Risk Assessment,N04.452.871.715
19430253,2009-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19430253,2009-05-01T00:00:00,Risk Assessment,N06.850.505.715
19430253,2009-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19430253,2009-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19430253,2009-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19430253,2009-05-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19430253,2009-05-01T00:00:00,Spinal Cord Injuries,C10.900.850
19430253,2009-05-01T00:00:00,Spinal Cord Injuries,C21.866.819
19430253,2009-05-01T00:00:00,Treatment Outcome,E01.789.800
19430253,2009-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19430253,2009-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19430253,2009-05-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
19430253,2009-05-01T00:00:00,"Wounds, Penetrating",C21.866.986
19430253,2009-05-01T00:00:00,Young Adult,M01.060.116.815
19449205,2009-05-01T00:00:00,Antineoplastic Agents,D27.505.954.248
19449205,2009-05-01T00:00:00,Breast Neoplasms,C04.588.180
19449205,2009-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
19449205,2009-05-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19449205,2009-05-01T00:00:00,Clinical Trials as Topic,E05.337.250
19449205,2009-05-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19449205,2009-05-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19449205,2009-05-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19451463,2009-05-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19451463,2009-05-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19451463,2009-05-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19451463,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19451463,2009-05-01T00:00:00,Infant,M01.060.703
19451463,2009-05-01T00:00:00,"Infant, Newborn",M01.060.703.520
19451463,2009-05-01T00:00:00,"Intubation, Intratracheal",E05.497.578
19451463,2009-05-01T00:00:00,Laryngostenosis,C08.360.591
19451463,2009-05-01T00:00:00,Laryngostenosis,C09.400.591
19451463,2009-05-01T00:00:00,Laryngostenosis,C16.131.740.658
19451463,2009-05-01T00:00:00,Larynx,A04.329
19451463,2009-05-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
19451463,2009-05-01T00:00:00,"Respiration, Artificial",E02.365.647.729
19451463,2009-05-01T00:00:00,"Respiration, Artificial",E02.880.820
19451463,2009-05-01T00:00:00,Trachea,A04.889
19451463,2009-05-01T00:00:00,Tracheotomy,E04.580.907
19451463,2009-05-01T00:00:00,Tracheotomy,E04.928.790
19451482,2009-05-01T00:00:00,Adolescent,M01.060.057
19451482,2009-05-01T00:00:00,Adult,M01.060.116
19451482,2009-05-01T00:00:00,Aged,M01.060.116.100
19451482,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19451482,2009-05-01T00:00:00,Length of Stay,E02.760.400.480
19451482,2009-05-01T00:00:00,Length of Stay,N02.421.585.400.480
19451482,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19451482,2009-05-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19451482,2009-05-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19451482,2009-05-01T00:00:00,Postoperative Complications,C23.550.767
19451482,2009-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19451482,2009-05-01T00:00:00,Risk Factors,N05.715.350.200.700
19451482,2009-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19451482,2009-05-01T00:00:00,Risk Factors,N06.850.490.625.750
19451482,2009-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19451482,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19451482,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19451482,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19451482,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19451482,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19451482,2009-05-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
19451482,2009-05-01T00:00:00,Trauma Centers,N02.421.297.195.480
19451482,2009-05-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
19451482,2009-05-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
19451489,2009-05-01T00:00:00,Adolescent,M01.060.057
19451489,2009-05-01T00:00:00,Aged,M01.060.116.100
19451489,2009-05-01T00:00:00,Breast Neoplasms,C04.588.180
19451489,2009-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
19451489,2009-05-01T00:00:00,"Carcinoma, Ductal",C04.557.470.200.025.232
19451489,2009-05-01T00:00:00,"Carcinoma, Ductal",C04.557.470.615.132
19451489,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19451489,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19451489,2009-05-01T00:00:00,Neoplasm Invasiveness,C04.697.645
19451489,2009-05-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
19451489,2009-05-01T00:00:00,Physician's Practice Patterns,N04.590.748
19451489,2009-05-01T00:00:00,Physician's Practice Patterns,N05.300.625
19451489,2009-05-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
19451489,2009-05-01T00:00:00,"Quality Assurance, Health Care",N05.700
19451489,2009-05-01T00:00:00,Treatment Outcome,E01.789.800
19451489,2009-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19451489,2009-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19454948,2009-05-01T00:00:00,Adult,M01.060.116
19454948,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19454948,2009-05-01T00:00:00,Orbit,A02.835.232.781.324.690
19454948,2009-05-01T00:00:00,Postpartum Period,G08.686.702
19454948,2009-05-01T00:00:00,Pregnancy,G08.686.785.760.769
19454948,2009-05-01T00:00:00,"Remission, Spontaneous",C23.550.291.656.700
19454948,2009-05-01T00:00:00,"Remission, Spontaneous",G16.100.870
19454948,2009-05-01T00:00:00,Vision Disorders,C10.597.751.941
19454948,2009-05-01T00:00:00,Vision Disorders,C11.966
19454948,2009-05-01T00:00:00,Vision Disorders,C23.888.592.763.941
19465831,2009-05-01T00:00:00,Adult,M01.060.116
19465831,2009-05-01T00:00:00,Aged,M01.060.116.100
19465831,2009-05-01T00:00:00,Contrast Media,D27.720.259
19465831,2009-05-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19465831,2009-05-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19465831,2009-05-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19465831,2009-05-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19465831,2009-05-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19465831,2009-05-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19465831,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19465831,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19465831,2009-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19465831,2009-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19465831,2009-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19465831,2009-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19465831,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19465831,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19465831,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19465831,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19465831,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19465832,2009-05-01T00:00:00,Adult,M01.060.116
19465832,2009-05-01T00:00:00,Aged,M01.060.116.100
19465832,2009-05-01T00:00:00,Contrast Media,D27.720.259
19465832,2009-05-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19465832,2009-05-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19465832,2009-05-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19465832,2009-05-01T00:00:00,Heart Transplantation,E04.100.376.475
19465832,2009-05-01T00:00:00,Heart Transplantation,E04.928.220.390
19465832,2009-05-01T00:00:00,Heart Transplantation,E04.936.450.475
19465832,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19465832,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19465832,2009-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19465832,2009-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19465832,2009-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19465832,2009-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19465832,2009-05-01T00:00:00,Software,L01.224.900
19465832,2009-05-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
19465832,2009-05-01T00:00:00,Stroke Volume,G09.330.380.124.882
19465832,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19465832,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19465832,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19465832,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19465832,2009-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19465832,2009-05-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
19471134,2009-05-01T00:00:00,Adult,M01.060.116
19471134,2009-05-01T00:00:00,Aged,M01.060.116.100
19471134,2009-05-01T00:00:00,Coronary Disease,C14.280.647.250
19471134,2009-05-01T00:00:00,Coronary Disease,C14.907.585.250
19471134,2009-05-01T00:00:00,Exercise Therapy,E02.779.483
19471134,2009-05-01T00:00:00,Exercise Therapy,E02.831.387
19471134,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19471134,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19471134,2009-05-01T00:00:00,Psychotic Disorders,F03.700.675
19471134,2009-05-01T00:00:00,Quality of Life,I01.800
19471134,2009-05-01T00:00:00,Quality of Life,K01.752.400.750
19471134,2009-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19471134,2009-05-01T00:00:00,Risk Factors,N05.715.350.200.700
19471134,2009-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19471134,2009-05-01T00:00:00,Risk Factors,N06.850.490.625.750
19471134,2009-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19471134,2009-05-01T00:00:00,United States,Z01.107.567.875
19476198,2009-05-01T00:00:00,Adolescent,M01.060.057
19476198,2009-05-01T00:00:00,Adult,M01.060.116
19476198,2009-05-01T00:00:00,African Americans,M01.686.508.100.100
19476198,2009-05-01T00:00:00,African Americans,M01.686.754.100
19476198,2009-05-01T00:00:00,Aged,M01.060.116.100
19476198,2009-05-01T00:00:00,Behavior Therapy,F04.754.137
19476198,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19476198,2009-05-01T00:00:00,Mass Screening,E01.370.500
19476198,2009-05-01T00:00:00,Mass Screening,E05.318.308.250.580
19476198,2009-05-01T00:00:00,Mass Screening,N02.421.143.827.233.443
19476198,2009-05-01T00:00:00,Mass Screening,N02.421.726.233.443
19476198,2009-05-01T00:00:00,Mass Screening,N05.715.360.300.375.500
19476198,2009-05-01T00:00:00,Mass Screening,N06.850.520.308.250.580
19476198,2009-05-01T00:00:00,Mass Screening,N06.850.780.500
19476198,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19476198,2009-05-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
19476198,2009-05-01T00:00:00,Questionnaires,E05.318.308.750
19476198,2009-05-01T00:00:00,Questionnaires,L01.280.800
19476198,2009-05-01T00:00:00,Questionnaires,N05.715.360.300.695
19476198,2009-05-01T00:00:00,Questionnaires,N06.850.520.308.750
19476198,2009-05-01T00:00:00,Smoking,F01.145.466.753
19476198,2009-05-01T00:00:00,Smoking Cessation,F01.145.940.700
19476198,2009-05-01T00:00:00,Young Adult,M01.060.116.815
19506439,2009-05-01T00:00:00,Delivery of Health Care,N04.590.374
19506439,2009-05-01T00:00:00,Delivery of Health Care,N05.300
19506439,2009-05-01T00:00:00,Health Care Costs,N03.219.151.400
19506439,2009-05-01T00:00:00,Health Care Costs,N05.300.375
19506439,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19506439,2009-05-01T00:00:00,Interprofessional Relations,F01.829.401.205
19506439,2009-05-01T00:00:00,United States,Z01.107.567.875
19517701,2009-05-01T00:00:00,Abdominal Pain,C23.888.646.100
19517701,2009-05-01T00:00:00,Abdominal Pain,C23.888.821.030
19517701,2009-05-01T00:00:00,Adult,M01.060.116
19517701,2009-05-01T00:00:00,Appendicitis,C06.405.205.099
19517701,2009-05-01T00:00:00,Appendicitis,C06.405.469.110.207
19517701,2009-05-01T00:00:00,Appendix,A03.556.124.526.209.290
19517701,2009-05-01T00:00:00,Appendix,A03.556.249.249.209.290
19517701,2009-05-01T00:00:00,"Diagnosis, Differential",E01.171
19517701,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19517701,2009-05-01T00:00:00,"Infant, Newborn",M01.060.703.520
19517701,2009-05-01T00:00:00,"Labor, Induced",E04.520.252.968
19517701,2009-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19517701,2009-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19517701,2009-05-01T00:00:00,Pre-Eclampsia,C13.703.395.249
19517701,2009-05-01T00:00:00,Pregnancy,G08.686.785.760.769
19517701,2009-05-01T00:00:00,Pregnancy Complications,C13.703
19517701,2009-05-01T00:00:00,Pregnancy Outcome,E01.789.700
19517701,2009-05-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
19517702,2009-05-01T00:00:00,Adult,M01.060.116
19517702,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19517702,2009-05-01T00:00:00,Peritoneal Diseases,C06.844
19517702,2009-05-01T00:00:00,Postoperative Complications,C23.550.767
19517702,2009-05-01T00:00:00,Pregnancy,G08.686.785.760.769
19630748,2009-05-01T00:00:00,Animals,B01.050
19630748,2009-05-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19630748,2009-05-01T00:00:00,"Behavior, Animal",F01.145.113
19630748,2009-05-01T00:00:00,"Disease Models, Animal",C22.232
19630748,2009-05-01T00:00:00,"Disease Models, Animal",E05.598.500
19630748,2009-05-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19630748,2009-05-01T00:00:00,Self Administration,E02.319.890
19630748,2009-05-01T00:00:00,Self Administration,E02.900.890
19630748,2009-05-01T00:00:00,Substance-Related Disorders,C21.739
19630748,2009-05-01T00:00:00,Substance-Related Disorders,F03.900
19651063,2009-05-01T00:00:00,Adult,M01.060.116
19651063,2009-05-01T00:00:00,Aged,M01.060.116.100
19651063,2009-05-01T00:00:00,Cardiac Volume,G09.330.380.249
19651063,2009-05-01T00:00:00,Echocardiography,E01.370.350.850.220
19651063,2009-05-01T00:00:00,Echocardiography,E01.370.370.380.220
19651063,2009-05-01T00:00:00,Hemodynamics,G09.330.190.400
19651063,2009-05-01T00:00:00,Hemodynamics,G09.330.380
19651063,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19651063,2009-05-01T00:00:00,Intensive Care Units,N02.278.388.493
19651063,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19651063,2009-05-01T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
19662971,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19662971,2009-05-01T00:00:00,Lung Transplantation,E04.928.600.495
19662971,2009-05-01T00:00:00,Lung Transplantation,E04.936.450.495
19662971,2009-05-01T00:00:00,Patient Selection,E05.581.500.653
19662971,2009-05-01T00:00:00,Patient Selection,N04.590.731
19662971,2009-05-01T00:00:00,Pulmonary Emphysema,C08.381.748
19662971,2009-05-01T00:00:00,Treatment Outcome,E01.789.800
19662971,2009-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19662971,2009-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19808348,2009-05-01T00:00:00,Animals,B01.050
19808348,2009-05-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
19808348,2009-05-01T00:00:00,"Disease Models, Animal",C22.232
19808348,2009-05-01T00:00:00,"Disease Models, Animal",E05.598.500
19808348,2009-05-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19808348,2009-05-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
19808348,2009-05-01T00:00:00,Heart Failure,C14.280.434
19808348,2009-05-01T00:00:00,Heart-Assist Devices,E04.050.430
19808348,2009-05-01T00:00:00,Heart-Assist Devices,E07.695.300.300
19808348,2009-05-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
19808348,2009-05-01T00:00:00,Hemodynamics,G09.330.190.400
19808348,2009-05-01T00:00:00,Hemodynamics,G09.330.380
19808348,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19808348,2009-05-01T00:00:00,Myocardium,A02.633.580
19808348,2009-05-01T00:00:00,Myocardium,A07.541.704
19808348,2009-05-01T00:00:00,Myocardium,A10.690.552.750
19808348,2009-05-01T00:00:00,Phenotype,G05.695
19808348,2009-05-01T00:00:00,Swine,B01.050.150.900.649.077.880
19938252,2009-05-01T00:00:00,Adult,M01.060.116
19938252,2009-05-01T00:00:00,African Americans,M01.686.508.100.100
19938252,2009-05-01T00:00:00,African Americans,M01.686.754.100
19938252,2009-05-01T00:00:00,Aged,M01.060.116.100
19938252,2009-05-01T00:00:00,Dental Care for Chronically Ill,E06.170.205
19938252,2009-05-01T00:00:00,Dental Care for Chronically Ill,N02.421.240.190.220
19938252,2009-05-01T00:00:00,Dental Plaque,C07.793.208.377
19938252,2009-05-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19938252,2009-05-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19938252,2009-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19938252,2009-05-01T00:00:00,Middle Aged,M01.060.116.630
19938252,2009-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19938252,2009-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19409383,2009-05-04T00:00:00,Animals,B01.050
19409383,2009-05-04T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
19409383,2009-05-04T00:00:00,Brain Chemistry,G02.111.100
19409383,2009-05-04T00:00:00,Brain Chemistry,G03.200
19409383,2009-05-04T00:00:00,Depressive Disorder,F03.600.300
19409383,2009-05-04T00:00:00,Diagnostic Imaging,E01.370.350
19409383,2009-05-04T00:00:00,"Disease Models, Animal",C22.232
19409383,2009-05-04T00:00:00,"Disease Models, Animal",E05.598.500
19409383,2009-05-04T00:00:00,"Disease Models, Animal",E05.599.395.080
19409383,2009-05-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19409383,2009-05-04T00:00:00,Limbic System,A08.186.211.464
19409383,2009-05-04T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19409383,2009-05-04T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19409383,2009-05-04T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19409383,2009-05-04T00:00:00,Treatment Outcome,E01.789.800
19409383,2009-05-04T00:00:00,Treatment Outcome,N04.761.559.590.800
19409383,2009-05-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19417087,2009-05-05T00:00:00,5' Untranslated Regions,D13.444.735.544.875.885
19417087,2009-05-05T00:00:00,5' Untranslated Regions,D13.444.735.790.878.885
19417087,2009-05-05T00:00:00,5' Untranslated Regions,G05.360.340.024.220.880.885
19417087,2009-05-05T00:00:00,5' Untranslated Regions,G05.360.340.024.340.137.910.885
19417087,2009-05-05T00:00:00,Adenoviridae,B04.280.030
19417087,2009-05-05T00:00:00,Adenoviridae,B04.909.204.097
19417087,2009-05-05T00:00:00,Animals,B01.050
19417087,2009-05-05T00:00:00,Cell Proliferation,G04.299.233.750
19417087,2009-05-05T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19417087,2009-05-05T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19417087,2009-05-05T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19417087,2009-05-05T00:00:00,"Myocytes, Cardiac",A11.620.500
19417087,2009-05-05T00:00:00,Protein Biosynthesis,G02.111.087.675.871
19417087,2009-05-05T00:00:00,Protein Biosynthesis,G02.149.115.675.871
19417087,2009-05-05T00:00:00,Protein Biosynthesis,G03.495.770.871
19417087,2009-05-05T00:00:00,Protein Biosynthesis,G05.355.310.670
19417087,2009-05-05T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
19417087,2009-05-05T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
19417087,2009-05-05T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
19417087,2009-05-05T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
19417087,2009-05-05T00:00:00,"RNA, Messenger",D13.444.735.544
19417087,2009-05-05T00:00:00,"Transduction, Genetic",E05.393.350.800
19417087,2009-05-05T00:00:00,"Transduction, Genetic",G05.355.760.850
19417161,2009-05-05T00:00:00,Apoptosis,G04.299.139.160
19417161,2009-05-05T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
19417161,2009-05-05T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
19417161,2009-05-05T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
19417161,2009-05-05T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
19417161,2009-05-05T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
19417161,2009-05-05T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
19417161,2009-05-05T00:00:00,Cell Survival,G04.299.316
19417161,2009-05-05T00:00:00,Ceramides,D02.065.313
19417161,2009-05-05T00:00:00,Ceramides,D09.400.410.420.525.200
19417161,2009-05-05T00:00:00,Ceramides,D10.390.470.675.200
19417161,2009-05-05T00:00:00,Ceramides,D10.570.877.360.612.200
19417161,2009-05-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19417161,2009-05-05T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19417161,2009-05-05T00:00:00,Signal Transduction,G02.111.087.800
19417161,2009-05-05T00:00:00,Signal Transduction,G02.149.115.800
19417161,2009-05-05T00:00:00,Signal Transduction,G04.299.880
19417161,2009-05-05T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
19417161,2009-05-05T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
19417161,2009-05-05T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
19417161,2009-05-05T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
19422758,2009-05-05T00:00:00,Adult,M01.060.116
19422758,2009-05-05T00:00:00,Aged,M01.060.116.100
19422758,2009-05-05T00:00:00,Anxiety Disorders,F03.080
19422758,2009-05-05T00:00:00,Cataplexy,C10.886.425.800.200.750.500
19422758,2009-05-05T00:00:00,Cataplexy,F03.870.400.800.200.750.500
19422758,2009-05-05T00:00:00,"Diagnosis, Differential",E01.171
19422758,2009-05-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19422758,2009-05-05T00:00:00,Middle Aged,M01.060.116.630
19422758,2009-05-05T00:00:00,Narcolepsy,C10.886.425.800.200.750
19422758,2009-05-05T00:00:00,Narcolepsy,F03.870.400.800.200.750
19422758,2009-05-05T00:00:00,Panic Disorder,F03.080.700
19422758,2009-05-05T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19422758,2009-05-05T00:00:00,Young Adult,M01.060.116.815
19420420,2009-05-06T00:00:00,Breast Neoplasms,C04.588.180
19420420,2009-05-06T00:00:00,Breast Neoplasms,C17.800.090.500
19420420,2009-05-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19420420,2009-05-06T00:00:00,Mammography,E01.370.350.700.500
19420420,2009-05-06T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19420420,2009-05-06T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19420420,2009-05-06T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19420420,2009-05-06T00:00:00,Refractometry,E05.196.808
19420420,2009-05-06T00:00:00,Refractometry,H01.671.617.755
19420420,2009-05-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19420420,2009-05-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19420420,2009-05-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19420420,2009-05-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19420420,2009-05-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19423243,2009-05-06T00:00:00,Alcohol Drinking,F01.145.317.269
19423243,2009-05-06T00:00:00,Alcoholism,C21.739.100.250
19423243,2009-05-06T00:00:00,Alcoholism,F03.900.100.350
19423243,2009-05-06T00:00:00,Avoidance Learning,F02.463.425.097
19423243,2009-05-06T00:00:00,Cues,F02.463.425.234
19423243,2009-05-06T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19423243,2009-05-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19423243,2009-05-06T00:00:00,Internal-External Control,F01.829.379
19423243,2009-05-06T00:00:00,Interviews as Topic,E05.318.308.420
19423243,2009-05-06T00:00:00,Interviews as Topic,L01.280.520
19423243,2009-05-06T00:00:00,Interviews as Topic,N05.715.360.300.400
19423243,2009-05-06T00:00:00,Interviews as Topic,N06.850.520.308.420
19423243,2009-05-06T00:00:00,"Models, Psychological",E05.599.695
19423243,2009-05-06T00:00:00,Patient Selection,E05.581.500.653
19423243,2009-05-06T00:00:00,Patient Selection,N04.590.731
19423243,2009-05-06T00:00:00,Questionnaires,E05.318.308.750
19423243,2009-05-06T00:00:00,Questionnaires,L01.280.800
19423243,2009-05-06T00:00:00,Questionnaires,N05.715.360.300.695
19423243,2009-05-06T00:00:00,Questionnaires,N06.850.520.308.750
19423851,2009-05-07T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19423851,2009-05-07T00:00:00,Delivery of Health Care,N04.590.374
19423851,2009-05-07T00:00:00,Delivery of Health Care,N05.300
19423851,2009-05-07T00:00:00,Health Policy,I01.880.604.825.608.400
19423851,2009-05-07T00:00:00,Health Policy,N03.706.825.608.428
19423851,2009-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19423851,2009-05-07T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19423851,2009-05-07T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19423851,2009-05-07T00:00:00,Stroke,C10.228.140.300.775
19423851,2009-05-07T00:00:00,Stroke,C14.907.253.855
19423851,2009-05-07T00:00:00,Telemedicine,H02.403.840
19423851,2009-05-07T00:00:00,Telemedicine,L01.178.847.652
19423851,2009-05-07T00:00:00,Telemedicine,N04.590.374.800
19423851,2009-05-07T00:00:00,United States,Z01.107.567.875
19423852,2009-05-07T00:00:00,Delivery of Health Care,N04.590.374
19423852,2009-05-07T00:00:00,Delivery of Health Care,N05.300
19423852,2009-05-07T00:00:00,Disability Evaluation,E01.370.400
19423852,2009-05-07T00:00:00,Evidence-Based Medicine,H02.249.750
19423852,2009-05-07T00:00:00,Evidence-Based Medicine,H02.403.200.400
19423852,2009-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19423852,2009-05-07T00:00:00,Stroke,C10.228.140.300.775
19423852,2009-05-07T00:00:00,Stroke,C14.907.253.855
19423852,2009-05-07T00:00:00,Telemedicine,H02.403.840
19423852,2009-05-07T00:00:00,Telemedicine,L01.178.847.652
19423852,2009-05-07T00:00:00,Telemedicine,N04.590.374.800
19423852,2009-05-07T00:00:00,Thrombolytic Therapy,E02.319.913
19423852,2009-05-07T00:00:00,United States,Z01.107.567.875
19425768,2009-05-07T00:00:00,Algorithms,G17.035
19425768,2009-05-07T00:00:00,Algorithms,L01.224.050
19425768,2009-05-07T00:00:00,Amino Acid Sequence,G02.111.570.060
19425768,2009-05-07T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19425768,2009-05-07T00:00:00,Computer Simulation,L01.224.160
19425768,2009-05-07T00:00:00,"Models, Molecular",E05.599.595
19425768,2009-05-07T00:00:00,Monte Carlo Method,E05.318.740.525
19425768,2009-05-07T00:00:00,Monte Carlo Method,L01.906.575.422
19425768,2009-05-07T00:00:00,Monte Carlo Method,N05.715.360.750.540
19425768,2009-05-07T00:00:00,Monte Carlo Method,N06.850.520.830.525
19425768,2009-05-07T00:00:00,Oligopeptides,D12.644.456
19425768,2009-05-07T00:00:00,Protein Conformation,G02.111.570.790.709
19425768,2009-05-07T00:00:00,Solvents,D27.720.844
19425768,2009-05-07T00:00:00,Temperature,G01.906.595
19425768,2009-05-07T00:00:00,Temperature,G16.500.275.063.725.710
19425768,2009-05-07T00:00:00,Temperature,G16.500.750.775.710
19425768,2009-05-07T00:00:00,Temperature,N06.230.150.450
19425768,2009-05-07T00:00:00,Temperature,N06.230.300.100.725.710
19427412,2009-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19427412,2009-05-07T00:00:00,Inflammation,C23.550.470
19427412,2009-05-07T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19427412,2009-05-07T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19427412,2009-05-07T00:00:00,Osteoporosis,C05.116.198.579
19427412,2009-05-07T00:00:00,Risk Factors,E05.318.740.600.800.725
19427412,2009-05-07T00:00:00,Risk Factors,N05.715.350.200.700
19427412,2009-05-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19427412,2009-05-07T00:00:00,Risk Factors,N06.850.490.625.750
19427412,2009-05-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19427412,2009-05-07T00:00:00,Vitamin D,D04.808.812.768
19424488,2009-05-08T00:00:00,Animals,B01.050
19424488,2009-05-08T00:00:00,Chickens,B01.050.150.900.248.350.150
19424488,2009-05-08T00:00:00,Chickens,B01.050.150.900.248.617.192
19424488,2009-05-08T00:00:00,Chorioallantoic Membrane,A10.615.284.375
19424488,2009-05-08T00:00:00,Chorioallantoic Membrane,A13.350.575
19424488,2009-05-08T00:00:00,Chorioallantoic Membrane,A16.331.400
19424488,2009-05-08T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
19424488,2009-05-08T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
19424488,2009-05-08T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
19424488,2009-05-08T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19424488,2009-05-08T00:00:00,Pregnancy,G08.686.785.760.769
19424488,2009-05-08T00:00:00,Progesterone,D04.808.745.745.654.829
19424488,2009-05-08T00:00:00,Progesterone,D06.472.334.734.623
19424488,2009-05-08T00:00:00,Progesterone,D06.472.334.851.687.750
19424488,2009-05-08T00:00:00,Protein Isoforms,D12.776.800
19424488,2009-05-08T00:00:00,Protein Transport,G03.495.166.700
19424488,2009-05-08T00:00:00,"RNA, Messenger",D13.444.735.544
19424488,2009-05-08T00:00:00,"Receptors, Progesterone",D12.776.260.698.750.765
19424488,2009-05-08T00:00:00,"Receptors, Progesterone",D12.776.826.750.765
19424488,2009-05-08T00:00:00,"Receptors, Progesterone",D12.776.930.669.750.765
19424488,2009-05-08T00:00:00,Signal Transduction,G02.111.087.800
19424488,2009-05-08T00:00:00,Signal Transduction,G02.149.115.800
19424488,2009-05-08T00:00:00,Signal Transduction,G04.299.880
19424766,2009-05-08T00:00:00,Esophagus,A03.556.875.500
19424766,2009-05-08T00:00:00,Gastroplasty,E02.065.062.750
19424766,2009-05-08T00:00:00,Gastroplasty,E04.062.750
19424766,2009-05-08T00:00:00,Gastroplasty,E04.210.485
19424766,2009-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19424766,2009-05-08T00:00:00,Laparoscopy,E01.370.388.250.520
19424766,2009-05-08T00:00:00,Laparoscopy,E04.800.250.520
19424766,2009-05-08T00:00:00,Manometry,E05.559
19424766,2009-05-08T00:00:00,Middle Aged,M01.060.116.630
19427818,2009-05-08T00:00:00,Animals,B01.050
19427818,2009-05-08T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
19427818,2009-05-08T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
19427818,2009-05-08T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
19427818,2009-05-08T00:00:00,Antigen-Antibody Complex,D23.050.101
19427818,2009-05-08T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
19427818,2009-05-08T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
19427818,2009-05-08T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
19427818,2009-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19427818,2009-05-08T00:00:00,"Immunity, Humoral",G12.450.050.420
19427818,2009-05-08T00:00:00,Inflammation,C23.550.470
19427818,2009-05-08T00:00:00,"Lipoproteins, LDL",D10.532.515
19427818,2009-05-08T00:00:00,"Lipoproteins, LDL",D12.776.521.550
19429703,2009-05-08T00:00:00,African Americans,M01.686.508.100.100
19429703,2009-05-08T00:00:00,African Americans,M01.686.754.100
19429703,2009-05-08T00:00:00,Aged,M01.060.116.100
19429703,2009-05-08T00:00:00,Blood Pressure,E01.370.600.875.249
19429703,2009-05-08T00:00:00,Blood Pressure,G09.330.380.076
19429703,2009-05-08T00:00:00,European Continental Ancestry Group,M01.686.508.400
19429703,2009-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19429703,2009-05-08T00:00:00,Hypertension,C14.907.489
19808359,2009-05-08T00:00:00,Aging,G07.700.320.124
19808359,2009-05-08T00:00:00,Animals,B01.050
19808359,2009-05-08T00:00:00,Gene Expression,G05.355.310
19808359,2009-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19808359,2009-05-08T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
19808359,2009-05-08T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
19808359,2009-05-08T00:00:00,Myocardium,A02.633.580
19808359,2009-05-08T00:00:00,Myocardium,A07.541.704
19808359,2009-05-08T00:00:00,Myocardium,A10.690.552.750
19808359,2009-05-08T00:00:00,Ventricular Remodeling,C23.300.985
19808359,2009-05-08T00:00:00,Ventricular Remodeling,G09.330.190.962.975
19433651,2009-05-11T00:00:00,African Americans,M01.686.508.100.100
19433651,2009-05-11T00:00:00,African Americans,M01.686.754.100
19433651,2009-05-11T00:00:00,Aged,M01.060.116.100
19433651,2009-05-11T00:00:00,Ethnic Groups,M01.686.754
19433651,2009-05-11T00:00:00,Ethnic Groups,N01.224.317
19433651,2009-05-11T00:00:00,European Continental Ancestry Group,M01.686.508.400
19433651,2009-05-11T00:00:00,Geriatric Assessment,E05.318.308.225
19433651,2009-05-11T00:00:00,Geriatric Assessment,I01.240.425.350
19433651,2009-05-11T00:00:00,Geriatric Assessment,L01.280.360
19433651,2009-05-11T00:00:00,Geriatric Assessment,N01.224.425.350
19433651,2009-05-11T00:00:00,Geriatric Assessment,N05.715.360.300.360
19433651,2009-05-11T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
19433651,2009-05-11T00:00:00,Geriatric Assessment,N06.850.520.308.225
19433651,2009-05-11T00:00:00,Hispanic Americans,M01.686.754.441
19433651,2009-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19433651,2009-05-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19433651,2009-05-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19433651,2009-05-11T00:00:00,Neuropsychological Tests,F04.711.513
19433651,2009-05-11T00:00:00,Questionnaires,E05.318.308.750
19433651,2009-05-11T00:00:00,Questionnaires,L01.280.800
19433651,2009-05-11T00:00:00,Questionnaires,N05.715.360.300.695
19433651,2009-05-11T00:00:00,Questionnaires,N06.850.520.308.750
19433651,2009-05-11T00:00:00,Self Concept,F01.752.747.792
19433651,2009-05-11T00:00:00,Stroke,C10.228.140.300.775
19433651,2009-05-11T00:00:00,Stroke,C14.907.253.855
19435851,2009-05-12T00:00:00,Animals,B01.050
19435851,2009-05-12T00:00:00,Body Weight,C23.888.144
19435851,2009-05-12T00:00:00,Body Weight,E01.370.600.115.100.160.120
19435851,2009-05-12T00:00:00,Body Weight,E05.041.124.160.750
19435851,2009-05-12T00:00:00,Body Weight,G07.100.100.160.120
19435851,2009-05-12T00:00:00,Body Weight,G07.700.320.249.314.120
19435851,2009-05-12T00:00:00,Ceramides,D02.065.313
19435851,2009-05-12T00:00:00,Ceramides,D09.400.410.420.525.200
19435851,2009-05-12T00:00:00,Ceramides,D10.390.470.675.200
19435851,2009-05-12T00:00:00,Ceramides,D10.570.877.360.612.200
19435851,2009-05-12T00:00:00,Energy Metabolism,G03.495.335
19435851,2009-05-12T00:00:00,"Fatty Acids, Monounsaturated",D10.251.355.325
19435851,2009-05-12T00:00:00,Lysophospholipids,D10.570.755.375.760.550
19435851,2009-05-12T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
19435851,2009-05-12T00:00:00,Metabolic Syndrome X,C18.452.625
19435851,2009-05-12T00:00:00,Mitochondrial Proteins,D12.776.575
19435851,2009-05-12T00:00:00,Obesity,C18.654.726.500
19435851,2009-05-12T00:00:00,Obesity,C23.888.144.699.500
19435851,2009-05-12T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19435851,2009-05-12T00:00:00,Obesity,G07.100.100.160.120.699.500
19435851,2009-05-12T00:00:00,Sphingolipids,D10.570.877
19435851,2009-05-12T00:00:00,Sphingolipids,D10.808
19435851,2009-05-12T00:00:00,Sphingosine,D02.033.100.700
19435851,2009-05-12T00:00:00,Sphingosine,D02.033.455.843
19435851,2009-05-12T00:00:00,Sphingosine,D02.092.063.700
19435851,2009-05-12T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.644.360.024.374
19435851,2009-05-12T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.157.057.249
19435851,2009-05-12T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.476.024.437
19435911,2009-05-12T00:00:00,Cell Division,G04.299.134.220
19435911,2009-05-12T00:00:00,Cell Division,G04.299.233.750.500
19435911,2009-05-12T00:00:00,Cell Division,G05.355.105
19435911,2009-05-12T00:00:00,Cell Division,G07.700.320.249.410.750.500
19435911,2009-05-12T00:00:00,Cell Survival,G04.299.316
19435911,2009-05-12T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
19435911,2009-05-12T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
19435911,2009-05-12T00:00:00,Epithelial Cells,A11.436
19435911,2009-05-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19435911,2009-05-12T00:00:00,Signal Transduction,G02.111.087.800
19435911,2009-05-12T00:00:00,Signal Transduction,G02.149.115.800
19435911,2009-05-12T00:00:00,Signal Transduction,G04.299.880
19439585,2009-05-13T00:00:00,Adult,M01.060.116
19439585,2009-05-13T00:00:00,Aged,M01.060.116.100
19439585,2009-05-13T00:00:00,Aging,G07.700.320.124
19439585,2009-05-13T00:00:00,Auditory Cortex,A08.186.211.730.885.287.500.863.297
19439585,2009-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19439585,2009-05-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19439585,2009-05-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19439585,2009-05-13T00:00:00,Middle Aged,M01.060.116.630
19439585,2009-05-13T00:00:00,"Models, Neurological",E05.599.395.642
19439585,2009-05-13T00:00:00,"Pattern Recognition, Physiological",F02.463.593.524
19439585,2009-05-13T00:00:00,Speech Perception,F02.463.593.071.875
19439585,2009-05-13T00:00:00,Young Adult,M01.060.116.815
19535166,2009-05-13T00:00:00,Computer Simulation,L01.224.160
19535166,2009-05-13T00:00:00,Environmental Monitoring,N06.850.460.350.080
19535166,2009-05-13T00:00:00,Environmental Monitoring,N06.850.780.375
19535166,2009-05-13T00:00:00,Environmental Remediation,N06.850.460.375
19535166,2009-05-13T00:00:00,Ethylene Dibromide,D02.455.526.368.225
19535166,2009-05-13T00:00:00,Ethylene Dichlorides,D02.455.326.146.379.350
19535166,2009-05-13T00:00:00,Ethylene Dichlorides,D02.455.526.439.458
19535166,2009-05-13T00:00:00,Gasoline,D20.345.630.540
19535166,2009-05-13T00:00:00,Gasoline,N06.230.132.258.630.540
19535166,2009-05-13T00:00:00,Soil Pollutants,D27.888.284.756
19535166,2009-05-13T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
19535166,2009-05-13T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
19535166,2009-05-13T00:00:00,Water Purification,N06.850.860.510.900.900
19535166,2009-05-13T00:00:00,Water Purification,N06.850.860.510.915.900
19440200,2009-05-14T00:00:00,Age of Onset,N05.715.350.075.100
19440200,2009-05-14T00:00:00,Age of Onset,N06.850.490.250.100
19440200,2009-05-14T00:00:00,Bayes Theorem,E05.318.740.600.200
19440200,2009-05-14T00:00:00,Bayes Theorem,N05.715.360.750.625.150
19440200,2009-05-14T00:00:00,Bayes Theorem,N06.850.520.830.600.200
19440200,2009-05-14T00:00:00,Case-Control Studies,E05.318.760.500.500
19440200,2009-05-14T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19440200,2009-05-14T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19440200,2009-05-14T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19440200,2009-05-14T00:00:00,Genetic Predisposition to Disease,G05.380.355
19440200,2009-05-14T00:00:00,Genome-Wide Association Study,E05.318.416.249
19440200,2009-05-14T00:00:00,Genome-Wide Association Study,E05.318.780.392
19440200,2009-05-14T00:00:00,Genome-Wide Association Study,E05.393.385.500
19440200,2009-05-14T00:00:00,Genome-Wide Association Study,E05.393.522.500
19440200,2009-05-14T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19440200,2009-05-14T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19440200,2009-05-14T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19440200,2009-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19440200,2009-05-14T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19440200,2009-05-14T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19440200,2009-05-14T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19440201,2009-05-14T00:00:00,African Americans,M01.686.508.100.100
19440201,2009-05-14T00:00:00,African Americans,M01.686.754.100
19440201,2009-05-14T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19440201,2009-05-14T00:00:00,Genetic Predisposition to Disease,G05.380.355
19440201,2009-05-14T00:00:00,Hispanic Americans,M01.686.754.441
19440201,2009-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19440201,2009-05-14T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19440201,2009-05-14T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19440201,2009-05-14T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
19440201,2009-05-14T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
19440201,2009-05-14T00:00:00,Lupus Nephritis,C17.300.480.680
19440201,2009-05-14T00:00:00,Lupus Nephritis,C20.111.590.560
19440201,2009-05-14T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19443750,2009-05-15T00:00:00,Biomedical Research,H01.770.644.145
19443750,2009-05-15T00:00:00,Career Choice,F02.463.785.373.346.400
19443750,2009-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19443750,2009-05-15T00:00:00,Interdisciplinary Communication,F01.145.209.381
19443750,2009-05-15T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
19443750,2009-05-15T00:00:00,Interdisciplinary Communication,L01.143.474
19443750,2009-05-15T00:00:00,Internet,L01.224.230.110.500
19443750,2009-05-15T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
19443750,2009-05-15T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
19443750,2009-05-15T00:00:00,United States,Z01.107.567.875
19498242,2009-05-16T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
19498242,2009-05-16T00:00:00,Ethers,D02.355
19498242,2009-05-16T00:00:00,Hydrogen Bonding,G02.149.767.620
19498242,2009-05-16T00:00:00,Hydrogen Bonding,G02.842.750.620
19498242,2009-05-16T00:00:00,"Models, Molecular",E05.599.595
19498242,2009-05-16T00:00:00,Propionates,D02.241.081.751
19498242,2009-05-16T00:00:00,Propionates,D10.251.400.706
19498242,2009-05-16T00:00:00,Pyrazoles,D03.383.129.539
19276681,2009-05-18T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
19276681,2009-05-18T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
19276681,2009-05-18T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
19276681,2009-05-18T00:00:00,Animals,B01.050
19276681,2009-05-18T00:00:00,Gene Expression Regulation,G05.355.315
19276681,2009-05-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19276681,2009-05-18T00:00:00,Phosphoproteins,D12.776.744
19276681,2009-05-18T00:00:00,Phosphorylation,G02.111.087.677
19276681,2009-05-18T00:00:00,Phosphorylation,G02.149.115.677
19276681,2009-05-18T00:00:00,Phosphorylation,G02.149.465.700
19276681,2009-05-18T00:00:00,Phosphorylation,G02.607.750.700
19276681,2009-05-18T00:00:00,Phosphorylation,G03.495.790
19276681,2009-05-18T00:00:00,Protein Kinases,D08.811.913.696.620.682
19276681,2009-05-18T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
19276681,2009-05-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
19276681,2009-05-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
19276681,2009-05-18T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
19276681,2009-05-18T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
19276681,2009-05-18T00:00:00,Signal Transduction,G02.111.087.800
19276681,2009-05-18T00:00:00,Signal Transduction,G02.149.115.800
19276681,2009-05-18T00:00:00,Signal Transduction,G04.299.880
19450595,2009-05-18T00:00:00,Clinical Competence,I02.399.630.210
19450595,2009-05-18T00:00:00,Clinical Competence,N04.761.210
19450595,2009-05-18T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19450595,2009-05-18T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19450595,2009-05-18T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19450595,2009-05-18T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19450595,2009-05-18T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19450595,2009-05-18T00:00:00,Colonic Polyps,C23.300.825.411.235
19450595,2009-05-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19450595,2009-05-18T00:00:00,Mass Screening,E01.370.500
19450595,2009-05-18T00:00:00,Mass Screening,E05.318.308.250.580
19450595,2009-05-18T00:00:00,Mass Screening,N02.421.143.827.233.443
19450595,2009-05-18T00:00:00,Mass Screening,N02.421.726.233.443
19450595,2009-05-18T00:00:00,Mass Screening,N05.715.360.300.375.500
19450595,2009-05-18T00:00:00,Mass Screening,N06.850.520.308.250.580
19450595,2009-05-18T00:00:00,Mass Screening,N06.850.780.500
19450595,2009-05-18T00:00:00,Patient Satisfaction,N04.452.822.360.600
19450595,2009-05-18T00:00:00,Patient Satisfaction,N05.300.150.600.630
19450595,2009-05-18T00:00:00,Patient Satisfaction,N05.715.360.600
19450595,2009-05-18T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19450595,2009-05-18T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19432493,2009-05-19T00:00:00,Adsorption,G02.149.047
19432493,2009-05-19T00:00:00,Adsorption,G02.149.767.029
19432493,2009-05-19T00:00:00,Adsorption,G02.842.750.029
19432493,2009-05-19T00:00:00,Amino Acids,D12.125
19432493,2009-05-19T00:00:00,"Models, Chemical",E05.599.495
19432493,2009-05-19T00:00:00,Peptides,D12.644
19432493,2009-05-19T00:00:00,Proteins,D12.776
19432493,2009-05-19T00:00:00,Surface Properties,G02.842.850
19452122,2009-05-19T00:00:00,African Americans,M01.686.508.100.100
19452122,2009-05-19T00:00:00,African Americans,M01.686.754.100
19452122,2009-05-19T00:00:00,Aged,M01.060.116.100
19452122,2009-05-19T00:00:00,European Continental Ancestry Group,M01.686.508.400
19452122,2009-05-19T00:00:00,Hip Joint,A02.835.583.411
19452122,2009-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19452122,2009-05-19T00:00:00,Middle Aged,M01.060.116.630
19452122,2009-05-19T00:00:00,South Carolina,Z01.107.567.875.075.662
19452122,2009-05-19T00:00:00,South Carolina,Z01.107.567.875.750.700
19452271,2009-05-19T00:00:00,"Adaptation, Psychological",F01.058
19452271,2009-05-19T00:00:00,Adult,M01.060.116
19452271,2009-05-19T00:00:00,Cognitive Therapy,F04.754.137.428
19452271,2009-05-19T00:00:00,HIV Infections,C02.782.815.616.400
19452271,2009-05-19T00:00:00,HIV Infections,C02.800.801.400
19452271,2009-05-19T00:00:00,HIV Infections,C20.673.480
19452271,2009-05-19T00:00:00,Health Education,I02.233.332
19452271,2009-05-19T00:00:00,Health Education,N02.421.143.827.407
19452271,2009-05-19T00:00:00,Health Education,N02.421.726.407
19452271,2009-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19452271,2009-05-19T00:00:00,Risk Reduction Behavior,F01.145.699
19452271,2009-05-19T00:00:00,Risk-Taking,F01.145.722
19452271,2009-05-19T00:00:00,Sexual Behavior,F01.145.802
19452271,2009-05-19T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19452271,2009-05-19T00:00:00,Substance-Related Disorders,C21.739
19452271,2009-05-19T00:00:00,Substance-Related Disorders,F03.900
19452271,2009-05-19T00:00:00,Treatment Outcome,E01.789.800
19452271,2009-05-19T00:00:00,Treatment Outcome,N04.761.559.590.800
19452271,2009-05-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19452271,2009-05-19T00:00:00,Wounds and Injuries,C21.866
19454550,2009-05-19T00:00:00,Adult,M01.060.116
19454550,2009-05-19T00:00:00,Aged,M01.060.116.100
19454550,2009-05-19T00:00:00,Attitude to Health,F01.100.150
19454550,2009-05-19T00:00:00,Attitude to Health,N05.300.150
19454550,2009-05-19T00:00:00,Health Education,I02.233.332
19454550,2009-05-19T00:00:00,Health Education,N02.421.143.827.407
19454550,2009-05-19T00:00:00,Health Education,N02.421.726.407
19454550,2009-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19454550,2009-05-19T00:00:00,Middle Aged,M01.060.116.630
19454550,2009-05-19T00:00:00,Questionnaires,E05.318.308.750
19454550,2009-05-19T00:00:00,Questionnaires,L01.280.800
19454550,2009-05-19T00:00:00,Questionnaires,N05.715.360.300.695
19454550,2009-05-19T00:00:00,Questionnaires,N06.850.520.308.750
19454550,2009-05-19T00:00:00,Risk Factors,E05.318.740.600.800.725
19454550,2009-05-19T00:00:00,Risk Factors,N05.715.350.200.700
19454550,2009-05-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19454550,2009-05-19T00:00:00,Risk Factors,N06.850.490.625.750
19454550,2009-05-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19454550,2009-05-19T00:00:00,Smoking,F01.145.466.753
19454550,2009-05-19T00:00:00,Smoking Cessation,F01.145.940.700
19454550,2009-05-19T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19454550,2009-05-19T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19454550,2009-05-19T00:00:00,United States,Z01.107.567.875
19454550,2009-05-19T00:00:00,Workplace,N01.824.245.925
19454550,2009-05-19T00:00:00,Workplace,N04.452.677.975
19454550,2009-05-19T00:00:00,Young Adult,M01.060.116.815
19458221,2009-05-20T00:00:00,Amygdala,A08.186.211.464.090
19458221,2009-05-20T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
19458221,2009-05-20T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
19458221,2009-05-20T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
19458221,2009-05-20T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
19458221,2009-05-20T00:00:00,Animals,B01.050
19458221,2009-05-20T00:00:00,Attention,F02.830.104.214
19458221,2009-05-20T00:00:00,"Behavior, Animal",F01.145.113
19458221,2009-05-20T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19458221,2009-05-20T00:00:00,Cues,F02.463.425.234
19458221,2009-05-20T00:00:00,Eating,G07.610.593.260
19458221,2009-05-20T00:00:00,Eating,G07.700.620.260
19458221,2009-05-20T00:00:00,Eating,G10.261.326.240
19458221,2009-05-20T00:00:00,Gene Expression,G05.355.310
19458221,2009-05-20T00:00:00,Motivation,F01.658
19458221,2009-05-20T00:00:00,Motivation,F01.752.543.500.750
19458221,2009-05-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19458221,2009-05-20T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19458327,2009-05-20T00:00:00,Animals,B01.050
19458327,2009-05-20T00:00:00,Carrier Proteins,D12.776.157
19458327,2009-05-20T00:00:00,Cattle,B01.050.150.900.649.077.380.271
19458327,2009-05-20T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
19458327,2009-05-20T00:00:00,Eye Proteins,D12.776.306
19458327,2009-05-20T00:00:00,Gene Expression,G05.355.310
19458327,2009-05-20T00:00:00,Genetic Vectors,G05.360.337
19458327,2009-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19458327,2009-05-20T00:00:00,Kidney,A05.810.453
19458327,2009-05-20T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
19458327,2009-05-20T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
19464870,2009-05-22T00:00:00,"Anesthesia, Obstetrical",E03.155.364
19464870,2009-05-22T00:00:00,Catheterization,E02.148
19464870,2009-05-22T00:00:00,Catheterization,E05.157
19464870,2009-05-22T00:00:00,Device Removal,E04.199
19464870,2009-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19464870,2009-05-22T00:00:00,"Obesity, Morbid",C18.654.726.500.700
19464870,2009-05-22T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
19464870,2009-05-22T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
19464870,2009-05-22T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
19464870,2009-05-22T00:00:00,Pregnancy,G08.686.785.760.769
19464870,2009-05-22T00:00:00,Pregnancy Complications,C13.703
19524242,2009-05-22T00:00:00,Adult,M01.060.116
19524242,2009-05-22T00:00:00,Age of Onset,N05.715.350.075.100
19524242,2009-05-22T00:00:00,Age of Onset,N06.850.490.250.100
19524242,2009-05-22T00:00:00,Aged,M01.060.116.100
19524242,2009-05-22T00:00:00,Biological Markers,D23.101
19524242,2009-05-22T00:00:00,Case-Control Studies,E05.318.760.500.500
19524242,2009-05-22T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19524242,2009-05-22T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19524242,2009-05-22T00:00:00,"Cholesterol, HDL",D10.532.432.400
19524242,2009-05-22T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
19524242,2009-05-22T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
19524242,2009-05-22T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19524242,2009-05-22T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19524242,2009-05-22T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19524242,2009-05-22T00:00:00,Genetic Testing,E01.370.427
19524242,2009-05-22T00:00:00,Genetic Testing,E05.393.435
19524242,2009-05-22T00:00:00,Genetic Testing,N02.421.143.827.233.221
19524242,2009-05-22T00:00:00,Genetic Testing,N02.421.308.430
19524242,2009-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19524242,2009-05-22T00:00:00,Lipoproteins,D10.532
19524242,2009-05-22T00:00:00,Lipoproteins,D12.776.521
19524242,2009-05-22T00:00:00,Middle Aged,M01.060.116.630
19524242,2009-05-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
19524242,2009-05-22T00:00:00,Risk Assessment,N04.452.871.715
19524242,2009-05-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19524242,2009-05-22T00:00:00,Risk Assessment,N06.850.505.715
19524242,2009-05-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19524242,2009-05-22T00:00:00,Risk Factors,E05.318.740.600.800.725
19524242,2009-05-22T00:00:00,Risk Factors,N05.715.350.200.700
19524242,2009-05-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19524242,2009-05-22T00:00:00,Risk Factors,N06.850.490.625.750
19524242,2009-05-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19892220,2009-05-23T00:00:00,Aged,M01.060.116.100
19892220,2009-05-23T00:00:00,Anxiety Disorders,F03.080
19892220,2009-05-23T00:00:00,Community Health Services,N02.421.143
19892220,2009-05-23T00:00:00,Community Mental Health Services,F04.408.307
19892220,2009-05-23T00:00:00,Community Mental Health Services,N02.421.143.183
19892220,2009-05-23T00:00:00,Community Mental Health Services,N02.421.461.232
19892220,2009-05-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19892220,2009-05-23T00:00:00,Mental Disorders,F03
19892220,2009-05-23T00:00:00,Middle Aged,M01.060.116.630
19892220,2009-05-23T00:00:00,Mood Disorders,F03.600
19892220,2009-05-23T00:00:00,Substance-Related Disorders,C21.739
19892220,2009-05-23T00:00:00,Substance-Related Disorders,F03.900
19892220,2009-05-23T00:00:00,United States,Z01.107.567.875
19892220,2009-05-23T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
19892220,2009-05-23T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
19892220,2009-05-23T00:00:00,Veterans,M01.930
19348429,2009-05-26T00:00:00,Animals,B01.050
19348429,2009-05-26T00:00:00,Light,G01.201.875.770.578
19348429,2009-05-26T00:00:00,Light,G01.590.540
19348429,2009-05-26T00:00:00,"Models, Molecular",E05.599.595
19348429,2009-05-26T00:00:00,Rhodopsin,D12.776.543.750.100.955
19348429,2009-05-26T00:00:00,Rhodopsin,D23.767.930.750.500.500
19348429,2009-05-26T00:00:00,Transducin,D08.811.277.040.330.300.200.800
19348429,2009-05-26T00:00:00,Transducin,D12.644.360.375.940
19348429,2009-05-26T00:00:00,Transducin,D12.776.157.325.332.940
19348429,2009-05-26T00:00:00,Transducin,D12.776.476.375.940
19348429,2009-05-26T00:00:00,Transducin,D12.776.543.325.800
19470767,2009-05-26T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
19470767,2009-05-26T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
19470767,2009-05-26T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
19470767,2009-05-26T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
19470767,2009-05-26T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
19470767,2009-05-26T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
19470767,2009-05-26T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
19470767,2009-05-26T00:00:00,Doxorubicin,D04.615.562.050.200.175
19470767,2009-05-26T00:00:00,Doxorubicin,D09.408.051.059.200.175
19470767,2009-05-26T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
19470767,2009-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19470767,2009-05-26T00:00:00,Hyaluronic Acid,D09.698.373.475
19470767,2009-05-26T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19470767,2009-05-26T00:00:00,"Microscopy, Confocal",E05.595.395
19470767,2009-05-26T00:00:00,Nerve Sheath Neoplasms,C04.557.580.600
19470767,2009-05-26T00:00:00,Nerve Sheath Neoplasms,C10.551.775.500
19470767,2009-05-26T00:00:00,Nerve Sheath Neoplasms,C10.668.829.725.500
19470790,2009-05-26T00:00:00,Aged,M01.060.116.100
19470790,2009-05-26T00:00:00,Body Mass Index,E01.370.600.115.100.125
19470790,2009-05-26T00:00:00,Body Mass Index,E05.041.124.125
19470790,2009-05-26T00:00:00,Body Mass Index,G07.100.100.125
19470790,2009-05-26T00:00:00,Body Mass Index,N06.850.505.200.100.175
19470790,2009-05-26T00:00:00,Breast Neoplasms,C04.588.180
19470790,2009-05-26T00:00:00,Breast Neoplasms,C17.800.090.500
19470790,2009-05-26T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
19470790,2009-05-26T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
19470790,2009-05-26T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
19470790,2009-05-26T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
19470790,2009-05-26T00:00:00,Case-Control Studies,E05.318.760.500.500
19470790,2009-05-26T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19470790,2009-05-26T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19470790,2009-05-26T00:00:00,Estrogens,D27.505.696.399.472.277
19470790,2009-05-26T00:00:00,Ethnic Groups,M01.686.754
19470790,2009-05-26T00:00:00,Ethnic Groups,N01.224.317
19470790,2009-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19470790,2009-05-26T00:00:00,Middle Aged,M01.060.116.630
19470790,2009-05-26T00:00:00,New York,Z01.107.567.875.075.437
19470790,2009-05-26T00:00:00,New York,Z01.107.567.875.350.530
19470790,2009-05-26T00:00:00,New York,Z01.107.567.875.500.530
19470790,2009-05-26T00:00:00,Progesterone,D04.808.745.745.654.829
19470790,2009-05-26T00:00:00,Progesterone,D06.472.334.734.623
19470790,2009-05-26T00:00:00,Progesterone,D06.472.334.851.687.750
19470790,2009-05-26T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
19470790,2009-05-26T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
19470790,2009-05-26T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
19470790,2009-05-26T00:00:00,"Receptors, Progesterone",D12.776.260.698.750.765
19470790,2009-05-26T00:00:00,"Receptors, Progesterone",D12.776.826.750.765
19470790,2009-05-26T00:00:00,"Receptors, Progesterone",D12.776.930.669.750.765
19470790,2009-05-26T00:00:00,Vitamin D,D04.808.812.768
19470790,2009-05-26T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19471017,2009-05-26T00:00:00,Animals,B01.050
19471017,2009-05-26T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
19471017,2009-05-26T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
19471017,2009-05-26T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
19471017,2009-05-26T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
19471017,2009-05-26T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
19471017,2009-05-26T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19471017,2009-05-26T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19471017,2009-05-26T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19471017,2009-05-26T00:00:00,Interferon-gamma,D12.644.276.718.550
19471017,2009-05-26T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19471017,2009-05-26T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19471017,2009-05-26T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19471017,2009-05-26T00:00:00,Interferon-gamma,D12.776.467.718.550
19471017,2009-05-26T00:00:00,Interferon-gamma,D23.529.374.440.893
19471017,2009-05-26T00:00:00,Interferon-gamma,D23.529.374.480.350
19471017,2009-05-26T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19471017,2009-05-26T00:00:00,Interferon-gamma,D23.529.718.550
19471017,2009-05-26T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
19471017,2009-05-26T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
19471017,2009-05-26T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
19471017,2009-05-26T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
19471017,2009-05-26T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
19471017,2009-05-26T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
19471017,2009-05-26T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.283.875
19471017,2009-05-26T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.567.569.220.200
19471017,2009-05-26T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.283.875
19471017,2009-05-26T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.567.569.220.200
19471017,2009-05-26T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.283.875
19471017,2009-05-26T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.567.569.220.200
19471045,2009-05-26T00:00:00,Adult,M01.060.116
19471045,2009-05-26T00:00:00,Child,M01.060.406
19471045,2009-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19471045,2009-05-26T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
19471045,2009-05-26T00:00:00,Treatment Outcome,E01.789.800
19471045,2009-05-26T00:00:00,Treatment Outcome,N04.761.559.590.800
19471045,2009-05-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19485969,2009-05-26T00:00:00,Adult,M01.060.116
19485969,2009-05-26T00:00:00,Alcohol Drinking,F01.145.317.269
19485969,2009-05-26T00:00:00,Amines,D02.092
19485969,2009-05-26T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
19485969,2009-05-26T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
19485969,2009-05-26T00:00:00,Double-Blind Method,E05.318.780.300
19485969,2009-05-26T00:00:00,Double-Blind Method,E05.581.500.300
19485969,2009-05-26T00:00:00,Double-Blind Method,N05.715.360.780.320
19485969,2009-05-26T00:00:00,Double-Blind Method,N06.850.520.445.300
19485969,2009-05-26T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
19485969,2009-05-26T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
19485969,2009-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19485969,2009-05-26T00:00:00,Psychiatric Status Rating Scales,F04.586
19485969,2009-05-26T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19485969,2009-05-26T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19485969,2009-05-26T00:00:00,Treatment Outcome,E01.789.800
19485969,2009-05-26T00:00:00,Treatment Outcome,N04.761.559.590.800
19485969,2009-05-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19485969,2009-05-26T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19485969,2009-05-26T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
19471940,2009-05-27T00:00:00,Aged,M01.060.116.100
19471940,2009-05-27T00:00:00,Angiography,E01.370.350.700.060
19471940,2009-05-27T00:00:00,Angiography,E01.370.370.050
19471940,2009-05-27T00:00:00,Contrast Media,D27.720.259
19471940,2009-05-27T00:00:00,Diagnostic Imaging,E01.370.350
19471940,2009-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19471940,2009-05-27T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
19471940,2009-05-27T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
19471940,2009-05-27T00:00:00,Middle Aged,M01.060.116.630
19471940,2009-05-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19471940,2009-05-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19471940,2009-05-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19471940,2009-05-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19471940,2009-05-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19564984,2009-05-27T00:00:00,"Education, Pharmacy",I02.358.525
19564984,2009-05-27T00:00:00,Guidelines as Topic,N04.761.700.350
19564984,2009-05-27T00:00:00,Guidelines as Topic,N05.700.350
19564984,2009-05-27T00:00:00,Publishing,L01.737
19474425,2009-05-28T00:00:00,Aged,M01.060.116.100
19474425,2009-05-28T00:00:00,Catheter Ablation,E01.370.370.380.410.200
19474425,2009-05-28T00:00:00,Catheter Ablation,E02.148.110
19474425,2009-05-28T00:00:00,Catheter Ablation,E02.148.442.110
19474425,2009-05-28T00:00:00,Catheter Ablation,E02.154.402.110
19474425,2009-05-28T00:00:00,Catheter Ablation,E04.014.170.402.110
19474425,2009-05-28T00:00:00,Disease Progression,C23.550.291.656
19474425,2009-05-28T00:00:00,Esophagus,A03.556.875.500
19474425,2009-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19474425,2009-05-28T00:00:00,Middle Aged,M01.060.116.630
19474425,2009-05-28T00:00:00,Treatment Outcome,E01.789.800
19474425,2009-05-28T00:00:00,Treatment Outcome,N04.761.559.590.800
19474425,2009-05-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19478085,2009-05-28T00:00:00,Amino Acid Sequence,G02.111.570.060
19478085,2009-05-28T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19478085,2009-05-28T00:00:00,Animals,B01.050
19478085,2009-05-28T00:00:00,Binding Sites,G02.111.570.120
19478085,2009-05-28T00:00:00,Cell Line,A11.251.210
19478085,2009-05-28T00:00:00,DNA Replication,G02.111.087.222
19478085,2009-05-28T00:00:00,DNA Replication,G02.149.115.222
19478085,2009-05-28T00:00:00,DNA Replication,G05.355.200
19478085,2009-05-28T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
19478085,2009-05-28T00:00:00,DNA-Directed DNA Polymerase,D08.811.913.696.445.308.300
19478085,2009-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19478085,2009-05-28T00:00:00,Molecular Sequence Data,L01.453.245.667
19478085,2009-05-28T00:00:00,Mutation,G05.365.590
19478085,2009-05-28T00:00:00,Recombinant Proteins,D12.776.828
19478085,2009-05-28T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
19478085,2009-05-28T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
19478221,2009-05-28T00:00:00,Brain Ischemia,C10.228.140.300.150
19478221,2009-05-28T00:00:00,Brain Ischemia,C14.907.253.092
19478221,2009-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19478221,2009-05-28T00:00:00,Stroke,C10.228.140.300.775
19478221,2009-05-28T00:00:00,Stroke,C14.907.253.855
19478221,2009-05-28T00:00:00,Time Factors,G01.910.857
19478221,2009-05-28T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
19478221,2009-05-28T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
19478221,2009-05-28T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
19478221,2009-05-28T00:00:00,Tissue Plasminogen Activator,D23.119.970
19478221,2009-05-28T00:00:00,Treatment Outcome,E01.789.800
19478221,2009-05-28T00:00:00,Treatment Outcome,N04.761.559.590.800
19478221,2009-05-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19478221,2009-05-28T00:00:00,United States,Z01.107.567.875
19483104,2009-05-29T00:00:00,"Antigens, CD",D23.050.301.264.035
19483104,2009-05-29T00:00:00,"Antigens, CD",D23.101.100.110
19483104,2009-05-29T00:00:00,Antineoplastic Agents,D27.505.954.248
19483104,2009-05-29T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
19483104,2009-05-29T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
19483104,2009-05-29T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19483104,2009-05-29T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19483104,2009-05-29T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19483104,2009-05-29T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19483104,2009-05-29T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19483104,2009-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19483104,2009-05-29T00:00:00,Membrane Proteins,D12.776.543
19483104,2009-05-29T00:00:00,Oxidoreductases,D08.811.682
19483104,2009-05-29T00:00:00,Pyridines,D03.383.725
19482279,2009-05-30T00:00:00,Adult,M01.060.116
19482279,2009-05-30T00:00:00,Aged,M01.060.116.100
19482279,2009-05-30T00:00:00,Alloys,D01.552.033
19482279,2009-05-30T00:00:00,Alloys,D25.058
19482279,2009-05-30T00:00:00,Alloys,J01.637.051.058
19482279,2009-05-30T00:00:00,Catheterization,E02.148
19482279,2009-05-30T00:00:00,Catheterization,E05.157
19482279,2009-05-30T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
19482279,2009-05-30T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
19482279,2009-05-30T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
19482279,2009-05-30T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
19482279,2009-05-30T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
19482279,2009-05-30T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
19482279,2009-05-30T00:00:00,Cholestasis,C06.130.120.135
19482279,2009-05-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19482279,2009-05-30T00:00:00,Middle Aged,M01.060.116.630
19482279,2009-05-30T00:00:00,Neoplasm Staging,E01.370.550
19482279,2009-05-30T00:00:00,Palliative Care,E02.760.666
19482279,2009-05-30T00:00:00,Palliative Care,N02.421.585.666
19482279,2009-05-30T00:00:00,Patient Selection,E05.581.500.653
19482279,2009-05-30T00:00:00,Patient Selection,N04.590.731
19482279,2009-05-30T00:00:00,Probability,E05.318.740.600
19482279,2009-05-30T00:00:00,Probability,G17.680
19482279,2009-05-30T00:00:00,Probability,N05.715.360.750.625
19482279,2009-05-30T00:00:00,Probability,N06.850.520.830.600
19482279,2009-05-30T00:00:00,Prosthesis Design,E05.320.550
19482279,2009-05-30T00:00:00,Prosthesis Design,E07.695.680
19482279,2009-05-30T00:00:00,Prosthesis Failure,C23.550.767.865
19482279,2009-05-30T00:00:00,Prosthesis Failure,E05.325.771
19482279,2009-05-30T00:00:00,Quality of Life,I01.800
19482279,2009-05-30T00:00:00,Quality of Life,K01.752.400.750
19482279,2009-05-30T00:00:00,Risk Assessment,E05.318.740.600.800.715
19482279,2009-05-30T00:00:00,Risk Assessment,N04.452.871.715
19482279,2009-05-30T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19482279,2009-05-30T00:00:00,Risk Assessment,N06.850.505.715
19482279,2009-05-30T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19482279,2009-05-30T00:00:00,Stents,E07.695.750
19482279,2009-05-30T00:00:00,Treatment Outcome,E01.789.800
19482279,2009-05-30T00:00:00,Treatment Outcome,N04.761.559.590.800
19482279,2009-05-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19486896,2009-05-30T00:00:00,Animals,B01.050
19486896,2009-05-30T00:00:00,Down-Regulation,G02.111.087.225
19486896,2009-05-30T00:00:00,Down-Regulation,G02.149.115.225
19486896,2009-05-30T00:00:00,Down-Regulation,G05.355.315.200
19486896,2009-05-30T00:00:00,Down-Regulation,G07.690.812.230
19486896,2009-05-30T00:00:00,Down-Regulation,G07.700.680.230
19486896,2009-05-30T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
19486896,2009-05-30T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
19486896,2009-05-30T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
19486896,2009-05-30T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
19486896,2009-05-30T00:00:00,Spleen,A10.549.700
19486896,2009-05-30T00:00:00,Spleen,A15.382.520.604.700
18928400,2009-06-01T00:00:00,Animals,B01.050
18928400,2009-06-01T00:00:00,Biocompatible Materials,D25.130
18928400,2009-06-01T00:00:00,Biocompatible Materials,D27.720.102.130
18928400,2009-06-01T00:00:00,Biocompatible Materials,J01.637.051.130
18928400,2009-06-01T00:00:00,Calcium,D01.268.552.100
18928400,2009-06-01T00:00:00,Calcium,D01.552.539.288
18928400,2009-06-01T00:00:00,Calcium,D23.119.100
18928400,2009-06-01T00:00:00,Collagen,D05.750.078.280
18928400,2009-06-01T00:00:00,Collagen,D12.776.860.300.250
18928400,2009-06-01T00:00:00,Extracellular Matrix,A11.284.295.310
18928400,2009-06-01T00:00:00,Heart Valves,A07.541.510
18928400,2009-06-01T00:00:00,Materials Testing,E05.570
18928400,2009-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18928400,2009-06-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18928400,2009-06-01T00:00:00,Tissue Engineering,E05.200.249.750
18928400,2009-06-01T00:00:00,Tissue Scaffolds,E07.206.627
18928400,2009-06-01T00:00:00,Tissue Scaffolds,E07.695.825
19092677,2009-06-01T00:00:00,Adult,M01.060.116
19092677,2009-06-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
19092677,2009-06-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
19092677,2009-06-01T00:00:00,Electrodes,E07.305.250
19092677,2009-06-01T00:00:00,Functional Laterality,F02.830.297.425
19092677,2009-06-01T00:00:00,Functional Laterality,G11.561.225.425
19092677,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19092677,2009-06-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19092677,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19092677,2009-06-01T00:00:00,Pain,C10.597.617
19092677,2009-06-01T00:00:00,Pain,C23.888.592.612
19092677,2009-06-01T00:00:00,Pain,C23.888.646
19092677,2009-06-01T00:00:00,Pain,F02.830.816.444
19092677,2009-06-01T00:00:00,Pain,G11.561.600.810.444
19092677,2009-06-01T00:00:00,Pain Measurement,E01.370.376.550.600
19092677,2009-06-01T00:00:00,Perception,F02.463.593
19092677,2009-06-01T00:00:00,Young Adult,M01.060.116.815
19198009,2009-06-01T00:00:00,Aged,M01.060.116.100
19198009,2009-06-01T00:00:00,Cardiovascular Diseases,C14
19198009,2009-06-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
19198009,2009-06-01T00:00:00,Hospital Mortality,L01.280.975.550.400
19198009,2009-06-01T00:00:00,Hospital Mortality,N01.224.935.698.400
19198009,2009-06-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
19198009,2009-06-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
19198009,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19198009,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19198009,2009-06-01T00:00:00,Myocardial Infarction,C14.280.647.500
19198009,2009-06-01T00:00:00,Myocardial Infarction,C14.907.585.500
19198009,2009-06-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19198009,2009-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19198009,2009-06-01T00:00:00,Risk Assessment,N04.452.871.715
19198009,2009-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19198009,2009-06-01T00:00:00,Risk Assessment,N06.850.505.715
19198009,2009-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19198009,2009-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19198009,2009-06-01T00:00:00,Risk Factors,N05.715.350.200.700
19198009,2009-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19198009,2009-06-01T00:00:00,Risk Factors,N06.850.490.625.750
19198009,2009-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19198009,2009-06-01T00:00:00,Ticlopidine,D02.886.778.834
19198009,2009-06-01T00:00:00,Ticlopidine,D03.383.903.834
19198009,2009-06-01T00:00:00,Time Factors,G01.910.857
19198009,2009-06-01T00:00:00,Treatment Outcome,E01.789.800
19198009,2009-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19198009,2009-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19283727,2009-06-01T00:00:00,Animals,B01.050
19283727,2009-06-01T00:00:00,Bioprosthesis,E07.695.100
19283727,2009-06-01T00:00:00,Calcinosis,C18.452.174.130
19283727,2009-06-01T00:00:00,Calcium,D01.268.552.100
19283727,2009-06-01T00:00:00,Calcium,D01.552.539.288
19283727,2009-06-01T00:00:00,Calcium,D23.119.100
19283727,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19283727,2009-06-01T00:00:00,Recombinant Proteins,D12.776.828
19283727,2009-06-01T00:00:00,Swine,B01.050.150.900.649.077.880
19283727,2009-06-01T00:00:00,Tissue Engineering,E05.200.249.750
19296515,2009-06-01T00:00:00,African Americans,M01.686.508.100.100
19296515,2009-06-01T00:00:00,African Americans,M01.686.754.100
19296515,2009-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19296515,2009-06-01T00:00:00,Health Surveys,E05.318.308.250
19296515,2009-06-01T00:00:00,Health Surveys,N05.715.360.300.375
19296515,2009-06-01T00:00:00,Health Surveys,N06.850.520.308.250
19296515,2009-06-01T00:00:00,Healthcare Disparities,N04.590.374.380
19296515,2009-06-01T00:00:00,Healthcare Disparities,N05.300.493
19296515,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19296515,2009-06-01T00:00:00,Incidence,E05.318.308.985.525.375
19296515,2009-06-01T00:00:00,Incidence,L01.280.975.525.375
19296515,2009-06-01T00:00:00,Incidence,N01.224.935.597.500
19296515,2009-06-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19296515,2009-06-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19296515,2009-06-01T00:00:00,Neoplasms,C04
19296515,2009-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19296515,2009-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19296516,2009-06-01T00:00:00,African Americans,M01.686.508.100.100
19296516,2009-06-01T00:00:00,African Americans,M01.686.754.100
19296516,2009-06-01T00:00:00,Attitude to Health,F01.100.150
19296516,2009-06-01T00:00:00,Attitude to Health,N05.300.150
19296516,2009-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19296516,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19296516,2009-06-01T00:00:00,Interpersonal Relations,F01.829.401
19296516,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19296516,2009-06-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
19296516,2009-06-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19296516,2009-06-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
19296516,2009-06-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
19296516,2009-06-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
19338063,2009-06-01T00:00:00,Adolescent,M01.060.057
19338063,2009-06-01T00:00:00,Adult,M01.060.116
19338063,2009-06-01T00:00:00,Child,M01.060.406
19338063,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19338063,2009-06-01T00:00:00,Organometallic Compounds,D01.632
19338063,2009-06-01T00:00:00,Organometallic Compounds,D02.691
19338063,2009-06-01T00:00:00,Radiometry,E05.799
19338063,2009-06-01T00:00:00,Radiotherapy Dosage,E02.815.639
19338063,2009-06-01T00:00:00,Thrombocytopenia,C15.378.140.855
19338063,2009-06-01T00:00:00,Treatment Outcome,E01.789.800
19338063,2009-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19338063,2009-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19358167,2009-06-01T00:00:00,Debridement,E04.176
19358167,2009-06-01T00:00:00,"Diagnosis, Differential",E01.171
19358167,2009-06-01T00:00:00,Endoscopy,E01.370.388.250
19358167,2009-06-01T00:00:00,Endoscopy,E04.800.250
19358167,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19358167,2009-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19358167,2009-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19358167,2009-06-01T00:00:00,Mucocele,C04.182.511
19358167,2009-06-01T00:00:00,Reoperation,E04.690
19358167,2009-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19358167,2009-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19358167,2009-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19358167,2009-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19358167,2009-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19358167,2009-06-01T00:00:00,Young Adult,M01.060.116.815
19385020,2009-06-01T00:00:00,Adult,M01.060.116
19385020,2009-06-01T00:00:00,Brain,A08.186.211
19385020,2009-06-01T00:00:00,Evoked Potentials,G07.265.500
19385020,2009-06-01T00:00:00,Evoked Potentials,G11.561.270
19385020,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19385020,2009-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19385020,2009-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19385020,2009-06-01T00:00:00,Young Adult,M01.060.116.815
19417663,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19417663,2009-06-01T00:00:00,Nasal Polyps,C08.460.572
19417663,2009-06-01T00:00:00,Nasal Polyps,C09.603.557
19417663,2009-06-01T00:00:00,Nasal Polyps,C23.300.825.557
19417663,2009-06-01T00:00:00,Paranasal Sinuses,A04.531.621
19417663,2009-06-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
19417663,2009-06-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
19417663,2009-06-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
19417663,2009-06-01T00:00:00,Superantigens,D23.050.820
19417663,2009-06-01T00:00:00,Turbinates,A02.835.232.781.324.948
19417663,2009-06-01T00:00:00,Turbinates,A04.531.898
19418446,2009-06-01T00:00:00,Animals,B01.050
19418446,2009-06-01T00:00:00,Chick Embryo,A13.350.150
19418446,2009-06-01T00:00:00,Chick Embryo,A16.331.200
19418446,2009-06-01T00:00:00,Echocardiography,E01.370.350.850.220
19418446,2009-06-01T00:00:00,Echocardiography,E01.370.370.380.220
19418446,2009-06-01T00:00:00,Heart,A07.541
19418446,2009-06-01T00:00:00,Heart Ventricles,A07.541.560
19418446,2009-06-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
19418446,2009-06-01T00:00:00,Myocardial Contraction,G09.330.190.541
19418446,2009-06-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
19418446,2009-06-01T00:00:00,"Stress, Mechanical",G01.374.676.830
19418446,2009-06-01T00:00:00,"Stress, Mechanical",G01.595.540.830
19451616,2009-06-01T00:00:00,Academic Medical Centers,N02.278.020
19451616,2009-06-01T00:00:00,Data Collection,E05.318.308
19451616,2009-06-01T00:00:00,Data Collection,L01.280
19451616,2009-06-01T00:00:00,Data Collection,N05.715.360.300
19451616,2009-06-01T00:00:00,Data Collection,N06.850.520.308
19451616,2009-06-01T00:00:00,"Databases, Factual",L01.470.750.750
19451616,2009-06-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
19451616,2009-06-01T00:00:00,Documentation,L01.453.245
19451616,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19451616,2009-06-01T00:00:00,Information Dissemination,F01.145.209.364
19451616,2009-06-01T00:00:00,Information Dissemination,L01.143.443
19451616,2009-06-01T00:00:00,Poison Control Centers,N02.278.726
19451616,2009-06-01T00:00:00,Poison Control Centers,N02.421.297.695
19451616,2009-06-01T00:00:00,Software,L01.224.900
19451616,2009-06-01T00:00:00,United States,Z01.107.567.875
19455707,2009-06-01T00:00:00,Adolescent,M01.060.057
19455707,2009-06-01T00:00:00,Adult,M01.060.116
19455707,2009-06-01T00:00:00,Aged,M01.060.116.100
19455707,2009-06-01T00:00:00,Anxiety Disorders,F03.080
19455707,2009-06-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
19455707,2009-06-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19455707,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19455707,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19455707,2009-06-01T00:00:00,Panic Disorder,F03.080.700
19455707,2009-06-01T00:00:00,Questionnaires,E05.318.308.750
19455707,2009-06-01T00:00:00,Questionnaires,L01.280.800
19455707,2009-06-01T00:00:00,Questionnaires,N05.715.360.300.695
19455707,2009-06-01T00:00:00,Questionnaires,N06.850.520.308.750
19455707,2009-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19455707,2009-06-01T00:00:00,Risk Factors,N05.715.350.200.700
19455707,2009-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19455707,2009-06-01T00:00:00,Risk Factors,N06.850.490.625.750
19455707,2009-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19455707,2009-06-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19455707,2009-06-01T00:00:00,Young Adult,M01.060.116.815
19467161,2009-06-01T00:00:00,Cystic Fibrosis,C06.689.202
19467161,2009-06-01T00:00:00,Cystic Fibrosis,C08.381.187
19467161,2009-06-01T00:00:00,Cystic Fibrosis,C16.320.190
19467161,2009-06-01T00:00:00,Cystic Fibrosis,C16.614.213
19467161,2009-06-01T00:00:00,Exercise Therapy,E02.779.483
19467161,2009-06-01T00:00:00,Exercise Therapy,E02.831.387
19467161,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19467161,2009-06-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19467161,2009-06-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19467161,2009-06-01T00:00:00,Suction,E04.237.890
19467161,2009-06-01T00:00:00,Treatment Outcome,E01.789.800
19467161,2009-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19467161,2009-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19478290,2009-06-01T00:00:00,"Adaptation, Psychological",F01.058
19478290,2009-06-01T00:00:00,Adult,M01.060.116
19478290,2009-06-01T00:00:00,Aged,M01.060.116.100
19478290,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19478290,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19478290,2009-06-01T00:00:00,Primary Health Care,N04.590.233.727
19478290,2009-06-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19478290,2009-06-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19478290,2009-06-01T00:00:00,Time Factors,G01.910.857
19478290,2009-06-01T00:00:00,United States,Z01.107.567.875
19478290,2009-06-01T00:00:00,Veterans,M01.930
19485583,2009-06-01T00:00:00,Adolescent,M01.060.057
19485583,2009-06-01T00:00:00,Antisocial Personality Disorder,F03.675.050
19485583,2009-06-01T00:00:00,Child,M01.060.406
19485583,2009-06-01T00:00:00,Family Therapy,F04.754.864.581.273
19485583,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19485583,2009-06-01T00:00:00,Inservice Training,I02.574
19485583,2009-06-01T00:00:00,Internal-External Control,F01.829.379
19485583,2009-06-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19485583,2009-06-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19485583,2009-06-01T00:00:00,Treatment Outcome,E01.789.800
19485583,2009-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19485583,2009-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19485583,2009-06-01T00:00:00,United States,Z01.107.567.875
19485587,2009-06-01T00:00:00,Adolescent,M01.060.057
19485587,2009-06-01T00:00:00,Antisocial Personality Disorder,F03.675.050
19485587,2009-06-01T00:00:00,Conduct Disorder,F03.550.150.300
19485587,2009-06-01T00:00:00,Education,I02
19485587,2009-06-01T00:00:00,Family Therapy,F04.754.864.581.273
19485587,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19485587,2009-06-01T00:00:00,Internal-External Control,F01.829.379
19485587,2009-06-01T00:00:00,Juvenile Delinquency,I01.880.735.479
19485587,2009-06-01T00:00:00,Motivation,F01.658
19485587,2009-06-01T00:00:00,Motivation,F01.752.543.500.750
19485587,2009-06-01T00:00:00,Parent-Child Relations,F01.829.263.370.290
19485587,2009-06-01T00:00:00,Parenting,F01.829.263.370.310
19485587,2009-06-01T00:00:00,Peer Group,F01.829.316.483
19485587,2009-06-01T00:00:00,Sex Offenses,I01.198.240.748
19485587,2009-06-01T00:00:00,Sexual Behavior,F01.145.802
19485587,2009-06-01T00:00:00,Substance-Related Disorders,C21.739
19485587,2009-06-01T00:00:00,Substance-Related Disorders,F03.900
19490037,2009-06-01T00:00:00,Adolescent,M01.060.057
19490037,2009-06-01T00:00:00,Adult,M01.060.116
19490037,2009-06-01T00:00:00,Attitude to Health,F01.100.150
19490037,2009-06-01T00:00:00,Attitude to Health,N05.300.150
19490037,2009-06-01T00:00:00,Caregivers,M01.085
19490037,2009-06-01T00:00:00,Caregivers,M01.526.485.200
19490037,2009-06-01T00:00:00,Caregivers,N02.360.200
19490037,2009-06-01T00:00:00,Child,M01.060.406
19490037,2009-06-01T00:00:00,Epilepsy,C10.228.140.490
19490037,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19490037,2009-06-01T00:00:00,International Classification of Diseases,L01.453.245.945.400
19490037,2009-06-01T00:00:00,Personality Inventory,F04.711.647.513
19490037,2009-06-01T00:00:00,Questionnaires,E05.318.308.750
19490037,2009-06-01T00:00:00,Questionnaires,L01.280.800
19490037,2009-06-01T00:00:00,Questionnaires,N05.715.360.300.695
19490037,2009-06-01T00:00:00,Questionnaires,N06.850.520.308.750
19490037,2009-06-01T00:00:00,Self Care,E02.900
19490037,2009-06-01T00:00:00,Self Care,N02.421.784.680
19490037,2009-06-01T00:00:00,Self Efficacy,F01.752.747.792.700
19490037,2009-06-01T00:00:00,Social Support,I01.880.656.600
19501240,2009-06-01T00:00:00,Diet,E05.272
19501240,2009-06-01T00:00:00,Diet,G07.610.240
19501240,2009-06-01T00:00:00,Exercise,G11.427.590.237
19501240,2009-06-01T00:00:00,Exercise,I03.350
19501240,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19501240,2009-06-01T00:00:00,Obesity,C18.654.726.500
19501240,2009-06-01T00:00:00,Obesity,C23.888.144.699.500
19501240,2009-06-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19501240,2009-06-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19501240,2009-06-01T00:00:00,Primary Health Care,N04.590.233.727
19501240,2009-06-01T00:00:00,United States,Z01.107.567.875
19501250,2009-06-01T00:00:00,Complementary Therapies,E02.190
19501250,2009-06-01T00:00:00,Dietary Supplements,J02.500.456
19501250,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19501250,2009-06-01T00:00:00,Obesity,C18.654.726.500
19501250,2009-06-01T00:00:00,Obesity,C23.888.144.699.500
19501250,2009-06-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19501250,2009-06-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19501250,2009-06-01T00:00:00,Weight Loss,C23.888.144.243.963
19501250,2009-06-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19501252,2009-06-01T00:00:00,Bariatric Surgery,E02.065.062
19501252,2009-06-01T00:00:00,Bariatric Surgery,E04.062
19501252,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19501252,2009-06-01T00:00:00,Obesity,C18.654.726.500
19501252,2009-06-01T00:00:00,Obesity,C23.888.144.699.500
19501252,2009-06-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19501252,2009-06-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19501252,2009-06-01T00:00:00,Weight Loss,C23.888.144.243.963
19501252,2009-06-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19505428,2009-06-01T00:00:00,Animals,B01.050
19505428,2009-06-01T00:00:00,"Disease Models, Animal",C22.232
19505428,2009-06-01T00:00:00,"Disease Models, Animal",E05.598.500
19505428,2009-06-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19505428,2009-06-01T00:00:00,Endothelin-1,D12.644.276.400.225
19505428,2009-06-01T00:00:00,Endothelin-1,D12.776.467.400.225
19505428,2009-06-01T00:00:00,Endothelin-1,D23.529.400.225
19505428,2009-06-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
19505428,2009-06-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
19505428,2009-06-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
19505428,2009-06-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
19505428,2009-06-01T00:00:00,Fibronectins,D12.776.377.715.390
19505428,2009-06-01T00:00:00,Fibronectins,D12.776.395.550.350
19505428,2009-06-01T00:00:00,Fibronectins,D12.776.543.550.350
19505428,2009-06-01T00:00:00,Fibronectins,D12.776.860.300.450
19505428,2009-06-01T00:00:00,Liver,A03.620
19505428,2009-06-01T00:00:00,Phosphorylation,G02.111.087.677
19505428,2009-06-01T00:00:00,Phosphorylation,G02.149.115.677
19505428,2009-06-01T00:00:00,Phosphorylation,G02.149.465.700
19505428,2009-06-01T00:00:00,Phosphorylation,G02.607.750.700
19505428,2009-06-01T00:00:00,Phosphorylation,G03.495.790
19505428,2009-06-01T00:00:00,Probability,E05.318.740.600
19505428,2009-06-01T00:00:00,Probability,G17.680
19505428,2009-06-01T00:00:00,Probability,N05.715.360.750.625
19505428,2009-06-01T00:00:00,Probability,N06.850.520.830.600
19505428,2009-06-01T00:00:00,"RNA, Messenger",D13.444.735.544
19505428,2009-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19505428,2009-06-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19505428,2009-06-01T00:00:00,Signal Transduction,G02.111.087.800
19505428,2009-06-01T00:00:00,Signal Transduction,G02.149.115.800
19505428,2009-06-01T00:00:00,Signal Transduction,G04.299.880
19505428,2009-06-01T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
19524729,2009-06-01T00:00:00,Adolescent,M01.060.057
19524729,2009-06-01T00:00:00,Age Factors,N05.715.350.075
19524729,2009-06-01T00:00:00,Age Factors,N06.850.490.250
19524729,2009-06-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
19524729,2009-06-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
19524729,2009-06-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
19524729,2009-06-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
19524729,2009-06-01T00:00:00,Child,M01.060.406
19524729,2009-06-01T00:00:00,"Child, Preschool",M01.060.406.448
19524729,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19524729,2009-06-01T00:00:00,Infant,M01.060.703
19524729,2009-06-01T00:00:00,Sepsis,C01.539.757
19524729,2009-06-01T00:00:00,Sepsis,C23.550.470.790.500
19524729,2009-06-01T00:00:00,Spleen,A10.549.700
19524729,2009-06-01T00:00:00,Spleen,A15.382.520.604.700
19524729,2009-06-01T00:00:00,Splenectomy,E04.726
19524729,2009-06-01T00:00:00,Young Adult,M01.060.116.815
19528134,2009-06-01T00:00:00,Adolescent,M01.060.057
19528134,2009-06-01T00:00:00,Adult,M01.060.116
19528134,2009-06-01T00:00:00,Behavior Therapy,F04.754.137
19528134,2009-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19528134,2009-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
19528134,2009-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19528134,2009-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19528134,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19528134,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19528134,2009-06-01T00:00:00,Minority Groups,I01.880.371
19528134,2009-06-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
19528134,2009-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19528134,2009-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19528134,2009-06-01T00:00:00,Substance-Related Disorders,C21.739
19528134,2009-06-01T00:00:00,Substance-Related Disorders,F03.900
19528134,2009-06-01T00:00:00,Treatment Outcome,E01.789.800
19528134,2009-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19528134,2009-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19528134,2009-06-01T00:00:00,Young Adult,M01.060.116.815
19528382,2009-06-01T00:00:00,Aged,M01.060.116.100
19528382,2009-06-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19528382,2009-06-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19528382,2009-06-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19528382,2009-06-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19528382,2009-06-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19528382,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19528382,2009-06-01T00:00:00,Lymphocytes,A11.118.637.555.567
19528382,2009-06-01T00:00:00,Lymphocytes,A15.145.229.637.555.567
19528382,2009-06-01T00:00:00,Lymphocytes,A15.382.490.555.567
19530970,2009-06-01T00:00:00,Adult,M01.060.116
19530970,2009-06-01T00:00:00,Aged,M01.060.116.100
19530970,2009-06-01T00:00:00,Anticoagulants,D27.505.954.502.119
19530970,2009-06-01T00:00:00,DNA,D13.444.308
19530970,2009-06-01T00:00:00,Ethnic Groups,M01.686.754
19530970,2009-06-01T00:00:00,Ethnic Groups,N01.224.317
19530970,2009-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19530970,2009-06-01T00:00:00,Genetic Variation,G05.365
19530970,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19530970,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19530970,2009-06-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19530970,2009-06-01T00:00:00,Young Adult,M01.060.116.815
19545095,2009-06-01T00:00:00,Aged,M01.060.116.100
19545095,2009-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
19545095,2009-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
19545095,2009-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
19545095,2009-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
19545095,2009-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
19545095,2009-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
19545095,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19545095,2009-06-01T00:00:00,Iatrogenic Disease,C23.550.291.875
19545095,2009-06-01T00:00:00,Intestinal Perforation,C06.405.469.557
19545095,2009-06-01T00:00:00,Length of Stay,E02.760.400.480
19545095,2009-06-01T00:00:00,Length of Stay,N02.421.585.400.480
19545095,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19545095,2009-06-01T00:00:00,Postoperative Complications,C23.550.767
19545095,2009-06-01T00:00:00,Treatment Outcome,E01.789.800
19545095,2009-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19545095,2009-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19603582,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19603582,2009-06-01T00:00:00,Materials Testing,E05.570
19639767,2009-06-01T00:00:00,HIV Infections,C02.782.815.616.400
19639767,2009-06-01T00:00:00,HIV Infections,C02.800.801.400
19639767,2009-06-01T00:00:00,HIV Infections,C20.673.480
19639767,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19655583,2009-06-01T00:00:00,Alcoholism,C21.739.100.250
19655583,2009-06-01T00:00:00,Alcoholism,F03.900.100.350
19655583,2009-06-01T00:00:00,Biological Markers,D23.101
19655583,2009-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19655583,2009-06-01T00:00:00,Middle Aged,M01.060.116.630
19655583,2009-06-01T00:00:00,Substance Abuse Detection,E05.885
19655583,2009-06-01T00:00:00,Substance Abuse Detection,N06.850.780.500.765
19655583,2009-06-01T00:00:00,Transferrin,D12.776.124.050.800
19655583,2009-06-01T00:00:00,Transferrin,D12.776.124.790.223.839
19655583,2009-06-01T00:00:00,Transferrin,D12.776.157.427.500
19655583,2009-06-01T00:00:00,Transferrin,D12.776.377.715.182.839
19655583,2009-06-01T00:00:00,Transferrin,D12.776.556.579.500
19655583,2009-06-01T00:00:00,United States,Z01.107.567.875
19681306,2009-06-01T00:00:00,Animals,B01.050
19681306,2009-06-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
19681306,2009-06-01T00:00:00,"Models, Animal",E05.598
19681306,2009-06-01T00:00:00,Pericardium,A07.541.795
19681306,2009-06-01T00:00:00,Pericardium,A10.615.789.470
19681306,2009-06-01T00:00:00,Suction,E04.237.890
19681306,2009-06-01T00:00:00,Swine,B01.050.150.900.649.077.880
19681306,2009-06-01T00:00:00,Temperature,G01.906.595
19681306,2009-06-01T00:00:00,Temperature,G16.500.275.063.725.710
19681306,2009-06-01T00:00:00,Temperature,G16.500.750.775.710
19681306,2009-06-01T00:00:00,Temperature,N06.230.150.450
19681306,2009-06-01T00:00:00,Temperature,N06.230.300.100.725.710
20355925,2009-06-01T00:00:00,Color,G01.201.875.770.578.199
20355925,2009-06-01T00:00:00,Color,G01.590.540.199
20355925,2009-06-01T00:00:00,Crystallization,E05.196.300
20355925,2009-06-01T00:00:00,Crystallization,G02.149.767.505
20355925,2009-06-01T00:00:00,Crystallization,G02.842.750.505
20355925,2009-06-01T00:00:00,Liposomes,D25.479.517
20355925,2009-06-01T00:00:00,Liposomes,D26.255.260.517
20355925,2009-06-01T00:00:00,Liposomes,D27.720.280.260.517
20355925,2009-06-01T00:00:00,Liposomes,J01.637.051.479.517
20355925,2009-06-01T00:00:00,Liposomes,J01.637.087.500.517
20355925,2009-06-01T00:00:00,Materials Testing,E05.570
20355925,2009-06-01T00:00:00,Polymers,D05.750
20355925,2009-06-01T00:00:00,Polymers,D25.720
20355925,2009-06-01T00:00:00,Polymers,J01.637.051.720
20355925,2009-06-01T00:00:00,"Spectrum Analysis, Raman",E05.196.822.860
20355925,2009-06-01T00:00:00,"Spectrum Analysis, Raman",E05.196.867.890
19491250,2009-06-02T00:00:00,Animals,B01.050
19491250,2009-06-02T00:00:00,Body Weight,C23.888.144
19491250,2009-06-02T00:00:00,Body Weight,E01.370.600.115.100.160.120
19491250,2009-06-02T00:00:00,Body Weight,E05.041.124.160.750
19491250,2009-06-02T00:00:00,Body Weight,G07.100.100.160.120
19491250,2009-06-02T00:00:00,Body Weight,G07.700.320.249.314.120
19491250,2009-06-02T00:00:00,Gastric Acid,A12.200.307.603
19491250,2009-06-02T00:00:00,Gastric Mucosa,A03.556.875.875.440
19491250,2009-06-02T00:00:00,Gastric Mucosa,A10.615.550.291
19491250,2009-06-02T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
19491250,2009-06-02T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
19491250,2009-06-02T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
19493696,2009-06-02T00:00:00,Adult,M01.060.116
19493696,2009-06-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19493696,2009-06-02T00:00:00,New York,Z01.107.567.875.075.437
19493696,2009-06-02T00:00:00,New York,Z01.107.567.875.350.530
19493696,2009-06-02T00:00:00,New York,Z01.107.567.875.500.530
19493696,2009-06-02T00:00:00,Occupational Exposure,N06.850.460.350.600
19493696,2009-06-02T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
19493696,2009-06-02T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
19493696,2009-06-02T00:00:00,Risk Assessment,E05.318.740.600.800.715
19493696,2009-06-02T00:00:00,Risk Assessment,N04.452.871.715
19493696,2009-06-02T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19493696,2009-06-02T00:00:00,Risk Assessment,N06.850.505.715
19493696,2009-06-02T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19497319,2009-06-02T00:00:00,Animals,B01.050
19497319,2009-06-02T00:00:00,Avian Proteins,D12.776.093
19497319,2009-06-02T00:00:00,Bone Morphogenetic Protein 2,D12.644.276.954.200.200
19497319,2009-06-02T00:00:00,Bone Morphogenetic Protein 2,D12.776.467.942.200.200
19497319,2009-06-02T00:00:00,Bone Morphogenetic Protein 2,D23.529.942.200.200
19497319,2009-06-02T00:00:00,Chick Embryo,A13.350.150
19497319,2009-06-02T00:00:00,Chick Embryo,A16.331.200
19497319,2009-06-02T00:00:00,Heart,A07.541
19497319,2009-06-02T00:00:00,Homeodomain Proteins,D12.776.260.400
19497319,2009-06-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19497319,2009-06-02T00:00:00,Morphogenesis,G07.700.320.500
19497319,2009-06-02T00:00:00,Stem Cells,A11.872
19497319,2009-06-02T00:00:00,Transcription Factors,D12.776.930
19497828,2009-06-02T00:00:00,Adult,M01.060.116
19497828,2009-06-02T00:00:00,Algorithms,G17.035
19497828,2009-06-02T00:00:00,Algorithms,L01.224.050
19497828,2009-06-02T00:00:00,Electric Stimulation,E05.723.402
19497828,2009-06-02T00:00:00,"Feedback, Physiological",G07.700.360.732
19497828,2009-06-02T00:00:00,"Feedback, Physiological",L01.143.283.425.311
19497828,2009-06-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19497828,2009-06-02T00:00:00,Knee Joint,A02.835.583.475
19497828,2009-06-02T00:00:00,Movement,G07.700.560
19497828,2009-06-02T00:00:00,Movement,G11.427.590.530
19497828,2009-06-02T00:00:00,Muscle Contraction,G11.427.590.540
19497828,2009-06-02T00:00:00,"Muscle, Skeletal",A02.633.567
19497828,2009-06-02T00:00:00,"Muscle, Skeletal",A10.690.552.500
19497828,2009-06-02T00:00:00,Task Performance and Analysis,F02.784.412.846
19497828,2009-06-02T00:00:00,Task Performance and Analysis,F02.784.692.746
19497828,2009-06-02T00:00:00,Task Performance and Analysis,F02.808.600
19497828,2009-06-02T00:00:00,Young Adult,M01.060.116.815
19540763,2009-06-02T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
19540763,2009-06-02T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
19540763,2009-06-02T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
19540763,2009-06-02T00:00:00,Animals,B01.050
19540763,2009-06-02T00:00:00,Molecular Structure,G02.111.570
19540763,2009-06-02T00:00:00,Molecular Structure,G02.575
19540763,2009-06-02T00:00:00,Molecular Structure,G02.842.575
19540763,2009-06-02T00:00:00,Pain,C10.597.617
19540763,2009-06-02T00:00:00,Pain,C23.888.592.612
19540763,2009-06-02T00:00:00,Pain,C23.888.646
19540763,2009-06-02T00:00:00,Pain,F02.830.816.444
19540763,2009-06-02T00:00:00,Pain,G11.561.600.810.444
19540763,2009-06-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19540763,2009-06-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19540763,2009-06-02T00:00:00,"Receptors, Opioid",D12.776.543.750.100.620
19540763,2009-06-02T00:00:00,"Receptors, Opioid",D12.776.543.750.720.600.610
19540763,2009-06-02T00:00:00,"Receptors, Opioid",D12.776.543.750.750.555.610
19490732,2009-06-03T00:00:00,Animals,B01.050
19490732,2009-06-03T00:00:00,Astrocytes,A08.637.200
19490732,2009-06-03T00:00:00,Astrocytes,A11.650.200
19490732,2009-06-03T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
19490732,2009-06-03T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
19490732,2009-06-03T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
19490732,2009-06-03T00:00:00,Major Histocompatibility Complex,G05.360.340.024.340.610
19490732,2009-06-03T00:00:00,Major Histocompatibility Complex,G05.360.340.024.380.500
19490732,2009-06-03T00:00:00,Major Histocompatibility Complex,G12.500.500
19490732,2009-06-03T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
19490732,2009-06-03T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
19490732,2009-06-03T00:00:00,Neurons,A08.663
19490732,2009-06-03T00:00:00,Neurons,A11.671
19490732,2009-06-03T00:00:00,Oxidative Stress,G03.495.710
19490732,2009-06-03T00:00:00,Oxidative Stress,G07.700.830.750
19490732,2009-06-03T00:00:00,Proteins,D12.776
19490732,2009-06-03T00:00:00,Signal Transduction,G02.111.087.800
19490732,2009-06-03T00:00:00,Signal Transduction,G02.149.115.800
19490732,2009-06-03T00:00:00,Signal Transduction,G04.299.880
19494111,2009-06-03T00:00:00,Apoptosis,G04.299.139.160
19494111,2009-06-03T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
19494111,2009-06-03T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
19494111,2009-06-03T00:00:00,Binding Sites,G02.111.570.120
19494111,2009-06-03T00:00:00,Cell Death,G04.299.139
19494111,2009-06-03T00:00:00,Hepatocytes,A11.436.348
19494111,2009-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19494111,2009-06-03T00:00:00,Membrane Proteins,D12.776.543
19494111,2009-06-03T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19494111,2009-06-03T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19494111,2009-06-03T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19494111,2009-06-03T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
19494111,2009-06-03T00:00:00,"RNA, Messenger",D13.444.735.544
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D23.529.374.687
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
19494111,2009-06-03T00:00:00,Transforming Growth Factor beta,D23.529.960.720
19494565,2009-06-03T00:00:00,Adolescent,M01.060.057
19494565,2009-06-03T00:00:00,Adult,M01.060.116
19494565,2009-06-03T00:00:00,Child,M01.060.406
19494565,2009-06-03T00:00:00,"Child, Preschool",M01.060.406.448
19494565,2009-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19494565,2009-06-03T00:00:00,Infant,M01.060.703
19494565,2009-06-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19494565,2009-06-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19494565,2009-06-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19494565,2009-06-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19494565,2009-06-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19576347,2009-06-03T00:00:00,Aged,M01.060.116.100
19576347,2009-06-03T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19576347,2009-06-03T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19576347,2009-06-03T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19576347,2009-06-03T00:00:00,Coronary Vessels,A07.231.114.269
19576347,2009-06-03T00:00:00,Coronary Vessels,A07.231.908.194
19576347,2009-06-03T00:00:00,Heart Ventricles,A07.541.560
19576347,2009-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19576347,2009-06-03T00:00:00,Middle Aged,M01.060.116.630
19576347,2009-06-03T00:00:00,Myocardial Contraction,G09.330.190.541
19576347,2009-06-03T00:00:00,Myocardial Contraction,G11.427.590.540.570
19576347,2009-06-03T00:00:00,Takotsubo Cardiomyopathy,C14.280.945.900.500
19498013,2009-06-04T00:00:00,Adult,M01.060.116
19498013,2009-06-04T00:00:00,Aged,M01.060.116.100
19498013,2009-06-04T00:00:00,Disability Evaluation,E01.370.400
19498013,2009-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19498013,2009-06-04T00:00:00,Middle Aged,M01.060.116.630
19498013,2009-06-04T00:00:00,Motor Activity,F01.145.632
19498013,2009-06-04T00:00:00,Motor Activity,G11.427.590.530.698
19498013,2009-06-04T00:00:00,Movement Disorders,C10.228.662
19498013,2009-06-04T00:00:00,Stroke,C10.228.140.300.775
19498013,2009-06-04T00:00:00,Stroke,C14.907.253.855
19498013,2009-06-04T00:00:00,Time Factors,G01.910.857
19498013,2009-06-04T00:00:00,Young Adult,M01.060.116.815
19498344,2009-06-04T00:00:00,Adult,M01.060.116
19498344,2009-06-04T00:00:00,Body Mass Index,E01.370.600.115.100.125
19498344,2009-06-04T00:00:00,Body Mass Index,E05.041.124.125
19498344,2009-06-04T00:00:00,Body Mass Index,G07.100.100.125
19498344,2009-06-04T00:00:00,Body Mass Index,N06.850.505.200.100.175
19498344,2009-06-04T00:00:00,Gastric Bypass,E02.065.062.249
19498344,2009-06-04T00:00:00,Gastric Bypass,E04.035.398.385
19498344,2009-06-04T00:00:00,Gastric Bypass,E04.062.249
19498344,2009-06-04T00:00:00,Gastric Bypass,E04.210.457.430
19498344,2009-06-04T00:00:00,Health Status,I01.240.425
19498344,2009-06-04T00:00:00,Health Status,N01.224.425
19498344,2009-06-04T00:00:00,Health Status,N06.850.505.400.425
19498344,2009-06-04T00:00:00,Health Surveys,E05.318.308.250
19498344,2009-06-04T00:00:00,Health Surveys,N05.715.360.300.375
19498344,2009-06-04T00:00:00,Health Surveys,N06.850.520.308.250
19498344,2009-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19498344,2009-06-04T00:00:00,Middle Aged,M01.060.116.630
19498344,2009-06-04T00:00:00,Obesity,C18.654.726.500
19498344,2009-06-04T00:00:00,Obesity,C23.888.144.699.500
19498344,2009-06-04T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19498344,2009-06-04T00:00:00,Obesity,G07.100.100.160.120.699.500
19498344,2009-06-04T00:00:00,Quality of Life,I01.800
19498344,2009-06-04T00:00:00,Quality of Life,K01.752.400.750
19498344,2009-06-04T00:00:00,Questionnaires,E05.318.308.750
19498344,2009-06-04T00:00:00,Questionnaires,L01.280.800
19498344,2009-06-04T00:00:00,Questionnaires,N05.715.360.300.695
19498344,2009-06-04T00:00:00,Questionnaires,N06.850.520.308.750
19498344,2009-06-04T00:00:00,Regression Analysis,E05.318.740.750
19498344,2009-06-04T00:00:00,Regression Analysis,N05.715.360.750.695
19498344,2009-06-04T00:00:00,Regression Analysis,N06.850.520.830.750
19498344,2009-06-04T00:00:00,Treatment Outcome,E01.789.800
19498344,2009-06-04T00:00:00,Treatment Outcome,N04.761.559.590.800
19498344,2009-06-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19498344,2009-06-04T00:00:00,Weight Loss,C23.888.144.243.963
19498344,2009-06-04T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19499338,2009-06-05T00:00:00,Adolescent,M01.060.057
19499338,2009-06-05T00:00:00,Adult,M01.060.116
19499338,2009-06-05T00:00:00,Aged,M01.060.116.100
19499338,2009-06-05T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
19499338,2009-06-05T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
19499338,2009-06-05T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
19499338,2009-06-05T00:00:00,Autoimmunity,G12.450.192
19499338,2009-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19499338,2009-06-05T00:00:00,Middle Aged,M01.060.116.630
19499338,2009-06-05T00:00:00,Neuroglia,A08.637
19499338,2009-06-05T00:00:00,Neuroglia,A11.650
19499338,2009-06-05T00:00:00,Young Adult,M01.060.116.815
19500430,2009-06-05T00:00:00,Animals,B01.050
19500430,2009-06-05T00:00:00,Electric Conductivity,G01.201.249.277
19500430,2009-06-05T00:00:00,Larva,B05.500.500
19500430,2009-06-05T00:00:00,Larva,G07.700.320.500.550.500.500
19500430,2009-06-05T00:00:00,Membranes,A10.615
19500430,2009-06-05T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
19500430,2009-06-05T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
19500430,2009-06-05T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
19500430,2009-06-05T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
19500430,2009-06-05T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
19500430,2009-06-05T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
19500430,2009-06-05T00:00:00,Time Factors,G01.910.857
19501011,2009-06-05T00:00:00,Adult,M01.060.116
19501011,2009-06-05T00:00:00,Aged,M01.060.116.100
19501011,2009-06-05T00:00:00,Clinical Trials as Topic,E05.318.760.535
19501011,2009-06-05T00:00:00,Clinical Trials as Topic,E05.337.250
19501011,2009-06-05T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19501011,2009-06-05T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19501011,2009-06-05T00:00:00,Cognition,F02.463.188
19501011,2009-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19501011,2009-06-05T00:00:00,Informed Consent,I01.880.604.473.650.718
19501011,2009-06-05T00:00:00,Informed Consent,I01.880.604.583.427
19501011,2009-06-05T00:00:00,Informed Consent,N03.706.437.650.312
19501011,2009-06-05T00:00:00,Informed Consent,N03.706.535.489
19501011,2009-06-05T00:00:00,Medication Adherence,F01.145.488.500.500
19501011,2009-06-05T00:00:00,Medication Adherence,N05.300.150.600.600.500
19501011,2009-06-05T00:00:00,Middle Aged,M01.060.116.630
19501011,2009-06-05T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19501011,2009-06-05T00:00:00,Parkinson Disease,C10.228.662.600.400
19501011,2009-06-05T00:00:00,Parkinson Disease,C10.574.812
19501011,2009-06-05T00:00:00,Questionnaires,E05.318.308.750
19501011,2009-06-05T00:00:00,Questionnaires,L01.280.800
19501011,2009-06-05T00:00:00,Questionnaires,N05.715.360.300.695
19501011,2009-06-05T00:00:00,Questionnaires,N06.850.520.308.750
19501011,2009-06-05T00:00:00,Treatment Outcome,E01.789.800
19501011,2009-06-05T00:00:00,Treatment Outcome,N04.761.559.590.800
19501011,2009-06-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19503839,2009-06-05T00:00:00,Anti-Infective Agents,D27.505.954.122
19503839,2009-06-05T00:00:00,Antimicrobial Cationic Peptides,D12.644.050
19503839,2009-06-05T00:00:00,Antimicrobial Cationic Peptides,D12.776.543.695.054
19503839,2009-06-05T00:00:00,Gene Expression Regulation,G05.355.315
19503839,2009-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19503839,2009-06-05T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
19503839,2009-06-05T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
19503839,2009-06-05T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
19503839,2009-06-05T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
19503839,2009-06-05T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
19503839,2009-06-05T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
19503839,2009-06-05T00:00:00,"Models, Biological",E05.599.395
19503839,2009-06-05T00:00:00,Monocytes,A11.118.637.555.652
19503839,2009-06-05T00:00:00,Monocytes,A11.148.580
19503839,2009-06-05T00:00:00,Monocytes,A11.627.624
19503839,2009-06-05T00:00:00,Monocytes,A11.733.547
19503839,2009-06-05T00:00:00,Monocytes,A15.145.229.637.555.652
19503839,2009-06-05T00:00:00,Monocytes,A15.378.316.580
19503839,2009-06-05T00:00:00,Monocytes,A15.382.490.555.652
19503839,2009-06-05T00:00:00,Monocytes,A15.382.680.547
19503839,2009-06-05T00:00:00,Monocytes,A15.382.812.547
19503839,2009-06-05T00:00:00,Mycobacterium tuberculosis,B03.510.024.049.525.500.702
19503839,2009-06-05T00:00:00,Mycobacterium tuberculosis,B03.510.460.400.410.552.552.702
19503839,2009-06-05T00:00:00,NF-kappa B,D12.776.260.600
19503839,2009-06-05T00:00:00,NF-kappa B,D12.776.660.600
19503839,2009-06-05T00:00:00,NF-kappa B,D12.776.930.600
19503839,2009-06-05T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19503839,2009-06-05T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19503839,2009-06-05T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19503839,2009-06-05T00:00:00,Stem Cells,A11.872
19503839,2009-06-05T00:00:00,beta-Defensins,D12.644.050.200.075
19503839,2009-06-05T00:00:00,beta-Defensins,D12.776.543.695.054.200.075
19501042,2009-06-06T00:00:00,Alzheimer Disease,C10.228.140.380.100
19501042,2009-06-06T00:00:00,Alzheimer Disease,C10.574.945.249
19501042,2009-06-06T00:00:00,Alzheimer Disease,F03.087.400.100
19501042,2009-06-06T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
19501042,2009-06-06T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
19501042,2009-06-06T00:00:00,Animals,B01.050
19501042,2009-06-06T00:00:00,Brain,A08.186.211
19501042,2009-06-06T00:00:00,Cathepsin B,D08.811.277.656.224.125
19501042,2009-06-06T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
19501042,2009-06-06T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
19501042,2009-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19501042,2009-06-06T00:00:00,Mutation,G05.365.590
19501042,2009-06-06T00:00:00,Peptide Fragments,D12.644.541
19501198,2009-06-06T00:00:00,DNA-Directed DNA Polymerase,D08.811.913.696.445.308.300
19501198,2009-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19501198,2009-06-06T00:00:00,Infant,M01.060.703
19501198,2009-06-06T00:00:00,Molecular Sequence Data,L01.453.245.667
19501198,2009-06-06T00:00:00,Mutation,G05.365.590
19501198,2009-06-06T00:00:00,Point Mutation,G05.365.590.675
19501198,2009-06-06T00:00:00,RNA Stability,G02.111.780
19501426,2009-06-06T00:00:00,Age Factors,N05.715.350.075
19501426,2009-06-06T00:00:00,Age Factors,N06.850.490.250
19501426,2009-06-06T00:00:00,Child,M01.060.406
19501426,2009-06-06T00:00:00,"Child, Preschool",M01.060.406.448
19501426,2009-06-06T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19501426,2009-06-06T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19501426,2009-06-06T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19501426,2009-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19501426,2009-06-06T00:00:00,Infant,M01.060.703
19501426,2009-06-06T00:00:00,Ketamine,D02.455.426.392.368.367.652
19501426,2009-06-06T00:00:00,Psychomotor Agitation,C10.597.350.600
19501426,2009-06-06T00:00:00,Psychomotor Agitation,C10.597.606.881.700
19501426,2009-06-06T00:00:00,Psychomotor Agitation,C23.888.592.350.600
19501426,2009-06-06T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
19501426,2009-06-06T00:00:00,Psychomotor Agitation,F01.700.875.700
19501426,2009-06-06T00:00:00,Risk Factors,E05.318.740.600.800.725
19501426,2009-06-06T00:00:00,Risk Factors,N05.715.350.200.700
19501426,2009-06-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19501426,2009-06-06T00:00:00,Risk Factors,N06.850.490.625.750
19501426,2009-06-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19501426,2009-06-06T00:00:00,Vomiting,C23.888.821.937
19505441,2009-06-06T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19505441,2009-06-06T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19505441,2009-06-06T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19505441,2009-06-06T00:00:00,Apoptosis,G04.299.139.160
19505441,2009-06-06T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
19505441,2009-06-06T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
19505441,2009-06-06T00:00:00,Cell Cycle,G04.299.134
19505441,2009-06-06T00:00:00,Enzyme Inhibitors,D27.505.519.389
19505441,2009-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19505441,2009-06-06T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
19505441,2009-06-06T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
19505441,2009-06-06T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
19505441,2009-06-06T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19616661,2009-06-06T00:00:00,Aged,M01.060.116.100
19616661,2009-06-06T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19616661,2009-06-06T00:00:00,Coronary Angiography,E01.370.370.050.200
19616661,2009-06-06T00:00:00,Coronary Angiography,E01.370.370.380.200
19616661,2009-06-06T00:00:00,Coronary Stenosis,C14.280.647.250.285
19616661,2009-06-06T00:00:00,Coronary Stenosis,C14.907.585.250.285
19616661,2009-06-06T00:00:00,Coronary Vessels,A07.231.114.269
19616661,2009-06-06T00:00:00,Coronary Vessels,A07.231.908.194
19616661,2009-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19616661,2009-06-06T00:00:00,Middle Aged,M01.060.116.630
19616661,2009-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
19616661,2009-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
19616661,2009-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
19616661,2009-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
19616661,2009-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
19616661,2009-06-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19616661,2009-06-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19616661,2009-06-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19616661,2009-06-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19616661,2009-06-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19616678,2009-06-06T00:00:00,Adolescent,M01.060.057
19616678,2009-06-06T00:00:00,Cardiac Volume,G09.330.380.249
19616678,2009-06-06T00:00:00,Child,M01.060.406
19616678,2009-06-06T00:00:00,Diastole,G09.330.190.541.295
19616678,2009-06-06T00:00:00,Diastole,G11.427.590.540.554.250
19616678,2009-06-06T00:00:00,Diastole,G11.427.590.540.570.295
19616678,2009-06-06T00:00:00,Echocardiography,E01.370.350.850.220
19616678,2009-06-06T00:00:00,Echocardiography,E01.370.370.380.220
19616678,2009-06-06T00:00:00,Fontan Procedure,E04.035.410.295
19616678,2009-06-06T00:00:00,Fontan Procedure,E04.100.376.410.295
19616678,2009-06-06T00:00:00,Fontan Procedure,E04.928.220.370.295
19616678,2009-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19616678,2009-06-06T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19616678,2009-06-06T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19616678,2009-06-06T00:00:00,Stroke Volume,E01.370.370.380.150.700
19616678,2009-06-06T00:00:00,Stroke Volume,G09.330.380.124.882
19616678,2009-06-06T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
19616678,2009-06-06T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
19786282,2009-06-06T00:00:00,Adult,M01.060.116
19786282,2009-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19786282,2009-06-06T00:00:00,Mass Screening,E01.370.500
19786282,2009-06-06T00:00:00,Mass Screening,E05.318.308.250.580
19786282,2009-06-06T00:00:00,Mass Screening,N02.421.143.827.233.443
19786282,2009-06-06T00:00:00,Mass Screening,N02.421.726.233.443
19786282,2009-06-06T00:00:00,Mass Screening,N05.715.360.300.375.500
19786282,2009-06-06T00:00:00,Mass Screening,N06.850.520.308.250.580
19786282,2009-06-06T00:00:00,Mass Screening,N06.850.780.500
19786282,2009-06-06T00:00:00,Trauma Centers,N02.278.354.422.336.500
19786282,2009-06-06T00:00:00,Trauma Centers,N02.421.297.195.480
19786282,2009-06-06T00:00:00,Trauma Centers,N04.452.442.422.336.400
19506231,2009-06-09T00:00:00,Brain,A08.186.211
19506231,2009-06-09T00:00:00,Disease Progression,C23.550.291.656
19506231,2009-06-09T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
19506231,2009-06-09T00:00:00,Hippocampus,A08.186.211.464.405
19506231,2009-06-09T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
19506231,2009-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19506231,2009-06-09T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19506231,2009-06-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19506231,2009-06-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19506231,2009-06-09T00:00:00,Neural Pathways,A08.612
19509254,2009-06-09T00:00:00,Apoptosis,G04.299.139.160
19509254,2009-06-09T00:00:00,Cell Cycle,G04.299.134
19509254,2009-06-09T00:00:00,Cell Proliferation,G04.299.233.750
19509254,2009-06-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19509254,2009-06-09T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.644.360.225.600
19509254,2009-06-09T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.167.187.600
19509254,2009-06-09T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.476.225.600
19509254,2009-06-09T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.624.776.355.600
19509254,2009-06-09T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19509254,2009-06-09T00:00:00,Flow Cytometry,E05.200.500.386.350
19509254,2009-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19509254,2009-06-09T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19509254,2009-06-09T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19509254,2009-06-09T00:00:00,Leukemia,C04.557.337
19509254,2009-06-09T00:00:00,Molecular Structure,G02.111.570
19509254,2009-06-09T00:00:00,Molecular Structure,G02.575
19509254,2009-06-09T00:00:00,Molecular Structure,G02.842.575
19509254,2009-06-09T00:00:00,Phosphorylation,G02.111.087.677
19509254,2009-06-09T00:00:00,Phosphorylation,G02.149.115.677
19509254,2009-06-09T00:00:00,Phosphorylation,G02.149.465.700
19509254,2009-06-09T00:00:00,Phosphorylation,G02.607.750.700
19509254,2009-06-09T00:00:00,Phosphorylation,G03.495.790
19509254,2009-06-09T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19509254,2009-06-09T00:00:00,Prostatic Neoplasms,C12.294.260.750
19509254,2009-06-09T00:00:00,Prostatic Neoplasms,C12.294.565.625
19509254,2009-06-09T00:00:00,Prostatic Neoplasms,C12.758.409.750
19509254,2009-06-09T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19509254,2009-06-09T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
19509254,2009-06-09T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
19509254,2009-06-09T00:00:00,bcl-Associated Death Protein,D12.644.360.075.718.100
19509254,2009-06-09T00:00:00,bcl-Associated Death Protein,D12.776.476.075.718.100
19509254,2009-06-09T00:00:00,bcl-Associated Death Protein,D12.776.744.049
19513121,2009-06-09T00:00:00,Animals,B01.050
19513121,2009-06-09T00:00:00,Computational Biology,H01.158.273.180
19513121,2009-06-09T00:00:00,Fibrosis,C23.550.355
19513121,2009-06-09T00:00:00,Gene Expression Regulation,G05.355.315
19513121,2009-06-09T00:00:00,Inflammation,C23.550.470
19513121,2009-06-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19513121,2009-06-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19513121,2009-06-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19513121,2009-06-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19513121,2009-06-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19513121,2009-06-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19513121,2009-06-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19513121,2009-06-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19513121,2009-06-09T00:00:00,Spinal Cord Injuries,C10.228.854.770
19513121,2009-06-09T00:00:00,Spinal Cord Injuries,C10.900.850
19513121,2009-06-09T00:00:00,Spinal Cord Injuries,C21.866.819
19513121,2009-06-09T00:00:00,Time Factors,G01.910.857
19513121,2009-06-09T00:00:00,Urinary Bladder,A05.810.890
19520479,2009-06-10T00:00:00,Animals,B01.050
19520479,2009-06-10T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
19520479,2009-06-10T00:00:00,"Disease Models, Animal",C22.232
19520479,2009-06-10T00:00:00,"Disease Models, Animal",E05.598.500
19520479,2009-06-10T00:00:00,"Disease Models, Animal",E05.599.395.080
19520479,2009-06-10T00:00:00,Heart Arrest,C14.280.383
19520479,2009-06-10T00:00:00,Hemodynamics,G09.330.190.400
19520479,2009-06-10T00:00:00,Hemodynamics,G09.330.380
19520479,2009-06-10T00:00:00,Oxygen,D01.268.185.550
19520479,2009-06-10T00:00:00,Oxygen,D01.362.670
19520479,2009-06-10T00:00:00,Oxygen Consumption,G03.730
19520479,2009-06-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19520479,2009-06-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19520479,2009-06-10T00:00:00,Treatment Outcome,E01.789.800
19520479,2009-06-10T00:00:00,Treatment Outcome,N04.761.559.590.800
19520479,2009-06-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19660396,2009-06-10T00:00:00,Adult,M01.060.116
19660396,2009-06-10T00:00:00,Bioprosthesis,E07.695.100
19660396,2009-06-10T00:00:00,Heart Valve Prosthesis,E07.695.310
19660396,2009-06-10T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
19660396,2009-06-10T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
19660396,2009-06-10T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
19660396,2009-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19660396,2009-06-10T00:00:00,Treatment Outcome,E01.789.800
19660396,2009-06-10T00:00:00,Treatment Outcome,N04.761.559.590.800
19660396,2009-06-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20811099,2009-06-10T00:00:00,Animals,B01.050
20811099,2009-06-10T00:00:00,Biocompatible Materials,D25.130
20811099,2009-06-10T00:00:00,Biocompatible Materials,D27.720.102.130
20811099,2009-06-10T00:00:00,Biocompatible Materials,J01.637.051.130
20811099,2009-06-10T00:00:00,Biomimetic Materials,J01.637.087
20811099,2009-06-10T00:00:00,Bioreactors,E07.115
20811099,2009-06-10T00:00:00,Bioreactors,J01.897.120.115
20811099,2009-06-10T00:00:00,Biotechnology,H01.158.550
20811099,2009-06-10T00:00:00,Biotechnology,J01.897.120
20811099,2009-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20811099,2009-06-10T00:00:00,Tissue Engineering,E05.200.249.750
19523932,2009-06-11T00:00:00,Adult,M01.060.116
19523932,2009-06-11T00:00:00,Brain Mapping,E01.370.350.086
19523932,2009-06-11T00:00:00,Brain Mapping,E01.370.376.149
19523932,2009-06-11T00:00:00,Brain Mapping,E05.132
19523932,2009-06-11T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
19523932,2009-06-11T00:00:00,Functional Laterality,F02.830.297.425
19523932,2009-06-11T00:00:00,Functional Laterality,G11.561.225.425
19523932,2009-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19523932,2009-06-11T00:00:00,Imagination,F02.463.188.634
19523932,2009-06-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19523932,2009-06-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19523932,2009-06-11T00:00:00,Middle Aged,M01.060.116.630
19523932,2009-06-11T00:00:00,Movement,G07.700.560
19523932,2009-06-11T00:00:00,Movement,G11.427.590.530
19523932,2009-06-11T00:00:00,Neural Pathways,A08.612
19523932,2009-06-11T00:00:00,Neuropsychological Tests,F04.711.513
19523932,2009-06-11T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
19523932,2009-06-11T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19523932,2009-06-11T00:00:00,Psychomotor Performance,F02.808
19523932,2009-06-11T00:00:00,Psychomotor Performance,G11.427.700
19523932,2009-06-11T00:00:00,Psychomotor Performance,G11.561.623
19523932,2009-06-11T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19523932,2009-06-11T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19524044,2009-06-11T00:00:00,Adult,M01.060.116
19524044,2009-06-11T00:00:00,Aged,M01.060.116.100
19524044,2009-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19524044,2009-06-11T00:00:00,Image Enhancement,E01.370.350.600.350
19524044,2009-06-11T00:00:00,Image Enhancement,L01.224.308.380
19524044,2009-06-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19524044,2009-06-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19524044,2009-06-11T00:00:00,Middle Aged,M01.060.116.630
19524044,2009-06-11T00:00:00,Young Adult,M01.060.116.815
19546037,2009-06-11T00:00:00,Cell Cycle,G04.299.134
19546037,2009-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19546037,2009-06-11T00:00:00,Neoplasms,C04
19546037,2009-06-11T00:00:00,Protein Biosynthesis,G02.111.087.675.871
19546037,2009-06-11T00:00:00,Protein Biosynthesis,G02.149.115.675.871
19546037,2009-06-11T00:00:00,Protein Biosynthesis,G03.495.770.871
19546037,2009-06-11T00:00:00,Protein Biosynthesis,G05.355.310.670
19766948,2009-06-12T00:00:00,Adolescent,M01.060.057
19766948,2009-06-12T00:00:00,African Americans,M01.686.508.100.100
19766948,2009-06-12T00:00:00,African Americans,M01.686.754.100
19766948,2009-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19766948,2009-06-12T00:00:00,Obesity,C18.654.726.500
19766948,2009-06-12T00:00:00,Obesity,C23.888.144.699.500
19766948,2009-06-12T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19766948,2009-06-12T00:00:00,Obesity,G07.100.100.160.120.699.500
20633410,2009-06-13T00:00:00,Brain,A08.186.211
20633410,2009-06-13T00:00:00,Electric Stimulation,E05.723.402
20633410,2009-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633410,2009-06-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20633410,2009-06-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20633410,2009-06-13T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20633410,2009-06-13T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19525962,2009-06-14T00:00:00,Animals,B01.050
19525962,2009-06-14T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
19525962,2009-06-14T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
19525962,2009-06-14T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
19525962,2009-06-14T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
19525962,2009-06-14T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
19525962,2009-06-14T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
19525962,2009-06-14T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
19525962,2009-06-14T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
19525962,2009-06-14T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
19525962,2009-06-14T00:00:00,Cell Differentiation,G04.299.151
19525962,2009-06-14T00:00:00,Hematopoietic Stem Cells,A11.148.378
19525962,2009-06-14T00:00:00,Hematopoietic Stem Cells,A11.872.378
19525962,2009-06-14T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
19525962,2009-06-14T00:00:00,Lymphocyte Activation,E01.450.495.482
19525962,2009-06-14T00:00:00,Lymphocyte Activation,E05.478.594.530
19525962,2009-06-14T00:00:00,Lymphocyte Activation,G12.425.747
19525962,2009-06-14T00:00:00,Lymphocyte Activation,G12.450.050.400.545
19525962,2009-06-14T00:00:00,Signal Transduction,G02.111.087.800
19525962,2009-06-14T00:00:00,Signal Transduction,G02.149.115.800
19525962,2009-06-14T00:00:00,Signal Transduction,G04.299.880
19525962,2009-06-14T00:00:00,Wnt Proteins,D12.644.276.984
19525962,2009-06-14T00:00:00,Wnt Proteins,D12.776.467.984
19525962,2009-06-14T00:00:00,Wnt Proteins,D23.529.984
19525962,2009-06-14T00:00:00,beta Catenin,D12.776.091.249
19525962,2009-06-14T00:00:00,beta Catenin,D12.776.220.145.500
19525962,2009-06-14T00:00:00,beta Catenin,D12.776.930.130
19494326,2009-06-15T00:00:00,Animals,B01.050
19494326,2009-06-15T00:00:00,Central Nervous System,A08.186
19494326,2009-06-15T00:00:00,Chronic Disease,C23.550.291.500
19494326,2009-06-15T00:00:00,Cytokines,D12.644.276.374
19494326,2009-06-15T00:00:00,Cytokines,D12.776.467.374
19494326,2009-06-15T00:00:00,Cytokines,D23.529.374
19494326,2009-06-15T00:00:00,"Disease Models, Animal",C22.232
19494326,2009-06-15T00:00:00,"Disease Models, Animal",E05.598.500
19494326,2009-06-15T00:00:00,"Disease Models, Animal",E05.599.395.080
19494326,2009-06-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
19494326,2009-06-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
19494326,2009-06-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
19494326,2009-06-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
19494326,2009-06-15T00:00:00,Lipid Metabolism,G03.495.520
19494326,2009-06-15T00:00:00,Multiple Sclerosis,C10.114.375.500
19494326,2009-06-15T00:00:00,Multiple Sclerosis,C10.314.350.500
19494326,2009-06-15T00:00:00,Multiple Sclerosis,C20.111.258.250.500
19523266,2009-06-15T00:00:00,Adolescent,M01.060.057
19523266,2009-06-15T00:00:00,Child,M01.060.406
19523266,2009-06-15T00:00:00,Fontan Procedure,E04.035.410.295
19523266,2009-06-15T00:00:00,Fontan Procedure,E04.100.376.410.295
19523266,2009-06-15T00:00:00,Fontan Procedure,E04.928.220.370.295
19523266,2009-06-15T00:00:00,"Heart Defects, Congenital",C14.240.400
19523266,2009-06-15T00:00:00,"Heart Defects, Congenital",C14.280.400
19523266,2009-06-15T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19523266,2009-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19523266,2009-06-15T00:00:00,Recovery of Function,G16.757
19523266,2009-06-15T00:00:00,Stroke Volume,E01.370.370.380.150.700
19523266,2009-06-15T00:00:00,Stroke Volume,G09.330.380.124.882
19523266,2009-06-15T00:00:00,Treatment Outcome,E01.789.800
19523266,2009-06-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19523266,2009-06-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19528266,2009-06-15T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19528266,2009-06-15T00:00:00,Bacterial Proteins,D12.776.097
19528266,2009-06-15T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
19528266,2009-06-15T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
19528266,2009-06-15T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
19528266,2009-06-15T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
19528633,2009-06-15T00:00:00,Apoptosis,G04.299.139.160
19528633,2009-06-15T00:00:00,Breast Neoplasms,C04.588.180
19528633,2009-06-15T00:00:00,Breast Neoplasms,C17.800.090.500
19528633,2009-06-15T00:00:00,Cell Proliferation,G04.299.233.750
19528633,2009-06-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19528633,2009-06-15T00:00:00,Ceramides,D02.065.313
19528633,2009-06-15T00:00:00,Ceramides,D09.400.410.420.525.200
19528633,2009-06-15T00:00:00,Ceramides,D10.390.470.675.200
19528633,2009-06-15T00:00:00,Ceramides,D10.570.877.360.612.200
19528633,2009-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19528633,2009-06-15T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19528633,2009-06-15T00:00:00,Mitochondria,A11.284.835.626
19528633,2009-06-15T00:00:00,Oxidoreductases,D08.811.682
19528633,2009-06-15T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19528633,2009-06-15T00:00:00,Protein Transport,G03.495.166.700
19528633,2009-06-15T00:00:00,Pyrazoles,D03.383.129.539
19528633,2009-06-15T00:00:00,Pyrimidines,D03.383.742
19528633,2009-06-15T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
19528633,2009-06-15T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
19528633,2009-06-15T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
19603658,2009-06-15T00:00:00,Bayes Theorem,E05.318.740.600.200
19603658,2009-06-15T00:00:00,Bayes Theorem,N05.715.360.750.625.150
19603658,2009-06-15T00:00:00,Bayes Theorem,N06.850.520.830.600.200
19603658,2009-06-15T00:00:00,"Data Interpretation, Statistical",E05.245.380
19603658,2009-06-15T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19603658,2009-06-15T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19603658,2009-06-15T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19603658,2009-06-15T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19603658,2009-06-15T00:00:00,Environmental Monitoring,N06.850.460.350.080
19603658,2009-06-15T00:00:00,Environmental Monitoring,N06.850.780.375
19603658,2009-06-15T00:00:00,Mercury,D01.268.556.504
19603658,2009-06-15T00:00:00,Mercury,D01.268.956.437
19603658,2009-06-15T00:00:00,Mercury,D01.552.544.504
19603658,2009-06-15T00:00:00,Soil Pollutants,D27.888.284.756
19533564,2009-06-16T00:00:00,Adult,M01.060.116
19533564,2009-06-16T00:00:00,Aged,M01.060.116.100
19533564,2009-06-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
19533564,2009-06-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
19533564,2009-06-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
19533564,2009-06-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
19533564,2009-06-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
19533564,2009-06-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
19533564,2009-06-16T00:00:00,Contrast Media,D27.720.259
19533564,2009-06-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19533564,2009-06-16T00:00:00,Iodine,D01.268.380.400
19533564,2009-06-16T00:00:00,Middle Aged,M01.060.116.630
19535296,2009-06-16T00:00:00,Animals,B01.050
19535296,2009-06-16T00:00:00,Cardiovascular Diseases,C14
19535296,2009-06-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19535495,2009-06-17T00:00:00,Adult,M01.060.116
19535495,2009-06-17T00:00:00,Alcohol Drinking,F01.145.317.269
19535495,2009-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19535495,2009-06-17T00:00:00,Hypertension,C14.907.489
19535495,2009-06-17T00:00:00,Liver Diseases,C06.552
19535495,2009-06-17T00:00:00,Middle Aged,M01.060.116.630
19539891,2009-06-18T00:00:00,Adenocarcinoma,C04.557.470.200.025
19539891,2009-06-18T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19539891,2009-06-18T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19539891,2009-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19539891,2009-06-18T00:00:00,Neoplasm Invasiveness,C04.697.645
19539891,2009-06-18T00:00:00,Neoplasm Invasiveness,C23.550.727.645
19539891,2009-06-18T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19539891,2009-06-18T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19539891,2009-06-18T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
19539891,2009-06-18T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
19539891,2009-06-18T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
19539891,2009-06-18T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
19539891,2009-06-18T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
19539891,2009-06-18T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
19540207,2009-06-18T00:00:00,Apoptosis,G04.299.139.160
19540207,2009-06-18T00:00:00,Cell Cycle,G04.299.134
19540207,2009-06-18T00:00:00,Cell Differentiation,G04.299.151
19540207,2009-06-18T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
19540207,2009-06-18T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
19540207,2009-06-18T00:00:00,Fenretinide,D02.455.849.131.495.270
19540207,2009-06-18T00:00:00,Fenretinide,D23.767.261.700.270
19540207,2009-06-18T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19540207,2009-06-18T00:00:00,Flow Cytometry,E05.200.500.386.350
19540207,2009-06-18T00:00:00,"Genes, p53",G05.360.340.024.340.375.249.385
19540207,2009-06-18T00:00:00,"Genes, p53",G05.360.340.024.340.415.400.385
19540207,2009-06-18T00:00:00,Glutathione Transferase,D08.811.913.225.500
19540207,2009-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19540207,2009-06-18T00:00:00,Mutation,G05.365.590
19540207,2009-06-18T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
19540207,2009-06-18T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
19540207,2009-06-18T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
19540207,2009-06-18T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
19540207,2009-06-18T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
19540207,2009-06-18T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
19540207,2009-06-18T00:00:00,Signal Transduction,G02.111.087.800
19540207,2009-06-18T00:00:00,Signal Transduction,G02.149.115.800
19540207,2009-06-18T00:00:00,Signal Transduction,G04.299.880
19540315,2009-06-18T00:00:00,Animals,B01.050
19540315,2009-06-18T00:00:00,Anticarcinogenic Agents,D27.505.696.706.018
19540315,2009-06-18T00:00:00,Anticarcinogenic Agents,D27.505.954.248.125
19540315,2009-06-18T00:00:00,Anticarcinogenic Agents,D27.720.799.018
19540315,2009-06-18T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19540315,2009-06-18T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19540315,2009-06-18T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19540315,2009-06-18T00:00:00,Apoptosis,G04.299.139.160
19540315,2009-06-18T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
19540315,2009-06-18T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
19540315,2009-06-18T00:00:00,Body Weight,C23.888.144
19540315,2009-06-18T00:00:00,Body Weight,E01.370.600.115.100.160.120
19540315,2009-06-18T00:00:00,Body Weight,E05.041.124.160.750
19540315,2009-06-18T00:00:00,Body Weight,G07.100.100.160.120
19540315,2009-06-18T00:00:00,Body Weight,G07.700.320.249.314.120
19540315,2009-06-18T00:00:00,Cell Proliferation,G04.299.233.750
19540315,2009-06-18T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19540315,2009-06-18T00:00:00,"Disease Models, Animal",C22.232
19540315,2009-06-18T00:00:00,"Disease Models, Animal",E05.598.500
19540315,2009-06-18T00:00:00,"Disease Models, Animal",E05.599.395.080
19540315,2009-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19540315,2009-06-18T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
19540315,2009-06-18T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
19540315,2009-06-18T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
19540315,2009-06-18T00:00:00,NF-kappa B,D12.776.260.600
19540315,2009-06-18T00:00:00,NF-kappa B,D12.776.660.600
19540315,2009-06-18T00:00:00,NF-kappa B,D12.776.930.600
19540315,2009-06-18T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
19540315,2009-06-18T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
19540315,2009-06-18T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
19540315,2009-06-18T00:00:00,Treatment Outcome,E01.789.800
19540315,2009-06-18T00:00:00,Treatment Outcome,N04.761.559.590.800
19540315,2009-06-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19541814,2009-06-18T00:00:00,African Continental Ancestry Group,M01.686.508.100
19541814,2009-06-18T00:00:00,Aged,M01.060.116.100
19541814,2009-06-18T00:00:00,Cadaver,C23.550.260.224
19541814,2009-06-18T00:00:00,Diabetes Complications,C19.246.099
19541814,2009-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19541814,2009-06-18T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
19541814,2009-06-18T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
19541814,2009-06-18T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
19541814,2009-06-18T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
19541814,2009-06-18T00:00:00,Kidney Transplantation,E02.870.500
19541814,2009-06-18T00:00:00,Kidney Transplantation,E04.936.450.485
19541814,2009-06-18T00:00:00,Kidney Transplantation,E04.950.774.400
19541814,2009-06-18T00:00:00,Middle Aged,M01.060.116.630
19541814,2009-06-18T00:00:00,Risk Factors,E05.318.740.600.800.725
19541814,2009-06-18T00:00:00,Risk Factors,N05.715.350.200.700
19541814,2009-06-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19541814,2009-06-18T00:00:00,Risk Factors,N06.850.490.625.750
19541814,2009-06-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19541814,2009-06-18T00:00:00,Tissue Donors,M01.898
19541814,2009-06-18T00:00:00,Tissue and Organ Procurement,N02.421.911
19541814,2009-06-18T00:00:00,Waiting Lists,N04.452.095.738
19542054,2009-06-18T00:00:00,Adolescent,M01.060.057
19542054,2009-06-18T00:00:00,Adult,M01.060.116
19542054,2009-06-18T00:00:00,African Americans,M01.686.508.100.100
19542054,2009-06-18T00:00:00,African Americans,M01.686.754.100
19542054,2009-06-18T00:00:00,Age Factors,N05.715.350.075
19542054,2009-06-18T00:00:00,Age Factors,N06.850.490.250
19542054,2009-06-18T00:00:00,Aged,M01.060.116.100
19542054,2009-06-18T00:00:00,Child,M01.060.406
19542054,2009-06-18T00:00:00,"Child, Preschool",M01.060.406.448
19542054,2009-06-18T00:00:00,European Continental Ancestry Group,M01.686.508.400
19542054,2009-06-18T00:00:00,Hospital Mortality,E05.318.308.985.550.400
19542054,2009-06-18T00:00:00,Hospital Mortality,L01.280.975.550.400
19542054,2009-06-18T00:00:00,Hospital Mortality,N01.224.935.698.400
19542054,2009-06-18T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
19542054,2009-06-18T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
19542054,2009-06-18T00:00:00,Hospitalization,E02.760.400
19542054,2009-06-18T00:00:00,Hospitalization,N02.421.585.400
19542054,2009-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19542054,2009-06-18T00:00:00,Infant,M01.060.703
19542054,2009-06-18T00:00:00,"Infant, Newborn",M01.060.703.520
19542054,2009-06-18T00:00:00,Intensive Care Units,N02.278.388.493
19542054,2009-06-18T00:00:00,Length of Stay,E02.760.400.480
19542054,2009-06-18T00:00:00,Length of Stay,N02.421.585.400.480
19542054,2009-06-18T00:00:00,Middle Aged,M01.060.116.630
19542054,2009-06-18T00:00:00,Patient Discharge,E02.760.400.610
19542054,2009-06-18T00:00:00,Patient Discharge,N02.421.585.400.610
19542054,2009-06-18T00:00:00,South Carolina,Z01.107.567.875.075.662
19542054,2009-06-18T00:00:00,South Carolina,Z01.107.567.875.750.700
19542054,2009-06-18T00:00:00,Stroke,C10.228.140.300.775
19542054,2009-06-18T00:00:00,Stroke,C14.907.253.855
19542056,2009-06-18T00:00:00,Aged,M01.060.116.100
19542056,2009-06-18T00:00:00,Body Mass Index,E01.370.600.115.100.125
19542056,2009-06-18T00:00:00,Body Mass Index,E05.041.124.125
19542056,2009-06-18T00:00:00,Body Mass Index,G07.100.100.125
19542056,2009-06-18T00:00:00,Body Mass Index,N06.850.505.200.100.175
19542056,2009-06-18T00:00:00,Health Surveys,E05.318.308.250
19542056,2009-06-18T00:00:00,Health Surveys,N05.715.360.300.375
19542056,2009-06-18T00:00:00,Health Surveys,N06.850.520.308.250
19542056,2009-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19542056,2009-06-18T00:00:00,Middle Aged,M01.060.116.630
19542056,2009-06-18T00:00:00,Obesity,C18.654.726.500
19542056,2009-06-18T00:00:00,Obesity,C23.888.144.699.500
19542056,2009-06-18T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19542056,2009-06-18T00:00:00,Obesity,G07.100.100.160.120.699.500
19542056,2009-06-18T00:00:00,Overweight,C23.888.144.699
19542056,2009-06-18T00:00:00,Overweight,E01.370.600.115.100.160.120.699
19542056,2009-06-18T00:00:00,Overweight,G07.100.100.160.120.699
19542056,2009-06-18T00:00:00,Risk Factors,E05.318.740.600.800.725
19542056,2009-06-18T00:00:00,Risk Factors,N05.715.350.200.700
19542056,2009-06-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19542056,2009-06-18T00:00:00,Risk Factors,N06.850.490.625.750
19542056,2009-06-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19542056,2009-06-18T00:00:00,Stroke,C10.228.140.300.775
19542056,2009-06-18T00:00:00,Stroke,C14.907.253.855
19542081,2009-06-18T00:00:00,Adult,M01.060.116
19542081,2009-06-18T00:00:00,Case-Control Studies,E05.318.760.500.500
19542081,2009-06-18T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19542081,2009-06-18T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19542081,2009-06-18T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19542081,2009-06-18T00:00:00,Genetic Predisposition to Disease,G05.380.355
19542081,2009-06-18T00:00:00,Genome-Wide Association Study,E05.318.416.249
19542081,2009-06-18T00:00:00,Genome-Wide Association Study,E05.318.780.392
19542081,2009-06-18T00:00:00,Genome-Wide Association Study,E05.393.385.500
19542081,2009-06-18T00:00:00,Genome-Wide Association Study,E05.393.522.500
19542081,2009-06-18T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19542081,2009-06-18T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19542081,2009-06-18T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19542081,2009-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19542081,2009-06-18T00:00:00,Liver,A03.620
19542081,2009-06-18T00:00:00,Membrane Proteins,D12.776.543
19542081,2009-06-18T00:00:00,Middle Aged,M01.060.116.630
19542081,2009-06-18T00:00:00,Obesity,C18.654.726.500
19542081,2009-06-18T00:00:00,Obesity,C23.888.144.699.500
19542081,2009-06-18T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19542081,2009-06-18T00:00:00,Obesity,G07.100.100.160.120.699.500
19541501,2009-06-21T00:00:00,African Americans,M01.686.508.100.100
19541501,2009-06-21T00:00:00,African Americans,M01.686.754.100
19541501,2009-06-21T00:00:00,Child,M01.060.406
19541501,2009-06-21T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
19541501,2009-06-21T00:00:00,"Child, Preschool",M01.060.406.448
19541501,2009-06-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
19541501,2009-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19541501,2009-06-21T00:00:00,Population Surveillance,E05.318.308.250.700
19541501,2009-06-21T00:00:00,Population Surveillance,N05.715.360.300.375.625
19541501,2009-06-21T00:00:00,Population Surveillance,N06.850.520.308.250.700
19541501,2009-06-21T00:00:00,Population Surveillance,N06.850.780.675
19541501,2009-06-21T00:00:00,South Carolina,Z01.107.567.875.075.662
19541501,2009-06-21T00:00:00,South Carolina,Z01.107.567.875.750.700
19541511,2009-06-21T00:00:00,Adolescent,M01.060.057
19541511,2009-06-21T00:00:00,Adult,M01.060.116
19541511,2009-06-21T00:00:00,Aged,M01.060.116.100
19541511,2009-06-21T00:00:00,Alleles,G05.360.340.024.340.030
19541511,2009-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19541511,2009-06-21T00:00:00,Middle Aged,M01.060.116.630
19541511,2009-06-21T00:00:00,"Polymorphism, Genetic",G05.365.795
19541511,2009-06-21T00:00:00,Young Adult,M01.060.116.815
19650619,2009-06-22T00:00:00,Aged,M01.060.116.100
19650619,2009-06-22T00:00:00,Blood Glucose,D09.546.359.448.500
19650619,2009-06-22T00:00:00,Blood Pressure,E01.370.600.875.249
19650619,2009-06-22T00:00:00,Blood Pressure,G09.330.380.076
19650619,2009-06-22T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19650619,2009-06-22T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19650619,2009-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19650619,2009-06-22T00:00:00,Lipids,D10
19548039,2009-06-23T00:00:00,Adult,M01.060.116
19548039,2009-06-23T00:00:00,Aged,M01.060.116.100
19548039,2009-06-23T00:00:00,"Anastomosis, Surgical",E04.035
19548039,2009-06-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19548039,2009-06-23T00:00:00,Middle Aged,M01.060.116.630
19548039,2009-06-23T00:00:00,Pancreatic Neoplasms,C04.588.274.761
19548039,2009-06-23T00:00:00,Pancreatic Neoplasms,C04.588.322.421
19548039,2009-06-23T00:00:00,Pancreatic Neoplasms,C06.301.761
19548039,2009-06-23T00:00:00,Pancreatic Neoplasms,C06.689.667
19548039,2009-06-23T00:00:00,Pancreatic Neoplasms,C19.344.421
19548039,2009-06-23T00:00:00,Pancreaticoduodenectomy,E04.210.760
19548039,2009-06-23T00:00:00,Postoperative Complications,C23.550.767
19548039,2009-06-23T00:00:00,Probability,E05.318.740.600
19548039,2009-06-23T00:00:00,Probability,G17.680
19548039,2009-06-23T00:00:00,Probability,N05.715.360.750.625
19548039,2009-06-23T00:00:00,Probability,N06.850.520.830.600
19548039,2009-06-23T00:00:00,Risk Assessment,E05.318.740.600.800.715
19548039,2009-06-23T00:00:00,Risk Assessment,N04.452.871.715
19548039,2009-06-23T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19548039,2009-06-23T00:00:00,Risk Assessment,N06.850.505.715
19548039,2009-06-23T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19548039,2009-06-23T00:00:00,Surgical Flaps,A10.850.710
19548039,2009-06-23T00:00:00,Surgical Flaps,E07.862.710
19548039,2009-06-23T00:00:00,Treatment Outcome,E01.789.800
19548039,2009-06-23T00:00:00,Treatment Outcome,N04.761.559.590.800
19548039,2009-06-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19548039,2009-06-23T00:00:00,Young Adult,M01.060.116.815
19548047,2009-06-23T00:00:00,Cardiomyopathies,C14.280.238
19548047,2009-06-23T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
19548047,2009-06-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19548047,2009-06-23T00:00:00,Image Enhancement,E01.370.350.600.350
19548047,2009-06-23T00:00:00,Image Enhancement,L01.224.308.380
19548047,2009-06-23T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
19548047,2009-06-23T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
19548047,2009-06-23T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
19548047,2009-06-23T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
19548047,2009-06-23T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
19548047,2009-06-23T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
19548047,2009-06-23T00:00:00,Sarcoidosis,C15.604.515.827
19548047,2009-06-23T00:00:00,Subtraction Technique,E01.370.350.760
19548047,2009-06-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19548047,2009-06-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19548047,2009-06-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19548047,2009-06-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19548047,2009-06-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19548119,2009-06-23T00:00:00,Antioxidants,D27.505.519.217
19548119,2009-06-23T00:00:00,Antioxidants,D27.505.696.706.125
19548119,2009-06-23T00:00:00,Antioxidants,D27.720.799.047
19548119,2009-06-23T00:00:00,Apoptosis,G04.299.139.160
19548119,2009-06-23T00:00:00,Metals,D01.552
19548119,2009-06-23T00:00:00,Reactive Oxygen Species,D01.339.431
19548119,2009-06-23T00:00:00,Reactive Oxygen Species,D01.650.775
19548119,2009-06-23T00:00:00,Selenium,D01.268.185.850
19548119,2009-06-23T00:00:00,Selenium,D01.578.700
19548119,2009-06-23T00:00:00,Sulfur,D01.268.185.900
19552977,2009-06-23T00:00:00,Animals,B01.050
19552977,2009-06-23T00:00:00,Bayes Theorem,E05.318.740.600.200
19552977,2009-06-23T00:00:00,Bayes Theorem,N05.715.360.750.625.150
19552977,2009-06-23T00:00:00,Bayes Theorem,N06.850.520.830.600.200
19552977,2009-06-23T00:00:00,Incidence,E05.318.308.985.525.375
19552977,2009-06-23T00:00:00,Incidence,L01.280.975.525.375
19552977,2009-06-23T00:00:00,Incidence,N01.224.935.597.500
19552977,2009-06-23T00:00:00,Incidence,N06.850.505.400.975.525.375
19552977,2009-06-23T00:00:00,Incidence,N06.850.520.308.985.525.375
19552977,2009-06-23T00:00:00,Sex Factors,N05.715.350.675
19552977,2009-06-23T00:00:00,Sex Factors,N06.850.490.875
19530723,2009-06-24T00:00:00,Gold,D01.268.556.322
19530723,2009-06-24T00:00:00,Gold,D01.268.956.186
19530723,2009-06-24T00:00:00,Gold,D01.552.544.322
19530723,2009-06-24T00:00:00,Metal Nanoparticles,J01.637.512.600.500
19530723,2009-06-24T00:00:00,Nanotechnology,H01.603
19530723,2009-06-24T00:00:00,Nanotechnology,J01.897.520.600
19530723,2009-06-24T00:00:00,Pyridines,D03.383.725
19551425,2009-06-24T00:00:00,Duodenal Diseases,C06.405.469.275
19551425,2009-06-24T00:00:00,"Hernia, Abdominal",C23.300.707.374
19551425,2009-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19551425,2009-06-24T00:00:00,Middle Aged,M01.060.116.630
19551425,2009-06-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19551425,2009-06-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19551425,2009-06-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19551425,2009-06-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19551425,2009-06-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19553538,2009-06-24T00:00:00,Animals,B01.050
19553538,2009-06-24T00:00:00,B-Lymphocytes,A11.063.438
19553538,2009-06-24T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
19553538,2009-06-24T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
19553538,2009-06-24T00:00:00,B-Lymphocytes,A15.382.032.438
19553538,2009-06-24T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
19553538,2009-06-24T00:00:00,Cell Movement,G04.299.283
19553538,2009-06-24T00:00:00,Cell Movement,G07.700.560.500.180
19553538,2009-06-24T00:00:00,Dendritic Cells,A11.066.270
19553538,2009-06-24T00:00:00,Dendritic Cells,A11.436.270
19553538,2009-06-24T00:00:00,Dendritic Cells,A15.382.066.270
19553538,2009-06-24T00:00:00,Dendritic Cells,A15.382.812.260
19553538,2009-06-24T00:00:00,Lymphocyte Activation,E01.450.495.482
19553538,2009-06-24T00:00:00,Lymphocyte Activation,E05.478.594.530
19553538,2009-06-24T00:00:00,Lymphocyte Activation,G12.425.747
19553538,2009-06-24T00:00:00,Lymphocyte Activation,G12.450.050.400.545
19553538,2009-06-24T00:00:00,Lymphocytes,A11.118.637.555.567
19553538,2009-06-24T00:00:00,Lymphocytes,A15.145.229.637.555.567
19553538,2009-06-24T00:00:00,Lymphocytes,A15.382.490.555.567
19553538,2009-06-24T00:00:00,Spleen,A10.549.700
19553538,2009-06-24T00:00:00,Spleen,A15.382.520.604.700
19553538,2009-06-24T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
19553538,2009-06-24T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
19553538,2009-06-24T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19556344,2009-06-25T00:00:00,Gene Expression Regulation,G05.355.315
19556344,2009-06-25T00:00:00,Heat-Shock Proteins,D12.776.580.216
19556344,2009-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19556344,2009-06-25T00:00:00,"Models, Biological",E05.599.395
19556344,2009-06-25T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
19556344,2009-06-25T00:00:00,Osteitis Deformans,C05.116.692
19556344,2009-06-25T00:00:00,Osteoclasts,A11.329.372.700
19556344,2009-06-25T00:00:00,Osteoclasts,A11.627.482.700
19556344,2009-06-25T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19556344,2009-06-25T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19556344,2009-06-25T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19556344,2009-06-25T00:00:00,RANK Ligand,D12.644.276.374.750.562
19556344,2009-06-25T00:00:00,RANK Ligand,D12.644.276.972.562
19556344,2009-06-25T00:00:00,RANK Ligand,D12.776.467.374.750.562
19556344,2009-06-25T00:00:00,RANK Ligand,D12.776.467.972.562
19556344,2009-06-25T00:00:00,RANK Ligand,D23.529.374.750.562
19556344,2009-06-25T00:00:00,RANK Ligand,D23.529.972.562
19556344,2009-06-25T00:00:00,Stromal Cells,A11.329.830
19556344,2009-06-25T00:00:00,Transcription Factors,D12.776.930
19556534,2009-06-25T00:00:00,Adult,M01.060.116
19556534,2009-06-25T00:00:00,Aged,M01.060.116.100
19556534,2009-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19556534,2009-06-25T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
19556534,2009-06-25T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
19556534,2009-06-25T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
19556534,2009-06-25T00:00:00,Middle Aged,M01.060.116.630
19556534,2009-06-25T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19556534,2009-06-25T00:00:00,Risk Factors,E05.318.740.600.800.725
19556534,2009-06-25T00:00:00,Risk Factors,N05.715.350.200.700
19556534,2009-06-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19556534,2009-06-25T00:00:00,Risk Factors,N06.850.490.625.750
19556534,2009-06-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19556534,2009-06-25T00:00:00,Stroke,C10.228.140.300.775
19556534,2009-06-25T00:00:00,Stroke,C14.907.253.855
19556534,2009-06-25T00:00:00,Treatment Outcome,E01.789.800
19556534,2009-06-25T00:00:00,Treatment Outcome,N04.761.559.590.800
19556534,2009-06-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19560469,2009-06-25T00:00:00,Animals,B01.050
19560469,2009-06-25T00:00:00,Cicatrix,A10.165.450.300
19560469,2009-06-25T00:00:00,Cicatrix,C23.550.355.274
19560469,2009-06-25T00:00:00,Cicatrix,G16.100.856.891.249
19560469,2009-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19560469,2009-06-25T00:00:00,"Models, Biological",E05.599.395
19560469,2009-06-25T00:00:00,Myocardial Infarction,C14.280.647.500
19560469,2009-06-25T00:00:00,Myocardial Infarction,C14.907.585.500
19560469,2009-06-25T00:00:00,Myocardium,A02.633.580
19560469,2009-06-25T00:00:00,Myocardium,A07.541.704
19560469,2009-06-25T00:00:00,Myocardium,A10.690.552.750
19560469,2009-06-25T00:00:00,Skin,A17.815
19560469,2009-06-25T00:00:00,Wound Healing,G16.100.856.891
19560252,2009-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19560252,2009-06-26T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19560252,2009-06-26T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19560252,2009-06-26T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19560252,2009-06-26T00:00:00,"Phantoms, Imaging",E07.671
19560252,2009-06-26T00:00:00,"Quality Assurance, Health Care",N04.761.700
19560252,2009-06-26T00:00:00,"Quality Assurance, Health Care",N05.700
19560252,2009-06-26T00:00:00,Ultrasonography,E01.370.350.850
19561089,2009-06-26T00:00:00,Actins,D05.750.078.730.250
19561089,2009-06-26T00:00:00,Actins,D12.776.210.500.100
19561089,2009-06-26T00:00:00,Actins,D12.776.220.525.255
19561089,2009-06-26T00:00:00,Animals,B01.050
19561089,2009-06-26T00:00:00,B-Lymphocytes,A11.063.438
19561089,2009-06-26T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
19561089,2009-06-26T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
19561089,2009-06-26T00:00:00,B-Lymphocytes,A15.382.032.438
19561089,2009-06-26T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
19561089,2009-06-26T00:00:00,Extracellular Matrix,A11.284.295.310
19561089,2009-06-26T00:00:00,Integrins,D12.776.543.750.705.408
19561089,2009-06-26T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19561089,2009-06-26T00:00:00,"Microscopy, Confocal",E05.595.395
19561089,2009-06-26T00:00:00,Phosphorylation,G02.111.087.677
19561089,2009-06-26T00:00:00,Phosphorylation,G02.149.115.677
19561089,2009-06-26T00:00:00,Phosphorylation,G02.149.465.700
19561089,2009-06-26T00:00:00,Phosphorylation,G02.607.750.700
19561089,2009-06-26T00:00:00,Phosphorylation,G03.495.790
19561095,2009-06-26T00:00:00,Animals,B01.050
19561095,2009-06-26T00:00:00,Bone and Bones,A02.835.232
19561095,2009-06-26T00:00:00,Bone and Bones,A10.165.265
19561095,2009-06-26T00:00:00,Interleukin-10,D12.644.276.374.465.510
19561095,2009-06-26T00:00:00,Interleukin-10,D12.776.467.374.465.510
19561095,2009-06-26T00:00:00,Interleukin-10,D23.529.374.465.510
19561095,2009-06-26T00:00:00,Macrophages,A11.329.372
19561095,2009-06-26T00:00:00,Macrophages,A11.627.482
19561095,2009-06-26T00:00:00,Macrophages,A11.733.397
19561095,2009-06-26T00:00:00,Macrophages,A15.382.680.397
19561095,2009-06-26T00:00:00,Macrophages,A15.382.812.522
19561095,2009-06-26T00:00:00,Neutrophils,A11.118.637.415.583
19561095,2009-06-26T00:00:00,Neutrophils,A11.627.340.583
19561095,2009-06-26T00:00:00,Neutrophils,A11.733.689
19561095,2009-06-26T00:00:00,Neutrophils,A15.145.229.637.415.583
19561095,2009-06-26T00:00:00,Neutrophils,A15.382.490.315.583
19561095,2009-06-26T00:00:00,Neutrophils,A15.382.680.689
19561095,2009-06-26T00:00:00,Pregnancy,G08.686.785.760.769
19561095,2009-06-26T00:00:00,Pregnancy Complications,C13.703
19561095,2009-06-26T00:00:00,Pregnancy Outcome,E01.789.700
19561095,2009-06-26T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
19561095,2009-06-26T00:00:00,Premature Birth,C13.703.420.491.500
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19561095,2009-06-26T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19561095,2009-06-26T00:00:00,Uterus,A05.360.319.679
19560906,2009-06-27T00:00:00,Adolescent,M01.060.057
19560906,2009-06-27T00:00:00,Adult,M01.060.116
19560906,2009-06-27T00:00:00,Brain,A08.186.211
19560906,2009-06-27T00:00:00,Evoked Potentials,G07.265.500
19560906,2009-06-27T00:00:00,Evoked Potentials,G11.561.270
19560906,2009-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19560906,2009-06-27T00:00:00,Personality,F01.752
19560906,2009-06-27T00:00:00,Photic Stimulation,E05.723.729
19560906,2009-06-27T00:00:00,Psychomotor Performance,F02.808
19560906,2009-06-27T00:00:00,Psychomotor Performance,G11.427.700
19560906,2009-06-27T00:00:00,Psychomotor Performance,G11.561.623
19567782,2009-06-30T00:00:00,Cell Line,A11.251.210
19567782,2009-06-30T00:00:00,Cell Movement,G04.299.283
19567782,2009-06-30T00:00:00,Cell Movement,G07.700.560.500.180
19567782,2009-06-30T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
19567782,2009-06-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19567782,2009-06-30T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
19567782,2009-06-30T00:00:00,"Microscopy, Fluorescence",E05.595.458
19567782,2009-06-30T00:00:00,Neoplasms,C04
19567782,2009-06-30T00:00:00,Phosphorylation,G02.111.087.677
19567782,2009-06-30T00:00:00,Phosphorylation,G02.149.115.677
19567782,2009-06-30T00:00:00,Phosphorylation,G02.149.465.700
19567782,2009-06-30T00:00:00,Phosphorylation,G02.607.750.700
19567782,2009-06-30T00:00:00,Phosphorylation,G03.495.790
19567782,2009-06-30T00:00:00,Protein Stability,G02.111.700
19567782,2009-06-30T00:00:00,"Receptor, EphA2",D08.811.913.696.620.682.725.400.850.100
19567782,2009-06-30T00:00:00,"Receptor, EphA2",D12.776.543.750.060.500.100
19567782,2009-06-30T00:00:00,Signal Transduction,G02.111.087.800
19567782,2009-06-30T00:00:00,Signal Transduction,G02.149.115.800
19567782,2009-06-30T00:00:00,Signal Transduction,G04.299.880
18973261,2009-07-01T00:00:00,Adult,M01.060.116
18973261,2009-07-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
18973261,2009-07-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
18973261,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18973261,2009-07-01T00:00:00,Motor Activity,F01.145.632
18973261,2009-07-01T00:00:00,Motor Activity,G11.427.590.530.698
18973261,2009-07-01T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
18973261,2009-07-01T00:00:00,Schizophrenia,F03.700.750
18973261,2009-07-01T00:00:00,Skull,A02.835.232.781
18973261,2009-07-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
18973261,2009-07-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19090493,2009-07-01T00:00:00,Collagen,D05.750.078.280
19090493,2009-07-01T00:00:00,Collagen,D12.776.860.300.250
19090493,2009-07-01T00:00:00,Hot Temperature,G01.906.595.543
19090493,2009-07-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
19090493,2009-07-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
19090493,2009-07-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
19090493,2009-07-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
19090493,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19090493,2009-07-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
19090493,2009-07-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
19090493,2009-07-01T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
19090493,2009-07-01T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
19090493,2009-07-01T00:00:00,Solubility,G02.842.800
19240657,2009-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19240657,2009-07-01T00:00:00,Body Mass Index,E05.041.124.125
19240657,2009-07-01T00:00:00,Body Mass Index,G07.100.100.125
19240657,2009-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19240657,2009-07-01T00:00:00,Diet,E05.272
19240657,2009-07-01T00:00:00,Diet,G07.610.240
19240657,2009-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19240657,2009-07-01T00:00:00,Exercise,G11.427.590.237
19240657,2009-07-01T00:00:00,Exercise,I03.350
19240657,2009-07-01T00:00:00,Hip Fractures,C21.866.404.061.425
19240657,2009-07-01T00:00:00,Hip Fractures,C21.866.404.484
19240657,2009-07-01T00:00:00,Hip Fractures,C21.866.531.750
19240657,2009-07-01T00:00:00,Hip Fractures,C21.866.558.276.425
19240657,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19240657,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19240657,2009-07-01T00:00:00,Nutrition Surveys,E05.318.308.250.600
19240657,2009-07-01T00:00:00,Nutrition Surveys,E05.318.308.585.550
19240657,2009-07-01T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
19240657,2009-07-01T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
19240657,2009-07-01T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
19240657,2009-07-01T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
19240657,2009-07-01T00:00:00,Parathyroid Hormone,D06.472.699.590
19240657,2009-07-01T00:00:00,Parathyroid Hormone,D12.644.548.587
19240657,2009-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19240657,2009-07-01T00:00:00,Risk Factors,N05.715.350.200.700
19240657,2009-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19240657,2009-07-01T00:00:00,Risk Factors,N06.850.490.625.750
19240657,2009-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19240657,2009-07-01T00:00:00,Smoking,F01.145.466.753
19240657,2009-07-01T00:00:00,Vitamin D,D04.808.812.768
19404209,2009-07-01T00:00:00,Adult,M01.060.116
19404209,2009-07-01T00:00:00,Bacteremia,C01.252.100
19404209,2009-07-01T00:00:00,Bacteremia,C01.539.757.100
19404209,2009-07-01T00:00:00,Bacteremia,C23.550.470.790.500.100
19404209,2009-07-01T00:00:00,Gastrointestinal Stromal Tumors,C04.588.274.476.308
19404209,2009-07-01T00:00:00,Gastrointestinal Stromal Tumors,C06.301.371.308
19404209,2009-07-01T00:00:00,Gastrointestinal Stromal Tumors,C06.405.249.308
19404209,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19404209,2009-07-01T00:00:00,Streptococcal Infections,C01.252.410.890
19404209,2009-07-01T00:00:00,Treatment Outcome,E01.789.800
19404209,2009-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19404209,2009-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19444881,2009-07-01T00:00:00,Aged,M01.060.116.100
19444881,2009-07-01T00:00:00,Bone Transplantation,E04.555.130
19444881,2009-07-01T00:00:00,Bone Transplantation,E04.936.450.050
19444881,2009-07-01T00:00:00,Endoscopy,E01.370.388.250
19444881,2009-07-01T00:00:00,Endoscopy,E04.800.250
19444881,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19444881,2009-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19444881,2009-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19444881,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19444881,2009-07-01T00:00:00,Postoperative Complications,C23.550.767
19444881,2009-07-01T00:00:00,Surgical Flaps,A10.850.710
19444881,2009-07-01T00:00:00,Surgical Flaps,E07.862.710
19444881,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19444881,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19444881,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19444881,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19444881,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19448547,2009-07-01T00:00:00,Gynecologic Surgical Procedures,E04.950.300
19448547,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19448547,2009-07-01T00:00:00,Suburethral Slings,E07.695.752
19448547,2009-07-01T00:00:00,Treatment Outcome,E01.789.800
19448547,2009-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19448547,2009-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19448547,2009-07-01T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
19448547,2009-07-01T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
19448547,2009-07-01T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
19448547,2009-07-01T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
19448547,2009-07-01T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
19448547,2009-07-01T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
19499464,2009-07-01T00:00:00,Adolescent,M01.060.057
19499464,2009-07-01T00:00:00,Antidotes,D27.505.696.706.037
19499464,2009-07-01T00:00:00,Antidotes,D27.720.799.037
19499464,2009-07-01T00:00:00,Charcoal,D01.268.150.150
19499464,2009-07-01T00:00:00,Child,M01.060.406
19499464,2009-07-01T00:00:00,"Child, Preschool",M01.060.406.448
19499464,2009-07-01T00:00:00,Emergency Medical Services,N02.421.297
19499464,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19499464,2009-07-01T00:00:00,Poisoning,C21.613
19499464,2009-07-01T00:00:00,Time Factors,G01.910.857
19499464,2009-07-01T00:00:00,Transportation of Patients,E02.365.839
19499464,2009-07-01T00:00:00,Transportation of Patients,N02.421.297.879
19521273,2009-07-01T00:00:00,Adult,M01.060.116
19521273,2009-07-01T00:00:00,Aged,M01.060.116.100
19521273,2009-07-01T00:00:00,Equipment Failure Analysis,E05.325.192
19521273,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19521273,2009-07-01T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
19521273,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19521273,2009-07-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19521273,2009-07-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19521273,2009-07-01T00:00:00,Postoperative Care,E02.760.722.700
19521273,2009-07-01T00:00:00,Postoperative Care,E04.624
19521273,2009-07-01T00:00:00,Postoperative Care,N02.421.585.722.700
19521273,2009-07-01T00:00:00,Postoperative Complications,C23.550.767
19521273,2009-07-01T00:00:00,Radiography,E01.370.350.700
19521273,2009-07-01T00:00:00,Reoperation,E04.690
19521273,2009-07-01T00:00:00,Spinal Fractures,C21.866.117.500.500
19521273,2009-07-01T00:00:00,Spinal Fractures,C21.866.404.812
19521273,2009-07-01T00:00:00,Spinal Fractures,C21.866.831.600
19521273,2009-07-01T00:00:00,Spinal Fusion,E04.555.100.700
19521273,2009-07-01T00:00:00,Treatment Outcome,E01.789.800
19521273,2009-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19521273,2009-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19525703,2009-07-01T00:00:00,"Adaptation, Psychological",F01.058
19525703,2009-07-01T00:00:00,African Americans,M01.686.508.100.100
19525703,2009-07-01T00:00:00,African Americans,M01.686.754.100
19525703,2009-07-01T00:00:00,Breast Neoplasms,C04.588.180
19525703,2009-07-01T00:00:00,Breast Neoplasms,C17.800.090.500
19525703,2009-07-01T00:00:00,Genetic Counseling,H01.158.273.343.315.384
19525703,2009-07-01T00:00:00,Genetic Counseling,N02.421.308.400
19525703,2009-07-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19525703,2009-07-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19525703,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19525703,2009-07-01T00:00:00,Interviews as Topic,E05.318.308.420
19525703,2009-07-01T00:00:00,Interviews as Topic,L01.280.520
19525703,2009-07-01T00:00:00,Interviews as Topic,N05.715.360.300.400
19525703,2009-07-01T00:00:00,Interviews as Topic,N06.850.520.308.420
19525703,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19525703,2009-07-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
19525703,2009-07-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
19525703,2009-07-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
19525703,2009-07-01T00:00:00,Ovarian Neoplasms,C19.344.410
19525703,2009-07-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
19526453,2009-07-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
19526453,2009-07-01T00:00:00,Depression,F01.145.126.350
19526453,2009-07-01T00:00:00,Double-Blind Method,E05.318.780.300
19526453,2009-07-01T00:00:00,Double-Blind Method,E05.581.500.300
19526453,2009-07-01T00:00:00,Double-Blind Method,N05.715.360.780.320
19526453,2009-07-01T00:00:00,Double-Blind Method,N06.850.520.445.300
19526453,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19526453,2009-07-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
19526453,2009-07-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
19526453,2009-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19526453,2009-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19526453,2009-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19526453,2009-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19526453,2009-07-01T00:00:00,Regression Analysis,E05.318.740.750
19526453,2009-07-01T00:00:00,Regression Analysis,N05.715.360.750.695
19526453,2009-07-01T00:00:00,Regression Analysis,N06.850.520.830.750
19531705,2009-07-01T00:00:00,Animals,B01.050
19531705,2009-07-01T00:00:00,Chickens,B01.050.150.900.248.350.150
19531705,2009-07-01T00:00:00,Chickens,B01.050.150.900.248.617.192
19531705,2009-07-01T00:00:00,Diet,E05.272
19531705,2009-07-01T00:00:00,Diet,G07.610.240
19531705,2009-07-01T00:00:00,Dietary Fats,D10.212.302
19531705,2009-07-01T00:00:00,Dietary Fats,J02.500.375
19531705,2009-07-01T00:00:00,Dietary Supplements,J02.500.456
19531705,2009-07-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
19531705,2009-07-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
19531705,2009-07-01T00:00:00,Poultry Diseases,C22.131.728
19542794,2009-07-01T00:00:00,Adult,M01.060.116
19542794,2009-07-01T00:00:00,Aged,M01.060.116.100
19542794,2009-07-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
19542794,2009-07-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
19542794,2009-07-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
19542794,2009-07-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19542794,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19542794,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19542794,2009-07-01T00:00:00,Opioid-Related Disorders,C21.739.675
19542794,2009-07-01T00:00:00,Opioid-Related Disorders,F03.900.675
19542794,2009-07-01T00:00:00,Pain,C10.597.617
19542794,2009-07-01T00:00:00,Pain,C23.888.592.612
19542794,2009-07-01T00:00:00,Pain,C23.888.646
19542794,2009-07-01T00:00:00,Pain,F02.830.816.444
19542794,2009-07-01T00:00:00,Pain,G11.561.600.810.444
19542794,2009-07-01T00:00:00,Pilot Projects,E05.318.760.750
19542794,2009-07-01T00:00:00,Pilot Projects,E05.337.737
19542794,2009-07-01T00:00:00,Pilot Projects,N05.715.360.775.625
19542794,2009-07-01T00:00:00,Pilot Projects,N06.850.520.450.720
19542794,2009-07-01T00:00:00,Prescriptions,N02.421.668.778
19542794,2009-07-01T00:00:00,Sex Factors,N05.715.350.675
19542794,2009-07-01T00:00:00,Sex Factors,N06.850.490.875
19545814,2009-07-01T00:00:00,Adult,M01.060.116
19545814,2009-07-01T00:00:00,Aged,M01.060.116.100
19545814,2009-07-01T00:00:00,Cataract,C11.510.245
19545814,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19545814,2009-07-01T00:00:00,Incidence,E05.318.308.985.525.375
19545814,2009-07-01T00:00:00,Incidence,L01.280.975.525.375
19545814,2009-07-01T00:00:00,Incidence,N01.224.935.597.500
19545814,2009-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19545814,2009-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19545814,2009-07-01T00:00:00,"Lasers, Solid-State",E07.632.490.490
19545814,2009-07-01T00:00:00,"Lasers, Solid-State",E07.710.520.490
19545814,2009-07-01T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
19545814,2009-07-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
19545814,2009-07-01T00:00:00,"Lenses, Intraocular",E07.632.500.460
19545814,2009-07-01T00:00:00,"Lenses, Intraocular",E07.695.460
19545814,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19545814,2009-07-01T00:00:00,Postoperative Complications,C23.550.767
19545814,2009-07-01T00:00:00,Visual Acuity,E01.370.380.850.950
19545814,2009-07-01T00:00:00,Visual Acuity,F02.463.593.932.901
19545814,2009-07-01T00:00:00,Visual Acuity,G14.940
19559132,2009-07-01T00:00:00,Adult,M01.060.116
19559132,2009-07-01T00:00:00,Age Factors,N05.715.350.075
19559132,2009-07-01T00:00:00,Age Factors,N06.850.490.250
19559132,2009-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19559132,2009-07-01T00:00:00,Body Mass Index,E05.041.124.125
19559132,2009-07-01T00:00:00,Body Mass Index,G07.100.100.125
19559132,2009-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19559132,2009-07-01T00:00:00,Diet,E05.272
19559132,2009-07-01T00:00:00,Diet,G07.610.240
19559132,2009-07-01T00:00:00,Dietary Carbohydrates,D09.301
19559132,2009-07-01T00:00:00,Dietary Carbohydrates,J02.500.362
19559132,2009-07-01T00:00:00,Energy Intake,G07.610.240.340
19559132,2009-07-01T00:00:00,Exercise,G11.427.590.237
19559132,2009-07-01T00:00:00,Exercise,I03.350
19559132,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19559132,2009-07-01T00:00:00,Mental Recall,F02.463.425.540.641
19559132,2009-07-01T00:00:00,Obesity,C18.654.726.500
19559132,2009-07-01T00:00:00,Obesity,C23.888.144.699.500
19559132,2009-07-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19559132,2009-07-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19559132,2009-07-01T00:00:00,Overweight,C23.888.144.699
19559132,2009-07-01T00:00:00,Overweight,E01.370.600.115.100.160.120.699
19559132,2009-07-01T00:00:00,Overweight,G07.100.100.160.120.699
19559132,2009-07-01T00:00:00,Questionnaires,E05.318.308.750
19559132,2009-07-01T00:00:00,Questionnaires,L01.280.800
19559132,2009-07-01T00:00:00,Questionnaires,N05.715.360.300.695
19559132,2009-07-01T00:00:00,Questionnaires,N06.850.520.308.750
19559132,2009-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19559132,2009-07-01T00:00:00,Risk Factors,N05.715.350.200.700
19559132,2009-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19559132,2009-07-01T00:00:00,Risk Factors,N06.850.490.625.750
19559132,2009-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19559132,2009-07-01T00:00:00,Sex Factors,N05.715.350.675
19559132,2009-07-01T00:00:00,Sex Factors,N06.850.490.875
19559132,2009-07-01T00:00:00,Smoking,F01.145.466.753
19559172,2009-07-01T00:00:00,Colonic Polyps,C23.300.825.411.235
19559172,2009-07-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
19559172,2009-07-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
19559172,2009-07-01T00:00:00,Colonoscopy,E04.210.240.250.160
19559172,2009-07-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
19559172,2009-07-01T00:00:00,Gastroenterology,H02.403.429.405
19559172,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19559172,2009-07-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
19559172,2009-07-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
19559172,2009-07-01T00:00:00,Patient Satisfaction,N05.715.360.600
19559172,2009-07-01T00:00:00,Primary Health Care,N04.590.233.727
19559172,2009-07-01T00:00:00,Questionnaires,E05.318.308.750
19559172,2009-07-01T00:00:00,Questionnaires,L01.280.800
19559172,2009-07-01T00:00:00,Questionnaires,N05.715.360.300.695
19559172,2009-07-01T00:00:00,Questionnaires,N06.850.520.308.750
19559179,2009-07-01T00:00:00,Adult,M01.060.116
19559179,2009-07-01T00:00:00,Attitude of Health Personnel,F01.100.050
19559179,2009-07-01T00:00:00,Attitude of Health Personnel,N05.300.100
19559179,2009-07-01T00:00:00,Attitude to Health,F01.100.150
19559179,2009-07-01T00:00:00,Attitude to Health,N05.300.150
19559179,2009-07-01T00:00:00,Bioprosthesis,E07.695.100
19559179,2009-07-01T00:00:00,Decision Making,F02.463.785.373
19559179,2009-07-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
19559179,2009-07-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
19559179,2009-07-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
19559179,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19559179,2009-07-01T00:00:00,Patient Compliance,F01.145.488.500
19559179,2009-07-01T00:00:00,Patient Compliance,N05.300.150.600.600
19559179,2009-07-01T00:00:00,Prosthesis-Related Infections,C01.539.685
19559179,2009-07-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
19559179,2009-07-01T00:00:00,Reoperation,E04.690
19559179,2009-07-01T00:00:00,United States,Z01.107.567.875
19559926,2009-07-01T00:00:00,Adult,M01.060.116
19559926,2009-07-01T00:00:00,Aged,M01.060.116.100
19559926,2009-07-01T00:00:00,"Embolization, Therapeutic",E02.520.360
19559926,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19559926,2009-07-01T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
19559926,2009-07-01T00:00:00,Intracranial Aneurysm,C14.907.055.635
19559926,2009-07-01T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
19559926,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19559926,2009-07-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19559926,2009-07-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19559926,2009-07-01T00:00:00,Postoperative Complications,C23.550.767
19559926,2009-07-01T00:00:00,Prostheses and Implants,E07.695
19559926,2009-07-01T00:00:00,Reoperation,E04.690
19559926,2009-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19559926,2009-07-01T00:00:00,Risk Assessment,N04.452.871.715
19559926,2009-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19559926,2009-07-01T00:00:00,Risk Assessment,N06.850.505.715
19559926,2009-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19559926,2009-07-01T00:00:00,Stents,E07.695.750
19559926,2009-07-01T00:00:00,Treatment Outcome,E01.789.800
19559926,2009-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19559926,2009-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19559966,2009-07-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19559966,2009-07-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19559966,2009-07-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19559966,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19559966,2009-07-01T00:00:00,Nasal Cavity,A04.531.449
19559966,2009-07-01T00:00:00,Sinusitis,C08.460.692.752
19559966,2009-07-01T00:00:00,Sinusitis,C08.730.749
19559966,2009-07-01T00:00:00,Sinusitis,C09.603.692.752
19560061,2009-07-01T00:00:00,Algorithms,G17.035
19560061,2009-07-01T00:00:00,Algorithms,L01.224.050
19560061,2009-07-01T00:00:00,Body Burden,E05.799.638.231
19560061,2009-07-01T00:00:00,Body Burden,N06.850.460.200
19560061,2009-07-01T00:00:00,Internet,L01.224.230.110.500
19560061,2009-07-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
19560061,2009-07-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
19560061,2009-07-01T00:00:00,Radiometry,E05.799
19560061,2009-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19560061,2009-07-01T00:00:00,Risk Assessment,N04.452.871.715
19560061,2009-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19560061,2009-07-01T00:00:00,Risk Assessment,N06.850.505.715
19560061,2009-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19560061,2009-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19560061,2009-07-01T00:00:00,Risk Factors,N05.715.350.200.700
19560061,2009-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19560061,2009-07-01T00:00:00,Risk Factors,N06.850.490.625.750
19560061,2009-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19560061,2009-07-01T00:00:00,Software,L01.224.900
19560061,2009-07-01T00:00:00,User-Computer Interface,L01.224.900.910
19560061,2009-07-01T00:00:00,X-Rays,G01.201.875.750.918
19560689,2009-07-01T00:00:00,Brain,A08.186.211
19560689,2009-07-01T00:00:00,Disease Progression,C23.550.291.656
19560689,2009-07-01T00:00:00,Down Syndrome,C10.597.606.643.220
19560689,2009-07-01T00:00:00,Down Syndrome,C16.131.077.327
19560689,2009-07-01T00:00:00,Down Syndrome,C16.131.260.260
19560689,2009-07-01T00:00:00,Down Syndrome,C16.320.180.260
19560689,2009-07-01T00:00:00,Echocardiography,E01.370.350.850.220
19560689,2009-07-01T00:00:00,Echocardiography,E01.370.370.380.220
19560689,2009-07-01T00:00:00,Hemiplegia,C10.597.622.295
19560689,2009-07-01T00:00:00,Hemiplegia,C23.888.592.636.312
19560689,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19560689,2009-07-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
19560689,2009-07-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
19560689,2009-07-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
19560689,2009-07-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
19560689,2009-07-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
19560689,2009-07-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
19560689,2009-07-01T00:00:00,Intracranial Embolism,C10.228.140.300.525.400
19560689,2009-07-01T00:00:00,Intracranial Embolism,C14.907.253.566.300
19560689,2009-07-01T00:00:00,Intracranial Embolism,C14.907.355.590.213.300
19560689,2009-07-01T00:00:00,Intracranial Embolism,C14.907.355.830.850.213.300
19560689,2009-07-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
19560689,2009-07-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
19560689,2009-07-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
19560689,2009-07-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
19560689,2009-07-01T00:00:00,Renal Dialysis,E02.870.300
19560689,2009-07-01T00:00:00,Renal Dialysis,E02.912.800
19560689,2009-07-01T00:00:00,Seizures,C10.228.140.490.631
19560689,2009-07-01T00:00:00,Seizures,C10.597.742
19560689,2009-07-01T00:00:00,Seizures,C23.888.592.742
19560689,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19560689,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19560689,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19560689,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19560689,2009-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19560689,2009-07-01T00:00:00,Treatment Outcome,E01.789.800
19560689,2009-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19560689,2009-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19560689,2009-07-01T00:00:00,Young Adult,M01.060.116.815
19563285,2009-07-01T00:00:00,Adult,M01.060.116
19563285,2009-07-01T00:00:00,African Americans,M01.686.508.100.100
19563285,2009-07-01T00:00:00,African Americans,M01.686.754.100
19563285,2009-07-01T00:00:00,Aged,M01.060.116.100
19563285,2009-07-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19563285,2009-07-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19563285,2009-07-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
19563285,2009-07-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
19563285,2009-07-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
19563285,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19563285,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19563285,2009-07-01T00:00:00,Periodontal Diseases,C07.465.714
19563285,2009-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19563285,2009-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19563285,2009-07-01T00:00:00,United States,Z01.107.567.875
19564217,2009-07-01T00:00:00,Adult,M01.060.116
19564217,2009-07-01T00:00:00,Child,M01.060.406
19564217,2009-07-01T00:00:00,Health Care Coalitions,N03.540.452.188
19564217,2009-07-01T00:00:00,Health Services Research,N03.349.380
19564217,2009-07-01T00:00:00,Health Services Research,N05.425
19564217,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19564217,2009-07-01T00:00:00,Leadership,F01.752.609
19564217,2009-07-01T00:00:00,Mental Disorders,F03
19564217,2009-07-01T00:00:00,Mental Health Services,F04.408
19564217,2009-07-01T00:00:00,Mental Health Services,N02.421.461
19564217,2009-07-01T00:00:00,Organizational Objectives,N04.452.615
19564217,2009-07-01T00:00:00,Physician's Practice Patterns,N04.590.748
19564217,2009-07-01T00:00:00,Physician's Practice Patterns,N05.300.625
19564217,2009-07-01T00:00:00,Professional Competence,I02.399.630
19564217,2009-07-01T00:00:00,Quality of Health Care,N04.761
19564217,2009-07-01T00:00:00,Quality of Health Care,N05.715
19564217,2009-07-01T00:00:00,Self Care,E02.900
19564217,2009-07-01T00:00:00,Self Care,N02.421.784.680
19564217,2009-07-01T00:00:00,Staff Development,I02.574.700
19564217,2009-07-01T00:00:00,Staff Development,N04.452.677.822
19564217,2009-07-01T00:00:00,Substance-Related Disorders,C21.739
19564217,2009-07-01T00:00:00,Substance-Related Disorders,F03.900
19564217,2009-07-01T00:00:00,United States,Z01.107.567.875
19570938,2009-07-01T00:00:00,Adult,M01.060.116
19570938,2009-07-01T00:00:00,Cognitive Therapy,F04.754.137.428
19570938,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19570938,2009-07-01T00:00:00,Military Personnel,M01.526.625
19570938,2009-07-01T00:00:00,Obsessive-Compulsive Disorder,F03.080.600
19570938,2009-07-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
19570938,2009-07-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
19570938,2009-07-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
19570938,2009-07-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
19570938,2009-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19570938,2009-07-01T00:00:00,Veterans,M01.930
19570938,2009-07-01T00:00:00,Young Adult,M01.060.116.815
19571793,2009-07-01T00:00:00,Animals,B01.050
19571793,2009-07-01T00:00:00,Glutamic Acid,D12.125.067.750
19571793,2009-07-01T00:00:00,Glutamic Acid,D12.125.119.450
19571793,2009-07-01T00:00:00,Glutamic Acid,D12.125.427.300
19571793,2009-07-01T00:00:00,Homeostasis,G07.700.360
19571793,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19571793,2009-07-01T00:00:00,"Models, Biological",E05.599.395
19571793,2009-07-01T00:00:00,Neural Pathways,A08.612
19571793,2009-07-01T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19571793,2009-07-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19571793,2009-07-01T00:00:00,Substance-Related Disorders,C21.739
19571793,2009-07-01T00:00:00,Substance-Related Disorders,F03.900
19576166,2009-07-01T00:00:00,Animals,B01.050
19576166,2009-07-01T00:00:00,Apoptosis,G04.299.139.160
19576166,2009-07-01T00:00:00,Calcium,D01.268.552.100
19576166,2009-07-01T00:00:00,Calcium,D01.552.539.288
19576166,2009-07-01T00:00:00,Calcium,D23.119.100
19576166,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19576166,2009-07-01T00:00:00,Liver Transplantation,E04.210.650
19576166,2009-07-01T00:00:00,Liver Transplantation,E04.936.450.490
19576166,2009-07-01T00:00:00,Liver Transplantation,E04.936.580.490
19576166,2009-07-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19576166,2009-07-01T00:00:00,Mitochondria,A11.284.835.626
19576166,2009-07-01T00:00:00,Oxidative Stress,G03.495.710
19576166,2009-07-01T00:00:00,Oxidative Stress,G07.700.830.750
19576299,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19576299,2009-07-01T00:00:00,Mental Health Services,F04.408
19576299,2009-07-01T00:00:00,Mental Health Services,N02.421.461
19576299,2009-07-01T00:00:00,Psychotherapy,F04.754
19576299,2009-07-01T00:00:00,Research Design,E05.581.500
19576299,2009-07-01T00:00:00,Research Design,H01.770.644.728
19576299,2009-07-01T00:00:00,Rural Health Services,N02.421.816
19576299,2009-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19576299,2009-07-01T00:00:00,Telemedicine,H02.403.840
19576299,2009-07-01T00:00:00,Telemedicine,L01.178.847.652
19576299,2009-07-01T00:00:00,Telemedicine,N04.590.374.800
19576299,2009-07-01T00:00:00,Veterans,M01.930
19576376,2009-07-01T00:00:00,Adult,M01.060.116
19576376,2009-07-01T00:00:00,"Cerclage, Cervical",E04.520.100
19576376,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19576376,2009-07-01T00:00:00,Laparoscopy,E01.370.388.250.520
19576376,2009-07-01T00:00:00,Laparoscopy,E04.800.250.520
19576376,2009-07-01T00:00:00,Pregnancy,G08.686.785.760.769
19576376,2009-07-01T00:00:00,Pregnancy Outcome,E01.789.700
19576376,2009-07-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
19576376,2009-07-01T00:00:00,Young Adult,M01.060.116.815
19590298,2009-07-01T00:00:00,"Accidents, Traffic",N06.850.135.392
19590298,2009-07-01T00:00:00,"Amputation, Traumatic",C21.866.062
19590298,2009-07-01T00:00:00,Anemia,C15.378.071
19590298,2009-07-01T00:00:00,Blood Transfusion,E02.095.135
19590298,2009-07-01T00:00:00,Hemoglobins,D12.776.124.400
19590298,2009-07-01T00:00:00,Hemoglobins,D12.776.422.316.762
19590298,2009-07-01T00:00:00,Hemorrhage,C23.550.414
19590298,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19590298,2009-07-01T00:00:00,Jehovah's Witnesses,K01.844.188.573
19590298,2009-07-01T00:00:00,Jehovah's Witnesses,M01.352
19590298,2009-07-01T00:00:00,Multiple Trauma,C21.866.640
19590298,2009-07-01T00:00:00,Orthopedic Procedures,E02.718
19590298,2009-07-01T00:00:00,Orthopedic Procedures,E04.555
19590298,2009-07-01T00:00:00,Young Adult,M01.060.116.815
19595396,2009-07-01T00:00:00,Aged,M01.060.116.100
19595396,2009-07-01T00:00:00,Brain Ischemia,C10.228.140.300.150
19595396,2009-07-01T00:00:00,Brain Ischemia,C14.907.253.092
19595396,2009-07-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19595396,2009-07-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19595396,2009-07-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19595396,2009-07-01T00:00:00,Heart Diseases,C14.280
19595396,2009-07-01T00:00:00,Hemorrhage,C23.550.414
19595396,2009-07-01T00:00:00,Heparin,D09.698.373.400
19595396,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19595396,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19595396,2009-07-01T00:00:00,Myocardial Infarction,C14.280.647.500
19595396,2009-07-01T00:00:00,Myocardial Infarction,C14.907.585.500
19595396,2009-07-01T00:00:00,Peptide Fragments,D12.644.541
19595396,2009-07-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19595396,2009-07-01T00:00:00,Recombinant Proteins,D12.776.828
19595396,2009-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19595396,2009-07-01T00:00:00,Risk Assessment,N04.452.871.715
19595396,2009-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19595396,2009-07-01T00:00:00,Risk Assessment,N06.850.505.715
19595396,2009-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19595396,2009-07-01T00:00:00,Stroke,C10.228.140.300.775
19595396,2009-07-01T00:00:00,Stroke,C14.907.253.855
19595396,2009-07-01T00:00:00,Time Factors,G01.910.857
19595396,2009-07-01T00:00:00,Treatment Outcome,E01.789.800
19595396,2009-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19595396,2009-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19609004,2009-07-01T00:00:00,Apoptosis,G04.299.139.160
19609004,2009-07-01T00:00:00,Arachidonic Acids,D10.251.355.096
19609004,2009-07-01T00:00:00,Arachidonic Acids,D10.251.355.255.100
19609004,2009-07-01T00:00:00,Arachidonic Acids,D10.251.355.310.166
19609004,2009-07-01T00:00:00,Cannabinoids,D02.455.849.090
19609004,2009-07-01T00:00:00,Ceramides,D02.065.313
19609004,2009-07-01T00:00:00,Ceramides,D09.400.410.420.525.200
19609004,2009-07-01T00:00:00,Ceramides,D10.390.470.675.200
19609004,2009-07-01T00:00:00,Ceramides,D10.570.877.360.612.200
19609004,2009-07-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
19609004,2009-07-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19609004,2009-07-01T00:00:00,Flow Cytometry,E05.200.500.386.350
19609004,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19617808,2009-07-01T00:00:00,"Diagnosis, Differential",E01.171
19617808,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19617808,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19617808,2009-07-01T00:00:00,Time Factors,G01.910.857
19620848,2009-07-01T00:00:00,Activities of Daily Living,E02.831.067
19620848,2009-07-01T00:00:00,Activities of Daily Living,I03.050
19620848,2009-07-01T00:00:00,Activities of Daily Living,N02.421.784.110
19620848,2009-07-01T00:00:00,Aged,M01.060.116.100
19620848,2009-07-01T00:00:00,Antiparkinson Agents,D27.505.954.427.090.050
19620848,2009-07-01T00:00:00,Double-Blind Method,E05.318.780.300
19620848,2009-07-01T00:00:00,Double-Blind Method,E05.581.500.300
19620848,2009-07-01T00:00:00,Double-Blind Method,N05.715.360.780.320
19620848,2009-07-01T00:00:00,Double-Blind Method,N06.850.520.445.300
19620848,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19620848,2009-07-01T00:00:00,Movement,G07.700.560
19620848,2009-07-01T00:00:00,Movement,G11.427.590.530
19620848,2009-07-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19620848,2009-07-01T00:00:00,Parkinson Disease,C10.228.662.600.400
19620848,2009-07-01T00:00:00,Parkinson Disease,C10.574.812
19639572,2009-07-01T00:00:00,Algorithms,G17.035
19639572,2009-07-01T00:00:00,Algorithms,L01.224.050
19639572,2009-07-01T00:00:00,Electromagnetic Fields,G01.201.260
19639572,2009-07-01T00:00:00,Electromagnetic Fields,G01.201.875.240
19639572,2009-07-01T00:00:00,Electrophoresis,E05.196.401
19639572,2009-07-01T00:00:00,Electrophoresis,E05.301.300
19639572,2009-07-01T00:00:00,Electrophoresis,G02.149.767.570
19639572,2009-07-01T00:00:00,Electrophoresis,G02.842.750.570
19639572,2009-07-01T00:00:00,Finite Element Analysis,E05.355
19639572,2009-07-01T00:00:00,"Models, Chemical",E05.599.495
19653978,2009-07-01T00:00:00,Adult,M01.060.116
19653978,2009-07-01T00:00:00,Age of Onset,N05.715.350.075.100
19653978,2009-07-01T00:00:00,Age of Onset,N06.850.490.250.100
19653978,2009-07-01T00:00:00,Bipolar Disorder,F03.600.150.150
19653978,2009-07-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19653978,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19653978,2009-07-01T00:00:00,"Models, Psychological",E05.599.695
19653978,2009-07-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19653978,2009-07-01T00:00:00,Sex Factors,N05.715.350.675
19653978,2009-07-01T00:00:00,Sex Factors,N06.850.490.875
19653978,2009-07-01T00:00:00,Substance-Related Disorders,C21.739
19653978,2009-07-01T00:00:00,Substance-Related Disorders,F03.900
19656140,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19656140,2009-07-01T00:00:00,Liver Transplantation,E04.210.650
19656140,2009-07-01T00:00:00,Liver Transplantation,E04.936.450.490
19656140,2009-07-01T00:00:00,Liver Transplantation,E04.936.580.490
19656140,2009-07-01T00:00:00,Tissue Donors,M01.898
19656140,2009-07-01T00:00:00,Treatment Outcome,E01.789.800
19656140,2009-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19656140,2009-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19670354,2009-07-01T00:00:00,Academic Medical Centers,N02.278.020
19670354,2009-07-01T00:00:00,Adult,M01.060.116
19670354,2009-07-01T00:00:00,Aged,M01.060.116.100
19670354,2009-07-01T00:00:00,Blood Glucose,D09.546.359.448.500
19670354,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19670354,2009-07-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
19670354,2009-07-01T00:00:00,Insulin,D06.472.699.587.740.625
19670354,2009-07-01T00:00:00,Insulin,D12.644.548.586.740.625
19670354,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
19670354,2009-07-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19670354,2009-07-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19670354,2009-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19670354,2009-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19671261,2009-07-01T00:00:00,Cadaver,C23.550.260.224
19671261,2009-07-01T00:00:00,Endoscopy,E01.370.388.250
19671261,2009-07-01T00:00:00,Endoscopy,E04.800.250
19671261,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19671261,2009-07-01T00:00:00,Maxilla,A02.835.232.781.324.502.645
19671261,2009-07-01T00:00:00,Maxilla,A14.521.645
19671261,2009-07-01T00:00:00,Nasal Septum,A04.531.591
19671261,2009-07-01T00:00:00,Temporal Bone,A02.835.232.781.885
19681288,2009-07-01T00:00:00,Animals,B01.050
19681288,2009-07-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
19681288,2009-07-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
19681288,2009-07-01T00:00:00,"Models, Biological",E05.599.395
19681288,2009-07-01T00:00:00,"Models, Theoretical",E05.599
19681288,2009-07-01T00:00:00,Time Factors,G01.910.857
19681288,2009-07-01T00:00:00,Water,D01.455.900
19681288,2009-07-01T00:00:00,Water,D01.650.550.925
19691257,2009-07-01T00:00:00,Adult,M01.060.116
19691257,2009-07-01T00:00:00,Age Factors,N05.715.350.075
19691257,2009-07-01T00:00:00,Age Factors,N06.850.490.250
19691257,2009-07-01T00:00:00,Cervical Intraepithelial Neoplasia,C04.557.470.200.240.250
19691257,2009-07-01T00:00:00,Disease Progression,C23.550.291.656
19691257,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19691257,2009-07-01T00:00:00,Papillomavirus Infections,C02.256.650
19691257,2009-07-01T00:00:00,Papillomavirus Infections,C02.928.725
19691257,2009-07-01T00:00:00,Patient Compliance,F01.145.488.500
19691257,2009-07-01T00:00:00,Patient Compliance,N05.300.150.600.600
19691257,2009-07-01T00:00:00,Pregnancy,G08.686.785.760.769
19691257,2009-07-01T00:00:00,Urban Population,N01.600.900
19691257,2009-07-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
19691257,2009-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
19691257,2009-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
19691257,2009-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
19691257,2009-07-01T00:00:00,Young Adult,M01.060.116.815
20161065,2009-07-01T00:00:00,Adult,M01.060.116
20161065,2009-07-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20161065,2009-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20161065,2009-07-01T00:00:00,Middle Aged,M01.060.116.630
20161065,2009-07-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20161065,2009-07-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20161065,2009-07-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20161065,2009-07-01T00:00:00,Treatment Outcome,E01.789.800
20161065,2009-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20161065,2009-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19576839,2009-07-02T00:00:00,Benzo(a)pyrene,D02.455.426.559.847.799.306.300
19576839,2009-07-02T00:00:00,Benzo(a)pyrene,D04.615.799.306.300
19576839,2009-07-02T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19576839,2009-07-02T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19576839,2009-07-02T00:00:00,Cytochrome P-450 CYP1A1,D08.244.453.040.555
19576839,2009-07-02T00:00:00,Cytochrome P-450 CYP1A1,D08.811.682.690.708.170.040.332
19576839,2009-07-02T00:00:00,Cytochrome P-450 CYP1A1,D12.776.422.220.453.040.332
19576839,2009-07-02T00:00:00,Head and Neck Neoplasms,C04.588.443
19576839,2009-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19576839,2009-07-02T00:00:00,Middle Aged,M01.060.116.630
19576839,2009-07-02T00:00:00,Mouth Mucosa,A10.615.550.599
19576839,2009-07-02T00:00:00,Mouth Mucosa,A14.549.512
19576839,2009-07-02T00:00:00,Mouth Neoplasms,C04.588.443.591
19576839,2009-07-02T00:00:00,Mouth Neoplasms,C07.465.565
19576839,2009-07-02T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19576839,2009-07-02T00:00:00,Smoking,F01.145.466.753
19576951,2009-07-02T00:00:00,Adipocytes,A11.329.114
19576951,2009-07-02T00:00:00,Animals,B01.050
19576951,2009-07-02T00:00:00,Bone Marrow Transplantation,E04.936.580.040
19576951,2009-07-02T00:00:00,Carrier Proteins,D12.776.157
19576951,2009-07-02T00:00:00,Cell Differentiation,G04.299.151
19576951,2009-07-02T00:00:00,Diet,E05.272
19576951,2009-07-02T00:00:00,Diet,G07.610.240
19576951,2009-07-02T00:00:00,Hematopoietic Stem Cells,A11.148.378
19576951,2009-07-02T00:00:00,Hematopoietic Stem Cells,A11.872.378
19576951,2009-07-02T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
19576951,2009-07-02T00:00:00,Hypoglycemic Agents,D27.505.696.422
19576951,2009-07-02T00:00:00,Phosphoproteins,D12.776.744
19577572,2009-07-03T00:00:00,Animals,B01.050
19577572,2009-07-03T00:00:00,Extracellular Matrix,A11.284.295.310
19577572,2009-07-03T00:00:00,Fibrillar Collagens,D05.750.078.280.300
19577572,2009-07-03T00:00:00,Fibrillar Collagens,D12.776.860.300.250.300
19577572,2009-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19577572,2009-07-03T00:00:00,"Models, Biological",E05.599.395
19577572,2009-07-03T00:00:00,Myocardium,A02.633.580
19577572,2009-07-03T00:00:00,Myocardium,A07.541.704
19577572,2009-07-03T00:00:00,Myocardium,A10.690.552.750
19577572,2009-07-03T00:00:00,Osteonectin,D12.776.157.125.715
19577572,2009-07-03T00:00:00,Osteonectin,D12.776.395.600
21994103,2009-07-03T00:00:00,Angioplasty,E02.148.050
21994103,2009-07-03T00:00:00,Angioplasty,E04.100.814.050
21994103,2009-07-03T00:00:00,Anticoagulants,D27.505.954.502.119
21994103,2009-07-03T00:00:00,Brain Ischemia,C10.228.140.300.150
21994103,2009-07-03T00:00:00,Brain Ischemia,C14.907.253.092
21994103,2009-07-03T00:00:00,Evidence-Based Medicine,H02.249.750
21994103,2009-07-03T00:00:00,Evidence-Based Medicine,H02.403.200.400
21994103,2009-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21994103,2009-07-03T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
21994103,2009-07-03T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
21994103,2009-07-03T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
21994103,2009-07-03T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
21994103,2009-07-03T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
21994103,2009-07-03T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
21994103,2009-07-03T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
21994103,2009-07-03T00:00:00,Stents,E07.695.750
21994103,2009-07-03T00:00:00,Stroke,C10.228.140.300.775
21994103,2009-07-03T00:00:00,Stroke,C14.907.253.855
19581931,2009-07-06T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
19581931,2009-07-06T00:00:00,Animals,B01.050
19581931,2009-07-06T00:00:00,Cell Line,A11.251.210
19581931,2009-07-06T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19581931,2009-07-06T00:00:00,"Models, Biological",E05.599.395
19581931,2009-07-06T00:00:00,Phosphoproteins,D12.776.744
19581931,2009-07-06T00:00:00,Phosphorylation,G02.111.087.677
19581931,2009-07-06T00:00:00,Phosphorylation,G02.149.115.677
19581931,2009-07-06T00:00:00,Phosphorylation,G02.149.465.700
19581931,2009-07-06T00:00:00,Phosphorylation,G02.607.750.700
19581931,2009-07-06T00:00:00,Phosphorylation,G03.495.790
19581931,2009-07-06T00:00:00,Protein Phosphatase 1,D08.811.277.352.650.625.687
19581931,2009-07-06T00:00:00,Repressor Proteins,D12.776.260.703
19581931,2009-07-06T00:00:00,Repressor Proteins,D12.776.930.700
19581931,2009-07-06T00:00:00,Signal Transduction,G02.111.087.800
19581931,2009-07-06T00:00:00,Signal Transduction,G02.149.115.800
19581931,2009-07-06T00:00:00,Signal Transduction,G04.299.880
19581931,2009-07-06T00:00:00,Wnt Proteins,D12.644.276.984
19581931,2009-07-06T00:00:00,Wnt Proteins,D12.776.467.984
19581931,2009-07-06T00:00:00,Wnt Proteins,D23.529.984
19581931,2009-07-06T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
19581931,2009-07-06T00:00:00,Zebrafish Proteins,D12.776.325.500
19581931,2009-07-06T00:00:00,beta Catenin,D12.776.091.249
19581931,2009-07-06T00:00:00,beta Catenin,D12.776.220.145.500
19581931,2009-07-06T00:00:00,beta Catenin,D12.776.930.130
19594842,2009-07-06T00:00:00,Adult,M01.060.116
19594842,2009-07-06T00:00:00,Chronic Disease,C23.550.291.500
19594842,2009-07-06T00:00:00,Functional Laterality,F02.830.297.425
19594842,2009-07-06T00:00:00,Functional Laterality,G11.561.225.425
19594842,2009-07-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19594842,2009-07-06T00:00:00,Middle Aged,M01.060.116.630
19594842,2009-07-06T00:00:00,Pain,C10.597.617
19594842,2009-07-06T00:00:00,Pain,C23.888.592.612
19594842,2009-07-06T00:00:00,Pain,C23.888.646
19594842,2009-07-06T00:00:00,Pain,F02.830.816.444
19594842,2009-07-06T00:00:00,Pain,G11.561.600.810.444
19594842,2009-07-06T00:00:00,Pain Measurement,E01.370.376.550.600
19594842,2009-07-06T00:00:00,Pain Threshold,F02.463.593.710.560
19594842,2009-07-06T00:00:00,Pain Threshold,F02.830.816.444.700
19594842,2009-07-06T00:00:00,Pain Threshold,G11.561.600.810.444.700
19594842,2009-07-06T00:00:00,Peripheral Nervous System Diseases,C10.668.829
19594842,2009-07-06T00:00:00,Pilot Projects,E05.318.760.750
19594842,2009-07-06T00:00:00,Pilot Projects,E05.337.737
19594842,2009-07-06T00:00:00,Pilot Projects,N05.715.360.775.625
19594842,2009-07-06T00:00:00,Pilot Projects,N06.850.520.450.720
19594842,2009-07-06T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19594842,2009-07-06T00:00:00,Questionnaires,E05.318.308.750
19594842,2009-07-06T00:00:00,Questionnaires,L01.280.800
19594842,2009-07-06T00:00:00,Questionnaires,N05.715.360.300.695
19594842,2009-07-06T00:00:00,Questionnaires,N06.850.520.308.750
19594842,2009-07-06T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19594842,2009-07-06T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19505151,2009-07-07T00:00:00,DNA,D13.444.308
19505151,2009-07-07T00:00:00,Fluorescent Dyes,D27.720.233.348
19505151,2009-07-07T00:00:00,Fluorescent Dyes,D27.720.470.330.348
19505151,2009-07-07T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
19505151,2009-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19505151,2009-07-07T00:00:00,Light,G01.201.875.770.578
19505151,2009-07-07T00:00:00,Light,G01.590.540
19505151,2009-07-07T00:00:00,Protein Conformation,G02.111.570.790.709
19505151,2009-07-07T00:00:00,Protein Denaturation,G02.111.087.685
19505151,2009-07-07T00:00:00,Protein Denaturation,G02.149.115.685
19505151,2009-07-07T00:00:00,Protein Folding,G01.154.100.640
19505151,2009-07-07T00:00:00,Protein Folding,G01.595.100.640
19505151,2009-07-07T00:00:00,Protein Folding,G02.111.087.690
19505151,2009-07-07T00:00:00,Protein Folding,G02.149.115.690
19505151,2009-07-07T00:00:00,Protein Stability,G02.111.700
19505151,2009-07-07T00:00:00,Recombinant Proteins,D12.776.828
19505151,2009-07-07T00:00:00,"Scattering, Radiation",E05.196.822
19505151,2009-07-07T00:00:00,"Scattering, Radiation",G01.595.861
19505151,2009-07-07T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
19505151,2009-07-07T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
19505151,2009-07-07T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
19505151,2009-07-07T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
19505151,2009-07-07T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
19505151,2009-07-07T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
19505151,2009-07-07T00:00:00,Water,D01.455.900
19505151,2009-07-07T00:00:00,Water,D01.650.550.925
19591850,2009-07-08T00:00:00,Animals,B01.050
19591850,2009-07-08T00:00:00,Cocaine,D02.145.074.722.388
19591850,2009-07-08T00:00:00,Cocaine,D03.132.889.354
19591850,2009-07-08T00:00:00,Cocaine,D03.605.869.388
19591850,2009-07-08T00:00:00,Cocaine,D04.075.080.875.099.722.388
19591850,2009-07-08T00:00:00,Cocaine-Related Disorders,C21.739.300
19591850,2009-07-08T00:00:00,Cocaine-Related Disorders,F03.900.300
19591850,2009-07-08T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19591850,2009-07-08T00:00:00,"Disease Models, Animal",C22.232
19591850,2009-07-08T00:00:00,"Disease Models, Animal",E05.598.500
19591850,2009-07-08T00:00:00,"Disease Models, Animal",E05.599.395.080
19591850,2009-07-08T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19591850,2009-07-08T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19591850,2009-07-08T00:00:00,Neuropeptides,D12.644.400
19591850,2009-07-08T00:00:00,Neuropeptides,D12.776.641.650
19591850,2009-07-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19591850,2009-07-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19591850,2009-07-08T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
19591850,2009-07-08T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.720.600
19591850,2009-07-08T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.750.555
19591850,2009-07-08T00:00:00,Self Administration,E02.319.890
19591850,2009-07-08T00:00:00,Self Administration,E02.900.890
19591850,2009-07-08T00:00:00,Time Factors,G01.910.857
19602126,2009-07-08T00:00:00,Bacteria,B03
19602126,2009-07-08T00:00:00,Biofilms,G06.120
19602126,2009-07-08T00:00:00,Chronic Periodontitis,C07.465.714.533.324
19602126,2009-07-08T00:00:00,"Colony Count, Microbial",E05.200.875.220
19602126,2009-07-08T00:00:00,Dental Plaque,C07.793.208.377
19602126,2009-07-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19602126,2009-07-08T00:00:00,Methylene Blue,D02.886.369.517
19602126,2009-07-08T00:00:00,Methylene Blue,D03.494.741.517
19602126,2009-07-08T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19602126,2009-07-08T00:00:00,"Microscopy, Confocal",E05.595.395
19602126,2009-07-08T00:00:00,Periodontal Pocket,C07.465.714.533.750
19602126,2009-07-08T00:00:00,Photochemotherapy,E02.186.500
19602126,2009-07-08T00:00:00,Photochemotherapy,E02.319.685
19602126,2009-07-08T00:00:00,Photochemotherapy,E02.774.722
19602126,2009-07-08T00:00:00,Photosensitizing Agents,D27.505.696.750.710
19602126,2009-07-08T00:00:00,Photosensitizing Agents,D27.505.954.444.600
19602126,2009-07-08T00:00:00,Radiation Dosage,E05.799.513
19602126,2009-07-08T00:00:00,Radiation Dosage,G01.201.875.740
19602126,2009-07-08T00:00:00,Radiation Dosage,N06.850.810.250
19545855,2009-07-09T00:00:00,Adult,M01.060.116
19545855,2009-07-09T00:00:00,Aged,M01.060.116.100
19545855,2009-07-09T00:00:00,Depression,F01.145.126.350
19545855,2009-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19545855,2009-07-09T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19545855,2009-07-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19545855,2009-07-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19545855,2009-07-09T00:00:00,Middle Aged,M01.060.116.630
19545855,2009-07-09T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19545855,2009-07-09T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19545855,2009-07-09T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19545855,2009-07-09T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19545855,2009-07-09T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19545855,2009-07-09T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19545855,2009-07-09T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19590054,2009-07-09T00:00:00,Adult,M01.060.116
19590054,2009-07-09T00:00:00,Aged,M01.060.116.100
19590054,2009-07-09T00:00:00,Alleles,G05.360.340.024.340.030
19590054,2009-07-09T00:00:00,C-Reactive Protein,D12.776.034.145
19590054,2009-07-09T00:00:00,C-Reactive Protein,D12.776.124.050.120
19590054,2009-07-09T00:00:00,C-Reactive Protein,D12.776.124.486.157
19590054,2009-07-09T00:00:00,Cardiovascular Diseases,C14
19590054,2009-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19590054,2009-07-09T00:00:00,Middle Aged,M01.060.116.630
19590054,2009-07-09T00:00:00,Neuropsychological Tests,F04.711.513
19590054,2009-07-09T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19592083,2009-07-09T00:00:00,Adsorption,G02.149.047
19592083,2009-07-09T00:00:00,Adsorption,G02.149.767.029
19592083,2009-07-09T00:00:00,Adsorption,G02.842.750.029
19592083,2009-07-09T00:00:00,Composite Resins,D05.750.716.822.308
19592083,2009-07-09T00:00:00,Composite Resins,D25.339.816.500
19592083,2009-07-09T00:00:00,Composite Resins,D25.720.716.822.308
19592083,2009-07-09T00:00:00,Composite Resins,J01.637.051.339.816.500
19592083,2009-07-09T00:00:00,Composite Resins,J01.637.051.720.716.822.308
19592083,2009-07-09T00:00:00,Diffusion,G01.595.200
19592083,2009-07-09T00:00:00,Diffusion,G02.149.767.560
19592083,2009-07-09T00:00:00,Diffusion,G02.842.750.560
19592083,2009-07-09T00:00:00,Ethanol,D02.033.375
19592083,2009-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19592083,2009-07-09T00:00:00,Materials Testing,E05.570
19592083,2009-07-09T00:00:00,Polyethylene Glycols,D02.033.455.250.700
19592083,2009-07-09T00:00:00,Polyethylene Glycols,D05.750.741
19592083,2009-07-09T00:00:00,Polyethylene Glycols,D25.720.741
19592083,2009-07-09T00:00:00,Polyethylene Glycols,J01.637.051.720.741
19592083,2009-07-09T00:00:00,Polymers,D05.750
19592083,2009-07-09T00:00:00,Polymers,D25.720
19592083,2009-07-09T00:00:00,Polymers,J01.637.051.720
19592083,2009-07-09T00:00:00,Polymethacrylic Acids,D02.241.081.069.800
19592083,2009-07-09T00:00:00,Polymethacrylic Acids,D05.750.716.822.111.650
19592083,2009-07-09T00:00:00,Polymethacrylic Acids,D25.720.716.822.111.650
19592083,2009-07-09T00:00:00,Polymethacrylic Acids,J01.637.051.720.716.822.111.650
19592083,2009-07-09T00:00:00,Resin Cements,D05.750.716.822.730
19592083,2009-07-09T00:00:00,Resin Cements,D25.339.291.750
19592083,2009-07-09T00:00:00,Resin Cements,D25.720.716.822.730
19592083,2009-07-09T00:00:00,Resin Cements,J01.637.051.339.291.750
19592083,2009-07-09T00:00:00,Resin Cements,J01.637.051.720.716.822.730
19592083,2009-07-09T00:00:00,Solubility,G02.842.800
19592083,2009-07-09T00:00:00,Solvents,D27.720.844
19592083,2009-07-09T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
19592083,2009-07-09T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
19592083,2009-07-09T00:00:00,Time Factors,G01.910.857
19592083,2009-07-09T00:00:00,Water,D01.455.900
19592083,2009-07-09T00:00:00,Water,D01.650.550.925
19592612,2009-07-10T00:00:00,Animals,B01.050
19592612,2009-07-10T00:00:00,Cell Movement,G04.299.283
19592612,2009-07-10T00:00:00,Cell Movement,G07.700.560.500.180
19592612,2009-07-10T00:00:00,Collagen,D05.750.078.280
19592612,2009-07-10T00:00:00,Collagen,D12.776.860.300.250
19592612,2009-07-10T00:00:00,"Disease Models, Animal",C22.232
19592612,2009-07-10T00:00:00,"Disease Models, Animal",E05.598.500
19592612,2009-07-10T00:00:00,"Disease Models, Animal",E05.599.395.080
19592612,2009-07-10T00:00:00,Endothelial Cells,A11.436.275
19592612,2009-07-10T00:00:00,Femoral Artery,A07.231.114.351
19592612,2009-07-10T00:00:00,Gene Transfer Techniques,E05.393.350
19592612,2009-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19592612,2009-07-10T00:00:00,Ischemia,C23.550.513
19592612,2009-07-10T00:00:00,"Muscle, Skeletal",A02.633.567
19592612,2009-07-10T00:00:00,"Muscle, Skeletal",A10.690.552.500
19592612,2009-07-10T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
19592612,2009-07-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19592612,2009-07-10T00:00:00,Signal Transduction,G02.111.087.800
19592612,2009-07-10T00:00:00,Signal Transduction,G02.149.115.800
19592612,2009-07-10T00:00:00,Signal Transduction,G04.299.880
19592612,2009-07-10T00:00:00,Umbilical Veins,A07.231.908.670.874
19592612,2009-07-10T00:00:00,Umbilical Veins,A16.378.693.807
19594459,2009-07-10T00:00:00,Biomedical Research,H01.770.644.145
19594459,2009-07-10T00:00:00,Conflict of Interest,K01.316.130
19594459,2009-07-10T00:00:00,Conflict of Interest,N05.350.225
19594459,2009-07-10T00:00:00,Guidelines as Topic,N04.761.700.350
19594459,2009-07-10T00:00:00,Guidelines as Topic,N05.700.350
19594459,2009-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19594459,2009-07-10T00:00:00,Interprofessional Relations,F01.829.401.205
19594459,2009-07-10T00:00:00,Physicians,M01.526.485.810
19594459,2009-07-10T00:00:00,Physicians,N02.360.810
19594459,2009-07-10T00:00:00,United States,Z01.107.567.875
19596593,2009-07-10T00:00:00,Breast Neoplasms,C04.588.180
19596593,2009-07-10T00:00:00,Breast Neoplasms,C17.800.090.500
19596593,2009-07-10T00:00:00,Equipment Failure Analysis,E05.325.192
19596593,2009-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19596593,2009-07-10T00:00:00,Mammography,E01.370.350.700.500
19596593,2009-07-10T00:00:00,Pilot Projects,E05.318.760.750
19596593,2009-07-10T00:00:00,Pilot Projects,E05.337.737
19596593,2009-07-10T00:00:00,Pilot Projects,N05.715.360.775.625
19596593,2009-07-10T00:00:00,Pilot Projects,N06.850.520.450.720
19596593,2009-07-10T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19596593,2009-07-10T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19596593,2009-07-10T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19596593,2009-07-10T00:00:00,X-Ray Diffraction,E05.196.309.742
19596593,2009-07-10T00:00:00,X-Ray Diffraction,E05.196.822.950
19596593,2009-07-10T00:00:00,X-Ray Diffraction,G01.595.861.950
19596593,2009-07-10T00:00:00,X-Ray Diffraction,G02.149.767.915
19596593,2009-07-10T00:00:00,X-Ray Diffraction,G02.842.750.915
19913154,2009-07-10T00:00:00,"Abortion, Induced",E04.520.050
19913154,2009-07-10T00:00:00,Adult,M01.060.116
19913154,2009-07-10T00:00:00,"Anesthesia, General",E03.155.197
19913154,2009-07-10T00:00:00,"Anesthesia, Obstetrical",E03.155.364
19913154,2009-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19913154,2009-07-10T00:00:00,"Pain, Postoperative",C23.550.767.700
19913154,2009-07-10T00:00:00,"Pain, Postoperative",C23.888.646.530
19913154,2009-07-10T00:00:00,Patient Satisfaction,N04.452.822.360.600
19913154,2009-07-10T00:00:00,Patient Satisfaction,N05.300.150.600.630
19913154,2009-07-10T00:00:00,Patient Satisfaction,N05.715.360.600
19913154,2009-07-10T00:00:00,Pregnancy,G08.686.785.760.769
19593635,2009-07-11T00:00:00,Breast Neoplasms,C04.588.180
19593635,2009-07-11T00:00:00,Breast Neoplasms,C17.800.090.500
19593635,2009-07-11T00:00:00,Gene Expression,G05.355.310
19593635,2009-07-11T00:00:00,Gene Expression Profiling,E05.393.332
19593635,2009-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19593635,2009-07-11T00:00:00,Mutation,G05.365.590
19593635,2009-07-11T00:00:00,"Tumor Markers, Biological",D23.101.840
19597700,2009-07-12T00:00:00,Animals,B01.050
19597700,2009-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19597700,2009-07-12T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
19597700,2009-07-12T00:00:00,Signal Transduction,G02.111.087.800
19597700,2009-07-12T00:00:00,Signal Transduction,G02.149.115.800
19597700,2009-07-12T00:00:00,Signal Transduction,G04.299.880
19596821,2009-07-13T00:00:00,Animals,B01.050
19596821,2009-07-13T00:00:00,Bacterial Adhesion,G06.099.112.100
19596821,2009-07-13T00:00:00,Bacterial Adhesion,G06.590.110.100
19596821,2009-07-13T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
19596821,2009-07-13T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
19596821,2009-07-13T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
19596821,2009-07-13T00:00:00,Time Factors,G01.910.857
19627458,2009-07-13T00:00:00,Animals,B01.050
19627458,2009-07-13T00:00:00,Central Nervous System,A08.186
19627458,2009-07-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19627458,2009-07-13T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19627458,2009-07-13T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19602418,2009-07-14T00:00:00,Animals,B01.050
19602418,2009-07-14T00:00:00,Cilia,A11.284.180.165
19602418,2009-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19602418,2009-07-14T00:00:00,"Mechanotransduction, Cellular",G01.154.100.440
19602418,2009-07-14T00:00:00,"Mechanotransduction, Cellular",G01.595.100.440
19602418,2009-07-14T00:00:00,"Mechanotransduction, Cellular",G02.111.087.800.580
19602418,2009-07-14T00:00:00,"Mechanotransduction, Cellular",G02.149.115.800.580
19602418,2009-07-14T00:00:00,"Mechanotransduction, Cellular",G04.299.880.580
19602418,2009-07-14T00:00:00,Signal Transduction,G02.111.087.800
19602418,2009-07-14T00:00:00,Signal Transduction,G02.149.115.800
19602418,2009-07-14T00:00:00,Signal Transduction,G04.299.880
19602418,2009-07-14T00:00:00,Wnt Proteins,D12.644.276.984
19602418,2009-07-14T00:00:00,Wnt Proteins,D12.776.467.984
19602418,2009-07-14T00:00:00,Wnt Proteins,D23.529.984
19607889,2009-07-14T00:00:00,Animals,B01.050
19607889,2009-07-14T00:00:00,"Behavior, Animal",F01.145.113
19607889,2009-07-14T00:00:00,Columbidae,B01.050.150.900.248.165.150
19607889,2009-07-14T00:00:00,Discrimination Learning,F02.463.425.280
19412939,2009-07-15T00:00:00,Aged,M01.060.116.100
19412939,2009-07-15T00:00:00,Depression,F01.145.126.350
19412939,2009-07-15T00:00:00,Disease Progression,C23.550.291.656
19412939,2009-07-15T00:00:00,Geriatric Assessment,E05.318.308.225
19412939,2009-07-15T00:00:00,Geriatric Assessment,I01.240.425.350
19412939,2009-07-15T00:00:00,Geriatric Assessment,L01.280.360
19412939,2009-07-15T00:00:00,Geriatric Assessment,N01.224.425.350
19412939,2009-07-15T00:00:00,Geriatric Assessment,N05.715.360.300.360
19412939,2009-07-15T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
19412939,2009-07-15T00:00:00,Geriatric Assessment,N06.850.520.308.225
19412939,2009-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19412939,2009-07-15T00:00:00,Middle Aged,M01.060.116.630
19412939,2009-07-15T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19412939,2009-07-15T00:00:00,Parkinson Disease,C10.228.662.600.400
19412939,2009-07-15T00:00:00,Parkinson Disease,C10.574.812
19574605,2009-07-15T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19574605,2009-07-15T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19574605,2009-07-15T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19574605,2009-07-15T00:00:00,Hospitalization,E02.760.400
19574605,2009-07-15T00:00:00,Hospitalization,N02.421.585.400
19574605,2009-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19574605,2009-07-15T00:00:00,Medication Therapy Management,N02.421.668.438
19574605,2009-07-15T00:00:00,Medication Therapy Management,N03.219.521.576.343.575.500.500
19574605,2009-07-15T00:00:00,Medication Therapy Management,N03.219.521.576.343.840.938.500
19574605,2009-07-15T00:00:00,Medication Therapy Management,N04.590.661
19574605,2009-07-15T00:00:00,Pharmacists,M01.526.485.780
19574605,2009-07-15T00:00:00,Pharmacists,N02.360.780
19574605,2009-07-15T00:00:00,Thrombin,D08.811.277.656.300.760.855
19574605,2009-07-15T00:00:00,Thrombin,D08.811.277.656.959.350.855
19574605,2009-07-15T00:00:00,Thrombin,D12.776.124.125.890
19574605,2009-07-15T00:00:00,Thrombin,D23.119.960
19574605,2009-07-15T00:00:00,Thrombocytopenia,C15.378.140.855
19605772,2009-07-15T00:00:00,Animals,B01.050
19605772,2009-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19605772,2009-07-15T00:00:00,Inflammation,C23.550.470
19605772,2009-07-15T00:00:00,Mental Disorders,F03
19608538,2009-07-15T00:00:00,Animals,B01.050
19608538,2009-07-15T00:00:00,Binding Sites,G02.111.570.120
19608538,2009-07-15T00:00:00,Eye Proteins,D12.776.306
19608538,2009-07-15T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
19608538,2009-07-15T00:00:00,Protein Conformation,G02.111.570.790.709
19608538,2009-07-15T00:00:00,Recombinant Proteins,D12.776.828
19608538,2009-07-15T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
19608538,2009-07-15T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
19608538,2009-07-15T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
19627443,2009-07-17T00:00:00,Animals,B01.050
19627443,2009-07-17T00:00:00,Calcium-Binding Proteins,D12.776.157.125
19627443,2009-07-17T00:00:00,Calpain,D08.811.277.656.262.500.120
19627443,2009-07-17T00:00:00,Calpain,D08.811.277.656.300.200.120
19627443,2009-07-17T00:00:00,Cell Survival,G04.299.316
19627443,2009-07-17T00:00:00,Demyelinating Diseases,C10.314
19627443,2009-07-17T00:00:00,"Disease Models, Animal",C22.232
19627443,2009-07-17T00:00:00,"Disease Models, Animal",E05.598.500
19627443,2009-07-17T00:00:00,"Disease Models, Animal",E05.599.395.080
19627443,2009-07-17T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
19627443,2009-07-17T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
19627443,2009-07-17T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
19627443,2009-07-17T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
19627443,2009-07-17T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
19627443,2009-07-17T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
19627443,2009-07-17T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19627443,2009-07-17T00:00:00,Time Factors,G01.910.857
19616802,2009-07-18T00:00:00,Adult,M01.060.116
19616802,2009-07-18T00:00:00,Aged,M01.060.116.100
19616802,2009-07-18T00:00:00,Electric Stimulation Therapy,E02.342
19616802,2009-07-18T00:00:00,Electric Stimulation Therapy,E02.779.468
19616802,2009-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19616802,2009-07-18T00:00:00,Middle Aged,M01.060.116.630
19616802,2009-07-18T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
19616802,2009-07-18T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
19616802,2009-07-18T00:00:00,Phenylpropanolamine,D02.033.100.624.706
19616802,2009-07-18T00:00:00,Phenylpropanolamine,D02.033.755.624.706
19616802,2009-07-18T00:00:00,Phenylpropanolamine,D02.092.063.624.706
19616802,2009-07-18T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
19616802,2009-07-18T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
19616802,2009-07-18T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
19616802,2009-07-18T00:00:00,Young Adult,M01.060.116.815
19620784,2009-07-20T00:00:00,Animals,B01.050
19620784,2009-07-20T00:00:00,Complement C3,D12.776.124.050.140
19620784,2009-07-20T00:00:00,Complement C3,D12.776.124.486.274.250
19620784,2009-07-20T00:00:00,Hepatectomy,E04.210.556
19620784,2009-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19620784,2009-07-20T00:00:00,Interleukin-6,D12.644.276.374.465.506
19620784,2009-07-20T00:00:00,Interleukin-6,D12.776.467.374.465.506
19620784,2009-07-20T00:00:00,Interleukin-6,D23.529.374.465.506
19620784,2009-07-20T00:00:00,Liver,A03.620
19620784,2009-07-20T00:00:00,Liver Regeneration,G10.261.326.520
19620784,2009-07-20T00:00:00,Liver Regeneration,G16.100.856.468
19620784,2009-07-20T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19620784,2009-07-20T00:00:00,Reperfusion Injury,C14.907.725
19620784,2009-07-20T00:00:00,Reperfusion Injury,C23.550.767.877
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19620784,2009-07-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19625063,2009-07-21T00:00:00,Antineoplastic Agents,D27.505.954.248
19625063,2009-07-21T00:00:00,Apoptosis,G04.299.139.160
19625063,2009-07-21T00:00:00,Down-Regulation,G02.111.087.225
19625063,2009-07-21T00:00:00,Down-Regulation,G02.149.115.225
19625063,2009-07-21T00:00:00,Down-Regulation,G05.355.315.200
19625063,2009-07-21T00:00:00,Down-Regulation,G07.690.812.230
19625063,2009-07-21T00:00:00,Down-Regulation,G07.700.680.230
19625063,2009-07-21T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
19625063,2009-07-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19625063,2009-07-21T00:00:00,Oxidative Stress,G03.495.710
19625063,2009-07-21T00:00:00,Oxidative Stress,G07.700.830.750
19625063,2009-07-21T00:00:00,Signal Transduction,G02.111.087.800
19625063,2009-07-21T00:00:00,Signal Transduction,G02.149.115.800
19625063,2009-07-21T00:00:00,Signal Transduction,G04.299.880
19625063,2009-07-21T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
19625063,2009-07-21T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
19625063,2009-07-21T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
19625063,2009-07-21T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
19625063,2009-07-21T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
19625063,2009-07-21T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
19625063,2009-07-21T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
19625063,2009-07-21T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
19625063,2009-07-21T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
19625063,2009-07-21T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
19625063,2009-07-21T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
19703635,2009-07-21T00:00:00,Adolescent,M01.060.057
19703635,2009-07-21T00:00:00,Adult,M01.060.116
19703635,2009-07-21T00:00:00,Aged,M01.060.116.100
19703635,2009-07-21T00:00:00,Depression,F01.145.126.350
19703635,2009-07-21T00:00:00,Diabetes Mellitus,C18.452.394.750
19703635,2009-07-21T00:00:00,Diabetes Mellitus,C19.246
19703635,2009-07-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19703635,2009-07-21T00:00:00,Middle Aged,M01.060.116.630
19703635,2009-07-21T00:00:00,Quality of Health Care,N04.761
19703635,2009-07-21T00:00:00,Quality of Health Care,N05.715
19703635,2009-07-21T00:00:00,Self Care,E02.900
19703635,2009-07-21T00:00:00,Self Care,N02.421.784.680
19703635,2009-07-21T00:00:00,Young Adult,M01.060.116.815
19623260,2009-07-22T00:00:00,Animals,B01.050
19623260,2009-07-22T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19623260,2009-07-22T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19623260,2009-07-22T00:00:00,Neuropeptides,D12.644.400
19623260,2009-07-22T00:00:00,Neuropeptides,D12.776.641.650
19623260,2009-07-22T00:00:00,"Sleep, REM",F02.830.855.796.671
19623260,2009-07-22T00:00:00,"Sleep, REM",G11.561.600.815.754.671
19596035,2009-07-23T00:00:00,Adult,M01.060.116
19596035,2009-07-23T00:00:00,Aged,M01.060.116.100
19596035,2009-07-23T00:00:00,Aging,G07.700.320.124
19596035,2009-07-23T00:00:00,Cytokines,D12.644.276.374
19596035,2009-07-23T00:00:00,Cytokines,D12.776.467.374
19596035,2009-07-23T00:00:00,Cytokines,D23.529.374
19596035,2009-07-23T00:00:00,Dendritic Cells,A11.066.270
19596035,2009-07-23T00:00:00,Dendritic Cells,A11.436.270
19596035,2009-07-23T00:00:00,Dendritic Cells,A15.382.066.270
19596035,2009-07-23T00:00:00,Dendritic Cells,A15.382.812.260
19596035,2009-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19596035,2009-07-23T00:00:00,Interferon-alpha,D12.644.276.374.440.890.250
19596035,2009-07-23T00:00:00,Interferon-alpha,D12.644.276.718.500.250
19596035,2009-07-23T00:00:00,Interferon-alpha,D12.776.467.374.440.890.250
19596035,2009-07-23T00:00:00,Interferon-alpha,D12.776.467.718.500.250
19596035,2009-07-23T00:00:00,Interferon-alpha,D23.529.374.440.890.250
19596035,2009-07-23T00:00:00,Interferon-alpha,D23.529.718.500.250
19596035,2009-07-23T00:00:00,Middle Aged,M01.060.116.630
19596035,2009-07-23T00:00:00,Myeloid Cells,A11.627
19626043,2009-07-23T00:00:00,Adult,M01.060.116
19626043,2009-07-23T00:00:00,Biological Markers,D23.101
19626043,2009-07-23T00:00:00,Blood Pressure,E01.370.600.875.249
19626043,2009-07-23T00:00:00,Blood Pressure,G09.330.380.076
19626043,2009-07-23T00:00:00,"Endothelium, Vascular",A07.231.330
19626043,2009-07-23T00:00:00,"Endothelium, Vascular",A10.272.491.355
19626043,2009-07-23T00:00:00,Fruit,A18.024.500
19626043,2009-07-23T00:00:00,Fruit,J02.500.562
19626043,2009-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19626043,2009-07-23T00:00:00,Hypertension,C14.907.489
19626043,2009-07-23T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
19626043,2009-07-23T00:00:00,Metabolic Syndrome X,C18.452.625
19626043,2009-07-23T00:00:00,Middle Aged,M01.060.116.630
19626043,2009-07-23T00:00:00,Obesity,C18.654.726.500
19626043,2009-07-23T00:00:00,Obesity,C23.888.144.699.500
19626043,2009-07-23T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19626043,2009-07-23T00:00:00,Obesity,G07.100.100.160.120.699.500
19626043,2009-07-23T00:00:00,Young Adult,M01.060.116.815
19631926,2009-07-24T00:00:00,Adult,M01.060.116
19631926,2009-07-24T00:00:00,Case-Control Studies,E05.318.760.500.500
19631926,2009-07-24T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19631926,2009-07-24T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19631926,2009-07-24T00:00:00,Cholesterol,D04.808.247.222.284
19631926,2009-07-24T00:00:00,Cholesterol,D04.808.247.808.197
19631926,2009-07-24T00:00:00,Cholesterol,D10.570.938.208
19631926,2009-07-24T00:00:00,Cholesterol,D10.851.208
19631926,2009-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19631926,2009-07-24T00:00:00,Pre-Eclampsia,C13.703.395.249
19631926,2009-07-24T00:00:00,Pregnancy,G08.686.785.760.769
19631926,2009-07-24T00:00:00,Pregnancy Complications,C13.703
19631926,2009-07-24T00:00:00,Young Adult,M01.060.116.815
19633277,2009-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19633277,2009-07-24T00:00:00,Research,H01.770.644
19633277,2009-07-24T00:00:00,Smoking,F01.145.466.753
19633277,2009-07-24T00:00:00,Smoking Cessation,F01.145.940.700
19633277,2009-07-24T00:00:00,Tobacco Use Disorder,C21.739.912
19633277,2009-07-24T00:00:00,Tobacco Use Disorder,F03.900.912
19633277,2009-07-24T00:00:00,Treatment Outcome,E01.789.800
19633277,2009-07-24T00:00:00,Treatment Outcome,N04.761.559.590.800
19633277,2009-07-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19647229,2009-07-24T00:00:00,Adolescent,M01.060.057
19647229,2009-07-24T00:00:00,Adult,M01.060.116
19647229,2009-07-24T00:00:00,Crime Victims,M01.135
19647229,2009-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19647229,2009-07-24T00:00:00,Interpersonal Relations,F01.829.401
19647229,2009-07-24T00:00:00,Life Change Events,F01.829.458.410
19647229,2009-07-24T00:00:00,Risk Factors,E05.318.740.600.800.725
19647229,2009-07-24T00:00:00,Risk Factors,N05.715.350.200.700
19647229,2009-07-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19647229,2009-07-24T00:00:00,Risk Factors,N06.850.490.625.750
19647229,2009-07-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19647229,2009-07-24T00:00:00,Sex Offenses,I01.198.240.748
19647229,2009-07-24T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19647229,2009-07-24T00:00:00,Violence,I01.198.240.856
19647229,2009-07-24T00:00:00,Violence,I01.880.735.900
19635961,2009-07-27T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19635961,2009-07-27T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
19635961,2009-07-27T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
19635961,2009-07-27T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
19635961,2009-07-27T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
19635961,2009-07-27T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
19635961,2009-07-27T00:00:00,United States,Z01.107.567.875
19635961,2009-07-27T00:00:00,Vancomycin,D09.400.420.925
19635961,2009-07-27T00:00:00,Vancomycin,D12.644.233.925
19651613,2009-07-27T00:00:00,Adolescent,M01.060.057
19651613,2009-07-27T00:00:00,Adult,M01.060.116
19651613,2009-07-27T00:00:00,Brain,A08.186.211
19651613,2009-07-27T00:00:00,Cues,F02.463.425.234
19651613,2009-07-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19651613,2009-07-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19651613,2009-07-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19651613,2009-07-27T00:00:00,Marijuana Abuse,C21.739.635
19651613,2009-07-27T00:00:00,Marijuana Abuse,F03.900.635
19651613,2009-07-27T00:00:00,Middle Aged,M01.060.116.630
19651613,2009-07-27T00:00:00,Oxygen,D01.268.185.550
19651613,2009-07-27T00:00:00,Oxygen,D01.362.670
19656314,2009-07-27T00:00:00,Animals,B01.050
19656314,2009-07-27T00:00:00,"Disease Models, Animal",C22.232
19656314,2009-07-27T00:00:00,"Disease Models, Animal",E05.598.500
19656314,2009-07-27T00:00:00,"Disease Models, Animal",E05.599.395.080
19656314,2009-07-27T00:00:00,Herpesviridae Infections,C02.256.466
19656314,2009-07-27T00:00:00,Muromegalovirus,B04.280.382.150.500
19656314,2009-07-27T00:00:00,Muromegalovirus,B04.909.204.382.150.500
19638401,2009-07-28T00:00:00,Animals,B01.050
19638401,2009-07-28T00:00:00,Homeodomain Proteins,D12.776.260.400
19638401,2009-07-28T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19638401,2009-07-28T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19638401,2009-07-28T00:00:00,"Myocytes, Cardiac",A11.620.500
19638401,2009-07-28T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19638401,2009-07-28T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19638401,2009-07-28T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19638401,2009-07-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19638401,2009-07-28T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
19638401,2009-07-28T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
19638401,2009-07-28T00:00:00,Transcription Factors,D12.776.930
19638595,2009-07-28T00:00:00,Cell Death,G04.299.139
19638595,2009-07-28T00:00:00,Epitopes,D23.050.550
19638595,2009-07-28T00:00:00,"Epitopes, T-Lymphocyte",D23.050.550.402
19638595,2009-07-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19638595,2009-07-28T00:00:00,Lymphocyte Activation,E01.450.495.482
19638595,2009-07-28T00:00:00,Lymphocyte Activation,E05.478.594.530
19638595,2009-07-28T00:00:00,Lymphocyte Activation,G12.425.747
19638595,2009-07-28T00:00:00,Lymphocyte Activation,G12.450.050.400.545
19638595,2009-07-28T00:00:00,"Lymphocytes, Tumor-Infiltrating",A11.118.637.555.567.650
19638595,2009-07-28T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.145.229.637.555.567.650
19638595,2009-07-28T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.382.490.555.567.650
19638595,2009-07-28T00:00:00,Melanoma,C04.557.465.625.650.510
19638595,2009-07-28T00:00:00,Melanoma,C04.557.580.625.650.510
19638595,2009-07-28T00:00:00,Melanoma,C04.557.665.510
19638595,2009-07-28T00:00:00,Neoplasm Proteins,D12.776.624
19638595,2009-07-28T00:00:00,Superoxides,D01.248.497.158.685.750.850
19638595,2009-07-28T00:00:00,Superoxides,D01.339.431.374.850
19638595,2009-07-28T00:00:00,Superoxides,D01.339.431.750
19638595,2009-07-28T00:00:00,Superoxides,D01.650.550.750.800
19638595,2009-07-28T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.283.875
19638595,2009-07-28T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.567.569.220.200
19638595,2009-07-28T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.283.875
19638595,2009-07-28T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.567.569.220.200
19638595,2009-07-28T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.283.875
19638595,2009-07-28T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.567.569.220.200
19656173,2009-07-28T00:00:00,Animals,B01.050
19656173,2009-07-28T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19656173,2009-07-28T00:00:00,Brain,A08.186.211
19656173,2009-07-28T00:00:00,Cocaine,D02.145.074.722.388
19656173,2009-07-28T00:00:00,Cocaine,D03.132.889.354
19656173,2009-07-28T00:00:00,Cocaine,D03.605.869.388
19656173,2009-07-28T00:00:00,Cocaine,D04.075.080.875.099.722.388
19656173,2009-07-28T00:00:00,Cocaine-Related Disorders,C21.739.300
19656173,2009-07-28T00:00:00,Cocaine-Related Disorders,F03.900.300
19656173,2009-07-28T00:00:00,Cues,F02.463.425.234
19656173,2009-07-28T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
19656173,2009-07-28T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
19656173,2009-07-28T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
19656173,2009-07-28T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
19656173,2009-07-28T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19656173,2009-07-28T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19656173,2009-07-28T00:00:00,Neuropeptides,D12.644.400
19656173,2009-07-28T00:00:00,Neuropeptides,D12.776.641.650
19656173,2009-07-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19656173,2009-07-28T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19656173,2009-07-28T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
19656173,2009-07-28T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.720.600
19656173,2009-07-28T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.750.555
19656173,2009-07-28T00:00:00,Signal Transduction,G02.111.087.800
19656173,2009-07-28T00:00:00,Signal Transduction,G02.149.115.800
19656173,2009-07-28T00:00:00,Signal Transduction,G04.299.880
19473115,2009-07-29T00:00:00,Animals,B01.050
19473115,2009-07-29T00:00:00,Fetus,A16.378
19473115,2009-07-29T00:00:00,Fibroblasts,A11.329.228
19473115,2009-07-29T00:00:00,Fibroblasts,A11.872.228
19473115,2009-07-29T00:00:00,Green Fluorescent Proteins,D12.776.532.265
19473115,2009-07-29T00:00:00,Polyamines,D02.092.782
19473115,2009-07-29T00:00:00,Protein Transport,G03.495.166.700
19473115,2009-07-29T00:00:00,"RNA, Messenger",D13.444.735.544
19473115,2009-07-29T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19473115,2009-07-29T00:00:00,Spermine,D02.092.211.415.701.801.821
19473115,2009-07-29T00:00:00,Spermine,D02.092.782.802
19473115,2009-07-29T00:00:00,"Transcription, Genetic",G02.111.087.847
19473115,2009-07-29T00:00:00,"Transcription, Genetic",G02.149.115.847
19473115,2009-07-29T00:00:00,"Transcription, Genetic",G05.355.310.700
19641486,2009-07-29T00:00:00,Animals,B01.050
19641486,2009-07-29T00:00:00,Carrier Proteins,D12.776.157
19641486,2009-07-29T00:00:00,Evoked Potentials,G07.265.500
19641486,2009-07-29T00:00:00,Evoked Potentials,G11.561.270
19641486,2009-07-29T00:00:00,Glutamic Acid,D12.125.067.750
19641486,2009-07-29T00:00:00,Glutamic Acid,D12.125.119.450
19641486,2009-07-29T00:00:00,Glutamic Acid,D12.125.427.300
19641486,2009-07-29T00:00:00,"Memory, Short-Term",F02.463.425.540.407
19641486,2009-07-29T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
19641486,2009-07-29T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
19641486,2009-07-29T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
19641486,2009-07-29T00:00:00,Neural Pathways,A08.612
19641486,2009-07-29T00:00:00,Neuropsychological Tests,F04.711.513
19641486,2009-07-29T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19641486,2009-07-29T00:00:00,Space Perception,F02.463.593.778
19641486,2009-07-29T00:00:00,Space Perception,F02.463.593.932.869
19641486,2009-07-29T00:00:00,Synapses,A08.850
19641486,2009-07-29T00:00:00,Synapses,A11.284.149.165.420.780
19641486,2009-07-29T00:00:00,Synaptic Transmission,G02.111.087.800.850
19641486,2009-07-29T00:00:00,Synaptic Transmission,G02.149.115.800.850
19641486,2009-07-29T00:00:00,Synaptic Transmission,G04.299.880.850
19641486,2009-07-29T00:00:00,Synaptic Transmission,G07.265.337.900
19641486,2009-07-29T00:00:00,Synaptic Transmission,G07.700.240.900
19641486,2009-07-29T00:00:00,Synaptic Transmission,G11.561.600.835
19452561,2009-07-30T00:00:00,Adult,M01.060.116
19452561,2009-07-30T00:00:00,Aged,M01.060.116.100
19452561,2009-07-30T00:00:00,Cognition Disorders,F03.087.250
19452561,2009-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19452561,2009-07-30T00:00:00,Middle Aged,M01.060.116.630
19452561,2009-07-30T00:00:00,Neuropsychological Tests,F04.711.513
19452561,2009-07-30T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19452561,2009-07-30T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19452561,2009-07-30T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19452561,2009-07-30T00:00:00,Parkinson Disease,C10.228.662.600.400
19452561,2009-07-30T00:00:00,Parkinson Disease,C10.574.812
19642973,2009-07-30T00:00:00,Child,M01.060.406
19642973,2009-07-30T00:00:00,DNA-Binding Proteins,D12.776.260
19642973,2009-07-30T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19642973,2009-07-30T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19642973,2009-07-30T00:00:00,Genetic Predisposition to Disease,G05.380.355
19642973,2009-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19642973,2009-07-30T00:00:00,Lymphocytes,A11.118.637.555.567
19642973,2009-07-30T00:00:00,Lymphocytes,A15.145.229.637.555.567
19642973,2009-07-30T00:00:00,Lymphocytes,A15.382.490.555.567
19642973,2009-07-30T00:00:00,Ovarian Neoplasms,C04.588.322.455
19642973,2009-07-30T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
19642973,2009-07-30T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
19642973,2009-07-30T00:00:00,Ovarian Neoplasms,C19.344.410
19642973,2009-07-30T00:00:00,Ovarian Neoplasms,C19.391.630.705
19642973,2009-07-30T00:00:00,Ovary,A05.360.319.114.630
19642973,2009-07-30T00:00:00,Ovary,A05.360.576.497
19642973,2009-07-30T00:00:00,Ovary,A06.407.312.497
19642973,2009-07-30T00:00:00,"Translocation, Genetic",C23.550.210.870
19642973,2009-07-30T00:00:00,"Translocation, Genetic",G05.355.600.860
19642973,2009-07-30T00:00:00,"Translocation, Genetic",G05.365.590.175.870
19646930,2009-07-30T00:00:00,Adult,M01.060.116
19646930,2009-07-30T00:00:00,Caregivers,M01.085
19646930,2009-07-30T00:00:00,Caregivers,M01.526.485.200
19646930,2009-07-30T00:00:00,Caregivers,N02.360.200
19646930,2009-07-30T00:00:00,Child,M01.060.406
19646930,2009-07-30T00:00:00,"Data Interpretation, Statistical",E05.245.380
19646930,2009-07-30T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19646930,2009-07-30T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19646930,2009-07-30T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19646930,2009-07-30T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19646930,2009-07-30T00:00:00,Education,I02
19646930,2009-07-30T00:00:00,Epilepsy,C10.228.140.490
19646930,2009-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19646930,2009-07-30T00:00:00,Parents,F01.829.263.500.320
19646930,2009-07-30T00:00:00,Parents,I01.880.225.500.340
19646930,2009-07-30T00:00:00,Parents,M01.620
19646930,2009-07-30T00:00:00,Peer Group,F01.829.316.483
19646930,2009-07-30T00:00:00,Risk Assessment,E05.318.740.600.800.715
19646930,2009-07-30T00:00:00,Risk Assessment,N04.452.871.715
19646930,2009-07-30T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19646930,2009-07-30T00:00:00,Risk Assessment,N06.850.505.715
19646930,2009-07-30T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19646930,2009-07-30T00:00:00,Schools,I02.233.659
19646930,2009-07-30T00:00:00,Schools,I02.783
19646930,2009-07-30T00:00:00,Seizures,C10.228.140.490.631
19646930,2009-07-30T00:00:00,Seizures,C10.597.742
19646930,2009-07-30T00:00:00,Seizures,C23.888.592.742
19695571,2009-07-30T00:00:00,Animals,B01.050
19695571,2009-07-30T00:00:00,Carotid Arteries,A07.231.114.186
19695571,2009-07-30T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
19695571,2009-07-30T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
19695571,2009-07-30T00:00:00,Cell Adhesion Molecules,D23.050.301.350
19695571,2009-07-30T00:00:00,Cell Movement,G04.299.283
19695571,2009-07-30T00:00:00,Cell Movement,G07.700.560.500.180
19695571,2009-07-30T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19695571,2009-07-30T00:00:00,Flow Cytometry,E05.200.500.386.350
19695571,2009-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19695571,2009-07-30T00:00:00,"Models, Biological",E05.599.395
19695571,2009-07-30T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
19695571,2009-07-30T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
19695571,2009-07-30T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
19695571,2009-07-30T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
19648146,2009-07-31T00:00:00,Anticoagulants,D27.505.954.502.119
19648146,2009-07-31T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
19648146,2009-07-31T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
19648146,2009-07-31T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
19648146,2009-07-31T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
19648146,2009-07-31T00:00:00,Blood Coagulation,G09.188.124.560.150
19648146,2009-07-31T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
19648146,2009-07-31T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
19648146,2009-07-31T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
19648146,2009-07-31T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
19648146,2009-07-31T00:00:00,Evidence-Based Medicine,H02.249.750
19648146,2009-07-31T00:00:00,Evidence-Based Medicine,H02.403.200.400
19648146,2009-07-31T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19648146,2009-07-31T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19648146,2009-07-31T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19648146,2009-07-31T00:00:00,Hemorrhage,C23.550.414
19648146,2009-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19648146,2009-07-31T00:00:00,Pyridines,D03.383.725
19648146,2009-07-31T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19648146,2009-07-31T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19648146,2009-07-31T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19648146,2009-07-31T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19648146,2009-07-31T00:00:00,Risk Assessment,E05.318.740.600.800.715
19648146,2009-07-31T00:00:00,Risk Assessment,N04.452.871.715
19648146,2009-07-31T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19648146,2009-07-31T00:00:00,Risk Assessment,N06.850.505.715
19648146,2009-07-31T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19648146,2009-07-31T00:00:00,Thrombin,D08.811.277.656.300.760.855
19648146,2009-07-31T00:00:00,Thrombin,D08.811.277.656.959.350.855
19648146,2009-07-31T00:00:00,Thrombin,D12.776.124.125.890
19648146,2009-07-31T00:00:00,Thrombin,D23.119.960
19648146,2009-07-31T00:00:00,Venous Thromboembolism,C14.907.355.590.700
19648146,2009-07-31T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
19648221,2009-07-31T00:00:00,Adult,M01.060.116
19648221,2009-07-31T00:00:00,Attitude to Health,F01.100.150
19648221,2009-07-31T00:00:00,Attitude to Health,N05.300.150
19648221,2009-07-31T00:00:00,Cystic Fibrosis,C06.689.202
19648221,2009-07-31T00:00:00,Cystic Fibrosis,C08.381.187
19648221,2009-07-31T00:00:00,Cystic Fibrosis,C16.320.190
19648221,2009-07-31T00:00:00,Cystic Fibrosis,C16.614.213
19648221,2009-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19648221,2009-07-31T00:00:00,Palliative Care,E02.760.666
19648221,2009-07-31T00:00:00,Palliative Care,N02.421.585.666
19648221,2009-07-31T00:00:00,Qualitative Research,H01.770.644.241.850
19648221,2009-07-31T00:00:00,Questionnaires,E05.318.308.750
19648221,2009-07-31T00:00:00,Questionnaires,L01.280.800
19648221,2009-07-31T00:00:00,Questionnaires,N05.715.360.300.695
19648221,2009-07-31T00:00:00,Questionnaires,N06.850.520.308.750
19648221,2009-07-31T00:00:00,"Stress, Psychological",F01.145.126.990
19648221,2009-07-31T00:00:00,"Stress, Psychological",F02.830.900
19648221,2009-07-31T00:00:00,Young Adult,M01.060.116.815
19648469,2009-07-31T00:00:00,Amphetamine-Related Disorders,C21.739.225
19648469,2009-07-31T00:00:00,Amphetamine-Related Disorders,F03.900.225
19648469,2009-07-31T00:00:00,Animals,B01.050
19648469,2009-07-31T00:00:00,Brain Chemistry,G02.111.100
19648469,2009-07-31T00:00:00,Brain Chemistry,G03.200
19648469,2009-07-31T00:00:00,Central Nervous System Stimulants,D27.505.696.282
19648469,2009-07-31T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
19648469,2009-07-31T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
19648469,2009-07-31T00:00:00,Cues,F02.463.425.234
19648469,2009-07-31T00:00:00,Dopamine,D02.092.211.215.311.342
19648469,2009-07-31T00:00:00,Dopamine,D02.092.311.342
19648469,2009-07-31T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
19648469,2009-07-31T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
19648469,2009-07-31T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
19648469,2009-07-31T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
19648469,2009-07-31T00:00:00,Methamphetamine,D02.092.471.683.152.619
19648469,2009-07-31T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19648469,2009-07-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19648469,2009-07-31T00:00:00,Self Administration,E02.319.890
19648469,2009-07-31T00:00:00,Self Administration,E02.900.890
19648469,2009-07-31T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.450.625.311
19648469,2009-07-31T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.562.374.875
19648469,2009-07-31T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.450.625.374
19648469,2009-07-31T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.562.374.875
19666492,2009-07-31T00:00:00,Animals,B01.050
19666492,2009-07-31T00:00:00,Blood Platelets,A11.118.188
19666492,2009-07-31T00:00:00,Blood Platelets,A15.145.229.188
19666492,2009-07-31T00:00:00,Cell Lineage,G04.172
19666492,2009-07-31T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
19666492,2009-07-31T00:00:00,Cell Lineage,G08.686.155
19666492,2009-07-31T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
19666492,2009-07-31T00:00:00,Gene Expression Regulation,G05.355.315
19666492,2009-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19666492,2009-07-31T00:00:00,"Models, Genetic",E05.599.395.397
19666492,2009-07-31T00:00:00,Mutation,G05.365.590
19666492,2009-07-31T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
19666492,2009-07-31T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
19666492,2009-07-31T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
19061351,2009-08-01T00:00:00,Endoscopy,E01.370.388.250
19061351,2009-08-01T00:00:00,Endoscopy,E04.800.250
19061351,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19061351,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19061351,2009-08-01T00:00:00,Postoperative Complications,C23.550.767
19061351,2009-08-01T00:00:00,Reconstructive Surgical Procedures,E04.680
19061351,2009-08-01T00:00:00,Skull Base,A01.456.830
19061351,2009-08-01T00:00:00,Skull Base,A02.835.232.781.750
19061351,2009-08-01T00:00:00,Surgical Flaps,A10.850.710
19061351,2009-08-01T00:00:00,Surgical Flaps,E07.862.710
19072895,2009-08-01T00:00:00,Adult,M01.060.116
19072895,2009-08-01T00:00:00,Attention,F02.830.104.214
19072895,2009-08-01T00:00:00,Brain,A08.186.211
19072895,2009-08-01T00:00:00,Brain Mapping,E01.370.350.086
19072895,2009-08-01T00:00:00,Brain Mapping,E01.370.376.149
19072895,2009-08-01T00:00:00,Brain Mapping,E05.132
19072895,2009-08-01T00:00:00,Functional Laterality,F02.830.297.425
19072895,2009-08-01T00:00:00,Functional Laterality,G11.561.225.425
19072895,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19072895,2009-08-01T00:00:00,Neural Pathways,A08.612
19072895,2009-08-01T00:00:00,Neuropsychological Tests,F04.711.513
19072895,2009-08-01T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
19072895,2009-08-01T00:00:00,"Pattern Recognition, Physiological",F02.463.593.524
19072895,2009-08-01T00:00:00,Space Perception,F02.463.593.778
19072895,2009-08-01T00:00:00,Space Perception,F02.463.593.932.869
19072895,2009-08-01T00:00:00,Speech Perception,F02.463.593.071.875
19072895,2009-08-01T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
19072895,2009-08-01T00:00:00,Visual Perception,F02.463.593.932
19317592,2009-08-01T00:00:00,Animals,B01.050
19317592,2009-08-01T00:00:00,Motor Activity,F01.145.632
19317592,2009-08-01T00:00:00,Motor Activity,G11.427.590.530.698
19317592,2009-08-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19317592,2009-08-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19317592,2009-08-01T00:00:00,Polyethylene Glycols,D02.033.455.250.700
19317592,2009-08-01T00:00:00,Polyethylene Glycols,D05.750.741
19317592,2009-08-01T00:00:00,Polyethylene Glycols,D25.720.741
19317592,2009-08-01T00:00:00,Polyethylene Glycols,J01.637.051.720.741
19317592,2009-08-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19317592,2009-08-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19317592,2009-08-01T00:00:00,Recovery of Function,G16.757
19317592,2009-08-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19317592,2009-08-01T00:00:00,Spinal Cord Injuries,C10.900.850
19317592,2009-08-01T00:00:00,Spinal Cord Injuries,C21.866.819
19317592,2009-08-01T00:00:00,Thoracic Vertebrae,A02.835.232.834.892
19317592,2009-08-01T00:00:00,Time Factors,G01.910.857
19317592,2009-08-01T00:00:00,Treatment Outcome,E01.789.800
19317592,2009-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19317592,2009-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19424071,2009-08-01T00:00:00,Acoustic Stimulation,E02.037
19424071,2009-08-01T00:00:00,Acoustic Stimulation,E02.190.888.030
19424071,2009-08-01T00:00:00,Acoustic Stimulation,E05.723.136
19424071,2009-08-01T00:00:00,Cadaver,C23.550.260.224
19424071,2009-08-01T00:00:00,"Hearing Loss, Conductive",C09.218.458.341.562
19424071,2009-08-01T00:00:00,"Hearing Loss, Conductive",C10.597.751.418.341.562
19424071,2009-08-01T00:00:00,"Hearing Loss, Conductive",C23.888.592.763.393.341.562
19424071,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19424071,2009-08-01T00:00:00,"Models, Biological",E05.599.395
19424071,2009-08-01T00:00:00,Temporal Bone,A02.835.232.781.885
19444906,2009-08-01T00:00:00,Adult,M01.060.116
19444906,2009-08-01T00:00:00,Aged,M01.060.116.100
19444906,2009-08-01T00:00:00,Carcinoma,C04.557.470.200
19444906,2009-08-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19444906,2009-08-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19444906,2009-08-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19444906,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19444906,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19444906,2009-08-01T00:00:00,Neoplasm Invasiveness,C04.697.645
19444906,2009-08-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
19444906,2009-08-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
19444906,2009-08-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
19444906,2009-08-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
19444906,2009-08-01T00:00:00,Ovarian Neoplasms,C19.344.410
19444906,2009-08-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
19444906,2009-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19444906,2009-08-01T00:00:00,Risk Factors,N05.715.350.200.700
19444906,2009-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19444906,2009-08-01T00:00:00,Risk Factors,N06.850.490.625.750
19444906,2009-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19444906,2009-08-01T00:00:00,Time Factors,G01.910.857
19444906,2009-08-01T00:00:00,"Tumor Markers, Biological",D23.101.840
19526516,2009-08-01T00:00:00,Algorithms,G17.035
19526516,2009-08-01T00:00:00,Algorithms,L01.224.050
19526516,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19526516,2009-08-01T00:00:00,Image Enhancement,E01.370.350.600.350
19526516,2009-08-01T00:00:00,Image Enhancement,L01.224.308.380
19526516,2009-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19526516,2009-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19526516,2009-08-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19526516,2009-08-01T00:00:00,Liver,A03.620
19526516,2009-08-01T00:00:00,Myocardium,A02.633.580
19526516,2009-08-01T00:00:00,Myocardium,A07.541.704
19526516,2009-08-01T00:00:00,Myocardium,A10.690.552.750
19526516,2009-08-01T00:00:00,Respiratory Mechanics,G09.772.770.755.700
19526516,2009-08-01T00:00:00,Young Adult,M01.060.116.815
19554553,2009-08-01T00:00:00,Animals,B01.050
19554553,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19554553,2009-08-01T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
19554553,2009-08-01T00:00:00,Phosphoproteins,D12.776.744
19554553,2009-08-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
19554553,2009-08-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
19554553,2009-08-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
19554553,2009-08-01T00:00:00,RNA-Binding Proteins,D12.776.157.725
19554553,2009-08-01T00:00:00,RNA-Binding Proteins,D12.776.664.962
19580954,2009-08-01T00:00:00,Cartilage,A02.165
19580954,2009-08-01T00:00:00,Cartilage,A10.165.382
19580954,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19580954,2009-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19580954,2009-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19580954,2009-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19580954,2009-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19580954,2009-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19580954,2009-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19580954,2009-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19580954,2009-08-01T00:00:00,"Technology Assessment, Biomedical",N03.880
19580954,2009-08-01T00:00:00,"Technology Assessment, Biomedical",N05.715.360.825
19580954,2009-08-01T00:00:00,X-Ray Diffraction,E05.196.309.742
19580954,2009-08-01T00:00:00,X-Ray Diffraction,E05.196.822.950
19580954,2009-08-01T00:00:00,X-Ray Diffraction,G01.595.861.950
19580954,2009-08-01T00:00:00,X-Ray Diffraction,G02.149.767.915
19580954,2009-08-01T00:00:00,X-Ray Diffraction,G02.842.750.915
19590443,2009-08-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
19590443,2009-08-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
19590443,2009-08-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
19590443,2009-08-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
19590443,2009-08-01T00:00:00,"Biopsy, Needle",E04.074.119
19590443,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19590443,2009-08-01T00:00:00,Young Adult,M01.060.116.815
19593171,2009-08-01T00:00:00,Adult,M01.060.116
19593171,2009-08-01T00:00:00,Alcohol Drinking,F01.145.317.269
19593171,2009-08-01T00:00:00,Alcoholism,C21.739.100.250
19593171,2009-08-01T00:00:00,Alcoholism,F03.900.100.350
19593171,2009-08-01T00:00:00,Amines,D02.092
19593171,2009-08-01T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
19593171,2009-08-01T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
19593171,2009-08-01T00:00:00,Double-Blind Method,E05.318.780.300
19593171,2009-08-01T00:00:00,Double-Blind Method,E05.581.500.300
19593171,2009-08-01T00:00:00,Double-Blind Method,N05.715.360.780.320
19593171,2009-08-01T00:00:00,Double-Blind Method,N06.850.520.445.300
19593171,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19593171,2009-08-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19593171,2009-08-01T00:00:00,Medication Adherence,F01.145.488.500.500
19593171,2009-08-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
19593171,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19593171,2009-08-01T00:00:00,Patient Selection,E05.581.500.653
19593171,2009-08-01T00:00:00,Patient Selection,N04.590.731
19593171,2009-08-01T00:00:00,Sleep,F02.830.855
19593171,2009-08-01T00:00:00,Sleep,G11.561.600.815
19593171,2009-08-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19593171,2009-08-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19593171,2009-08-01T00:00:00,Time Factors,G01.910.857
19593171,2009-08-01T00:00:00,Treatment Outcome,E01.789.800
19593171,2009-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19593171,2009-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19593171,2009-08-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19593171,2009-08-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
19594195,2009-08-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
19594195,2009-08-01T00:00:00,Cognitive Therapy,F04.754.137.428
19594195,2009-08-01T00:00:00,Drug Therapy,E02.319
19594195,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19594195,2009-08-01T00:00:00,Neuropsychological Tests,F04.711.513
19594195,2009-08-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19594195,2009-08-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19594195,2009-08-01T00:00:00,Smoking,F01.145.466.753
19615535,2009-08-01T00:00:00,Certification,N03.706.110.120
19615535,2009-08-01T00:00:00,Certification,N05.700.200.190
19615535,2009-08-01T00:00:00,Clinical Competence,I02.399.630.210
19615535,2009-08-01T00:00:00,Clinical Competence,N04.761.210
19615535,2009-08-01T00:00:00,Dermatology,H02.403.225
19615535,2009-08-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
19615535,2009-08-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
19615535,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19615535,2009-08-01T00:00:00,Physician's Practice Patterns,N04.590.748
19615535,2009-08-01T00:00:00,Physician's Practice Patterns,N05.300.625
19615535,2009-08-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19615535,2009-08-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19615535,2009-08-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
19615535,2009-08-01T00:00:00,"Quality Assurance, Health Care",N05.700
19615535,2009-08-01T00:00:00,United States,Z01.107.567.875
19619841,2009-08-01T00:00:00,African Americans,M01.686.508.100.100
19619841,2009-08-01T00:00:00,African Americans,M01.686.754.100
19619841,2009-08-01T00:00:00,Birth Weight,C23.888.144.186
19619841,2009-08-01T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
19619841,2009-08-01T00:00:00,Birth Weight,E05.041.124.160.750.149
19619841,2009-08-01T00:00:00,Birth Weight,G07.100.100.160.120.186
19619841,2009-08-01T00:00:00,Birth Weight,G07.700.320.249.314.120.186
19619841,2009-08-01T00:00:00,Chronic Disease,C23.550.291.500
19619841,2009-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19619841,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19619841,2009-08-01T00:00:00,Kidney Diseases,C12.777.419
19619841,2009-08-01T00:00:00,Kidney Diseases,C13.351.968.419
19620436,2009-08-01T00:00:00,Adult,M01.060.116
19620436,2009-08-01T00:00:00,Angiography,E01.370.350.700.060
19620436,2009-08-01T00:00:00,Angiography,E01.370.370.050
19620436,2009-08-01T00:00:00,Chest Pain,C23.888.646.215
19620436,2009-08-01T00:00:00,Coronary Disease,C14.280.647.250
19620436,2009-08-01T00:00:00,Coronary Disease,C14.907.585.250
19620436,2009-08-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19620436,2009-08-01T00:00:00,"Diagnosis, Differential",E01.171
19620436,2009-08-01T00:00:00,Emergency Medical Services,N02.421.297
19620436,2009-08-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19620436,2009-08-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19620436,2009-08-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19620436,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19620436,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19620436,2009-08-01T00:00:00,Pulmonary Embolism,C08.381.746
19620436,2009-08-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
19620436,2009-08-01T00:00:00,Radiation Dosage,E05.799.513
19620436,2009-08-01T00:00:00,Radiation Dosage,G01.201.875.740
19620436,2009-08-01T00:00:00,Radiation Dosage,N06.850.810.250
19620436,2009-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19620436,2009-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19620436,2009-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19620436,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19620436,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19620436,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19620436,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19620436,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19620437,2009-08-01T00:00:00,Adolescent,M01.060.057
19620437,2009-08-01T00:00:00,Adult,M01.060.116
19620437,2009-08-01T00:00:00,Aged,M01.060.116.100
19620437,2009-08-01T00:00:00,Calcinosis,C18.452.174.130
19620437,2009-08-01T00:00:00,Calcium,D01.268.552.100
19620437,2009-08-01T00:00:00,Calcium,D01.552.539.288
19620437,2009-08-01T00:00:00,Calcium,D23.119.100
19620437,2009-08-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19620437,2009-08-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19620437,2009-08-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19620437,2009-08-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
19620437,2009-08-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
19620437,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19620437,2009-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19620437,2009-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19620437,2009-08-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19620437,2009-08-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19620437,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19620437,2009-08-01T00:00:00,Myocardial Perfusion Imaging,E01.370.350.710.600.500
19620437,2009-08-01T00:00:00,Myocardial Perfusion Imaging,E01.370.370.380.500
19620437,2009-08-01T00:00:00,Myocardial Perfusion Imaging,E01.370.384.730.354.500
19620437,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19620437,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19620437,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19620437,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19620437,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19620437,2009-08-01T00:00:00,Young Adult,M01.060.116.815
19621378,2009-08-01T00:00:00,Electromagnetic Fields,G01.201.260
19621378,2009-08-01T00:00:00,Electromagnetic Fields,G01.201.875.240
19621378,2009-08-01T00:00:00,Electroosmosis,E05.196.385
19621378,2009-08-01T00:00:00,Electroosmosis,E05.301.270
19621378,2009-08-01T00:00:00,Electroosmosis,G02.149.535.250
19621378,2009-08-01T00:00:00,Electroosmosis,G02.149.767.645.250
19621378,2009-08-01T00:00:00,Electroosmosis,G02.685.495.250
19621378,2009-08-01T00:00:00,Electroosmosis,G02.842.700.495.250
19621378,2009-08-01T00:00:00,Electroosmosis,G02.842.750.645.250
19621378,2009-08-01T00:00:00,Electrophoresis,E05.196.401
19621378,2009-08-01T00:00:00,Electrophoresis,E05.301.300
19621378,2009-08-01T00:00:00,Electrophoresis,G02.149.767.570
19621378,2009-08-01T00:00:00,Electrophoresis,G02.842.750.570
19621378,2009-08-01T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
19621378,2009-08-01T00:00:00,Microfluidic Analytical Techniques,E05.588.465
19621378,2009-08-01T00:00:00,"Models, Chemical",E05.599.495
19622979,2009-08-01T00:00:00,Adult,M01.060.116
19622979,2009-08-01T00:00:00,Cesarean Section,E04.520.252.500
19622979,2009-08-01T00:00:00,Consumer Satisfaction,N04.452.822.360
19622979,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19622979,2009-08-01T00:00:00,Pregnancy,G08.686.785.760.769
19624328,2009-08-01T00:00:00,Health Behavior,F01.145.488
19624328,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19624328,2009-08-01T00:00:00,Licensure,N03.706.110.510
19624328,2009-08-01T00:00:00,Licensure,N05.700.200.450
19624328,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19624328,2009-08-01T00:00:00,Nicotine,D03.132.760.570
19624328,2009-08-01T00:00:00,Nicotine,D03.383.725.518
19624328,2009-08-01T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
19624328,2009-08-01T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
19624328,2009-08-01T00:00:00,Smoking,F01.145.466.753
19624328,2009-08-01T00:00:00,Smoking Cessation,F01.145.940.700
19624328,2009-08-01T00:00:00,United States,Z01.107.567.875
19627244,2009-08-01T00:00:00,Adolescent,M01.060.057
19627244,2009-08-01T00:00:00,Adult,M01.060.116
19627244,2009-08-01T00:00:00,Health Behavior,F01.145.488
19627244,2009-08-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19627244,2009-08-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19627244,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19627244,2009-08-01T00:00:00,Office Visits,N04.452.758.635
19627244,2009-08-01T00:00:00,Questionnaires,E05.318.308.750
19627244,2009-08-01T00:00:00,Questionnaires,L01.280.800
19627244,2009-08-01T00:00:00,Questionnaires,N05.715.360.300.695
19627244,2009-08-01T00:00:00,Questionnaires,N06.850.520.308.750
19627244,2009-08-01T00:00:00,Sexual Behavior,F01.145.802
19627244,2009-08-01T00:00:00,Sexual Partners,M01.778
19627244,2009-08-01T00:00:00,Sexually Transmitted Diseases,C01.539.778
19627244,2009-08-01T00:00:00,Sexually Transmitted Diseases,C02.800
19627244,2009-08-01T00:00:00,Sexually Transmitted Diseases,C12.294.668
19627244,2009-08-01T00:00:00,Sexually Transmitted Diseases,C13.351.500.711
19627244,2009-08-01T00:00:00,Students,I02.233.748
19627244,2009-08-01T00:00:00,Students,I02.851
19627244,2009-08-01T00:00:00,Students,M01.848
19627244,2009-08-01T00:00:00,United States,Z01.107.567.875
19627244,2009-08-01T00:00:00,Young Adult,M01.060.116.815
19629983,2009-08-01T00:00:00,Adolescent,M01.060.057
19629983,2009-08-01T00:00:00,Adult,M01.060.116
19629983,2009-08-01T00:00:00,Aged,M01.060.116.100
19629983,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19629983,2009-08-01T00:00:00,Image Enhancement,E01.370.350.600.350
19629983,2009-08-01T00:00:00,Image Enhancement,L01.224.308.380
19629983,2009-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19629983,2009-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19629983,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19629983,2009-08-01T00:00:00,Myocardium,A02.633.580
19629983,2009-08-01T00:00:00,Myocardium,A07.541.704
19629983,2009-08-01T00:00:00,Myocardium,A10.690.552.750
19631050,2009-08-01T00:00:00,Animals,B01.050
19631050,2009-08-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19631050,2009-08-01T00:00:00,Body Mass Index,E05.041.124.125
19631050,2009-08-01T00:00:00,Body Mass Index,G07.100.100.125
19631050,2009-08-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19631050,2009-08-01T00:00:00,Cholesterol,D04.808.247.222.284
19631050,2009-08-01T00:00:00,Cholesterol,D04.808.247.808.197
19631050,2009-08-01T00:00:00,Cholesterol,D10.570.938.208
19631050,2009-08-01T00:00:00,Cholesterol,D10.851.208
19631050,2009-08-01T00:00:00,Coronary Disease,C14.280.647.250
19631050,2009-08-01T00:00:00,Coronary Disease,C14.907.585.250
19631050,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19631050,2009-08-01T00:00:00,Incidence,E05.318.308.985.525.375
19631050,2009-08-01T00:00:00,Incidence,L01.280.975.525.375
19631050,2009-08-01T00:00:00,Incidence,N01.224.935.597.500
19631050,2009-08-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19631050,2009-08-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19631050,2009-08-01T00:00:00,Lipids,D10
19631050,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19631050,2009-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19631050,2009-08-01T00:00:00,Risk Factors,N05.715.350.200.700
19631050,2009-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19631050,2009-08-01T00:00:00,Risk Factors,N06.850.490.625.750
19631050,2009-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19633173,2009-08-01T00:00:00,Animals,B01.050
19633173,2009-08-01T00:00:00,Bone Development,G07.700.320.500.325.377.625.100
19633173,2009-08-01T00:00:00,Bone Development,G11.427.590.560.100
19633173,2009-08-01T00:00:00,Cell Proliferation,G04.299.233.750
19633173,2009-08-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19633173,2009-08-01T00:00:00,Chondrocytes,A11.329.171
19633173,2009-08-01T00:00:00,Extracellular Matrix,A11.284.295.310
19633173,2009-08-01T00:00:00,Extremities,A01.378
19633173,2009-08-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19633173,2009-08-01T00:00:00,Gene Silencing,G05.355.315.203.374
19633173,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19633173,2009-08-01T00:00:00,Hyaluronic Acid,D09.698.373.475
19633173,2009-08-01T00:00:00,Joints,A02.835.583
19633173,2009-08-01T00:00:00,Mesoderm,A16.504.660
19634955,2009-08-01T00:00:00,Adolescent,M01.060.057
19634955,2009-08-01T00:00:00,Adult,M01.060.116
19634955,2009-08-01T00:00:00,Aged,M01.060.116.100
19634955,2009-08-01T00:00:00,Cognitive Therapy,F04.754.137.428
19634955,2009-08-01T00:00:00,Health Education,I02.233.332
19634955,2009-08-01T00:00:00,Health Education,N02.421.143.827.407
19634955,2009-08-01T00:00:00,Health Education,N02.421.726.407
19634955,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19634955,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19634955,2009-08-01T00:00:00,Personality Inventory,F04.711.647.513
19634955,2009-08-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19634955,2009-08-01T00:00:00,Substance-Related Disorders,C21.739
19634955,2009-08-01T00:00:00,Substance-Related Disorders,F03.900
19634955,2009-08-01T00:00:00,Treatment Outcome,E01.789.800
19634955,2009-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19634955,2009-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19634955,2009-08-01T00:00:00,United States,Z01.107.567.875
19634955,2009-08-01T00:00:00,Young Adult,M01.060.116.815
19635234,2009-08-01T00:00:00,Anti-Anxiety Agents,D27.505.696.277.950.015
19635234,2009-08-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.210.950.015
19635234,2009-08-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.700.872.015
19635234,2009-08-01T00:00:00,Anxiety Disorders,F03.080
19635234,2009-08-01T00:00:00,Behavior Therapy,F04.754.137
19635234,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19635234,2009-08-01T00:00:00,"Models, Theoretical",E05.599
19635234,2009-08-01T00:00:00,Panic Disorder,F03.080.700
19635234,2009-08-01T00:00:00,Sleep Disorders,C10.886
19635234,2009-08-01T00:00:00,Sleep Disorders,C23.888.592.796
19635234,2009-08-01T00:00:00,Sleep Disorders,F03.870
19635234,2009-08-01T00:00:00,Sleep Initiation and Maintenance Disorders,C10.886.425.800.800
19635234,2009-08-01T00:00:00,Sleep Initiation and Maintenance Disorders,F03.870.400.800.800
19635234,2009-08-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19635855,2009-08-01T00:00:00,Animals,B01.050
19635855,2009-08-01T00:00:00,"Models, Theoretical",E05.599
19635855,2009-08-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
19635855,2009-08-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
19635855,2009-08-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
19635855,2009-08-01T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
19635855,2009-08-01T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
19635855,2009-08-01T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
19635855,2009-08-01T00:00:00,Retinaldehyde,D02.047.850
19635855,2009-08-01T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
19635855,2009-08-01T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
19635855,2009-08-01T00:00:00,Retinaldehyde,D02.455.849.131.495.690
19635855,2009-08-01T00:00:00,Retinaldehyde,D23.767.261.700.690
19635855,2009-08-01T00:00:00,Rhodopsin,D12.776.543.750.100.955
19635855,2009-08-01T00:00:00,Rhodopsin,D23.767.930.750.500.500
19636350,2009-08-01T00:00:00,Animals,B01.050
19636350,2009-08-01T00:00:00,Cocaine,D02.145.074.722.388
19636350,2009-08-01T00:00:00,Cocaine,D03.132.889.354
19636350,2009-08-01T00:00:00,Cocaine,D03.605.869.388
19636350,2009-08-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
19636350,2009-08-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19636350,2009-08-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19636350,2009-08-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
19636350,2009-08-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
19636350,2009-08-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
19636350,2009-08-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
19636350,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19636350,2009-08-01T00:00:00,Motor Activity,F01.145.632
19636350,2009-08-01T00:00:00,Motor Activity,G11.427.590.530.698
19636350,2009-08-01T00:00:00,Neurons,A08.663
19636350,2009-08-01T00:00:00,Neurons,A11.671
19636350,2009-08-01T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19636350,2009-08-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.260.108.765
19636350,2009-08-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.624.664.700.179
19636350,2009-08-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.660.760
19636350,2009-08-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.930.127.765
19636350,2009-08-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19637954,2009-08-01T00:00:00,Amines,D02.092
19637954,2009-08-01T00:00:00,Analgesics,D27.505.696.663.850.014
19637954,2009-08-01T00:00:00,Analgesics,D27.505.954.427.040
19637954,2009-08-01T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
19637954,2009-08-01T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
19637954,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19637954,2009-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
19637954,2009-08-01T00:00:00,Pain,C10.597.617
19637954,2009-08-01T00:00:00,Pain,C23.888.592.612
19637954,2009-08-01T00:00:00,Pain,C23.888.646
19637954,2009-08-01T00:00:00,Pain,F02.830.816.444
19637954,2009-08-01T00:00:00,Pain,G11.561.600.810.444
19637954,2009-08-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19637954,2009-08-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
19638916,2009-08-01T00:00:00,Acetylglucosamine,D09.067.342.531.050
19638916,2009-08-01T00:00:00,Animals,B01.050
19638916,2009-08-01T00:00:00,Cell Movement,G04.299.283
19638916,2009-08-01T00:00:00,Cell Movement,G07.700.560.500.180
19638916,2009-08-01T00:00:00,Cell Proliferation,G04.299.233.750
19638916,2009-08-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19638916,2009-08-01T00:00:00,Diabetes Complications,C19.246.099
19638916,2009-08-01T00:00:00,"Disease Models, Animal",C22.232
19638916,2009-08-01T00:00:00,"Disease Models, Animal",E05.598.500
19638916,2009-08-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19638916,2009-08-01T00:00:00,Endothelial Cells,A11.436.275
19638916,2009-08-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
19638916,2009-08-01T00:00:00,Tissue Scaffolds,E07.206.627
19638916,2009-08-01T00:00:00,Tissue Scaffolds,E07.695.825
19638916,2009-08-01T00:00:00,Wound Healing,G16.100.856.891
19638923,2009-08-01T00:00:00,Adult,M01.060.116
19638923,2009-08-01T00:00:00,Aged,M01.060.116.100
19638923,2009-08-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
19638923,2009-08-01T00:00:00,Hospital Mortality,L01.280.975.550.400
19638923,2009-08-01T00:00:00,Hospital Mortality,N01.224.935.698.400
19638923,2009-08-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
19638923,2009-08-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
19638923,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19638923,2009-08-01T00:00:00,Iatrogenic Disease,C23.550.291.875
19638923,2009-08-01T00:00:00,Internship and Residency,I02.358.399.644
19638923,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19638923,2009-08-01T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
19638923,2009-08-01T00:00:00,Postoperative Complications,C23.550.767
19638923,2009-08-01T00:00:00,Salaries and Fringe Benefits,N01.824.417.700
19638923,2009-08-01T00:00:00,Salaries and Fringe Benefits,N04.452.677.800
19638923,2009-08-01T00:00:00,United States,Z01.107.567.875
19638923,2009-08-01T00:00:00,Workload,N04.452.677.950
19644854,2009-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19644854,2009-08-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19644854,2009-08-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19644854,2009-08-01T00:00:00,Hispanic Americans,M01.686.754.441
19644854,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19644854,2009-08-01T00:00:00,Linkage Disequilibrium,G05.540.500
19644854,2009-08-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19644854,2009-08-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19644854,2009-08-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19644854,2009-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19644854,2009-08-01T00:00:00,Risk Factors,N05.715.350.200.700
19644854,2009-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19644854,2009-08-01T00:00:00,Risk Factors,N06.850.490.625.750
19644854,2009-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19648104,2009-08-01T00:00:00,Gait,E01.370.600.250
19648104,2009-08-01T00:00:00,Gait,G11.427.590.530.389
19648104,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19648104,2009-08-01T00:00:00,Stroke,C10.228.140.300.775
19648104,2009-08-01T00:00:00,Stroke,C14.907.253.855
19648617,2009-08-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
19648617,2009-08-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
19648617,2009-08-01T00:00:00,Hip Prosthesis,E07.695.400.400
19648617,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19648617,2009-08-01T00:00:00,Postoperative Complications,C23.550.767
19648617,2009-08-01T00:00:00,Prosthesis-Related Infections,C01.539.685
19648617,2009-08-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
19648620,2009-08-01T00:00:00,Anticoagulants,D27.505.954.502.119
19648620,2009-08-01T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
19648620,2009-08-01T00:00:00,"Arthroplasty, Replacement",E04.650.110
19648620,2009-08-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
19648620,2009-08-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
19648620,2009-08-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
19648620,2009-08-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
19648620,2009-08-01T00:00:00,"Heparin, Low-Molecular-Weight",D09.698.373.400.300
19648620,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19648620,2009-08-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19648620,2009-08-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19648620,2009-08-01T00:00:00,Pulmonary Embolism,C08.381.746
19648620,2009-08-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
19648620,2009-08-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
19648620,2009-08-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
19648620,2009-08-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
19648620,2009-08-01T00:00:00,Warfarin,D03.438.150.446.520.914
19648620,2009-08-01T00:00:00,Warfarin,D03.830.219.446.520.914
19648630,2009-08-01T00:00:00,Algorithms,G17.035
19648630,2009-08-01T00:00:00,Algorithms,L01.224.050
19648630,2009-08-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
19648630,2009-08-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
19648630,2009-08-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19648630,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19648630,2009-08-01T00:00:00,Knee Prosthesis,E07.695.400.410
19648630,2009-08-01T00:00:00,Preoperative Care,E02.760.795
19648630,2009-08-01T00:00:00,Preoperative Care,E04.641
19648630,2009-08-01T00:00:00,Preoperative Care,N02.421.585.795
19648630,2009-08-01T00:00:00,Prosthesis Failure,C23.550.767.865
19648630,2009-08-01T00:00:00,Prosthesis Failure,E05.325.771
19648630,2009-08-01T00:00:00,Prosthesis-Related Infections,C01.539.685
19648630,2009-08-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
19648630,2009-08-01T00:00:00,Reoperation,E04.690
19648632,2009-08-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
19648632,2009-08-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
19648632,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19648632,2009-08-01T00:00:00,Knee Joint,A02.835.583.475
19648632,2009-08-01T00:00:00,Knee Prosthesis,E07.695.400.410
19648632,2009-08-01T00:00:00,Reoperation,E04.690
19666750,2009-08-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
19666750,2009-08-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
19666750,2009-08-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
19666750,2009-08-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
19666750,2009-08-01T00:00:00,Endosonography,E01.370.350.850.280
19666750,2009-08-01T00:00:00,Forecasting,I01.320
19666750,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19666750,2009-08-01T00:00:00,Lymph Nodes,A10.549.400
19666750,2009-08-01T00:00:00,Lymph Nodes,A15.382.520.604.412
19666750,2009-08-01T00:00:00,Sarcoidosis,C15.604.515.827
19667891,2009-08-01T00:00:00,Adult,M01.060.116
19667891,2009-08-01T00:00:00,Hospitalization,E02.760.400
19667891,2009-08-01T00:00:00,Hospitalization,N02.421.585.400
19667891,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19667891,2009-08-01T00:00:00,Incidence,E05.318.308.985.525.375
19667891,2009-08-01T00:00:00,Incidence,L01.280.975.525.375
19667891,2009-08-01T00:00:00,Incidence,N01.224.935.597.500
19667891,2009-08-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19667891,2009-08-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19667891,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19667891,2009-08-01T00:00:00,Rural Population,N01.600.725
19667891,2009-08-01T00:00:00,Self-Injurious Behavior,F01.145.126.980
19667891,2009-08-01T00:00:00,Suicide,F01.145.126.980.875
19667891,2009-08-01T00:00:00,Suicide,I01.880.735.856
19667891,2009-08-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
19667891,2009-08-01T00:00:00,Trauma Centers,N02.421.297.195.480
19667891,2009-08-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
19680022,2009-08-01T00:00:00,Anti-Glomerular Basement Membrane Disease,C08.381.483.156
19680022,2009-08-01T00:00:00,Anti-Glomerular Basement Membrane Disease,C12.777.419.570.363.304
19680022,2009-08-01T00:00:00,Anti-Glomerular Basement Membrane Disease,C13.351.968.419.570.363.304
19680022,2009-08-01T00:00:00,Anti-Glomerular Basement Membrane Disease,C20.111.190
19680022,2009-08-01T00:00:00,"History, 20th Century",K01.400.504.968
19680022,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19680022,2009-08-01T00:00:00,"Influenza, Human",C02.782.620.365
19680022,2009-08-01T00:00:00,"Influenza, Human",C08.730.310
19680027,2009-08-01T00:00:00,Adult,M01.060.116
19680027,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19680027,2009-08-01T00:00:00,Stroke,C10.228.140.300.775
19680027,2009-08-01T00:00:00,Stroke,C14.907.253.855
19680027,2009-08-01T00:00:00,Vertebrobasilar Insufficiency,C10.228.140.300.150.956
19680027,2009-08-01T00:00:00,Vertebrobasilar Insufficiency,C14.907.253.092.956
19680027,2009-08-01T00:00:00,Vertebrobasilar Insufficiency,C14.907.253.956
19683188,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19683188,2009-08-01T00:00:00,Incidence,E05.318.308.985.525.375
19683188,2009-08-01T00:00:00,Incidence,L01.280.975.525.375
19683188,2009-08-01T00:00:00,Incidence,N01.224.935.597.500
19683188,2009-08-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19683188,2009-08-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19683188,2009-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
19683188,2009-08-01T00:00:00,"Infant, Premature",M01.060.703.520.520
19683188,2009-08-01T00:00:00,Retinopathy of Prematurity,C11.768.836
19683188,2009-08-01T00:00:00,Retinopathy of Prematurity,C16.614.521.731
19683188,2009-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19683188,2009-08-01T00:00:00,Risk Factors,N05.715.350.200.700
19683188,2009-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19683188,2009-08-01T00:00:00,Risk Factors,N06.850.490.625.750
19683188,2009-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19683188,2009-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19683188,2009-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19686993,2009-08-01T00:00:00,Algorithms,G17.035
19686993,2009-08-01T00:00:00,Algorithms,L01.224.050
19686993,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19686993,2009-08-01T00:00:00,"Models, Theoretical",E05.599
19686993,2009-08-01T00:00:00,Skin,A17.815
19686993,2009-08-01T00:00:00,Transducers,E07.305.812
19686993,2009-08-01T00:00:00,Ultrasonography,E01.370.350.850
19689440,2009-08-01T00:00:00,Anus Neoplasms,C04.588.274.476.411.307.790.040
19689440,2009-08-01T00:00:00,Anus Neoplasms,C06.301.371.411.307.790.040
19689440,2009-08-01T00:00:00,Anus Neoplasms,C06.405.249.411.307.790.040
19689440,2009-08-01T00:00:00,Anus Neoplasms,C06.405.469.491.307.790.040
19689440,2009-08-01T00:00:00,Anus Neoplasms,C06.405.469.860.101.163
19689440,2009-08-01T00:00:00,Anus Neoplasms,C06.405.469.860.180.500.040
19689440,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19689440,2009-08-01T00:00:00,Mass Screening,E01.370.500
19689440,2009-08-01T00:00:00,Mass Screening,E05.318.308.250.580
19689440,2009-08-01T00:00:00,Mass Screening,N02.421.143.827.233.443
19689440,2009-08-01T00:00:00,Mass Screening,N02.421.726.233.443
19689440,2009-08-01T00:00:00,Mass Screening,N05.715.360.300.375.500
19689440,2009-08-01T00:00:00,Mass Screening,N06.850.520.308.250.580
19689440,2009-08-01T00:00:00,Mass Screening,N06.850.780.500
19689440,2009-08-01T00:00:00,Papillomavirus Infections,C02.256.650
19689440,2009-08-01T00:00:00,Papillomavirus Infections,C02.928.725
19689440,2009-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19689440,2009-08-01T00:00:00,Risk Factors,N05.715.350.200.700
19689440,2009-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19689440,2009-08-01T00:00:00,Risk Factors,N06.850.490.625.750
19689440,2009-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19689440,2009-08-01T00:00:00,Risk-Taking,F01.145.722
19689440,2009-08-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
19689440,2009-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
19689440,2009-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
19689440,2009-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
19702433,2009-08-01T00:00:00,"Adaptation, Psychological",F01.058
19702433,2009-08-01T00:00:00,Adult,M01.060.116
19702433,2009-08-01T00:00:00,African Americans,M01.686.508.100.100
19702433,2009-08-01T00:00:00,African Americans,M01.686.754.100
19702433,2009-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19702433,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19702433,2009-08-01T00:00:00,Quality of Life,I01.800
19702433,2009-08-01T00:00:00,Quality of Life,K01.752.400.750
19702433,2009-08-01T00:00:00,Questionnaires,E05.318.308.750
19702433,2009-08-01T00:00:00,Questionnaires,L01.280.800
19702433,2009-08-01T00:00:00,Questionnaires,N05.715.360.300.695
19702433,2009-08-01T00:00:00,Questionnaires,N06.850.520.308.750
19702433,2009-08-01T00:00:00,Self Disclosure,F01.752.747.792.662
19702433,2009-08-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19702433,2009-08-01T00:00:00,Spinal Cord Injuries,C10.900.850
19702433,2009-08-01T00:00:00,Spinal Cord Injuries,C21.866.819
19702433,2009-08-01T00:00:00,United States,Z01.107.567.875
19703878,2009-08-01T00:00:00,Adult,M01.060.116
19703878,2009-08-01T00:00:00,Aged,M01.060.116.100
19703878,2009-08-01T00:00:00,Breast Neoplasms,C04.588.180
19703878,2009-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
19703878,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19703878,2009-08-01T00:00:00,Mammography,E01.370.350.700.500
19703878,2009-08-01T00:00:00,Mass Screening,E01.370.500
19703878,2009-08-01T00:00:00,Mass Screening,E05.318.308.250.580
19703878,2009-08-01T00:00:00,Mass Screening,N02.421.143.827.233.443
19703878,2009-08-01T00:00:00,Mass Screening,N02.421.726.233.443
19703878,2009-08-01T00:00:00,Mass Screening,N05.715.360.300.375.500
19703878,2009-08-01T00:00:00,Mass Screening,N06.850.520.308.250.580
19703878,2009-08-01T00:00:00,Mass Screening,N06.850.780.500
19703878,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19703878,2009-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19703878,2009-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19703878,2009-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19703878,2009-08-01T00:00:00,Regression Analysis,E05.318.740.750
19703878,2009-08-01T00:00:00,Regression Analysis,N05.715.360.750.695
19703878,2009-08-01T00:00:00,Regression Analysis,N06.850.520.830.750
19703878,2009-08-01T00:00:00,Young Adult,M01.060.116.815
19711642,2009-08-01T00:00:00,Arterial Occlusive Diseases,C14.907.137
19711642,2009-08-01T00:00:00,Graft Rejection,G12.425.901.545.328
19711642,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19711642,2009-08-01T00:00:00,Kidney,A05.810.453
19711642,2009-08-01T00:00:00,Kidney Diseases,C12.777.419
19711642,2009-08-01T00:00:00,Kidney Diseases,C13.351.968.419
19711642,2009-08-01T00:00:00,Kidney Transplantation,E02.870.500
19711642,2009-08-01T00:00:00,Kidney Transplantation,E04.936.450.485
19711642,2009-08-01T00:00:00,Kidney Transplantation,E04.950.774.400
19711642,2009-08-01T00:00:00,Postoperative Complications,C23.550.767
19725297,2009-08-01T00:00:00,Adult,M01.060.116
19725297,2009-08-01T00:00:00,Aged,M01.060.116.100
19725297,2009-08-01T00:00:00,Cholestasis,C06.130.120.135
19725297,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19725297,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19725297,2009-08-01T00:00:00,Peptic Ulcer,C06.405.469.275.800
19725297,2009-08-01T00:00:00,Peptic Ulcer,C06.405.608
19725297,2009-08-01T00:00:00,Peptic Ulcer,C06.405.748.586
19731668,2009-08-01T00:00:00,Adsorption,G02.149.047
19731668,2009-08-01T00:00:00,Adsorption,G02.149.767.029
19731668,2009-08-01T00:00:00,Adsorption,G02.842.750.029
19731668,2009-08-01T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
19731668,2009-08-01T00:00:00,Carbon,D01.268.150
19731668,2009-08-01T00:00:00,"Models, Theoretical",E05.599
19731668,2009-08-01T00:00:00,Nanotechnology,H01.603
19731668,2009-08-01T00:00:00,Nanotechnology,J01.897.520.600
19731668,2009-08-01T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
19731668,2009-08-01T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
19731668,2009-08-01T00:00:00,Nitrogen,D01.268.604
19731668,2009-08-01T00:00:00,Nitrogen,D01.362.625
19731668,2009-08-01T00:00:00,Organic Chemicals,D02
19731668,2009-08-01T00:00:00,Oxygen,D01.268.185.550
19731668,2009-08-01T00:00:00,Oxygen,D01.362.670
19731668,2009-08-01T00:00:00,Surface Properties,G02.842.850
19731668,2009-08-01T00:00:00,Water,D01.455.900
19731668,2009-08-01T00:00:00,Water,D01.650.550.925
19731668,2009-08-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
19746750,2009-08-01T00:00:00,Adult,M01.060.116
19746750,2009-08-01T00:00:00,Aged,M01.060.116.100
19746750,2009-08-01T00:00:00,Biocompatible Materials,D25.130
19746750,2009-08-01T00:00:00,Biocompatible Materials,D27.720.102.130
19746750,2009-08-01T00:00:00,Biocompatible Materials,J01.637.051.130
19746750,2009-08-01T00:00:00,Durapatite,D01.146.360.050.300.200
19746750,2009-08-01T00:00:00,Durapatite,D01.578.122.477.300
19746750,2009-08-01T00:00:00,Durapatite,D01.695.625.675.650.075.025.300.150
19746750,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19746750,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19746750,2009-08-01T00:00:00,Treatment Outcome,E01.789.800
19746750,2009-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19746750,2009-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19746750,2009-08-01T00:00:00,Vocal Cord Paralysis,C08.360.931
19746750,2009-08-01T00:00:00,Vocal Cord Paralysis,C09.400.931
19746750,2009-08-01T00:00:00,Vocal Cord Paralysis,C10.292.887.800
19746750,2009-08-01T00:00:00,Vocal Cord Paralysis,C10.597.622.943
19746750,2009-08-01T00:00:00,Vocal Cord Paralysis,C23.888.592.636.943
19755094,2009-08-01T00:00:00,Adult,M01.060.116
19755094,2009-08-01T00:00:00,Aged,M01.060.116.100
19755094,2009-08-01T00:00:00,Child,M01.060.406
19755094,2009-08-01T00:00:00,Endoscopy,E01.370.388.250
19755094,2009-08-01T00:00:00,Endoscopy,E04.800.250
19755094,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19755094,2009-08-01T00:00:00,Middle Aged,M01.060.116.630
19755094,2009-08-01T00:00:00,Skull Base,A01.456.830
19755094,2009-08-01T00:00:00,Skull Base,A02.835.232.781.750
19755094,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19755094,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19755094,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19755094,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19755094,2009-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19755094,2009-08-01T00:00:00,Young Adult,M01.060.116.815
20141611,2009-08-01T00:00:00,Animals,B01.050
20141611,2009-08-01T00:00:00,Cell Line,A11.251.210
20141611,2009-08-01T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
20141611,2009-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20141611,2009-08-01T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
20141611,2009-08-01T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
20141611,2009-08-01T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
20141611,2009-08-01T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
20141611,2009-08-01T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
20141611,2009-08-01T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
20141611,2009-08-01T00:00:00,Islets of Langerhans,A03.734.414
20141611,2009-08-01T00:00:00,Islets of Langerhans,A06.407.414
19651222,2009-08-03T00:00:00,Acoustic Stimulation,E02.037
19651222,2009-08-03T00:00:00,Acoustic Stimulation,E02.190.888.030
19651222,2009-08-03T00:00:00,Acoustic Stimulation,E05.723.136
19651222,2009-08-03T00:00:00,Adult,M01.060.116
19651222,2009-08-03T00:00:00,Functional Laterality,F02.830.297.425
19651222,2009-08-03T00:00:00,Functional Laterality,G11.561.225.425
19651222,2009-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19651222,2009-08-03T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19651222,2009-08-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19651222,2009-08-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19651222,2009-08-03T00:00:00,Speech Perception,F02.463.593.071.875
19651222,2009-08-03T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
19651222,2009-08-03T00:00:00,Young Adult,M01.060.116.815
19652077,2009-08-03T00:00:00,Adolescent,M01.060.057
19652077,2009-08-03T00:00:00,African Americans,M01.686.508.100.100
19652077,2009-08-03T00:00:00,African Americans,M01.686.754.100
19652077,2009-08-03T00:00:00,Blood Pressure,E01.370.600.875.249
19652077,2009-08-03T00:00:00,Blood Pressure,G09.330.380.076
19652077,2009-08-03T00:00:00,Body Mass Index,E01.370.600.115.100.125
19652077,2009-08-03T00:00:00,Body Mass Index,E05.041.124.125
19652077,2009-08-03T00:00:00,Body Mass Index,G07.100.100.125
19652077,2009-08-03T00:00:00,Body Mass Index,N06.850.505.200.100.175
19652077,2009-08-03T00:00:00,Child,M01.060.406
19652077,2009-08-03T00:00:00,"Child, Preschool",M01.060.406.448
19652077,2009-08-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
19652077,2009-08-03T00:00:00,Hispanic Americans,M01.686.754.441
19652077,2009-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19652077,2009-08-03T00:00:00,Hypertension,C14.907.489
19652077,2009-08-03T00:00:00,Infant,M01.060.703
19652077,2009-08-03T00:00:00,Sex Factors,N05.715.350.675
19652077,2009-08-03T00:00:00,Sex Factors,N06.850.490.875
19652077,2009-08-03T00:00:00,United States,Z01.107.567.875
19656557,2009-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19656557,2009-08-03T00:00:00,"Labor, Induced",E04.520.252.968
19656557,2009-08-03T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
19656557,2009-08-03T00:00:00,Multicenter Studies as Topic,E05.337.250.500
19656557,2009-08-03T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
19656557,2009-08-03T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
19656557,2009-08-03T00:00:00,Pre-Eclampsia,C13.703.395.249
19656557,2009-08-03T00:00:00,Pregnancy,G08.686.785.760.769
19656557,2009-08-03T00:00:00,Pregnancy Outcome,E01.789.700
19656557,2009-08-03T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
19656557,2009-08-03T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19656557,2009-08-03T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19656557,2009-08-03T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19656557,2009-08-03T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19656557,2009-08-03T00:00:00,Research Design,E05.581.500
19656557,2009-08-03T00:00:00,Research Design,H01.770.644.728
19681804,2009-08-04T00:00:00,Academic Medical Centers,N02.278.020
19681804,2009-08-04T00:00:00,Adolescent,M01.060.057
19681804,2009-08-04T00:00:00,Adult,M01.060.116
19681804,2009-08-04T00:00:00,African Americans,M01.686.508.100.100
19681804,2009-08-04T00:00:00,African Americans,M01.686.754.100
19681804,2009-08-04T00:00:00,Age Factors,N05.715.350.075
19681804,2009-08-04T00:00:00,Age Factors,N06.850.490.250
19681804,2009-08-04T00:00:00,Anxiety Disorders,F03.080
19681804,2009-08-04T00:00:00,"Data Interpretation, Statistical",E05.245.380
19681804,2009-08-04T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19681804,2009-08-04T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19681804,2009-08-04T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19681804,2009-08-04T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19681804,2009-08-04T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19681804,2009-08-04T00:00:00,European Continental Ancestry Group,M01.686.508.400
19681804,2009-08-04T00:00:00,Hispanic Americans,M01.686.754.441
19681804,2009-08-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19681804,2009-08-04T00:00:00,"Interview, Psychological",F04.669.599
19681804,2009-08-04T00:00:00,Substance-Related Disorders,C21.739
19681804,2009-08-04T00:00:00,Substance-Related Disorders,F03.900
19681804,2009-08-04T00:00:00,Young Adult,M01.060.116.815
19590392,2009-08-05T00:00:00,Adult,M01.060.116
19590392,2009-08-05T00:00:00,Brain,A08.186.211
19590392,2009-08-05T00:00:00,Brain Mapping,E01.370.350.086
19590392,2009-08-05T00:00:00,Brain Mapping,E01.370.376.149
19590392,2009-08-05T00:00:00,Brain Mapping,E05.132
19590392,2009-08-05T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
19590392,2009-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19590392,2009-08-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19590392,2009-08-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19590392,2009-08-05T00:00:00,Reaction Time,F02.830.650
19590392,2009-08-05T00:00:00,Reaction Time,F04.669.817
19590392,2009-08-05T00:00:00,Reaction Time,G11.561.677
19590392,2009-08-05T00:00:00,Thinking,F02.463.785
19654866,2009-08-05T00:00:00,Animals,B01.050
19654866,2009-08-05T00:00:00,Dopamine,D02.092.211.215.311.342
19654866,2009-08-05T00:00:00,Dopamine,D02.092.311.342
19654866,2009-08-05T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19654866,2009-08-05T00:00:00,Synapses,A08.850
19654866,2009-08-05T00:00:00,Synapses,A11.284.149.165.420.780
19656799,2009-08-05T00:00:00,Counseling,F02.784.176
19656799,2009-08-05T00:00:00,Counseling,F04.408.413
19656799,2009-08-05T00:00:00,Counseling,N02.421.143.303
19656799,2009-08-05T00:00:00,Counseling,N02.421.461.363
19656799,2009-08-05T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19656799,2009-08-05T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19656799,2009-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19656799,2009-08-05T00:00:00,Motivation,F01.658
19656799,2009-08-05T00:00:00,Motivation,F01.752.543.500.750
19656799,2009-08-05T00:00:00,New York,Z01.107.567.875.075.437
19656799,2009-08-05T00:00:00,New York,Z01.107.567.875.350.530
19656799,2009-08-05T00:00:00,New York,Z01.107.567.875.500.530
19656799,2009-08-05T00:00:00,Patient Education as Topic,I02.233.332.500
19656799,2009-08-05T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19656799,2009-08-05T00:00:00,Patient Education as Topic,N02.421.726.407.680
19656799,2009-08-05T00:00:00,Smoking Cessation,F01.145.940.700
19660800,2009-08-05T00:00:00,Biocompatible Materials,D25.130
19660800,2009-08-05T00:00:00,Biocompatible Materials,D27.720.102.130
19660800,2009-08-05T00:00:00,Biocompatible Materials,J01.637.051.130
19660800,2009-08-05T00:00:00,Collagen,D05.750.078.280
19660800,2009-08-05T00:00:00,Collagen,D12.776.860.300.250
19660800,2009-08-05T00:00:00,Dextrans,D05.750.078.562.272
19660800,2009-08-05T00:00:00,Dextrans,D09.698.365.272
19660800,2009-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19660800,2009-08-05T00:00:00,Hyaluronic Acid,D09.698.373.475
19660800,2009-08-05T00:00:00,Middle Aged,M01.060.116.630
19660800,2009-08-05T00:00:00,Urethra,A05.360.444.492.726
19660800,2009-08-05T00:00:00,Urethra,A05.810.876
19660800,2009-08-05T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
19660800,2009-08-05T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
19660800,2009-08-05T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
19657724,2009-08-06T00:00:00,"Adaptation, Psychological",F01.058
19657724,2009-08-06T00:00:00,Health Services Accessibility,N04.590.374.350
19657724,2009-08-06T00:00:00,Health Services Accessibility,N05.300.430
19657724,2009-08-06T00:00:00,Health Surveys,E05.318.308.250
19657724,2009-08-06T00:00:00,Health Surveys,N05.715.360.300.375
19657724,2009-08-06T00:00:00,Health Surveys,N06.850.520.308.250
19657724,2009-08-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19657724,2009-08-06T00:00:00,Middle Aged,M01.060.116.630
19657724,2009-08-06T00:00:00,Neoplasms,C04
19657724,2009-08-06T00:00:00,Quality of Life,I01.800
19657724,2009-08-06T00:00:00,Quality of Life,K01.752.400.750
19657724,2009-08-06T00:00:00,Questionnaires,E05.318.308.750
19657724,2009-08-06T00:00:00,Questionnaires,L01.280.800
19657724,2009-08-06T00:00:00,Questionnaires,N05.715.360.300.695
19657724,2009-08-06T00:00:00,Questionnaires,N06.850.520.308.750
19657724,2009-08-06T00:00:00,Social Support,I01.880.656.600
19657724,2009-08-06T00:00:00,"Stress, Psychological",F01.145.126.990
19657724,2009-08-06T00:00:00,"Stress, Psychological",F02.830.900
19661061,2009-08-06T00:00:00,Animals,B01.050
19661061,2009-08-06T00:00:00,Anti-Arrhythmia Agents,D27.505.954.411.097
19661061,2009-08-06T00:00:00,"Calcium Channels, L-Type",D12.776.157.530.400.150.400
19661061,2009-08-06T00:00:00,"Calcium Channels, L-Type",D12.776.543.550.425.150.400
19661061,2009-08-06T00:00:00,"Calcium Channels, L-Type",D12.776.543.585.400.150.400
19661061,2009-08-06T00:00:00,Heart,A07.541
19661061,2009-08-06T00:00:00,Myocardium,A02.633.580
19661061,2009-08-06T00:00:00,Myocardium,A07.541.704
19661061,2009-08-06T00:00:00,Myocardium,A10.690.552.750
19661061,2009-08-06T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19661061,2009-08-06T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19661061,2009-08-06T00:00:00,"Myocytes, Cardiac",A11.620.500
19661061,2009-08-06T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
19661061,2009-08-06T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
19661061,2009-08-06T00:00:00,Sodium-Hydrogen Antiporter,D12.776.157.530.450.162.775
19661061,2009-08-06T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.550.190.775
19661061,2009-08-06T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.585.450.162.775
19661061,2009-08-06T00:00:00,Time Factors,G01.910.857
19661061,2009-08-06T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
19661061,2009-08-06T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
19661061,2009-08-06T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
19661061,2009-08-06T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
19666632,2009-08-06T00:00:00,African Continental Ancestry Group,M01.686.508.100
19666632,2009-08-06T00:00:00,Cardiovascular Diseases,C14
19666632,2009-08-06T00:00:00,Cholesterol,D04.808.247.222.284
19666632,2009-08-06T00:00:00,Cholesterol,D04.808.247.808.197
19666632,2009-08-06T00:00:00,Cholesterol,D10.570.938.208
19666632,2009-08-06T00:00:00,Cholesterol,D10.851.208
19666632,2009-08-06T00:00:00,Hispanic Americans,M01.686.754.441
19666632,2009-08-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19666632,2009-08-06T00:00:00,Minority Groups,I01.880.371
19666632,2009-08-06T00:00:00,United States,Z01.107.567.875
19674194,2009-08-06T00:00:00,Adolescent,M01.060.057
19674194,2009-08-06T00:00:00,Child,M01.060.406
19674194,2009-08-06T00:00:00,Demography,I01.240
19674194,2009-08-06T00:00:00,Demography,N01.224
19674194,2009-08-06T00:00:00,Demography,N06.850.505.400
19674194,2009-08-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19674194,2009-08-06T00:00:00,Juvenile Delinquency,I01.880.735.479
19674194,2009-08-06T00:00:00,Prescription Drugs,D26.670
19674194,2009-08-06T00:00:00,Questionnaires,E05.318.308.750
19674194,2009-08-06T00:00:00,Questionnaires,L01.280.800
19674194,2009-08-06T00:00:00,Questionnaires,N05.715.360.300.695
19674194,2009-08-06T00:00:00,Questionnaires,N06.850.520.308.750
19674194,2009-08-06T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19674194,2009-08-06T00:00:00,Substance-Related Disorders,C21.739
19674194,2009-08-06T00:00:00,Substance-Related Disorders,F03.900
19733441,2009-08-07T00:00:00,Adult,M01.060.116
19733441,2009-08-07T00:00:00,Aged,M01.060.116.100
19733441,2009-08-07T00:00:00,Alcohol-Related Disorders,C21.739.100
19733441,2009-08-07T00:00:00,Alcohol-Related Disorders,F03.900.100
19733441,2009-08-07T00:00:00,Anxiety Disorders,F03.080
19733441,2009-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19733441,2009-08-07T00:00:00,Middle Aged,M01.060.116.630
19733441,2009-08-07T00:00:00,Substance-Related Disorders,C21.739
19733441,2009-08-07T00:00:00,Substance-Related Disorders,F03.900
19733441,2009-08-07T00:00:00,United States,Z01.107.567.875
19733441,2009-08-07T00:00:00,Young Adult,M01.060.116.815
19665944,2009-08-08T00:00:00,Adolescent,M01.060.057
19665944,2009-08-08T00:00:00,Adult,M01.060.116
19665944,2009-08-08T00:00:00,Cystic Fibrosis,C06.689.202
19665944,2009-08-08T00:00:00,Cystic Fibrosis,C08.381.187
19665944,2009-08-08T00:00:00,Cystic Fibrosis,C16.320.190
19665944,2009-08-08T00:00:00,Cystic Fibrosis,C16.614.213
19665944,2009-08-08T00:00:00,Health Surveys,E05.318.308.250
19665944,2009-08-08T00:00:00,Health Surveys,N05.715.360.300.375
19665944,2009-08-08T00:00:00,Health Surveys,N06.850.520.308.250
19665944,2009-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19665944,2009-08-08T00:00:00,Middle Aged,M01.060.116.630
19665944,2009-08-08T00:00:00,Pain,C10.597.617
19665944,2009-08-08T00:00:00,Pain,C23.888.592.612
19665944,2009-08-08T00:00:00,Pain,C23.888.646
19665944,2009-08-08T00:00:00,Pain,F02.830.816.444
19665944,2009-08-08T00:00:00,Pain,G11.561.600.810.444
19665944,2009-08-08T00:00:00,Sleep Disorders,C10.886
19665944,2009-08-08T00:00:00,Sleep Disorders,C23.888.592.796
19665944,2009-08-08T00:00:00,Sleep Disorders,F03.870
19665944,2009-08-08T00:00:00,Young Adult,M01.060.116.815
19673962,2009-08-08T00:00:00,Adolescent,M01.060.057
19673962,2009-08-08T00:00:00,Adult,M01.060.116
19673962,2009-08-08T00:00:00,Age Factors,N05.715.350.075
19673962,2009-08-08T00:00:00,Age Factors,N06.850.490.250
19673962,2009-08-08T00:00:00,Aged,M01.060.116.100
19673962,2009-08-08T00:00:00,Bacteremia,C01.252.100
19673962,2009-08-08T00:00:00,Bacteremia,C01.539.757.100
19673962,2009-08-08T00:00:00,Bacteremia,C23.550.470.790.500.100
19673962,2009-08-08T00:00:00,Diabetes Complications,C19.246.099
19673962,2009-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19673962,2009-08-08T00:00:00,Incidence,E05.318.308.985.525.375
19673962,2009-08-08T00:00:00,Incidence,L01.280.975.525.375
19673962,2009-08-08T00:00:00,Incidence,N01.224.935.597.500
19673962,2009-08-08T00:00:00,Incidence,N06.850.505.400.975.525.375
19673962,2009-08-08T00:00:00,Incidence,N06.850.520.308.985.525.375
19673962,2009-08-08T00:00:00,Middle Aged,M01.060.116.630
19673962,2009-08-08T00:00:00,Young Adult,M01.060.116.815
19720467,2009-08-08T00:00:00,Adult,M01.060.116
19720467,2009-08-08T00:00:00,Anxiety Disorders,F03.080
19720467,2009-08-08T00:00:00,Child,M01.060.406
19720467,2009-08-08T00:00:00,Child Abuse,I01.198.240.856.350.250
19720467,2009-08-08T00:00:00,Child Abuse,I01.880.735.900.350.250
19720467,2009-08-08T00:00:00,Child Abuse,I01.880.787.293.292
19720467,2009-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19720467,2009-08-08T00:00:00,Life Change Events,F01.829.458.410
19720467,2009-08-08T00:00:00,Middle Aged,M01.060.116.630
19720467,2009-08-08T00:00:00,Mood Disorders,F03.600
19720467,2009-08-08T00:00:00,Risk Factors,E05.318.740.600.800.725
19720467,2009-08-08T00:00:00,Risk Factors,N05.715.350.200.700
19720467,2009-08-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19720467,2009-08-08T00:00:00,Risk Factors,N06.850.490.625.750
19720467,2009-08-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19720467,2009-08-08T00:00:00,Substance-Related Disorders,C21.739
19720467,2009-08-08T00:00:00,Substance-Related Disorders,F03.900
19667132,2009-08-10T00:00:00,Animals,B01.050
19667132,2009-08-10T00:00:00,Binding Sites,G02.111.570.120
19667132,2009-08-10T00:00:00,Drug Therapy,E02.319
19667132,2009-08-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19667132,2009-08-10T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
19670144,2009-08-10T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
19670144,2009-08-10T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
19670144,2009-08-10T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
19670144,2009-08-10T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
19670144,2009-08-10T00:00:00,Endosonography,E01.370.350.850.280
19670144,2009-08-10T00:00:00,"Vocabulary, Controlled",L01.453.245.945
19671535,2009-08-10T00:00:00,Adult,M01.060.116
19671535,2009-08-10T00:00:00,Aged,M01.060.116.100
19671535,2009-08-10T00:00:00,Cues,F02.463.425.234
19671535,2009-08-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19671535,2009-08-10T00:00:00,Middle Aged,M01.060.116.630
19671535,2009-08-10T00:00:00,Smoking,F01.145.466.753
19671535,2009-08-10T00:00:00,Smoking Cessation,F01.145.940.700
19671535,2009-08-10T00:00:00,Young Adult,M01.060.116.815
19673742,2009-08-10T00:00:00,Alcohol Deterrents,D27.505.954.427.020
19673742,2009-08-10T00:00:00,Alcohol Drinking,F01.145.317.269
19673742,2009-08-10T00:00:00,Aldehyde Dehydrogenase,D08.811.682.657.163.249
19673742,2009-08-10T00:00:00,Animals,B01.050
19673742,2009-08-10T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19673742,2009-08-10T00:00:00,Cues,F02.463.425.234
19673742,2009-08-10T00:00:00,Dopamine,D02.092.211.215.311.342
19673742,2009-08-10T00:00:00,Dopamine,D02.092.311.342
19673742,2009-08-10T00:00:00,Enzyme Inhibitors,D27.505.519.389
19673742,2009-08-10T00:00:00,Mitochondrial Proteins,D12.776.575
19673742,2009-08-10T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19673742,2009-08-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19673742,2009-08-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19673742,2009-08-10T00:00:00,Self Administration,E02.319.890
19673742,2009-08-10T00:00:00,Self Administration,E02.900.890
19673744,2009-08-10T00:00:00,Animals,B01.050
19673744,2009-08-10T00:00:00,Astrocytes,A08.637.200
19673744,2009-08-10T00:00:00,Astrocytes,A11.650.200
19673744,2009-08-10T00:00:00,Central Nervous System Depressants,D27.505.696.277
19673744,2009-08-10T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
19673744,2009-08-10T00:00:00,Coloring Agents,D27.720.233
19673744,2009-08-10T00:00:00,Coloring Agents,D27.720.470.330
19673744,2009-08-10T00:00:00,Ethanol,D02.033.375
19673744,2009-08-10T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
19673744,2009-08-10T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
19673744,2009-08-10T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
19673744,2009-08-10T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
19673744,2009-08-10T00:00:00,Hippocampus,A08.186.211.464.405
19673744,2009-08-10T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
19673744,2009-08-10T00:00:00,Neurons,A08.663
19673744,2009-08-10T00:00:00,Neurons,A11.671
19673744,2009-08-10T00:00:00,Pregnancy,G08.686.785.760.769
19673744,2009-08-10T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
19673744,2009-08-10T00:00:00,Thiazoles,D02.886.675
19673744,2009-08-10T00:00:00,Thiazoles,D03.383.129.708
19667320,2009-08-11T00:00:00,Aged,M01.060.116.100
19667320,2009-08-11T00:00:00,Cerebrovascular Disorders,C10.228.140.300
19667320,2009-08-11T00:00:00,Cerebrovascular Disorders,C14.907.253
19667320,2009-08-11T00:00:00,Cognition Disorders,F03.087.250
19667320,2009-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19667320,2009-08-11T00:00:00,Neuropsychological Tests,F04.711.513
19671677,2009-08-11T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19671677,2009-08-11T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19671677,2009-08-11T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19671677,2009-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19671677,2009-08-11T00:00:00,Leukemia,C04.557.337
19671677,2009-08-11T00:00:00,Phosphoproteins,D12.776.744
19671677,2009-08-11T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
19671677,2009-08-11T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
19671677,2009-08-11T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
19671677,2009-08-11T00:00:00,RNA Stability,G02.111.780
19671677,2009-08-11T00:00:00,"RNA, Messenger",D13.444.735.544
19671677,2009-08-11T00:00:00,RNA-Binding Proteins,D12.776.157.725
19671677,2009-08-11T00:00:00,RNA-Binding Proteins,D12.776.664.962
19671677,2009-08-11T00:00:00,Recombinant Proteins,D12.776.828
19671684,2009-08-11T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19671684,2009-08-11T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19671684,2009-08-11T00:00:00,Chemokine CXCL13,D12.644.276.374.200.120.650
19671684,2009-08-11T00:00:00,Chemokine CXCL13,D12.776.467.374.200.120.650
19671684,2009-08-11T00:00:00,Chemokine CXCL13,D23.125.300.120.650
19671684,2009-08-11T00:00:00,Chemokine CXCL13,D23.469.200.120.650
19671684,2009-08-11T00:00:00,Chemokine CXCL13,D23.529.374.200.120.650
19671684,2009-08-11T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19671684,2009-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19671684,2009-08-11T00:00:00,Mouth Neoplasms,C04.588.443.591
19671684,2009-08-11T00:00:00,Mouth Neoplasms,C07.465.565
19671684,2009-08-11T00:00:00,Phosphoproteins,D12.776.744
19671684,2009-08-11T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19671684,2009-08-11T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19671684,2009-08-11T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19671684,2009-08-11T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
19671684,2009-08-11T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
19671684,2009-08-11T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
19671684,2009-08-11T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
19671684,2009-08-11T00:00:00,RANK Ligand,D12.644.276.374.750.562
19671684,2009-08-11T00:00:00,RANK Ligand,D12.644.276.972.562
19671684,2009-08-11T00:00:00,RANK Ligand,D12.776.467.374.750.562
19671684,2009-08-11T00:00:00,RANK Ligand,D12.776.467.972.562
19671684,2009-08-11T00:00:00,RANK Ligand,D23.529.374.750.562
19671684,2009-08-11T00:00:00,RANK Ligand,D23.529.972.562
19671684,2009-08-11T00:00:00,Transcription Factors,D12.776.930
19671924,2009-08-11T00:00:00,Acetylglucosamine,D09.067.342.531.050
19671924,2009-08-11T00:00:00,Amino Acid Sequence,G02.111.570.060
19671924,2009-08-11T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19671924,2009-08-11T00:00:00,Animals,B01.050
19671924,2009-08-11T00:00:00,Binding Sites,G02.111.570.120
19671924,2009-08-11T00:00:00,Cell Line,A11.251.210
19671924,2009-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19671924,2009-08-11T00:00:00,Insulin Receptor Substrate Proteins,D12.644.360.024.301
19671924,2009-08-11T00:00:00,Insulin Receptor Substrate Proteins,D12.776.157.057.039
19671924,2009-08-11T00:00:00,Insulin Receptor Substrate Proteins,D12.776.476.024.382
19671924,2009-08-11T00:00:00,Mass Spectrometry,E05.196.566
19671924,2009-08-11T00:00:00,Molecular Sequence Data,L01.453.245.667
19671924,2009-08-11T00:00:00,Phosphorylation,G02.111.087.677
19671924,2009-08-11T00:00:00,Phosphorylation,G02.149.115.677
19671924,2009-08-11T00:00:00,Phosphorylation,G02.149.465.700
19671924,2009-08-11T00:00:00,Phosphorylation,G02.607.750.700
19671924,2009-08-11T00:00:00,Phosphorylation,G03.495.790
19671924,2009-08-11T00:00:00,"Polymorphism, Genetic",G05.365.795
19671924,2009-08-11T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
19671924,2009-08-11T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
19671924,2009-08-11T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
19671924,2009-08-11T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
19671924,2009-08-11T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
19671924,2009-08-11T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
19671924,2009-08-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19671924,2009-08-11T00:00:00,Serine,D12.125.154.800
19671924,2009-08-11T00:00:00,Serine,D12.125.837
19534534,2009-08-13T00:00:00,Animals,B01.050
19534534,2009-08-13T00:00:00,Antineoplastic Agents,D27.505.954.248
19534534,2009-08-13T00:00:00,Breast Neoplasms,C04.588.180
19534534,2009-08-13T00:00:00,Breast Neoplasms,C17.800.090.500
19534534,2009-08-13T00:00:00,DNA,D13.444.308
19534534,2009-08-13T00:00:00,Drug Discovery,E05.295
19534534,2009-08-13T00:00:00,Drug Discovery,H01.158.703.007.675
19534534,2009-08-13T00:00:00,Drug Discovery,H01.181.466.675
19534534,2009-08-13T00:00:00,Eflornithine,D12.125.068.665.340
19534534,2009-08-13T00:00:00,Eflornithine,D12.125.095.765.340
19534534,2009-08-13T00:00:00,Enzyme Inhibitors,D27.505.519.389
19534534,2009-08-13T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
19534534,2009-08-13T00:00:00,Histone Demethylases,D08.811.682.662.582.475
19534534,2009-08-13T00:00:00,Homeostasis,G07.700.360
19534534,2009-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19534534,2009-08-13T00:00:00,Polyamines,D02.092.782
19678934,2009-08-13T00:00:00,Animals,B01.050
19678934,2009-08-13T00:00:00,Blood-Brain Barrier,A07.035
19678934,2009-08-13T00:00:00,Blood-Brain Barrier,A08.186.211.035
19678934,2009-08-13T00:00:00,Brain Infarction,C10.228.140.300.150.477
19678934,2009-08-13T00:00:00,Brain Infarction,C10.228.140.300.775.200
19678934,2009-08-13T00:00:00,Brain Infarction,C14.907.253.092.477
19678934,2009-08-13T00:00:00,Brain Infarction,C14.907.253.855.200
19678934,2009-08-13T00:00:00,Cell Membrane,A11.284.149
19678934,2009-08-13T00:00:00,"Disease Models, Animal",C22.232
19678934,2009-08-13T00:00:00,"Disease Models, Animal",E05.598.500
19678934,2009-08-13T00:00:00,"Disease Models, Animal",E05.599.395.080
19678934,2009-08-13T00:00:00,Enzyme Inhibitors,D27.505.519.389
19678934,2009-08-13T00:00:00,"Fatty Acids, Unsaturated",D10.251.355
19678934,2009-08-13T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
19678934,2009-08-13T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
19678934,2009-08-13T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
19678934,2009-08-13T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
19678934,2009-08-13T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
19678934,2009-08-13T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
19678934,2009-08-13T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19678934,2009-08-13T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19678934,2009-08-13T00:00:00,Oxidative Stress,G03.495.710
19678934,2009-08-13T00:00:00,Oxidative Stress,G07.700.830.750
19678934,2009-08-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19678934,2009-08-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19678934,2009-08-13T00:00:00,Reactive Oxygen Species,D01.339.431
19678934,2009-08-13T00:00:00,Reactive Oxygen Species,D01.650.775
19678934,2009-08-13T00:00:00,Stroke,C10.228.140.300.775
19678934,2009-08-13T00:00:00,Stroke,C14.907.253.855
19678934,2009-08-13T00:00:00,Treatment Outcome,E01.789.800
19678934,2009-08-13T00:00:00,Treatment Outcome,N04.761.559.590.800
19678934,2009-08-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19679844,2009-08-13T00:00:00,Aged,M01.060.116.100
19679844,2009-08-13T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19679844,2009-08-13T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19679844,2009-08-13T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19679844,2009-08-13T00:00:00,Diabetes Complications,C19.246.099
19679844,2009-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19679844,2009-08-13T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
19679844,2009-08-13T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
19679844,2009-08-13T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
19679844,2009-08-13T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
19679844,2009-08-13T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
19679844,2009-08-13T00:00:00,Mass Screening,E01.370.500
19679844,2009-08-13T00:00:00,Mass Screening,E05.318.308.250.580
19679844,2009-08-13T00:00:00,Mass Screening,N02.421.143.827.233.443
19679844,2009-08-13T00:00:00,Mass Screening,N02.421.726.233.443
19679844,2009-08-13T00:00:00,Mass Screening,N05.715.360.300.375.500
19679844,2009-08-13T00:00:00,Mass Screening,N06.850.520.308.250.580
19679844,2009-08-13T00:00:00,Mass Screening,N06.850.780.500
19679844,2009-08-13T00:00:00,Middle Aged,M01.060.116.630
19679844,2009-08-13T00:00:00,Patient Compliance,F01.145.488.500
19679844,2009-08-13T00:00:00,Patient Compliance,N05.300.150.600.600
19679844,2009-08-13T00:00:00,"Physicians, Family",M01.526.485.810.770
19679844,2009-08-13T00:00:00,"Physicians, Family",N02.360.810.770
19679844,2009-08-13T00:00:00,Referral and Consultation,N04.452.758.849
19679844,2009-08-13T00:00:00,Risk Factors,E05.318.740.600.800.725
19679844,2009-08-13T00:00:00,Risk Factors,N05.715.350.200.700
19679844,2009-08-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19679844,2009-08-13T00:00:00,Risk Factors,N06.850.490.625.750
19679844,2009-08-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19679844,2009-08-13T00:00:00,Stroke,C10.228.140.300.775
19679844,2009-08-13T00:00:00,Stroke,C14.907.253.855
19685420,2009-08-14T00:00:00,Adult,M01.060.116
19685420,2009-08-14T00:00:00,Case-Control Studies,E05.318.760.500.500
19685420,2009-08-14T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19685420,2009-08-14T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19685420,2009-08-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19685420,2009-08-14T00:00:00,Oxidative Stress,G03.495.710
19685420,2009-08-14T00:00:00,Oxidative Stress,G07.700.830.750
19685420,2009-08-14T00:00:00,Pre-Eclampsia,C13.703.395.249
19685420,2009-08-14T00:00:00,Pregnancy,G08.686.785.760.769
19685420,2009-08-14T00:00:00,Prenatal Diagnosis,E01.370.378.630
19685420,2009-08-14T00:00:00,Young Adult,M01.060.116.815
19526592,2009-08-15T00:00:00,Algorithms,G17.035
19526592,2009-08-15T00:00:00,Algorithms,L01.224.050
19526592,2009-08-15T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19526592,2009-08-15T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19526592,2009-08-15T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19526592,2009-08-15T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19526592,2009-08-15T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19526592,2009-08-15T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19526592,2009-08-15T00:00:00,Drug Delivery Systems,E02.319.300
19526592,2009-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19526592,2009-08-15T00:00:00,Mutation,G05.365.590
19526592,2009-08-15T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
19526592,2009-08-15T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
19526592,2009-08-15T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
19526592,2009-08-15T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
19526592,2009-08-15T00:00:00,Signal Transduction,G02.111.087.800
19526592,2009-08-15T00:00:00,Signal Transduction,G02.149.115.800
19526592,2009-08-15T00:00:00,Signal Transduction,G04.299.880
19526592,2009-08-15T00:00:00,Treatment Outcome,E01.789.800
19526592,2009-08-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19526592,2009-08-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19683850,2009-08-15T00:00:00,Animals,B01.050
19683850,2009-08-15T00:00:00,Cell Differentiation,G04.299.151
19683850,2009-08-15T00:00:00,Gene Expression Regulation,G05.355.315
19683850,2009-08-15T00:00:00,Hair,A17.360
19683850,2009-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19683850,2009-08-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19683850,2009-08-15T00:00:00,Signal Transduction,G02.111.087.800
19683850,2009-08-15T00:00:00,Signal Transduction,G02.149.115.800
19683850,2009-08-15T00:00:00,Signal Transduction,G04.299.880
19683850,2009-08-15T00:00:00,Transcription Factors,D12.776.930
19683850,2009-08-15T00:00:00,"Transcription, Genetic",G02.111.087.847
19683850,2009-08-15T00:00:00,"Transcription, Genetic",G02.149.115.847
19683850,2009-08-15T00:00:00,"Transcription, Genetic",G05.355.310.700
19687094,2009-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19687094,2009-08-17T00:00:00,Incidence,E05.318.308.985.525.375
19687094,2009-08-17T00:00:00,Incidence,L01.280.975.525.375
19687094,2009-08-17T00:00:00,Incidence,N01.224.935.597.500
19687094,2009-08-17T00:00:00,Incidence,N06.850.505.400.975.525.375
19687094,2009-08-17T00:00:00,Incidence,N06.850.520.308.985.525.375
19687094,2009-08-17T00:00:00,Lung Neoplasms,C04.588.894.797.520
19687094,2009-08-17T00:00:00,Lung Neoplasms,C08.381.540
19687094,2009-08-17T00:00:00,Lung Neoplasms,C08.785.520
19687094,2009-08-17T00:00:00,Mass Screening,E01.370.500
19687094,2009-08-17T00:00:00,Mass Screening,E05.318.308.250.580
19687094,2009-08-17T00:00:00,Mass Screening,N02.421.143.827.233.443
19687094,2009-08-17T00:00:00,Mass Screening,N02.421.726.233.443
19687094,2009-08-17T00:00:00,Mass Screening,N05.715.360.300.375.500
19687094,2009-08-17T00:00:00,Mass Screening,N06.850.520.308.250.580
19687094,2009-08-17T00:00:00,Mass Screening,N06.850.780.500
19687094,2009-08-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19687094,2009-08-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19687094,2009-08-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19687094,2009-08-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19687094,2009-08-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19687294,2009-08-17T00:00:00,Adult,M01.060.116
19687294,2009-08-17T00:00:00,Aged,M01.060.116.100
19687294,2009-08-17T00:00:00,Brain,A08.186.211
19687294,2009-08-17T00:00:00,Brain Mapping,E01.370.350.086
19687294,2009-08-17T00:00:00,Brain Mapping,E01.370.376.149
19687294,2009-08-17T00:00:00,Brain Mapping,E05.132
19687294,2009-08-17T00:00:00,Functional Laterality,F02.830.297.425
19687294,2009-08-17T00:00:00,Functional Laterality,G11.561.225.425
19687294,2009-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19687294,2009-08-17T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19687294,2009-08-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19687294,2009-08-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19687294,2009-08-17T00:00:00,Middle Aged,M01.060.116.630
19687294,2009-08-17T00:00:00,Neuropsychological Tests,F04.711.513
19687294,2009-08-17T00:00:00,Oxygen,D01.268.185.550
19687294,2009-08-17T00:00:00,Oxygen,D01.362.670
19687294,2009-08-17T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
19687294,2009-08-17T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
19687294,2009-08-17T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
19687294,2009-08-17T00:00:00,Photic Stimulation,E05.723.729
19687294,2009-08-17T00:00:00,Regression Analysis,E05.318.740.750
19687294,2009-08-17T00:00:00,Regression Analysis,N05.715.360.750.695
19687294,2009-08-17T00:00:00,Regression Analysis,N06.850.520.830.750
19610641,2009-08-18T00:00:00,Adsorption,G02.149.047
19610641,2009-08-18T00:00:00,Adsorption,G02.149.767.029
19610641,2009-08-18T00:00:00,Adsorption,G02.842.750.029
19610641,2009-08-18T00:00:00,Mass Spectrometry,E05.196.566
19610641,2009-08-18T00:00:00,"Models, Molecular",E05.599.595
19610641,2009-08-18T00:00:00,Muramidase,D08.811.277.450.642
19610641,2009-08-18T00:00:00,Protein Conformation,G02.111.570.790.709
19610641,2009-08-18T00:00:00,Surface Properties,G02.842.850
19688587,2009-08-18T00:00:00,"Adaptation, Psychological",F01.058
19688587,2009-08-18T00:00:00,Adolescent,M01.060.057
19688587,2009-08-18T00:00:00,African Americans,M01.686.508.100.100
19688587,2009-08-18T00:00:00,African Americans,M01.686.754.100
19688587,2009-08-18T00:00:00,Antisocial Personality Disorder,F03.675.050
19688587,2009-08-18T00:00:00,Attention Deficit and Disruptive Behavior Disorders,F03.550.150
19688587,2009-08-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19688587,2009-08-18T00:00:00,Interpersonal Relations,F01.829.401
19688587,2009-08-18T00:00:00,Life Change Events,F01.829.458.410
19688587,2009-08-18T00:00:00,Social Environment,I01.880.656
19688587,2009-08-18T00:00:00,United States,Z01.107.567.875
19688587,2009-08-18T00:00:00,Urban Population,N01.600.900
19688587,2009-08-18T00:00:00,Young Adult,M01.060.116.815
19690195,2009-08-18T00:00:00,Aged,M01.060.116.100
19690195,2009-08-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19690195,2009-08-18T00:00:00,Middle Aged,M01.060.116.630
19690195,2009-08-18T00:00:00,Peptide Fragments,D12.644.541
19690195,2009-08-18T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19690195,2009-08-18T00:00:00,Prostatic Neoplasms,C12.294.260.750
19690195,2009-08-18T00:00:00,Prostatic Neoplasms,C12.294.565.625
19690195,2009-08-18T00:00:00,Prostatic Neoplasms,C12.758.409.750
19690195,2009-08-18T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19690195,2009-08-18T00:00:00,"Tumor Markers, Biological",D23.101.840
19690551,2009-08-18T00:00:00,Adult,M01.060.116
19690551,2009-08-18T00:00:00,Aged,M01.060.116.100
19690551,2009-08-18T00:00:00,Body Mass Index,E01.370.600.115.100.125
19690551,2009-08-18T00:00:00,Body Mass Index,E05.041.124.125
19690551,2009-08-18T00:00:00,Body Mass Index,G07.100.100.125
19690551,2009-08-18T00:00:00,Body Mass Index,N06.850.505.200.100.175
19690551,2009-08-18T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19690551,2009-08-18T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19690551,2009-08-18T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19690551,2009-08-18T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19690551,2009-08-18T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19690551,2009-08-18T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19690551,2009-08-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19690551,2009-08-18T00:00:00,Middle Aged,M01.060.116.630
19690551,2009-08-18T00:00:00,Vitamin D,D04.808.812.768
19695221,2009-08-18T00:00:00,Apoptosis,G04.299.139.160
19695221,2009-08-18T00:00:00,Cell Survival,G04.299.316
19695221,2009-08-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19695221,2009-08-18T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
19695221,2009-08-18T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
19695221,2009-08-18T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
19695221,2009-08-18T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
19695221,2009-08-18T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
19695221,2009-08-18T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
19695221,2009-08-18T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
19695221,2009-08-18T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
19695221,2009-08-18T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
19695221,2009-08-18T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
19695221,2009-08-18T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19695221,2009-08-18T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19695221,2009-08-18T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20031172,2009-08-18T00:00:00,Apoptosis,G04.299.139.160
20031172,2009-08-18T00:00:00,Breast Neoplasms,C04.588.180
20031172,2009-08-18T00:00:00,Breast Neoplasms,C17.800.090.500
20031172,2009-08-18T00:00:00,Caspases,D08.811.277.656.262.500.126
20031172,2009-08-18T00:00:00,Caspases,D08.811.277.656.300.200.126
20031172,2009-08-18T00:00:00,Caspases,D12.644.360.075.405
20031172,2009-08-18T00:00:00,Caspases,D12.776.476.075.405
20031172,2009-08-18T00:00:00,Cell Cycle,G04.299.134
20031172,2009-08-18T00:00:00,Cell Division,G04.299.134.220
20031172,2009-08-18T00:00:00,Cell Division,G04.299.233.750.500
20031172,2009-08-18T00:00:00,Cell Division,G05.355.105
20031172,2009-08-18T00:00:00,Cell Division,G07.700.320.249.410.750.500
20031172,2009-08-18T00:00:00,Cell Survival,G04.299.316
20031172,2009-08-18T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20031172,2009-08-18T00:00:00,Flow Cytometry,E05.200.500.386.350
20031172,2009-08-18T00:00:00,Fruit,A18.024.500
20031172,2009-08-18T00:00:00,Fruit,J02.500.562
20031172,2009-08-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20031172,2009-08-18T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20031172,2009-08-18T00:00:00,Mitochondria,A11.284.835.626
20031172,2009-08-18T00:00:00,Plant Extracts,D20.215.784.500
20031172,2009-08-18T00:00:00,Plant Extracts,D26.667
20031172,2009-08-18T00:00:00,Stilbenes,D02.455.426.559.389.150.700
20031172,2009-08-18T00:00:00,Superoxides,D01.248.497.158.685.750.850
20031172,2009-08-18T00:00:00,Superoxides,D01.339.431.374.850
20031172,2009-08-18T00:00:00,Superoxides,D01.339.431.750
20031172,2009-08-18T00:00:00,Superoxides,D01.650.550.750.800
19692028,2009-08-19T00:00:00,Bladder Exstrophy,C12.706.132
19692028,2009-08-19T00:00:00,Bladder Exstrophy,C12.777.829.132
19692028,2009-08-19T00:00:00,Bladder Exstrophy,C13.351.875.132
19692028,2009-08-19T00:00:00,Bladder Exstrophy,C13.351.968.829.132
19692028,2009-08-19T00:00:00,Bladder Exstrophy,C16.131.939.132
19692028,2009-08-19T00:00:00,"Child, Preschool",M01.060.406.448
19692028,2009-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19692028,2009-08-19T00:00:00,Infant,M01.060.703
19692028,2009-08-19T00:00:00,Urinary Bladder,A05.810.890
19692028,2009-08-19T00:00:00,Urinary Incontinence,C12.777.934.852
19692028,2009-08-19T00:00:00,Urinary Incontinence,C13.351.968.934.814
19692028,2009-08-19T00:00:00,Urinary Incontinence,C23.888.942.800
19692028,2009-08-19T00:00:00,Urologic Surgical Procedures,E04.950.774
19694798,2009-08-19T00:00:00,Adolescent,M01.060.057
19694798,2009-08-19T00:00:00,Child,M01.060.406
19694798,2009-08-19T00:00:00,"Child, Preschool",M01.060.406.448
19694798,2009-08-19T00:00:00,Developing Countries,I01.615.500.300
19694798,2009-08-19T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19694798,2009-08-19T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19694798,2009-08-19T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19694798,2009-08-19T00:00:00,Health Services Accessibility,N04.590.374.350
19694798,2009-08-19T00:00:00,Health Services Accessibility,N05.300.430
19694798,2009-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19694798,2009-08-19T00:00:00,Infant,M01.060.703
19694798,2009-08-19T00:00:00,Population Surveillance,E05.318.308.250.700
19694798,2009-08-19T00:00:00,Population Surveillance,N05.715.360.300.375.625
19694798,2009-08-19T00:00:00,Population Surveillance,N06.850.520.308.250.700
19694798,2009-08-19T00:00:00,Population Surveillance,N06.850.780.675
19694798,2009-08-19T00:00:00,Risk Factors,E05.318.740.600.800.725
19694798,2009-08-19T00:00:00,Risk Factors,N05.715.350.200.700
19694798,2009-08-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19694798,2009-08-19T00:00:00,Risk Factors,N06.850.490.625.750
19694798,2009-08-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19694798,2009-08-19T00:00:00,Rural Population,N01.600.725
19694798,2009-08-19T00:00:00,Seizures,C10.228.140.490.631
19694798,2009-08-19T00:00:00,Seizures,C10.597.742
19694798,2009-08-19T00:00:00,Seizures,C23.888.592.742
19694798,2009-08-19T00:00:00,Sex Factors,N05.715.350.675
19694798,2009-08-19T00:00:00,Sex Factors,N06.850.490.875
19694798,2009-08-19T00:00:00,Status Epilepticus,C10.228.140.490.690
19698705,2009-08-19T00:00:00,Artifacts,E05.047
19698705,2009-08-19T00:00:00,Blood Chemical Analysis,E01.450.150.100
19698705,2009-08-19T00:00:00,Diabetes Complications,C19.246.099
19698705,2009-08-19T00:00:00,Diabetes Mellitus,C18.452.394.750
19698705,2009-08-19T00:00:00,Diabetes Mellitus,C19.246
19698705,2009-08-19T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
19698705,2009-08-19T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
19698705,2009-08-19T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
19698705,2009-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19693531,2009-08-20T00:00:00,Adult,M01.060.116
19693531,2009-08-20T00:00:00,Aged,M01.060.116.100
19693531,2009-08-20T00:00:00,Calcium-Binding Proteins,D12.776.157.125
19693531,2009-08-20T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19693531,2009-08-20T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19693531,2009-08-20T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19693531,2009-08-20T00:00:00,Fibrinogen,D12.776.124.050.250
19693531,2009-08-20T00:00:00,Fibrinogen,D12.776.124.125.500
19693531,2009-08-20T00:00:00,Fibrinogen,D12.776.811.300
19693531,2009-08-20T00:00:00,Fibrinogen,D23.119.490
19693531,2009-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19693531,2009-08-20T00:00:00,Middle Aged,M01.060.116.630
19695613,2009-08-20T00:00:00,Adolescent,M01.060.057
19695613,2009-08-20T00:00:00,Child,M01.060.406
19695613,2009-08-20T00:00:00,"Child, Preschool",M01.060.406.448
19695613,2009-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19695613,2009-08-20T00:00:00,Infant,M01.060.703
19695613,2009-08-20T00:00:00,Remission Induction,E02.860
19696417,2009-08-20T00:00:00,Aged,M01.060.116.100
19696417,2009-08-20T00:00:00,Biological Markers,D23.101
19696417,2009-08-20T00:00:00,Cerebrovascular Disorders,C10.228.140.300
19696417,2009-08-20T00:00:00,Cerebrovascular Disorders,C14.907.253
19696417,2009-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19696417,2009-08-20T00:00:00,Risk Factors,E05.318.740.600.800.725
19696417,2009-08-20T00:00:00,Risk Factors,N05.715.350.200.700
19696417,2009-08-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19696417,2009-08-20T00:00:00,Risk Factors,N06.850.490.625.750
19696417,2009-08-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19699593,2009-08-21T00:00:00,Adult,M01.060.116
19699593,2009-08-21T00:00:00,Anti-Anxiety Agents,D27.505.696.277.950.015
19699593,2009-08-21T00:00:00,Anti-Anxiety Agents,D27.505.954.427.210.950.015
19699593,2009-08-21T00:00:00,Anti-Anxiety Agents,D27.505.954.427.700.872.015
19699593,2009-08-21T00:00:00,Anxiety,F01.470.132
19699593,2009-08-21T00:00:00,Cannabinoids,D02.455.849.090
19699593,2009-08-21T00:00:00,Double-Blind Method,E05.318.780.300
19699593,2009-08-21T00:00:00,Double-Blind Method,E05.581.500.300
19699593,2009-08-21T00:00:00,Double-Blind Method,N05.715.360.780.320
19699593,2009-08-21T00:00:00,Double-Blind Method,N06.850.520.445.300
19699593,2009-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19699593,2009-08-21T00:00:00,Marijuana Abuse,C21.739.635
19699593,2009-08-21T00:00:00,Marijuana Abuse,F03.900.635
19699593,2009-08-21T00:00:00,Motivation,F01.658
19699593,2009-08-21T00:00:00,Motivation,F01.752.543.500.750
19699593,2009-08-21T00:00:00,Psychiatric Status Rating Scales,F04.586
19699593,2009-08-21T00:00:00,Questionnaires,E05.318.308.750
19699593,2009-08-21T00:00:00,Questionnaires,L01.280.800
19699593,2009-08-21T00:00:00,Questionnaires,N05.715.360.300.695
19699593,2009-08-21T00:00:00,Questionnaires,N06.850.520.308.750
19699593,2009-08-21T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19699593,2009-08-21T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19699593,2009-08-21T00:00:00,Treatment Outcome,E01.789.800
19699593,2009-08-21T00:00:00,Treatment Outcome,N04.761.559.590.800
19699593,2009-08-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19699601,2009-08-21T00:00:00,Adolescent,M01.060.057
19699601,2009-08-21T00:00:00,Adult,M01.060.116
19699601,2009-08-21T00:00:00,Aged,M01.060.116.100
19699601,2009-08-21T00:00:00,Blood Glucose,D09.546.359.448.500
19699601,2009-08-21T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19699601,2009-08-21T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19699601,2009-08-21T00:00:00,Health Behavior,F01.145.488
19699601,2009-08-21T00:00:00,Health Education,I02.233.332
19699601,2009-08-21T00:00:00,Health Education,N02.421.143.827.407
19699601,2009-08-21T00:00:00,Health Education,N02.421.726.407
19699601,2009-08-21T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19699601,2009-08-21T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19699601,2009-08-21T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
19699601,2009-08-21T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
19699601,2009-08-21T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
19699601,2009-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19699601,2009-08-21T00:00:00,Middle Aged,M01.060.116.630
19699601,2009-08-21T00:00:00,"Models, Educational",E05.599.545
19699601,2009-08-21T00:00:00,"Models, Educational",I02.903.302
19699601,2009-08-21T00:00:00,"Models, Psychological",E05.599.695
19699601,2009-08-21T00:00:00,Motivation,F01.658
19699601,2009-08-21T00:00:00,Motivation,F01.752.543.500.750
19699601,2009-08-21T00:00:00,Patient Education as Topic,I02.233.332.500
19699601,2009-08-21T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19699601,2009-08-21T00:00:00,Patient Education as Topic,N02.421.726.407.680
19699601,2009-08-21T00:00:00,Qualitative Research,H01.770.644.241.850
19699601,2009-08-21T00:00:00,Questionnaires,E05.318.308.750
19699601,2009-08-21T00:00:00,Questionnaires,L01.280.800
19699601,2009-08-21T00:00:00,Questionnaires,N05.715.360.300.695
19699601,2009-08-21T00:00:00,Questionnaires,N06.850.520.308.750
19699601,2009-08-21T00:00:00,Self Care,E02.900
19699601,2009-08-21T00:00:00,Self Care,N02.421.784.680
19699601,2009-08-21T00:00:00,Social Support,I01.880.656.600
19699601,2009-08-21T00:00:00,United States,Z01.107.567.875
19699601,2009-08-21T00:00:00,Young Adult,M01.060.116.815
19700408,2009-08-21T00:00:00,Animals,B01.050
19700408,2009-08-21T00:00:00,"Immunity, Innate",G12.450.575
19700408,2009-08-21T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
19700408,2009-08-21T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
19700408,2009-08-21T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
19700408,2009-08-21T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19700408,2009-08-21T00:00:00,"Microscopy, Confocal",E05.595.395
19700408,2009-08-21T00:00:00,Protein Isoforms,D12.776.800
19700408,2009-08-21T00:00:00,Signal Transduction,G02.111.087.800
19700408,2009-08-21T00:00:00,Signal Transduction,G02.149.115.800
19700408,2009-08-21T00:00:00,Signal Transduction,G04.299.880
19713698,2009-08-22T00:00:00,Aged,M01.060.116.100
19713698,2009-08-22T00:00:00,Biological Markers,D23.101
19713698,2009-08-22T00:00:00,Brain Ischemia,C10.228.140.300.150
19713698,2009-08-22T00:00:00,Brain Ischemia,C14.907.253.092
19713698,2009-08-22T00:00:00,Cholesterol,D04.808.247.222.284
19713698,2009-08-22T00:00:00,Cholesterol,D04.808.247.808.197
19713698,2009-08-22T00:00:00,Cholesterol,D10.570.938.208
19713698,2009-08-22T00:00:00,Cholesterol,D10.851.208
19713698,2009-08-22T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19713698,2009-08-22T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19713698,2009-08-22T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19713698,2009-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19713698,2009-08-22T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
19713698,2009-08-22T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
19713698,2009-08-22T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
19713698,2009-08-22T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19713698,2009-08-22T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
19713698,2009-08-22T00:00:00,Intracranial Hemorrhages,C14.907.253.573
19713698,2009-08-22T00:00:00,Intracranial Hemorrhages,C23.550.414.913
19713698,2009-08-22T00:00:00,Middle Aged,M01.060.116.630
19713698,2009-08-22T00:00:00,Recovery of Function,G16.757
19713698,2009-08-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
19713698,2009-08-22T00:00:00,Risk Assessment,N04.452.871.715
19713698,2009-08-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19713698,2009-08-22T00:00:00,Risk Assessment,N06.850.505.715
19713698,2009-08-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19713698,2009-08-22T00:00:00,Risk Factors,E05.318.740.600.800.725
19713698,2009-08-22T00:00:00,Risk Factors,N05.715.350.200.700
19713698,2009-08-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19713698,2009-08-22T00:00:00,Risk Factors,N06.850.490.625.750
19713698,2009-08-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19713698,2009-08-22T00:00:00,Stroke,C10.228.140.300.775
19713698,2009-08-22T00:00:00,Stroke,C14.907.253.855
19713698,2009-08-22T00:00:00,Thrombolytic Therapy,E02.319.913
19713698,2009-08-22T00:00:00,Time Factors,G01.910.857
19713698,2009-08-22T00:00:00,Treatment Outcome,E01.789.800
19713698,2009-08-22T00:00:00,Treatment Outcome,N04.761.559.590.800
19713698,2009-08-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19703321,2009-08-25T00:00:00,Adolescent,M01.060.057
19703321,2009-08-25T00:00:00,Attention,F02.830.104.214
19703321,2009-08-25T00:00:00,Child,M01.060.406
19703321,2009-08-25T00:00:00,Child Abuse,I01.198.240.856.350.250
19703321,2009-08-25T00:00:00,Child Abuse,I01.880.735.900.350.250
19703321,2009-08-25T00:00:00,Child Abuse,I01.880.787.293.292
19703321,2009-08-25T00:00:00,"Child, Preschool",M01.060.406.448
19703321,2009-08-25T00:00:00,Cognition Disorders,F03.087.250
19703321,2009-08-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19703321,2009-08-25T00:00:00,Intelligence Tests,F04.711.141.493
19703321,2009-08-25T00:00:00,Language,F01.145.209.399
19703321,2009-08-25T00:00:00,Language,L01.143.506
19703321,2009-08-25T00:00:00,Learning,F02.463.425
19703321,2009-08-25T00:00:00,Learning,F02.784.629.529
19703321,2009-08-25T00:00:00,Neuropsychological Tests,F04.711.513
19703321,2009-08-25T00:00:00,Pediatrics,H02.403.670
19703321,2009-08-25T00:00:00,Psychiatric Status Rating Scales,F04.586
19703321,2009-08-25T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19703321,2009-08-25T00:00:00,Visual Perception,F02.463.593.932
19705187,2009-08-25T00:00:00,Adolescent,M01.060.057
19705187,2009-08-25T00:00:00,Adult,M01.060.116
19705187,2009-08-25T00:00:00,Cardiology,H02.403.429.163
19705187,2009-08-25T00:00:00,Chromosome Aberrations,C23.550.210
19705187,2009-08-25T00:00:00,Chromosome Aberrations,G05.365.590.175
19705187,2009-08-25T00:00:00,Decision Making,F02.463.785.373
19705187,2009-08-25T00:00:00,Echocardiography,E01.370.350.850.220
19705187,2009-08-25T00:00:00,Echocardiography,E01.370.370.380.220
19705187,2009-08-25T00:00:00,"Heart Defects, Congenital",C14.240.400
19705187,2009-08-25T00:00:00,"Heart Defects, Congenital",C14.280.400
19705187,2009-08-25T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19705187,2009-08-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19705187,2009-08-25T00:00:00,"Infant, Newborn",M01.060.703.520
19705187,2009-08-25T00:00:00,Parents,F01.829.263.500.320
19705187,2009-08-25T00:00:00,Parents,I01.880.225.500.340
19705187,2009-08-25T00:00:00,Parents,M01.620
19705187,2009-08-25T00:00:00,Pregnancy,G08.686.785.760.769
19705187,2009-08-25T00:00:00,Risk Factors,E05.318.740.600.800.725
19705187,2009-08-25T00:00:00,Risk Factors,N05.715.350.200.700
19705187,2009-08-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19705187,2009-08-25T00:00:00,Risk Factors,N06.850.490.625.750
19705187,2009-08-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19705187,2009-08-25T00:00:00,"Ultrasonography, Prenatal",E01.370.350.850.865
19705187,2009-08-25T00:00:00,"Ultrasonography, Prenatal",E01.370.378.630.865
19705187,2009-08-25T00:00:00,Young Adult,M01.060.116.815
20207269,2009-08-25T00:00:00,"Adaptation, Psychological",F01.058
20207269,2009-08-25T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20207269,2009-08-25T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20207269,2009-08-25T00:00:00,"Defibrillators, Implantable",E07.695.175
20207269,2009-08-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20207269,2009-08-25T00:00:00,Internet,L01.224.230.110.500
20207269,2009-08-25T00:00:00,Middle Aged,M01.060.116.630
20207269,2009-08-25T00:00:00,Patient Satisfaction,N04.452.822.360.600
20207269,2009-08-25T00:00:00,Patient Satisfaction,N05.300.150.600.630
20207269,2009-08-25T00:00:00,Patient Satisfaction,N05.715.360.600
20207269,2009-08-25T00:00:00,Pilot Projects,E05.318.760.750
20207269,2009-08-25T00:00:00,Pilot Projects,E05.337.737
20207269,2009-08-25T00:00:00,Pilot Projects,N05.715.360.775.625
20207269,2009-08-25T00:00:00,Pilot Projects,N06.850.520.450.720
20207269,2009-08-25T00:00:00,Self-Help Groups,N03.540.782
20207269,2009-08-25T00:00:00,User-Computer Interface,L01.224.900.910
19710500,2009-08-26T00:00:00,Adult,M01.060.116
19710500,2009-08-26T00:00:00,Aged,M01.060.116.100
19710500,2009-08-26T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
19710500,2009-08-26T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
19710500,2009-08-26T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
19710500,2009-08-26T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19710500,2009-08-26T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19710500,2009-08-26T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19710500,2009-08-26T00:00:00,Double-Blind Method,E05.318.780.300
19710500,2009-08-26T00:00:00,Double-Blind Method,E05.581.500.300
19710500,2009-08-26T00:00:00,Double-Blind Method,N05.715.360.780.320
19710500,2009-08-26T00:00:00,Double-Blind Method,N06.850.520.445.300
19710500,2009-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19710500,2009-08-26T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19710500,2009-08-26T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
19710500,2009-08-26T00:00:00,Middle Aged,M01.060.116.630
19710500,2009-08-26T00:00:00,Remission Induction,E02.860
19710500,2009-08-26T00:00:00,Young Adult,M01.060.116.815
19715609,2009-08-28T00:00:00,Antineoplastic Agents,D27.505.954.248
19715609,2009-08-28T00:00:00,Apoptosis,G04.299.139.160
19715609,2009-08-28T00:00:00,Caspases,D08.811.277.656.262.500.126
19715609,2009-08-28T00:00:00,Caspases,D08.811.277.656.300.200.126
19715609,2009-08-28T00:00:00,Caspases,D12.644.360.075.405
19715609,2009-08-28T00:00:00,Caspases,D12.776.476.075.405
19715609,2009-08-28T00:00:00,Cathepsin B,D08.811.277.656.224.125
19715609,2009-08-28T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
19715609,2009-08-28T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
19715609,2009-08-28T00:00:00,Cell Cycle,G04.299.134
19715609,2009-08-28T00:00:00,Cell Survival,G04.299.316
19715609,2009-08-28T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19715609,2009-08-28T00:00:00,Flow Cytometry,E05.200.500.386.350
19715609,2009-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19715609,2009-08-28T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
19715609,2009-08-28T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
19715609,2009-08-28T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
19715609,2009-08-28T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
19715609,2009-08-28T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19715609,2009-08-28T00:00:00,Prostatic Neoplasms,C12.294.260.750
19715609,2009-08-28T00:00:00,Prostatic Neoplasms,C12.294.565.625
19715609,2009-08-28T00:00:00,Prostatic Neoplasms,C12.758.409.750
19715609,2009-08-28T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
19715609,2009-08-28T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
19715609,2009-08-28T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
19715609,2009-08-28T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
19715609,2009-08-28T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
19715609,2009-08-28T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
19715609,2009-08-28T00:00:00,Time Factors,G01.910.857
19777094,2009-08-28T00:00:00,Curriculum,I02.158
19777094,2009-08-28T00:00:00,"Education, Pharmacy",I02.358.525
19777094,2009-08-28T00:00:00,Faculty,I02.463
19777094,2009-08-28T00:00:00,Faculty,M01.526.339
19777094,2009-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19777094,2009-08-28T00:00:00,Peer Group,F01.829.316.483
19777094,2009-08-28T00:00:00,Peer Review,F01.829.316.549
19777094,2009-08-28T00:00:00,Peer Review,I01.880.604.640
19777094,2009-08-28T00:00:00,Peer Review,N03.706.700
19777094,2009-08-28T00:00:00,Perception,F02.463.593
19777094,2009-08-28T00:00:00,Professional Competence,I02.399.630
19777094,2009-08-28T00:00:00,Program Development,N04.452.760
19777094,2009-08-28T00:00:00,Program Evaluation,E05.337.820
19777094,2009-08-28T00:00:00,Program Evaluation,N04.761.685
19777094,2009-08-28T00:00:00,Program Evaluation,N05.715.360.650
19777094,2009-08-28T00:00:00,Questionnaires,E05.318.308.750
19777094,2009-08-28T00:00:00,Questionnaires,L01.280.800
19777094,2009-08-28T00:00:00,Questionnaires,N05.715.360.300.695
19777094,2009-08-28T00:00:00,Questionnaires,N06.850.520.308.750
19777094,2009-08-28T00:00:00,Teaching,I02.903
19717245,2009-08-29T00:00:00,Adolescent,M01.060.057
19717245,2009-08-29T00:00:00,Adult,M01.060.116
19717245,2009-08-29T00:00:00,Age Factors,N05.715.350.075
19717245,2009-08-29T00:00:00,Age Factors,N06.850.490.250
19717245,2009-08-29T00:00:00,Amphetamine-Related Disorders,C21.739.225
19717245,2009-08-29T00:00:00,Amphetamine-Related Disorders,F03.900.225
19717245,2009-08-29T00:00:00,Bayes Theorem,E05.318.740.600.200
19717245,2009-08-29T00:00:00,Bayes Theorem,N05.715.360.750.625.150
19717245,2009-08-29T00:00:00,Bayes Theorem,N06.850.520.830.600.200
19717245,2009-08-29T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19717245,2009-08-29T00:00:00,Cocaine-Related Disorders,C21.739.300
19717245,2009-08-29T00:00:00,Cocaine-Related Disorders,F03.900.300
19717245,2009-08-29T00:00:00,Cues,F02.463.425.234
19717245,2009-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19717245,2009-08-29T00:00:00,Markov Chains,E05.318.740.600.500
19717245,2009-08-29T00:00:00,Markov Chains,E05.318.740.996.500
19717245,2009-08-29T00:00:00,Markov Chains,G17.830.500
19717245,2009-08-29T00:00:00,Markov Chains,N05.715.360.750.625.500
19717245,2009-08-29T00:00:00,Markov Chains,N05.715.360.750.770.500
19717245,2009-08-29T00:00:00,Markov Chains,N06.850.520.830.600.500
19717245,2009-08-29T00:00:00,Markov Chains,N06.850.520.830.996.500
19717245,2009-08-29T00:00:00,Middle Aged,M01.060.116.630
19717245,2009-08-29T00:00:00,Sex Factors,N05.715.350.675
19717245,2009-08-29T00:00:00,Sex Factors,N06.850.490.875
19717245,2009-08-29T00:00:00,"Stress, Physiological",G07.700.830
19727732,2009-08-30T00:00:00,Animals,B01.050
19727732,2009-08-30T00:00:00,Antineoplastic Agents,D27.505.954.248
19727732,2009-08-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19727732,2009-08-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19727732,2009-08-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19727732,2009-08-30T00:00:00,Breast Neoplasms,C04.588.180
19727732,2009-08-30T00:00:00,Breast Neoplasms,C17.800.090.500
19727732,2009-08-30T00:00:00,Cell Line,A11.251.210
19727732,2009-08-30T00:00:00,Cell Proliferation,G04.299.233.750
19727732,2009-08-30T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19727732,2009-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19727732,2009-08-30T00:00:00,Molecular Structure,G02.111.570
19727732,2009-08-30T00:00:00,Molecular Structure,G02.575
19727732,2009-08-30T00:00:00,Molecular Structure,G02.842.575
19727732,2009-08-30T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
19727732,2009-08-30T00:00:00,RNA Interference,G05.355.315.203.374.790
19727732,2009-08-30T00:00:00,Spermine,D02.092.211.415.701.801.821
19727732,2009-08-30T00:00:00,Spermine,D02.092.782.802
19720873,2009-08-31T00:00:00,Animals,B01.050
19720873,2009-08-31T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
19720873,2009-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19720873,2009-08-31T00:00:00,Major Histocompatibility Complex,G05.360.340.024.340.610
19720873,2009-08-31T00:00:00,Major Histocompatibility Complex,G05.360.340.024.380.500
19720873,2009-08-31T00:00:00,Major Histocompatibility Complex,G12.500.500
19720873,2009-08-31T00:00:00,Mutation,G05.365.590
19720873,2009-08-31T00:00:00,RNA Interference,G05.355.315.203.374.790
19720873,2009-08-31T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19720873,2009-08-31T00:00:00,Viral Envelope Proteins,D12.776.964.970.880
19720951,2009-08-31T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19720951,2009-08-31T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
19720951,2009-08-31T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
19720951,2009-08-31T00:00:00,Cardiovascular Diseases,C14
19720951,2009-08-31T00:00:00,Disease Progression,C23.550.291.656
19720951,2009-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19720951,2009-08-31T00:00:00,Hypertension,C14.907.489
19720951,2009-08-31T00:00:00,Incidence,E05.318.308.985.525.375
19720951,2009-08-31T00:00:00,Incidence,L01.280.975.525.375
19720951,2009-08-31T00:00:00,Incidence,N01.224.935.597.500
19720951,2009-08-31T00:00:00,Incidence,N06.850.505.400.975.525.375
19720951,2009-08-31T00:00:00,Incidence,N06.850.520.308.985.525.375
19720951,2009-08-31T00:00:00,Risk Assessment,E05.318.740.600.800.715
19720951,2009-08-31T00:00:00,Risk Assessment,N04.452.871.715
19720951,2009-08-31T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19720951,2009-08-31T00:00:00,Risk Assessment,N06.850.505.715
19720951,2009-08-31T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19721013,2009-08-31T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
19721013,2009-08-31T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
19721013,2009-08-31T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
19721013,2009-08-31T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
19721013,2009-08-31T00:00:00,Blood Transfusion,E02.095.135
19721013,2009-08-31T00:00:00,Child,M01.060.406
19721013,2009-08-31T00:00:00,Ferritins,D12.776.157.427.249
19721013,2009-08-31T00:00:00,Ferritins,D12.776.556.579.249
19721013,2009-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19721013,2009-08-31T00:00:00,Liver,A03.620
19721013,2009-08-31T00:00:00,Liver Cirrhosis,C06.552.630
19721013,2009-08-31T00:00:00,Stroke,C10.228.140.300.775
19721013,2009-08-31T00:00:00,Stroke,C14.907.253.855
19172645,2009-09-01T00:00:00,Adult,M01.060.116
19172645,2009-09-01T00:00:00,Age Factors,N05.715.350.075
19172645,2009-09-01T00:00:00,Age Factors,N06.850.490.250
19172645,2009-09-01T00:00:00,Aged,M01.060.116.100
19172645,2009-09-01T00:00:00,Aging,G07.700.320.124
19172645,2009-09-01T00:00:00,Algorithms,G17.035
19172645,2009-09-01T00:00:00,Algorithms,L01.224.050
19172645,2009-09-01T00:00:00,Brain,A08.186.211
19172645,2009-09-01T00:00:00,Brain Ischemia,C10.228.140.300.150
19172645,2009-09-01T00:00:00,Brain Ischemia,C14.907.253.092
19172645,2009-09-01T00:00:00,Brain Mapping,E01.370.350.086
19172645,2009-09-01T00:00:00,Brain Mapping,E01.370.376.149
19172645,2009-09-01T00:00:00,Brain Mapping,E05.132
19172645,2009-09-01T00:00:00,Cerebrovascular Disorders,C10.228.140.300
19172645,2009-09-01T00:00:00,Cerebrovascular Disorders,C14.907.253
19172645,2009-09-01T00:00:00,Functional Laterality,F02.830.297.425
19172645,2009-09-01T00:00:00,Functional Laterality,G11.561.225.425
19172645,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19172645,2009-09-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19172645,2009-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19172645,2009-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19172645,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19172645,2009-09-01T00:00:00,Sex Characteristics,G08.686.815
19172645,2009-09-01T00:00:00,Young Adult,M01.060.116.815
19434631,2009-09-01T00:00:00,Animals,B01.050
19434631,2009-09-01T00:00:00,Biological Markers,D23.101
19434631,2009-09-01T00:00:00,Gene Expression,G05.355.310
19434631,2009-09-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
19434631,2009-09-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
19434631,2009-09-01T00:00:00,"Models, Animal",E05.598
19434631,2009-09-01T00:00:00,Osteoclasts,A11.329.372.700
19434631,2009-09-01T00:00:00,Osteoclasts,A11.627.482.700
19434631,2009-09-01T00:00:00,Signal Transduction,G02.111.087.800
19434631,2009-09-01T00:00:00,Signal Transduction,G02.149.115.800
19434631,2009-09-01T00:00:00,Signal Transduction,G04.299.880
19434631,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19434631,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19434631,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19434631,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19434631,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19603826,2009-09-01T00:00:00,Aging,G07.700.320.124
19603826,2009-09-01T00:00:00,Animals,B01.050
19603826,2009-09-01T00:00:00,Heart Ventricles,A07.541.560
19603826,2009-09-01T00:00:00,Myocardium,A02.633.580
19603826,2009-09-01T00:00:00,Myocardium,A07.541.704
19603826,2009-09-01T00:00:00,Myocardium,A10.690.552.750
19603826,2009-09-01T00:00:00,Proteomics,H01.158.201.843
19603826,2009-09-01T00:00:00,Proteomics,H01.158.273.180.350.700
19603826,2009-09-01T00:00:00,Proteomics,H01.158.273.343.350.700
19603826,2009-09-01T00:00:00,Proteomics,H01.181.122.738
19603826,2009-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19603826,2009-09-01T00:00:00,Signal Transduction,G02.111.087.800
19603826,2009-09-01T00:00:00,Signal Transduction,G02.149.115.800
19603826,2009-09-01T00:00:00,Signal Transduction,G04.299.880
19603826,2009-09-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19603828,2009-09-01T00:00:00,Algorithms,G17.035
19603828,2009-09-01T00:00:00,Algorithms,L01.224.050
19603828,2009-09-01T00:00:00,Blood Proteins,D12.776.124
19603828,2009-09-01T00:00:00,"Chromatography, Ion Exchange",E05.196.181.400.383
19603828,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19603828,2009-09-01T00:00:00,Peptide Fragments,D12.644.541
19603828,2009-09-01T00:00:00,Prostatic Hyperplasia,C12.294.565.500
19603828,2009-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19603828,2009-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
19603828,2009-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
19603828,2009-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
19603828,2009-09-01T00:00:00,Proteomics,H01.158.201.843
19603828,2009-09-01T00:00:00,Proteomics,H01.158.273.180.350.700
19603828,2009-09-01T00:00:00,Proteomics,H01.158.273.343.350.700
19603828,2009-09-01T00:00:00,Proteomics,H01.181.122.738
19603828,2009-09-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19653832,2009-09-01T00:00:00,"Antigens, Viral",D23.050.327
19653832,2009-09-01T00:00:00,"Herpesvirus 4, Human",B04.280.382.400.500.450
19653832,2009-09-01T00:00:00,"Herpesvirus 4, Human",B04.909.204.210.400.500.400
19653832,2009-09-01T00:00:00,"Herpesvirus 4, Human",B04.909.204.382.400.500.400
19653832,2009-09-01T00:00:00,"Herpesvirus 4, Human",B04.909.574.204.500.500.400
19653832,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
19653832,2009-09-01T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
19655763,2009-09-01T00:00:00,"Adenoviruses, Human",B04.280.030.500.350
19655763,2009-09-01T00:00:00,"Adenoviruses, Human",B04.909.204.097.500.350
19655763,2009-09-01T00:00:00,Cell Death,G04.299.139
19655763,2009-09-01T00:00:00,Gene Expression,G05.355.310
19655763,2009-09-01T00:00:00,Genetic Vectors,G05.360.337
19655763,2009-09-01T00:00:00,Green Fluorescent Proteins,D12.776.532.265
19655763,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19655763,2009-09-01T00:00:00,Polymers,D05.750
19655763,2009-09-01T00:00:00,Polymers,D25.720
19655763,2009-09-01T00:00:00,Polymers,J01.637.051.720
19655763,2009-09-01T00:00:00,"Receptors, Virus",D12.776.543.750.925
19655763,2009-09-01T00:00:00,Recombinant Proteins,D12.776.828
19655763,2009-09-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
19655763,2009-09-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
19655763,2009-09-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
19655763,2009-09-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
19655763,2009-09-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
19655763,2009-09-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
19655763,2009-09-01T00:00:00,"Transduction, Genetic",E05.393.350.800
19655763,2009-09-01T00:00:00,"Transduction, Genetic",G05.355.760.850
19655763,2009-09-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
19655763,2009-09-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
19655763,2009-09-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
19655763,2009-09-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
19655763,2009-09-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
19664381,2009-09-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
19664381,2009-09-01T00:00:00,Cardiovascular Diseases,C14
19664381,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19664381,2009-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19664381,2009-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19664381,2009-09-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19664381,2009-09-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19664381,2009-09-01T00:00:00,Treatment Outcome,E01.789.800
19664381,2009-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19664381,2009-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19664381,2009-09-01T00:00:00,United States,Z01.107.567.875
19681152,2009-09-01T00:00:00,Ectodermal Dysplasia,C16.131.077.350
19681152,2009-09-01T00:00:00,Ectodermal Dysplasia,C16.131.831.350
19681152,2009-09-01T00:00:00,Ectodermal Dysplasia,C16.320.850.250
19681152,2009-09-01T00:00:00,Ectodermal Dysplasia,C17.800.804.350
19681152,2009-09-01T00:00:00,Ectodermal Dysplasia,C17.800.827.250
19681152,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19681152,2009-09-01T00:00:00,Molecular Biology,H01.158.201.636
19681152,2009-09-01T00:00:00,Molecular Biology,H01.158.273.343.595
19681152,2009-09-01T00:00:00,Molecular Biology,H01.181.122.650
19681152,2009-09-01T00:00:00,Terminology as Topic,L01.143.506.598.400
19687273,2009-09-01T00:00:00,Aging,G07.700.320.124
19687273,2009-09-01T00:00:00,Animals,B01.050
19687273,2009-09-01T00:00:00,Chickens,B01.050.150.900.248.350.150
19687273,2009-09-01T00:00:00,Chickens,B01.050.150.900.248.617.192
19687273,2009-09-01T00:00:00,Diet,E05.272
19687273,2009-09-01T00:00:00,Diet,G07.610.240
19687273,2009-09-01T00:00:00,Dietary Fats,D10.212.302
19687273,2009-09-01T00:00:00,Dietary Fats,J02.500.375
19687273,2009-09-01T00:00:00,Dietary Supplements,J02.500.456
19687273,2009-09-01T00:00:00,Fatty Acids,D10.251
19687273,2009-09-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
19687273,2009-09-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
19687273,2009-09-01T00:00:00,Poultry Diseases,C22.131.728
19699907,2009-09-01T00:00:00,Brachiocephalic Trunk,A07.231.114.145
19699907,2009-09-01T00:00:00,Cardiac Output,E01.370.370.380.150
19699907,2009-09-01T00:00:00,Cardiac Output,G09.330.380.124
19699907,2009-09-01T00:00:00,Computer Simulation,L01.224.160
19699907,2009-09-01T00:00:00,Decision Support Techniques,E05.245
19699907,2009-09-01T00:00:00,Decision Support Techniques,L01.700.508.190
19699907,2009-09-01T00:00:00,Finite Element Analysis,E05.355
19699907,2009-09-01T00:00:00,Heart Ventricles,A07.541.560
19699907,2009-09-01T00:00:00,Hemodynamics,G09.330.190.400
19699907,2009-09-01T00:00:00,Hemodynamics,G09.330.380
19699907,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19699907,2009-09-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
19699907,2009-09-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
19699907,2009-09-01T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
19699907,2009-09-01T00:00:00,Infant,M01.060.703
19699907,2009-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
19699907,2009-09-01T00:00:00,Lung,A04.411
19699907,2009-09-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
19699907,2009-09-01T00:00:00,Neural Networks (Computer),G17.485
19699907,2009-09-01T00:00:00,Neural Networks (Computer),L01.224.065.605
19699907,2009-09-01T00:00:00,Neural Networks (Computer),L01.725.500
19699907,2009-09-01T00:00:00,Oxygen,D01.268.185.550
19699907,2009-09-01T00:00:00,Oxygen,D01.362.670
19699907,2009-09-01T00:00:00,Palliative Care,E02.760.666
19699907,2009-09-01T00:00:00,Palliative Care,N02.421.585.666
19699907,2009-09-01T00:00:00,Postoperative Complications,C23.550.767
19699907,2009-09-01T00:00:00,Pulmonary Artery,A07.231.114.715
19699907,2009-09-01T00:00:00,Reoperation,E04.690
19699907,2009-09-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
19699907,2009-09-01T00:00:00,Stroke Volume,G09.330.380.124.882
19699907,2009-09-01T00:00:00,Treatment Outcome,E01.789.800
19699907,2009-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19699907,2009-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19699948,2009-09-01T00:00:00,Calcinosis,C18.452.174.130
19699948,2009-09-01T00:00:00,Chylothorax,C08.528.142
19699948,2009-09-01T00:00:00,Fibrosis,C23.550.355
19699948,2009-09-01T00:00:00,Histoplasma,B01.300.381.440
19699948,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19699948,2009-09-01T00:00:00,Lymph Nodes,A10.549.400
19699948,2009-09-01T00:00:00,Lymph Nodes,A15.382.520.604.412
19699948,2009-09-01T00:00:00,Pleural Effusion,C08.528.652
19699948,2009-09-01T00:00:00,Reoperation,E04.690
19699948,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19699948,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19699948,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19699948,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19699948,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19699948,2009-09-01T00:00:00,Young Adult,M01.060.116.815
19714584,2009-09-01T00:00:00,Adolescent,M01.060.057
19714584,2009-09-01T00:00:00,Biological Markers,D23.101
19714584,2009-09-01T00:00:00,Child,M01.060.406
19714584,2009-09-01T00:00:00,Creatinine,D03.383.129.308.207
19714584,2009-09-01T00:00:00,Disease Progression,C23.550.291.656
19714584,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19714584,2009-09-01T00:00:00,Kidney Diseases,C12.777.419
19714584,2009-09-01T00:00:00,Kidney Diseases,C13.351.968.419
19714584,2009-09-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19714584,2009-09-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19714584,2009-09-01T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
19715122,2009-09-01T00:00:00,Adult,M01.060.116
19715122,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19715122,2009-09-01T00:00:00,Meningoencephalitis,C10.228.140.430.550
19715122,2009-09-01T00:00:00,Meningoencephalitis,C10.228.228.245.550
19715122,2009-09-01T00:00:00,Meningoencephalitis,C10.228.228.507.850
19715122,2009-09-01T00:00:00,Meningoencephalitis,C10.228.228.553
19715122,2009-09-01T00:00:00,Meningoencephalitis,C10.228.566.500
19715122,2009-09-01T00:00:00,Mycobacterium Infections,C01.252.410.040.552
19718644,2009-09-01T00:00:00,Animals,B01.050
19718644,2009-09-01T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
19718644,2009-09-01T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
19718644,2009-09-01T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
19718644,2009-09-01T00:00:00,Cell Death,G04.299.139
19718644,2009-09-01T00:00:00,"Disease Models, Animal",C22.232
19718644,2009-09-01T00:00:00,"Disease Models, Animal",E05.598.500
19718644,2009-09-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19718644,2009-09-01T00:00:00,Endotoxins,D23.946.123.329
19718644,2009-09-01T00:00:00,Fatty Liver,C06.552.241
19718644,2009-09-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19718644,2009-09-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19718644,2009-09-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19718644,2009-09-01T00:00:00,Interferon-gamma,D12.644.276.718.550
19718644,2009-09-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19718644,2009-09-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19718644,2009-09-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19718644,2009-09-01T00:00:00,Interferon-gamma,D12.776.467.718.550
19718644,2009-09-01T00:00:00,Interferon-gamma,D23.529.374.440.893
19718644,2009-09-01T00:00:00,Interferon-gamma,D23.529.374.480.350
19718644,2009-09-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19718644,2009-09-01T00:00:00,Interferon-gamma,D23.529.718.550
19718644,2009-09-01T00:00:00,Interleukin-10,D12.644.276.374.465.510
19718644,2009-09-01T00:00:00,Interleukin-10,D12.776.467.374.465.510
19718644,2009-09-01T00:00:00,Interleukin-10,D23.529.374.465.510
19718644,2009-09-01T00:00:00,Interleukin-12,D12.644.276.374.465.512
19718644,2009-09-01T00:00:00,Interleukin-12,D12.776.467.374.465.512
19718644,2009-09-01T00:00:00,Interleukin-12,D23.529.374.465.512
19718644,2009-09-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
19718644,2009-09-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
19718644,2009-09-01T00:00:00,Interleukin-6,D23.529.374.465.506
19718644,2009-09-01T00:00:00,Liver,A03.620
19718644,2009-09-01T00:00:00,Liver Transplantation,E04.210.650
19718644,2009-09-01T00:00:00,Liver Transplantation,E04.936.450.490
19718644,2009-09-01T00:00:00,Liver Transplantation,E04.936.580.490
19718644,2009-09-01T00:00:00,"RNA, Messenger",D13.444.735.544
19718644,2009-09-01T00:00:00,Reperfusion Injury,C14.907.725
19718644,2009-09-01T00:00:00,Reperfusion Injury,C23.550.767.877
19718644,2009-09-01T00:00:00,Time Factors,G01.910.857
19718644,2009-09-01T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
19723623,2009-09-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
19723623,2009-09-01T00:00:00,Animals,B01.050
19723623,2009-09-01T00:00:00,Eye Proteins,D12.776.306
19723623,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19723623,2009-09-01T00:00:00,Macular Degeneration,C11.768.585.439
19723623,2009-09-01T00:00:00,Nerve Growth Factors,D12.644.276.860
19723623,2009-09-01T00:00:00,Nerve Growth Factors,D12.776.467.860
19723623,2009-09-01T00:00:00,Nerve Growth Factors,D12.776.641.600
19723623,2009-09-01T00:00:00,Nerve Growth Factors,D23.529.850
19723623,2009-09-01T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
19723623,2009-09-01T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
19723623,2009-09-01T00:00:00,Serpins,D12.644.822.750
19723623,2009-09-01T00:00:00,Serpins,D12.644.861
19723623,2009-09-01T00:00:00,Serpins,D12.776.645.750
19723623,2009-09-01T00:00:00,Serpins,D12.776.872
19723623,2009-09-01T00:00:00,Signal Transduction,G02.111.087.800
19723623,2009-09-01T00:00:00,Signal Transduction,G02.149.115.800
19723623,2009-09-01T00:00:00,Signal Transduction,G04.299.880
19723623,2009-09-01T00:00:00,Swine,B01.050.150.900.649.077.880
19723623,2009-09-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19723623,2009-09-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19723623,2009-09-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19723703,2009-09-01T00:00:00,Apoptosis,G04.299.139.160
19723703,2009-09-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19723703,2009-09-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19723703,2009-09-01T00:00:00,Ceramides,D02.065.313
19723703,2009-09-01T00:00:00,Ceramides,D09.400.410.420.525.200
19723703,2009-09-01T00:00:00,Ceramides,D10.390.470.675.200
19723703,2009-09-01T00:00:00,Ceramides,D10.570.877.360.612.200
19723703,2009-09-01T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
19723703,2009-09-01T00:00:00,Head and Neck Neoplasms,C04.588.443
19723703,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19723703,2009-09-01T00:00:00,Membrane Proteins,D12.776.543
19723703,2009-09-01T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
19723703,2009-09-01T00:00:00,Oxidoreductases,D08.811.682
19723703,2009-09-01T00:00:00,Recombinant Proteins,D12.776.828
19723703,2009-09-01T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
19723703,2009-09-01T00:00:00,"Stress, Physiological",G07.700.830
19723738,2009-09-01T00:00:00,Aged,M01.060.116.100
19723738,2009-09-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19723738,2009-09-01T00:00:00,Health Status,I01.240.425
19723738,2009-09-01T00:00:00,Health Status,N01.224.425
19723738,2009-09-01T00:00:00,Health Status,N06.850.505.400.425
19723738,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19723738,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19723738,2009-09-01T00:00:00,Patient Preference,N04.452.822.360.600.500
19723738,2009-09-01T00:00:00,Patient Preference,N05.300.150.600.630.500
19723738,2009-09-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19723738,2009-09-01T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
19723738,2009-09-01T00:00:00,Questionnaires,E05.318.308.750
19723738,2009-09-01T00:00:00,Questionnaires,L01.280.800
19723738,2009-09-01T00:00:00,Questionnaires,N05.715.360.300.695
19723738,2009-09-01T00:00:00,Questionnaires,N06.850.520.308.750
19723738,2009-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19723738,2009-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19723738,2009-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19723738,2009-09-01T00:00:00,Veterans,M01.930
19723774,2009-09-01T00:00:00,Animals,B01.050
19723774,2009-09-01T00:00:00,Aortic Valve,A07.541.510.110
19723774,2009-09-01T00:00:00,Calcinosis,C18.452.174.130
19723774,2009-09-01T00:00:00,Carrier Proteins,D12.776.157
19723774,2009-09-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
19723774,2009-09-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
19723774,2009-09-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
19723774,2009-09-01T00:00:00,Cytokines,D12.644.276.374
19723774,2009-09-01T00:00:00,Cytokines,D12.776.467.374
19723774,2009-09-01T00:00:00,Cytokines,D23.529.374
19723774,2009-09-01T00:00:00,Echocardiography,E01.370.350.850.220
19723774,2009-09-01T00:00:00,Echocardiography,E01.370.370.380.220
19723774,2009-09-01T00:00:00,Gene Expression Profiling,E05.393.332
19723774,2009-09-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19723774,2009-09-01T00:00:00,Heart Valve Diseases,C14.280.484
19723774,2009-09-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
19723774,2009-09-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
19723774,2009-09-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
19723774,2009-09-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
19723774,2009-09-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
19723774,2009-09-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
19723774,2009-09-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
19723774,2009-09-01T00:00:00,Myocardium,A02.633.580
19723774,2009-09-01T00:00:00,Myocardium,A07.541.704
19723774,2009-09-01T00:00:00,Myocardium,A10.690.552.750
19723774,2009-09-01T00:00:00,Signal Transduction,G02.111.087.800
19723774,2009-09-01T00:00:00,Signal Transduction,G02.149.115.800
19723774,2009-09-01T00:00:00,Signal Transduction,G04.299.880
19723774,2009-09-01T00:00:00,Time Factors,G01.910.857
19730217,2009-09-01T00:00:00,Adult,M01.060.116
19730217,2009-09-01T00:00:00,Aged,M01.060.116.100
19730217,2009-09-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19730217,2009-09-01T00:00:00,Double-Blind Method,E05.318.780.300
19730217,2009-09-01T00:00:00,Double-Blind Method,E05.581.500.300
19730217,2009-09-01T00:00:00,Double-Blind Method,N05.715.360.780.320
19730217,2009-09-01T00:00:00,Double-Blind Method,N06.850.520.445.300
19730217,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19730217,2009-09-01T00:00:00,Intensive Care,E02.760.190.400
19730217,2009-09-01T00:00:00,Intensive Care,N02.421.585.190.400
19730217,2009-09-01T00:00:00,Length of Stay,E02.760.400.480
19730217,2009-09-01T00:00:00,Length of Stay,N02.421.585.400.480
19730217,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19730217,2009-09-01T00:00:00,Spinal Fusion,E04.555.100.700
19730217,2009-09-01T00:00:00,Time Factors,G01.910.857
19730217,2009-09-01T00:00:00,Treatment Outcome,E01.789.800
19730217,2009-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19730217,2009-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19734398,2009-09-01T00:00:00,Adult,M01.060.116
19734398,2009-09-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
19734398,2009-09-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
19734398,2009-09-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
19734398,2009-09-01T00:00:00,Health Surveys,E05.318.308.250
19734398,2009-09-01T00:00:00,Health Surveys,N05.715.360.300.375
19734398,2009-09-01T00:00:00,Health Surveys,N06.850.520.308.250
19734398,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19734398,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19734398,2009-09-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19734398,2009-09-01T00:00:00,Young Adult,M01.060.116.815
19739951,2009-09-01T00:00:00,Body Weight,C23.888.144
19739951,2009-09-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
19739951,2009-09-01T00:00:00,Body Weight,E05.041.124.160.750
19739951,2009-09-01T00:00:00,Body Weight,G07.100.100.160.120
19739951,2009-09-01T00:00:00,Body Weight,G07.700.320.249.314.120
19739951,2009-09-01T00:00:00,Energy Intake,G07.610.240.340
19739951,2009-09-01T00:00:00,Enteral Nutrition,E02.421.360
19739951,2009-09-01T00:00:00,Enteral Nutrition,E02.642.500.360
19739951,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19739951,2009-09-01T00:00:00,Infant Care,N02.421.088.120
19739951,2009-09-01T00:00:00,Infant Formula,J02.200.700.249
19739951,2009-09-01T00:00:00,Infant Formula,J02.200.712.249
19739951,2009-09-01T00:00:00,Infant Formula,J02.500.350.525.332
19739951,2009-09-01T00:00:00,Infant Formula,J02.500.525.350.500
19739951,2009-09-01T00:00:00,Infant Formula,J02.500.525.500.500
19739951,2009-09-01T00:00:00,Infant Nutritional Physiological Phenomena,G07.610.220.500
19739951,2009-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
19739951,2009-09-01T00:00:00,"Infant, Premature",M01.060.703.520.520
19739951,2009-09-01T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
19739951,2009-09-01T00:00:00,Weight Gain,C23.888.144.243.926
19739951,2009-09-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
19740151,2009-09-01T00:00:00,Adult,M01.060.116
19740151,2009-09-01T00:00:00,Dental Care,E06.170
19740151,2009-09-01T00:00:00,Dental Care,N02.421.240.190
19740151,2009-09-01T00:00:00,Feedback,L01.143.283.425
19740151,2009-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
19740151,2009-09-01T00:00:00,Health Services Accessibility,N05.300.430
19740151,2009-09-01T00:00:00,Home Care Services,N02.421.143.524
19740151,2009-09-01T00:00:00,Home Care Services,N02.421.539.089
19740151,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19740151,2009-09-01T00:00:00,Internet,L01.224.230.110.500
19740151,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19740151,2009-09-01T00:00:00,Occupational Therapy,E02.831.489
19740151,2009-09-01T00:00:00,Occupational Therapy,H02.010.500
19740151,2009-09-01T00:00:00,Patient Education as Topic,I02.233.332.500
19740151,2009-09-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19740151,2009-09-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
19740151,2009-09-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
19740151,2009-09-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
19740151,2009-09-01T00:00:00,Patient Satisfaction,N05.715.360.600
19740151,2009-09-01T00:00:00,Pilot Projects,E05.318.760.750
19740151,2009-09-01T00:00:00,Pilot Projects,E05.337.737
19740151,2009-09-01T00:00:00,Pilot Projects,N05.715.360.775.625
19740151,2009-09-01T00:00:00,Pilot Projects,N06.850.520.450.720
19740151,2009-09-01T00:00:00,Program Evaluation,E05.337.820
19740151,2009-09-01T00:00:00,Program Evaluation,N04.761.685
19740151,2009-09-01T00:00:00,Program Evaluation,N05.715.360.650
19740151,2009-09-01T00:00:00,Quadriplegia,C10.597.622.760
19740151,2009-09-01T00:00:00,Quadriplegia,C23.888.592.636.786
19740151,2009-09-01T00:00:00,Self-Help Devices,E07.796
19740151,2009-09-01T00:00:00,Telemedicine,H02.403.840
19740151,2009-09-01T00:00:00,Telemedicine,L01.178.847.652
19740151,2009-09-01T00:00:00,Telemedicine,N04.590.374.800
19744594,2009-09-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19744594,2009-09-01T00:00:00,Clinical Trials as Topic,E05.337.250
19744594,2009-09-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19744594,2009-09-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19744594,2009-09-01T00:00:00,Contrast Media,D27.720.259
19744594,2009-09-01T00:00:00,Creatinine,D03.383.129.308.207
19744594,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19744594,2009-09-01T00:00:00,Incidence,E05.318.308.985.525.375
19744594,2009-09-01T00:00:00,Incidence,L01.280.975.525.375
19744594,2009-09-01T00:00:00,Incidence,N01.224.935.597.500
19744594,2009-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19744594,2009-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19744594,2009-09-01T00:00:00,Kidney Diseases,C12.777.419
19744594,2009-09-01T00:00:00,Kidney Diseases,C13.351.968.419
19744594,2009-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19744594,2009-09-01T00:00:00,Risk Factors,N05.715.350.200.700
19744594,2009-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19744594,2009-09-01T00:00:00,Risk Factors,N06.850.490.625.750
19744594,2009-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19745093,2009-09-01T00:00:00,Acetylcysteine,D02.886.030.230.259
19745093,2009-09-01T00:00:00,Acetylcysteine,D12.125.166.230.259
19745093,2009-09-01T00:00:00,Animals,B01.050
19745093,2009-09-01T00:00:00,"Animals, Newborn",B01.050.050.282
19745093,2009-09-01T00:00:00,Brain Injuries,C10.228.140.199
19745093,2009-09-01T00:00:00,Brain Injuries,C10.900.300.087
19745093,2009-09-01T00:00:00,Brain Injuries,C21.866.260.118
19745093,2009-09-01T00:00:00,Brain Injuries,C21.866.915.300.200
19745093,2009-09-01T00:00:00,"Disease Models, Animal",C22.232
19745093,2009-09-01T00:00:00,"Disease Models, Animal",E05.598.500
19745093,2009-09-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19745093,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19745093,2009-09-01T00:00:00,"Hypothermia, Induced",E02.258.750
19745093,2009-09-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19745093,2009-09-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19745093,2009-09-01T00:00:00,Oligodendroglia,A08.637.600
19745093,2009-09-01T00:00:00,Oligodendroglia,A11.650.600
19745093,2009-09-01T00:00:00,Oxidative Stress,G03.495.710
19745093,2009-09-01T00:00:00,Oxidative Stress,G07.700.830.750
19745093,2009-09-01T00:00:00,Pregnancy,G08.686.785.760.769
19745093,2009-09-01T00:00:00,Prenatal Exposure Delayed Effects,C13.703.824.500
19745093,2009-09-01T00:00:00,Research Design,E05.581.500
19745093,2009-09-01T00:00:00,Research Design,H01.770.644.728
19745093,2009-09-01T00:00:00,Time Factors,G01.910.857
19745221,2009-09-01T00:00:00,Aged,M01.060.116.100
19745221,2009-09-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19745221,2009-09-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19745221,2009-09-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19745221,2009-09-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19745221,2009-09-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19745221,2009-09-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19745221,2009-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
19745221,2009-09-01T00:00:00,Health Services Accessibility,N05.300.430
19745221,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19745221,2009-09-01T00:00:00,Mass Screening,E01.370.500
19745221,2009-09-01T00:00:00,Mass Screening,E05.318.308.250.580
19745221,2009-09-01T00:00:00,Mass Screening,N02.421.143.827.233.443
19745221,2009-09-01T00:00:00,Mass Screening,N02.421.726.233.443
19745221,2009-09-01T00:00:00,Mass Screening,N05.715.360.300.375.500
19745221,2009-09-01T00:00:00,Mass Screening,N06.850.520.308.250.580
19745221,2009-09-01T00:00:00,Mass Screening,N06.850.780.500
19745221,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19745221,2009-09-01T00:00:00,Primary Health Care,N04.590.233.727
19745608,2009-09-01T00:00:00,Acetylglucosamine,D09.067.342.531.050
19745608,2009-09-01T00:00:00,Graft Rejection,G12.425.901.545.328
19745608,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19745608,2009-09-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
19745608,2009-09-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
19745608,2009-09-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
19745608,2009-09-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
19745608,2009-09-01T00:00:00,Kidney Transplantation,E02.870.500
19745608,2009-09-01T00:00:00,Kidney Transplantation,E04.936.450.485
19745608,2009-09-01T00:00:00,Kidney Transplantation,E04.950.774.400
19745608,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19745608,2009-09-01T00:00:00,Renal Dialysis,E02.870.300
19745608,2009-09-01T00:00:00,Renal Dialysis,E02.912.800
19752471,2009-09-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19752471,2009-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
19752471,2009-09-01T00:00:00,Health Services Accessibility,N05.300.430
19752471,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19752471,2009-09-01T00:00:00,Internet,L01.224.230.110.500
19752471,2009-09-01T00:00:00,Prescription Drugs,D26.670
19755885,2009-09-01T00:00:00,Biomedical Research,H01.770.644.145
19755885,2009-09-01T00:00:00,Child,M01.060.406
19755885,2009-09-01T00:00:00,Curriculum,I02.158
19755885,2009-09-01T00:00:00,Emergency Medicine,H02.403.250
19755885,2009-09-01T00:00:00,"Faculty, Medical",I02.463.373
19755885,2009-09-01T00:00:00,"Faculty, Medical",M01.526.339.373
19755885,2009-09-01T00:00:00,"Faculty, Medical",M01.526.485.375
19755885,2009-09-01T00:00:00,"Faculty, Medical",N02.360.375
19755885,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19755885,2009-09-01T00:00:00,Internship and Residency,I02.358.399.644
19755885,2009-09-01T00:00:00,Pediatrics,H02.403.670
19755885,2009-09-01T00:00:00,Questionnaires,E05.318.308.750
19755885,2009-09-01T00:00:00,Questionnaires,L01.280.800
19755885,2009-09-01T00:00:00,Questionnaires,N05.715.360.300.695
19755885,2009-09-01T00:00:00,Questionnaires,N06.850.520.308.750
19755885,2009-09-01T00:00:00,United States,Z01.107.567.875
19774967,2009-09-01T00:00:00,Angiography,E01.370.350.700.060
19774967,2009-09-01T00:00:00,Angiography,E01.370.370.050
19774967,2009-09-01T00:00:00,"Diagnosis, Differential",E01.171
19774967,2009-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
19774967,2009-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
19774967,2009-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
19774967,2009-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
19774967,2009-09-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
19774967,2009-09-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
19774967,2009-09-01T00:00:00,Gastrostomy,E04.210.496
19774967,2009-09-01T00:00:00,Gastrostomy,E04.579.408
19774967,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19774967,2009-09-01T00:00:00,"Pancreatitis, Alcoholic",C06.689.750.660
19774967,2009-09-01T00:00:00,"Pancreatitis, Alcoholic",C21.739.100.087.730
19774967,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19774967,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19774967,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19774967,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19774967,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19774967,2009-09-01T00:00:00,Young Adult,M01.060.116.815
19797108,2009-09-01T00:00:00,Aged,M01.060.116.100
19797108,2009-09-01T00:00:00,Antineoplastic Agents,D27.505.954.248
19797108,2009-09-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
19797108,2009-09-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
19797108,2009-09-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19797108,2009-09-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19797108,2009-09-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19797108,2009-09-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19797108,2009-09-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19797108,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19797108,2009-09-01T00:00:00,Lymphocytes,A11.118.637.555.567
19797108,2009-09-01T00:00:00,Lymphocytes,A15.145.229.637.555.567
19797108,2009-09-01T00:00:00,Lymphocytes,A15.382.490.555.567
19797108,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19797108,2009-09-01T00:00:00,Neoplasm Staging,E01.370.550
19797108,2009-09-01T00:00:00,Treatment Outcome,E01.789.800
19797108,2009-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19797108,2009-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19806800,2009-09-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
19806800,2009-09-01T00:00:00,Child,M01.060.406
19806800,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19806800,2009-09-01T00:00:00,Miniaturization,J01.897.520
19807987,2009-09-01T00:00:00,Cadaver,C23.550.260.224
19807987,2009-09-01T00:00:00,Endoscopy,E01.370.388.250
19807987,2009-09-01T00:00:00,Endoscopy,E04.800.250
19807987,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19807987,2009-09-01T00:00:00,Reconstructive Surgical Procedures,E04.680
19807987,2009-09-01T00:00:00,Skull Base,A01.456.830
19807987,2009-09-01T00:00:00,Skull Base,A02.835.232.781.750
19807987,2009-09-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
19807987,2009-09-01T00:00:00,"Surgery, Computer-Assisted",E04.749
19807987,2009-09-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
19807987,2009-09-01T00:00:00,Surgical Flaps,A10.850.710
19807987,2009-09-01T00:00:00,Surgical Flaps,E07.862.710
19807987,2009-09-01T00:00:00,Turbinates,A02.835.232.781.324.948
19807987,2009-09-01T00:00:00,Turbinates,A04.531.898
19820503,2009-09-01T00:00:00,Adolescent,M01.060.057
19820503,2009-09-01T00:00:00,Adult,M01.060.116
19820503,2009-09-01T00:00:00,Aged,M01.060.116.100
19820503,2009-09-01T00:00:00,Cause of Death,E05.318.308.985.550.250
19820503,2009-09-01T00:00:00,Cause of Death,L01.280.975.550.250
19820503,2009-09-01T00:00:00,Cause of Death,N01.224.935.698.100
19820503,2009-09-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
19820503,2009-09-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
19820503,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19820503,2009-09-01T00:00:00,Intensive Care,E02.760.190.400
19820503,2009-09-01T00:00:00,Intensive Care,N02.421.585.190.400
19820503,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19820503,2009-09-01T00:00:00,Pulmonary Artery,A07.231.114.715
19820503,2009-09-01T00:00:00,Pulmonary Embolism,C08.381.746
19820503,2009-09-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
19820503,2009-09-01T00:00:00,Pulmonary Veins,A07.231.908.713
19820503,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19820503,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19820503,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19820503,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19820503,2009-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19820503,2009-09-01T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
19820503,2009-09-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
19820503,2009-09-01T00:00:00,Young Adult,M01.060.116.815
19820558,2009-09-01T00:00:00,Bipolar Disorder,F03.600.150.150
19820558,2009-09-01T00:00:00,Catatonia,C10.597.606.115
19820558,2009-09-01T00:00:00,Catatonia,C23.888.592.604.115
19820558,2009-09-01T00:00:00,Catatonia,F01.145.126.156
19820558,2009-09-01T00:00:00,Catatonia,F01.700.165
19820558,2009-09-01T00:00:00,"Diagnosis, Differential",E01.171
19820558,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19820558,2009-09-01T00:00:00,Young Adult,M01.060.116.815
19895500,2009-09-01T00:00:00,Animals,B01.050
19895500,2009-09-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
19895500,2009-09-01T00:00:00,Dietary Fats,D10.212.302
19895500,2009-09-01T00:00:00,Dietary Fats,J02.500.375
19895500,2009-09-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
19895500,2009-09-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
19895500,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19895500,2009-09-01T00:00:00,United States,Z01.107.567.875
19895500,2009-09-01T00:00:00,Volatile Organic Compounds,D02.974
19895500,2009-09-01T00:00:00,Water,D01.455.900
19895500,2009-09-01T00:00:00,Water,D01.650.550.925
19953833,2009-09-01T00:00:00,Adult,M01.060.116
19953833,2009-09-01T00:00:00,African Americans,M01.686.508.100.100
19953833,2009-09-01T00:00:00,African Americans,M01.686.754.100
19953833,2009-09-01T00:00:00,Aged,M01.060.116.100
19953833,2009-09-01T00:00:00,Blood Glucose,D09.546.359.448.500
19953833,2009-09-01T00:00:00,Blood Pressure,E01.370.600.875.249
19953833,2009-09-01T00:00:00,Blood Pressure,G09.330.380.076
19953833,2009-09-01T00:00:00,Diet,E05.272
19953833,2009-09-01T00:00:00,Diet,G07.610.240
19953833,2009-09-01T00:00:00,Exercise,G11.427.590.237
19953833,2009-09-01T00:00:00,Exercise,I03.350
19953833,2009-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19953833,2009-09-01T00:00:00,Middle Aged,M01.060.116.630
19953833,2009-09-01T00:00:00,Physical Fitness,I03.621
19953833,2009-09-01T00:00:00,Physical Fitness,N01.400.545
19953833,2009-09-01T00:00:00,Self Efficacy,F01.752.747.792.700
19953833,2009-09-01T00:00:00,Social Support,I01.880.656.600
20811105,2009-09-01T00:00:00,Animals,B01.050
20811105,2009-09-01T00:00:00,Biocompatible Materials,D25.130
20811105,2009-09-01T00:00:00,Biocompatible Materials,D27.720.102.130
20811105,2009-09-01T00:00:00,Biocompatible Materials,J01.637.051.130
20811105,2009-09-01T00:00:00,Hydrogels,D20.280.320.375
20811105,2009-09-01T00:00:00,Hydrogels,D26.255.165.320.375
20811105,2009-09-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20811105,2009-09-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20811105,2009-09-01T00:00:00,"Myocytes, Cardiac",A11.620.500
20811105,2009-09-01T00:00:00,Prosthesis Design,E05.320.550
20811105,2009-09-01T00:00:00,Prosthesis Design,E07.695.680
20811105,2009-09-01T00:00:00,Tissue Engineering,E05.200.249.750
20811105,2009-09-01T00:00:00,Tissue Scaffolds,E07.206.627
20811105,2009-09-01T00:00:00,Tissue Scaffolds,E07.695.825
19726138,2009-09-02T00:00:00,Adult,M01.060.116
19726138,2009-09-02T00:00:00,Cocaine-Related Disorders,C21.739.300
19726138,2009-09-02T00:00:00,Cocaine-Related Disorders,F03.900.300
19726138,2009-09-02T00:00:00,Corticotropin-Releasing Hormone,D06.472.699.327.740.140
19726138,2009-09-02T00:00:00,Corticotropin-Releasing Hormone,D12.644.400.400.740.140
19726138,2009-09-02T00:00:00,Corticotropin-Releasing Hormone,D12.644.548.365.740.140
19726138,2009-09-02T00:00:00,Corticotropin-Releasing Hormone,D12.776.641.650.405.740.140
19726138,2009-09-02T00:00:00,Cues,F02.463.425.234
19726138,2009-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19726138,2009-09-02T00:00:00,Neurosecretory Systems,A06.688
19726138,2009-09-02T00:00:00,Neurosecretory Systems,A08.713
19726138,2009-09-02T00:00:00,Psychiatric Status Rating Scales,F04.586
19726138,2009-09-02T00:00:00,"Stress, Psychological",F01.145.126.990
19726138,2009-09-02T00:00:00,"Stress, Psychological",F02.830.900
19726695,2009-09-02T00:00:00,Cell Line,A11.251.210
19726695,2009-09-02T00:00:00,Cell Membrane,A11.284.149
19726695,2009-09-02T00:00:00,Glycine,D12.125.481
19726695,2009-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19726695,2009-09-02T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
19726695,2009-09-02T00:00:00,Protein Isoforms,D12.776.800
19726695,2009-09-02T00:00:00,Protein Transport,G03.495.166.700
19726695,2009-09-02T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
19726695,2009-09-02T00:00:00,Recombinant Proteins,D12.776.828
19732758,2009-09-02T00:00:00,Animals,B01.050
19732758,2009-09-02T00:00:00,Brain,A08.186.211
19732758,2009-09-02T00:00:00,Cocaine,D02.145.074.722.388
19732758,2009-09-02T00:00:00,Cocaine,D03.132.889.354
19732758,2009-09-02T00:00:00,Cocaine,D03.605.869.388
19732758,2009-09-02T00:00:00,Cocaine,D04.075.080.875.099.722.388
19732758,2009-09-02T00:00:00,Cocaine-Related Disorders,C21.739.300
19732758,2009-09-02T00:00:00,Cocaine-Related Disorders,F03.900.300
19732758,2009-09-02T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
19732758,2009-09-02T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
19732758,2009-09-02T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
19732758,2009-09-02T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
19732758,2009-09-02T00:00:00,Glutamic Acid,D12.125.067.750
19732758,2009-09-02T00:00:00,Glutamic Acid,D12.125.119.450
19732758,2009-09-02T00:00:00,Glutamic Acid,D12.125.427.300
19732758,2009-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19732758,2009-09-02T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
19732758,2009-09-02T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
19732758,2009-09-02T00:00:00,MAP Kinase Signaling System,G03.495.553.560
19732758,2009-09-02T00:00:00,MAP Kinase Signaling System,G04.299.880.560
19732758,2009-09-02T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19732758,2009-09-02T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19729411,2009-09-03T00:00:00,Adult,M01.060.116
19729411,2009-09-03T00:00:00,Aged,M01.060.116.100
19729411,2009-09-03T00:00:00,Case-Control Studies,E05.318.760.500.500
19729411,2009-09-03T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19729411,2009-09-03T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19729411,2009-09-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
19729411,2009-09-03T00:00:00,Genetic Variation,G05.365
19729411,2009-09-03T00:00:00,Genome-Wide Association Study,E05.318.416.249
19729411,2009-09-03T00:00:00,Genome-Wide Association Study,E05.318.780.392
19729411,2009-09-03T00:00:00,Genome-Wide Association Study,E05.393.385.500
19729411,2009-09-03T00:00:00,Genome-Wide Association Study,E05.393.522.500
19729411,2009-09-03T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19729411,2009-09-03T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19729411,2009-09-03T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19729411,2009-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19729411,2009-09-03T00:00:00,Lipoproteins,D10.532
19729411,2009-09-03T00:00:00,Lipoproteins,D12.776.521
19729411,2009-09-03T00:00:00,Membrane Proteins,D12.776.543
19729411,2009-09-03T00:00:00,Middle Aged,M01.060.116.630
19729411,2009-09-03T00:00:00,Obesity,C18.654.726.500
19729411,2009-09-03T00:00:00,Obesity,C23.888.144.699.500
19729411,2009-09-03T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19729411,2009-09-03T00:00:00,Obesity,G07.100.100.160.120.699.500
19729411,2009-09-03T00:00:00,Young Adult,M01.060.116.815
19729479,2009-09-03T00:00:00,Animals,B01.050
19729479,2009-09-03T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
19729479,2009-09-03T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
19729479,2009-09-03T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
19729479,2009-09-03T00:00:00,Apoptosis,G04.299.139.160
19729479,2009-09-03T00:00:00,Collagen,D05.750.078.280
19729479,2009-09-03T00:00:00,Collagen,D12.776.860.300.250
19729479,2009-09-03T00:00:00,Elastin,D05.750.078.421
19729479,2009-09-03T00:00:00,Elastin,D12.776.860.300.350
19729479,2009-09-03T00:00:00,Fibroblasts,A11.329.228
19729479,2009-09-03T00:00:00,Fibroblasts,A11.872.228
19729612,2009-09-03T00:00:00,Alleles,G05.360.340.024.340.030
19729612,2009-09-03T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
19729612,2009-09-03T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
19729612,2009-09-03T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
19729612,2009-09-03T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19729612,2009-09-03T00:00:00,Genetic Predisposition to Disease,G05.380.355
19729612,2009-09-03T00:00:00,Genome-Wide Association Study,E05.318.416.249
19729612,2009-09-03T00:00:00,Genome-Wide Association Study,E05.318.780.392
19729612,2009-09-03T00:00:00,Genome-Wide Association Study,E05.393.385.500
19729612,2009-09-03T00:00:00,Genome-Wide Association Study,E05.393.522.500
19729612,2009-09-03T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19729612,2009-09-03T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19729612,2009-09-03T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19729612,2009-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19729612,2009-09-03T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19729612,2009-09-03T00:00:00,Solubility,G02.842.800
19729669,2009-09-03T00:00:00,Adrenal Cortex Hormones,D06.472.040
19729669,2009-09-03T00:00:00,Aminoglycosides,D09.408.051
19729669,2009-09-03T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19729669,2009-09-03T00:00:00,Cystic Fibrosis,C06.689.202
19729669,2009-09-03T00:00:00,Cystic Fibrosis,C08.381.187
19729669,2009-09-03T00:00:00,Cystic Fibrosis,C16.320.190
19729669,2009-09-03T00:00:00,Cystic Fibrosis,C16.614.213
19729669,2009-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19734364,2009-09-04T00:00:00,Animals,B01.050
19734364,2009-09-04T00:00:00,Apoptosis,G04.299.139.160
19734364,2009-09-04T00:00:00,Calpain,D08.811.277.656.262.500.120
19734364,2009-09-04T00:00:00,Calpain,D08.811.277.656.300.200.120
19734364,2009-09-04T00:00:00,Cardiotonic Agents,D27.505.954.411.222
19734364,2009-09-04T00:00:00,Cardiotonic Agents,D27.720.799.080
19734364,2009-09-04T00:00:00,"Disease Models, Animal",C22.232
19734364,2009-09-04T00:00:00,"Disease Models, Animal",E05.598.500
19734364,2009-09-04T00:00:00,"Disease Models, Animal",E05.599.395.080
19734364,2009-09-04T00:00:00,Myocardial Contraction,G09.330.190.541
19734364,2009-09-04T00:00:00,Myocardial Contraction,G11.427.590.540.570
19734364,2009-09-04T00:00:00,Myocardial Infarction,C14.280.647.500
19734364,2009-09-04T00:00:00,Myocardial Infarction,C14.907.585.500
19734364,2009-09-04T00:00:00,Myocardium,A02.633.580
19734364,2009-09-04T00:00:00,Myocardium,A07.541.704
19734364,2009-09-04T00:00:00,Myocardium,A10.690.552.750
19734364,2009-09-04T00:00:00,Stroke Volume,E01.370.370.380.150.700
19734364,2009-09-04T00:00:00,Stroke Volume,G09.330.380.124.882
19734364,2009-09-04T00:00:00,Time Factors,G01.910.857
19734364,2009-09-04T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
19734364,2009-09-04T00:00:00,Ventricular Remodeling,C23.300.985
19734364,2009-09-04T00:00:00,Ventricular Remodeling,G09.330.190.962.975
19737567,2009-09-06T00:00:00,Animals,B01.050
19737567,2009-09-06T00:00:00,Bone Marrow,A15.382.216
19737567,2009-09-06T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
19737567,2009-09-06T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
19737567,2009-09-06T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
19737567,2009-09-06T00:00:00,Cell Differentiation,G04.299.151
19737567,2009-09-06T00:00:00,Endothelial Cells,A11.436.275
19737567,2009-09-06T00:00:00,Herpesviridae Infections,C02.256.466
19737567,2009-09-06T00:00:00,Immune Tolerance,G12.425.746.425
19737567,2009-09-06T00:00:00,Liver,A03.620
19737567,2009-09-06T00:00:00,Muromegalovirus,B04.280.382.150.500
19737567,2009-09-06T00:00:00,Muromegalovirus,B04.909.204.382.150.500
19737567,2009-09-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19737567,2009-09-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19737567,2009-09-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19737567,2009-09-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19737567,2009-09-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19737567,2009-09-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19959120,2009-09-06T00:00:00,"Cardiac Pacing, Artificial",E02.145
19959120,2009-09-06T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
19959120,2009-09-06T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
19959120,2009-09-06T00:00:00,"Defibrillators, Implantable",E07.695.175
19959120,2009-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959120,2009-09-06T00:00:00,Myocardial Infarction,C14.280.647.500
19959120,2009-09-06T00:00:00,Myocardial Infarction,C14.907.585.500
19959120,2009-09-06T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19959120,2009-09-06T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19959120,2009-09-06T00:00:00,Time Factors,G01.910.857
19959120,2009-09-06T00:00:00,United States,Z01.107.567.875
19736559,2009-09-08T00:00:00,Adult,M01.060.116
19736559,2009-09-08T00:00:00,"Data Interpretation, Statistical",E05.245.380
19736559,2009-09-08T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19736559,2009-09-08T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19736559,2009-09-08T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19736559,2009-09-08T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19736559,2009-09-08T00:00:00,Depressive Disorder,F03.600.300
19736559,2009-09-08T00:00:00,Hospitalization,E02.760.400
19736559,2009-09-08T00:00:00,Hospitalization,N02.421.585.400
19736559,2009-09-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19736559,2009-09-08T00:00:00,Inpatients,M01.643.470
19736559,2009-09-08T00:00:00,Psychiatric Status Rating Scales,F04.586
19736559,2009-09-08T00:00:00,Regression Analysis,E05.318.740.750
19736559,2009-09-08T00:00:00,Regression Analysis,N05.715.360.750.695
19736559,2009-09-08T00:00:00,Regression Analysis,N06.850.520.830.750
19736559,2009-09-08T00:00:00,Spinal Cord Injuries,C10.228.854.770
19736559,2009-09-08T00:00:00,Spinal Cord Injuries,C10.900.850
19736559,2009-09-08T00:00:00,Spinal Cord Injuries,C21.866.819
19737992,2009-09-08T00:00:00,Aged,M01.060.116.100
19737992,2009-09-08T00:00:00,Ambulatory Care,E02.760.106
19737992,2009-09-08T00:00:00,Ambulatory Care,N02.421.585.106
19737992,2009-09-08T00:00:00,Anticoagulants,D27.505.954.502.119
19737992,2009-09-08T00:00:00,Diabetes Mellitus,C18.452.394.750
19737992,2009-09-08T00:00:00,Diabetes Mellitus,C19.246
19737992,2009-09-08T00:00:00,Documentation,L01.453.245
19737992,2009-09-08T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
19737992,2009-09-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19737992,2009-09-08T00:00:00,Middle Aged,M01.060.116.630
19737992,2009-09-08T00:00:00,"Models, Theoretical",E05.599
19737992,2009-09-08T00:00:00,Patient Education as Topic,I02.233.332.500
19737992,2009-09-08T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19737992,2009-09-08T00:00:00,Patient Education as Topic,N02.421.726.407.680
19737992,2009-09-08T00:00:00,Pharmaceutical Services,N02.421.668
19737992,2009-09-08T00:00:00,Pharmacists,M01.526.485.780
19737992,2009-09-08T00:00:00,Pharmacists,N02.360.780
19737992,2009-09-08T00:00:00,Professional Role,F01.829.316.616.625
19737992,2009-09-08T00:00:00,Smoking Cessation,F01.145.940.700
19737992,2009-09-08T00:00:00,South Carolina,Z01.107.567.875.075.662
19737992,2009-09-08T00:00:00,South Carolina,Z01.107.567.875.750.700
19793604,2009-09-08T00:00:00,Methane,D02.455.326.146.571
19793604,2009-09-08T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
19793604,2009-09-08T00:00:00,Water Supply,N06.850.860.510.915
19743478,2009-09-09T00:00:00,Adolescent,M01.060.057
19743478,2009-09-09T00:00:00,Adult,M01.060.116
19743478,2009-09-09T00:00:00,Aged,M01.060.116.100
19743478,2009-09-09T00:00:00,Child,M01.060.406
19743478,2009-09-09T00:00:00,Cyclonic Storms,G16.500.240.135.500
19743478,2009-09-09T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19743478,2009-09-09T00:00:00,Health Surveys,E05.318.308.250
19743478,2009-09-09T00:00:00,Health Surveys,N05.715.360.300.375
19743478,2009-09-09T00:00:00,Health Surveys,N06.850.520.308.250
19743478,2009-09-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19743478,2009-09-09T00:00:00,Middle Aged,M01.060.116.630
19743478,2009-09-09T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19743478,2009-09-09T00:00:00,United States,Z01.107.567.875
19744728,2009-09-10T00:00:00,Adult,M01.060.116
19744728,2009-09-10T00:00:00,Aged,M01.060.116.100
19744728,2009-09-10T00:00:00,China,Z01.252.474.164
19744728,2009-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19744728,2009-09-10T00:00:00,Middle Aged,M01.060.116.630
19744728,2009-09-10T00:00:00,Risk Factors,E05.318.740.600.800.725
19744728,2009-09-10T00:00:00,Risk Factors,N05.715.350.200.700
19744728,2009-09-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19744728,2009-09-10T00:00:00,Risk Factors,N06.850.490.625.750
19744728,2009-09-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19744728,2009-09-10T00:00:00,Rural Population,N01.600.725
19747985,2009-09-10T00:00:00,Adult,M01.060.116
19747985,2009-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19747985,2009-09-10T00:00:00,Pregnancy,G08.686.785.760.769
19747985,2009-09-10T00:00:00,Pregnancy Complications,C13.703
19747985,2009-09-10T00:00:00,Premature Birth,C13.703.420.491.500
19747985,2009-09-10T00:00:00,Treatment Outcome,E01.789.800
19747985,2009-09-10T00:00:00,Treatment Outcome,N04.761.559.590.800
19747985,2009-09-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19747985,2009-09-10T00:00:00,Young Adult,M01.060.116.815
19748217,2009-09-11T00:00:00,Aged,M01.060.116.100
19748217,2009-09-11T00:00:00,Anticoagulants,D27.505.954.502.119
19748217,2009-09-11T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19748217,2009-09-11T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19748217,2009-09-11T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19748217,2009-09-11T00:00:00,Femoral Artery,A07.231.114.351
19748217,2009-09-11T00:00:00,Hematoma,C23.550.414.838
19748217,2009-09-11T00:00:00,Hemorrhage,C23.550.414
19748217,2009-09-11T00:00:00,Hemostatic Techniques,E02.520
19748217,2009-09-11T00:00:00,Heparin,D09.698.373.400
19748217,2009-09-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19748217,2009-09-11T00:00:00,Middle Aged,M01.060.116.630
19748217,2009-09-11T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19748217,2009-09-11T00:00:00,Risk Assessment,E05.318.740.600.800.715
19748217,2009-09-11T00:00:00,Risk Assessment,N04.452.871.715
19748217,2009-09-11T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19748217,2009-09-11T00:00:00,Risk Assessment,N06.850.505.715
19748217,2009-09-11T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19748217,2009-09-11T00:00:00,Risk Factors,E05.318.740.600.800.725
19748217,2009-09-11T00:00:00,Risk Factors,N05.715.350.200.700
19748217,2009-09-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19748217,2009-09-11T00:00:00,Risk Factors,N06.850.490.625.750
19748217,2009-09-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19748217,2009-09-11T00:00:00,Sex Factors,N05.715.350.675
19748217,2009-09-11T00:00:00,Sex Factors,N06.850.490.875
19748217,2009-09-11T00:00:00,Ticlopidine,D02.886.778.834
19748217,2009-09-11T00:00:00,Ticlopidine,D03.383.903.834
19748493,2009-09-11T00:00:00,Animals,B01.050
19748493,2009-09-11T00:00:00,Apoptosis,G04.299.139.160
19748493,2009-09-11T00:00:00,Cell Survival,G04.299.316
19748493,2009-09-11T00:00:00,Estradiol,D04.808.365.415.248
19748493,2009-09-11T00:00:00,Estradiol,D06.472.334.851.437.500
19748493,2009-09-11T00:00:00,Estrogens,D27.505.696.399.472.277
19748493,2009-09-11T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19748493,2009-09-11T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19748493,2009-09-11T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19748493,2009-09-11T00:00:00,Interferon-gamma,D12.644.276.718.550
19748493,2009-09-11T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19748493,2009-09-11T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19748493,2009-09-11T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19748493,2009-09-11T00:00:00,Interferon-gamma,D12.776.467.718.550
19748493,2009-09-11T00:00:00,Interferon-gamma,D23.529.374.440.893
19748493,2009-09-11T00:00:00,Interferon-gamma,D23.529.374.480.350
19748493,2009-09-11T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19748493,2009-09-11T00:00:00,Interferon-gamma,D23.529.718.550
19748493,2009-09-11T00:00:00,Motor Neurons,A08.663.655.500
19748493,2009-09-11T00:00:00,Motor Neurons,A11.671.655.500
19748493,2009-09-11T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
19748493,2009-09-11T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
19748493,2009-09-11T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
19748493,2009-09-11T00:00:00,Phosphorylation,G02.111.087.677
19748493,2009-09-11T00:00:00,Phosphorylation,G02.149.115.677
19748493,2009-09-11T00:00:00,Phosphorylation,G02.149.465.700
19748493,2009-09-11T00:00:00,Phosphorylation,G02.607.750.700
19748493,2009-09-11T00:00:00,Phosphorylation,G03.495.790
19748493,2009-09-11T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
19748493,2009-09-11T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
19748493,2009-09-11T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
19748493,2009-09-11T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
19748493,2009-09-11T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
19748493,2009-09-11T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
19748493,2009-09-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19748493,2009-09-11T00:00:00,Signal Transduction,G02.111.087.800
19748493,2009-09-11T00:00:00,Signal Transduction,G02.149.115.800
19748493,2009-09-11T00:00:00,Signal Transduction,G04.299.880
19748493,2009-09-11T00:00:00,Spinal Cord,A08.186.854
19748493,2009-09-11T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
19748493,2009-09-11T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
19748278,2009-09-12T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
19748278,2009-09-12T00:00:00,Foreign Bodies,C21.866.392
19748278,2009-09-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19748278,2009-09-12T00:00:00,Middle Aged,M01.060.116.630
19748278,2009-09-12T00:00:00,"Pacemaker, Artificial",E07.858.082.748
19751739,2009-09-12T00:00:00,Animals,B01.050
19751739,2009-09-12T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
19751739,2009-09-12T00:00:00,Heart Arrest,C14.280.383
19751739,2009-09-12T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
19751739,2009-09-12T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
19751739,2009-09-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19751739,2009-09-12T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19781848,2009-09-12T00:00:00,Aged,M01.060.116.100
19781848,2009-09-12T00:00:00,Catheterization,E02.148
19781848,2009-09-12T00:00:00,Catheterization,E05.157
19781848,2009-09-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19781848,2009-09-12T00:00:00,Laparoscopy,E01.370.388.250.520
19781848,2009-09-12T00:00:00,Laparoscopy,E04.800.250.520
19781848,2009-09-12T00:00:00,Middle Aged,M01.060.116.630
19781848,2009-09-12T00:00:00,Postoperative Complications,C23.550.767
19781848,2009-09-12T00:00:00,Prostatectomy,E04.950.774.860.625
19781848,2009-09-12T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19781848,2009-09-12T00:00:00,Prostatic Neoplasms,C12.294.260.750
19781848,2009-09-12T00:00:00,Prostatic Neoplasms,C12.294.565.625
19781848,2009-09-12T00:00:00,Prostatic Neoplasms,C12.758.409.750
19781848,2009-09-12T00:00:00,Recovery of Function,G16.757
19781848,2009-09-12T00:00:00,Robotics,H01.671.293.643
19781848,2009-09-12T00:00:00,Robotics,J01.897.104.834
19781848,2009-09-12T00:00:00,Robotics,L01.224.065.630
19781848,2009-09-12T00:00:00,Urinary Bladder,A05.810.890
19781848,2009-09-12T00:00:00,Urinary Incontinence,C12.777.934.852
19781848,2009-09-12T00:00:00,Urinary Incontinence,C13.351.968.934.814
19781848,2009-09-12T00:00:00,Urinary Incontinence,C23.888.942.800
19752222,2009-09-14T00:00:00,Animals,B01.050
19752222,2009-09-14T00:00:00,Complement C3,D12.776.124.050.140
19752222,2009-09-14T00:00:00,Complement C3,D12.776.124.486.274.250
19752222,2009-09-14T00:00:00,Dietary Fats,D10.212.302
19752222,2009-09-14T00:00:00,Dietary Fats,J02.500.375
19752222,2009-09-14T00:00:00,Fatty Liver,C06.552.241
19752222,2009-09-14T00:00:00,Graft Rejection,G12.425.901.545.328
19752222,2009-09-14T00:00:00,Liver,A03.620
19752222,2009-09-14T00:00:00,Liver Transplantation,E04.210.650
19752222,2009-09-14T00:00:00,Liver Transplantation,E04.936.450.490
19752222,2009-09-14T00:00:00,Liver Transplantation,E04.936.580.490
19752222,2009-09-14T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19752222,2009-09-14T00:00:00,Reperfusion Injury,C14.907.725
19752222,2009-09-14T00:00:00,Reperfusion Injury,C23.550.767.877
19752493,2009-09-14T00:00:00,"Models, Theoretical",E05.599
19752493,2009-09-14T00:00:00,Neural Networks (Computer),G17.485
19752493,2009-09-14T00:00:00,Neural Networks (Computer),L01.224.065.605
19752493,2009-09-14T00:00:00,Neural Networks (Computer),L01.725.500
18671270,2009-09-15T00:00:00,Biocompatible Materials,D25.130
18671270,2009-09-15T00:00:00,Biocompatible Materials,D27.720.102.130
18671270,2009-09-15T00:00:00,Biocompatible Materials,J01.637.051.130
18671270,2009-09-15T00:00:00,Cell Adhesion,G04.299.117
18671270,2009-09-15T00:00:00,Cell Survival,G04.299.316
18671270,2009-09-15T00:00:00,Drug Carriers,D26.255.260
18671270,2009-09-15T00:00:00,Drug Carriers,D27.720.280.260
18671270,2009-09-15T00:00:00,Drug Carriers,E02.319.300.380
18671270,2009-09-15T00:00:00,Fibroblasts,A11.329.228
18671270,2009-09-15T00:00:00,Fibroblasts,A11.872.228
18671270,2009-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18671270,2009-09-15T00:00:00,Hydrogels,D20.280.320.375
18671270,2009-09-15T00:00:00,Hydrogels,D26.255.165.320.375
18671270,2009-09-15T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18671270,2009-09-15T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18671270,2009-09-15T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18671270,2009-09-15T00:00:00,Polyethylene Glycols,D02.033.455.250.700
18671270,2009-09-15T00:00:00,Polyethylene Glycols,D05.750.741
18671270,2009-09-15T00:00:00,Polyethylene Glycols,D25.720.741
18671270,2009-09-15T00:00:00,Polyethylene Glycols,J01.637.051.720.741
19514076,2009-09-15T00:00:00,Clinical Trials as Topic,E05.318.760.535
19514076,2009-09-15T00:00:00,Clinical Trials as Topic,E05.337.250
19514076,2009-09-15T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19514076,2009-09-15T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19514076,2009-09-15T00:00:00,"Data Interpretation, Statistical",E05.245.380
19514076,2009-09-15T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19514076,2009-09-15T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19514076,2009-09-15T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19514076,2009-09-15T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19514076,2009-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19514076,2009-09-15T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19514076,2009-09-15T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19514076,2009-09-15T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19514076,2009-09-15T00:00:00,Parkinson Disease,C10.228.662.600.400
19514076,2009-09-15T00:00:00,Parkinson Disease,C10.574.812
19752372,2009-09-15T00:00:00,Animals,B01.050
19752372,2009-09-15T00:00:00,Collagen,D05.750.078.280
19752372,2009-09-15T00:00:00,Collagen,D12.776.860.300.250
19752372,2009-09-15T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
19752372,2009-09-15T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
19752372,2009-09-15T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
19752372,2009-09-15T00:00:00,Myocardial Infarction,C14.280.647.500
19752372,2009-09-15T00:00:00,Myocardial Infarction,C14.907.585.500
19752372,2009-09-15T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
19752372,2009-09-15T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
19752372,2009-09-15T00:00:00,Ventricular Remodeling,C23.300.985
19752372,2009-09-15T00:00:00,Ventricular Remodeling,G09.330.190.962.975
19752377,2009-09-15T00:00:00,Angiotensin II,D06.472.699.094.078
19752377,2009-09-15T00:00:00,Angiotensin II,D12.644.400.070.078
19752377,2009-09-15T00:00:00,Angiotensin II,D12.644.456.073.041
19752377,2009-09-15T00:00:00,Angiotensin II,D12.644.548.058.078
19752377,2009-09-15T00:00:00,Angiotensin II,D12.776.641.650.070.078
19752377,2009-09-15T00:00:00,Angiotensin II,D23.469.050.050.050
19752377,2009-09-15T00:00:00,Animals,B01.050
19752377,2009-09-15T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
19752377,2009-09-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
19752377,2009-09-15T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19752377,2009-09-15T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19752377,2009-09-15T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19752377,2009-09-15T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
19752377,2009-09-15T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
19752377,2009-09-15T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
19752377,2009-09-15T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
19752377,2009-09-15T00:00:00,Signal Transduction,G02.111.087.800
19752377,2009-09-15T00:00:00,Signal Transduction,G02.149.115.800
19752377,2009-09-15T00:00:00,Signal Transduction,G04.299.880
19752377,2009-09-15T00:00:00,"Stress, Mechanical",G01.374.676.830
19752377,2009-09-15T00:00:00,"Stress, Mechanical",G01.595.540.830
19755654,2009-09-15T00:00:00,Adult,M01.060.116
19755654,2009-09-15T00:00:00,Aged,M01.060.116.100
19755654,2009-09-15T00:00:00,Health Education,I02.233.332
19755654,2009-09-15T00:00:00,Health Education,N02.421.143.827.407
19755654,2009-09-15T00:00:00,Health Education,N02.421.726.407
19755654,2009-09-15T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19755654,2009-09-15T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19755654,2009-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19755654,2009-09-15T00:00:00,Middle Aged,M01.060.116.630
19755654,2009-09-15T00:00:00,Risk Factors,E05.318.740.600.800.725
19755654,2009-09-15T00:00:00,Risk Factors,N05.715.350.200.700
19755654,2009-09-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19755654,2009-09-15T00:00:00,Risk Factors,N06.850.490.625.750
19755654,2009-09-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19755654,2009-09-15T00:00:00,Skin Neoplasms,C04.588.805
19755654,2009-09-15T00:00:00,Skin Neoplasms,C17.800.882
19758770,2009-09-15T00:00:00,Adolescent,M01.060.057
19758770,2009-09-15T00:00:00,Adult,M01.060.116
19758770,2009-09-15T00:00:00,Alcoholism,C21.739.100.250
19758770,2009-09-15T00:00:00,Alcoholism,F03.900.100.350
19758770,2009-09-15T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
19758770,2009-09-15T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
19758770,2009-09-15T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
19758770,2009-09-15T00:00:00,Anxiety,F01.470.132
19758770,2009-09-15T00:00:00,Depression,F01.145.126.350
19758770,2009-09-15T00:00:00,Health Surveys,E05.318.308.250
19758770,2009-09-15T00:00:00,Health Surveys,N05.715.360.300.375
19758770,2009-09-15T00:00:00,Health Surveys,N06.850.520.308.250
19758770,2009-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19758770,2009-09-15T00:00:00,Income,N01.824.417
19758770,2009-09-15T00:00:00,Substance-Related Disorders,C21.739
19758770,2009-09-15T00:00:00,Substance-Related Disorders,F03.900
19758770,2009-09-15T00:00:00,Young Adult,M01.060.116.815
19758650,2009-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19758650,2009-09-16T00:00:00,Kidney,A05.810.453
19758650,2009-09-16T00:00:00,Kidney Neoplasms,C04.588.945.947.535
19758650,2009-09-16T00:00:00,Kidney Neoplasms,C12.758.820.750
19758650,2009-09-16T00:00:00,Kidney Neoplasms,C12.777.419.473
19758650,2009-09-16T00:00:00,Kidney Neoplasms,C13.351.937.820.535
19758650,2009-09-16T00:00:00,Kidney Neoplasms,C13.351.968.419.473
19758650,2009-09-16T00:00:00,Laparoscopy,E01.370.388.250.520
19758650,2009-09-16T00:00:00,Laparoscopy,E04.800.250.520
19758650,2009-09-16T00:00:00,Nephrectomy,E04.950.774.435
19758650,2009-09-16T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
19759368,2009-09-16T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
19759368,2009-09-16T00:00:00,Animals,B01.050
19759368,2009-09-16T00:00:00,Gene Expression,G05.355.310
19759368,2009-09-16T00:00:00,Ovary,A05.360.319.114.630
19759368,2009-09-16T00:00:00,Ovary,A05.360.576.497
19759368,2009-09-16T00:00:00,Ovary,A06.407.312.497
19759368,2009-09-16T00:00:00,"RNA, Messenger",D13.444.735.544
19759368,2009-09-16T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
19759368,2009-09-16T00:00:00,"Receptors, Androgen",D12.776.826.750.150
19759368,2009-09-16T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
19759368,2009-09-16T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
19759368,2009-09-16T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
19759368,2009-09-16T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
19759368,2009-09-16T00:00:00,Sex Characteristics,G08.686.815
19759368,2009-09-16T00:00:00,Temperature,G01.906.595
19759368,2009-09-16T00:00:00,Temperature,G16.500.275.063.725.710
19759368,2009-09-16T00:00:00,Temperature,G16.500.750.775.710
19759368,2009-09-16T00:00:00,Temperature,N06.230.150.450
19759368,2009-09-16T00:00:00,Temperature,N06.230.300.100.725.710
19759368,2009-09-16T00:00:00,Testis,A05.360.444.849
19759368,2009-09-16T00:00:00,Testis,A05.360.576.782
19759368,2009-09-16T00:00:00,Testis,A06.407.312.782
19760538,2009-09-16T00:00:00,Cystic Fibrosis,C06.689.202
19760538,2009-09-16T00:00:00,Cystic Fibrosis,C08.381.187
19760538,2009-09-16T00:00:00,Cystic Fibrosis,C16.320.190
19760538,2009-09-16T00:00:00,Cystic Fibrosis,C16.614.213
19760538,2009-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19760538,2009-09-16T00:00:00,Lung Diseases,C08.381
19760538,2009-09-16T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19760538,2009-09-16T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19760538,2009-09-16T00:00:00,Quality of Life,I01.800
19760538,2009-09-16T00:00:00,Quality of Life,K01.752.400.750
19840572,2009-09-16T00:00:00,Aged,M01.060.116.100
19840572,2009-09-16T00:00:00,Anticoagulants,D27.505.954.502.119
19840572,2009-09-16T00:00:00,Atrial Fibrillation,C14.280.067.198
19840572,2009-09-16T00:00:00,Atrial Fibrillation,C23.550.073.198
19840572,2009-09-16T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
19840572,2009-09-16T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
19840572,2009-09-16T00:00:00,"Defibrillators, Implantable",E07.695.175
19840572,2009-09-16T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
19840572,2009-09-16T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
19840572,2009-09-16T00:00:00,Electric Countershock,E02.342.287
19840572,2009-09-16T00:00:00,Heart Atria,A07.541.358
19840572,2009-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19840572,2009-09-16T00:00:00,Thrombosis,C14.907.355.830
19761569,2009-09-17T00:00:00,Algorithms,G17.035
19761569,2009-09-17T00:00:00,Algorithms,L01.224.050
19761569,2009-09-17T00:00:00,Artificial Intelligence,L01.224.065
19761569,2009-09-17T00:00:00,Brain,A08.186.211
19761569,2009-09-17T00:00:00,Brain Mapping,E01.370.350.086
19761569,2009-09-17T00:00:00,Brain Mapping,E01.370.376.149
19761569,2009-09-17T00:00:00,Brain Mapping,E05.132
19761569,2009-09-17T00:00:00,Computational Biology,H01.158.273.180
19761569,2009-09-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19761569,2009-09-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19762372,2009-09-17T00:00:00,DNA Repair,G02.111.087.219
19762372,2009-09-17T00:00:00,DNA Repair,G02.149.115.219
19762372,2009-09-17T00:00:00,DNA Repair,G05.355.195
19762372,2009-09-17T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19762372,2009-09-17T00:00:00,Genetic Predisposition to Disease,G05.380.355
19762372,2009-09-17T00:00:00,Genome-Wide Association Study,E05.318.416.249
19762372,2009-09-17T00:00:00,Genome-Wide Association Study,E05.318.780.392
19762372,2009-09-17T00:00:00,Genome-Wide Association Study,E05.393.385.500
19762372,2009-09-17T00:00:00,Genome-Wide Association Study,E05.393.522.500
19762372,2009-09-17T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19762372,2009-09-17T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19762372,2009-09-17T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19762372,2009-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19762372,2009-09-17T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19764936,2009-09-17T00:00:00,Animals,B01.050
19764936,2009-09-17T00:00:00,Central Nervous System Depressants,D27.505.696.277
19764936,2009-09-17T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
19764936,2009-09-17T00:00:00,Ethanol,D02.033.375
19764936,2009-09-17T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
19764936,2009-09-17T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
19764936,2009-09-17T00:00:00,Neurons,A08.663
19764936,2009-09-17T00:00:00,Neurons,A11.671
19764936,2009-09-17T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19764936,2009-09-17T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
19764936,2009-09-17T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19764936,2009-09-17T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
20633436,2009-09-17T00:00:00,Adult,M01.060.116
20633436,2009-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633436,2009-09-17T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
20633436,2009-09-17T00:00:00,Neural Inhibition,G07.265.337.615
20633436,2009-09-17T00:00:00,Neural Inhibition,G07.700.240.615
20633436,2009-09-17T00:00:00,Neural Inhibition,G11.561.600.625
20633436,2009-09-17T00:00:00,Research Design,E05.581.500
20633436,2009-09-17T00:00:00,Research Design,H01.770.644.728
20633436,2009-09-17T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20633436,2009-09-17T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20633436,2009-09-17T00:00:00,Young Adult,M01.060.116.815
19760466,2009-09-18T00:00:00,Adult,M01.060.116
19760466,2009-09-18T00:00:00,Aged,M01.060.116.100
19760466,2009-09-18T00:00:00,Bariatric Surgery,E02.065.062
19760466,2009-09-18T00:00:00,Bariatric Surgery,E04.062
19760466,2009-09-18T00:00:00,Depression,F01.145.126.350
19760466,2009-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19760466,2009-09-18T00:00:00,Middle Aged,M01.060.116.630
19760466,2009-09-18T00:00:00,"Models, Statistical",E05.318.740.500
19760466,2009-09-18T00:00:00,"Models, Statistical",E05.599.835
19760466,2009-09-18T00:00:00,"Models, Statistical",N05.715.360.750.530
19760466,2009-09-18T00:00:00,"Models, Statistical",N06.850.520.830.500
19760466,2009-09-18T00:00:00,Obesity,C18.654.726.500
19760466,2009-09-18T00:00:00,Obesity,C23.888.144.699.500
19760466,2009-09-18T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19760466,2009-09-18T00:00:00,Obesity,G07.100.100.160.120.699.500
19760466,2009-09-18T00:00:00,Psychiatric Status Rating Scales,F04.586
19760466,2009-09-18T00:00:00,Young Adult,M01.060.116.815
19763254,2009-09-18T00:00:00,Algorithms,G17.035
19763254,2009-09-18T00:00:00,Algorithms,L01.224.050
19763254,2009-09-18T00:00:00,Computer Simulation,L01.224.160
19763254,2009-09-18T00:00:00,Gene Expression Profiling,E05.393.332
19763254,2009-09-18T00:00:00,"Models, Genetic",E05.599.395.397
19763254,2009-09-18T00:00:00,"Models, Statistical",E05.318.740.500
19763254,2009-09-18T00:00:00,"Models, Statistical",E05.599.835
19763254,2009-09-18T00:00:00,"Models, Statistical",N05.715.360.750.530
19763254,2009-09-18T00:00:00,"Models, Statistical",N06.850.520.830.500
19763254,2009-09-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19763254,2009-09-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19763254,2009-09-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19763254,2009-09-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19763254,2009-09-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19763254,2009-09-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19763254,2009-09-18T00:00:00,"Pattern Recognition, Automated",L01.725
19763254,2009-09-18T00:00:00,Software,L01.224.900
19763254,2009-09-18T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19763707,2009-09-18T00:00:00,Adult,M01.060.116
19763707,2009-09-18T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
19763707,2009-09-18T00:00:00,Gastroplasty,E02.065.062.750
19763707,2009-09-18T00:00:00,Gastroplasty,E04.062.750
19763707,2009-09-18T00:00:00,Gastroplasty,E04.210.485
19763707,2009-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19763707,2009-09-18T00:00:00,Laparoscopy,E01.370.388.250.520
19763707,2009-09-18T00:00:00,Laparoscopy,E04.800.250.520
19763707,2009-09-18T00:00:00,Manometry,E05.559
19763707,2009-09-18T00:00:00,Middle Aged,M01.060.116.630
19763707,2009-09-18T00:00:00,"Obesity, Morbid",C18.654.726.500.700
19763707,2009-09-18T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
19763707,2009-09-18T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
19763707,2009-09-18T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
19763707,2009-09-18T00:00:00,Postoperative Complications,C23.550.767
19763707,2009-09-18T00:00:00,Video Recording,L01.240.960
19769800,2009-09-18T00:00:00,Cell Line,A11.251.210
19769800,2009-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19769800,2009-09-18T00:00:00,Immunization,E02.095.465.425.400
19769800,2009-09-18T00:00:00,Immunization,E05.478.550
19769800,2009-09-18T00:00:00,Immunization,N02.421.726.758.310
19769800,2009-09-18T00:00:00,Immunization,N06.850.780.200.425
19769800,2009-09-18T00:00:00,Immunization,N06.850.780.680.310
19769800,2009-09-18T00:00:00,Recombinant Proteins,D12.776.828
19769800,2009-09-18T00:00:00,Respiratory Mucosa,A04.760
19769800,2009-09-18T00:00:00,Respiratory Mucosa,A10.615.550.760
19769800,2009-09-18T00:00:00,Smoking,F01.145.466.753
19769800,2009-09-18T00:00:00,Superoxide Dismutase,D08.811.682.881
19796943,2009-09-18T00:00:00,Apoptosis,G04.299.139.160
19796943,2009-09-18T00:00:00,Catalytic Domain,G02.111.570.120.704
19796943,2009-09-18T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
19796943,2009-09-18T00:00:00,Cell Proliferation,G04.299.233.750
19796943,2009-09-18T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19796943,2009-09-18T00:00:00,Computer Simulation,L01.224.160
19796943,2009-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19796943,2009-09-18T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
19796943,2009-09-18T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
19796943,2009-09-18T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
19796943,2009-09-18T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
19796943,2009-09-18T00:00:00,Phosphorylation,G02.111.087.677
19796943,2009-09-18T00:00:00,Phosphorylation,G02.149.115.677
19796943,2009-09-18T00:00:00,Phosphorylation,G02.149.465.700
19796943,2009-09-18T00:00:00,Phosphorylation,G02.607.750.700
19796943,2009-09-18T00:00:00,Phosphorylation,G03.495.790
19796943,2009-09-18T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19768554,2009-09-19T00:00:00,Adolescent,M01.060.057
19768554,2009-09-19T00:00:00,Adult,M01.060.116
19768554,2009-09-19T00:00:00,Aged,M01.060.116.100
19768554,2009-09-19T00:00:00,Alphapapillomavirus,B04.280.535.050
19768554,2009-09-19T00:00:00,Alphapapillomavirus,B04.909.204.210.655.050
19768554,2009-09-19T00:00:00,Alphapapillomavirus,B04.909.574.204.655.050
19768554,2009-09-19T00:00:00,Alphapapillomavirus,B04.909.624.050
19768554,2009-09-19T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19768554,2009-09-19T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19768554,2009-09-19T00:00:00,Child,M01.060.406
19768554,2009-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19768554,2009-09-19T00:00:00,Incidence,E05.318.308.985.525.375
19768554,2009-09-19T00:00:00,Incidence,L01.280.975.525.375
19768554,2009-09-19T00:00:00,Incidence,N01.224.935.597.500
19768554,2009-09-19T00:00:00,Incidence,N06.850.505.400.975.525.375
19768554,2009-09-19T00:00:00,Incidence,N06.850.520.308.985.525.375
19768554,2009-09-19T00:00:00,Middle Aged,M01.060.116.630
19768554,2009-09-19T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
19768554,2009-09-19T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
19768554,2009-09-19T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
19768554,2009-09-19T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
19768554,2009-09-19T00:00:00,Papillomavirus Infections,C02.256.650
19768554,2009-09-19T00:00:00,Papillomavirus Infections,C02.928.725
19768554,2009-09-19T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19768554,2009-09-19T00:00:00,"RNA, Viral",D13.444.735.828
19768554,2009-09-19T00:00:00,Risk Factors,E05.318.740.600.800.725
19768554,2009-09-19T00:00:00,Risk Factors,N05.715.350.200.700
19768554,2009-09-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19768554,2009-09-19T00:00:00,Risk Factors,N06.850.490.625.750
19768554,2009-09-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19768554,2009-09-19T00:00:00,Sexual Behavior,F01.145.802
19773442,2009-09-22T00:00:00,Amino Acid Sequence,G02.111.570.060
19773442,2009-09-22T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19773442,2009-09-22T00:00:00,Azo Compounds,D02.172
19773442,2009-09-22T00:00:00,Catalytic Domain,G02.111.570.120.704
19773442,2009-09-22T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
19773442,2009-09-22T00:00:00,Glutathione,D12.644.456.448
19773442,2009-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19773442,2009-09-22T00:00:00,"Models, Molecular",E05.599.595
19773442,2009-09-22T00:00:00,Molecular Sequence Data,L01.453.245.667
19773442,2009-09-22T00:00:00,Neoplasms,C04
19773442,2009-09-22T00:00:00,Nitric Oxide,D01.339.387
19773442,2009-09-22T00:00:00,Nitric Oxide,D01.625.550.500
19773442,2009-09-22T00:00:00,Nitric Oxide,D01.625.700.500
19773442,2009-09-22T00:00:00,Nitric Oxide,D01.650.550.587.600
19773442,2009-09-22T00:00:00,Ovarian Neoplasms,C04.588.322.455
19773442,2009-09-22T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
19773442,2009-09-22T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
19773442,2009-09-22T00:00:00,Ovarian Neoplasms,C19.344.410
19773442,2009-09-22T00:00:00,Ovarian Neoplasms,C19.391.630.705
19773442,2009-09-22T00:00:00,Protein Disulfide-Isomerases,D08.811.399.475.800.550
19773442,2009-09-22T00:00:00,Protein Folding,G01.154.100.640
19773442,2009-09-22T00:00:00,Protein Folding,G01.595.100.640
19773442,2009-09-22T00:00:00,Protein Folding,G02.111.087.690
19773442,2009-09-22T00:00:00,Protein Folding,G02.149.115.690
19773442,2009-09-22T00:00:00,Proteomics,H01.158.201.843
19773442,2009-09-22T00:00:00,Proteomics,H01.158.273.180.350.700
19773442,2009-09-22T00:00:00,Proteomics,H01.158.273.343.350.700
19773442,2009-09-22T00:00:00,Proteomics,H01.181.122.738
19773450,2009-09-22T00:00:00,Adenocarcinoma,C04.557.470.200.025
19773450,2009-09-22T00:00:00,Androgens,D27.505.696.399.472.161
19773450,2009-09-22T00:00:00,Animals,B01.050
19773450,2009-09-22T00:00:00,"Disease Models, Animal",C22.232
19773450,2009-09-22T00:00:00,"Disease Models, Animal",E05.598.500
19773450,2009-09-22T00:00:00,"Disease Models, Animal",E05.599.395.080
19773450,2009-09-22T00:00:00,Disease Progression,C23.550.291.656
19773450,2009-09-22T00:00:00,Enzyme Inhibitors,D27.505.519.389
19773450,2009-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19773450,2009-09-22T00:00:00,Oxidative Stress,G03.495.710
19773450,2009-09-22T00:00:00,Oxidative Stress,G07.700.830.750
19773450,2009-09-22T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
19773450,2009-09-22T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19773450,2009-09-22T00:00:00,Prostatic Neoplasms,C12.294.260.750
19773450,2009-09-22T00:00:00,Prostatic Neoplasms,C12.294.565.625
19773450,2009-09-22T00:00:00,Prostatic Neoplasms,C12.758.409.750
19773450,2009-09-22T00:00:00,Reactive Oxygen Species,D01.339.431
19773450,2009-09-22T00:00:00,Reactive Oxygen Species,D01.650.775
19773461,2009-09-22T00:00:00,Adolescent,M01.060.057
19773461,2009-09-22T00:00:00,Brain,A08.186.211
19773461,2009-09-22T00:00:00,Child,M01.060.406
19773461,2009-09-22T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
19773461,2009-09-22T00:00:00,"Child, Preschool",M01.060.406.448
19773461,2009-09-22T00:00:00,Energy Metabolism,G03.495.335
19773461,2009-09-22T00:00:00,Fever,C23.888.119.344
19773461,2009-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19773461,2009-09-22T00:00:00,Incidence,E05.318.308.985.525.375
19773461,2009-09-22T00:00:00,Incidence,L01.280.975.525.375
19773461,2009-09-22T00:00:00,Incidence,N01.224.935.597.500
19773461,2009-09-22T00:00:00,Incidence,N06.850.505.400.975.525.375
19773461,2009-09-22T00:00:00,Incidence,N06.850.520.308.985.525.375
19773461,2009-09-22T00:00:00,Infant,M01.060.703
19773461,2009-09-22T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19773461,2009-09-22T00:00:00,Mitochondria,A11.284.835.626
19773461,2009-09-22T00:00:00,Mitochondrial Diseases,C18.452.660
19773461,2009-09-22T00:00:00,Risk Factors,E05.318.740.600.800.725
19773461,2009-09-22T00:00:00,Risk Factors,N05.715.350.200.700
19773461,2009-09-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19773461,2009-09-22T00:00:00,Risk Factors,N06.850.490.625.750
19773461,2009-09-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19773461,2009-09-22T00:00:00,"Stress, Physiological",G07.700.830
19773461,2009-09-22T00:00:00,Young Adult,M01.060.116.815
19776231,2009-09-23T00:00:00,Bacterial Infections,C01.252
19776231,2009-09-23T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19781548,2009-09-23T00:00:00,Animals,B01.050
19781548,2009-09-23T00:00:00,Cardiovascular Diseases,C14
19781548,2009-09-23T00:00:00,Cardiovascular System,A07
19781548,2009-09-23T00:00:00,Extracellular Matrix,A11.284.295.310
19781548,2009-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19777160,2009-09-24T00:00:00,Apoptosis,G04.299.139.160
19777160,2009-09-24T00:00:00,Cell Cycle,G04.299.134
19777160,2009-09-24T00:00:00,Cell Proliferation,G04.299.233.750
19777160,2009-09-24T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19777160,2009-09-24T00:00:00,Cell Survival,G04.299.316
19777160,2009-09-24T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.644.360.225.500
19777160,2009-09-24T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.167.187.500
19777160,2009-09-24T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.476.225.500
19777160,2009-09-24T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.624.776.355.500
19777160,2009-09-24T00:00:00,Down-Regulation,G02.111.087.225
19777160,2009-09-24T00:00:00,Down-Regulation,G02.149.115.225
19777160,2009-09-24T00:00:00,Down-Regulation,G05.355.315.200
19777160,2009-09-24T00:00:00,Down-Regulation,G07.690.812.230
19777160,2009-09-24T00:00:00,Down-Regulation,G07.700.680.230
19777160,2009-09-24T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19777160,2009-09-24T00:00:00,Flow Cytometry,E05.200.500.386.350
19777160,2009-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19777160,2009-09-24T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19777160,2009-09-24T00:00:00,Mitochondria,A11.284.835.626
19777160,2009-09-24T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
19777160,2009-09-24T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
19777160,2009-09-24T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
19777160,2009-09-24T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
19777160,2009-09-24T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
19777160,2009-09-24T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
19777160,2009-09-24T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
19777160,2009-09-24T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
19777160,2009-09-24T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
19777160,2009-09-24T00:00:00,Pyridines,D03.383.725
19777160,2009-09-24T00:00:00,Signal Transduction,G02.111.087.800
19777160,2009-09-24T00:00:00,Signal Transduction,G02.149.115.800
19777160,2009-09-24T00:00:00,Signal Transduction,G04.299.880
19777160,2009-09-24T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
19777160,2009-09-24T00:00:00,Telomerase,D12.776.157.725.500.921
19777160,2009-09-24T00:00:00,Telomerase,D12.776.664.962.500.921
19777160,2009-09-24T00:00:00,Treatment Outcome,E01.789.800
19777160,2009-09-24T00:00:00,Treatment Outcome,N04.761.559.590.800
19777160,2009-09-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19777160,2009-09-24T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
19777160,2009-09-24T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
19777160,2009-09-24T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
19777160,2009-09-24T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
19777160,2009-09-24T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
19777160,2009-09-24T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
19777192,2009-09-24T00:00:00,Adolescent,M01.060.057
19777192,2009-09-24T00:00:00,Adult,M01.060.116
19777192,2009-09-24T00:00:00,Aged,M01.060.116.100
19777192,2009-09-24T00:00:00,Hepatectomy,E04.210.556
19777192,2009-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19777192,2009-09-24T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
19777192,2009-09-24T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
19777192,2009-09-24T00:00:00,Liver Neoplasms,C04.588.274.623
19777192,2009-09-24T00:00:00,Liver Neoplasms,C06.301.623
19777192,2009-09-24T00:00:00,Liver Neoplasms,C06.552.697
19777192,2009-09-24T00:00:00,"Lymphocytes, Tumor-Infiltrating",A11.118.637.555.567.650
19777192,2009-09-24T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.145.229.637.555.567.650
19777192,2009-09-24T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.382.490.555.567.650
19777192,2009-09-24T00:00:00,Melanoma,C04.557.465.625.650.510
19777192,2009-09-24T00:00:00,Melanoma,C04.557.580.625.650.510
19777192,2009-09-24T00:00:00,Melanoma,C04.557.665.510
19777192,2009-09-24T00:00:00,Middle Aged,M01.060.116.630
19777192,2009-09-24T00:00:00,Neoplasm Staging,E01.370.550
19777192,2009-09-24T00:00:00,Skin Neoplasms,C04.588.805
19777192,2009-09-24T00:00:00,Skin Neoplasms,C17.800.882
19777192,2009-09-24T00:00:00,Treatment Outcome,E01.789.800
19777192,2009-09-24T00:00:00,Treatment Outcome,N04.761.559.590.800
19777192,2009-09-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19777192,2009-09-24T00:00:00,Young Adult,M01.060.116.815
19778517,2009-09-24T00:00:00,Bayes Theorem,E05.318.740.600.200
19778517,2009-09-24T00:00:00,Bayes Theorem,N05.715.360.750.625.150
19778517,2009-09-24T00:00:00,Bayes Theorem,N06.850.520.830.600.200
19778517,2009-09-24T00:00:00,Brain Mapping,E01.370.350.086
19778517,2009-09-24T00:00:00,Brain Mapping,E01.370.376.149
19778517,2009-09-24T00:00:00,Brain Mapping,E05.132
19778517,2009-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19778517,2009-09-24T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19778517,2009-09-24T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19778517,2009-09-24T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19778517,2009-09-24T00:00:00,"Models, Neurological",E05.599.395.642
19778517,2009-09-24T00:00:00,Oxygen,D01.268.185.550
19778517,2009-09-24T00:00:00,Oxygen,D01.362.670
19778517,2009-09-24T00:00:00,Photic Stimulation,E05.723.729
19778517,2009-09-24T00:00:00,Semantics,L01.143.506.598.745
19778517,2009-09-24T00:00:00,Visual Cortex,A08.186.211.730.885.287.500.571.735
19778517,2009-09-24T00:00:00,Visual Perception,F02.463.593.932
19781909,2009-09-24T00:00:00,Animals,B01.050
19781909,2009-09-24T00:00:00,Apoptosis,G04.299.139.160
19781909,2009-09-24T00:00:00,Biological Markers,D23.101
19781909,2009-09-24T00:00:00,Cell Proliferation,G04.299.233.750
19781909,2009-09-24T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19781909,2009-09-24T00:00:00,Cell Size,G04.190
19781909,2009-09-24T00:00:00,"Constriction, Pathologic",C23.300.287
19781909,2009-09-24T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
19781909,2009-09-24T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
19781909,2009-09-24T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
19781909,2009-09-24T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
19781909,2009-09-24T00:00:00,Phenotype,G05.695
19781909,2009-09-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19781909,2009-09-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19781909,2009-09-24T00:00:00,"Stress, Mechanical",G01.374.676.830
19781909,2009-09-24T00:00:00,"Stress, Mechanical",G01.595.540.830
19782005,2009-09-24T00:00:00,Adolescent,M01.060.057
19782005,2009-09-24T00:00:00,Adult,M01.060.116
19782005,2009-09-24T00:00:00,Aged,M01.060.116.100
19782005,2009-09-24T00:00:00,Delivery of Health Care,N04.590.374
19782005,2009-09-24T00:00:00,Delivery of Health Care,N05.300
19782005,2009-09-24T00:00:00,Employment,N01.824.245
19782005,2009-09-24T00:00:00,Epilepsy,C10.228.140.490
19782005,2009-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19782005,2009-09-24T00:00:00,Middle Aged,M01.060.116.630
19782005,2009-09-24T00:00:00,Quality of Life,I01.800
19782005,2009-09-24T00:00:00,Quality of Life,K01.752.400.750
19782005,2009-09-24T00:00:00,Questionnaires,E05.318.308.750
19782005,2009-09-24T00:00:00,Questionnaires,L01.280.800
19782005,2009-09-24T00:00:00,Questionnaires,N05.715.360.300.695
19782005,2009-09-24T00:00:00,Questionnaires,N06.850.520.308.750
19782005,2009-09-24T00:00:00,Self Efficacy,F01.752.747.792.700
19782005,2009-09-24T00:00:00,Young Adult,M01.060.116.815
19782156,2009-09-24T00:00:00,Anticonvulsants,D27.505.954.427.080
19782156,2009-09-24T00:00:00,Data Collection,E05.318.308
19782156,2009-09-24T00:00:00,Data Collection,L01.280
19782156,2009-09-24T00:00:00,Data Collection,N05.715.360.300
19782156,2009-09-24T00:00:00,Data Collection,N06.850.520.308
19782156,2009-09-24T00:00:00,Documentation,L01.453.245
19782156,2009-09-24T00:00:00,Double-Blind Method,E05.318.780.300
19782156,2009-09-24T00:00:00,Double-Blind Method,E05.581.500.300
19782156,2009-09-24T00:00:00,Double-Blind Method,N05.715.360.780.320
19782156,2009-09-24T00:00:00,Double-Blind Method,N06.850.520.445.300
19782156,2009-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19782156,2009-09-24T00:00:00,Internet,L01.224.230.110.500
19782156,2009-09-24T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
19782156,2009-09-24T00:00:00,Multicenter Studies as Topic,E05.337.250.500
19782156,2009-09-24T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
19782156,2009-09-24T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
19782156,2009-09-24T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19782156,2009-09-24T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19782156,2009-09-24T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19782156,2009-09-24T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19782156,2009-09-24T00:00:00,Serum Albumin,D12.776.034.841
19782156,2009-09-24T00:00:00,Serum Albumin,D12.776.124.050.700
19782156,2009-09-24T00:00:00,Serum Albumin,D12.776.124.727
19782156,2009-09-24T00:00:00,Status Epilepticus,C10.228.140.490.690
19797187,2009-09-24T00:00:00,Aged,M01.060.116.100
19797187,2009-09-24T00:00:00,Blood Pressure,E01.370.600.875.249
19797187,2009-09-24T00:00:00,Blood Pressure,G09.330.380.076
19797187,2009-09-24T00:00:00,Brain Ischemia,C10.228.140.300.150
19797187,2009-09-24T00:00:00,Brain Ischemia,C14.907.253.092
19797187,2009-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19797187,2009-09-24T00:00:00,Hypertension,C14.907.489
19797187,2009-09-24T00:00:00,Middle Aged,M01.060.116.630
19797187,2009-09-24T00:00:00,Stroke,C10.228.140.300.775
19797187,2009-09-24T00:00:00,Stroke,C14.907.253.855
19778726,2009-09-25T00:00:00,Animals,B01.050
19778726,2009-09-25T00:00:00,Cell Line,A11.251.210
19778726,2009-09-25T00:00:00,Enzyme Inhibitors,D27.505.519.389
19778726,2009-09-25T00:00:00,Gene Silencing,G05.355.315.203.374
19778726,2009-09-25T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
19778726,2009-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19778726,2009-09-25T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19778726,2009-09-25T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19778726,2009-09-25T00:00:00,Recombinant Proteins,D12.776.828
19783527,2009-09-25T00:00:00,Adult,M01.060.116
19783527,2009-09-25T00:00:00,African Americans,M01.686.508.100.100
19783527,2009-09-25T00:00:00,African Americans,M01.686.754.100
19783527,2009-09-25T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19783527,2009-09-25T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19783527,2009-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19783527,2009-09-25T00:00:00,Lipoproteins,D10.532
19783527,2009-09-25T00:00:00,Lipoproteins,D12.776.521
19783527,2009-09-25T00:00:00,Middle Aged,M01.060.116.630
19783527,2009-09-25T00:00:00,Phenotype,G05.695
19783527,2009-09-25T00:00:00,United States,Z01.107.567.875
19784636,2009-09-26T00:00:00,Amphetamine-Related Disorders,C21.739.225
19784636,2009-09-26T00:00:00,Amphetamine-Related Disorders,F03.900.225
19784636,2009-09-26T00:00:00,Animals,B01.050
19784636,2009-09-26T00:00:00,Central Nervous System Stimulants,D27.505.696.282
19784636,2009-09-26T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
19784636,2009-09-26T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19784636,2009-09-26T00:00:00,Dextroamphetamine,D02.092.471.683.152.110.200
19784636,2009-09-26T00:00:00,Impulsive Behavior,F01.145.527
19784636,2009-09-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19784636,2009-09-26T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19784636,2009-09-26T00:00:00,Self Administration,E02.319.890
19784636,2009-09-26T00:00:00,Self Administration,E02.900.890
19784636,2009-09-26T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19784636,2009-09-26T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19786066,2009-09-26T00:00:00,Actins,D05.750.078.730.250
19786066,2009-09-26T00:00:00,Actins,D12.776.210.500.100
19786066,2009-09-26T00:00:00,Actins,D12.776.220.525.255
19786066,2009-09-26T00:00:00,Cell Lineage,G04.172
19786066,2009-09-26T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
19786066,2009-09-26T00:00:00,Cell Lineage,G08.686.155
19786066,2009-09-26T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
19786066,2009-09-26T00:00:00,Collagen Type I,D05.750.078.280.300.100
19786066,2009-09-26T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
19786066,2009-09-26T00:00:00,Fibroblasts,A11.329.228
19786066,2009-09-26T00:00:00,Fibroblasts,A11.872.228
19786066,2009-09-26T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19786066,2009-09-26T00:00:00,Flow Cytometry,E05.200.500.386.350
19786066,2009-09-26T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
19786066,2009-09-26T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
19786066,2009-09-26T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
19786066,2009-09-26T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
19786066,2009-09-26T00:00:00,Hematopoietic Stem Cell Mobilization,E02.095.410
19786066,2009-09-26T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
19786066,2009-09-26T00:00:00,Hematopoietic Stem Cells,A11.148.378
19786066,2009-09-26T00:00:00,Hematopoietic Stem Cells,A11.872.378
19786066,2009-09-26T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
19786066,2009-09-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19786066,2009-09-26T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
19786066,2009-09-26T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
19786066,2009-09-26T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
19786066,2009-09-26T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
19786066,2009-09-26T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
19786066,2009-09-26T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
19786066,2009-09-26T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
19786066,2009-09-26T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
19786066,2009-09-26T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
19786066,2009-09-26T00:00:00,"Muscle, Smooth",A02.633.570
19786066,2009-09-26T00:00:00,"Muscle, Smooth",A10.690.467
19784073,2009-09-28T00:00:00,Breast Neoplasms,C04.588.180
19784073,2009-09-28T00:00:00,Breast Neoplasms,C17.800.090.500
19784073,2009-09-28T00:00:00,Cell Proliferation,G04.299.233.750
19784073,2009-09-28T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19784073,2009-09-28T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
19784073,2009-09-28T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
19784073,2009-09-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19784073,2009-09-28T00:00:00,"RNA, Messenger",D13.444.735.544
19786699,2009-09-29T00:00:00,Adult,M01.060.116
19786699,2009-09-29T00:00:00,Aged,M01.060.116.100
19786699,2009-09-29T00:00:00,Brain Ischemia,C10.228.140.300.150
19786699,2009-09-29T00:00:00,Brain Ischemia,C14.907.253.092
19786699,2009-09-29T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
19786699,2009-09-29T00:00:00,Carotid Stenosis,C14.907.137.230
19786699,2009-09-29T00:00:00,Carotid Stenosis,C14.907.253.123.360
19786699,2009-09-29T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19786699,2009-09-29T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19786699,2009-09-29T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19786699,2009-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19786699,2009-09-29T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
19786699,2009-09-29T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
19786699,2009-09-29T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
19786699,2009-09-29T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
19786699,2009-09-29T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
19786699,2009-09-29T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
19786699,2009-09-29T00:00:00,Middle Aged,M01.060.116.630
19786699,2009-09-29T00:00:00,Pilot Projects,E05.318.760.750
19786699,2009-09-29T00:00:00,Pilot Projects,E05.337.737
19786699,2009-09-29T00:00:00,Pilot Projects,N05.715.360.775.625
19786699,2009-09-29T00:00:00,Pilot Projects,N06.850.520.450.720
19786699,2009-09-29T00:00:00,Time Factors,G01.910.857
19786699,2009-09-29T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
19786699,2009-09-29T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
19786699,2009-09-29T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
19786699,2009-09-29T00:00:00,Tissue Plasminogen Activator,D23.119.970
19786699,2009-09-29T00:00:00,Treatment Outcome,E01.789.800
19786699,2009-09-29T00:00:00,Treatment Outcome,N04.761.559.590.800
19786699,2009-09-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19786699,2009-09-29T00:00:00,Young Adult,M01.060.116.815
19794104,2009-09-30T00:00:00,Adolescent,M01.060.057
19794104,2009-09-30T00:00:00,Brain,A08.186.211
19794104,2009-09-30T00:00:00,Brain Ischemia,C10.228.140.300.150
19794104,2009-09-30T00:00:00,Brain Ischemia,C14.907.253.092
19794104,2009-09-30T00:00:00,Brain Mapping,E01.370.350.086
19794104,2009-09-30T00:00:00,Brain Mapping,E01.370.376.149
19794104,2009-09-30T00:00:00,Brain Mapping,E05.132
19794104,2009-09-30T00:00:00,"Diagnosis, Differential",E01.171
19794104,2009-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19794104,2009-09-30T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19794104,2009-09-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19794104,2009-09-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19794104,2009-09-30T00:00:00,Multiple Sclerosis,C10.114.375.500
19794104,2009-09-30T00:00:00,Multiple Sclerosis,C10.314.350.500
19794104,2009-09-30T00:00:00,Multiple Sclerosis,C20.111.258.250.500
19794104,2009-09-30T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
19794104,2009-09-30T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
19794104,2009-09-30T00:00:00,Stroke,C10.228.140.300.775
19794104,2009-09-30T00:00:00,Stroke,C14.907.253.855
19794132,2009-09-30T00:00:00,Aged,M01.060.116.100
19794132,2009-09-30T00:00:00,Chronic Disease,C23.550.291.500
19794132,2009-09-30T00:00:00,Disability Evaluation,E01.370.400
19794132,2009-09-30T00:00:00,Electromyography,E01.370.405.255
19794132,2009-09-30T00:00:00,Electromyography,E01.370.530.255
19794132,2009-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19794132,2009-09-30T00:00:00,Leg,A01.378.610.500
19794132,2009-09-30T00:00:00,Middle Aged,M01.060.116.630
19794132,2009-09-30T00:00:00,"Muscle, Skeletal",A02.633.567
19794132,2009-09-30T00:00:00,"Muscle, Skeletal",A10.690.552.500
19794132,2009-09-30T00:00:00,Paresis,C10.597.636
19794132,2009-09-30T00:00:00,Paresis,C23.888.592.643
19794132,2009-09-30T00:00:00,Stroke,C10.228.140.300.775
19794132,2009-09-30T00:00:00,Stroke,C14.907.253.855
19794132,2009-09-30T00:00:00,Walking,G11.427.590.530.568.900
19794132,2009-09-30T00:00:00,Walking,G11.427.590.530.698.940
19794132,2009-09-30T00:00:00,Walking,I03.450.642.845.940
19254115,2009-10-01T00:00:00,Animals,B01.050
19254115,2009-10-01T00:00:00,Blood Vessel Prosthesis,E07.695.110
19254115,2009-10-01T00:00:00,Elastin,D05.750.078.421
19254115,2009-10-01T00:00:00,Elastin,D12.776.860.300.350
19254115,2009-10-01T00:00:00,Hydrolyzable Tannins,D02.241.223.100.380.350.299
19254115,2009-10-01T00:00:00,Hydrolyzable Tannins,D02.241.511.390.350.299
19254115,2009-10-01T00:00:00,Hydrolyzable Tannins,D02.755.410.350.299
19254115,2009-10-01T00:00:00,Hydrolyzable Tannins,D05.750.078.937.214
19254115,2009-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19254115,2009-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19254115,2009-10-01T00:00:00,Swine,B01.050.150.900.649.077.880
19254115,2009-10-01T00:00:00,Tissue Engineering,E05.200.249.750
19254115,2009-10-01T00:00:00,Tissue Scaffolds,E07.206.627
19254115,2009-10-01T00:00:00,Tissue Scaffolds,E07.695.825
19398927,2009-10-01T00:00:00,Esophagus,A03.556.875.500
19398927,2009-10-01T00:00:00,Gastric Acid,A12.200.307.603
19398927,2009-10-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
19398927,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19398927,2009-10-01T00:00:00,Manometry,E05.559
19398927,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
19398927,2009-10-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
19398927,2009-10-01T00:00:00,Time Factors,G01.910.857
19398927,2009-10-01T00:00:00,Treatment Outcome,E01.789.800
19398927,2009-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19398927,2009-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19404878,2009-10-01T00:00:00,Adolescent,M01.060.057
19404878,2009-10-01T00:00:00,Adolescent Behavior,F01.145.022
19404878,2009-10-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19404878,2009-10-01T00:00:00,Body Mass Index,E05.041.124.125
19404878,2009-10-01T00:00:00,Body Mass Index,G07.100.100.125
19404878,2009-10-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19404878,2009-10-01T00:00:00,Child,M01.060.406
19404878,2009-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19404878,2009-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19404878,2009-10-01T00:00:00,Health Surveys,E05.318.308.250
19404878,2009-10-01T00:00:00,Health Surveys,N05.715.360.300.375
19404878,2009-10-01T00:00:00,Health Surveys,N06.850.520.308.250
19404878,2009-10-01T00:00:00,Hispanic Americans,M01.686.754.441
19404878,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19404878,2009-10-01T00:00:00,Life Style,F01.829.458
19404878,2009-10-01T00:00:00,Motor Activity,F01.145.632
19404878,2009-10-01T00:00:00,Motor Activity,G11.427.590.530.698
19404878,2009-10-01T00:00:00,Obesity,C18.654.726.500
19404878,2009-10-01T00:00:00,Obesity,C23.888.144.699.500
19404878,2009-10-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19404878,2009-10-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19404878,2009-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19404878,2009-10-01T00:00:00,Risk Factors,N05.715.350.200.700
19404878,2009-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19404878,2009-10-01T00:00:00,Risk Factors,N06.850.490.625.750
19404878,2009-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19404878,2009-10-01T00:00:00,United States,Z01.107.567.875
19473291,2009-10-01T00:00:00,Animals,B01.050
19473291,2009-10-01T00:00:00,Apoptosis,G04.299.139.160
19473291,2009-10-01T00:00:00,Cell Proliferation,G04.299.233.750
19473291,2009-10-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19473291,2009-10-01T00:00:00,Cell Survival,G04.299.316
19473291,2009-10-01T00:00:00,Combined Modality Therapy,E02.186
19473291,2009-10-01T00:00:00,Down-Regulation,G02.111.087.225
19473291,2009-10-01T00:00:00,Down-Regulation,G02.149.115.225
19473291,2009-10-01T00:00:00,Down-Regulation,G05.355.315.200
19473291,2009-10-01T00:00:00,Down-Regulation,G07.690.812.230
19473291,2009-10-01T00:00:00,Down-Regulation,G07.700.680.230
19473291,2009-10-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19473291,2009-10-01T00:00:00,Flow Cytometry,E05.200.500.386.350
19473291,2009-10-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19473291,2009-10-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
19473291,2009-10-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
19473291,2009-10-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
19473291,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19473291,2009-10-01T00:00:00,Neoplasm Invasiveness,C04.697.645
19473291,2009-10-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
19473291,2009-10-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
19473291,2009-10-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
19473291,2009-10-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
19473291,2009-10-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
19473291,2009-10-01T00:00:00,"RNA, Messenger",D13.444.735.544
19488989,2009-10-01T00:00:00,Artifacts,E05.047
19488989,2009-10-01T00:00:00,Brain,A08.186.211
19488989,2009-10-01T00:00:00,Equipment Failure Analysis,E05.325.192
19488989,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19488989,2009-10-01T00:00:00,Image Enhancement,E01.370.350.600.350
19488989,2009-10-01T00:00:00,Image Enhancement,L01.224.308.380
19488989,2009-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19488989,2009-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19488989,2009-10-01T00:00:00,Optical Devices,E07.632
19569235,2009-10-01T00:00:00,Breast Neoplasms,C04.588.180
19569235,2009-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
19569235,2009-10-01T00:00:00,DNA Methylation,G02.111.087.029.538.161
19569235,2009-10-01T00:00:00,DNA Methylation,G02.111.087.218
19569235,2009-10-01T00:00:00,DNA Methylation,G02.149.115.029.538.161
19569235,2009-10-01T00:00:00,DNA Methylation,G02.149.115.218
19569235,2009-10-01T00:00:00,DNA Methylation,G03.495.130.538.161
19569235,2009-10-01T00:00:00,DNA Methylation,G05.355.190
19569235,2009-10-01T00:00:00,Down-Regulation,G02.111.087.225
19569235,2009-10-01T00:00:00,Down-Regulation,G02.149.115.225
19569235,2009-10-01T00:00:00,Down-Regulation,G05.355.315.200
19569235,2009-10-01T00:00:00,Down-Regulation,G07.690.812.230
19569235,2009-10-01T00:00:00,Down-Regulation,G07.700.680.230
19569235,2009-10-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19569235,2009-10-01T00:00:00,Gene Silencing,G05.355.315.203.374
19569235,2009-10-01T00:00:00,Homeodomain Proteins,D12.776.260.400
19569235,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19569235,2009-10-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
19569235,2009-10-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
19569235,2009-10-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
19569235,2009-10-01T00:00:00,Membrane Proteins,D12.776.543
19569235,2009-10-01T00:00:00,Signal Transduction,G02.111.087.800
19569235,2009-10-01T00:00:00,Signal Transduction,G02.149.115.800
19569235,2009-10-01T00:00:00,Signal Transduction,G04.299.880
19569235,2009-10-01T00:00:00,"Transduction, Genetic",E05.393.350.800
19569235,2009-10-01T00:00:00,"Transduction, Genetic",G05.355.760.850
19569235,2009-10-01T00:00:00,Wnt Proteins,D12.644.276.984
19569235,2009-10-01T00:00:00,Wnt Proteins,D12.776.467.984
19569235,2009-10-01T00:00:00,Wnt Proteins,D23.529.984
19618437,2009-10-01T00:00:00,Adult,M01.060.116
19618437,2009-10-01T00:00:00,Aged,M01.060.116.100
19618437,2009-10-01T00:00:00,Ascitic Fluid,A12.207.119
19618437,2009-10-01T00:00:00,"Diagnosis, Differential",E01.171
19618437,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19618437,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
19618437,2009-10-01T00:00:00,Paracentesis,E01.450.865.632.600
19618437,2009-10-01T00:00:00,Paracentesis,E02.800.550
19618437,2009-10-01T00:00:00,Paracentesis,E04.581
19672652,2009-10-01T00:00:00,Bariatric Surgery,E02.065.062
19672652,2009-10-01T00:00:00,Bariatric Surgery,E04.062
19672652,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19672652,2009-10-01T00:00:00,Neoplasms,C04
19672652,2009-10-01T00:00:00,Obesity,C18.654.726.500
19672652,2009-10-01T00:00:00,Obesity,C23.888.144.699.500
19672652,2009-10-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19672652,2009-10-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19672652,2009-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19672652,2009-10-01T00:00:00,Risk Factors,N05.715.350.200.700
19672652,2009-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19672652,2009-10-01T00:00:00,Risk Factors,N06.850.490.625.750
19672652,2009-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19672652,2009-10-01T00:00:00,Weight Loss,C23.888.144.243.963
19672652,2009-10-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19672949,2009-10-01T00:00:00,Algorithms,G17.035
19672949,2009-10-01T00:00:00,Algorithms,L01.224.050
19672949,2009-10-01T00:00:00,Contrast Media,D27.720.259
19672949,2009-10-01T00:00:00,Electromagnetic Fields,G01.201.260
19672949,2009-10-01T00:00:00,Electromagnetic Fields,G01.201.875.240
19672949,2009-10-01T00:00:00,Gadolinium DTPA,D01.632.400
19672949,2009-10-01T00:00:00,Gadolinium DTPA,D02.092.782.590.401
19672949,2009-10-01T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
19672949,2009-10-01T00:00:00,Gadolinium DTPA,D02.691.400
19672949,2009-10-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19672949,2009-10-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19672949,2009-10-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19672949,2009-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19672949,2009-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19672949,2009-10-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
19672949,2009-10-01T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
19672949,2009-10-01T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
19685509,2009-10-01T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
19685509,2009-10-01T00:00:00,Animals,B01.050
19685509,2009-10-01T00:00:00,Glycosaminoglycans,D09.698.373
19685509,2009-10-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D08.811.277.040.025.810
19685509,2009-10-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.162.780
19685509,2009-10-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.250.880
19685509,2009-10-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.162.800
19685509,2009-10-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.250.890
19718758,2009-10-01T00:00:00,Adolescent,M01.060.057
19718758,2009-10-01T00:00:00,Child,M01.060.406
19718758,2009-10-01T00:00:00,Child Abuse,I01.198.240.856.350.250
19718758,2009-10-01T00:00:00,Child Abuse,I01.880.735.900.350.250
19718758,2009-10-01T00:00:00,Child Abuse,I01.880.787.293.292
19718758,2009-10-01T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
19718758,2009-10-01T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
19718758,2009-10-01T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
19718758,2009-10-01T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
19718758,2009-10-01T00:00:00,Chronic Disease,C23.550.291.500
19718758,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19718758,2009-10-01T00:00:00,Military Personnel,M01.526.625
19718758,2009-10-01T00:00:00,Regression Analysis,E05.318.740.750
19718758,2009-10-01T00:00:00,Regression Analysis,N05.715.360.750.695
19718758,2009-10-01T00:00:00,Regression Analysis,N06.850.520.830.750
19718758,2009-10-01T00:00:00,"Resilience, Psychological",F02.940
19718758,2009-10-01T00:00:00,Spouse Abuse,I01.198.240.856.350.750
19718758,2009-10-01T00:00:00,Spouse Abuse,I01.880.735.900.350.750
19718758,2009-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19718758,2009-10-01T00:00:00,United States,Z01.107.567.875
19730243,2009-10-01T00:00:00,African Americans,M01.686.508.100.100
19730243,2009-10-01T00:00:00,African Americans,M01.686.754.100
19730243,2009-10-01T00:00:00,Aged,M01.060.116.100
19730243,2009-10-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19730243,2009-10-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19730243,2009-10-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19730243,2009-10-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19730243,2009-10-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19730243,2009-10-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19730243,2009-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19730243,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19730243,2009-10-01T00:00:00,Income,N01.824.417
19730243,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
19730243,2009-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19730243,2009-10-01T00:00:00,Risk Factors,N05.715.350.200.700
19730243,2009-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19730243,2009-10-01T00:00:00,Risk Factors,N06.850.490.625.750
19730243,2009-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19730243,2009-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19730243,2009-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19730243,2009-10-01T00:00:00,United States,Z01.107.567.875
19738462,2009-10-01T00:00:00,Animals,B01.050
19738462,2009-10-01T00:00:00,Columbidae,B01.050.150.900.248.165.150
19738462,2009-10-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19738462,2009-10-01T00:00:00,Dextroamphetamine,D02.092.471.683.152.110.200
19738462,2009-10-01T00:00:00,Discrimination Learning,F02.463.425.280
19738462,2009-10-01T00:00:00,Drug Tolerance,G07.690.812.260
19738462,2009-10-01T00:00:00,Drug Tolerance,G07.700.680.260
19738462,2009-10-01T00:00:00,Time Factors,G01.910.857
19752747,2009-10-01T00:00:00,Cell Proliferation,G04.299.233.750
19752747,2009-10-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19752747,2009-10-01T00:00:00,Disease Progression,C23.550.291.656
19752747,2009-10-01T00:00:00,"Epitopes, T-Lymphocyte",D23.050.550.402
19752747,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19752747,2009-10-01T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
19752747,2009-10-01T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
19752747,2009-10-01T00:00:00,"Lymphocytes, Tumor-Infiltrating",A11.118.637.555.567.650
19752747,2009-10-01T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.145.229.637.555.567.650
19752747,2009-10-01T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.382.490.555.567.650
19752747,2009-10-01T00:00:00,Melanoma,C04.557.465.625.650.510
19752747,2009-10-01T00:00:00,Melanoma,C04.557.580.625.650.510
19752747,2009-10-01T00:00:00,Melanoma,C04.557.665.510
19752747,2009-10-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
19752747,2009-10-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
19752747,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
19754456,2009-10-01T00:00:00,Animals,B01.050
19754456,2009-10-01T00:00:00,Anticonvulsants,D27.505.954.427.080
19754456,2009-10-01T00:00:00,Bipolar Disorder,F03.600.150.150
19754456,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19754456,2009-10-01T00:00:00,Treatment Outcome,E01.789.800
19754456,2009-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19754456,2009-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19754456,2009-10-01T00:00:00,Triazines,D03.383.931
19763125,2009-10-01T00:00:00,Breast Neoplasms,C04.588.180
19763125,2009-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
19763125,2009-10-01T00:00:00,Cholecalciferol,D04.808.247.222.159
19763125,2009-10-01T00:00:00,Cholecalciferol,D04.808.247.808.146
19763125,2009-10-01T00:00:00,Cholecalciferol,D04.808.812.768.196
19763125,2009-10-01T00:00:00,Cholecalciferol,D10.570.938.146
19763125,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19763125,2009-10-01T00:00:00,Vitamin D,D04.808.812.768
19763125,2009-10-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19764032,2009-10-01T00:00:00,"Abnormalities, Multiple",C16.131.077
19764032,2009-10-01T00:00:00,Cilia,A11.284.180.165
19764032,2009-10-01T00:00:00,Fetus,A16.378
19764032,2009-10-01T00:00:00,Gene Deletion,G05.355.600.800.320
19764032,2009-10-01T00:00:00,Gene Deletion,G05.365.590.762.320
19764032,2009-10-01T00:00:00,Genetic Testing,E01.370.427
19764032,2009-10-01T00:00:00,Genetic Testing,E05.393.435
19764032,2009-10-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
19764032,2009-10-01T00:00:00,Genetic Testing,N02.421.308.430
19764032,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19764032,2009-10-01T00:00:00,Neoplasm Proteins,D12.776.624
19764032,2009-10-01T00:00:00,"RNA, Messenger",D13.444.735.544
19764032,2009-10-01T00:00:00,Syndrome,C23.550.288.500
19766781,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19766781,2009-10-01T00:00:00,Tissue Donors,M01.898
19766781,2009-10-01T00:00:00,Tissue and Organ Procurement,N02.421.911
19786212,2009-10-01T00:00:00,Chronic Disease,C23.550.291.500
19786212,2009-10-01T00:00:00,Endoscopy,E01.370.388.250
19786212,2009-10-01T00:00:00,Endoscopy,E04.800.250
19786212,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19786212,2009-10-01T00:00:00,Inflammation,C23.550.470
19786212,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
19786212,2009-10-01T00:00:00,Quality of Life,I01.800
19786212,2009-10-01T00:00:00,Quality of Life,K01.752.400.750
19786212,2009-10-01T00:00:00,Rhinitis,C08.460.799
19786212,2009-10-01T00:00:00,Rhinitis,C08.730.674
19786212,2009-10-01T00:00:00,Rhinitis,C09.603.799
19786212,2009-10-01T00:00:00,Sinusitis,C08.460.692.752
19786212,2009-10-01T00:00:00,Sinusitis,C08.730.749
19786212,2009-10-01T00:00:00,Sinusitis,C09.603.692.752
19786212,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19786212,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19786212,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19786212,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19786212,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19787707,2009-10-01T00:00:00,Animals,B01.050
19787707,2009-10-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
19787707,2009-10-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
19787707,2009-10-01T00:00:00,Epithelial Cells,A11.436
19787707,2009-10-01T00:00:00,Forecasting,I01.320
19787707,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19787707,2009-10-01T00:00:00,Mesoderm,A16.504.660
19787707,2009-10-01T00:00:00,Signal Transduction,G02.111.087.800
19787707,2009-10-01T00:00:00,Signal Transduction,G02.149.115.800
19787707,2009-10-01T00:00:00,Signal Transduction,G04.299.880
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
19787707,2009-10-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
19787707,2009-10-01T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
19788970,2009-10-01T00:00:00,Adult,M01.060.116
19788970,2009-10-01T00:00:00,"Cerclage, Cervical",E04.520.100
19788970,2009-10-01T00:00:00,Cervix Uteri,A05.360.319.679.256
19788970,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19788970,2009-10-01T00:00:00,Pregnancy,G08.686.785.760.769
19788970,2009-10-01T00:00:00,Pregnancy Outcome,E01.789.700
19788970,2009-10-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
19788970,2009-10-01T00:00:00,Premature Birth,C13.703.420.491.500
19788970,2009-10-01T00:00:00,"Ultrasonography, Prenatal",E01.370.350.850.865
19788970,2009-10-01T00:00:00,"Ultrasonography, Prenatal",E01.370.378.630.865
19788970,2009-10-01T00:00:00,Young Adult,M01.060.116.815
19796289,2009-10-01T00:00:00,Activities of Daily Living,E02.831.067
19796289,2009-10-01T00:00:00,Activities of Daily Living,I03.050
19796289,2009-10-01T00:00:00,Activities of Daily Living,N02.421.784.110
19796289,2009-10-01T00:00:00,"Adaptation, Psychological",F01.058
19796289,2009-10-01T00:00:00,Anxiety,F01.470.132
19796289,2009-10-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
19796289,2009-10-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
19796289,2009-10-01T00:00:00,"Defibrillators, Implantable",E07.695.175
19796289,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19796289,2009-10-01T00:00:00,Interpersonal Relations,F01.829.401
19796289,2009-10-01T00:00:00,Quality of Life,I01.800
19796289,2009-10-01T00:00:00,Quality of Life,K01.752.400.750
19796289,2009-10-01T00:00:00,Sexuality,F01.145.802.975
19796289,2009-10-01T00:00:00,Sexuality,G08.686.867
19796289,2009-10-01T00:00:00,Social Support,I01.880.656.600
19797588,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19797588,2009-10-01T00:00:00,Leadership,F01.752.609
19797588,2009-10-01T00:00:00,Orthopedics,H02.403.810.494
19797614,2009-10-01T00:00:00,Breast Neoplasms,C04.588.180
19797614,2009-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
19797614,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19797614,2009-10-01T00:00:00,Lymph Nodes,A10.549.400
19797614,2009-10-01T00:00:00,Lymph Nodes,A15.382.520.604.412
19800193,2009-10-01T00:00:00,Aged,M01.060.116.100
19800193,2009-10-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
19800193,2009-10-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
19800193,2009-10-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
19800193,2009-10-01T00:00:00,"Defibrillators, Implantable",E07.695.175
19800193,2009-10-01T00:00:00,Disease Progression,C23.550.291.656
19800193,2009-10-01T00:00:00,Heart Failure,C14.280.434
19800193,2009-10-01T00:00:00,Hospitalization,E02.760.400
19800193,2009-10-01T00:00:00,Hospitalization,N02.421.585.400
19800193,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19800193,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
19800193,2009-10-01T00:00:00,Treatment Outcome,E01.789.800
19800193,2009-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19800193,2009-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19800193,2009-10-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
19800193,2009-10-01T00:00:00,Ventricular Remodeling,C23.300.985
19800193,2009-10-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
19800847,2009-10-01T00:00:00,Anticoagulants,D27.505.954.502.119
19800847,2009-10-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19800847,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19800847,2009-10-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
19800847,2009-10-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
19800847,2009-10-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
19800847,2009-10-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19800847,2009-10-01T00:00:00,Stroke,C10.228.140.300.775
19800847,2009-10-01T00:00:00,Stroke,C14.907.253.855
19800847,2009-10-01T00:00:00,Thrombolytic Therapy,E02.319.913
19801060,2009-10-01T00:00:00,Adult,M01.060.116
19801060,2009-10-01T00:00:00,Age Factors,N05.715.350.075
19801060,2009-10-01T00:00:00,Age Factors,N06.850.490.250
19801060,2009-10-01T00:00:00,Health Behavior,F01.145.488
19801060,2009-10-01T00:00:00,Health Status,I01.240.425
19801060,2009-10-01T00:00:00,Health Status,N01.224.425
19801060,2009-10-01T00:00:00,Health Status,N06.850.505.400.425
19801060,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19801060,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
19801060,2009-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19801060,2009-10-01T00:00:00,Risk Assessment,N04.452.871.715
19801060,2009-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19801060,2009-10-01T00:00:00,Risk Assessment,N06.850.505.715
19801060,2009-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19801060,2009-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19801060,2009-10-01T00:00:00,Risk Factors,N05.715.350.200.700
19801060,2009-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19801060,2009-10-01T00:00:00,Risk Factors,N06.850.490.625.750
19801060,2009-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19801060,2009-10-01T00:00:00,Social Support,I01.880.656.600
19801060,2009-10-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19801060,2009-10-01T00:00:00,Spinal Cord Injuries,C10.900.850
19801060,2009-10-01T00:00:00,Spinal Cord Injuries,C21.866.819
19801060,2009-10-01T00:00:00,Time Factors,G01.910.857
19803599,2009-10-01T00:00:00,Adolescent,M01.060.057
19803599,2009-10-01T00:00:00,Adult,M01.060.116
19803599,2009-10-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
19803599,2009-10-01T00:00:00,Antisocial Personality Disorder,F03.675.050
19803599,2009-10-01T00:00:00,Caregivers,M01.085
19803599,2009-10-01T00:00:00,Caregivers,M01.526.485.200
19803599,2009-10-01T00:00:00,Caregivers,N02.360.200
19803599,2009-10-01T00:00:00,Child,M01.060.406
19803599,2009-10-01T00:00:00,Cultural Diversity,I01.076.201.450.350
19803599,2009-10-01T00:00:00,Cultural Diversity,I01.880.143.450
19803599,2009-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19803599,2009-10-01T00:00:00,Family Therapy,F04.754.864.581.273
19803599,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19803599,2009-10-01T00:00:00,Juvenile Delinquency,I01.880.735.479
19803599,2009-10-01T00:00:00,Motivation,F01.658
19803599,2009-10-01T00:00:00,Motivation,F01.752.543.500.750
19803599,2009-10-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
19803599,2009-10-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
19803599,2009-10-01T00:00:00,Pilot Projects,E05.318.760.750
19803599,2009-10-01T00:00:00,Pilot Projects,E05.337.737
19803599,2009-10-01T00:00:00,Pilot Projects,N05.715.360.775.625
19803599,2009-10-01T00:00:00,Pilot Projects,N06.850.520.450.720
19803599,2009-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19803599,2009-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19803599,2009-10-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19803599,2009-10-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19803599,2009-10-01T00:00:00,Social Identification,F01.145.813.708
19803599,2009-10-01T00:00:00,Substance-Related Disorders,C21.739
19803599,2009-10-01T00:00:00,Substance-Related Disorders,F03.900
19809060,2009-10-01T00:00:00,Adult,M01.060.116
19809060,2009-10-01T00:00:00,Cysts,C04.182
19809060,2009-10-01T00:00:00,Cysts,C23.300.306
19809060,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19809060,2009-10-01T00:00:00,Lung Diseases,C08.381
19809060,2009-10-01T00:00:00,Thoracic Injuries,C21.866.891
19809060,2009-10-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
19815861,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19815861,2009-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19815861,2009-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19816819,2009-10-01T00:00:00,"Abortion, Induced",E04.520.050
19816819,2009-10-01T00:00:00,Family Practice,H02.403.280
19816819,2009-10-01T00:00:00,Homicide,I01.198.240.470
19816819,2009-10-01T00:00:00,Homicide,I01.880.735.344
19816819,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19816822,2009-10-01T00:00:00,Family Practice,H02.403.280
19816822,2009-10-01T00:00:00,Organizational Objectives,N04.452.615
19816822,2009-10-01T00:00:00,Societies,N03.540.828
19830886,2009-10-01T00:00:00,Health Behavior,F01.145.488
19830886,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19830886,2009-10-01T00:00:00,Mass Screening,E01.370.500
19830886,2009-10-01T00:00:00,Mass Screening,E05.318.308.250.580
19830886,2009-10-01T00:00:00,Mass Screening,N02.421.143.827.233.443
19830886,2009-10-01T00:00:00,Mass Screening,N02.421.726.233.443
19830886,2009-10-01T00:00:00,Mass Screening,N05.715.360.300.375.500
19830886,2009-10-01T00:00:00,Mass Screening,N06.850.520.308.250.580
19830886,2009-10-01T00:00:00,Mass Screening,N06.850.780.500
19830886,2009-10-01T00:00:00,"Models, Theoretical",E05.599
19830886,2009-10-01T00:00:00,Neoplasms,C04
19834415,2009-10-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19834415,2009-10-01T00:00:00,Dacryocystitis,C11.496.221
19834415,2009-10-01T00:00:00,"Diagnosis, Differential",E01.171
19834415,2009-10-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19834415,2009-10-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19834415,2009-10-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19834415,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19834415,2009-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
19834415,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19834415,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19834415,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19834415,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19834415,2009-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19834421,2009-10-01T00:00:00,Asthma,C08.127.108
19834421,2009-10-01T00:00:00,Asthma,C08.381.495.108
19834421,2009-10-01T00:00:00,Asthma,C08.674.095
19834421,2009-10-01T00:00:00,Asthma,C20.543.480.680.095
19834421,2009-10-01T00:00:00,Bronchodilator Agents,D27.505.696.663.050.110
19834421,2009-10-01T00:00:00,Bronchodilator Agents,D27.505.954.796.050.100
19834421,2009-10-01T00:00:00,Child,M01.060.406
19834421,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19834421,2009-10-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19834421,2009-10-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19834421,2009-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19834421,2009-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19834421,2009-10-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19834421,2009-10-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19834426,2009-10-01T00:00:00,Blood Pressure,E01.370.600.875.249
19834426,2009-10-01T00:00:00,Blood Pressure,G09.330.380.076
19834426,2009-10-01T00:00:00,Heart Failure,C14.280.434
19834426,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19834426,2009-10-01T00:00:00,Hypertension,C14.907.489
19834426,2009-10-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
19834426,2009-10-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
19834426,2009-10-01T00:00:00,Kidney Diseases,C12.777.419
19834426,2009-10-01T00:00:00,Kidney Diseases,C13.351.968.419
19834426,2009-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19834426,2009-10-01T00:00:00,Risk Factors,N05.715.350.200.700
19834426,2009-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19834426,2009-10-01T00:00:00,Risk Factors,N06.850.490.625.750
19834426,2009-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19834426,2009-10-01T00:00:00,Treatment Outcome,E01.789.800
19834426,2009-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19834426,2009-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19840719,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19840719,2009-10-01T00:00:00,Oculomotor Muscles,A02.633.567.700
19840719,2009-10-01T00:00:00,Oculomotor Muscles,A09.371.613
19840719,2009-10-01T00:00:00,Ophthalmologic Surgical Procedures,E04.540
19841343,2009-10-01T00:00:00,Adolescent,M01.060.057
19841343,2009-10-01T00:00:00,Adult,M01.060.116
19841343,2009-10-01T00:00:00,Aged,M01.060.116.100
19841343,2009-10-01T00:00:00,Diagnostic Imaging,E01.370.350
19841343,2009-10-01T00:00:00,Endoscopy,E01.370.388.250
19841343,2009-10-01T00:00:00,Endoscopy,E04.800.250
19841343,2009-10-01T00:00:00,Head and Neck Neoplasms,C04.588.443
19841343,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19841343,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
19865038,2009-10-01T00:00:00,Civil Defense,I01.451.227
19865038,2009-10-01T00:00:00,Curriculum,I02.158
19865038,2009-10-01T00:00:00,Disaster Planning,N06.230.100.035
19865038,2009-10-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
19865038,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19865038,2009-10-01T00:00:00,Students,I02.233.748
19865038,2009-10-01T00:00:00,Students,I02.851
19865038,2009-10-01T00:00:00,Students,M01.848
19874737,2009-10-01T00:00:00,Age Factors,N05.715.350.075
19874737,2009-10-01T00:00:00,Age Factors,N06.850.490.250
19874737,2009-10-01T00:00:00,Behavior Therapy,F04.754.137
19874737,2009-10-01T00:00:00,Combined Modality Therapy,E02.186
19874737,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19874737,2009-10-01T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
19874737,2009-10-01T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
19874737,2009-10-01T00:00:00,Referral and Consultation,N04.452.758.849
19874737,2009-10-01T00:00:00,Sex Factors,N05.715.350.675
19874737,2009-10-01T00:00:00,Sex Factors,N06.850.490.875
19874737,2009-10-01T00:00:00,Treatment Outcome,E01.789.800
19874737,2009-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19874737,2009-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19874737,2009-10-01T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
19874737,2009-10-01T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
19874737,2009-10-01T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
19909862,2009-10-01T00:00:00,Chronic Disease,C23.550.291.500
19909862,2009-10-01T00:00:00,Drug Delivery Systems,E02.319.300
19909862,2009-10-01T00:00:00,Glucocorticoids,D06.472.040.543
19909862,2009-10-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
19909862,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19909862,2009-10-01T00:00:00,Paranasal Sinuses,A04.531.621
19909862,2009-10-01T00:00:00,Rhinitis,C08.460.799
19909862,2009-10-01T00:00:00,Rhinitis,C08.730.674
19909862,2009-10-01T00:00:00,Rhinitis,C09.603.799
19909862,2009-10-01T00:00:00,Sinusitis,C08.460.692.752
19909862,2009-10-01T00:00:00,Sinusitis,C08.730.749
19909862,2009-10-01T00:00:00,Sinusitis,C09.603.692.752
19955870,2009-10-01T00:00:00,Algorithms,G17.035
19955870,2009-10-01T00:00:00,Algorithms,L01.224.050
19955870,2009-10-01T00:00:00,Computer Simulation,L01.224.160
19955870,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19955870,2009-10-01T00:00:00,"Models, Biological",E05.599.395
19955870,2009-10-01T00:00:00,"Muscle, Skeletal",A02.633.567
19955870,2009-10-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
19955870,2009-10-01T00:00:00,Walking,G11.427.590.530.568.900
19955870,2009-10-01T00:00:00,Walking,G11.427.590.530.698.940
19955870,2009-10-01T00:00:00,Walking,I03.450.642.845.940
20100122,2009-10-01T00:00:00,Adult,M01.060.116
20100122,2009-10-01T00:00:00,Brain Injuries,C10.228.140.199
20100122,2009-10-01T00:00:00,Brain Injuries,C10.900.300.087
20100122,2009-10-01T00:00:00,Brain Injuries,C21.866.260.118
20100122,2009-10-01T00:00:00,Brain Injuries,C21.866.915.300.200
20100122,2009-10-01T00:00:00,Epilepsy,C10.228.140.490
20100122,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20100122,2009-10-01T00:00:00,Middle Aged,M01.060.116.630
20100122,2009-10-01T00:00:00,Population Surveillance,E05.318.308.250.700
20100122,2009-10-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
20100122,2009-10-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
20100122,2009-10-01T00:00:00,Population Surveillance,N06.850.780.675
20100122,2009-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20100122,2009-10-01T00:00:00,Risk Factors,N05.715.350.200.700
20100122,2009-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20100122,2009-10-01T00:00:00,Risk Factors,N06.850.490.625.750
20100122,2009-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20100122,2009-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20100122,2009-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20191092,2009-10-01T00:00:00,Animals,B01.050
20191092,2009-10-01T00:00:00,Autoimmune Diseases,C20.111
20191092,2009-10-01T00:00:00,Cannabinoids,D02.455.849.090
20191092,2009-10-01T00:00:00,Cytokines,D12.644.276.374
20191092,2009-10-01T00:00:00,Cytokines,D12.776.467.374
20191092,2009-10-01T00:00:00,Cytokines,D23.529.374
20191092,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20191092,2009-10-01T00:00:00,Immunosuppression,E02.095.465.425.450
20191092,2009-10-01T00:00:00,Immunosuppression,E05.478.610
20191092,2009-10-01T00:00:00,"Models, Biological",E05.599.395
20191092,2009-10-01T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
20191092,2009-10-01T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
20191092,2009-10-01T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
20234798,2009-10-01T00:00:00,Bayes Theorem,E05.318.740.600.200
20234798,2009-10-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
20234798,2009-10-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
20234798,2009-10-01T00:00:00,Computer Simulation,L01.224.160
20234798,2009-10-01T00:00:00,Environmental Exposure,N06.850.460.350
20234798,2009-10-01T00:00:00,Environmental Health,H02.229
20234798,2009-10-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
20234798,2009-10-01T00:00:00,Environmental Monitoring,N06.850.780.375
20234798,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20234798,2009-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20234798,2009-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20677487,2009-10-01T00:00:00,Adult,M01.060.116
20677487,2009-10-01T00:00:00,Cesarean Section,E04.520.252.500
20677487,2009-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20677487,2009-10-01T00:00:00,Hysterectomy,E04.950.300.399
20677487,2009-10-01T00:00:00,Ovary,A05.360.319.114.630
20677487,2009-10-01T00:00:00,Ovary,A05.360.576.497
20677487,2009-10-01T00:00:00,Ovary,A06.407.312.497
20677487,2009-10-01T00:00:00,Pregnancy,G08.686.785.760.769
20677487,2009-10-01T00:00:00,"Pregnancy, Ectopic",C13.703.733
19800143,2009-10-02T00:00:00,Adult,M01.060.116
19800143,2009-10-02T00:00:00,Attitude to Health,F01.100.150
19800143,2009-10-02T00:00:00,Attitude to Health,N05.300.150
19800143,2009-10-02T00:00:00,Diabetes Complications,C19.246.099
19800143,2009-10-02T00:00:00,Diabetes Mellitus,C18.452.394.750
19800143,2009-10-02T00:00:00,Diabetes Mellitus,C19.246
19800143,2009-10-02T00:00:00,Employment,N01.824.245
19800143,2009-10-02T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19800143,2009-10-02T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19800143,2009-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19800143,2009-10-02T00:00:00,Income,N01.824.417
19800143,2009-10-02T00:00:00,Oral Health,N01.400.535
19800143,2009-10-02T00:00:00,Psychometrics,F04.711.780
19800143,2009-10-02T00:00:00,Questionnaires,E05.318.308.750
19800143,2009-10-02T00:00:00,Questionnaires,L01.280.800
19800143,2009-10-02T00:00:00,Questionnaires,N05.715.360.300.695
19800143,2009-10-02T00:00:00,Questionnaires,N06.850.520.308.750
19800143,2009-10-02T00:00:00,United States,Z01.107.567.875
19800890,2009-10-02T00:00:00,Antineoplastic Agents,D27.505.954.248
19800890,2009-10-02T00:00:00,Binding Sites,G02.111.570.120
19800890,2009-10-02T00:00:00,"DNA, Single-Stranded",D13.444.308.497
19800890,2009-10-02T00:00:00,Deoxycytidine,D03.383.742.680.245.500
19800890,2009-10-02T00:00:00,Deoxycytidine,D13.570.230.329
19800890,2009-10-02T00:00:00,Deoxycytidine,D13.570.685.245.500
19800890,2009-10-02T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
19800890,2009-10-02T00:00:00,Doxorubicin,D04.615.562.050.200.175
19800890,2009-10-02T00:00:00,Doxorubicin,D09.408.051.059.200.175
19800890,2009-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19800890,2009-10-02T00:00:00,"Mutation, Missense",G05.365.590.650
19800958,2009-10-02T00:00:00,Acoustic Stimulation,E02.037
19800958,2009-10-02T00:00:00,Acoustic Stimulation,E02.190.888.030
19800958,2009-10-02T00:00:00,Acoustic Stimulation,E05.723.136
19800958,2009-10-02T00:00:00,Adult,M01.060.116
19800958,2009-10-02T00:00:00,Age Factors,N05.715.350.075
19800958,2009-10-02T00:00:00,Age Factors,N06.850.490.250
19800958,2009-10-02T00:00:00,Aged,M01.060.116.100
19800958,2009-10-02T00:00:00,Aging,G07.700.320.124
19800958,2009-10-02T00:00:00,Attention,F02.830.104.214
19800958,2009-10-02T00:00:00,Auditory Threshold,F02.463.593.071.173
19800958,2009-10-02T00:00:00,Auditory Threshold,F02.463.593.710.190
19800958,2009-10-02T00:00:00,Cognition,F02.463.188
19800958,2009-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19800958,2009-10-02T00:00:00,Middle Aged,M01.060.116.630
19800958,2009-10-02T00:00:00,Neuropsychological Tests,F04.711.513
19800958,2009-10-02T00:00:00,Noise,G01.595.907.567
19800958,2009-10-02T00:00:00,Noise,G16.500.275.600
19800958,2009-10-02T00:00:00,Noise,N06.230.400
19800958,2009-10-02T00:00:00,Noise,N06.850.460.610
19800958,2009-10-02T00:00:00,Perceptual Masking,F02.463.593.071.594
19800958,2009-10-02T00:00:00,Perceptual Masking,F02.463.593.932.733
19800958,2009-10-02T00:00:00,Speech Perception,F02.463.593.071.875
19800958,2009-10-02T00:00:00,Task Performance and Analysis,F02.784.412.846
19800958,2009-10-02T00:00:00,Task Performance and Analysis,F02.784.692.746
19800958,2009-10-02T00:00:00,Task Performance and Analysis,F02.808.600
19800958,2009-10-02T00:00:00,Time Factors,G01.910.857
19800958,2009-10-02T00:00:00,Workload,N04.452.677.950
19800958,2009-10-02T00:00:00,Young Adult,M01.060.116.815
19804989,2009-10-04T00:00:00,Adult,M01.060.116
19804989,2009-10-04T00:00:00,Age Factors,N05.715.350.075
19804989,2009-10-04T00:00:00,Age Factors,N06.850.490.250
19804989,2009-10-04T00:00:00,Body Weight,C23.888.144
19804989,2009-10-04T00:00:00,Body Weight,E01.370.600.115.100.160.120
19804989,2009-10-04T00:00:00,Body Weight,E05.041.124.160.750
19804989,2009-10-04T00:00:00,Body Weight,G07.100.100.160.120
19804989,2009-10-04T00:00:00,Body Weight,G07.700.320.249.314.120
19804989,2009-10-04T00:00:00,Diabetes Mellitus,C18.452.394.750
19804989,2009-10-04T00:00:00,Diabetes Mellitus,C19.246
19804989,2009-10-04T00:00:00,Heart Diseases,C14.280
19804989,2009-10-04T00:00:00,Heart Transplantation,E04.100.376.475
19804989,2009-10-04T00:00:00,Heart Transplantation,E04.928.220.390
19804989,2009-10-04T00:00:00,Heart Transplantation,E04.936.450.475
19804989,2009-10-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19804989,2009-10-04T00:00:00,Hypertension,C14.907.489
19804989,2009-10-04T00:00:00,Middle Aged,M01.060.116.630
19804989,2009-10-04T00:00:00,Sex Factors,N05.715.350.675
19804989,2009-10-04T00:00:00,Sex Factors,N06.850.490.875
19804989,2009-10-04T00:00:00,Tissue Donors,M01.898
19815001,2009-10-06T00:00:00,Animals,B01.050
19815001,2009-10-06T00:00:00,Dopamine,D02.092.211.215.311.342
19815001,2009-10-06T00:00:00,Dopamine,D02.092.311.342
19815001,2009-10-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19815001,2009-10-06T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19815001,2009-10-06T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19815001,2009-10-06T00:00:00,Neural Pathways,A08.612
19815001,2009-10-06T00:00:00,Neurons,A08.663
19815001,2009-10-06T00:00:00,Neurons,A11.671
19815001,2009-10-06T00:00:00,Neuropeptides,D12.644.400
19815001,2009-10-06T00:00:00,Neuropeptides,D12.776.641.650
19815001,2009-10-06T00:00:00,Substance-Related Disorders,C21.739
19815001,2009-10-06T00:00:00,Substance-Related Disorders,F03.900
19815001,2009-10-06T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
19815001,2009-10-06T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
19809026,2009-10-07T00:00:00,Adult,M01.060.116
19809026,2009-10-07T00:00:00,Altitude,G16.500.275.058
19809026,2009-10-07T00:00:00,Altitude,N06.230.058
19809026,2009-10-07T00:00:00,Anoxia,C23.888.852.079
19809026,2009-10-07T00:00:00,Blood Pressure,E01.370.600.875.249
19809026,2009-10-07T00:00:00,Blood Pressure,G09.330.380.076
19809026,2009-10-07T00:00:00,Double-Blind Method,E05.318.780.300
19809026,2009-10-07T00:00:00,Double-Blind Method,E05.581.500.300
19809026,2009-10-07T00:00:00,Double-Blind Method,N05.715.360.780.320
19809026,2009-10-07T00:00:00,Double-Blind Method,N06.850.520.445.300
19809026,2009-10-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19809026,2009-10-07T00:00:00,"Hypertension, Pulmonary",C08.381.423
19809026,2009-10-07T00:00:00,Iron,D01.268.556.412
19809026,2009-10-07T00:00:00,Iron,D01.268.956.287
19809026,2009-10-07T00:00:00,Iron,D01.552.544.412
19809026,2009-10-07T00:00:00,Middle Aged,M01.060.116.630
19809026,2009-10-07T00:00:00,Phlebotomy,E01.450.865.632.150.625
19809026,2009-10-07T00:00:00,Phlebotomy,E02.800.558
19809026,2009-10-07T00:00:00,Pulmonary Artery,A07.231.114.715
19809026,2009-10-07T00:00:00,Young Adult,M01.060.116.815
20368153,2009-10-07T00:00:00,Animals,B01.050
20368153,2009-10-07T00:00:00,Arrestins,D12.776.306.090
20368153,2009-10-07T00:00:00,Arrestins,D12.776.543.090
20368153,2009-10-07T00:00:00,Bone Development,G07.700.320.500.325.377.625.100
20368153,2009-10-07T00:00:00,Bone Development,G11.427.590.560.100
20368153,2009-10-07T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
20368153,2009-10-07T00:00:00,GTP-Binding Proteins,D12.776.157.325
20368153,2009-10-07T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.100.650.100
20368153,2009-10-07T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.750.600.100
20368153,2009-10-07T00:00:00,Signal Transduction,G02.111.087.800
20368153,2009-10-07T00:00:00,Signal Transduction,G02.149.115.800
20368153,2009-10-07T00:00:00,Signal Transduction,G04.299.880
19593782,2009-10-08T00:00:00,Adsorption,G02.149.047
19593782,2009-10-08T00:00:00,Adsorption,G02.149.767.029
19593782,2009-10-08T00:00:00,Adsorption,G02.842.750.029
19593782,2009-10-08T00:00:00,Lactic Acid,D02.241.511.459.450
19593782,2009-10-08T00:00:00,Materials Testing,E05.570
19593782,2009-10-08T00:00:00,Molecular Structure,G02.111.570
19593782,2009-10-08T00:00:00,Molecular Structure,G02.575
19593782,2009-10-08T00:00:00,Molecular Structure,G02.842.575
19593782,2009-10-08T00:00:00,Nanostructures,J01.637.512
19593782,2009-10-08T00:00:00,Polymers,D05.750
19593782,2009-10-08T00:00:00,Polymers,D25.720
19593782,2009-10-08T00:00:00,Polymers,J01.637.051.720
19593782,2009-10-08T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
19593782,2009-10-08T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
19593782,2009-10-08T00:00:00,Surface Properties,G02.842.850
19814809,2009-10-08T00:00:00,Adolescent,M01.060.057
19814809,2009-10-08T00:00:00,Child,M01.060.406
19814809,2009-10-08T00:00:00,"Child, Preschool",M01.060.406.448
19814809,2009-10-08T00:00:00,Data Collection,E05.318.308
19814809,2009-10-08T00:00:00,Data Collection,L01.280
19814809,2009-10-08T00:00:00,Data Collection,N05.715.360.300
19814809,2009-10-08T00:00:00,Data Collection,N06.850.520.308
19814809,2009-10-08T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
19814809,2009-10-08T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
19814809,2009-10-08T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
19814809,2009-10-08T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19814809,2009-10-08T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19814809,2009-10-08T00:00:00,Geographic Information Systems,L01.470.750.750.462
19814809,2009-10-08T00:00:00,Geographic Information Systems,L01.700.508.300.314
19814809,2009-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19814809,2009-10-08T00:00:00,Infant,M01.060.703
19814809,2009-10-08T00:00:00,"Infant, Newborn",M01.060.703.520
19814809,2009-10-08T00:00:00,Stochastic Processes,E05.318.740.996
19814809,2009-10-08T00:00:00,Stochastic Processes,G17.830
19814809,2009-10-08T00:00:00,Stochastic Processes,N05.715.360.750.770
19814809,2009-10-08T00:00:00,Stochastic Processes,N06.850.520.830.996
19814809,2009-10-08T00:00:00,United States,Z01.107.567.875
19814809,2009-10-08T00:00:00,Young Adult,M01.060.116.815
19815654,2009-10-08T00:00:00,Adolescent,M01.060.057
19815654,2009-10-08T00:00:00,Family Therapy,F04.754.864.581.273
19815654,2009-10-08T00:00:00,HIV Infections,C02.782.815.616.400
19815654,2009-10-08T00:00:00,HIV Infections,C02.800.801.400
19815654,2009-10-08T00:00:00,HIV Infections,C20.673.480
19815654,2009-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19815654,2009-10-08T00:00:00,Medication Adherence,F01.145.488.500.500
19815654,2009-10-08T00:00:00,Medication Adherence,N05.300.150.600.600.500
19815654,2009-10-08T00:00:00,Risk-Taking,F01.145.722
19815654,2009-10-08T00:00:00,Sexual Behavior,F01.145.802
19815654,2009-10-08T00:00:00,Substance-Related Disorders,C21.739
19815654,2009-10-08T00:00:00,Substance-Related Disorders,F03.900
19815654,2009-10-08T00:00:00,Treatment Outcome,E01.789.800
19815654,2009-10-08T00:00:00,Treatment Outcome,N04.761.559.590.800
19815654,2009-10-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19815824,2009-10-08T00:00:00,Animals,B01.050
19815824,2009-10-08T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
19815824,2009-10-08T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
19815824,2009-10-08T00:00:00,Cell Adhesion Molecules,D23.050.301.350
19815824,2009-10-08T00:00:00,Complement Activation,G12.425.255
19815824,2009-10-08T00:00:00,"Disease Models, Animal",C22.232
19815824,2009-10-08T00:00:00,"Disease Models, Animal",E05.598.500
19815824,2009-10-08T00:00:00,"Disease Models, Animal",E05.599.395.080
19815824,2009-10-08T00:00:00,Gene Expression,G05.355.310
19815824,2009-10-08T00:00:00,Heart Transplantation,E04.100.376.475
19815824,2009-10-08T00:00:00,Heart Transplantation,E04.928.220.390
19815824,2009-10-08T00:00:00,Heart Transplantation,E04.936.450.475
19815824,2009-10-08T00:00:00,Tissue Donors,M01.898
19819233,2009-10-09T00:00:00,Adult,M01.060.116
19819233,2009-10-09T00:00:00,Aged,M01.060.116.100
19819233,2009-10-09T00:00:00,Aging,G07.700.320.124
19819233,2009-10-09T00:00:00,Brain Mapping,E01.370.350.086
19819233,2009-10-09T00:00:00,Brain Mapping,E01.370.376.149
19819233,2009-10-09T00:00:00,Brain Mapping,E05.132
19819233,2009-10-09T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
19819233,2009-10-09T00:00:00,Functional Laterality,F02.830.297.425
19819233,2009-10-09T00:00:00,Functional Laterality,G11.561.225.425
19819233,2009-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19819233,2009-10-09T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19819233,2009-10-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19819233,2009-10-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19819233,2009-10-09T00:00:00,Middle Aged,M01.060.116.630
19820079,2009-10-09T00:00:00,Adult,M01.060.116
19820079,2009-10-09T00:00:00,Asthma,C08.127.108
19820079,2009-10-09T00:00:00,Asthma,C08.381.495.108
19820079,2009-10-09T00:00:00,Asthma,C08.674.095
19820079,2009-10-09T00:00:00,Asthma,C20.543.480.680.095
19820079,2009-10-09T00:00:00,Disease Progression,C23.550.291.656
19820079,2009-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19820079,2009-10-09T00:00:00,"Infant, Newborn",M01.060.703.520
19820079,2009-10-09T00:00:00,Pregnancy,G08.686.785.760.769
19820079,2009-10-09T00:00:00,Pregnancy Complications,C13.703
19820079,2009-10-09T00:00:00,Pregnancy Outcome,E01.789.700
19820079,2009-10-09T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
19820079,2009-10-09T00:00:00,Questionnaires,E05.318.308.750
19820079,2009-10-09T00:00:00,Questionnaires,L01.280.800
19820079,2009-10-09T00:00:00,Questionnaires,N05.715.360.300.695
19820079,2009-10-09T00:00:00,Questionnaires,N06.850.520.308.750
19820079,2009-10-09T00:00:00,Smoking,F01.145.466.753
19820079,2009-10-09T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19820079,2009-10-09T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19820079,2009-10-09T00:00:00,Young Adult,M01.060.116.815
19822466,2009-10-09T00:00:00,Algorithms,G17.035
19822466,2009-10-09T00:00:00,Algorithms,L01.224.050
19822466,2009-10-09T00:00:00,Animals,B01.050
19822466,2009-10-09T00:00:00,Catheter Ablation,E01.370.370.380.410.200
19822466,2009-10-09T00:00:00,Catheter Ablation,E02.148.110
19822466,2009-10-09T00:00:00,Catheter Ablation,E02.148.442.110
19822466,2009-10-09T00:00:00,Catheter Ablation,E02.154.402.110
19822466,2009-10-09T00:00:00,Catheter Ablation,E04.014.170.402.110
19822466,2009-10-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19822466,2009-10-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19822466,2009-10-09T00:00:00,Skin,A17.815
19822466,2009-10-09T00:00:00,Skin Temperature,G07.110.753
19822466,2009-10-09T00:00:00,Skin Temperature,G13.750.844
19822466,2009-10-09T00:00:00,Swine,B01.050.150.900.649.077.880
19821938,2009-10-10T00:00:00,"Cardiac Pacing, Artificial",E02.145
19821938,2009-10-10T00:00:00,Double-Blind Method,E05.318.780.300
19821938,2009-10-10T00:00:00,Double-Blind Method,E05.581.500.300
19821938,2009-10-10T00:00:00,Double-Blind Method,N05.715.360.780.320
19821938,2009-10-10T00:00:00,Double-Blind Method,N06.850.520.445.300
19821938,2009-10-10T00:00:00,Echocardiography,E01.370.350.850.220
19821938,2009-10-10T00:00:00,Echocardiography,E01.370.370.380.220
19821938,2009-10-10T00:00:00,Electric Countershock,E02.342.287
19821938,2009-10-10T00:00:00,Heart Failure,C14.280.434
19821938,2009-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19821938,2009-10-10T00:00:00,Research Design,E05.581.500
19821938,2009-10-10T00:00:00,Research Design,H01.770.644.728
19826096,2009-10-13T00:00:00,Aged,M01.060.116.100
19826096,2009-10-13T00:00:00,Family Practice,H02.403.280
19826096,2009-10-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19826096,2009-10-13T00:00:00,Middle Aged,M01.060.116.630
19826096,2009-10-13T00:00:00,Osteoporosis,C05.116.198.579
19826096,2009-10-13T00:00:00,Patient Compliance,F01.145.488.500
19826096,2009-10-13T00:00:00,Patient Compliance,N05.300.150.600.600
19826096,2009-10-13T00:00:00,Patient Education as Topic,I02.233.332.500
19826096,2009-10-13T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19826096,2009-10-13T00:00:00,Patient Education as Topic,N02.421.726.407.680
19826096,2009-10-13T00:00:00,Pharmacists,M01.526.485.780
19826096,2009-10-13T00:00:00,Pharmacists,N02.360.780
19826096,2009-10-13T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19826096,2009-10-13T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19826096,2009-10-13T00:00:00,Professional Role,F01.829.316.616.625
19828624,2009-10-14T00:00:00,Animals,B01.050
19828624,2009-10-14T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
19828624,2009-10-14T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
19828624,2009-10-14T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
19828624,2009-10-14T00:00:00,"Arthritis, Experimental",C05.550.114.015
19828624,2009-10-14T00:00:00,"Arthritis, Experimental",E05.598.500.249
19828624,2009-10-14T00:00:00,Cattle,B01.050.150.900.649.077.380.271
19828624,2009-10-14T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
19828624,2009-10-14T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19828743,2009-10-14T00:00:00,Bacterial Proteins,D12.776.097
19828743,2009-10-14T00:00:00,Bacteriophages,B04.123
19828743,2009-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19828743,2009-10-14T00:00:00,"Recombination, Genetic",G05.355.760
19828743,2009-10-14T00:00:00,Yersinia pestis,B03.440.450.425.900.600
19828743,2009-10-14T00:00:00,Yersinia pestis,B03.660.250.150.950.580
19637342,2009-10-15T00:00:00,Adolescent,M01.060.057
19637342,2009-10-15T00:00:00,Adult,M01.060.116
19637342,2009-10-15T00:00:00,Aged,M01.060.116.100
19637342,2009-10-15T00:00:00,Bone Marrow,A15.382.216
19637342,2009-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19637342,2009-10-15T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
19637342,2009-10-15T00:00:00,Middle Aged,M01.060.116.630
19637342,2009-10-15T00:00:00,Mutation,G05.365.590
19637342,2009-10-15T00:00:00,Nuclear Proteins,D12.776.660
19637342,2009-10-15T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19790128,2009-10-15T00:00:00,Adult,M01.060.116
19790128,2009-10-15T00:00:00,Disease Outbreaks,N06.850.290
19790128,2009-10-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19790128,2009-10-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
19790128,2009-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
19790128,2009-10-15T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
19790128,2009-10-15T00:00:00,Middle Aged,M01.060.116.630
19790128,2009-10-15T00:00:00,Risk Factors,E05.318.740.600.800.725
19790128,2009-10-15T00:00:00,Risk Factors,N05.715.350.200.700
19790128,2009-10-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19790128,2009-10-15T00:00:00,Risk Factors,N06.850.490.625.750
19790128,2009-10-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19829305,2009-10-15T00:00:00,Animals,B01.050
19829305,2009-10-15T00:00:00,Binding Sites,G02.111.570.120
19829305,2009-10-15T00:00:00,Gene Expression Regulation,G05.355.315
19829305,2009-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19829305,2009-10-15T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
19829305,2009-10-15T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
19829305,2009-10-15T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
19829305,2009-10-15T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
19829305,2009-10-15T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
19829305,2009-10-15T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
19829305,2009-10-15T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
19829305,2009-10-15T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
19829305,2009-10-15T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19834023,2009-10-15T00:00:00,Adult,M01.060.116
19834023,2009-10-15T00:00:00,Aged,M01.060.116.100
19834023,2009-10-15T00:00:00,Brain Ischemia,C10.228.140.300.150
19834023,2009-10-15T00:00:00,Brain Ischemia,C14.907.253.092
19834023,2009-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19834023,2009-10-15T00:00:00,Middle Aged,M01.060.116.630
19834023,2009-10-15T00:00:00,Postoperative Complications,C23.550.767
19834023,2009-10-15T00:00:00,Stroke,C10.228.140.300.775
19834023,2009-10-15T00:00:00,Stroke,C14.907.253.855
19834023,2009-10-15T00:00:00,Thrombectomy,E04.100.814.842
19834023,2009-10-15T00:00:00,Treatment Outcome,E01.789.800
19834023,2009-10-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19834023,2009-10-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19836216,2009-10-15T00:00:00,Animals,B01.050
19836216,2009-10-15T00:00:00,Cardiomegaly,C14.280.195
19836216,2009-10-15T00:00:00,Cardiomegaly,C23.300.775.250
19836216,2009-10-15T00:00:00,Heart Failure,C14.280.434
19836216,2009-10-15T00:00:00,Hypertension,C14.907.489
19836216,2009-10-15T00:00:00,Obesity,C18.654.726.500
19836216,2009-10-15T00:00:00,Obesity,C23.888.144.699.500
19836216,2009-10-15T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19836216,2009-10-15T00:00:00,Obesity,G07.100.100.160.120.699.500
19836216,2009-10-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19836216,2009-10-15T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19836303,2009-10-15T00:00:00,Animals,B01.050
19836303,2009-10-15T00:00:00,"Databases, Factual",L01.470.750.750
19836303,2009-10-15T00:00:00,"Databases, Factual",L01.700.508.300.188.400
19836303,2009-10-15T00:00:00,"Diagnosis, Computer-Assisted",E01.158
19836303,2009-10-15T00:00:00,"Diagnosis, Computer-Assisted",L01.700.508.100.158
19836303,2009-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19836303,2009-10-15T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
19836303,2009-10-15T00:00:00,Multicenter Studies as Topic,E05.337.250.500
19836303,2009-10-15T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
19836303,2009-10-15T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
19836303,2009-10-15T00:00:00,Neural Networks (Computer),G17.485
19836303,2009-10-15T00:00:00,Neural Networks (Computer),L01.224.065.605
19836303,2009-10-15T00:00:00,Neural Networks (Computer),L01.725.500
19844098,2009-10-16T00:00:00,Aged,M01.060.116.100
19844098,2009-10-16T00:00:00,Chronic Disease,C23.550.291.500
19844098,2009-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19844098,2009-10-16T00:00:00,Incidence,E05.318.308.985.525.375
19844098,2009-10-16T00:00:00,Incidence,L01.280.975.525.375
19844098,2009-10-16T00:00:00,Incidence,N01.224.935.597.500
19844098,2009-10-16T00:00:00,Incidence,N06.850.505.400.975.525.375
19844098,2009-10-16T00:00:00,Incidence,N06.850.520.308.985.525.375
19844098,2009-10-16T00:00:00,Kidney,A05.810.453
19844098,2009-10-16T00:00:00,Kidney Diseases,C12.777.419
19844098,2009-10-16T00:00:00,Kidney Diseases,C13.351.968.419
19844098,2009-10-16T00:00:00,Middle Aged,M01.060.116.630
19844098,2009-10-16T00:00:00,Patient Discharge,E02.760.400.610
19844098,2009-10-16T00:00:00,Patient Discharge,N02.421.585.400.610
19844098,2009-10-16T00:00:00,Proteinuria,C12.777.934.734
19844098,2009-10-16T00:00:00,Proteinuria,C13.351.968.934.734
19844098,2009-10-16T00:00:00,Proteinuria,C23.888.942.750
19844098,2009-10-16T00:00:00,Risk Factors,E05.318.740.600.800.725
19844098,2009-10-16T00:00:00,Risk Factors,N05.715.350.200.700
19844098,2009-10-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19844098,2009-10-16T00:00:00,Risk Factors,N06.850.490.625.750
19844098,2009-10-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19844098,2009-10-16T00:00:00,Stroke,C10.228.140.300.775
19844098,2009-10-16T00:00:00,Stroke,C14.907.253.855
19837390,2009-10-17T00:00:00,Adult,M01.060.116
19837390,2009-10-17T00:00:00,Aged,M01.060.116.100
19837390,2009-10-17T00:00:00,Brachytherapy,E02.815.150
19837390,2009-10-17T00:00:00,Breast Neoplasms,C04.588.180
19837390,2009-10-17T00:00:00,Breast Neoplasms,C17.800.090.500
19837390,2009-10-17T00:00:00,Catheterization,E02.148
19837390,2009-10-17T00:00:00,Catheterization,E05.157
19837390,2009-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19837390,2009-10-17T00:00:00,Middle Aged,M01.060.116.630
19837390,2009-10-17T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
19837390,2009-10-17T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
19837394,2009-10-17T00:00:00,Aged,M01.060.116.100
19837394,2009-10-17T00:00:00,Collagen,D05.750.078.280
19837394,2009-10-17T00:00:00,Collagen,D12.776.860.300.250
19837394,2009-10-17T00:00:00,Graft Rejection,G12.425.901.545.328
19837394,2009-10-17T00:00:00,Graft Survival,G12.425.901.545.340
19837394,2009-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19837394,2009-10-17T00:00:00,Middle Aged,M01.060.116.630
19837394,2009-10-17T00:00:00,Neoplasm Staging,E01.370.550
19837394,2009-10-17T00:00:00,Reconstructive Surgical Procedures,E04.680
19837394,2009-10-17T00:00:00,Retroperitoneal Neoplasms,C04.588.033.731
19837394,2009-10-17T00:00:00,Risk Assessment,E05.318.740.600.800.715
19837394,2009-10-17T00:00:00,Risk Assessment,N04.452.871.715
19837394,2009-10-17T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19837394,2009-10-17T00:00:00,Risk Assessment,N06.850.505.715
19837394,2009-10-17T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19837394,2009-10-17T00:00:00,Surgical Flaps,A10.850.710
19837394,2009-10-17T00:00:00,Surgical Flaps,E07.862.710
19837394,2009-10-17T00:00:00,Treatment Outcome,E01.789.800
19837394,2009-10-17T00:00:00,Treatment Outcome,N04.761.559.590.800
19837394,2009-10-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19837394,2009-10-17T00:00:00,Wound Healing,G16.100.856.891
19837540,2009-10-17T00:00:00,Bone Cements,D05.750.716.822.300
19837540,2009-10-17T00:00:00,Bone Cements,D25.720.716.822.300
19837540,2009-10-17T00:00:00,Bone Cements,D27.720.102.158
19837540,2009-10-17T00:00:00,Bone Cements,J01.637.051.720.716.822.300
19837540,2009-10-17T00:00:00,Embolism,C14.907.355.350
19837540,2009-10-17T00:00:00,Heart Diseases,C14.280
19837540,2009-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19837540,2009-10-17T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
19837540,2009-10-17T00:00:00,Middle Aged,M01.060.116.630
19837540,2009-10-17T00:00:00,Polymethyl Methacrylate,D02.241.081.069.800.550.500
19837540,2009-10-17T00:00:00,Polymethyl Methacrylate,D05.750.716.822.111.650.605.500
19837540,2009-10-17T00:00:00,Polymethyl Methacrylate,D25.720.716.822.111.650.605.500
19837540,2009-10-17T00:00:00,Polymethyl Methacrylate,J01.637.051.720.716.822.111.650.605.500
19837540,2009-10-17T00:00:00,Pulmonary Embolism,C08.381.746
19837540,2009-10-17T00:00:00,Pulmonary Embolism,C14.907.355.350.700
19837540,2009-10-17T00:00:00,Spinal Fractures,C21.866.117.500.500
19837540,2009-10-17T00:00:00,Spinal Fractures,C21.866.404.812
19837540,2009-10-17T00:00:00,Spinal Fractures,C21.866.831.600
19837540,2009-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19837540,2009-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19837540,2009-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19837540,2009-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19837540,2009-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19837540,2009-10-17T00:00:00,Treatment Outcome,E01.789.800
19837540,2009-10-17T00:00:00,Treatment Outcome,N04.761.559.590.800
19837540,2009-10-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19837540,2009-10-17T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
19896793,2009-10-17T00:00:00,Animals,B01.050
19896793,2009-10-17T00:00:00,Antineoplastic Agents,D27.505.954.248
19896793,2009-10-17T00:00:00,Cisplatin,D01.210.375
19896793,2009-10-17T00:00:00,Cisplatin,D01.625.125
19896793,2009-10-17T00:00:00,Cisplatin,D01.710.100
19896793,2009-10-17T00:00:00,Creatinine,D03.383.129.308.207
19896793,2009-10-17T00:00:00,Glutathione Disulfide,D12.644.456.448.500
19896793,2009-10-17T00:00:00,Kidney Diseases,C12.777.419
19896793,2009-10-17T00:00:00,Kidney Diseases,C13.351.968.419
19896793,2009-10-17T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
19835628,2009-10-18T00:00:00,Computational Biology,H01.158.273.180
19835628,2009-10-18T00:00:00,Markov Chains,E05.318.740.600.500
19835628,2009-10-18T00:00:00,Markov Chains,E05.318.740.996.500
19835628,2009-10-18T00:00:00,Markov Chains,G17.830.500
19835628,2009-10-18T00:00:00,Markov Chains,N05.715.360.750.625.500
19835628,2009-10-18T00:00:00,Markov Chains,N05.715.360.750.770.500
19835628,2009-10-18T00:00:00,Markov Chains,N06.850.520.830.600.500
19835628,2009-10-18T00:00:00,Markov Chains,N06.850.520.830.996.500
19835628,2009-10-18T00:00:00,Monte Carlo Method,E05.318.740.525
19835628,2009-10-18T00:00:00,Monte Carlo Method,L01.906.575.422
19835628,2009-10-18T00:00:00,Monte Carlo Method,N05.715.360.750.540
19835628,2009-10-18T00:00:00,Monte Carlo Method,N06.850.520.830.525
19835628,2009-10-18T00:00:00,Proteins,D12.776
19835628,2009-10-18T00:00:00,Proteomics,H01.158.201.843
19835628,2009-10-18T00:00:00,Proteomics,H01.158.273.180.350.700
19835628,2009-10-18T00:00:00,Proteomics,H01.158.273.343.350.700
19835628,2009-10-18T00:00:00,Proteomics,H01.181.122.738
19835628,2009-10-18T00:00:00,Software,L01.224.900
19835667,2009-10-19T00:00:00,Animals,B01.050
19835667,2009-10-19T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
19835667,2009-10-19T00:00:00,Dopamine,D02.092.211.215.311.342
19835667,2009-10-19T00:00:00,Dopamine,D02.092.311.342
19835667,2009-10-19T00:00:00,Motor Activity,F01.145.632
19835667,2009-10-19T00:00:00,Motor Activity,G11.427.590.530.698
19835667,2009-10-19T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
19835667,2009-10-19T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
19835667,2009-10-19T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
19835667,2009-10-19T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
19835667,2009-10-19T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
19835667,2009-10-19T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
19835667,2009-10-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19835667,2009-10-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19835667,2009-10-19T00:00:00,Risperidone,D03.383.742.698.685
19838206,2009-10-19T00:00:00,Animals,B01.050
19838206,2009-10-19T00:00:00,Cell Movement,G04.299.283
19838206,2009-10-19T00:00:00,Cell Movement,G07.700.560.500.180
19838206,2009-10-19T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19838206,2009-10-19T00:00:00,Neoplasm Invasiveness,C04.697.645
19838206,2009-10-19T00:00:00,Neoplasm Invasiveness,C23.550.727.645
19841106,2009-10-19T00:00:00,Adolescent,M01.060.057
19841106,2009-10-19T00:00:00,Adolescent Behavior,F01.145.022
19841106,2009-10-19T00:00:00,African Americans,M01.686.508.100.100
19841106,2009-10-19T00:00:00,African Americans,M01.686.754.100
19841106,2009-10-19T00:00:00,Body Weight,C23.888.144
19841106,2009-10-19T00:00:00,Body Weight,E01.370.600.115.100.160.120
19841106,2009-10-19T00:00:00,Body Weight,E05.041.124.160.750
19841106,2009-10-19T00:00:00,Body Weight,G07.100.100.160.120
19841106,2009-10-19T00:00:00,Body Weight,G07.700.320.249.314.120
19841106,2009-10-19T00:00:00,European Continental Ancestry Group,M01.686.508.400
19841106,2009-10-19T00:00:00,Hispanic Americans,M01.686.754.441
19841106,2009-10-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19841106,2009-10-19T00:00:00,Sexual Behavior,F01.145.802
19841106,2009-10-19T00:00:00,United States,Z01.107.567.875
19841109,2009-10-19T00:00:00,Activities of Daily Living,E02.831.067
19841109,2009-10-19T00:00:00,Activities of Daily Living,I03.050
19841109,2009-10-19T00:00:00,Activities of Daily Living,N02.421.784.110
19841109,2009-10-19T00:00:00,Adolescent,M01.060.057
19841109,2009-10-19T00:00:00,Attitude to Health,F01.100.150
19841109,2009-10-19T00:00:00,Attitude to Health,N05.300.150
19841109,2009-10-19T00:00:00,Child,M01.060.406
19841109,2009-10-19T00:00:00,Fontan Procedure,E04.035.410.295
19841109,2009-10-19T00:00:00,Fontan Procedure,E04.100.376.410.295
19841109,2009-10-19T00:00:00,Fontan Procedure,E04.928.220.370.295
19841109,2009-10-19T00:00:00,Health Status,I01.240.425
19841109,2009-10-19T00:00:00,Health Status,N01.224.425
19841109,2009-10-19T00:00:00,Health Status,N06.850.505.400.425
19841109,2009-10-19T00:00:00,"Heart Defects, Congenital",C14.240.400
19841109,2009-10-19T00:00:00,"Heart Defects, Congenital",C14.280.400
19841109,2009-10-19T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19841109,2009-10-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19841109,2009-10-19T00:00:00,Parents,F01.829.263.500.320
19841109,2009-10-19T00:00:00,Parents,I01.880.225.500.340
19841109,2009-10-19T00:00:00,Parents,M01.620
19841109,2009-10-19T00:00:00,Quality of Life,I01.800
19841109,2009-10-19T00:00:00,Quality of Life,K01.752.400.750
19841109,2009-10-19T00:00:00,Questionnaires,E05.318.308.750
19841109,2009-10-19T00:00:00,Questionnaires,L01.280.800
19841109,2009-10-19T00:00:00,Questionnaires,N05.715.360.300.695
19841109,2009-10-19T00:00:00,Questionnaires,N06.850.520.308.750
19841152,2009-10-19T00:00:00,Adolescent,M01.060.057
19841152,2009-10-19T00:00:00,Adult,M01.060.116
19841152,2009-10-19T00:00:00,Age Factors,N05.715.350.075
19841152,2009-10-19T00:00:00,Age Factors,N06.850.490.250
19841152,2009-10-19T00:00:00,Aged,M01.060.116.100
19841152,2009-10-19T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19841152,2009-10-19T00:00:00,Child,M01.060.406
19841152,2009-10-19T00:00:00,"Child, Preschool",M01.060.406.448
19841152,2009-10-19T00:00:00,Hospital Costs,N03.219.151.400.687
19841152,2009-10-19T00:00:00,Hospital Costs,N03.219.262.500
19841152,2009-10-19T00:00:00,Hospital Costs,N05.300.375.500
19841152,2009-10-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19841152,2009-10-19T00:00:00,Infant,M01.060.703
19841152,2009-10-19T00:00:00,"Infant, Newborn",M01.060.703.520
19841152,2009-10-19T00:00:00,Length of Stay,E02.760.400.480
19841152,2009-10-19T00:00:00,Length of Stay,N02.421.585.400.480
19841152,2009-10-19T00:00:00,Middle Aged,M01.060.116.630
19841152,2009-10-19T00:00:00,Risk Factors,E05.318.740.600.800.725
19841152,2009-10-19T00:00:00,Risk Factors,N05.715.350.200.700
19841152,2009-10-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19841152,2009-10-19T00:00:00,Risk Factors,N06.850.490.625.750
19841152,2009-10-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19841152,2009-10-19T00:00:00,South Carolina,Z01.107.567.875.075.662
19841152,2009-10-19T00:00:00,South Carolina,Z01.107.567.875.750.700
19841152,2009-10-19T00:00:00,Young Adult,M01.060.116.815
19843227,2009-10-19T00:00:00,Amino Acid Sequence,G02.111.570.060
19843227,2009-10-19T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19843227,2009-10-19T00:00:00,Bacterial Proteins,D12.776.097
19843227,2009-10-19T00:00:00,DNA-Binding Proteins,D12.776.260
19843227,2009-10-19T00:00:00,Escherichia coli,B03.440.450.425.325.300
19843227,2009-10-19T00:00:00,Escherichia coli,B03.660.250.150.180.100
19843227,2009-10-19T00:00:00,Glucose,D09.546.359.448
19843227,2009-10-19T00:00:00,Molecular Chaperones,D12.776.580
19843227,2009-10-19T00:00:00,Protein Stability,G02.111.700
19845734,2009-10-20T00:00:00,Adolescent,M01.060.057
19845734,2009-10-20T00:00:00,Adult,M01.060.116
19845734,2009-10-20T00:00:00,Brain Injuries,C10.228.140.199
19845734,2009-10-20T00:00:00,Brain Injuries,C10.900.300.087
19845734,2009-10-20T00:00:00,Brain Injuries,C21.866.260.118
19845734,2009-10-20T00:00:00,Brain Injuries,C21.866.915.300.200
19845734,2009-10-20T00:00:00,Depressive Disorder,F03.600.300
19845734,2009-10-20T00:00:00,Hospitalization,E02.760.400
19845734,2009-10-20T00:00:00,Hospitalization,N02.421.585.400
19845734,2009-10-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19845734,2009-10-20T00:00:00,Incidence,E05.318.308.985.525.375
19845734,2009-10-20T00:00:00,Incidence,L01.280.975.525.375
19845734,2009-10-20T00:00:00,Incidence,N01.224.935.597.500
19845734,2009-10-20T00:00:00,Incidence,N06.850.505.400.975.525.375
19845734,2009-10-20T00:00:00,Incidence,N06.850.520.308.985.525.375
19845734,2009-10-20T00:00:00,International Classification of Diseases,L01.453.245.945.400
19845734,2009-10-20T00:00:00,Middle Aged,M01.060.116.630
19845734,2009-10-20T00:00:00,Patient Discharge,E02.760.400.610
19845734,2009-10-20T00:00:00,Patient Discharge,N02.421.585.400.610
19845734,2009-10-20T00:00:00,Population Surveillance,E05.318.308.250.700
19845734,2009-10-20T00:00:00,Population Surveillance,N05.715.360.300.375.625
19845734,2009-10-20T00:00:00,Population Surveillance,N06.850.520.308.250.700
19845734,2009-10-20T00:00:00,Population Surveillance,N06.850.780.675
19845734,2009-10-20T00:00:00,Risk Factors,E05.318.740.600.800.725
19845734,2009-10-20T00:00:00,Risk Factors,N05.715.350.200.700
19845734,2009-10-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19845734,2009-10-20T00:00:00,Risk Factors,N06.850.490.625.750
19845734,2009-10-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19845734,2009-10-20T00:00:00,South Carolina,Z01.107.567.875.075.662
19845734,2009-10-20T00:00:00,South Carolina,Z01.107.567.875.750.700
19850101,2009-10-20T00:00:00,"History, 20th Century",K01.400.504.968
19850101,2009-10-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19850101,2009-10-20T00:00:00,Neurons,A08.663
19850101,2009-10-20T00:00:00,Neurons,A11.671
19850106,2009-10-20T00:00:00,Animals,B01.050
19850106,2009-10-20T00:00:00,"Animals, Newborn",B01.050.050.282
19850106,2009-10-20T00:00:00,Calcium,D01.268.552.100
19850106,2009-10-20T00:00:00,Calcium,D01.552.539.288
19850106,2009-10-20T00:00:00,Calcium,D23.119.100
19850106,2009-10-20T00:00:00,Hippocampus,A08.186.211.464.405
19850106,2009-10-20T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
19850106,2009-10-20T00:00:00,Phosphorylation,G02.111.087.677
19850106,2009-10-20T00:00:00,Phosphorylation,G02.149.115.677
19850106,2009-10-20T00:00:00,Phosphorylation,G02.149.465.700
19850106,2009-10-20T00:00:00,Phosphorylation,G02.607.750.700
19850106,2009-10-20T00:00:00,Phosphorylation,G03.495.790
19850106,2009-10-20T00:00:00,Protein Transport,G03.495.166.700
19850106,2009-10-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19850106,2009-10-20T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19850106,2009-10-20T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
19850106,2009-10-20T00:00:00,Seizures,C10.228.140.490.631
19850106,2009-10-20T00:00:00,Seizures,C10.597.742
19850106,2009-10-20T00:00:00,Seizures,C23.888.592.742
21069147,2009-10-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21069147,2009-10-20T00:00:00,Iron,D01.268.556.412
21069147,2009-10-20T00:00:00,Iron,D01.268.956.287
21069147,2009-10-20T00:00:00,Iron,D01.552.544.412
21069147,2009-10-20T00:00:00,"Models, Molecular",E05.599.595
21069147,2009-10-20T00:00:00,Transferrin,D12.776.124.050.800
21069147,2009-10-20T00:00:00,Transferrin,D12.776.124.790.223.839
21069147,2009-10-20T00:00:00,Transferrin,D12.776.157.427.500
21069147,2009-10-20T00:00:00,Transferrin,D12.776.377.715.182.839
21069147,2009-10-20T00:00:00,Transferrin,D12.776.556.579.500
19850334,2009-10-21T00:00:00,Adsorption,G02.149.047
19850334,2009-10-21T00:00:00,Adsorption,G02.149.767.029
19850334,2009-10-21T00:00:00,Adsorption,G02.842.750.029
19850334,2009-10-21T00:00:00,Biocompatible Materials,D25.130
19850334,2009-10-21T00:00:00,Biocompatible Materials,D27.720.102.130
19850334,2009-10-21T00:00:00,Biocompatible Materials,J01.637.051.130
19850334,2009-10-21T00:00:00,Blood Platelets,A11.118.188
19850334,2009-10-21T00:00:00,Blood Platelets,A15.145.229.188
19850334,2009-10-21T00:00:00,Fibrinogen,D12.776.124.050.250
19850334,2009-10-21T00:00:00,Fibrinogen,D12.776.124.125.500
19850334,2009-10-21T00:00:00,Fibrinogen,D12.776.811.300
19850334,2009-10-21T00:00:00,Fibrinogen,D23.119.490
19850334,2009-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19850334,2009-10-21T00:00:00,Materials Testing,E05.570
19850334,2009-10-21T00:00:00,Surface Properties,G02.842.850
19850562,2009-10-21T00:00:00,Blood Chemical Analysis,E01.450.150.100
19850562,2009-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19850562,2009-10-21T00:00:00,"Infant, Newborn",M01.060.703.520
19850562,2009-10-21T00:00:00,Pilot Projects,E05.318.760.750
19850562,2009-10-21T00:00:00,Pilot Projects,E05.337.737
19850562,2009-10-21T00:00:00,Pilot Projects,N05.715.360.775.625
19850562,2009-10-21T00:00:00,Pilot Projects,N06.850.520.450.720
19850562,2009-10-21T00:00:00,South Carolina,Z01.107.567.875.075.662
19850562,2009-10-21T00:00:00,South Carolina,Z01.107.567.875.750.700
19850562,2009-10-21T00:00:00,Treatment Outcome,E01.789.800
19850562,2009-10-21T00:00:00,Treatment Outcome,N04.761.559.590.800
19850562,2009-10-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19853012,2009-10-21T00:00:00,Aging,G07.700.320.124
19853012,2009-10-21T00:00:00,Animals,B01.050
19853012,2009-10-21T00:00:00,"Disease Models, Animal",C22.232
19853012,2009-10-21T00:00:00,"Disease Models, Animal",E05.598.500
19853012,2009-10-21T00:00:00,"Disease Models, Animal",E05.599.395.080
19853012,2009-10-21T00:00:00,Dopamine,D02.092.211.215.311.342
19853012,2009-10-21T00:00:00,Dopamine,D02.092.311.342
19853012,2009-10-21T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
19853012,2009-10-21T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
19853012,2009-10-21T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
19853012,2009-10-21T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
19853012,2009-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19853012,2009-10-21T00:00:00,"Models, Biological",E05.599.395
19853012,2009-10-21T00:00:00,Neurons,A08.663
19853012,2009-10-21T00:00:00,Neurons,A11.671
19853012,2009-10-21T00:00:00,Parkinsonian Disorders,C10.228.140.079.862
19853012,2009-10-21T00:00:00,Parkinsonian Disorders,C10.228.662.600
19849810,2009-10-22T00:00:00,Adolescent,M01.060.057
19849810,2009-10-22T00:00:00,Adult,M01.060.116
19849810,2009-10-22T00:00:00,Aged,M01.060.116.100
19849810,2009-10-22T00:00:00,Asthma,C08.127.108
19849810,2009-10-22T00:00:00,Asthma,C08.381.495.108
19849810,2009-10-22T00:00:00,Asthma,C08.674.095
19849810,2009-10-22T00:00:00,Asthma,C20.543.480.680.095
19849810,2009-10-22T00:00:00,Employment,N01.824.245
19849810,2009-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19849810,2009-10-22T00:00:00,Middle Aged,M01.060.116.630
19849810,2009-10-22T00:00:00,Sex Factors,N05.715.350.675
19849810,2009-10-22T00:00:00,Sex Factors,N06.850.490.875
19849810,2009-10-22T00:00:00,Young Adult,M01.060.116.815
19851442,2009-10-23T00:00:00,Adolescent,M01.060.057
19851442,2009-10-23T00:00:00,Adult,M01.060.116
19851442,2009-10-23T00:00:00,Genome-Wide Association Study,E05.318.416.249
19851442,2009-10-23T00:00:00,Genome-Wide Association Study,E05.318.780.392
19851442,2009-10-23T00:00:00,Genome-Wide Association Study,E05.393.385.500
19851442,2009-10-23T00:00:00,Genome-Wide Association Study,E05.393.522.500
19851442,2009-10-23T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19851442,2009-10-23T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19851442,2009-10-23T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19851442,2009-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19851442,2009-10-23T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19851442,2009-10-23T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19851442,2009-10-23T00:00:00,Membrane Proteins,D12.776.543
19851442,2009-10-23T00:00:00,Middle Aged,M01.060.116.630
19851442,2009-10-23T00:00:00,Obesity,C18.654.726.500
19851442,2009-10-23T00:00:00,Obesity,C23.888.144.699.500
19851442,2009-10-23T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19851442,2009-10-23T00:00:00,Obesity,G07.100.100.160.120.699.500
19851442,2009-10-23T00:00:00,"Polymorphism, Genetic",G05.365.795
19851442,2009-10-23T00:00:00,Research Design,E05.581.500
19851442,2009-10-23T00:00:00,Research Design,H01.770.644.728
19851442,2009-10-23T00:00:00,Young Adult,M01.060.116.815
19851818,2009-10-23T00:00:00,Adolescent,M01.060.057
19851818,2009-10-23T00:00:00,Adult,M01.060.116
19851818,2009-10-23T00:00:00,Ankle Injuries,C21.866.558.100
19851818,2009-10-23T00:00:00,Ankle Joint,A02.835.583.378.062
19851818,2009-10-23T00:00:00,Arthroscopy,E01.370.388.250.070
19851818,2009-10-23T00:00:00,Arthroscopy,E04.555.113
19851818,2009-10-23T00:00:00,Arthroscopy,E04.800.250.070
19851818,2009-10-23T00:00:00,"Cartilage, Articular",A02.165.407.150
19851818,2009-10-23T00:00:00,"Cartilage, Articular",A02.835.583.192
19851818,2009-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19851818,2009-10-23T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19851818,2009-10-23T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19851818,2009-10-23T00:00:00,Middle Aged,M01.060.116.630
19851818,2009-10-23T00:00:00,Reconstructive Surgical Procedures,E04.680
19851818,2009-10-23T00:00:00,Tendon Injuries,C21.866.874
19851818,2009-10-23T00:00:00,Young Adult,M01.060.116.815
19853862,2009-10-24T00:00:00,Aged,M01.060.116.100
19853862,2009-10-24T00:00:00,Albuminuria,C12.777.934.734.269
19853862,2009-10-24T00:00:00,Albuminuria,C13.351.968.934.734.269
19853862,2009-10-24T00:00:00,Albuminuria,C23.888.942.750.269
19853862,2009-10-24T00:00:00,Cardiovascular Diseases,C14
19853862,2009-10-24T00:00:00,Chronic Disease,C23.550.291.500
19853862,2009-10-24T00:00:00,Creatinine,D03.383.129.308.207
19853862,2009-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19853862,2009-10-24T00:00:00,Kidney Diseases,C12.777.419
19853862,2009-10-24T00:00:00,Kidney Diseases,C13.351.968.419
19853862,2009-10-24T00:00:00,Middle Aged,M01.060.116.630
19853862,2009-10-24T00:00:00,Regression Analysis,E05.318.740.750
19853862,2009-10-24T00:00:00,Regression Analysis,N05.715.360.750.695
19853862,2009-10-24T00:00:00,Regression Analysis,N06.850.520.830.750
19853862,2009-10-24T00:00:00,Risk Factors,E05.318.740.600.800.725
19853862,2009-10-24T00:00:00,Risk Factors,N05.715.350.200.700
19853862,2009-10-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19853862,2009-10-24T00:00:00,Risk Factors,N06.850.490.625.750
19853862,2009-10-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19853862,2009-10-24T00:00:00,Stroke,C10.228.140.300.775
19853862,2009-10-24T00:00:00,Stroke,C14.907.253.855
19853862,2009-10-24T00:00:00,Treatment Outcome,E01.789.800
19853862,2009-10-24T00:00:00,Treatment Outcome,N04.761.559.590.800
19853862,2009-10-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19853862,2009-10-24T00:00:00,United States,Z01.107.567.875
19855918,2009-10-24T00:00:00,Adolescent,M01.060.057
19855918,2009-10-24T00:00:00,Adult,M01.060.116
19855918,2009-10-24T00:00:00,African Americans,M01.686.508.100.100
19855918,2009-10-24T00:00:00,African Americans,M01.686.754.100
19855918,2009-10-24T00:00:00,Aged,M01.060.116.100
19855918,2009-10-24T00:00:00,Blood Pressure,E01.370.600.875.249
19855918,2009-10-24T00:00:00,Blood Pressure,G09.330.380.076
19855918,2009-10-24T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19855918,2009-10-24T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19855918,2009-10-24T00:00:00,European Continental Ancestry Group,M01.686.508.400
19855918,2009-10-24T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19855918,2009-10-24T00:00:00,Genetic Predisposition to Disease,G05.380.355
19855918,2009-10-24T00:00:00,Genetic Variation,G05.365
19855918,2009-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19855918,2009-10-24T00:00:00,Hypertension,C14.907.489
19855918,2009-10-24T00:00:00,Middle Aged,M01.060.116.630
19855918,2009-10-24T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19855918,2009-10-24T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
19855918,2009-10-24T00:00:00,United States,Z01.107.567.875
19855918,2009-10-24T00:00:00,Young Adult,M01.060.116.815
19858234,2009-10-26T00:00:00,Bronchoscopy,E01.370.386.105
19858234,2009-10-26T00:00:00,Bronchoscopy,E01.370.388.250.100
19858234,2009-10-26T00:00:00,Bronchoscopy,E04.800.250.100
19858234,2009-10-26T00:00:00,Bronchoscopy,E04.928.600.080
19858234,2009-10-26T00:00:00,Clinical Competence,I02.399.630.210
19858234,2009-10-26T00:00:00,Clinical Competence,N04.761.210
19858234,2009-10-26T00:00:00,"Education, Medical, Graduate",I02.358.337.350
19858234,2009-10-26T00:00:00,"Education, Medical, Graduate",I02.358.399.350
19858234,2009-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19858234,2009-10-26T00:00:00,Internship and Residency,I02.358.399.644
19858234,2009-10-26T00:00:00,Learning,F02.463.425
19858234,2009-10-26T00:00:00,Learning,F02.784.629.529
19858234,2009-10-26T00:00:00,Manikins,J01.897.280.500.545.129.400
19858234,2009-10-26T00:00:00,Manikins,L01.178.820.090.545.129.400
19858419,2009-10-26T00:00:00,Aged,M01.060.116.100
19858419,2009-10-26T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
19858419,2009-10-26T00:00:00,"Cardiac Pacing, Artificial",E02.145
19858419,2009-10-26T00:00:00,Cardiac Volume,G09.330.380.249
19858419,2009-10-26T00:00:00,Combined Modality Therapy,E02.186
19858419,2009-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19858419,2009-10-26T00:00:00,Middle Aged,M01.060.116.630
19858419,2009-10-26T00:00:00,Stroke Volume,E01.370.370.380.150.700
19858419,2009-10-26T00:00:00,Stroke Volume,G09.330.380.124.882
19858419,2009-10-26T00:00:00,Treatment Outcome,E01.789.800
19858419,2009-10-26T00:00:00,Treatment Outcome,N04.761.559.590.800
19858419,2009-10-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19858419,2009-10-26T00:00:00,Ventricular Remodeling,C23.300.985
19858419,2009-10-26T00:00:00,Ventricular Remodeling,G09.330.190.962.975
19858433,2009-10-26T00:00:00,Adult,M01.060.116
19858433,2009-10-26T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19858433,2009-10-26T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19858433,2009-10-26T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19858433,2009-10-26T00:00:00,Diabetes Complications,C19.246.099
19858433,2009-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19858433,2009-10-26T00:00:00,Middle Aged,M01.060.116.630
19858433,2009-10-26T00:00:00,Myocardial Infarction,C14.280.647.500
19858433,2009-10-26T00:00:00,Myocardial Infarction,C14.907.585.500
19858433,2009-10-26T00:00:00,Myocardial Ischemia,C14.280.647
19858433,2009-10-26T00:00:00,Myocardial Ischemia,C14.907.585
19858433,2009-10-26T00:00:00,Nutrition Surveys,E05.318.308.250.600
19858433,2009-10-26T00:00:00,Nutrition Surveys,E05.318.308.585.550
19858433,2009-10-26T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
19858433,2009-10-26T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
19858433,2009-10-26T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
19858433,2009-10-26T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
19858433,2009-10-26T00:00:00,Population Surveillance,E05.318.308.250.700
19858433,2009-10-26T00:00:00,Population Surveillance,N05.715.360.300.375.625
19858433,2009-10-26T00:00:00,Population Surveillance,N06.850.520.308.250.700
19858433,2009-10-26T00:00:00,Population Surveillance,N06.850.780.675
19858433,2009-10-26T00:00:00,Risk Assessment,E05.318.740.600.800.715
19858433,2009-10-26T00:00:00,Risk Assessment,N04.452.871.715
19858433,2009-10-26T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19858433,2009-10-26T00:00:00,Risk Assessment,N06.850.505.715
19858433,2009-10-26T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19858433,2009-10-26T00:00:00,Risk Factors,E05.318.740.600.800.725
19858433,2009-10-26T00:00:00,Risk Factors,N05.715.350.200.700
19858433,2009-10-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19858433,2009-10-26T00:00:00,Risk Factors,N06.850.490.625.750
19858433,2009-10-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19858433,2009-10-26T00:00:00,Sex Factors,N05.715.350.675
19858433,2009-10-26T00:00:00,Sex Factors,N06.850.490.875
19858433,2009-10-26T00:00:00,United States,Z01.107.567.875
19863578,2009-10-27T00:00:00,Adolescent,M01.060.057
19863578,2009-10-27T00:00:00,Adult,M01.060.116
19863578,2009-10-27T00:00:00,Aged,M01.060.116.100
19863578,2009-10-27T00:00:00,Anticonvulsants,D27.505.954.427.080
19863578,2009-10-27T00:00:00,Carbamates,D02.241.081.251
19863578,2009-10-27T00:00:00,Dizziness,C10.597.751.237
19863578,2009-10-27T00:00:00,Dizziness,C23.888.592.763.237
19863578,2009-10-27T00:00:00,Double-Blind Method,E05.318.780.300
19863578,2009-10-27T00:00:00,Double-Blind Method,E05.581.500.300
19863578,2009-10-27T00:00:00,Double-Blind Method,N05.715.360.780.320
19863578,2009-10-27T00:00:00,Double-Blind Method,N06.850.520.445.300
19863578,2009-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19863578,2009-10-27T00:00:00,Middle Aged,M01.060.116.630
19863578,2009-10-27T00:00:00,Sleep,F02.830.855
19863578,2009-10-27T00:00:00,Sleep,G11.561.600.815
19863578,2009-10-27T00:00:00,Treatment Outcome,E01.789.800
19863578,2009-10-27T00:00:00,Treatment Outcome,N04.761.559.590.800
19863578,2009-10-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19864017,2009-10-27T00:00:00,Adsorption,G02.149.047
19864017,2009-10-27T00:00:00,Adsorption,G02.149.767.029
19864017,2009-10-27T00:00:00,Adsorption,G02.842.750.029
19864017,2009-10-27T00:00:00,Binding Sites,G02.111.570.120
19864017,2009-10-27T00:00:00,Blood Platelets,A11.118.188
19864017,2009-10-27T00:00:00,Blood Platelets,A15.145.229.188
19864017,2009-10-27T00:00:00,"Coated Materials, Biocompatible",D25.130.420
19864017,2009-10-27T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
19864017,2009-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19864017,2009-10-27T00:00:00,Materials Testing,E05.570
19864017,2009-10-27T00:00:00,Protein Denaturation,G02.111.087.685
19864017,2009-10-27T00:00:00,Protein Denaturation,G02.149.115.685
19864017,2009-10-27T00:00:00,Serum Albumin,D12.776.034.841
19864017,2009-10-27T00:00:00,Serum Albumin,D12.776.124.050.700
19864017,2009-10-27T00:00:00,Serum Albumin,D12.776.124.727
19846139,2009-10-28T00:00:00,Case-Control Studies,E05.318.760.500.500
19846139,2009-10-28T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19846139,2009-10-28T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19846139,2009-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19846139,2009-10-28T00:00:00,Middle Aged,M01.060.116.630
19846139,2009-10-28T00:00:00,"Polymorphism, Genetic",G05.365.795
19846139,2009-10-28T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19846139,2009-10-28T00:00:00,Prostatic Neoplasms,C12.294.260.750
19846139,2009-10-28T00:00:00,Prostatic Neoplasms,C12.294.565.625
19846139,2009-10-28T00:00:00,Prostatic Neoplasms,C12.758.409.750
19846139,2009-10-28T00:00:00,Risk Factors,E05.318.740.600.800.725
19846139,2009-10-28T00:00:00,Risk Factors,N05.715.350.200.700
19846139,2009-10-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19846139,2009-10-28T00:00:00,Risk Factors,N06.850.490.625.750
19846139,2009-10-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19846139,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19862532,2009-10-28T00:00:00,Adult,M01.060.116
19862532,2009-10-28T00:00:00,Aged,M01.060.116.100
19862532,2009-10-28T00:00:00,Algorithms,G17.035
19862532,2009-10-28T00:00:00,Algorithms,L01.224.050
19862532,2009-10-28T00:00:00,Calcinosis,C18.452.174.130
19862532,2009-10-28T00:00:00,Coronary Stenosis,C14.280.647.250.285
19862532,2009-10-28T00:00:00,Coronary Stenosis,C14.907.585.250.285
19862532,2009-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19862532,2009-10-28T00:00:00,Middle Aged,M01.060.116.630
19862532,2009-10-28T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19862532,2009-10-28T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19862532,2009-10-28T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19862532,2009-10-28T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19862532,2009-10-28T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19862532,2009-10-28T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19862532,2009-10-28T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19862532,2009-10-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19862532,2009-10-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19862532,2009-10-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19862532,2009-10-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19862532,2009-10-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19862617,2009-10-28T00:00:00,Animals,B01.050
19862617,2009-10-28T00:00:00,Chick Embryo,A13.350.150
19862617,2009-10-28T00:00:00,Chick Embryo,A16.331.200
19862617,2009-10-28T00:00:00,Heart Valve Diseases,C14.280.484
19862617,2009-10-28T00:00:00,Heart Valves,A07.541.510
19862617,2009-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19862617,2009-10-28T00:00:00,"Models, Cardiovascular",E05.599.395.161
19864004,2009-10-28T00:00:00,Animals,B01.050
19864004,2009-10-28T00:00:00,"Muscle, Smooth",A02.633.570
19864004,2009-10-28T00:00:00,"Muscle, Smooth",A10.690.467
19864004,2009-10-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19864004,2009-10-28T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19864004,2009-10-28T00:00:00,Urinary Bladder,A05.810.890
19864399,2009-10-28T00:00:00,Adult,M01.060.116
19864399,2009-10-28T00:00:00,Biological Markers,D23.101
19864399,2009-10-28T00:00:00,C-Reactive Protein,D12.776.034.145
19864399,2009-10-28T00:00:00,C-Reactive Protein,D12.776.124.050.120
19864399,2009-10-28T00:00:00,C-Reactive Protein,D12.776.124.486.157
19864399,2009-10-28T00:00:00,Diet,E05.272
19864399,2009-10-28T00:00:00,Diet,G07.610.240
19864399,2009-10-28T00:00:00,Energy Intake,G07.610.240.340
19864399,2009-10-28T00:00:00,Exercise,G11.427.590.237
19864399,2009-10-28T00:00:00,Exercise,I03.350
19864399,2009-10-28T00:00:00,Homeostasis,G07.700.360
19864399,2009-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19864399,2009-10-28T00:00:00,Inflammation,C23.550.470
19864399,2009-10-28T00:00:00,Interleukin-1,D12.644.276.374.465.501
19864399,2009-10-28T00:00:00,Interleukin-1,D12.644.276.374.500.400
19864399,2009-10-28T00:00:00,Interleukin-1,D12.776.467.374.465.501
19864399,2009-10-28T00:00:00,Interleukin-1,D12.776.467.374.500.400
19864399,2009-10-28T00:00:00,Interleukin-1,D23.529.374.465.501
19864399,2009-10-28T00:00:00,Interleukin-1,D23.529.374.500.400
19864399,2009-10-28T00:00:00,Interleukin-10,D12.644.276.374.465.510
19864399,2009-10-28T00:00:00,Interleukin-10,D12.776.467.374.465.510
19864399,2009-10-28T00:00:00,Interleukin-10,D23.529.374.465.510
19864399,2009-10-28T00:00:00,Interleukin-4,D12.644.276.374.465.504
19864399,2009-10-28T00:00:00,Interleukin-4,D12.776.467.374.465.504
19864399,2009-10-28T00:00:00,Interleukin-4,D23.529.374.465.504
19864399,2009-10-28T00:00:00,Interleukin-6,D12.644.276.374.465.506
19864399,2009-10-28T00:00:00,Interleukin-6,D12.776.467.374.465.506
19864399,2009-10-28T00:00:00,Interleukin-6,D23.529.374.465.506
19864399,2009-10-28T00:00:00,Interviews as Topic,E05.318.308.420
19864399,2009-10-28T00:00:00,Interviews as Topic,L01.280.520
19864399,2009-10-28T00:00:00,Interviews as Topic,N05.715.360.300.400
19864399,2009-10-28T00:00:00,Interviews as Topic,N06.850.520.308.420
19864399,2009-10-28T00:00:00,Middle Aged,M01.060.116.630
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19864399,2009-10-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19864641,2009-10-28T00:00:00,Alveolar Bone Loss,C05.116.264.150
19864641,2009-10-28T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
19864641,2009-10-28T00:00:00,Animals,B01.050
19864641,2009-10-28T00:00:00,Biological Markers,D23.101
19864641,2009-10-28T00:00:00,Cell Line,A11.251.210
19864641,2009-10-28T00:00:00,Cone-Beam Computed Tomography,E01.370.350.700.810.810.490
19864641,2009-10-28T00:00:00,Cone-Beam Computed Tomography,E01.370.350.825.810.810.399
19864641,2009-10-28T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.587.200
19864641,2009-10-28T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.625.225.200
19864641,2009-10-28T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.775.250.200
19864641,2009-10-28T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.268.200
19864641,2009-10-28T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.445.100
19864641,2009-10-28T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.268.200
19864641,2009-10-28T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.445.200
19864641,2009-10-28T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
19864641,2009-10-28T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
19864641,2009-10-28T00:00:00,"Immunity, Innate",G12.450.575
19864641,2009-10-28T00:00:00,Interleukin-6,D12.644.276.374.465.506
19864641,2009-10-28T00:00:00,Interleukin-6,D12.776.467.374.465.506
19864641,2009-10-28T00:00:00,Interleukin-6,D23.529.374.465.506
19864641,2009-10-28T00:00:00,Lipopolysaccharides,D09.400.500
19864641,2009-10-28T00:00:00,Lipopolysaccharides,D09.698.718.450
19864641,2009-10-28T00:00:00,Lipopolysaccharides,D10.494
19864641,2009-10-28T00:00:00,Lipopolysaccharides,D23.050.161.616.525
19864641,2009-10-28T00:00:00,Lipopolysaccharides,D23.946.123.329.500
19864641,2009-10-28T00:00:00,Osteoclasts,A11.329.372.700
19864641,2009-10-28T00:00:00,Osteoclasts,A11.627.482.700
19864641,2009-10-28T00:00:00,Periodontitis,C07.465.714.533
19864641,2009-10-28T00:00:00,Phosphorylation,G02.111.087.677
19864641,2009-10-28T00:00:00,Phosphorylation,G02.149.115.677
19864641,2009-10-28T00:00:00,Phosphorylation,G02.149.465.700
19864641,2009-10-28T00:00:00,Phosphorylation,G02.607.750.700
19864641,2009-10-28T00:00:00,Phosphorylation,G03.495.790
19864641,2009-10-28T00:00:00,Time Factors,G01.910.857
19864641,2009-10-28T00:00:00,X-Ray Microtomography,E01.370.350.700.810.810.900
19864641,2009-10-28T00:00:00,X-Ray Microtomography,E01.370.350.825.810.810.900
19864641,2009-10-28T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
19864641,2009-10-28T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
19864641,2009-10-28T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
19864641,2009-10-28T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
19874299,2009-10-28T00:00:00,Adolescent,M01.060.057
19874299,2009-10-28T00:00:00,Adult,M01.060.116
19874299,2009-10-28T00:00:00,Aged,M01.060.116.100
19874299,2009-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19874299,2009-10-28T00:00:00,Kidney,A05.810.453
19874299,2009-10-28T00:00:00,Middle Aged,M01.060.116.630
19874299,2009-10-28T00:00:00,Renal Insufficiency,C12.777.419.780
19874299,2009-10-28T00:00:00,Renal Insufficiency,C13.351.968.419.780
19874299,2009-10-28T00:00:00,Young Adult,M01.060.116.815
19878356,2009-10-28T00:00:00,Adipocytes,A11.329.114
19878356,2009-10-28T00:00:00,Cell Differentiation,G04.299.151
19878356,2009-10-28T00:00:00,"Diagnosis, Differential",E01.171
19878356,2009-10-28T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19878356,2009-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19878356,2009-10-28T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19878356,2009-10-28T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
19878356,2009-10-28T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
19878356,2009-10-28T00:00:00,"RNA, Messenger",D13.444.735.544
19878356,2009-10-28T00:00:00,Sarcoma,C04.557.450.795
19878356,2009-10-28T00:00:00,Tissue Array Analysis,E05.196.630.570.850
19878356,2009-10-28T00:00:00,Tissue Array Analysis,E05.588.570.850
19878356,2009-10-28T00:00:00,"Tumor Markers, Biological",D23.101.840
19875674,2009-10-29T00:00:00,Animals,B01.050
19875674,2009-10-29T00:00:00,Epithelial Cells,A11.436
19875674,2009-10-29T00:00:00,Heat-Shock Proteins,D12.776.580.216
19875674,2009-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19875674,2009-10-29T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
19875674,2009-10-29T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19875674,2009-10-29T00:00:00,Mitochondria,A11.284.835.626
19875674,2009-10-29T00:00:00,Oxygen Consumption,G03.730
19875674,2009-10-29T00:00:00,Piperazines,D03.383.606
19875674,2009-10-29T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19875674,2009-10-29T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19875674,2009-10-29T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19875674,2009-10-29T00:00:00,Rabbits,B01.050.150.900.649.521.700
19875674,2009-10-29T00:00:00,Spiro Compounds,D02.455.426.559.847.885
19875674,2009-10-29T00:00:00,Spiro Compounds,D04.615.885
19875674,2009-10-29T00:00:00,Transcription Factors,D12.776.930
19875730,2009-10-29T00:00:00,African Americans,M01.686.508.100.100
19875730,2009-10-29T00:00:00,African Americans,M01.686.754.100
19875730,2009-10-29T00:00:00,Body Mass Index,E01.370.600.115.100.125
19875730,2009-10-29T00:00:00,Body Mass Index,E05.041.124.125
19875730,2009-10-29T00:00:00,Body Mass Index,G07.100.100.125
19875730,2009-10-29T00:00:00,Body Mass Index,N06.850.505.200.100.175
19875730,2009-10-29T00:00:00,Community-Based Participatory Research,N05.425.104
19875730,2009-10-29T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19875730,2009-10-29T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19875730,2009-10-29T00:00:00,Health Promotion,N02.370
19875730,2009-10-29T00:00:00,Health Promotion,N02.421.726.507
19875730,2009-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19875730,2009-10-29T00:00:00,Patient Selection,E05.581.500.653
19875730,2009-10-29T00:00:00,Patient Selection,N04.590.731
19875730,2009-10-29T00:00:00,Risk Factors,E05.318.740.600.800.725
19875730,2009-10-29T00:00:00,Risk Factors,N05.715.350.200.700
19875730,2009-10-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19875730,2009-10-29T00:00:00,Risk Factors,N06.850.490.625.750
19875730,2009-10-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19875730,2009-10-29T00:00:00,Self Efficacy,F01.752.747.792.700
19875730,2009-10-29T00:00:00,Urban Population,N01.600.900
19879583,2009-10-30T00:00:00,"Adaptation, Physiological",G07.700.062
19879583,2009-10-30T00:00:00,"Adaptation, Physiological",G16.100.057.500
19879583,2009-10-30T00:00:00,Adult,M01.060.116
19879583,2009-10-30T00:00:00,Computer Simulation,L01.224.160
19879583,2009-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19879583,2009-10-30T00:00:00,"Models, Biological",E05.599.395
19879583,2009-10-30T00:00:00,Muscle Contraction,G11.427.590.540
19879583,2009-10-30T00:00:00,"Muscle, Skeletal",A02.633.567
19879583,2009-10-30T00:00:00,"Muscle, Skeletal",A10.690.552.500
19879583,2009-10-30T00:00:00,Postural Balance,G11.427.690
19879583,2009-10-30T00:00:00,Postural Balance,G11.561.600.810.541.595
19879583,2009-10-30T00:00:00,Walking,G11.427.590.530.568.900
19879583,2009-10-30T00:00:00,Walking,G11.427.590.530.698.940
19879583,2009-10-30T00:00:00,Walking,I03.450.642.845.940
19879583,2009-10-30T00:00:00,Weight-Bearing,G01.374.676.965
19879583,2009-10-30T00:00:00,Weight-Bearing,G01.595.540.965
19879697,2009-10-30T00:00:00,Adult,M01.060.116
19879697,2009-10-30T00:00:00,Aged,M01.060.116.100
19879697,2009-10-30T00:00:00,Breast Neoplasms,C04.588.180
19879697,2009-10-30T00:00:00,Breast Neoplasms,C17.800.090.500
19879697,2009-10-30T00:00:00,Heart,A07.541
19879697,2009-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19879697,2009-10-30T00:00:00,Lung,A04.411
19879697,2009-10-30T00:00:00,Lymph Nodes,A10.549.400
19879697,2009-10-30T00:00:00,Lymph Nodes,A15.382.520.604.412
19879697,2009-10-30T00:00:00,Middle Aged,M01.060.116.630
19879697,2009-10-30T00:00:00,Radiation Injuries,C21.866.733
19879697,2009-10-30T00:00:00,Radiation Injuries,N06.850.810.300.360
19879697,2009-10-30T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
19879697,2009-10-30T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
19879697,2009-10-30T00:00:00,"Radiotherapy, Intensity-Modulated",E02.815.635.700.700
19879697,2009-10-30T00:00:00,"Radiotherapy, Intensity-Modulated",L01.700.508.100.710.600.550.700
19879874,2009-10-30T00:00:00,Animals,B01.050
19879874,2009-10-30T00:00:00,Cell Movement,G04.299.283
19879874,2009-10-30T00:00:00,Cell Movement,G07.700.560.500.180
19879874,2009-10-30T00:00:00,Cell Proliferation,G04.299.233.750
19879874,2009-10-30T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19879874,2009-10-30T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
19879874,2009-10-30T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
19879874,2009-10-30T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
19879874,2009-10-30T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
19879874,2009-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19879874,2009-10-30T00:00:00,Keratinocytes,A11.436.397
19879874,2009-10-30T00:00:00,Kinins,D12.644.276.812
19879874,2009-10-30T00:00:00,Kinins,D12.776.467.812
19879874,2009-10-30T00:00:00,Kinins,D23.469.050.375
19879874,2009-10-30T00:00:00,Kinins,D23.529.812
19879874,2009-10-30T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
19879874,2009-10-30T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
19879874,2009-10-30T00:00:00,Nitric Oxide,D01.339.387
19879874,2009-10-30T00:00:00,Nitric Oxide,D01.625.550.500
19879874,2009-10-30T00:00:00,Nitric Oxide,D01.625.700.500
19879874,2009-10-30T00:00:00,Nitric Oxide,D01.650.550.587.600
19879874,2009-10-30T00:00:00,Phosphorylation,G02.111.087.677
19879874,2009-10-30T00:00:00,Phosphorylation,G02.149.115.677
19879874,2009-10-30T00:00:00,Phosphorylation,G02.149.465.700
19879874,2009-10-30T00:00:00,Phosphorylation,G02.607.750.700
19879874,2009-10-30T00:00:00,Phosphorylation,G03.495.790
19879874,2009-10-30T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
19879874,2009-10-30T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19879874,2009-10-30T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
19879874,2009-10-30T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
19879874,2009-10-30T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
19879874,2009-10-30T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
19879874,2009-10-30T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
19879874,2009-10-30T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
19879874,2009-10-30T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
19879874,2009-10-30T00:00:00,Signal Transduction,G02.111.087.800
19879874,2009-10-30T00:00:00,Signal Transduction,G02.149.115.800
19879874,2009-10-30T00:00:00,Signal Transduction,G04.299.880
19879874,2009-10-30T00:00:00,Skin,A17.815
19879874,2009-10-30T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
19879874,2009-10-30T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
19879874,2009-10-30T00:00:00,Tissue Kallikreins,D23.101.840.870
19879874,2009-10-30T00:00:00,Wound Healing,G16.100.856.891
20129521,2009-10-30T00:00:00,Algorithms,G17.035
20129521,2009-10-30T00:00:00,Algorithms,L01.224.050
20129521,2009-10-30T00:00:00,Calcinosis,C18.452.174.130
20129521,2009-10-30T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20129521,2009-10-30T00:00:00,Coronary Angiography,E01.370.370.050.200
20129521,2009-10-30T00:00:00,Coronary Angiography,E01.370.370.380.200
20129521,2009-10-30T00:00:00,Coronary Artery Disease,C14.280.647.250.260
20129521,2009-10-30T00:00:00,Coronary Artery Disease,C14.907.137.126.339
20129521,2009-10-30T00:00:00,Coronary Artery Disease,C14.907.585.250.260
20129521,2009-10-30T00:00:00,Disease Progression,C23.550.291.656
20129521,2009-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20129521,2009-10-30T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20129521,2009-10-30T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20129521,2009-10-30T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20129521,2009-10-30T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
20129521,2009-10-30T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
20129521,2009-10-30T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
20129521,2009-10-30T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
20129521,2009-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20129521,2009-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20129521,2009-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20129521,2009-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20129521,2009-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19672208,2009-11-01T00:00:00,Abdominal Pain,C23.888.646.100
19672208,2009-11-01T00:00:00,Abdominal Pain,C23.888.821.030
19672208,2009-11-01T00:00:00,Adult,M01.060.116
19672208,2009-11-01T00:00:00,Aged,M01.060.116.100
19672208,2009-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
19672208,2009-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
19672208,2009-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
19672208,2009-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
19672208,2009-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
19672208,2009-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
19672208,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19672208,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19672208,2009-11-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19672208,2009-11-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19672208,2009-11-01T00:00:00,Pancreatitis,C06.689.750
19672208,2009-11-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
19672208,2009-11-01T00:00:00,Time Factors,G01.910.857
19696678,2009-11-01T00:00:00,Adult,M01.060.116
19696678,2009-11-01T00:00:00,Chronic Disease,C23.550.291.500
19696678,2009-11-01T00:00:00,Cystic Fibrosis,C06.689.202
19696678,2009-11-01T00:00:00,Cystic Fibrosis,C08.381.187
19696678,2009-11-01T00:00:00,Cystic Fibrosis,C16.320.190
19696678,2009-11-01T00:00:00,Cystic Fibrosis,C16.614.213
19696678,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19696678,2009-11-01T00:00:00,Interprofessional Relations,F01.829.401.205
19696678,2009-11-01T00:00:00,"Models, Organizational",E05.599.670
19696678,2009-11-01T00:00:00,"Models, Organizational",N04.452.534
19696678,2009-11-01T00:00:00,Professional-Patient Relations,F01.829.401.650
19696678,2009-11-01T00:00:00,Professional-Patient Relations,N05.300.660
19696678,2009-11-01T00:00:00,United States,Z01.107.567.875
19730960,2009-11-01T00:00:00,"Adaptation, Physiological",G07.700.062
19730960,2009-11-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
19730960,2009-11-01T00:00:00,Gastroplasty,E02.065.062.750
19730960,2009-11-01T00:00:00,Gastroplasty,E04.062.750
19730960,2009-11-01T00:00:00,Gastroplasty,E04.210.485
19730960,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19730960,2009-11-01T00:00:00,Laparoscopy,E01.370.388.250.520
19730960,2009-11-01T00:00:00,Laparoscopy,E04.800.250.520
19730960,2009-11-01T00:00:00,Manometry,E05.559
19730960,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19730960,2009-11-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
19730960,2009-11-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
19730960,2009-11-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
19730960,2009-11-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
19730960,2009-11-01T00:00:00,Pressure,G01.374.715
19730960,2009-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19730960,2009-11-01T00:00:00,Risk Assessment,N04.452.871.715
19730960,2009-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19730960,2009-11-01T00:00:00,Risk Assessment,N06.850.505.715
19730960,2009-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19730960,2009-11-01T00:00:00,Treatment Outcome,E01.789.800
19730960,2009-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19730960,2009-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19730960,2009-11-01T00:00:00,Weight Loss,C23.888.144.243.963
19730960,2009-11-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19793242,2009-11-01T00:00:00,Adult,M01.060.116
19793242,2009-11-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19793242,2009-11-01T00:00:00,Body Mass Index,E05.041.124.125
19793242,2009-11-01T00:00:00,Body Mass Index,G07.100.100.125
19793242,2009-11-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19793242,2009-11-01T00:00:00,Diet,E05.272
19793242,2009-11-01T00:00:00,Diet,G07.610.240
19793242,2009-11-01T00:00:00,Exercise,G11.427.590.237
19793242,2009-11-01T00:00:00,Exercise,I03.350
19793242,2009-11-01T00:00:00,Health Behavior,F01.145.488
19793242,2009-11-01T00:00:00,Health Promotion,N02.370
19793242,2009-11-01T00:00:00,Health Promotion,N02.421.726.507
19793242,2009-11-01T00:00:00,Health Status,I01.240.425
19793242,2009-11-01T00:00:00,Health Status,N01.224.425
19793242,2009-11-01T00:00:00,Health Status,N06.850.505.400.425
19793242,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19793242,2009-11-01T00:00:00,Life Style,F01.829.458
19793242,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19793242,2009-11-01T00:00:00,Motor Activity,F01.145.632
19793242,2009-11-01T00:00:00,Motor Activity,G11.427.590.530.698
19793242,2009-11-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
19793242,2009-11-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
19793242,2009-11-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
19793242,2009-11-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
19793242,2009-11-01T00:00:00,Obesity,C18.654.726.500
19793242,2009-11-01T00:00:00,Obesity,C23.888.144.699.500
19793242,2009-11-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19793242,2009-11-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19793242,2009-11-01T00:00:00,Social Environment,I01.880.656
19811099,2009-11-01T00:00:00,Aged,M01.060.116.100
19811099,2009-11-01T00:00:00,Bacteremia,C01.252.100
19811099,2009-11-01T00:00:00,Bacteremia,C01.539.757.100
19811099,2009-11-01T00:00:00,Bacteremia,C23.550.470.790.500.100
19811099,2009-11-01T00:00:00,"Endocarditis, Bacterial",C01.252.300
19811099,2009-11-01T00:00:00,"Endocarditis, Bacterial",C01.539.190.249
19811099,2009-11-01T00:00:00,"Endocarditis, Bacterial",C14.260.249
19811099,2009-11-01T00:00:00,"Endocarditis, Bacterial",C14.280.282.407
19811099,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19811099,2009-11-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
19811099,2009-11-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
19811099,2009-11-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
19811099,2009-11-01T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
19811099,2009-11-01T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
19811099,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19811099,2009-11-01T00:00:00,Phenotype,G05.695
19811099,2009-11-01T00:00:00,Phylogeny,G05.697
19811099,2009-11-01T00:00:00,Phylogeny,G16.100.275.605
19811099,2009-11-01T00:00:00,Phylogeny,L01.100.697
19811099,2009-11-01T00:00:00,Population Surveillance,E05.318.308.250.700
19811099,2009-11-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
19811099,2009-11-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
19811099,2009-11-01T00:00:00,Population Surveillance,N06.850.780.675
19811099,2009-11-01T00:00:00,Staphylococcal Infections,C01.252.410.868
19815925,2009-11-01T00:00:00,Animals,B01.050
19815925,2009-11-01T00:00:00,Columbidae,B01.050.150.900.248.165.150
19815925,2009-11-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19815925,2009-11-01T00:00:00,"Models, Psychological",E05.599.695
19826244,2009-11-01T00:00:00,"History, 19th Century",K01.400.504.937
19826244,2009-11-01T00:00:00,"History, 20th Century",K01.400.504.968
19826244,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19826244,2009-11-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19826244,2009-11-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19826244,2009-11-01T00:00:00,Terminology as Topic,L01.143.506.598.400
19838850,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19838850,2009-11-01T00:00:00,Medical Oncology,H02.403.429.515
19838850,2009-11-01T00:00:00,Neoplasms,C04
19838850,2009-11-01T00:00:00,Physicians,M01.526.485.810
19838850,2009-11-01T00:00:00,Physicians,N02.360.810
19843739,2009-11-01T00:00:00,Adult,M01.060.116
19843739,2009-11-01T00:00:00,Aged,M01.060.116.100
19843739,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19843739,2009-11-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19843739,2009-11-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19843739,2009-11-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19843739,2009-11-01T00:00:00,Liver Diseases,C06.552
19843739,2009-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19843739,2009-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19843739,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19843950,2009-11-01T00:00:00,Animals,B01.050
19843950,2009-11-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
19843950,2009-11-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
19843950,2009-11-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
19843950,2009-11-01T00:00:00,Homeostasis,G07.700.360
19843950,2009-11-01T00:00:00,Phosphorylation,G02.111.087.677
19843950,2009-11-01T00:00:00,Phosphorylation,G02.149.115.677
19843950,2009-11-01T00:00:00,Phosphorylation,G02.149.465.700
19843950,2009-11-01T00:00:00,Phosphorylation,G02.607.750.700
19843950,2009-11-01T00:00:00,Phosphorylation,G03.495.790
19843950,2009-11-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
19843950,2009-11-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
19843950,2009-11-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
19843950,2009-11-01T00:00:00,Quinazolines,D03.438.786
19843950,2009-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19843950,2009-11-01T00:00:00,Spleen,A10.549.700
19843950,2009-11-01T00:00:00,Spleen,A15.382.520.604.700
19852059,2009-11-01T00:00:00,Chronic Disease,C23.550.291.500
19852059,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19852059,2009-11-01T00:00:00,Macrolides,D02.540.505
19852059,2009-11-01T00:00:00,Macrolides,D04.345.349
19852059,2009-11-01T00:00:00,Macrolides,D09.408.477
19852059,2009-11-01T00:00:00,Rhinitis,C08.460.799
19852059,2009-11-01T00:00:00,Rhinitis,C08.730.674
19852059,2009-11-01T00:00:00,Rhinitis,C09.603.799
19852059,2009-11-01T00:00:00,Sinusitis,C08.460.692.752
19852059,2009-11-01T00:00:00,Sinusitis,C08.730.749
19852059,2009-11-01T00:00:00,Sinusitis,C09.603.692.752
19852059,2009-11-01T00:00:00,Time Factors,G01.910.857
19857354,2009-11-01T00:00:00,Child,M01.060.406
19857354,2009-11-01T00:00:00,Critical Care,E02.760.190
19857354,2009-11-01T00:00:00,Critical Care,N02.421.585.190
19857354,2009-11-01T00:00:00,Diffusion of Innovation,L01.143.320
19857354,2009-11-01T00:00:00,"Heart Defects, Congenital",C14.240.400
19857354,2009-11-01T00:00:00,"Heart Defects, Congenital",C14.280.400
19857354,2009-11-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19857354,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19857354,2009-11-01T00:00:00,Intensive Care Units,N02.278.388.493
19857354,2009-11-01T00:00:00,Leadership,F01.752.609
19857354,2009-11-01T00:00:00,Quality of Health Care,N04.761
19857354,2009-11-01T00:00:00,Quality of Health Care,N05.715
19857354,2009-11-01T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
19857354,2009-11-01T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
19857359,2009-11-01T00:00:00,Competency-Based Education,I02.158.210
19857359,2009-11-01T00:00:00,"Heart Defects, Congenital",C14.240.400
19857359,2009-11-01T00:00:00,"Heart Defects, Congenital",C14.280.400
19857359,2009-11-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19857359,2009-11-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
19857359,2009-11-01T00:00:00,Hospital Mortality,L01.280.975.550.400
19857359,2009-11-01T00:00:00,Hospital Mortality,N01.224.935.698.400
19857359,2009-11-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
19857359,2009-11-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
19857359,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19857359,2009-11-01T00:00:00,Infant,M01.060.703
19857359,2009-11-01T00:00:00,"Infant, Newborn",M01.060.703.520
19857359,2009-11-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19857359,2009-11-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19857359,2009-11-01T00:00:00,Program Development,N04.452.760
19857359,2009-11-01T00:00:00,Thoracic Surgery,H02.403.810.803
19864526,2009-11-01T00:00:00,Contrast Media,D27.720.259
19864526,2009-11-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19864526,2009-11-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19864526,2009-11-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19864526,2009-11-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19864526,2009-11-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19864526,2009-11-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19864526,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19864526,2009-11-01T00:00:00,Radiation Dosage,E05.799.513
19864526,2009-11-01T00:00:00,Radiation Dosage,G01.201.875.740
19864526,2009-11-01T00:00:00,Radiation Dosage,N06.850.810.250
19864526,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19864526,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19864526,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19864526,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19864526,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19864965,2009-11-01T00:00:00,Adolescent,M01.060.057
19864965,2009-11-01T00:00:00,Child,M01.060.406
19864965,2009-11-01T00:00:00,"Child, Preschool",M01.060.406.448
19864965,2009-11-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19864965,2009-11-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19864965,2009-11-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19864965,2009-11-01T00:00:00,Enteral Nutrition,E02.421.360
19864965,2009-11-01T00:00:00,Enteral Nutrition,E02.642.500.360
19864965,2009-11-01T00:00:00,Gastric Outlet Obstruction,C06.405.748.340
19864965,2009-11-01T00:00:00,Gastrostomy,E04.210.496
19864965,2009-11-01T00:00:00,Gastrostomy,E04.579.408
19864965,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19864965,2009-11-01T00:00:00,Incidence,E05.318.308.985.525.375
19864965,2009-11-01T00:00:00,Incidence,L01.280.975.525.375
19864965,2009-11-01T00:00:00,Incidence,N01.224.935.597.500
19864965,2009-11-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19864965,2009-11-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19864965,2009-11-01T00:00:00,Infant,M01.060.703
19864965,2009-11-01T00:00:00,"Pneumonia, Aspiration",C08.381.677.529
19864965,2009-11-01T00:00:00,"Pneumonia, Aspiration",C08.730.610.529
19864965,2009-11-01T00:00:00,Reoperation,E04.690
19864965,2009-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19864965,2009-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19877031,2009-11-01T00:00:00,Actins,D05.750.078.730.250
19877031,2009-11-01T00:00:00,Actins,D12.776.210.500.100
19877031,2009-11-01T00:00:00,Actins,D12.776.220.525.255
19877031,2009-11-01T00:00:00,Anticoagulants,D27.505.954.502.119
19877031,2009-11-01T00:00:00,Cell Differentiation,G04.299.151
19877031,2009-11-01T00:00:00,Cell Proliferation,G04.299.233.750
19877031,2009-11-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19877031,2009-11-01T00:00:00,Collagen,D05.750.078.280
19877031,2009-11-01T00:00:00,Collagen,D12.776.860.300.250
19877031,2009-11-01T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
19877031,2009-11-01T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
19877031,2009-11-01T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
19877031,2009-11-01T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
19877031,2009-11-01T00:00:00,Fibroblasts,A11.329.228
19877031,2009-11-01T00:00:00,Fibroblasts,A11.872.228
19877031,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19877031,2009-11-01T00:00:00,Lung,A04.411
19877031,2009-11-01T00:00:00,Pulmonary Fibrosis,C08.381.765
19877031,2009-11-01T00:00:00,Pyridines,D03.383.725
19877031,2009-11-01T00:00:00,"Scleroderma, Systemic",C17.300.799
19877031,2009-11-01T00:00:00,"Scleroderma, Systemic",C17.800.784
19877031,2009-11-01T00:00:00,Signal Transduction,G02.111.087.800
19877031,2009-11-01T00:00:00,Signal Transduction,G02.149.115.800
19877031,2009-11-01T00:00:00,Signal Transduction,G04.299.880
19877031,2009-11-01T00:00:00,Thrombin,D08.811.277.656.300.760.855
19877031,2009-11-01T00:00:00,Thrombin,D08.811.277.656.959.350.855
19877031,2009-11-01T00:00:00,Thrombin,D12.776.124.125.890
19877031,2009-11-01T00:00:00,Thrombin,D23.119.960
19880048,2009-11-01T00:00:00,Cancer Vaccines,D20.215.894.200
19880048,2009-11-01T00:00:00,Forecasting,I01.320
19880048,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19880048,2009-11-01T00:00:00,Immunization,E02.095.465.425.400
19880048,2009-11-01T00:00:00,Immunization,E05.478.550
19880048,2009-11-01T00:00:00,Immunization,N02.421.726.758.310
19880048,2009-11-01T00:00:00,Immunization,N06.850.780.200.425
19880048,2009-11-01T00:00:00,Immunization,N06.850.780.680.310
19880048,2009-11-01T00:00:00,Melanoma,C04.557.465.625.650.510
19880048,2009-11-01T00:00:00,Melanoma,C04.557.580.625.650.510
19880048,2009-11-01T00:00:00,Melanoma,C04.557.665.510
19880048,2009-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
19880048,2009-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
19880048,2009-11-01T00:00:00,Neoplasm Staging,E01.370.550
19880048,2009-11-01T00:00:00,Peptides,D12.644
19880048,2009-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19880048,2009-11-01T00:00:00,Risk Assessment,N04.452.871.715
19880048,2009-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19880048,2009-11-01T00:00:00,Risk Assessment,N06.850.505.715
19880048,2009-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19880048,2009-11-01T00:00:00,Skin Neoplasms,C04.588.805
19880048,2009-11-01T00:00:00,Skin Neoplasms,C17.800.882
19880048,2009-11-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
19880048,2009-11-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
19880048,2009-11-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19880048,2009-11-01T00:00:00,Treatment Outcome,E01.789.800
19880048,2009-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19880048,2009-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19882389,2009-11-01T00:00:00,Clinical Clerkship,I02.358.399.450.110
19882389,2009-11-01T00:00:00,Cooperative Behavior,F01.145.813.115
19882389,2009-11-01T00:00:00,Family Practice,H02.403.280
19882389,2009-11-01T00:00:00,Guidelines as Topic,N04.761.700.350
19882389,2009-11-01T00:00:00,Guidelines as Topic,N05.700.350
19882389,2009-11-01T00:00:00,Hospitalists,M01.526.485.630.490.400
19882389,2009-11-01T00:00:00,Hospitalists,M01.526.485.740.422.400
19882389,2009-11-01T00:00:00,Hospitalists,M01.526.485.810.580
19882389,2009-11-01T00:00:00,Hospitalists,N02.360.630.490.400
19882389,2009-11-01T00:00:00,Hospitalists,N02.360.740.422.400
19882389,2009-11-01T00:00:00,Hospitalists,N02.360.810.580
19882389,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19884233,2009-11-01T00:00:00,Adult,M01.060.116
19884233,2009-11-01T00:00:00,Alcoholism,C21.739.100.250
19884233,2009-11-01T00:00:00,Alcoholism,F03.900.100.350
19884233,2009-11-01T00:00:00,Animals,B01.050
19884233,2009-11-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19884233,2009-11-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19884233,2009-11-01T00:00:00,"Disease Models, Animal",C22.232
19884233,2009-11-01T00:00:00,"Disease Models, Animal",E05.598.500
19884233,2009-11-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19884233,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19884233,2009-11-01T00:00:00,United States,Z01.107.567.875
19884233,2009-11-01T00:00:00,Vision Disorders,C10.597.751.941
19884233,2009-11-01T00:00:00,Vision Disorders,C11.966
19884233,2009-11-01T00:00:00,Vision Disorders,C23.888.592.763.941
19884233,2009-11-01T00:00:00,Visual Fields,E01.370.380.850.975
19884233,2009-11-01T00:00:00,Visual Fields,F02.463.593.932.934
19884233,2009-11-01T00:00:00,Visual Fields,G14.950
19884608,2009-11-01T00:00:00,Adolescent,M01.060.057
19884608,2009-11-01T00:00:00,Adult,M01.060.116
19884608,2009-11-01T00:00:00,African Americans,M01.686.508.100.100
19884608,2009-11-01T00:00:00,African Americans,M01.686.754.100
19884608,2009-11-01T00:00:00,Aged,M01.060.116.100
19884608,2009-11-01T00:00:00,Child,M01.060.406
19884608,2009-11-01T00:00:00,Child Abuse,I01.198.240.856.350.250
19884608,2009-11-01T00:00:00,Child Abuse,I01.880.735.900.350.250
19884608,2009-11-01T00:00:00,Child Abuse,I01.880.787.293.292
19884608,2009-11-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19884608,2009-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19884608,2009-11-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19884608,2009-11-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19884608,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19884608,2009-11-01T00:00:00,Life Change Events,F01.829.458.410
19884608,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19884608,2009-11-01T00:00:00,"Polymorphism, Genetic",G05.365.795
19884608,2009-11-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19884608,2009-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19884608,2009-11-01T00:00:00,Risk Factors,N05.715.350.200.700
19884608,2009-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19884608,2009-11-01T00:00:00,Risk Factors,N06.850.490.625.750
19884608,2009-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19884608,2009-11-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.450.625.311
19884608,2009-11-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.562.374.875
19884608,2009-11-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.450.625.374
19884608,2009-11-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.562.374.875
19884608,2009-11-01T00:00:00,Social Environment,I01.880.656
19884608,2009-11-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19884608,2009-11-01T00:00:00,Substance-Related Disorders,C21.739
19884608,2009-11-01T00:00:00,Substance-Related Disorders,F03.900
19887208,2009-11-01T00:00:00,Adult,M01.060.116
19887208,2009-11-01T00:00:00,Brain Injuries,C10.228.140.199
19887208,2009-11-01T00:00:00,Brain Injuries,C10.900.300.087
19887208,2009-11-01T00:00:00,Brain Injuries,C21.866.260.118
19887208,2009-11-01T00:00:00,Brain Injuries,C21.866.915.300.200
19887208,2009-11-01T00:00:00,Epilepsy,C10.228.140.490
19887208,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19887208,2009-11-01T00:00:00,Interviews as Topic,E05.318.308.420
19887208,2009-11-01T00:00:00,Interviews as Topic,L01.280.520
19887208,2009-11-01T00:00:00,Interviews as Topic,N05.715.360.300.400
19887208,2009-11-01T00:00:00,Interviews as Topic,N06.850.520.308.420
19887208,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19887208,2009-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19887208,2009-11-01T00:00:00,Risk Factors,N05.715.350.200.700
19887208,2009-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19887208,2009-11-01T00:00:00,Risk Factors,N06.850.490.625.750
19887208,2009-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19887208,2009-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19887208,2009-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19887208,2009-11-01T00:00:00,Substance-Related Disorders,C21.739
19887208,2009-11-01T00:00:00,Substance-Related Disorders,F03.900
19888709,2009-11-01T00:00:00,Aged,M01.060.116.100
19888709,2009-11-01T00:00:00,Biological Markers,D23.101
19888709,2009-11-01T00:00:00,Depressive Disorder,F03.600.300
19888709,2009-11-01T00:00:00,Geriatric Assessment,E05.318.308.225
19888709,2009-11-01T00:00:00,Geriatric Assessment,I01.240.425.350
19888709,2009-11-01T00:00:00,Geriatric Assessment,L01.280.360
19888709,2009-11-01T00:00:00,Geriatric Assessment,N01.224.425.350
19888709,2009-11-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
19888709,2009-11-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
19888709,2009-11-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
19888709,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19888709,2009-11-01T00:00:00,Motor Activity,F01.145.632
19888709,2009-11-01T00:00:00,Motor Activity,G11.427.590.530.698
19888709,2009-11-01T00:00:00,Nerve Growth Factors,D12.644.276.860
19888709,2009-11-01T00:00:00,Nerve Growth Factors,D12.776.467.860
19888709,2009-11-01T00:00:00,Nerve Growth Factors,D12.776.641.600
19888709,2009-11-01T00:00:00,Nerve Growth Factors,D23.529.850
19888709,2009-11-01T00:00:00,Questionnaires,E05.318.308.750
19888709,2009-11-01T00:00:00,Questionnaires,L01.280.800
19888709,2009-11-01T00:00:00,Questionnaires,N05.715.360.300.695
19888709,2009-11-01T00:00:00,Questionnaires,N06.850.520.308.750
19888709,2009-11-01T00:00:00,S100 Proteins,D12.776.157.125.750
19888709,2009-11-01T00:00:00,S100 Proteins,D12.776.641.655
19897687,2009-11-01T00:00:00,Aged,M01.060.116.100
19897687,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19897687,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19897687,2009-11-01T00:00:00,Nutrition Surveys,E05.318.308.250.600
19897687,2009-11-01T00:00:00,Nutrition Surveys,E05.318.308.585.550
19897687,2009-11-01T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
19897687,2009-11-01T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
19897687,2009-11-01T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
19897687,2009-11-01T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
19897687,2009-11-01T00:00:00,Stroke,C10.228.140.300.775
19897687,2009-11-01T00:00:00,Stroke,C14.907.253.855
19897687,2009-11-01T00:00:00,United States,Z01.107.567.875
19901171,2009-11-01T00:00:00,Aged,M01.060.116.100
19901171,2009-11-01T00:00:00,Aging,G07.700.320.124
19901171,2009-11-01T00:00:00,Hippocampus,A08.186.211.464.405
19901171,2009-11-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
19901171,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19901171,2009-11-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19901171,2009-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19901171,2009-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19901171,2009-11-01T00:00:00,Neuropsychological Tests,F04.711.513
19901311,2009-11-01T00:00:00,Adult,M01.060.116
19901311,2009-11-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19901311,2009-11-01T00:00:00,Health Education,I02.233.332
19901311,2009-11-01T00:00:00,Health Education,N02.421.143.827.407
19901311,2009-11-01T00:00:00,Health Education,N02.421.726.407
19901311,2009-11-01T00:00:00,Hispanic Americans,M01.686.754.441
19901311,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19901311,2009-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19901311,2009-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19908187,2009-11-01T00:00:00,Adult,M01.060.116
19908187,2009-11-01T00:00:00,Child,M01.060.406
19908187,2009-11-01T00:00:00,Developmental Disabilities,F03.550.362
19908187,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19908187,2009-11-01T00:00:00,Pregnancy,G08.686.785.760.769
19908187,2009-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19908187,2009-11-01T00:00:00,Risk Assessment,N04.452.871.715
19908187,2009-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19908187,2009-11-01T00:00:00,Risk Assessment,N06.850.505.715
19908187,2009-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19908187,2009-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19908187,2009-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19908187,2009-11-01T00:00:00,Young Adult,M01.060.116.815
19911454,2009-11-01T00:00:00,Adult,M01.060.116
19911454,2009-11-01T00:00:00,Aged,M01.060.116.100
19911454,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19911454,2009-11-01T00:00:00,Liver Cirrhosis,C06.552.630
19911454,2009-11-01T00:00:00,Liver Neoplasms,C04.588.274.623
19911454,2009-11-01T00:00:00,Liver Neoplasms,C06.301.623
19911454,2009-11-01T00:00:00,Liver Neoplasms,C06.552.697
19911454,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19911454,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19911454,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19911454,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19911454,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19911454,2009-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19913195,2009-11-01T00:00:00,Alcoholism,C21.739.100.250
19913195,2009-11-01T00:00:00,Alcoholism,F03.900.100.350
19913195,2009-11-01T00:00:00,Animals,B01.050
19913195,2009-11-01T00:00:00,Corticosterone,D04.808.745.745.654.237
19913195,2009-11-01T00:00:00,Corticosterone,D06.472.040.585.353.237
19913195,2009-11-01T00:00:00,Ethanol,D02.033.375
19913195,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19913195,2009-11-01T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
19913195,2009-11-01T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
19913195,2009-11-01T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
19913195,2009-11-01T00:00:00,Pituitary-Adrenal System,A06.407.691
19913195,2009-11-01T00:00:00,Social Isolation,F01.145.813.781
19913195,2009-11-01T00:00:00,Social Isolation,I01.880.683
19913195,2009-11-01T00:00:00,"Stress, Psychological",F01.145.126.990
19913195,2009-11-01T00:00:00,"Stress, Psychological",F02.830.900
19922873,2009-11-01T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
19922873,2009-11-01T00:00:00,ADAM Proteins,D09.400.430.500
19922873,2009-11-01T00:00:00,ADAM Proteins,D12.776.395.033
19922873,2009-11-01T00:00:00,Animals,B01.050
19922873,2009-11-01T00:00:00,Apoptosis,G04.299.139.160
19922873,2009-11-01T00:00:00,Calcium-Binding Proteins,D12.776.157.125
19922873,2009-11-01T00:00:00,Extremities,A01.378
19922873,2009-11-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19922873,2009-11-01T00:00:00,Versicans,D09.698.735.830.750
19922873,2009-11-01T00:00:00,Versicans,D12.776.395.650.750.750
19922873,2009-11-01T00:00:00,Versicans,D12.776.503.280.625
19929126,2009-11-01T00:00:00,Activities of Daily Living,E02.831.067
19929126,2009-11-01T00:00:00,Activities of Daily Living,I03.050
19929126,2009-11-01T00:00:00,Activities of Daily Living,N02.421.784.110
19929126,2009-11-01T00:00:00,Adult,M01.060.116
19929126,2009-11-01T00:00:00,Cervical Vertebrae,A02.835.232.834.151
19929126,2009-11-01T00:00:00,Depressive Disorder,F03.600.300
19929126,2009-11-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19929126,2009-11-01T00:00:00,Disability Evaluation,E01.370.400
19929126,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19929126,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19929126,2009-11-01T00:00:00,Motivation,F01.658
19929126,2009-11-01T00:00:00,Motivation,F01.752.543.500.750
19929126,2009-11-01T00:00:00,Personality Inventory,F04.711.647.513
19929126,2009-11-01T00:00:00,Psychometrics,F04.711.780
19929126,2009-11-01T00:00:00,Quality of Life,I01.800
19929126,2009-11-01T00:00:00,Quality of Life,K01.752.400.750
19929126,2009-11-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19929126,2009-11-01T00:00:00,Spinal Cord Injuries,C10.900.850
19929126,2009-11-01T00:00:00,Spinal Cord Injuries,C21.866.819
19935246,2009-11-01T00:00:00,Aged,M01.060.116.100
19935246,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19935246,2009-11-01T00:00:00,Ophthalmologic Surgical Procedures,E04.540
19958601,2009-11-01T00:00:00,Aged,M01.060.116.100
19958601,2009-11-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19958601,2009-11-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19958601,2009-11-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19958601,2009-11-01T00:00:00,Chronic Disease,C23.550.291.500
19958601,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19958601,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19958601,2009-11-01T00:00:00,Nasal Obstruction,C08.460.525
19958601,2009-11-01T00:00:00,Nasal Obstruction,C08.618.846.185.525
19958601,2009-11-01T00:00:00,Nasal Obstruction,C09.603.525
19958601,2009-11-01T00:00:00,Questionnaires,E05.318.308.750
19958601,2009-11-01T00:00:00,Questionnaires,L01.280.800
19958601,2009-11-01T00:00:00,Questionnaires,N05.715.360.300.695
19958601,2009-11-01T00:00:00,Questionnaires,N06.850.520.308.750
19958601,2009-11-01T00:00:00,Rhinitis,C08.460.799
19958601,2009-11-01T00:00:00,Rhinitis,C08.730.674
19958601,2009-11-01T00:00:00,Rhinitis,C09.603.799
19958601,2009-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19958601,2009-11-01T00:00:00,Risk Factors,N05.715.350.200.700
19958601,2009-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19958601,2009-11-01T00:00:00,Risk Factors,N06.850.490.625.750
19958601,2009-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19958601,2009-11-01T00:00:00,Sinusitis,C08.460.692.752
19958601,2009-11-01T00:00:00,Sinusitis,C08.730.749
19958601,2009-11-01T00:00:00,Sinusitis,C09.603.692.752
19958601,2009-11-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19958601,2009-11-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19958603,2009-11-01T00:00:00,Adolescent,M01.060.057
19958603,2009-11-01T00:00:00,Adult,M01.060.116
19958603,2009-11-01T00:00:00,Aged,M01.060.116.100
19958603,2009-11-01T00:00:00,Child,M01.060.406
19958603,2009-11-01T00:00:00,"Child, Preschool",M01.060.406.448
19958603,2009-11-01T00:00:00,Chronic Disease,C23.550.291.500
19958603,2009-11-01T00:00:00,Gene Expression Regulation,G05.355.315
19958603,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19958603,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
19958603,2009-11-01T00:00:00,Nasal Polyps,C08.460.572
19958603,2009-11-01T00:00:00,Nasal Polyps,C09.603.557
19958603,2009-11-01T00:00:00,Nasal Polyps,C23.300.825.557
19958603,2009-11-01T00:00:00,Nerve Growth Factor,D12.644.276.860.437
19958603,2009-11-01T00:00:00,Nerve Growth Factor,D12.776.467.860.437
19958603,2009-11-01T00:00:00,Nerve Growth Factor,D12.776.641.600.437
19958603,2009-11-01T00:00:00,Nerve Growth Factor,D23.529.850.437
19958603,2009-11-01T00:00:00,Paranasal Sinuses,A04.531.621
19958603,2009-11-01T00:00:00,Rhinitis,C08.460.799
19958603,2009-11-01T00:00:00,Rhinitis,C08.730.674
19958603,2009-11-01T00:00:00,Rhinitis,C09.603.799
19958603,2009-11-01T00:00:00,Sinusitis,C08.460.692.752
19958603,2009-11-01T00:00:00,Sinusitis,C08.730.749
19958603,2009-11-01T00:00:00,Sinusitis,C09.603.692.752
19960832,2009-11-01T00:00:00,Adult,M01.060.116
19960832,2009-11-01T00:00:00,Combat Disorders,F03.080.931.249
19960832,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19960832,2009-11-01T00:00:00,Implosive Therapy,F04.754.137.506.325
19960832,2009-11-01T00:00:00,"Monitoring, Physiologic",E01.370.520
19960832,2009-11-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20009822,2009-11-01T00:00:00,Adolescent,M01.060.057
20009822,2009-11-01T00:00:00,Adult,M01.060.116
20009822,2009-11-01T00:00:00,Aged,M01.060.116.100
20009822,2009-11-01T00:00:00,Breast Neoplasms,C04.588.180
20009822,2009-11-01T00:00:00,Breast Neoplasms,C17.800.090.500
20009822,2009-11-01T00:00:00,Carcinoma,C04.557.470.200
20009822,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20009822,2009-11-01T00:00:00,Incidence,E05.318.308.985.525.375
20009822,2009-11-01T00:00:00,Incidence,L01.280.975.525.375
20009822,2009-11-01T00:00:00,Incidence,N01.224.935.597.500
20009822,2009-11-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20009822,2009-11-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20009822,2009-11-01T00:00:00,Mammaplasty,E02.218.565
20009822,2009-11-01T00:00:00,Mammaplasty,E04.680.500
20009822,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
20009822,2009-11-01T00:00:00,United States,Z01.107.567.875
20009822,2009-11-01T00:00:00,Young Adult,M01.060.116.815
20013859,2009-11-01T00:00:00,Age Factors,N05.715.350.075
20013859,2009-11-01T00:00:00,Age Factors,N06.850.490.250
20013859,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20013859,2009-11-01T00:00:00,Income,N01.824.417
20013859,2009-11-01T00:00:00,Interprofessional Relations,F01.829.401.205
20013859,2009-11-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
20013859,2009-11-01T00:00:00,Physician-Patient Relations,N05.300.660.625
20013859,2009-11-01T00:00:00,Physicians,M01.526.485.810
20013859,2009-11-01T00:00:00,Physicians,N02.360.810
20013859,2009-11-01T00:00:00,Sex Factors,N05.715.350.675
20013859,2009-11-01T00:00:00,Sex Factors,N06.850.490.875
20013859,2009-11-01T00:00:00,Social Support,I01.880.656.600
20013859,2009-11-01T00:00:00,United States,Z01.107.567.875
20013859,2009-11-01T00:00:00,Workload,N04.452.677.950
20095454,2009-11-01T00:00:00,Adolescent,M01.060.057
20095454,2009-11-01T00:00:00,Adult,M01.060.116
20095454,2009-11-01T00:00:00,Ankle Joint,A02.835.583.378.062
20095454,2009-11-01T00:00:00,Electric Stimulation,E05.723.402
20095454,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20095454,2009-11-01T00:00:00,Isometric Contraction,G11.427.590.540.472
20095454,2009-11-01T00:00:00,Middle Aged,M01.060.116.630
20095454,2009-11-01T00:00:00,"Muscle, Skeletal",A02.633.567
20095454,2009-11-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
20095454,2009-11-01T00:00:00,Postural Balance,G11.427.690
20095454,2009-11-01T00:00:00,Postural Balance,G11.561.600.810.541.595
20095454,2009-11-01T00:00:00,"Stress, Mechanical",G01.374.676.830
20095454,2009-11-01T00:00:00,"Stress, Mechanical",G01.595.540.830
20095454,2009-11-01T00:00:00,Young Adult,M01.060.116.815
20132645,2009-11-01T00:00:00,Clinical Competence,I02.399.630.210
20132645,2009-11-01T00:00:00,Clinical Competence,N04.761.210
20132645,2009-11-01T00:00:00,Curriculum,I02.158
20132645,2009-11-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
20132645,2009-11-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
20132645,2009-11-01T00:00:00,Educational Measurement,I02.399
20132645,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20132645,2009-11-01T00:00:00,Primary Health Care,N04.590.233.727
20132645,2009-11-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
20132645,2009-11-01T00:00:00,"Quality Assurance, Health Care",N05.700
20132645,2009-11-01T00:00:00,Workplace,N01.824.245.925
20132645,2009-11-01T00:00:00,Workplace,N04.452.677.975
20142126,2009-11-01T00:00:00,Clinical Competence,I02.399.630.210
20142126,2009-11-01T00:00:00,Clinical Competence,N04.761.210
20142126,2009-11-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
20142126,2009-11-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
20142126,2009-11-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
20142126,2009-11-01T00:00:00,General Surgery,H02.403.810.300
20142126,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20142126,2009-11-01T00:00:00,Internal Medicine,H02.403.429
20142126,2009-11-01T00:00:00,Internship and Residency,I02.358.399.644
20142126,2009-11-01T00:00:00,School Admission Criteria,I02.399.750
20142126,2009-11-01T00:00:00,"Schools, Medical",I02.783.660.552
20142126,2009-11-01T00:00:00,"Schools, Medical",N02.278.020.578
20142126,2009-11-01T00:00:00,Societies,N03.540.828
20142126,2009-11-01T00:00:00,"Students, Medical",I02.851.686.602
20142126,2009-11-01T00:00:00,"Students, Medical",M01.848.769.602
20142126,2009-11-01T00:00:00,United States,Z01.107.567.875
20168116,2009-11-01T00:00:00,"Adaptation, Physiological",G07.700.062
20168116,2009-11-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
20168116,2009-11-01T00:00:00,Antioxidants,D27.505.519.217
20168116,2009-11-01T00:00:00,Antioxidants,D27.505.696.706.125
20168116,2009-11-01T00:00:00,Antioxidants,D27.720.799.047
20168116,2009-11-01T00:00:00,Breast Feeding,G07.610.220.500.500
20168116,2009-11-01T00:00:00,Breast Feeding,G07.610.593.185
20168116,2009-11-01T00:00:00,Breast Feeding,G07.700.620.185
20168116,2009-11-01T00:00:00,Diet,E05.272
20168116,2009-11-01T00:00:00,Diet,G07.610.240
20168116,2009-11-01T00:00:00,Dietary Supplements,J02.500.456
20168116,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20168116,2009-11-01T00:00:00,Infant Nutritional Physiological Phenomena,G07.610.220.500
20168116,2009-11-01T00:00:00,"Infant, Newborn",M01.060.703.520
20168116,2009-11-01T00:00:00,Pregnancy,G08.686.785.760.769
20168116,2009-11-01T00:00:00,Pregnancy Outcome,E01.789.700
20168116,2009-11-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
20168116,2009-11-01T00:00:00,"Pregnancy, Multiple",G08.686.710
20168116,2009-11-01T00:00:00,"Pregnancy, Multiple",G08.686.785.760.769.525
20168116,2009-11-01T00:00:00,Vitamin D,D04.808.812.768
20168116,2009-11-01T00:00:00,Weight Gain,C23.888.144.243.926
20168116,2009-11-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
20501432,2009-11-01T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
20501432,2009-11-01T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
20501432,2009-11-01T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
20501432,2009-11-01T00:00:00,Animals,B01.050
20501432,2009-11-01T00:00:00,Cell Membrane,A11.284.149
20501432,2009-11-01T00:00:00,Epithelial Cells,A11.436
20501432,2009-11-01T00:00:00,Gene Expression,G05.355.310
20501432,2009-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20501432,2009-11-01T00:00:00,"Models, Biological",E05.599.395
20501432,2009-11-01T00:00:00,Pyrazoles,D03.383.129.539
20501432,2009-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20501432,2009-11-01T00:00:00,Signal Transduction,G02.111.087.800
20501432,2009-11-01T00:00:00,Signal Transduction,G02.149.115.800
20501432,2009-11-01T00:00:00,Signal Transduction,G04.299.880
19884565,2009-11-02T00:00:00,Animals,B01.050
19884565,2009-11-02T00:00:00,Blood Pressure,E01.370.600.875.249
19884565,2009-11-02T00:00:00,Blood Pressure,G09.330.380.076
19884565,2009-11-02T00:00:00,Cardiomegaly,C14.280.195
19884565,2009-11-02T00:00:00,Cardiomegaly,C23.300.775.250
19884565,2009-11-02T00:00:00,Carrier Proteins,D12.776.157
19884565,2009-11-02T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
19884565,2009-11-02T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
19884565,2009-11-02T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
19884565,2009-11-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
19884565,2009-11-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
19884565,2009-11-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19884565,2009-11-02T00:00:00,"Rats, Inbred WKY",B01.050.050.157.760.390
19884565,2009-11-02T00:00:00,"Rats, Inbred WKY",B01.050.050.199.520.760.390
19884565,2009-11-02T00:00:00,"Rats, Inbred WKY",B01.050.150.900.649.865.635.505.700.400.390
19884565,2009-11-02T00:00:00,Signal Transduction,G02.111.087.800
19884565,2009-11-02T00:00:00,Signal Transduction,G02.149.115.800
19884565,2009-11-02T00:00:00,Signal Transduction,G04.299.880
19887592,2009-11-03T00:00:00,Adult,M01.060.116
19887592,2009-11-03T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19887592,2009-11-03T00:00:00,"Endocarditis, Bacterial",C01.252.300
19887592,2009-11-03T00:00:00,"Endocarditis, Bacterial",C01.539.190.249
19887592,2009-11-03T00:00:00,"Endocarditis, Bacterial",C14.260.249
19887592,2009-11-03T00:00:00,"Endocarditis, Bacterial",C14.280.282.407
19887592,2009-11-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19887592,2009-11-03T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
19887592,2009-11-03T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
19945730,2009-11-03T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
19945730,2009-11-03T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
19945730,2009-11-03T00:00:00,Electrons,G01.201.750
19945730,2009-11-03T00:00:00,Electrons,G01.249.335
19945730,2009-11-03T00:00:00,Environmental Remediation,N06.850.460.375
19945730,2009-11-03T00:00:00,"Hydrocarbons, Halogenated",D02.455.526
19945730,2009-11-03T00:00:00,Sulfates,D01.248.497.158.845
19945730,2009-11-03T00:00:00,Sulfates,D01.875.800.800.850
19945730,2009-11-03T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
19945730,2009-11-03T00:00:00,Water Supply,N06.850.860.510.915
19889062,2009-11-04T00:00:00,Adult,M01.060.116
19889062,2009-11-04T00:00:00,Aged,M01.060.116.100
19889062,2009-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19889062,2009-11-04T00:00:00,Middle Aged,M01.060.116.630
19889062,2009-11-04T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
19889062,2009-11-04T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
19889062,2009-11-04T00:00:00,Quality of Life,I01.800
19889062,2009-11-04T00:00:00,Quality of Life,K01.752.400.750
19889062,2009-11-04T00:00:00,Treatment Outcome,E01.789.800
19889062,2009-11-04T00:00:00,Treatment Outcome,N04.761.559.590.800
19889062,2009-11-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19889062,2009-11-04T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
19889062,2009-11-04T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
19889062,2009-11-04T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
19889062,2009-11-04T00:00:00,Urodynamics,G08.852.898
19889062,2009-11-04T00:00:00,Young Adult,M01.060.116.815
19889224,2009-11-04T00:00:00,Animals,B01.050
19889224,2009-11-04T00:00:00,Apoptosis,G04.299.139.160
19889224,2009-11-04T00:00:00,"Behavior, Animal",F01.145.113
19889224,2009-11-04T00:00:00,Blood-Brain Barrier,A07.035
19889224,2009-11-04T00:00:00,Blood-Brain Barrier,A08.186.211.035
19889224,2009-11-04T00:00:00,Brain,A08.186.211
19889224,2009-11-04T00:00:00,Brain Injuries,C10.228.140.199
19889224,2009-11-04T00:00:00,Brain Injuries,C10.900.300.087
19889224,2009-11-04T00:00:00,Brain Injuries,C21.866.260.118
19889224,2009-11-04T00:00:00,Brain Injuries,C21.866.915.300.200
19889224,2009-11-04T00:00:00,Edema,C23.888.277
19889224,2009-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19889224,2009-11-04T00:00:00,Macrophages,A11.329.372
19889224,2009-11-04T00:00:00,Macrophages,A11.627.482
19889224,2009-11-04T00:00:00,Macrophages,A11.733.397
19889224,2009-11-04T00:00:00,Macrophages,A15.382.680.397
19889224,2009-11-04T00:00:00,Macrophages,A15.382.812.522
19889224,2009-11-04T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
19889224,2009-11-04T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
19889224,2009-11-04T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
19889224,2009-11-04T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
19889224,2009-11-04T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
19889224,2009-11-04T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
19889224,2009-11-04T00:00:00,Microglia,A08.637.400
19889224,2009-11-04T00:00:00,Microglia,A11.650.400
19889224,2009-11-04T00:00:00,Neuropsychological Tests,F04.711.513
19889224,2009-11-04T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
19889224,2009-11-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19889224,2009-11-04T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19889224,2009-11-04T00:00:00,S-Nitrosoglutathione,D02.654.846.500.249
19889224,2009-11-04T00:00:00,S-Nitrosoglutathione,D02.886.489.650.750
19889224,2009-11-04T00:00:00,S-Nitrosoglutathione,D12.644.456.448.750
20095971,2009-11-04T00:00:00,Animals,B01.050
20095971,2009-11-04T00:00:00,"Chemistry, Pharmaceutical",H01.158.703.007
20095971,2009-11-04T00:00:00,"Chemistry, Pharmaceutical",H01.181.466
20095971,2009-11-04T00:00:00,DNA,D13.444.308
20095971,2009-11-04T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
20095971,2009-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20095971,2009-11-04T00:00:00,Metals,D01.552
20095971,2009-11-04T00:00:00,"Models, Biological",E05.599.395
20095971,2009-11-04T00:00:00,"Models, Chemical",E05.599.495
20095971,2009-11-04T00:00:00,Polyamines,D02.092.782
20095971,2009-11-04T00:00:00,Protein Isoforms,D12.776.800
20095972,2009-11-04T00:00:00,Amino Acid Sequence,G02.111.570.060
20095972,2009-11-04T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20095972,2009-11-04T00:00:00,Animals,B01.050
20095972,2009-11-04T00:00:00,DNA,D13.444.308
20095972,2009-11-04T00:00:00,Gene Expression Regulation,G05.355.315
20095972,2009-11-04T00:00:00,Gene Silencing,G05.355.315.203.374
20095972,2009-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20095972,2009-11-04T00:00:00,"Models, Biological",E05.599.395
20095972,2009-11-04T00:00:00,"Models, Chemical",E05.599.495
20095972,2009-11-04T00:00:00,Molecular Sequence Data,L01.453.245.667
20095972,2009-11-04T00:00:00,Neoplasms,C04
20095972,2009-11-04T00:00:00,Polyamines,D02.092.782
20095972,2009-11-04T00:00:00,RNA,D13.444.735
20095972,2009-11-04T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
20095972,2009-11-04T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
20142024,2009-11-04T00:00:00,Aged,M01.060.116.100
20142024,2009-11-04T00:00:00,Biological Markers,D23.101
20142024,2009-11-04T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
20142024,2009-11-04T00:00:00,Double-Blind Method,E05.318.780.300
20142024,2009-11-04T00:00:00,Double-Blind Method,E05.581.500.300
20142024,2009-11-04T00:00:00,Double-Blind Method,N05.715.360.780.320
20142024,2009-11-04T00:00:00,Double-Blind Method,N06.850.520.445.300
20142024,2009-11-04T00:00:00,Heart Failure,C14.280.434
20142024,2009-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20142024,2009-11-04T00:00:00,Internationality,I01.615
20142024,2009-11-04T00:00:00,Middle Aged,M01.060.116.630
20142024,2009-11-04T00:00:00,Peptide Fragments,D12.644.541
20142024,2009-11-04T00:00:00,Protein Precursors,D12.776.811
20142024,2009-11-04T00:00:00,Stroke Volume,E01.370.370.380.150.700
20142024,2009-11-04T00:00:00,Stroke Volume,G09.330.380.124.882
19890640,2009-11-05T00:00:00,Algorithms,G17.035
19890640,2009-11-05T00:00:00,Algorithms,L01.224.050
19890640,2009-11-05T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19890640,2009-11-05T00:00:00,Coronary Angiography,E01.370.370.050.200
19890640,2009-11-05T00:00:00,Coronary Angiography,E01.370.370.380.200
19890640,2009-11-05T00:00:00,Coronary Stenosis,C14.280.647.250.285
19890640,2009-11-05T00:00:00,Coronary Stenosis,C14.907.585.250.285
19890640,2009-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19890640,2009-11-05T00:00:00,Middle Aged,M01.060.116.630
19890640,2009-11-05T00:00:00,"Pattern Recognition, Automated",L01.725
19890640,2009-11-05T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19890640,2009-11-05T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19890640,2009-11-05T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19890640,2009-11-05T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19890640,2009-11-05T00:00:00,Software,L01.224.900
19890640,2009-11-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19890640,2009-11-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19890640,2009-11-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19890640,2009-11-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19890640,2009-11-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19893312,2009-11-05T00:00:00,Brain Ischemia,C10.228.140.300.150
19893312,2009-11-05T00:00:00,Brain Ischemia,C14.907.253.092
19893312,2009-11-05T00:00:00,Disability Evaluation,E01.370.400
19893312,2009-11-05T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19893312,2009-11-05T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19893312,2009-11-05T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19893312,2009-11-05T00:00:00,Heart Failure,C14.280.434
19893312,2009-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19893312,2009-11-05T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19893312,2009-11-05T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19893312,2009-11-05T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19893312,2009-11-05T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19893312,2009-11-05T00:00:00,Recovery of Function,G16.757
19893312,2009-11-05T00:00:00,Risk Assessment,E05.318.740.600.800.715
19893312,2009-11-05T00:00:00,Risk Assessment,N04.452.871.715
19893312,2009-11-05T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19893312,2009-11-05T00:00:00,Risk Assessment,N06.850.505.715
19893312,2009-11-05T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19893312,2009-11-05T00:00:00,Risk Factors,E05.318.740.600.800.725
19893312,2009-11-05T00:00:00,Risk Factors,N05.715.350.200.700
19893312,2009-11-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19893312,2009-11-05T00:00:00,Risk Factors,N06.850.490.625.750
19893312,2009-11-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19893312,2009-11-05T00:00:00,Stroke,C10.228.140.300.775
19893312,2009-11-05T00:00:00,Stroke,C14.907.253.855
19893312,2009-11-05T00:00:00,Thrombolytic Therapy,E02.319.913
19893312,2009-11-05T00:00:00,Time Factors,G01.910.857
19893312,2009-11-05T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
19893312,2009-11-05T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
19893312,2009-11-05T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
19893312,2009-11-05T00:00:00,Tissue Plasminogen Activator,D23.119.970
19893312,2009-11-05T00:00:00,Treatment Outcome,E01.789.800
19893312,2009-11-05T00:00:00,Treatment Outcome,N04.761.559.590.800
19893312,2009-11-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19893497,2009-11-05T00:00:00,Depression,F01.145.126.350
19893497,2009-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19893497,2009-11-05T00:00:00,Hypertension,C14.907.489
19893497,2009-11-05T00:00:00,Middle Aged,M01.060.116.630
19893497,2009-11-05T00:00:00,Myocardial Ischemia,C14.280.647
19893497,2009-11-05T00:00:00,Myocardial Ischemia,C14.907.585
19893497,2009-11-05T00:00:00,Nutrition Surveys,E05.318.308.250.600
19893497,2009-11-05T00:00:00,Nutrition Surveys,E05.318.308.585.550
19893497,2009-11-05T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
19893497,2009-11-05T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
19893497,2009-11-05T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
19893497,2009-11-05T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
19897030,2009-11-05T00:00:00,Animals,B01.050
19897030,2009-11-05T00:00:00,Cell Line,A11.251.210
19897030,2009-11-05T00:00:00,"Endothelium, Vascular",A07.231.330
19897030,2009-11-05T00:00:00,"Endothelium, Vascular",A10.272.491.355
19897030,2009-11-05T00:00:00,Fibroblasts,A11.329.228
19897030,2009-11-05T00:00:00,Fibroblasts,A11.872.228
19897030,2009-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19897030,2009-11-05T00:00:00,Macrophages,A11.329.372
19897030,2009-11-05T00:00:00,Macrophages,A11.627.482
19897030,2009-11-05T00:00:00,Macrophages,A11.733.397
19897030,2009-11-05T00:00:00,Macrophages,A15.382.680.397
19897030,2009-11-05T00:00:00,Macrophages,A15.382.812.522
19897030,2009-11-05T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
19897030,2009-11-05T00:00:00,"Microscopy, Fluorescence",E05.595.458
19897030,2009-11-05T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19897030,2009-11-05T00:00:00,Mitochondria,A11.284.835.626
19897030,2009-11-05T00:00:00,Nitric Oxide,D01.339.387
19897030,2009-11-05T00:00:00,Nitric Oxide,D01.625.550.500
19897030,2009-11-05T00:00:00,Nitric Oxide,D01.625.700.500
19897030,2009-11-05T00:00:00,Nitric Oxide,D01.650.550.587.600
19897030,2009-11-05T00:00:00,RNA-Binding Proteins,D12.776.157.725
19897030,2009-11-05T00:00:00,RNA-Binding Proteins,D12.776.664.962
19897030,2009-11-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19899028,2009-11-06T00:00:00,Clinical Competence,I02.399.630.210
19899028,2009-11-06T00:00:00,Clinical Competence,N04.761.210
19899028,2009-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19899028,2009-11-06T00:00:00,Internationality,I01.615
19899028,2009-11-06T00:00:00,"Quality Assurance, Health Care",N04.761.700
19899028,2009-11-06T00:00:00,"Quality Assurance, Health Care",N05.700
19897230,2009-11-07T00:00:00,Endometrial Neoplasms,C04.588.945.418.948.585
19897230,2009-11-07T00:00:00,Endometrial Neoplasms,C13.351.500.852.762.200
19897230,2009-11-07T00:00:00,Endometrial Neoplasms,C13.351.937.418.875.200
19897230,2009-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19897230,2009-11-07T00:00:00,Hysterectomy,E04.950.300.399
19897230,2009-11-07T00:00:00,Lymph Node Excision,E04.446
19897230,2009-11-07T00:00:00,Lymph Nodes,A10.549.400
19897230,2009-11-07T00:00:00,Lymph Nodes,A15.382.520.604.412
19897230,2009-11-07T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
19897230,2009-11-07T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
19897230,2009-11-07T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19897230,2009-11-07T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19897230,2009-11-07T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19897230,2009-11-07T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19900820,2009-11-08T00:00:00,Adolescent,M01.060.057
19900820,2009-11-08T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
19900820,2009-11-08T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
19900820,2009-11-08T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
19900820,2009-11-08T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
19900820,2009-11-08T00:00:00,Child,M01.060.406
19900820,2009-11-08T00:00:00,"Child, Preschool",M01.060.406.448
19900820,2009-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19900820,2009-11-08T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
19900820,2009-11-08T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
19900820,2009-11-08T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
19900820,2009-11-08T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
19900820,2009-11-08T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
19900820,2009-11-08T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
19900820,2009-11-08T00:00:00,Stroke,C10.228.140.300.775
19900820,2009-11-08T00:00:00,Stroke,C14.907.253.855
19900820,2009-11-08T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
19900820,2009-11-08T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
19900820,2009-11-08T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
19900820,2009-11-08T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
19900820,2009-11-08T00:00:00,Young Adult,M01.060.116.815
19901118,2009-11-09T00:00:00,Aged,M01.060.116.100
19901118,2009-11-09T00:00:00,Breast Neoplasms,C04.588.180
19901118,2009-11-09T00:00:00,Breast Neoplasms,C17.800.090.500
19901118,2009-11-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19901118,2009-11-09T00:00:00,Mammography,E01.370.350.700.500
19901118,2009-11-09T00:00:00,Middle Aged,M01.060.116.630
19901118,2009-11-09T00:00:00,Risk Factors,E05.318.740.600.800.725
19901118,2009-11-09T00:00:00,Risk Factors,N05.715.350.200.700
19901118,2009-11-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19901118,2009-11-09T00:00:00,Risk Factors,N06.850.490.625.750
19901118,2009-11-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19907169,2009-11-10T00:00:00,Aged,M01.060.116.100
19907169,2009-11-10T00:00:00,Brain,A08.186.211
19907169,2009-11-10T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
19907169,2009-11-10T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
19907169,2009-11-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
19907169,2009-11-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19907169,2009-11-10T00:00:00,Middle Aged,M01.060.116.630
19907169,2009-11-10T00:00:00,Patient Selection,E05.581.500.653
19907169,2009-11-10T00:00:00,Patient Selection,N04.590.731
19907169,2009-11-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
19907169,2009-11-10T00:00:00,Risk Assessment,N04.452.871.715
19907169,2009-11-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19907169,2009-11-10T00:00:00,Risk Assessment,N06.850.505.715
19907169,2009-11-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19907169,2009-11-10T00:00:00,Risk Factors,E05.318.740.600.800.725
19907169,2009-11-10T00:00:00,Risk Factors,N05.715.350.200.700
19907169,2009-11-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19907169,2009-11-10T00:00:00,Risk Factors,N06.850.490.625.750
19907169,2009-11-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19907169,2009-11-10T00:00:00,Stroke,C10.228.140.300.775
19907169,2009-11-10T00:00:00,Stroke,C14.907.253.855
19907169,2009-11-10T00:00:00,Thrombolytic Therapy,E02.319.913
19945703,2009-11-10T00:00:00,Adult,M01.060.116
19945703,2009-11-10T00:00:00,Age Factors,N05.715.350.075
19945703,2009-11-10T00:00:00,Age Factors,N06.850.490.250
19945703,2009-11-10T00:00:00,Aging,G07.700.320.124
19945703,2009-11-10T00:00:00,Calcinosis,C18.452.174.130
19945703,2009-11-10T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19945703,2009-11-10T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19945703,2009-11-10T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19945703,2009-11-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19945703,2009-11-10T00:00:00,Middle Aged,M01.060.116.630
19945703,2009-11-10T00:00:00,Risk Factors,E05.318.740.600.800.725
19945703,2009-11-10T00:00:00,Risk Factors,N05.715.350.200.700
19945703,2009-11-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19945703,2009-11-10T00:00:00,Risk Factors,N06.850.490.625.750
19945703,2009-11-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19728861,2009-11-11T00:00:00,Cell Cycle,G04.299.134
19728861,2009-11-11T00:00:00,Ceramides,D02.065.313
19728861,2009-11-11T00:00:00,Ceramides,D09.400.410.420.525.200
19728861,2009-11-11T00:00:00,Ceramides,D10.390.470.675.200
19728861,2009-11-11T00:00:00,Ceramides,D10.570.877.360.612.200
19728861,2009-11-11T00:00:00,Down-Regulation,G02.111.087.225
19728861,2009-11-11T00:00:00,Down-Regulation,G02.149.115.225
19728861,2009-11-11T00:00:00,Down-Regulation,G05.355.315.200
19728861,2009-11-11T00:00:00,Down-Regulation,G07.690.812.230
19728861,2009-11-11T00:00:00,Down-Regulation,G07.700.680.230
19728861,2009-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19728861,2009-11-11T00:00:00,Membrane Proteins,D12.776.543
19728861,2009-11-11T00:00:00,Protein Folding,G01.154.100.640
19728861,2009-11-11T00:00:00,Protein Folding,G01.595.100.640
19728861,2009-11-11T00:00:00,Protein Folding,G02.111.087.690
19728861,2009-11-11T00:00:00,Protein Folding,G02.149.115.690
19728861,2009-11-11T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
19728861,2009-11-11T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
19909989,2009-11-11T00:00:00,Cardiac Surgical Procedures,E04.100.376
19909989,2009-11-11T00:00:00,Cardiac Surgical Procedures,E04.928.220
19909989,2009-11-11T00:00:00,Clinical Competence,I02.399.630.210
19909989,2009-11-11T00:00:00,Clinical Competence,N04.761.210
19909989,2009-11-11T00:00:00,"Heart Defects, Congenital",C14.240.400
19909989,2009-11-11T00:00:00,"Heart Defects, Congenital",C14.280.400
19909989,2009-11-11T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19909989,2009-11-11T00:00:00,Hospitals,N02.278.421
19909989,2009-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19909989,2009-11-11T00:00:00,"Infant, Newborn",M01.060.703.520
19909989,2009-11-11T00:00:00,Thoracic Surgery,H02.403.810.803
19909989,2009-11-11T00:00:00,Treatment Outcome,E01.789.800
19909989,2009-11-11T00:00:00,Treatment Outcome,N04.761.559.590.800
19909989,2009-11-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19962902,2009-11-11T00:00:00,Apoptosis,G04.299.139.160
19962902,2009-11-11T00:00:00,DNA,D13.444.308
19962902,2009-11-11T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19962902,2009-11-11T00:00:00,Histones,D12.776.660.470
19962902,2009-11-11T00:00:00,Histones,D12.776.664.469
19962902,2009-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19962902,2009-11-11T00:00:00,Nylons,D05.750.716.392
19962902,2009-11-11T00:00:00,Nylons,D25.720.716.392
19962902,2009-11-11T00:00:00,Nylons,J01.576.885.800.600
19962902,2009-11-11T00:00:00,Nylons,J01.637.051.720.716.392
19962902,2009-11-11T00:00:00,Nylons,J01.637.548
19962902,2009-11-11T00:00:00,Pyrroles,D03.383.129.578
19831390,2009-11-12T00:00:00,Animals,B01.050
19831390,2009-11-12T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19831390,2009-11-12T00:00:00,Intraocular Pressure,G14.440
19831390,2009-11-12T00:00:00,Ocular Hypertension,C11.525
19831390,2009-11-12T00:00:00,Piperazines,D03.383.606
19831390,2009-11-12T00:00:00,Pyrimidines,D03.383.742
19831390,2009-11-12T00:00:00,Pyrroles,D03.383.129.578
19831390,2009-11-12T00:00:00,Swine,B01.050.150.900.649.077.880
19908102,2009-11-12T00:00:00,Adult,M01.060.116
19908102,2009-11-12T00:00:00,Aged,M01.060.116.100
19908102,2009-11-12T00:00:00,Attitude to Health,F01.100.150
19908102,2009-11-12T00:00:00,Attitude to Health,N05.300.150
19908102,2009-11-12T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19908102,2009-11-12T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19908102,2009-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19908102,2009-11-12T00:00:00,Middle Aged,M01.060.116.630
19908102,2009-11-12T00:00:00,Pilot Projects,E05.318.760.750
19908102,2009-11-12T00:00:00,Pilot Projects,E05.337.737
19908102,2009-11-12T00:00:00,Pilot Projects,N05.715.360.775.625
19908102,2009-11-12T00:00:00,Pilot Projects,N06.850.520.450.720
19908102,2009-11-12T00:00:00,Psychometrics,F04.711.780
19908102,2009-11-12T00:00:00,Quality of Life,I01.800
19908102,2009-11-12T00:00:00,Quality of Life,K01.752.400.750
19910509,2009-11-12T00:00:00,Animals,B01.050
19910509,2009-11-12T00:00:00,Choroidal Neovascularization,C11.941.160.244
19910509,2009-11-12T00:00:00,Choroidal Neovascularization,C23.550.589.500.145
19910509,2009-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19910509,2009-11-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19910509,2009-11-12T00:00:00,Retinal Vessels,A07.231.611
19910509,2009-11-12T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19910509,2009-11-12T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19910509,2009-11-12T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19912188,2009-11-12T00:00:00,Adolescent,M01.060.057
19912188,2009-11-12T00:00:00,Adult,M01.060.116
19912188,2009-11-12T00:00:00,Aged,M01.060.116.100
19912188,2009-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19912188,2009-11-12T00:00:00,Medication Adherence,F01.145.488.500.500
19912188,2009-11-12T00:00:00,Medication Adherence,N05.300.150.600.600.500
19912188,2009-11-12T00:00:00,Middle Aged,M01.060.116.630
19912188,2009-11-12T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
19912188,2009-11-12T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
19912188,2009-11-12T00:00:00,United States,Z01.107.567.875
19912188,2009-11-12T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
19912188,2009-11-12T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
19912188,2009-11-12T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
19912188,2009-11-12T00:00:00,Young Adult,M01.060.116.815
20024330,2009-11-12T00:00:00,Fluorescent Dyes,D27.720.233.348
20024330,2009-11-12T00:00:00,Fluorescent Dyes,D27.720.470.330.348
20024330,2009-11-12T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
20024330,2009-11-12T00:00:00,Insulin-Like Growth Factor Binding Protein 2,D12.776.157.420.260
20024330,2009-11-12T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
20024330,2009-11-12T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20024330,2009-11-12T00:00:00,"Microscopy, Fluorescence",E05.595.458
20024330,2009-11-12T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
20024330,2009-11-12T00:00:00,Nanotubes,J01.637.512.850
20024330,2009-11-12T00:00:00,Protein Folding,G01.154.100.640
20024330,2009-11-12T00:00:00,Protein Folding,G01.595.100.640
20024330,2009-11-12T00:00:00,Protein Folding,G02.111.087.690
20024330,2009-11-12T00:00:00,Protein Folding,G02.149.115.690
19783904,2009-11-13T00:00:00,Amines,D02.092
19783904,2009-11-13T00:00:00,Animals,B01.050
19783904,2009-11-13T00:00:00,Biological Transport,G03.495.166
19783904,2009-11-13T00:00:00,Cyclosporine,D04.345.566.235.300
19783904,2009-11-13T00:00:00,Cyclosporine,D12.644.641.235.300
19783904,2009-11-13T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
19783904,2009-11-13T00:00:00,Gene Expression Regulation,G05.355.315
19783904,2009-11-13T00:00:00,Hepatocytes,A11.436.348
19783904,2009-11-13T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
19783904,2009-11-13T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
19783904,2009-11-13T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
19783904,2009-11-13T00:00:00,"RNA, Messenger",D13.444.735.544
19783904,2009-11-13T00:00:00,RNA-Binding Proteins,D12.776.157.725
19783904,2009-11-13T00:00:00,RNA-Binding Proteins,D12.776.664.962
19783904,2009-11-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19783904,2009-11-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19783904,2009-11-13T00:00:00,Transcription Factors,D12.776.930
19914377,2009-11-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
19914377,2009-11-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
19914377,2009-11-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
19914377,2009-11-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
19914377,2009-11-13T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
19914377,2009-11-13T00:00:00,Animals,B01.050
19914377,2009-11-13T00:00:00,Astrocytes,A08.637.200
19914377,2009-11-13T00:00:00,Astrocytes,A11.650.200
19914377,2009-11-13T00:00:00,"Disease Models, Animal",C22.232
19914377,2009-11-13T00:00:00,"Disease Models, Animal",E05.598.500
19914377,2009-11-13T00:00:00,"Disease Models, Animal",E05.599.395.080
19914377,2009-11-13T00:00:00,Motor Neurons,A08.663.655.500
19914377,2009-11-13T00:00:00,Motor Neurons,A11.671.655.500
19914377,2009-11-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19914377,2009-11-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19914377,2009-11-13T00:00:00,Spinal Cord,A08.186.854
19914377,2009-11-13T00:00:00,Superoxide Dismutase,D08.811.682.881
19914377,2009-11-13T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19914377,2009-11-13T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19914377,2009-11-13T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20351866,2009-11-14T00:00:00,Adult,M01.060.116
20351866,2009-11-14T00:00:00,Aged,M01.060.116.100
20351866,2009-11-14T00:00:00,Diabetes Mellitus,C18.452.394.750
20351866,2009-11-14T00:00:00,Diabetes Mellitus,C19.246
20351866,2009-11-14T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20351866,2009-11-14T00:00:00,Genetic Predisposition to Disease,G05.380.355
20351866,2009-11-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20351866,2009-11-14T00:00:00,Middle Aged,M01.060.116.630
20351866,2009-11-14T00:00:00,Myocardial Infarction,C14.280.647.500
20351866,2009-11-14T00:00:00,Myocardial Infarction,C14.907.585.500
20351866,2009-11-14T00:00:00,Risk Assessment,E05.318.740.600.800.715
20351866,2009-11-14T00:00:00,Risk Assessment,N04.452.871.715
20351866,2009-11-14T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20351866,2009-11-14T00:00:00,Risk Assessment,N06.850.505.715
20351866,2009-11-14T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20351866,2009-11-14T00:00:00,Young Adult,M01.060.116.815
19626689,2009-11-15T00:00:00,Adolescent,M01.060.057
19626689,2009-11-15T00:00:00,Adult,M01.060.116
19626689,2009-11-15T00:00:00,Age Factors,N05.715.350.075
19626689,2009-11-15T00:00:00,Age Factors,N06.850.490.250
19626689,2009-11-15T00:00:00,Aged,M01.060.116.100
19626689,2009-11-15T00:00:00,Atrial Fibrillation,C14.280.067.198
19626689,2009-11-15T00:00:00,Atrial Fibrillation,C23.550.073.198
19626689,2009-11-15T00:00:00,Chronic Disease,C23.550.291.500
19626689,2009-11-15T00:00:00,"Foramen Ovale, Patent",C14.240.400.560.375.258
19626689,2009-11-15T00:00:00,"Foramen Ovale, Patent",C14.280.400.560.375.258
19626689,2009-11-15T00:00:00,"Foramen Ovale, Patent",C16.131.240.400.560.375.258
19626689,2009-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19626689,2009-11-15T00:00:00,Incidence,E05.318.308.985.525.375
19626689,2009-11-15T00:00:00,Incidence,L01.280.975.525.375
19626689,2009-11-15T00:00:00,Incidence,N01.224.935.597.500
19626689,2009-11-15T00:00:00,Incidence,N06.850.505.400.975.525.375
19626689,2009-11-15T00:00:00,Incidence,N06.850.520.308.985.525.375
19626689,2009-11-15T00:00:00,Middle Aged,M01.060.116.630
19626689,2009-11-15T00:00:00,Prosthesis Design,E05.320.550
19626689,2009-11-15T00:00:00,Prosthesis Design,E07.695.680
19626689,2009-11-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
19626689,2009-11-15T00:00:00,Risk Assessment,N04.452.871.715
19626689,2009-11-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19626689,2009-11-15T00:00:00,Risk Assessment,N06.850.505.715
19626689,2009-11-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19626689,2009-11-15T00:00:00,Risk Factors,E05.318.740.600.800.725
19626689,2009-11-15T00:00:00,Risk Factors,N05.715.350.200.700
19626689,2009-11-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19626689,2009-11-15T00:00:00,Risk Factors,N06.850.490.625.750
19626689,2009-11-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19626689,2009-11-15T00:00:00,Septal Occluder Device,E07.695.715
19626689,2009-11-15T00:00:00,Time Factors,G01.910.857
19626689,2009-11-15T00:00:00,Treatment Outcome,E01.789.800
19626689,2009-11-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19626689,2009-11-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19626689,2009-11-15T00:00:00,Young Adult,M01.060.116.815
19892060,2009-11-15T00:00:00,Diastole,G09.330.190.541.295
19892060,2009-11-15T00:00:00,Diastole,G11.427.590.540.554.250
19892060,2009-11-15T00:00:00,Diastole,G11.427.590.540.570.295
19892060,2009-11-15T00:00:00,Heart Failure,C14.280.434
19892060,2009-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19892060,2009-11-15T00:00:00,Hypertension,C14.907.489
19892060,2009-11-15T00:00:00,"Models, Cardiovascular",E05.599.395.161
19892060,2009-11-15T00:00:00,Myocardial Ischemia,C14.280.647
19892060,2009-11-15T00:00:00,Myocardial Ischemia,C14.907.585
19892060,2009-11-15T00:00:00,Stroke Volume,E01.370.370.380.150.700
19892060,2009-11-15T00:00:00,Stroke Volume,G09.330.380.124.882
19892060,2009-11-15T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
19892060,2009-11-15T00:00:00,Ventricular Remodeling,C23.300.985
19892060,2009-11-15T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20017294,2009-11-15T00:00:00,Breast Neoplasms,C04.588.180
20017294,2009-11-15T00:00:00,Breast Neoplasms,C17.800.090.500
20017294,2009-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20017294,2009-11-15T00:00:00,Risk Factors,E05.318.740.600.800.725
20017294,2009-11-15T00:00:00,Risk Factors,N05.715.350.200.700
20017294,2009-11-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20017294,2009-11-15T00:00:00,Risk Factors,N06.850.490.625.750
20017294,2009-11-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19912083,2009-11-16T00:00:00,Adolescent,M01.060.057
19912083,2009-11-16T00:00:00,Adult,M01.060.116
19912083,2009-11-16T00:00:00,Aged,M01.060.116.100
19912083,2009-11-16T00:00:00,Health Education,I02.233.332
19912083,2009-11-16T00:00:00,Health Education,N02.421.143.827.407
19912083,2009-11-16T00:00:00,Health Education,N02.421.726.407
19912083,2009-11-16T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19912083,2009-11-16T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19912083,2009-11-16T00:00:00,Health Services,N02.421
19912083,2009-11-16T00:00:00,Health Status,I01.240.425
19912083,2009-11-16T00:00:00,Health Status,N01.224.425
19912083,2009-11-16T00:00:00,Health Status,N06.850.505.400.425
19912083,2009-11-16T00:00:00,Health Surveys,E05.318.308.250
19912083,2009-11-16T00:00:00,Health Surveys,N05.715.360.300.375
19912083,2009-11-16T00:00:00,Health Surveys,N06.850.520.308.250
19912083,2009-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19912083,2009-11-16T00:00:00,Middle Aged,M01.060.116.630
19912083,2009-11-16T00:00:00,Risk Factors,E05.318.740.600.800.725
19912083,2009-11-16T00:00:00,Risk Factors,N05.715.350.200.700
19912083,2009-11-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19912083,2009-11-16T00:00:00,Risk Factors,N06.850.490.625.750
19912083,2009-11-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19912083,2009-11-16T00:00:00,Young Adult,M01.060.116.815
19917551,2009-11-16T00:00:00,Brachiocephalic Trunk,A07.231.114.145
19917551,2009-11-16T00:00:00,Cardiopulmonary Bypass,E04.292.413
19917551,2009-11-16T00:00:00,"Heart Defects, Congenital",C14.240.400
19917551,2009-11-16T00:00:00,"Heart Defects, Congenital",C14.280.400
19917551,2009-11-16T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19917551,2009-11-16T00:00:00,Hemodynamics,G09.330.190.400
19917551,2009-11-16T00:00:00,Hemodynamics,G09.330.380
19917551,2009-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19917551,2009-11-16T00:00:00,Infant,M01.060.703
19917551,2009-11-16T00:00:00,"Infant, Newborn",M01.060.703.520
19917551,2009-11-16T00:00:00,Treatment Outcome,E01.789.800
19917551,2009-11-16T00:00:00,Treatment Outcome,N04.761.559.590.800
19917551,2009-11-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19917551,2009-11-16T00:00:00,Young Adult,M01.060.116.815
19917914,2009-11-16T00:00:00,Carcinogens,D27.888.569.100
19917914,2009-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19917914,2009-11-16T00:00:00,Incidence,E05.318.308.985.525.375
19917914,2009-11-16T00:00:00,Incidence,L01.280.975.525.375
19917914,2009-11-16T00:00:00,Incidence,N01.224.935.597.500
19917914,2009-11-16T00:00:00,Incidence,N06.850.505.400.975.525.375
19917914,2009-11-16T00:00:00,Incidence,N06.850.520.308.985.525.375
19917914,2009-11-16T00:00:00,Nicotine,D03.132.760.570
19917914,2009-11-16T00:00:00,Nicotine,D03.383.725.518
19917914,2009-11-16T00:00:00,Risk Assessment,E05.318.740.600.800.715
19917914,2009-11-16T00:00:00,Risk Assessment,N04.452.871.715
19917914,2009-11-16T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19917914,2009-11-16T00:00:00,Risk Assessment,N06.850.505.715
19917914,2009-11-16T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19917914,2009-11-16T00:00:00,Risk Factors,E05.318.740.600.800.725
19917914,2009-11-16T00:00:00,Risk Factors,N05.715.350.200.700
19917914,2009-11-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19917914,2009-11-16T00:00:00,Risk Factors,N06.850.490.625.750
19917914,2009-11-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19917914,2009-11-16T00:00:00,Smoking,F01.145.466.753
19917914,2009-11-16T00:00:00,Smoking Cessation,F01.145.940.700
19917914,2009-11-16T00:00:00,Time Factors,G01.910.857
19917914,2009-11-16T00:00:00,Tobacco,B01.650.388.100.905.900
19917914,2009-11-16T00:00:00,United States,Z01.107.567.875
19917914,2009-11-16T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
19917914,2009-11-16T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
19917914,2009-11-16T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
19917914,2009-11-16T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
19917914,2009-11-16T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
19921513,2009-11-18T00:00:00,Animals,B01.050
19921513,2009-11-18T00:00:00,Cancer Vaccines,D20.215.894.200
19921513,2009-11-18T00:00:00,Dendritic Cells,A11.066.270
19921513,2009-11-18T00:00:00,Dendritic Cells,A11.436.270
19921513,2009-11-18T00:00:00,Dendritic Cells,A15.382.066.270
19921513,2009-11-18T00:00:00,Dendritic Cells,A15.382.812.260
19921513,2009-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19921513,2009-11-18T00:00:00,Neoplasms,C04
19921513,2009-11-18T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
19921513,2009-11-18T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
19921513,2009-11-18T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19921513,2009-11-18T00:00:00,Vaccination,E02.095.465.425.400.530.890
19921513,2009-11-18T00:00:00,Vaccination,E05.478.550.600.890
19921513,2009-11-18T00:00:00,Vaccination,N02.421.726.758.310.890
19921513,2009-11-18T00:00:00,Vaccination,N06.850.780.200.425.900
19921513,2009-11-18T00:00:00,Vaccination,N06.850.780.680.310.890
19923357,2009-11-18T00:00:00,Aged,M01.060.116.100
19923357,2009-11-18T00:00:00,Apoptosis,G04.299.139.160
19923357,2009-11-18T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
19923357,2009-11-18T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
19923357,2009-11-18T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
19923357,2009-11-18T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
19923357,2009-11-18T00:00:00,Cell Line,A11.251.210
19923357,2009-11-18T00:00:00,Cell Proliferation,G04.299.233.750
19923357,2009-11-18T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19923357,2009-11-18T00:00:00,Gene Silencing,G05.355.315.203.374
19923357,2009-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19923357,2009-11-18T00:00:00,Liver Neoplasms,C04.588.274.623
19923357,2009-11-18T00:00:00,Liver Neoplasms,C06.301.623
19923357,2009-11-18T00:00:00,Liver Neoplasms,C06.552.697
19923357,2009-11-18T00:00:00,Middle Aged,M01.060.116.630
19923357,2009-11-18T00:00:00,"Receptors, Opioid",D12.776.543.750.100.620
19923357,2009-11-18T00:00:00,"Receptors, Opioid",D12.776.543.750.720.600.610
19923357,2009-11-18T00:00:00,"Receptors, Opioid",D12.776.543.750.750.555.610
19926168,2009-11-18T00:00:00,Aged,M01.060.116.100
19926168,2009-11-18T00:00:00,Brain,A08.186.211
19926168,2009-11-18T00:00:00,Cognition Disorders,F03.087.250
19926168,2009-11-18T00:00:00,"Diagnosis, Differential",E01.171
19926168,2009-11-18T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
19926168,2009-11-18T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
19926168,2009-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19926168,2009-11-18T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19926168,2009-11-18T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
19926168,2009-11-18T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
20064791,2009-11-18T00:00:00,Adult,M01.060.116
20064791,2009-11-18T00:00:00,Aged,M01.060.116.100
20064791,2009-11-18T00:00:00,Breast Neoplasms,C04.588.180
20064791,2009-11-18T00:00:00,Breast Neoplasms,C17.800.090.500
20064791,2009-11-18T00:00:00,Case-Control Studies,E05.318.760.500.500
20064791,2009-11-18T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20064791,2009-11-18T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20064791,2009-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20064791,2009-11-18T00:00:00,Middle Aged,M01.060.116.630
20064791,2009-11-18T00:00:00,Mutation,G05.365.590
20064791,2009-11-18T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D02.455.426.559.847
20064791,2009-11-18T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D04.615
20064791,2009-11-18T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
20064791,2009-11-18T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
20064791,2009-11-18T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
20064791,2009-11-18T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
20064791,2009-11-18T00:00:00,Young Adult,M01.060.116.815
19933275,2009-11-20T00:00:00,Cell Cycle,G04.299.134
19933275,2009-11-20T00:00:00,Cell Death,G04.299.139
19933275,2009-11-20T00:00:00,Cell Line,A11.251.210
19933275,2009-11-20T00:00:00,Gene Silencing,G05.355.315.203.374
19933275,2009-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19933275,2009-11-20T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
19933275,2009-11-20T00:00:00,Serine,D12.125.154.800
19933275,2009-11-20T00:00:00,Serine,D12.125.837
19933275,2009-11-20T00:00:00,Transferases (Other Substituted Phosphate Groups),D08.811.913.696.900
19940440,2009-11-20T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
19940440,2009-11-20T00:00:00,Amino Acid Sequence,G02.111.570.060
19940440,2009-11-20T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19940440,2009-11-20T00:00:00,Animals,B01.050
19940440,2009-11-20T00:00:00,"Embryo, Nonmammalian",A13.350
19940440,2009-11-20T00:00:00,"Embryo, Nonmammalian",A16.331
19940440,2009-11-20T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19940440,2009-11-20T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
19940440,2009-11-20T00:00:00,Heat-Shock Proteins,D12.776.580.216
19940440,2009-11-20T00:00:00,Molecular Sequence Data,L01.453.245.667
19940440,2009-11-20T00:00:00,"RNA, Messenger",D13.444.735.544
19940440,2009-11-20T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
19940440,2009-11-20T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
19951304,2009-11-20T00:00:00,Adult,M01.060.116
19951304,2009-11-20T00:00:00,African Americans,M01.686.508.100.100
19951304,2009-11-20T00:00:00,African Americans,M01.686.754.100
19951304,2009-11-20T00:00:00,Antilymphocyte Serum,A12.207.152.846.500.203
19951304,2009-11-20T00:00:00,Antilymphocyte Serum,D12.776.124.486.485.114.573.203
19951304,2009-11-20T00:00:00,Antilymphocyte Serum,D12.776.124.790.651.114.573.203
19951304,2009-11-20T00:00:00,Antilymphocyte Serum,D12.776.377.715.548.114.573.203
19951304,2009-11-20T00:00:00,Antilymphocyte Serum,D20.215.401.203
19951304,2009-11-20T00:00:00,Graft Rejection,G12.425.901.545.328
19951304,2009-11-20T00:00:00,Graft Survival,G12.425.901.545.340
19951304,2009-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19951304,2009-11-20T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
19951304,2009-11-20T00:00:00,Kidney Transplantation,E02.870.500
19951304,2009-11-20T00:00:00,Kidney Transplantation,E04.936.450.485
19951304,2009-11-20T00:00:00,Kidney Transplantation,E04.950.774.400
19951304,2009-11-20T00:00:00,Middle Aged,M01.060.116.630
19951304,2009-11-20T00:00:00,Treatment Outcome,E01.789.800
19951304,2009-11-20T00:00:00,Treatment Outcome,N04.761.559.590.800
19951304,2009-11-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20096225,2009-11-22T00:00:00,Adult,M01.060.116
20096225,2009-11-22T00:00:00,Aged,M01.060.116.100
20096225,2009-11-22T00:00:00,Chronic Disease,C23.550.291.500
20096225,2009-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20096225,2009-11-22T00:00:00,Middle Aged,M01.060.116.630
20096225,2009-11-22T00:00:00,Nasal Polyps,C08.460.572
20096225,2009-11-22T00:00:00,Nasal Polyps,C09.603.557
20096225,2009-11-22T00:00:00,Nasal Polyps,C23.300.825.557
20096225,2009-11-22T00:00:00,Quality of Life,I01.800
20096225,2009-11-22T00:00:00,Quality of Life,K01.752.400.750
20096225,2009-11-22T00:00:00,Rhinitis,C08.460.799
20096225,2009-11-22T00:00:00,Rhinitis,C08.730.674
20096225,2009-11-22T00:00:00,Rhinitis,C09.603.799
20096225,2009-11-22T00:00:00,Sinusitis,C08.460.692.752
20096225,2009-11-22T00:00:00,Sinusitis,C08.730.749
20096225,2009-11-22T00:00:00,Sinusitis,C09.603.692.752
20096225,2009-11-22T00:00:00,Treatment Outcome,E01.789.800
20096225,2009-11-22T00:00:00,Treatment Outcome,N04.761.559.590.800
20096225,2009-11-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20096225,2009-11-22T00:00:00,Young Adult,M01.060.116.815
19931260,2009-11-23T00:00:00,Animals,B01.050
19931260,2009-11-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19931260,2009-11-23T00:00:00,Muscle Contraction,G11.427.590.540
19931260,2009-11-23T00:00:00,"Muscle, Smooth",A02.633.570
19931260,2009-11-23T00:00:00,"Muscle, Smooth",A10.690.467
19965690,2009-11-23T00:00:00,Animals,B01.050
19965690,2009-11-23T00:00:00,Apoptosis,G04.299.139.160
19965690,2009-11-23T00:00:00,Cell Division,G04.299.134.220
19965690,2009-11-23T00:00:00,Cell Division,G04.299.233.750.500
19965690,2009-11-23T00:00:00,Cell Division,G05.355.105
19965690,2009-11-23T00:00:00,Cell Division,G07.700.320.249.410.750.500
19965690,2009-11-23T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
19965690,2009-11-23T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
19965690,2009-11-23T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
19965690,2009-11-23T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
19965690,2009-11-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19965690,2009-11-23T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19965690,2009-11-23T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19965690,2009-11-23T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
19965690,2009-11-23T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
19965690,2009-11-23T00:00:00,MAP Kinase Signaling System,G03.495.553.560
19965690,2009-11-23T00:00:00,MAP Kinase Signaling System,G04.299.880.560
19965690,2009-11-23T00:00:00,Phosphorylation,G02.111.087.677
19965690,2009-11-23T00:00:00,Phosphorylation,G02.149.115.677
19965690,2009-11-23T00:00:00,Phosphorylation,G02.149.465.700
19965690,2009-11-23T00:00:00,Phosphorylation,G02.607.750.700
19965690,2009-11-23T00:00:00,Phosphorylation,G03.495.790
19965690,2009-11-23T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19965690,2009-11-23T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
19965690,2009-11-23T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
19965690,2009-11-23T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
19965690,2009-11-23T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
19965690,2009-11-23T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
19965690,2009-11-23T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
19965690,2009-11-23T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
19934284,2009-11-24T00:00:00,Amines,D02.092
19934284,2009-11-24T00:00:00,Animals,B01.050
19934284,2009-11-24T00:00:00,DNA Methylation,G02.111.087.029.538.161
19934284,2009-11-24T00:00:00,DNA Methylation,G02.111.087.218
19934284,2009-11-24T00:00:00,DNA Methylation,G02.149.115.029.538.161
19934284,2009-11-24T00:00:00,DNA Methylation,G02.149.115.218
19934284,2009-11-24T00:00:00,DNA Methylation,G03.495.130.538.161
19934284,2009-11-24T00:00:00,DNA Methylation,G05.355.190
19934284,2009-11-24T00:00:00,Gene Silencing,G05.355.315.203.374
19934284,2009-11-24T00:00:00,Histone Demethylases,D08.811.682.662.582.475
19934284,2009-11-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19934284,2009-11-24T00:00:00,Signal Transduction,G02.111.087.800
19934284,2009-11-24T00:00:00,Signal Transduction,G02.149.115.800
19934284,2009-11-24T00:00:00,Signal Transduction,G04.299.880
19934284,2009-11-24T00:00:00,Wnt Proteins,D12.644.276.984
19934284,2009-11-24T00:00:00,Wnt Proteins,D12.776.467.984
19934284,2009-11-24T00:00:00,Wnt Proteins,D23.529.984
19934306,2009-11-24T00:00:00,Animals,B01.050
19934306,2009-11-24T00:00:00,Brain Neoplasms,C04.588.614.250.195
19934306,2009-11-24T00:00:00,Brain Neoplasms,C10.228.140.211
19934306,2009-11-24T00:00:00,Brain Neoplasms,C10.551.240.250
19934306,2009-11-24T00:00:00,Disease Progression,C23.550.291.656
19934306,2009-11-24T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
19934306,2009-11-24T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
19934306,2009-11-24T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
19934306,2009-11-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19934306,2009-11-24T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19934306,2009-11-24T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19934306,2009-11-24T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19934306,2009-11-24T00:00:00,Interferon-gamma,D12.644.276.718.550
19934306,2009-11-24T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19934306,2009-11-24T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19934306,2009-11-24T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19934306,2009-11-24T00:00:00,Interferon-gamma,D12.776.467.718.550
19934306,2009-11-24T00:00:00,Interferon-gamma,D23.529.374.440.893
19934306,2009-11-24T00:00:00,Interferon-gamma,D23.529.374.480.350
19934306,2009-11-24T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19934306,2009-11-24T00:00:00,Interferon-gamma,D23.529.718.550
19934306,2009-11-24T00:00:00,Microcirculation,G09.330.190.163.645
19934306,2009-11-24T00:00:00,"Models, Biological",E05.599.395
19934306,2009-11-24T00:00:00,Neoplasm Invasiveness,C04.697.645
19934306,2009-11-24T00:00:00,Neoplasm Invasiveness,C23.550.727.645
19934306,2009-11-24T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
19934306,2009-11-24T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
19934306,2009-11-24T00:00:00,Telomerase,D12.776.157.725.500.921
19934306,2009-11-24T00:00:00,Telomerase,D12.776.664.962.500.921
19934306,2009-11-24T00:00:00,"Transcription, Genetic",G02.111.087.847
19934306,2009-11-24T00:00:00,"Transcription, Genetic",G02.149.115.847
19934306,2009-11-24T00:00:00,"Transcription, Genetic",G05.355.310.700
19935754,2009-11-24T00:00:00,Adult,M01.060.116
19935754,2009-11-24T00:00:00,Employment,N01.824.245
19935754,2009-11-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19935754,2009-11-24T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19935754,2009-11-24T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19935754,2009-11-24T00:00:00,Questionnaires,E05.318.308.750
19935754,2009-11-24T00:00:00,Questionnaires,L01.280.800
19935754,2009-11-24T00:00:00,Questionnaires,N05.715.360.300.695
19935754,2009-11-24T00:00:00,Questionnaires,N06.850.520.308.750
19935754,2009-11-24T00:00:00,Regression Analysis,E05.318.740.750
19935754,2009-11-24T00:00:00,Regression Analysis,N05.715.360.750.695
19935754,2009-11-24T00:00:00,Regression Analysis,N06.850.520.830.750
19935754,2009-11-24T00:00:00,Spinal Cord Injuries,C10.228.854.770
19935754,2009-11-24T00:00:00,Spinal Cord Injuries,C10.900.850
19935754,2009-11-24T00:00:00,Spinal Cord Injuries,C21.866.819
19935754,2009-11-24T00:00:00,Time Factors,G01.910.857
19935754,2009-11-24T00:00:00,Young Adult,M01.060.116.815
19939855,2009-11-25T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
19939855,2009-11-25T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
19939855,2009-11-25T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
19939855,2009-11-25T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19939855,2009-11-25T00:00:00,Genetic Predisposition to Disease,G05.380.355
19939855,2009-11-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19939855,2009-11-25T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19939855,2009-11-25T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19939855,2009-11-25T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
19939855,2009-11-25T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
19939855,2009-11-25T00:00:00,Lupus Nephritis,C17.300.480.680
19939855,2009-11-25T00:00:00,Lupus Nephritis,C20.111.590.560
19940103,2009-11-25T00:00:00,Animals,B01.050
19940103,2009-11-25T00:00:00,CD4 Lymphocyte Count,E01.450.375.107.595.500.150
19940103,2009-11-25T00:00:00,CD4 Lymphocyte Count,E05.200.500.195.107.595.500.150
19940103,2009-11-25T00:00:00,CD4 Lymphocyte Count,G04.170.107.595.500.150
19940103,2009-11-25T00:00:00,CD4 Lymphocyte Count,G09.188.105.595.500.150
19940103,2009-11-25T00:00:00,Colon,A03.556.124.526.356
19940103,2009-11-25T00:00:00,Colon,A03.556.249.249.356
19940103,2009-11-25T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
19940103,2009-11-25T00:00:00,Cytokines,D12.644.276.374
19940103,2009-11-25T00:00:00,Cytokines,D12.776.467.374
19940103,2009-11-25T00:00:00,Cytokines,D23.529.374
19940103,2009-11-25T00:00:00,Down-Regulation,G02.111.087.225
19940103,2009-11-25T00:00:00,Down-Regulation,G02.149.115.225
19940103,2009-11-25T00:00:00,Down-Regulation,G05.355.315.200
19940103,2009-11-25T00:00:00,Down-Regulation,G07.690.812.230
19940103,2009-11-25T00:00:00,Down-Regulation,G07.700.680.230
19940103,2009-11-25T00:00:00,Lymph Nodes,A10.549.400
19940103,2009-11-25T00:00:00,Lymph Nodes,A15.382.520.604.412
19940103,2009-11-25T00:00:00,Macrophages,A11.329.372
19940103,2009-11-25T00:00:00,Macrophages,A11.627.482
19940103,2009-11-25T00:00:00,Macrophages,A11.733.397
19940103,2009-11-25T00:00:00,Macrophages,A15.382.680.397
19940103,2009-11-25T00:00:00,Macrophages,A15.382.812.522
19940103,2009-11-25T00:00:00,NF-kappa B,D12.776.260.600
19940103,2009-11-25T00:00:00,NF-kappa B,D12.776.660.600
19940103,2009-11-25T00:00:00,NF-kappa B,D12.776.930.600
19940103,2009-11-25T00:00:00,Stilbenes,D02.455.426.559.389.150.700
19944062,2009-11-26T00:00:00,Ceramides,D02.065.313
19944062,2009-11-26T00:00:00,Ceramides,D09.400.410.420.525.200
19944062,2009-11-26T00:00:00,Ceramides,D10.390.470.675.200
19944062,2009-11-26T00:00:00,Ceramides,D10.570.877.360.612.200
19944062,2009-11-26T00:00:00,Down-Regulation,G02.111.087.225
19944062,2009-11-26T00:00:00,Down-Regulation,G02.149.115.225
19944062,2009-11-26T00:00:00,Down-Regulation,G05.355.315.200
19944062,2009-11-26T00:00:00,Down-Regulation,G07.690.812.230
19944062,2009-11-26T00:00:00,Down-Regulation,G07.700.680.230
19944062,2009-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19944062,2009-11-26T00:00:00,Photochemotherapy,E02.186.500
19944062,2009-11-26T00:00:00,Photochemotherapy,E02.319.685
19944062,2009-11-26T00:00:00,Photochemotherapy,E02.774.722
19944062,2009-11-26T00:00:00,Photosensitizing Agents,D27.505.696.750.710
19944062,2009-11-26T00:00:00,Photosensitizing Agents,D27.505.954.444.600
19944543,2009-11-26T00:00:00,Adolescent,M01.060.057
19944543,2009-11-26T00:00:00,Adolescent Behavior,F01.145.022
19944543,2009-11-26T00:00:00,Age Factors,N05.715.350.075
19944543,2009-11-26T00:00:00,Age Factors,N06.850.490.250
19944543,2009-11-26T00:00:00,Age of Onset,N05.715.350.075.100
19944543,2009-11-26T00:00:00,Age of Onset,N06.850.490.250.100
19944543,2009-11-26T00:00:00,Cocaine-Related Disorders,C21.739.300
19944543,2009-11-26T00:00:00,Cocaine-Related Disorders,F03.900.300
19944543,2009-11-26T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19944543,2009-11-26T00:00:00,Genetic Predisposition to Disease,G05.380.355
19944543,2009-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19944543,2009-11-26T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19944543,2009-11-26T00:00:00,Psychiatric Status Rating Scales,F04.586
19944543,2009-11-26T00:00:00,Risk Factors,E05.318.740.600.800.725
19944543,2009-11-26T00:00:00,Risk Factors,N05.715.350.200.700
19944543,2009-11-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19944543,2009-11-26T00:00:00,Risk Factors,N06.850.490.625.750
19944543,2009-11-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19944543,2009-11-26T00:00:00,United States,Z01.107.567.875
19944563,2009-11-26T00:00:00,Disability Evaluation,E01.370.400
19944563,2009-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19944563,2009-11-26T00:00:00,Middle Aged,M01.060.116.630
19944563,2009-11-26T00:00:00,Musculoskeletal Diseases,C05
19944563,2009-11-26T00:00:00,Questionnaires,E05.318.308.750
19944563,2009-11-26T00:00:00,Questionnaires,L01.280.800
19944563,2009-11-26T00:00:00,Questionnaires,N05.715.360.300.695
19944563,2009-11-26T00:00:00,Questionnaires,N06.850.520.308.750
19944563,2009-11-26T00:00:00,Upper Extremity,A01.378.800
19945310,2009-11-27T00:00:00,Disease Progression,C23.550.291.656
19945310,2009-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19945310,2009-11-27T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19945310,2009-11-27T00:00:00,Prostatic Neoplasms,C12.294.260.750
19945310,2009-11-27T00:00:00,Prostatic Neoplasms,C12.294.565.625
19945310,2009-11-27T00:00:00,Prostatic Neoplasms,C12.758.409.750
19945310,2009-11-27T00:00:00,Risk Factors,E05.318.740.600.800.725
19945310,2009-11-27T00:00:00,Risk Factors,N05.715.350.200.700
19945310,2009-11-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19945310,2009-11-27T00:00:00,Risk Factors,N06.850.490.625.750
19945310,2009-11-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19945464,2009-11-27T00:00:00,Aging,G07.700.320.124
19945464,2009-11-27T00:00:00,Animals,B01.050
19945464,2009-11-27T00:00:00,Cyclic AMP,D03.438.759.646.138.395
19945464,2009-11-27T00:00:00,Cyclic AMP,D13.695.462.200
19945464,2009-11-27T00:00:00,Cyclic AMP,D13.695.667.138.395
19945464,2009-11-27T00:00:00,Cyclic AMP,D13.695.827.068.395
19945464,2009-11-27T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
19945464,2009-11-27T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
19945464,2009-11-27T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
19945464,2009-11-27T00:00:00,Gene Deletion,G05.355.600.800.320
19945464,2009-11-27T00:00:00,Gene Deletion,G05.365.590.762.320
19945464,2009-11-27T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
19945464,2009-11-27T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
19945464,2009-11-27T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
19945464,2009-11-27T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
19945464,2009-11-27T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19945464,2009-11-27T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19945464,2009-11-27T00:00:00,"Myocytes, Cardiac",A11.620.500
19945464,2009-11-27T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19945464,2009-11-27T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19945464,2009-11-27T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19945464,2009-11-27T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19945464,2009-11-27T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
19945464,2009-11-27T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
19945464,2009-11-27T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
19945464,2009-11-27T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
19945464,2009-11-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19945464,2009-11-27T00:00:00,Signal Transduction,G02.111.087.800
19945464,2009-11-27T00:00:00,Signal Transduction,G02.149.115.800
19945464,2009-11-27T00:00:00,Signal Transduction,G04.299.880
19945464,2009-11-27T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
19945464,2009-11-27T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
20159631,2009-11-27T00:00:00,Adolescent,M01.060.057
20159631,2009-11-27T00:00:00,Angiography,E01.370.350.700.060
20159631,2009-11-27T00:00:00,Angiography,E01.370.370.050
20159631,2009-11-27T00:00:00,"Heart Defects, Congenital",C14.240.400
20159631,2009-11-27T00:00:00,"Heart Defects, Congenital",C14.280.400
20159631,2009-11-27T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20159631,2009-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20159631,2009-11-27T00:00:00,Reoperation,E04.690
20159631,2009-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20159631,2009-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20159631,2009-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20159631,2009-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20159631,2009-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20159631,2009-11-27T00:00:00,Treatment Outcome,E01.789.800
20159631,2009-11-27T00:00:00,Treatment Outcome,N04.761.559.590.800
20159631,2009-11-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19931573,2009-11-29T00:00:00,Animals,B01.050
19931573,2009-11-29T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19931573,2009-11-29T00:00:00,"Behavior, Animal",F01.145.113
19931573,2009-11-29T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19931573,2009-11-29T00:00:00,Cues,F02.463.425.234
19931573,2009-11-29T00:00:00,"Disease Models, Animal",C22.232
19931573,2009-11-29T00:00:00,"Disease Models, Animal",E05.598.500
19931573,2009-11-29T00:00:00,"Disease Models, Animal",E05.599.395.080
19931573,2009-11-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19931573,2009-11-29T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19931573,2009-11-29T00:00:00,Self Administration,E02.319.890
19931573,2009-11-29T00:00:00,Self Administration,E02.900.890
19931573,2009-11-29T00:00:00,"Stress, Psychological",F01.145.126.990
19931573,2009-11-29T00:00:00,"Stress, Psychological",F02.830.900
19931573,2009-11-29T00:00:00,Yohimbine,D03.132.436.681.933
19931573,2009-11-29T00:00:00,Yohimbine,D03.438.473.402.681.933
19948388,2009-11-30T00:00:00,Adult,M01.060.116
19948388,2009-11-30T00:00:00,African Americans,M01.686.508.100.100
19948388,2009-11-30T00:00:00,African Americans,M01.686.754.100
19948388,2009-11-30T00:00:00,Cultural Diversity,I01.076.201.450.350
19948388,2009-11-30T00:00:00,Cultural Diversity,I01.880.143.450
19948388,2009-11-30T00:00:00,Decision Making,F02.463.785.373
19948388,2009-11-30T00:00:00,Ethnic Groups,M01.686.754
19948388,2009-11-30T00:00:00,Ethnic Groups,N01.224.317
19948388,2009-11-30T00:00:00,European Continental Ancestry Group,M01.686.508.400
19948388,2009-11-30T00:00:00,Hispanic Americans,M01.686.754.441
19948388,2009-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19948388,2009-11-30T00:00:00,Middle Aged,M01.060.116.630
19948388,2009-11-30T00:00:00,Physician's Practice Patterns,N04.590.748
19948388,2009-11-30T00:00:00,Physician's Practice Patterns,N05.300.625
19948388,2009-11-30T00:00:00,Professional Role,F01.829.316.616.625
19948388,2009-11-30T00:00:00,Qualitative Research,H01.770.644.241.850
19948388,2009-11-30T00:00:00,Terminal Care,E02.760.905
19948388,2009-11-30T00:00:00,Terminal Care,N02.421.585.905
19965618,2009-11-30T00:00:00,Cell Adhesion,G04.299.117
19965618,2009-11-30T00:00:00,Cell Survival,G04.299.316
19965618,2009-11-30T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19965618,2009-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19965618,2009-11-30T00:00:00,Multiple Myeloma,C04.557.595.500
19965618,2009-11-30T00:00:00,Multiple Myeloma,C14.907.454.460
19965618,2009-11-30T00:00:00,Multiple Myeloma,C15.378.147.780.650
19965618,2009-11-30T00:00:00,Multiple Myeloma,C15.378.463.835.460
19965618,2009-11-30T00:00:00,Multiple Myeloma,C20.683.515.845
19965618,2009-11-30T00:00:00,Multiple Myeloma,C20.683.780.650
19965618,2009-11-30T00:00:00,Mutation,G05.365.590
19965618,2009-11-30T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
19965618,2009-11-30T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
19965618,2009-11-30T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
19965618,2009-11-30T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
19965618,2009-11-30T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
19965618,2009-11-30T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
19965618,2009-11-30T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
19965618,2009-11-30T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
19965618,2009-11-30T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
19965618,2009-11-30T00:00:00,Stromal Cells,A11.329.830
19657283,2009-12-01T00:00:00,Adolescent,M01.060.057
19657283,2009-12-01T00:00:00,African Americans,M01.686.508.100.100
19657283,2009-12-01T00:00:00,African Americans,M01.686.754.100
19657283,2009-12-01T00:00:00,Blood Pressure,E01.370.600.875.249
19657283,2009-12-01T00:00:00,Blood Pressure,G09.330.380.076
19657283,2009-12-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
19657283,2009-12-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
19657283,2009-12-01T00:00:00,Circadian Rhythm,G07.180.562.190
19657283,2009-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19657283,2009-12-01T00:00:00,Gene Expression Regulation,G05.355.315
19657283,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19657283,2009-12-01T00:00:00,Sex Factors,N05.715.350.675
19657283,2009-12-01T00:00:00,Sex Factors,N06.850.490.875
19657283,2009-12-01T00:00:00,United States,Z01.107.567.875
19820394,2009-12-01T00:00:00,Adolescent,M01.060.057
19820394,2009-12-01T00:00:00,"Diagnosis, Differential",E01.171
19820394,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19820394,2009-12-01T00:00:00,Skin Diseases,C17.800
19860484,2009-12-01T00:00:00,Adenylate Cyclase,D08.811.520.650.200
19860484,2009-12-01T00:00:00,Adenylate Cyclase,D12.644.360.050
19860484,2009-12-01T00:00:00,Adenylate Cyclase,D12.776.476.050
19860484,2009-12-01T00:00:00,Amino Acids,D12.125
19860484,2009-12-01T00:00:00,Binding Sites,G02.111.570.120
19860484,2009-12-01T00:00:00,Calcium,D01.268.552.100
19860484,2009-12-01T00:00:00,Calcium,D01.552.539.288
19860484,2009-12-01T00:00:00,Calcium,D23.119.100
19860484,2009-12-01T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
19860484,2009-12-01T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
19860484,2009-12-01T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
19860484,2009-12-01T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
19860484,2009-12-01T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
19874262,2009-12-01T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
19874262,2009-12-01T00:00:00,Animals,B01.050
19874262,2009-12-01T00:00:00,Antineoplastic Agents,D27.505.954.248
19874262,2009-12-01T00:00:00,Ceramides,D02.065.313
19874262,2009-12-01T00:00:00,Ceramides,D09.400.410.420.525.200
19874262,2009-12-01T00:00:00,Ceramides,D10.390.470.675.200
19874262,2009-12-01T00:00:00,Ceramides,D10.570.877.360.612.200
19874262,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19874262,2009-12-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19874262,2009-12-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
19874262,2009-12-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
19874262,2009-12-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
19874262,2009-12-01T00:00:00,Sphingolipids,D10.570.877
19874262,2009-12-01T00:00:00,Sphingolipids,D10.808
19885872,2009-12-01T00:00:00,Adolescent,M01.060.057
19885872,2009-12-01T00:00:00,Child,M01.060.406
19885872,2009-12-01T00:00:00,Health Surveys,E05.318.308.250
19885872,2009-12-01T00:00:00,Health Surveys,N05.715.360.300.375
19885872,2009-12-01T00:00:00,Health Surveys,N06.850.520.308.250
19885872,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19885872,2009-12-01T00:00:00,Incidence,E05.318.308.985.525.375
19885872,2009-12-01T00:00:00,Incidence,L01.280.975.525.375
19885872,2009-12-01T00:00:00,Incidence,N01.224.935.597.500
19885872,2009-12-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19885872,2009-12-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19885872,2009-12-01T00:00:00,Juvenile Delinquency,I01.880.735.479
19885872,2009-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19885872,2009-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19885872,2009-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19885872,2009-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19885872,2009-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19885872,2009-12-01T00:00:00,Spouse Abuse,I01.198.240.856.350.750
19885872,2009-12-01T00:00:00,Spouse Abuse,I01.880.735.900.350.750
19885872,2009-12-01T00:00:00,Substance-Related Disorders,C21.739
19885872,2009-12-01T00:00:00,Substance-Related Disorders,F03.900
19885872,2009-12-01T00:00:00,United States,Z01.107.567.875
19885872,2009-12-01T00:00:00,Violence,I01.198.240.856
19885872,2009-12-01T00:00:00,Violence,I01.880.735.900
19886800,2009-12-01T00:00:00,Adult,M01.060.116
19886800,2009-12-01T00:00:00,Amphotericin B,D02.540.505.050
19886800,2009-12-01T00:00:00,Amphotericin B,D04.345.349.050
19886800,2009-12-01T00:00:00,Amphotericin B,D09.408.477.050
19886800,2009-12-01T00:00:00,Antifungal Agents,D27.505.954.122.136
19886800,2009-12-01T00:00:00,Central Nervous System Diseases,C10.228
19886800,2009-12-01T00:00:00,Cryptococcosis,C01.703.248
19886800,2009-12-01T00:00:00,Drug Compounding,E05.916.270
19886800,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19886800,2009-12-01T00:00:00,Lipids,D10
19886800,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
19886800,2009-12-01T00:00:00,Treatment Outcome,E01.789.800
19886800,2009-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19886800,2009-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19901824,2009-12-01T00:00:00,Animals,B01.050
19901824,2009-12-01T00:00:00,"Behavior, Animal",F01.145.113
19901824,2009-12-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
19901824,2009-12-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
19901824,2009-12-01T00:00:00,Columbidae,B01.050.150.900.248.165.150
19901824,2009-12-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19901824,2009-12-01T00:00:00,Dextroamphetamine,D02.092.471.683.152.110.200
19901824,2009-12-01T00:00:00,Discrimination Learning,F02.463.425.280
19901824,2009-12-01T00:00:00,Time Factors,G01.910.857
19932850,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19932850,2009-12-01T00:00:00,Rhinitis,C08.460.799
19932850,2009-12-01T00:00:00,Rhinitis,C08.730.674
19932850,2009-12-01T00:00:00,Rhinitis,C09.603.799
19932850,2009-12-01T00:00:00,Self Care,E02.900
19932850,2009-12-01T00:00:00,Self Care,N02.421.784.680
19932850,2009-12-01T00:00:00,Sinusitis,C08.460.692.752
19932850,2009-12-01T00:00:00,Sinusitis,C08.730.749
19932850,2009-12-01T00:00:00,Sinusitis,C09.603.692.752
19940107,2009-12-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
19944960,2009-12-01T00:00:00,Cardiology,H02.403.429.163
19944960,2009-12-01T00:00:00,Cardiovascular Diseases,C14
19944960,2009-12-01T00:00:00,Echocardiography,E01.370.350.850.220
19944960,2009-12-01T00:00:00,Echocardiography,E01.370.370.380.220
19944960,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19944960,2009-12-01T00:00:00,Physician's Practice Patterns,N04.590.748
19944960,2009-12-01T00:00:00,Physician's Practice Patterns,N05.300.625
19944960,2009-12-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19944960,2009-12-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19944960,2009-12-01T00:00:00,United States,Z01.107.567.875
19952263,2009-12-01T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
19952263,2009-12-01T00:00:00,"Arthroplasty, Replacement",E04.650.110
19952263,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19952263,2009-12-01T00:00:00,Joint Diseases,C05.550
19952549,2009-12-01T00:00:00,Algorithms,G17.035
19952549,2009-12-01T00:00:00,Algorithms,L01.224.050
19952549,2009-12-01T00:00:00,Critical Pathways,N04.590.233.624.625
19952549,2009-12-01T00:00:00,Critical Pathways,N04.590.275
19952549,2009-12-01T00:00:00,Hospitalization,E02.760.400
19952549,2009-12-01T00:00:00,Hospitalization,N02.421.585.400
19952549,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19952549,2009-12-01T00:00:00,Intracranial Embolism,C10.228.140.300.525.400
19952549,2009-12-01T00:00:00,Intracranial Embolism,C14.907.253.566.300
19952549,2009-12-01T00:00:00,Intracranial Embolism,C14.907.355.590.213.300
19952549,2009-12-01T00:00:00,Intracranial Embolism,C14.907.355.830.850.213.300
19952549,2009-12-01T00:00:00,Program Evaluation,E05.337.820
19952549,2009-12-01T00:00:00,Program Evaluation,N04.761.685
19952549,2009-12-01T00:00:00,Program Evaluation,N05.715.360.650
19952549,2009-12-01T00:00:00,Stroke,C10.228.140.300.775
19952549,2009-12-01T00:00:00,Stroke,C14.907.253.855
19952617,2009-12-01T00:00:00,Adult,M01.060.116
19952617,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19952617,2009-12-01T00:00:00,Intestinal Fistula,C06.267.550
19952617,2009-12-01T00:00:00,Intestinal Fistula,C06.405.469.471
19952617,2009-12-01T00:00:00,Intestinal Fistula,C23.300.575.185.550
19952617,2009-12-01T00:00:00,Negative-Pressure Wound Therapy,E02.309.610
19952617,2009-12-01T00:00:00,Negative-Pressure Wound Therapy,E04.237.444
19952617,2009-12-01T00:00:00,Quality of Life,I01.800
19952617,2009-12-01T00:00:00,Quality of Life,K01.752.400.750
19952617,2009-12-01T00:00:00,Reconstructive Surgical Procedures,E04.680
19952617,2009-12-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19952617,2009-12-01T00:00:00,Risk Assessment,N04.452.871.715
19952617,2009-12-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19952617,2009-12-01T00:00:00,Risk Assessment,N06.850.505.715
19952617,2009-12-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19952617,2009-12-01T00:00:00,Treatment Outcome,E01.789.800
19952617,2009-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19952617,2009-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19952617,2009-12-01T00:00:00,Wound Healing,G16.100.856.891
19955550,2009-12-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
19955550,2009-12-01T00:00:00,Body Mass Index,E05.041.124.125
19955550,2009-12-01T00:00:00,Body Mass Index,G07.100.100.125
19955550,2009-12-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
19955550,2009-12-01T00:00:00,Body Weight,C23.888.144
19955550,2009-12-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
19955550,2009-12-01T00:00:00,Body Weight,E05.041.124.160.750
19955550,2009-12-01T00:00:00,Body Weight,G07.100.100.160.120
19955550,2009-12-01T00:00:00,Body Weight,G07.700.320.249.314.120
19955550,2009-12-01T00:00:00,Endoscopy,E01.370.388.250
19955550,2009-12-01T00:00:00,Endoscopy,E04.800.250
19955550,2009-12-01T00:00:00,Enteral Nutrition,E02.421.360
19955550,2009-12-01T00:00:00,Enteral Nutrition,E02.642.500.360
19955550,2009-12-01T00:00:00,Gastrostomy,E04.210.496
19955550,2009-12-01T00:00:00,Gastrostomy,E04.579.408
19955550,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19955550,2009-12-01T00:00:00,"Intubation, Gastrointestinal",E05.497.412
19955550,2009-12-01T00:00:00,Jejunostomy,E04.210.338.523
19955550,2009-12-01T00:00:00,Jejunostomy,E04.579.338.523
19955550,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
19955550,2009-12-01T00:00:00,Obesity,C18.654.726.500
19955550,2009-12-01T00:00:00,Obesity,C23.888.144.699.500
19955550,2009-12-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19955550,2009-12-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19955550,2009-12-01T00:00:00,Treatment Outcome,E01.789.800
19955550,2009-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19955550,2009-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19955739,2009-12-01T00:00:00,Brain Ischemia,C10.228.140.300.150
19955739,2009-12-01T00:00:00,Brain Ischemia,C14.907.253.092
19955739,2009-12-01T00:00:00,Double-Blind Method,E05.318.780.300
19955739,2009-12-01T00:00:00,Double-Blind Method,E05.581.500.300
19955739,2009-12-01T00:00:00,Double-Blind Method,N05.715.360.780.320
19955739,2009-12-01T00:00:00,Double-Blind Method,N06.850.520.445.300
19955739,2009-12-01T00:00:00,Health Behavior,F01.145.488
19955739,2009-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19955739,2009-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19955739,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19955739,2009-12-01T00:00:00,Medication Adherence,F01.145.488.500.500
19955739,2009-12-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
19955739,2009-12-01T00:00:00,Myocardial Infarction,C14.280.647.500
19955739,2009-12-01T00:00:00,Myocardial Infarction,C14.907.585.500
19955739,2009-12-01T00:00:00,Prescription Drugs,D26.670
19955739,2009-12-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19955739,2009-12-01T00:00:00,Risk Assessment,N04.452.871.715
19955739,2009-12-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19955739,2009-12-01T00:00:00,Risk Assessment,N06.850.505.715
19955739,2009-12-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19955739,2009-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19955739,2009-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19955739,2009-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19955739,2009-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19955739,2009-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19955739,2009-12-01T00:00:00,Stroke,C10.228.140.300.775
19955739,2009-12-01T00:00:00,Stroke,C14.907.253.855
19955739,2009-12-01T00:00:00,Time Factors,G01.910.857
19955739,2009-12-01T00:00:00,Treatment Outcome,E01.789.800
19955739,2009-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19955739,2009-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19955739,2009-12-01T00:00:00,United States,Z01.107.567.875
19959673,2009-12-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19959673,2009-12-01T00:00:00,Clinical Trials as Topic,E05.337.250
19959673,2009-12-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19959673,2009-12-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19959673,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959673,2009-12-01T00:00:00,Risk Reduction Behavior,F01.145.699
19959673,2009-12-01T00:00:00,Smoking,F01.145.466.753
19959673,2009-12-01T00:00:00,Smoking Cessation,F01.145.940.700
19959673,2009-12-01T00:00:00,Tobacco Industry,J01.576.919
19959673,2009-12-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19959673,2009-12-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19959675,2009-12-01T00:00:00,Environmental Exposure,N06.850.460.350
19959675,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959675,2009-12-01T00:00:00,Smoking Cessation,F01.145.940.700
19959675,2009-12-01T00:00:00,Tobacco Industry,J01.576.919
19959675,2009-12-01T00:00:00,Tobacco Use Disorder,C21.739.912
19959675,2009-12-01T00:00:00,Tobacco Use Disorder,F03.900.912
19959676,2009-12-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19959676,2009-12-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19959676,2009-12-01T00:00:00,Clinical Trials as Topic,E05.337.250
19959676,2009-12-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19959676,2009-12-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19959676,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959676,2009-12-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19959676,2009-12-01T00:00:00,Risk Assessment,N04.452.871.715
19959676,2009-12-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19959676,2009-12-01T00:00:00,Risk Assessment,N06.850.505.715
19959676,2009-12-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19959676,2009-12-01T00:00:00,Smoking Cessation,F01.145.940.700
19959676,2009-12-01T00:00:00,Tobacco,B01.650.388.100.905.900
19959676,2009-12-01T00:00:00,Tobacco Use Disorder,C21.739.912
19959676,2009-12-01T00:00:00,Tobacco Use Disorder,F03.900.912
19959679,2009-12-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19959679,2009-12-01T00:00:00,Biological Assay,E05.091
19959679,2009-12-01T00:00:00,Environmental Exposure,N06.850.460.350
19959679,2009-12-01T00:00:00,Filtration,E05.196.454
19959679,2009-12-01T00:00:00,Filtration,G01.595.280
19959679,2009-12-01T00:00:00,Filtration,G02.149.767.600
19959679,2009-12-01T00:00:00,Filtration,G02.842.750.600
19959679,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959679,2009-12-01T00:00:00,Smoking,F01.145.466.753
19959679,2009-12-01T00:00:00,Tobacco Use Disorder,C21.739.912
19959679,2009-12-01T00:00:00,Tobacco Use Disorder,F03.900.912
19959680,2009-12-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
19959680,2009-12-01T00:00:00,Environmental Monitoring,N06.850.780.375
19959680,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959680,2009-12-01T00:00:00,Population Surveillance,E05.318.308.250.700
19959680,2009-12-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
19959680,2009-12-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
19959680,2009-12-01T00:00:00,Population Surveillance,N06.850.780.675
19959680,2009-12-01T00:00:00,Smoking Cessation,F01.145.940.700
19959680,2009-12-01T00:00:00,Tobacco,B01.650.388.100.905.900
19959680,2009-12-01T00:00:00,Tobacco Use Disorder,C21.739.912
19959680,2009-12-01T00:00:00,Tobacco Use Disorder,F03.900.912
19959680,2009-12-01T00:00:00,United States,Z01.107.567.875
19959685,2009-12-01T00:00:00,Adolescent,M01.060.057
19959685,2009-12-01T00:00:00,Adult,M01.060.116
19959685,2009-12-01T00:00:00,Aged,M01.060.116.100
19959685,2009-12-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19959685,2009-12-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19959685,2009-12-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19959685,2009-12-01T00:00:00,Child,M01.060.406
19959685,2009-12-01T00:00:00,Environmental Exposure,N06.850.460.350
19959685,2009-12-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19959685,2009-12-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19959685,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959685,2009-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19959685,2009-12-01T00:00:00,Lung Neoplasms,C08.381.540
19959685,2009-12-01T00:00:00,Lung Neoplasms,C08.785.520
19959685,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
19959685,2009-12-01T00:00:00,"Polymorphism, Genetic",G05.365.795
19959685,2009-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19959685,2009-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19959685,2009-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19959685,2009-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19959685,2009-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19959685,2009-12-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19959685,2009-12-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19961129,2009-12-01T00:00:00,Anxiety,F01.470.132
19961129,2009-12-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19961129,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19961129,2009-12-01T00:00:00,Patient Care Team,N04.590.715
19961129,2009-12-01T00:00:00,Primary Health Care,N04.590.233.727
19961129,2009-12-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19972637,2009-12-01T00:00:00,Aged,M01.060.116.100
19972637,2009-12-01T00:00:00,Aging,G07.700.320.124
19972637,2009-12-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19972637,2009-12-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
19972637,2009-12-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
19972637,2009-12-01T00:00:00,Electroencephalography,E01.370.376.300
19972637,2009-12-01T00:00:00,Electroencephalography,E01.370.405.245
19972637,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19972637,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
19972637,2009-12-01T00:00:00,Nortriptyline,D02.455.426.559.847.181.384.535
19972637,2009-12-01T00:00:00,Nortriptyline,D04.615.181.384.535
19972637,2009-12-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19972637,2009-12-01T00:00:00,Seizures,C10.228.140.490.631
19972637,2009-12-01T00:00:00,Seizures,C10.597.742
19972637,2009-12-01T00:00:00,Seizures,C23.888.592.742
19972637,2009-12-01T00:00:00,Sex Characteristics,G08.686.815
19999931,2009-12-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19999931,2009-12-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19999931,2009-12-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19999931,2009-12-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19999931,2009-12-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19999931,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19999931,2009-12-01T00:00:00,Laparoscopy,E01.370.388.250.520
19999931,2009-12-01T00:00:00,Laparoscopy,E04.800.250.520
19999931,2009-12-01T00:00:00,"Radiography, Interventional",E01.370.350.700.725
19999931,2009-12-01T00:00:00,"Radiography, Interventional",E02.148.694
19999931,2009-12-01T00:00:00,"Radiography, Interventional",E04.800.780
19999931,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19999931,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19999931,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19999931,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19999931,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20005347,2009-12-01T00:00:00,Animals,B01.050
20005347,2009-12-01T00:00:00,DNA Damage,C21.111
20005347,2009-12-01T00:00:00,DNA Damage,G05.355.180
20005347,2009-12-01T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
20005347,2009-12-01T00:00:00,Fatty Liver,C06.552.241
20005347,2009-12-01T00:00:00,Glutathione,D12.644.456.448
20005347,2009-12-01T00:00:00,Liver,A03.620
20005347,2009-12-01T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
20005347,2009-12-01T00:00:00,Mitochondrial Proteins,D12.776.575
20005347,2009-12-01T00:00:00,"RNA, Messenger",D13.444.735.544
20005347,2009-12-01T00:00:00,Reperfusion Injury,C14.907.725
20005347,2009-12-01T00:00:00,Reperfusion Injury,C23.550.767.877
20005354,2009-12-01T00:00:00,Adolescent,M01.060.057
20005354,2009-12-01T00:00:00,Adult,M01.060.116
20005354,2009-12-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
20005354,2009-12-01T00:00:00,Ethnic Groups,M01.686.754
20005354,2009-12-01T00:00:00,Ethnic Groups,N01.224.317
20005354,2009-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20005354,2009-12-01T00:00:00,Graft Rejection,G12.425.901.545.328
20005354,2009-12-01T00:00:00,Graft Survival,G12.425.901.545.340
20005354,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20005354,2009-12-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
20005354,2009-12-01T00:00:00,Kidney Transplantation,E02.870.500
20005354,2009-12-01T00:00:00,Kidney Transplantation,E04.936.450.485
20005354,2009-12-01T00:00:00,Kidney Transplantation,E04.950.774.400
20005354,2009-12-01T00:00:00,Living Donors,M01.898.656
20005354,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20009689,2009-12-01T00:00:00,"Financial Management, Hospital",N02.278.354.180
20009689,2009-12-01T00:00:00,"Financial Management, Hospital",N03.219.463.280
20009689,2009-12-01T00:00:00,"Financial Management, Hospital",N04.452.442.180
20009689,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20009689,2009-12-01T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.576.343.480
20009689,2009-12-01T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.710
20009689,2009-12-01T00:00:00,Medicare,N03.219.521.346.506.564.663
20009689,2009-12-01T00:00:00,Medicare,N03.219.521.576.343.840
20009689,2009-12-01T00:00:00,Medicare,N03.706.615.696
20009689,2009-12-01T00:00:00,Questionnaires,E05.318.308.750
20009689,2009-12-01T00:00:00,Questionnaires,L01.280.800
20009689,2009-12-01T00:00:00,Questionnaires,N05.715.360.300.695
20009689,2009-12-01T00:00:00,Questionnaires,N06.850.520.308.750
20009689,2009-12-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
20009689,2009-12-01T00:00:00,Trauma Centers,N02.421.297.195.480
20009689,2009-12-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
20009689,2009-12-01T00:00:00,United States,Z01.107.567.875
20009910,2009-12-01T00:00:00,Animals,B01.050
20009910,2009-12-01T00:00:00,Antineoplastic Agents,D27.505.954.248
20009910,2009-12-01T00:00:00,Apoptosis,G04.299.139.160
20009910,2009-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
20009910,2009-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
20009910,2009-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
20009910,2009-12-01T00:00:00,Cell Proliferation,G04.299.233.750
20009910,2009-12-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20009910,2009-12-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20009910,2009-12-01T00:00:00,Flow Cytometry,E05.200.500.386.350
20009910,2009-12-01T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
20009910,2009-12-01T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
20009910,2009-12-01T00:00:00,Homeodomain Proteins,D12.776.260.400
20009910,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20009910,2009-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20009910,2009-12-01T00:00:00,Lung Neoplasms,C08.381.540
20009910,2009-12-01T00:00:00,Lung Neoplasms,C08.785.520
20009910,2009-12-01T00:00:00,Pyridines,D03.383.725
20009910,2009-12-01T00:00:00,"RNA, Messenger",D13.444.735.544
20009910,2009-12-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20009910,2009-12-01T00:00:00,Repressor Proteins,D12.776.260.703
20009910,2009-12-01T00:00:00,Repressor Proteins,D12.776.930.700
20009910,2009-12-01T00:00:00,Transcription Factors,D12.776.930
20010158,2009-12-01T00:00:00,"Diagnosis, Differential",E01.171
20010158,2009-12-01T00:00:00,Gastrointestinal Tract,A03.556
20010158,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20010158,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20017856,2009-12-01T00:00:00,Animals,B01.050
20017856,2009-12-01T00:00:00,Anterior Cruciate Ligament,A02.513.514.100
20017856,2009-12-01T00:00:00,Anterior Cruciate Ligament,A02.835.583.512.100
20017856,2009-12-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
20017856,2009-12-01T00:00:00,Treatment Outcome,E01.789.800
20017856,2009-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20017856,2009-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20021533,2009-12-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20021533,2009-12-01T00:00:00,Blood Pressure,E01.370.600.875.249
20021533,2009-12-01T00:00:00,Blood Pressure,G09.330.380.076
20021533,2009-12-01T00:00:00,Cardiovascular Diseases,C14
20021533,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20021533,2009-12-01T00:00:00,Hypertension,C14.907.489
20021533,2009-12-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20021533,2009-12-01T00:00:00,Risk Assessment,N04.452.871.715
20021533,2009-12-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20021533,2009-12-01T00:00:00,Risk Assessment,N06.850.505.715
20021533,2009-12-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20021533,2009-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20021533,2009-12-01T00:00:00,Risk Factors,N05.715.350.200.700
20021533,2009-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20021533,2009-12-01T00:00:00,Risk Factors,N06.850.490.625.750
20021533,2009-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20042415,2009-12-01T00:00:00,"Accidents, Traffic",N06.850.135.392
20042415,2009-12-01T00:00:00,Blood Vessel Prosthesis,E07.695.110
20042415,2009-12-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
20042415,2009-12-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
20042415,2009-12-01T00:00:00,Child,M01.060.406
20042415,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20042415,2009-12-01T00:00:00,Prosthesis Design,E05.320.550
20042415,2009-12-01T00:00:00,Prosthesis Design,E07.695.680
20042415,2009-12-01T00:00:00,Stents,E07.695.750
20042415,2009-12-01T00:00:00,Time Factors,G01.910.857
20042415,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20042415,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20042415,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20042415,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20042415,2009-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20042415,2009-12-01T00:00:00,Treatment Outcome,E01.789.800
20042415,2009-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20042415,2009-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20042415,2009-12-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
20055063,2009-12-01T00:00:00,Combat Disorders,F03.080.931.249
20055063,2009-12-01T00:00:00,Demography,I01.240
20055063,2009-12-01T00:00:00,Demography,N01.224
20055063,2009-12-01T00:00:00,Demography,N06.850.505.400
20055063,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20055063,2009-12-01T00:00:00,Interviews as Topic,E05.318.308.420
20055063,2009-12-01T00:00:00,Interviews as Topic,L01.280.520
20055063,2009-12-01T00:00:00,Interviews as Topic,N05.715.360.300.400
20055063,2009-12-01T00:00:00,Interviews as Topic,N06.850.520.308.420
20055063,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20055063,2009-12-01T00:00:00,Military Personnel,M01.526.625
20055063,2009-12-01T00:00:00,United States,Z01.107.567.875
20055063,2009-12-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
20055063,2009-12-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
20055063,2009-12-01T00:00:00,Veterans,M01.930
20083076,2009-12-01T00:00:00,Aged,M01.060.116.100
20083076,2009-12-01T00:00:00,Contrast Media,D27.720.259
20083076,2009-12-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20083076,2009-12-01T00:00:00,Coronary Angiography,E01.370.370.050.200
20083076,2009-12-01T00:00:00,Coronary Angiography,E01.370.370.380.200
20083076,2009-12-01T00:00:00,Femoral Artery,A07.231.114.351
20083076,2009-12-01T00:00:00,Heart Valve Diseases,C14.280.484
20083076,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20083076,2009-12-01T00:00:00,Peripheral Vascular Diseases,C14.907.617
20083076,2009-12-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.350.810.800
20083076,2009-12-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.600.350.700.810.800
20083076,2009-12-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.700.810.800
20083076,2009-12-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.810.810.800
20083076,2009-12-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.825.810.810.800
20104059,2009-12-01T00:00:00,Aging,G07.700.320.124
20104059,2009-12-01T00:00:00,Bipolar Disorder,F03.600.150.150
20104059,2009-12-01T00:00:00,Brain,A08.186.211
20104059,2009-12-01T00:00:00,"Brain Diseases, Metabolic",C10.228.140.163
20104059,2009-12-01T00:00:00,"Brain Diseases, Metabolic",C18.452.132
20104059,2009-12-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
20104059,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20104059,2009-12-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20104059,2009-12-01T00:00:00,Limbic System,A08.186.211.464
20104059,2009-12-01T00:00:00,Mental Recall,F02.463.425.540.641
20104059,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20104059,2009-12-01T00:00:00,Neuropsychological Tests,F04.711.513
20104059,2009-12-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
20104059,2009-12-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
20104059,2009-12-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
20104059,2009-12-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
20104059,2009-12-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
20104059,2009-12-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20104059,2009-12-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
20104059,2009-12-01T00:00:00,Verbal Learning,F02.463.425.952
20108705,2009-12-01T00:00:00,Biomedical Research,H01.770.644.145
20108705,2009-12-01T00:00:00,Diffusion of Innovation,L01.143.320
20108705,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108705,2009-12-01T00:00:00,Incidence,E05.318.308.985.525.375
20108705,2009-12-01T00:00:00,Incidence,L01.280.975.525.375
20108705,2009-12-01T00:00:00,Incidence,N01.224.935.597.500
20108705,2009-12-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20108705,2009-12-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20108705,2009-12-01T00:00:00,Mass Screening,E01.370.500
20108705,2009-12-01T00:00:00,Mass Screening,E05.318.308.250.580
20108705,2009-12-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20108705,2009-12-01T00:00:00,Mass Screening,N02.421.726.233.443
20108705,2009-12-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20108705,2009-12-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20108705,2009-12-01T00:00:00,Mass Screening,N06.850.780.500
20108705,2009-12-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
20108705,2009-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20108705,2009-12-01T00:00:00,Risk Factors,N05.715.350.200.700
20108705,2009-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20108705,2009-12-01T00:00:00,Risk Factors,N06.850.490.625.750
20108705,2009-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20108705,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20108705,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20108705,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20108705,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20108705,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20108705,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20108706,2009-12-01T00:00:00,Adolescent,M01.060.057
20108706,2009-12-01T00:00:00,Adult,M01.060.116
20108706,2009-12-01T00:00:00,Aged,M01.060.116.100
20108706,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108706,2009-12-01T00:00:00,Incidence,E05.318.308.985.525.375
20108706,2009-12-01T00:00:00,Incidence,L01.280.975.525.375
20108706,2009-12-01T00:00:00,Incidence,N01.224.935.597.500
20108706,2009-12-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20108706,2009-12-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20108706,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20108706,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20108706,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20108706,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20108706,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20108706,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20108706,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20108707,2009-12-01T00:00:00,Health Promotion,N02.370
20108707,2009-12-01T00:00:00,Health Promotion,N02.421.726.507
20108707,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108707,2009-12-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
20108707,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20108707,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20108707,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20108707,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20108707,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20108707,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20108710,2009-12-01T00:00:00,Adult,M01.060.116
20108710,2009-12-01T00:00:00,African Americans,M01.686.508.100.100
20108710,2009-12-01T00:00:00,African Americans,M01.686.754.100
20108710,2009-12-01T00:00:00,Aged,M01.060.116.100
20108710,2009-12-01T00:00:00,Demography,I01.240
20108710,2009-12-01T00:00:00,Demography,N01.224
20108710,2009-12-01T00:00:00,Demography,N06.850.505.400
20108710,2009-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20108710,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108710,2009-12-01T00:00:00,Incidence,E05.318.308.985.525.375
20108710,2009-12-01T00:00:00,Incidence,L01.280.975.525.375
20108710,2009-12-01T00:00:00,Incidence,N01.224.935.597.500
20108710,2009-12-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20108710,2009-12-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20108710,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20108710,2009-12-01T00:00:00,Neoplasm Staging,E01.370.550
20108710,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20108710,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20108710,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20108710,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20108710,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20108710,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20108715,2009-12-01T00:00:00,Adolescent,M01.060.057
20108715,2009-12-01T00:00:00,Adult,M01.060.116
20108715,2009-12-01T00:00:00,Aged,M01.060.116.100
20108715,2009-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20108715,2009-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20108715,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108715,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20108715,2009-12-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
20108715,2009-12-01T00:00:00,Questionnaires,E05.318.308.750
20108715,2009-12-01T00:00:00,Questionnaires,L01.280.800
20108715,2009-12-01T00:00:00,Questionnaires,N05.715.360.300.695
20108715,2009-12-01T00:00:00,Questionnaires,N06.850.520.308.750
20108715,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20108715,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20108715,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20108715,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20108715,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20108715,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20108716,2009-12-01T00:00:00,Adolescent,M01.060.057
20108716,2009-12-01T00:00:00,Cervical Intraepithelial Neoplasia,C04.557.470.200.240.250
20108716,2009-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20108716,2009-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20108716,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108716,2009-12-01T00:00:00,Interviews as Topic,E05.318.308.420
20108716,2009-12-01T00:00:00,Interviews as Topic,L01.280.520
20108716,2009-12-01T00:00:00,Interviews as Topic,N05.715.360.300.400
20108716,2009-12-01T00:00:00,Interviews as Topic,N06.850.520.308.420
20108716,2009-12-01T00:00:00,Papillomavirus Infections,C02.256.650
20108716,2009-12-01T00:00:00,Papillomavirus Infections,C02.928.725
20108716,2009-12-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
20108716,2009-12-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
20108716,2009-12-01T00:00:00,Physician-Patient Relations,N05.300.660.625
20108716,2009-12-01T00:00:00,Questionnaires,E05.318.308.750
20108716,2009-12-01T00:00:00,Questionnaires,L01.280.800
20108716,2009-12-01T00:00:00,Questionnaires,N05.715.360.300.695
20108716,2009-12-01T00:00:00,Questionnaires,N06.850.520.308.750
20108716,2009-12-01T00:00:00,Young Adult,M01.060.116.815
20108720,2009-12-01T00:00:00,African Americans,M01.686.508.100.100
20108720,2009-12-01T00:00:00,African Americans,M01.686.754.100
20108720,2009-12-01T00:00:00,Community Networks,I01.880.656.300
20108720,2009-12-01T00:00:00,Community Networks,L01.700.508.300.184
20108720,2009-12-01T00:00:00,Community Networks,N02.421.143.202
20108720,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108720,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20108720,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20108720,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20108720,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20108720,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20108720,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20108724,2009-12-01T00:00:00,Adult,M01.060.116
20108724,2009-12-01T00:00:00,Community Networks,I01.880.656.300
20108724,2009-12-01T00:00:00,Community Networks,L01.700.508.300.184
20108724,2009-12-01T00:00:00,Community Networks,N02.421.143.202
20108724,2009-12-01T00:00:00,Health Promotion,N02.370
20108724,2009-12-01T00:00:00,Health Promotion,N02.421.726.507
20108724,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108724,2009-12-01T00:00:00,Incidence,E05.318.308.985.525.375
20108724,2009-12-01T00:00:00,Incidence,L01.280.975.525.375
20108724,2009-12-01T00:00:00,Incidence,N01.224.935.597.500
20108724,2009-12-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20108724,2009-12-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20108724,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20108724,2009-12-01T00:00:00,Organizational Objectives,N04.452.615
20108724,2009-12-01T00:00:00,Papillomavirus Infections,C02.256.650
20108724,2009-12-01T00:00:00,Papillomavirus Infections,C02.928.725
20108724,2009-12-01T00:00:00,Program Evaluation,E05.337.820
20108724,2009-12-01T00:00:00,Program Evaluation,N04.761.685
20108724,2009-12-01T00:00:00,Program Evaluation,N05.715.360.650
20108724,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20108724,2009-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20108724,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20108724,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20108724,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20108724,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20108725,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20108725,2009-12-01T00:00:00,Papillomavirus Infections,C02.256.650
20108725,2009-12-01T00:00:00,Papillomavirus Infections,C02.928.725
20108725,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20108725,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20108725,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20108725,2009-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20126488,2009-12-01T00:00:00,Adolescent,M01.060.057
20126488,2009-12-01T00:00:00,Aging,G07.700.320.124
20126488,2009-12-01T00:00:00,Child,M01.060.406
20126488,2009-12-01T00:00:00,Eye,A01.456.505.420
20126488,2009-12-01T00:00:00,Eye,A09.371
20126488,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20126488,2009-12-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
20126488,2009-12-01T00:00:00,"Lenses, Intraocular",E07.632.500.460
20126488,2009-12-01T00:00:00,"Lenses, Intraocular",E07.695.460
20201481,2009-12-01T00:00:00,Anticoagulants,D27.505.954.502.119
20201481,2009-12-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
20201481,2009-12-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
20201481,2009-12-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
20201481,2009-12-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
20201481,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20201481,2009-12-01T00:00:00,Postoperative Complications,C23.550.767
20201481,2009-12-01T00:00:00,Primary Prevention,N02.421.726.758
20201481,2009-12-01T00:00:00,Primary Prevention,N06.850.780.680
20201481,2009-12-01T00:00:00,Pulmonary Embolism,C08.381.746
20201481,2009-12-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
20201481,2009-12-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20201481,2009-12-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20201481,2009-12-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20201481,2009-12-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20201481,2009-12-01T00:00:00,Thrombin,D08.811.277.656.300.760.855
20201481,2009-12-01T00:00:00,Thrombin,D08.811.277.656.959.350.855
20201481,2009-12-01T00:00:00,Thrombin,D12.776.124.125.890
20201481,2009-12-01T00:00:00,Thrombin,D23.119.960
20201481,2009-12-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
20364722,2009-12-01T00:00:00,African Americans,M01.686.508.100.100
20364722,2009-12-01T00:00:00,African Americans,M01.686.754.100
20364722,2009-12-01T00:00:00,Attitude to Health,F01.100.150
20364722,2009-12-01T00:00:00,Attitude to Health,N05.300.150
20364722,2009-12-01T00:00:00,Clinical Competence,I02.399.630.210
20364722,2009-12-01T00:00:00,Clinical Competence,N04.761.210
20364722,2009-12-01T00:00:00,Genetic Counseling,H01.158.273.343.315.384
20364722,2009-12-01T00:00:00,Genetic Counseling,N02.421.308.400
20364722,2009-12-01T00:00:00,Genetic Testing,E01.370.427
20364722,2009-12-01T00:00:00,Genetic Testing,E05.393.435
20364722,2009-12-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
20364722,2009-12-01T00:00:00,Genetic Testing,N02.421.308.430
20364722,2009-12-01T00:00:00,Genomics,H01.158.273.180.350
20364722,2009-12-01T00:00:00,Genomics,H01.158.273.343.350
20364722,2009-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20364722,2009-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20364722,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20364722,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20364722,2009-12-01T00:00:00,Needs Assessment,I02.594
20364722,2009-12-01T00:00:00,Needs Assessment,N03.349.380.565
20364722,2009-12-01T00:00:00,Needs Assessment,N05.300.537
20364722,2009-12-01T00:00:00,Pilot Projects,E05.318.760.750
20364722,2009-12-01T00:00:00,Pilot Projects,E05.337.737
20364722,2009-12-01T00:00:00,Pilot Projects,N05.715.360.775.625
20364722,2009-12-01T00:00:00,Pilot Projects,N06.850.520.450.720
20364722,2009-12-01T00:00:00,Questionnaires,E05.318.308.750
20364722,2009-12-01T00:00:00,Questionnaires,L01.280.800
20364722,2009-12-01T00:00:00,Questionnaires,N05.715.360.300.695
20364722,2009-12-01T00:00:00,Questionnaires,N06.850.520.308.750
20364722,2009-12-01T00:00:00,United States,Z01.107.567.875
20369149,2009-12-01T00:00:00,Gastroplasty,E02.065.062.750
20369149,2009-12-01T00:00:00,Gastroplasty,E04.062.750
20369149,2009-12-01T00:00:00,Gastroplasty,E04.210.485
20369149,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20369149,2009-12-01T00:00:00,Laparoscopy,E01.370.388.250.520
20369149,2009-12-01T00:00:00,Laparoscopy,E04.800.250.520
20369149,2009-12-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
20369149,2009-12-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
20369149,2009-12-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
20369149,2009-12-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
20369149,2009-12-01T00:00:00,Postoperative Complications,C23.550.767
20369149,2009-12-01T00:00:00,Treatment Outcome,E01.789.800
20369149,2009-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20369149,2009-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20369149,2009-12-01T00:00:00,Weight Loss,C23.888.144.243.963
20369149,2009-12-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20516268,2009-12-01T00:00:00,Aged,M01.060.116.100
20516268,2009-12-01T00:00:00,Alleles,G05.360.340.024.340.030
20516268,2009-12-01T00:00:00,Calcium,D01.268.552.100
20516268,2009-12-01T00:00:00,Calcium,D01.552.539.288
20516268,2009-12-01T00:00:00,Calcium,D23.119.100
20516268,2009-12-01T00:00:00,Cholecalciferol,D04.808.247.222.159
20516268,2009-12-01T00:00:00,Cholecalciferol,D04.808.247.808.146
20516268,2009-12-01T00:00:00,Cholecalciferol,D04.808.812.768.196
20516268,2009-12-01T00:00:00,Cholecalciferol,D10.570.938.146
20516268,2009-12-01T00:00:00,Dietary Supplements,J02.500.456
20516268,2009-12-01T00:00:00,Double-Blind Method,E05.318.780.300
20516268,2009-12-01T00:00:00,Double-Blind Method,E05.581.500.300
20516268,2009-12-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20516268,2009-12-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20516268,2009-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20516268,2009-12-01T00:00:00,Medication Adherence,F01.145.488.500.500
20516268,2009-12-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
20516268,2009-12-01T00:00:00,Middle Aged,M01.060.116.630
20516268,2009-12-01T00:00:00,Pilot Projects,E05.318.760.750
20516268,2009-12-01T00:00:00,Pilot Projects,E05.337.737
20516268,2009-12-01T00:00:00,Pilot Projects,N05.715.360.775.625
20516268,2009-12-01T00:00:00,Pilot Projects,N06.850.520.450.720
20516268,2009-12-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20516268,2009-12-01T00:00:00,Questionnaires,E05.318.308.750
20516268,2009-12-01T00:00:00,Questionnaires,L01.280.800
20516268,2009-12-01T00:00:00,Questionnaires,N05.715.360.300.695
20516268,2009-12-01T00:00:00,Questionnaires,N06.850.520.308.750
20516268,2009-12-01T00:00:00,Treatment Outcome,E01.789.800
20516268,2009-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20516268,2009-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20516268,2009-12-01T00:00:00,Vitamin D,D04.808.812.768
19957106,2009-12-02T00:00:00,Adolescent,M01.060.057
19957106,2009-12-02T00:00:00,Attention Deficit and Disruptive Behavior Disorders,F03.550.150
19957106,2009-12-02T00:00:00,Child,M01.060.406
19957106,2009-12-02T00:00:00,Child Abuse,I01.198.240.856.350.250
19957106,2009-12-02T00:00:00,Child Abuse,I01.880.735.900.350.250
19957106,2009-12-02T00:00:00,Child Abuse,I01.880.787.293.292
19957106,2009-12-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19957106,2009-12-02T00:00:00,"Interview, Psychological",F04.669.599
19957106,2009-12-02T00:00:00,Life Change Events,F01.829.458.410
19957106,2009-12-02T00:00:00,Psychotherapy,F04.754
19957106,2009-12-02T00:00:00,Questionnaires,E05.318.308.750
19957106,2009-12-02T00:00:00,Questionnaires,L01.280.800
19957106,2009-12-02T00:00:00,Questionnaires,N05.715.360.300.695
19957106,2009-12-02T00:00:00,Questionnaires,N06.850.520.308.750
19957106,2009-12-02T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19959570,2009-12-03T00:00:00,Adult,M01.060.116
19959570,2009-12-03T00:00:00,Aged,M01.060.116.100
19959570,2009-12-03T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19959570,2009-12-03T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19959570,2009-12-03T00:00:00,Health Policy,I01.880.604.825.608.400
19959570,2009-12-03T00:00:00,Health Policy,N03.706.825.608.428
19959570,2009-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959570,2009-12-03T00:00:00,Middle Aged,M01.060.116.630
19959570,2009-12-03T00:00:00,New York,Z01.107.567.875.075.437
19959570,2009-12-03T00:00:00,New York,Z01.107.567.875.350.530
19959570,2009-12-03T00:00:00,New York,Z01.107.567.875.500.530
19959570,2009-12-03T00:00:00,Private Sector,I01.791
19959570,2009-12-03T00:00:00,Private Sector,N04.452.633.390
19959570,2009-12-03T00:00:00,Questionnaires,E05.318.308.750
19959570,2009-12-03T00:00:00,Questionnaires,L01.280.800
19959570,2009-12-03T00:00:00,Questionnaires,N05.715.360.300.695
19959570,2009-12-03T00:00:00,Questionnaires,N06.850.520.308.750
19959570,2009-12-03T00:00:00,Smoking Cessation,F01.145.940.700
19959570,2009-12-03T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
19959570,2009-12-03T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19962125,2009-12-03T00:00:00,Adult,M01.060.116
19962125,2009-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19962125,2009-12-03T00:00:00,Methotrexate,D03.438.733.631.192.500
19962125,2009-12-03T00:00:00,Pregnancy,G08.686.785.760.769
19962125,2009-12-03T00:00:00,"Pregnancy, Ectopic",C13.703.733
19962194,2009-12-03T00:00:00,Animals,B01.050
19962194,2009-12-03T00:00:00,Bacteria,B03
19962194,2009-12-03T00:00:00,Gene Expression Profiling,E05.393.332
19962194,2009-12-03T00:00:00,Gene Expression Regulation,G05.355.315
19962194,2009-12-03T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19962194,2009-12-03T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19962194,2009-12-03T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19962194,2009-12-03T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19962194,2009-12-03T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19962194,2009-12-03T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19962194,2009-12-03T00:00:00,"RNA, Messenger",D13.444.735.544
19962194,2009-12-03T00:00:00,"Stress, Physiological",G07.700.830
19962194,2009-12-03T00:00:00,Time Factors,G01.910.857
19962194,2009-12-03T00:00:00,"Transcription, Genetic",G02.111.087.847
19962194,2009-12-03T00:00:00,"Transcription, Genetic",G02.149.115.847
19962194,2009-12-03T00:00:00,"Transcription, Genetic",G05.355.310.700
19923889,2009-12-05T00:00:00,Animals,B01.050
19923889,2009-12-05T00:00:00,Glutathione,D12.644.456.448
19923889,2009-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19923889,2009-12-05T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
19923889,2009-12-05T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
19923889,2009-12-05T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
19923889,2009-12-05T00:00:00,Peroxidases,D08.811.682.732
19923889,2009-12-05T00:00:00,Peroxiredoxins,D08.811.682.732.850
19923889,2009-12-05T00:00:00,Signal Transduction,G02.111.087.800
19923889,2009-12-05T00:00:00,Signal Transduction,G02.149.115.800
19923889,2009-12-05T00:00:00,Signal Transduction,G04.299.880
19923889,2009-12-05T00:00:00,Thioredoxins,D12.776.915
19963400,2009-12-05T00:00:00,Adult,M01.060.116
19963400,2009-12-05T00:00:00,Aged,M01.060.116.100
19963400,2009-12-05T00:00:00,Bone Plates,E07.695.125
19963400,2009-12-05T00:00:00,Bone Plates,E07.858.442.660.110
19963400,2009-12-05T00:00:00,Bone Plates,E07.858.690.650.110
19963400,2009-12-05T00:00:00,"Fracture Fixation, Internal",E04.555.300.300
19963400,2009-12-05T00:00:00,Fracture Healing,G16.100.856.891.500
19963400,2009-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19963400,2009-12-05T00:00:00,Middle Aged,M01.060.116.630
19963400,2009-12-05T00:00:00,Prosthesis Design,E05.320.550
19963400,2009-12-05T00:00:00,Prosthesis Design,E07.695.680
19963400,2009-12-05T00:00:00,Treatment Outcome,E01.789.800
19963400,2009-12-05T00:00:00,Treatment Outcome,N04.761.559.590.800
19963400,2009-12-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20036354,2009-12-05T00:00:00,Animals,B01.050
20036354,2009-12-05T00:00:00,Antigen Presentation,G12.425.107
20036354,2009-12-05T00:00:00,Antigen Presentation,G12.450.050.400.070
20036354,2009-12-05T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
20036354,2009-12-05T00:00:00,Cyclophosphamide,D02.705.670.243
20036354,2009-12-05T00:00:00,Dendritic Cells,A11.066.270
20036354,2009-12-05T00:00:00,Dendritic Cells,A11.436.270
20036354,2009-12-05T00:00:00,Dendritic Cells,A15.382.066.270
20036354,2009-12-05T00:00:00,Dendritic Cells,A15.382.812.260
20036354,2009-12-05T00:00:00,Stem Cells,A11.872
20036354,2009-12-05T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
20036354,2009-12-05T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
20036354,2009-12-05T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
20036354,2009-12-05T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
20036354,2009-12-05T00:00:00,Transplantation Conditioning,E02.095.465.425.450.800
20036354,2009-12-05T00:00:00,Transplantation Conditioning,E05.478.610.800
19969479,2009-12-06T00:00:00,Child,M01.060.406
19969479,2009-12-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19969479,2009-12-06T00:00:00,Lip,A01.456.505.631.515
19969479,2009-12-06T00:00:00,Lip,A14.549.336
19969479,2009-12-06T00:00:00,Lip Diseases,C07.465.409
19969479,2009-12-06T00:00:00,Mouth Mucosa,A10.615.550.599
19969479,2009-12-06T00:00:00,Mouth Mucosa,A14.549.512
19969479,2009-12-06T00:00:00,Mucocele,C04.182.511
19958968,2009-12-08T00:00:00,Animals,B01.050
19958968,2009-12-08T00:00:00,Aortic Valve,A07.541.510.110
19958968,2009-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19996146,2009-12-08T00:00:00,Adult,M01.060.116
19996146,2009-12-08T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19996146,2009-12-08T00:00:00,Conditioning (Psychology),F02.463.425.179
19996146,2009-12-08T00:00:00,Cues,F02.463.425.234
19996146,2009-12-08T00:00:00,Ganglionic Stimulants,D27.505.696.663.050.400
19996146,2009-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19996146,2009-12-08T00:00:00,Nicotine,D03.132.760.570
19996146,2009-12-08T00:00:00,Nicotine,D03.383.725.518
19996146,2009-12-08T00:00:00,Smoking,F01.145.466.753
19996146,2009-12-08T00:00:00,Young Adult,M01.060.116.815
19996612,2009-12-09T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19996612,2009-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19996612,2009-12-09T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
19996612,2009-12-09T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
19996612,2009-12-09T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
19996612,2009-12-09T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
19996612,2009-12-09T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
19996612,2009-12-09T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19996612,2009-12-09T00:00:00,Risk Reduction Behavior,F01.145.699
19996612,2009-12-09T00:00:00,Stroke,C10.228.140.300.775
19996612,2009-12-09T00:00:00,Stroke,C14.907.253.855
19997124,2009-12-09T00:00:00,Animals,B01.050
19997124,2009-12-09T00:00:00,"Behavior, Animal",F01.145.113
19997124,2009-12-09T00:00:00,"Models, Biological",E05.599.395
20004503,2009-12-09T00:00:00,Adult,M01.060.116
20004503,2009-12-09T00:00:00,Back,A01.176
20004503,2009-12-09T00:00:00,Equipment Failure Analysis,E05.325.192
20004503,2009-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20004503,2009-12-09T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
20004503,2009-12-09T00:00:00,Middle Aged,M01.060.116.630
20004503,2009-12-09T00:00:00,Orthotic Devices,E07.858.442.743
20004503,2009-12-09T00:00:00,Prosthesis Design,E05.320.550
20004503,2009-12-09T00:00:00,Prosthesis Design,E07.695.680
20004503,2009-12-09T00:00:00,Young Adult,M01.060.116.815
20004523,2009-12-09T00:00:00,Adult,M01.060.116
20004523,2009-12-09T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20004523,2009-12-09T00:00:00,Cocaine-Related Disorders,C21.739.300
20004523,2009-12-09T00:00:00,Cocaine-Related Disorders,F03.900.300
20004523,2009-12-09T00:00:00,Cues,F02.463.425.234
20004523,2009-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20004523,2009-12-09T00:00:00,Hydrocortisone,D04.808.745.745.654.600
20004523,2009-12-09T00:00:00,Hydrocortisone,D06.472.040.585.353.476
20004523,2009-12-09T00:00:00,Hydrocortisone,D06.472.040.585.478.392
20004523,2009-12-09T00:00:00,Sex Characteristics,G08.686.815
20004523,2009-12-09T00:00:00,"Stress, Psychological",F01.145.126.990
20004523,2009-12-09T00:00:00,"Stress, Psychological",F02.830.900
20007485,2009-12-09T00:00:00,Animals,B01.050
20007485,2009-12-09T00:00:00,Cell Movement,G04.299.283
20007485,2009-12-09T00:00:00,Cell Movement,G07.700.560.500.180
20007485,2009-12-09T00:00:00,Collagen,D05.750.078.280
20007485,2009-12-09T00:00:00,Collagen,D12.776.860.300.250
20007485,2009-12-09T00:00:00,"Disease Models, Animal",C22.232
20007485,2009-12-09T00:00:00,"Disease Models, Animal",E05.598.500
20007485,2009-12-09T00:00:00,"Disease Models, Animal",E05.599.395.080
20007485,2009-12-09T00:00:00,Extracellular Matrix,A11.284.295.310
20007485,2009-12-09T00:00:00,Neoplasm Invasiveness,C04.697.645
20007485,2009-12-09T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20007485,2009-12-09T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
20007485,2009-12-09T00:00:00,Osteonectin,D12.776.157.125.715
20007485,2009-12-09T00:00:00,Osteonectin,D12.776.395.600
20007485,2009-12-09T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20007485,2009-12-09T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20007485,2009-12-09T00:00:00,Pancreatic Neoplasms,C06.301.761
20007485,2009-12-09T00:00:00,Pancreatic Neoplasms,C06.689.667
20007485,2009-12-09T00:00:00,Pancreatic Neoplasms,C19.344.421
20007485,2009-12-09T00:00:00,Perfusion,E05.680
20007485,2009-12-09T00:00:00,Phenotype,G05.695
20007501,2009-12-09T00:00:00,Adult,M01.060.116
20007501,2009-12-09T00:00:00,Aged,M01.060.116.100
20007501,2009-12-09T00:00:00,Computer Simulation,L01.224.160
20007501,2009-12-09T00:00:00,"Gait Disorders, Neurologic",C10.597.404
20007501,2009-12-09T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
20007501,2009-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20007501,2009-12-09T00:00:00,Leg,A01.378.610.500
20007501,2009-12-09T00:00:00,Middle Aged,M01.060.116.630
20007501,2009-12-09T00:00:00,"Models, Neurological",E05.599.395.642
20007501,2009-12-09T00:00:00,Muscle Contraction,G11.427.590.540
20007501,2009-12-09T00:00:00,"Muscle, Skeletal",A02.633.567
20007501,2009-12-09T00:00:00,"Muscle, Skeletal",A10.690.552.500
20007501,2009-12-09T00:00:00,Postural Balance,G11.427.690
20007501,2009-12-09T00:00:00,Postural Balance,G11.561.600.810.541.595
20007501,2009-12-09T00:00:00,Recovery of Function,G16.757
20007501,2009-12-09T00:00:00,Stroke,C10.228.140.300.775
20007501,2009-12-09T00:00:00,Stroke,C14.907.253.855
20007501,2009-12-09T00:00:00,Task Performance and Analysis,F02.784.412.846
20007501,2009-12-09T00:00:00,Task Performance and Analysis,F02.784.692.746
20007501,2009-12-09T00:00:00,Task Performance and Analysis,F02.808.600
20010552,2009-12-09T00:00:00,Adolescent,M01.060.057
20010552,2009-12-09T00:00:00,Adult,M01.060.116
20010552,2009-12-09T00:00:00,Amidohydrolases,D08.811.277.087
20010552,2009-12-09T00:00:00,Brain,A08.186.211
20010552,2009-12-09T00:00:00,Brain Mapping,E01.370.350.086
20010552,2009-12-09T00:00:00,Brain Mapping,E01.370.376.149
20010552,2009-12-09T00:00:00,Brain Mapping,E05.132
20010552,2009-12-09T00:00:00,Cannabinoids,D02.455.849.090
20010552,2009-12-09T00:00:00,Cues,F02.463.425.234
20010552,2009-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20010552,2009-12-09T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20010552,2009-12-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20010552,2009-12-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20010552,2009-12-09T00:00:00,Marijuana Abuse,C21.739.635
20010552,2009-12-09T00:00:00,Marijuana Abuse,F03.900.635
20010552,2009-12-09T00:00:00,Middle Aged,M01.060.116.630
20010552,2009-12-09T00:00:00,Oxygen,D01.268.185.550
20010552,2009-12-09T00:00:00,Oxygen,D01.362.670
20010552,2009-12-09T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20010552,2009-12-09T00:00:00,"Receptor, Cannabinoid, CB1",D12.776.543.750.100.125.100
20010552,2009-12-09T00:00:00,Young Adult,M01.060.116.815
19954244,2009-12-10T00:00:00,"Chemistry, Pharmaceutical",H01.158.703.007
19954244,2009-12-10T00:00:00,"Chemistry, Pharmaceutical",H01.181.466
19954244,2009-12-10T00:00:00,Demography,I01.240
19954244,2009-12-10T00:00:00,Demography,N01.224
19954244,2009-12-10T00:00:00,Demography,N06.850.505.400
19954244,2009-12-10T00:00:00,"History, 19th Century",K01.400.504.937
19954244,2009-12-10T00:00:00,"History, 20th Century",K01.400.504.968
19954244,2009-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19954244,2009-12-10T00:00:00,Internationality,I01.615
19954244,2009-12-10T00:00:00,Internet,L01.224.230.110.500
19954244,2009-12-10T00:00:00,United States,Z01.107.567.875
20007708,2009-12-10T00:00:00,Adipocytes,A11.329.114
20007708,2009-12-10T00:00:00,Antibodies,D12.776.124.486.485.114
20007708,2009-12-10T00:00:00,Antibodies,D12.776.124.790.651.114
20007708,2009-12-10T00:00:00,Antibodies,D12.776.377.715.548.114
20007708,2009-12-10T00:00:00,Gene Expression,G05.355.310
20007708,2009-12-10T00:00:00,Glucose,D09.546.359.448
20007708,2009-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20007708,2009-12-10T00:00:00,Interleukin-6,D12.644.276.374.465.506
20007708,2009-12-10T00:00:00,Interleukin-6,D12.776.467.374.465.506
20007708,2009-12-10T00:00:00,Interleukin-6,D23.529.374.465.506
20007708,2009-12-10T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
20007708,2009-12-10T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
20007708,2009-12-10T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
20007708,2009-12-10T00:00:00,Lipopolysaccharides,D09.400.500
20007708,2009-12-10T00:00:00,Lipopolysaccharides,D09.698.718.450
20007708,2009-12-10T00:00:00,Lipopolysaccharides,D10.494
20007708,2009-12-10T00:00:00,Lipopolysaccharides,D23.050.161.616.525
20007708,2009-12-10T00:00:00,Lipopolysaccharides,D23.946.123.329.500
20007708,2009-12-10T00:00:00,Pyridines,D03.383.725
20007708,2009-12-10T00:00:00,RNA Interference,G05.355.315.203.374.790
20007708,2009-12-10T00:00:00,Recombinant Proteins,D12.776.828
20007708,2009-12-10T00:00:00,Signal Transduction,G02.111.087.800
20007708,2009-12-10T00:00:00,Signal Transduction,G02.149.115.800
20007708,2009-12-10T00:00:00,Signal Transduction,G04.299.880
20007708,2009-12-10T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
20007708,2009-12-10T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
20007708,2009-12-10T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
20007708,2009-12-10T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
20007708,2009-12-10T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
20004389,2009-12-11T00:00:00,Adult,M01.060.116
20004389,2009-12-11T00:00:00,Body Mass Index,E01.370.600.115.100.125
20004389,2009-12-11T00:00:00,Body Mass Index,E05.041.124.125
20004389,2009-12-11T00:00:00,Body Mass Index,G07.100.100.125
20004389,2009-12-11T00:00:00,Body Mass Index,N06.850.505.200.100.175
20004389,2009-12-11T00:00:00,Body Weight,C23.888.144
20004389,2009-12-11T00:00:00,Body Weight,E01.370.600.115.100.160.120
20004389,2009-12-11T00:00:00,Body Weight,E05.041.124.160.750
20004389,2009-12-11T00:00:00,Body Weight,G07.100.100.160.120
20004389,2009-12-11T00:00:00,Body Weight,G07.700.320.249.314.120
20004389,2009-12-11T00:00:00,Case-Control Studies,E05.318.760.500.500
20004389,2009-12-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20004389,2009-12-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20004389,2009-12-11T00:00:00,Estradiol,D04.808.365.415.248
20004389,2009-12-11T00:00:00,Estradiol,D06.472.334.851.437.500
20004389,2009-12-11T00:00:00,Gastric Bypass,E02.065.062.249
20004389,2009-12-11T00:00:00,Gastric Bypass,E04.035.398.385
20004389,2009-12-11T00:00:00,Gastric Bypass,E04.062.249
20004389,2009-12-11T00:00:00,Gastric Bypass,E04.210.457.430
20004389,2009-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20004389,2009-12-11T00:00:00,Middle Aged,M01.060.116.630
20004389,2009-12-11T00:00:00,Obesity,C18.654.726.500
20004389,2009-12-11T00:00:00,Obesity,C23.888.144.699.500
20004389,2009-12-11T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20004389,2009-12-11T00:00:00,Obesity,G07.100.100.160.120.699.500
20004389,2009-12-11T00:00:00,"Polymorphism, Genetic",G05.365.795
20008277,2009-12-11T00:00:00,Aging,G07.700.320.124
20008277,2009-12-11T00:00:00,Animals,B01.050
20008277,2009-12-11T00:00:00,"Disease Models, Animal",C22.232
20008277,2009-12-11T00:00:00,"Disease Models, Animal",E05.598.500
20008277,2009-12-11T00:00:00,"Disease Models, Animal",E05.599.395.080
20008277,2009-12-11T00:00:00,Fibrillar Collagens,D05.750.078.280.300
20008277,2009-12-11T00:00:00,Fibrillar Collagens,D12.776.860.300.250.300
20008277,2009-12-11T00:00:00,Heart,A07.541
20008277,2009-12-11T00:00:00,Myocardium,A02.633.580
20008277,2009-12-11T00:00:00,Myocardium,A07.541.704
20008277,2009-12-11T00:00:00,Myocardium,A10.690.552.750
20008277,2009-12-11T00:00:00,Osteonectin,D12.776.157.125.715
20008277,2009-12-11T00:00:00,Osteonectin,D12.776.395.600
20008277,2009-12-11T00:00:00,Procollagen,D12.776.811.690
20008277,2009-12-11T00:00:00,Procollagen,D12.776.860.300.250.600
20008277,2009-12-11T00:00:00,Ventricular Remodeling,C23.300.985
20008277,2009-12-11T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20012706,2009-12-12T00:00:00,Deglutition,G10.261.326.215
20012706,2009-12-12T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
20012706,2009-12-12T00:00:00,Esophagus,A03.556.875.500
20012706,2009-12-12T00:00:00,Gastroplasty,E02.065.062.750
20012706,2009-12-12T00:00:00,Gastroplasty,E04.062.750
20012706,2009-12-12T00:00:00,Gastroplasty,E04.210.485
20012706,2009-12-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20012706,2009-12-12T00:00:00,Laparoscopy,E01.370.388.250.520
20012706,2009-12-12T00:00:00,Laparoscopy,E04.800.250.520
20012706,2009-12-12T00:00:00,Manometry,E05.559
20012706,2009-12-12T00:00:00,Middle Aged,M01.060.116.630
20012706,2009-12-12T00:00:00,"Obesity, Morbid",C18.654.726.500.700
20012706,2009-12-12T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
20012706,2009-12-12T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
20012706,2009-12-12T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
20012706,2009-12-12T00:00:00,Postoperative Complications,C23.550.767
20012706,2009-12-12T00:00:00,Treatment Outcome,E01.789.800
20012706,2009-12-12T00:00:00,Treatment Outcome,N04.761.559.590.800
20012706,2009-12-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20012706,2009-12-12T00:00:00,Weight Loss,C23.888.144.243.963
20012706,2009-12-12T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20006966,2009-12-13T00:00:00,Animals,B01.050
20006966,2009-12-13T00:00:00,"Behavior, Animal",F01.145.113
20006966,2009-12-13T00:00:00,Brain,A08.186.211
20006966,2009-12-13T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
20006966,2009-12-13T00:00:00,Glutamic Acid,D12.125.067.750
20006966,2009-12-13T00:00:00,Glutamic Acid,D12.125.119.450
20006966,2009-12-13T00:00:00,Glutamic Acid,D12.125.427.300
20006966,2009-12-13T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
20006966,2009-12-13T00:00:00,Maze Learning,F02.463.425.507
20006966,2009-12-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20006966,2009-12-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20006966,2009-12-13T00:00:00,Risk-Taking,F01.145.722
20012859,2009-12-13T00:00:00,Adolescent,M01.060.057
20012859,2009-12-13T00:00:00,Child,M01.060.406
20012859,2009-12-13T00:00:00,Health Surveys,E05.318.308.250
20012859,2009-12-13T00:00:00,Health Surveys,N05.715.360.300.375
20012859,2009-12-13T00:00:00,Health Surveys,N06.850.520.308.250
20012859,2009-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20012859,2009-12-13T00:00:00,Mental Disorders,F03
20012859,2009-12-13T00:00:00,Minority Groups,I01.880.371
20012859,2009-12-13T00:00:00,Parents,F01.829.263.500.320
20012859,2009-12-13T00:00:00,Parents,I01.880.225.500.340
20012859,2009-12-13T00:00:00,Parents,M01.620
20012859,2009-12-13T00:00:00,Probability,E05.318.740.600
20012859,2009-12-13T00:00:00,Probability,G17.680
20012859,2009-12-13T00:00:00,Probability,N05.715.360.750.625
20012859,2009-12-13T00:00:00,Probability,N06.850.520.830.600
20012859,2009-12-13T00:00:00,Questionnaires,E05.318.308.750
20012859,2009-12-13T00:00:00,Questionnaires,L01.280.800
20012859,2009-12-13T00:00:00,Questionnaires,N05.715.360.300.695
20012859,2009-12-13T00:00:00,Questionnaires,N06.850.520.308.750
20006505,2009-12-14T00:00:00,Chronic Disease,C23.550.291.500
20006505,2009-12-14T00:00:00,"Gait Disorders, Neurologic",C10.597.404
20006505,2009-12-14T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
20006505,2009-12-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20006505,2009-12-14T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20006505,2009-12-14T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20006505,2009-12-14T00:00:00,Middle Aged,M01.060.116.630
20006505,2009-12-14T00:00:00,Paresis,C10.597.636
20006505,2009-12-14T00:00:00,Paresis,C23.888.592.643
20006505,2009-12-14T00:00:00,Stroke,C10.228.140.300.775
20006505,2009-12-14T00:00:00,Stroke,C14.907.253.855
20006505,2009-12-14T00:00:00,Walking,G11.427.590.530.568.900
20006505,2009-12-14T00:00:00,Walking,G11.427.590.530.698.940
20006505,2009-12-14T00:00:00,Walking,I03.450.642.845.940
19499935,2009-12-15T00:00:00,Adsorption,G02.149.047
19499935,2009-12-15T00:00:00,Adsorption,G02.149.767.029
19499935,2009-12-15T00:00:00,Adsorption,G02.842.750.029
19499935,2009-12-15T00:00:00,Glucose Oxidase,D08.811.682.047.239
19499935,2009-12-15T00:00:00,Muramidase,D08.811.277.450.642
19499935,2009-12-15T00:00:00,Protein Conformation,G02.111.570.790.709
19499935,2009-12-15T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
19499935,2009-12-15T00:00:00,Surface Properties,G02.842.850
19830706,2009-12-15T00:00:00,Cell Movement,G04.299.283
19830706,2009-12-15T00:00:00,Cell Movement,G07.700.560.500.180
19830706,2009-12-15T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19830706,2009-12-15T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19830706,2009-12-15T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19830706,2009-12-15T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19830706,2009-12-15T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19830706,2009-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19830706,2009-12-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
19830706,2009-12-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
19830706,2009-12-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
19830706,2009-12-15T00:00:00,"RNA, Messenger",D13.444.735.544
19830706,2009-12-15T00:00:00,Thioredoxins,D12.776.915
19911973,2009-12-15T00:00:00,Bacteremia,C01.252.100
19911973,2009-12-15T00:00:00,Bacteremia,C01.539.757.100
19911973,2009-12-15T00:00:00,Bacteremia,C23.550.470.790.500.100
19911973,2009-12-15T00:00:00,"Catheterization, Central Venous",E02.148.167
19911973,2009-12-15T00:00:00,Cross Infection,C01.539.248
19911973,2009-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20008841,2009-12-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
20008841,2009-12-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
20008841,2009-12-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
20008841,2009-12-15T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
20008841,2009-12-15T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
20008841,2009-12-15T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
20008841,2009-12-15T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
20008841,2009-12-15T00:00:00,Disease Progression,C23.550.291.656
20008841,2009-12-15T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
20008841,2009-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20008841,2009-12-15T00:00:00,"Models, Statistical",E05.318.740.500
20008841,2009-12-15T00:00:00,"Models, Statistical",E05.599.835
20008841,2009-12-15T00:00:00,"Models, Statistical",N05.715.360.750.530
20008841,2009-12-15T00:00:00,"Models, Statistical",N06.850.520.830.500
20008841,2009-12-15T00:00:00,Pain Measurement,E01.370.376.550.600
20008841,2009-12-15T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
20008841,2009-12-15T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
20008841,2009-12-15T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
20008841,2009-12-15T00:00:00,Prostate-Specific Antigen,D23.050.285.625
20008841,2009-12-15T00:00:00,Prostate-Specific Antigen,D23.101.840.625
20008841,2009-12-15T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20008841,2009-12-15T00:00:00,Prostatic Neoplasms,C12.294.260.750
20008841,2009-12-15T00:00:00,Prostatic Neoplasms,C12.294.565.625
20008841,2009-12-15T00:00:00,Prostatic Neoplasms,C12.758.409.750
20008841,2009-12-15T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20008841,2009-12-15T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20008841,2009-12-15T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20008841,2009-12-15T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20015093,2009-12-15T00:00:00,Animals,B01.050
20015093,2009-12-15T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
20015093,2009-12-15T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
20015093,2009-12-15T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
20015093,2009-12-15T00:00:00,Bone Marrow Transplantation,E04.936.580.040
20015093,2009-12-15T00:00:00,Cell Lineage,G04.172
20015093,2009-12-15T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
20015093,2009-12-15T00:00:00,Cell Lineage,G08.686.155
20015093,2009-12-15T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
20015093,2009-12-15T00:00:00,Disease Progression,C23.550.291.656
20015093,2009-12-15T00:00:00,Hematopoietic Stem Cells,A11.148.378
20015093,2009-12-15T00:00:00,Hematopoietic Stem Cells,A11.872.378
20015093,2009-12-15T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
20015093,2009-12-15T00:00:00,Kidney,A05.810.453
20015093,2009-12-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20015093,2009-12-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20015093,2009-12-15T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
20015093,2009-12-15T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
20015093,2009-12-15T00:00:00,Lupus Nephritis,C17.300.480.680
20015093,2009-12-15T00:00:00,Lupus Nephritis,C20.111.590.560
20015093,2009-12-15T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
20015093,2009-12-15T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
20015093,2009-12-15T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
20018882,2009-12-15T00:00:00,Bacterial Proteins,D12.776.097
20018882,2009-12-15T00:00:00,DNA Helicases,D08.811.277.040.025.159
20018882,2009-12-15T00:00:00,DNA Helicases,D08.811.399.340
20018882,2009-12-15T00:00:00,DNA-Binding Proteins,D12.776.260
20018882,2009-12-15T00:00:00,Escherichia coli,B03.440.450.425.325.300
20018882,2009-12-15T00:00:00,Escherichia coli,B03.660.250.150.180.100
20018882,2009-12-15T00:00:00,Mutation,G05.365.590
20018882,2009-12-15T00:00:00,Plasmids,G05.360.600
20018882,2009-12-15T00:00:00,Trans-Activators,D12.776.260.755
20018882,2009-12-15T00:00:00,Trans-Activators,D12.776.930.900
20018882,2009-12-15T00:00:00,Trans-Activators,D12.776.964.925.984
20021997,2009-12-15T00:00:00,Adult,M01.060.116
20021997,2009-12-15T00:00:00,Anti-Anxiety Agents,D27.505.696.277.950.015
20021997,2009-12-15T00:00:00,Anti-Anxiety Agents,D27.505.954.427.210.950.015
20021997,2009-12-15T00:00:00,Anti-Anxiety Agents,D27.505.954.427.700.872.015
20021997,2009-12-15T00:00:00,Double-Blind Method,E05.318.780.300
20021997,2009-12-15T00:00:00,Double-Blind Method,E05.581.500.300
20021997,2009-12-15T00:00:00,Double-Blind Method,N05.715.360.780.320
20021997,2009-12-15T00:00:00,Double-Blind Method,N06.850.520.445.300
20021997,2009-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20021997,2009-12-15T00:00:00,Phobic Disorders,F03.080.725
20021997,2009-12-15T00:00:00,Psychiatric Status Rating Scales,F04.586
20054236,2009-12-15T00:00:00,Animals,B01.050
20054236,2009-12-15T00:00:00,Antineoplastic Agents,D27.505.954.248
20054236,2009-12-15T00:00:00,Apoptosis,G04.299.139.160
20054236,2009-12-15T00:00:00,"Disease Models, Animal",C22.232
20054236,2009-12-15T00:00:00,"Disease Models, Animal",E05.598.500
20054236,2009-12-15T00:00:00,"Disease Models, Animal",E05.599.395.080
20054236,2009-12-15T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
20054236,2009-12-15T00:00:00,Graft Survival,G12.425.901.545.340
20054236,2009-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20054236,2009-12-15T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
20054236,2009-12-15T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
20054236,2009-12-15T00:00:00,Neoplasms,C04
20054236,2009-12-15T00:00:00,Phosphorylation,G02.111.087.677
20054236,2009-12-15T00:00:00,Phosphorylation,G02.149.115.677
20054236,2009-12-15T00:00:00,Phosphorylation,G02.149.465.700
20054236,2009-12-15T00:00:00,Phosphorylation,G02.607.750.700
20054236,2009-12-15T00:00:00,Phosphorylation,G03.495.790
20054236,2009-12-15T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
20054236,2009-12-15T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
20054236,2009-12-15T00:00:00,Signal Transduction,G02.111.087.800
20054236,2009-12-15T00:00:00,Signal Transduction,G02.149.115.800
20054236,2009-12-15T00:00:00,Signal Transduction,G04.299.880
20054236,2009-12-15T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
20054236,2009-12-15T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
20054236,2009-12-15T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
20054236,2009-12-15T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
20054236,2009-12-15T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
20016052,2009-12-16T00:00:00,Animals,B01.050
20016052,2009-12-16T00:00:00,Anticholesteremic Agents,D27.505.519.186.071.202
20016052,2009-12-16T00:00:00,Anticholesteremic Agents,D27.505.954.230.202
20016052,2009-12-16T00:00:00,Blood Chemical Analysis,E01.450.150.100
20016052,2009-12-16T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
20016052,2009-12-16T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
20016052,2009-12-16T00:00:00,Molecular Structure,G02.111.570
20016052,2009-12-16T00:00:00,Molecular Structure,G02.575
20016052,2009-12-16T00:00:00,Molecular Structure,G02.842.575
20016052,2009-12-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20016052,2009-12-16T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20016052,2009-12-16T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
20018308,2009-12-16T00:00:00,Aged,M01.060.116.100
20018308,2009-12-16T00:00:00,Brachytherapy,E02.815.150
20018308,2009-12-16T00:00:00,Gonadotropin-Releasing Hormone,D06.472.699.327.740.320
20018308,2009-12-16T00:00:00,Gonadotropin-Releasing Hormone,D12.644.400.400.740.320
20018308,2009-12-16T00:00:00,Gonadotropin-Releasing Hormone,D12.644.456.460
20018308,2009-12-16T00:00:00,Gonadotropin-Releasing Hormone,D12.644.548.365.740.320
20018308,2009-12-16T00:00:00,Gonadotropin-Releasing Hormone,D12.776.641.650.405.740.320
20018308,2009-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20018308,2009-12-16T00:00:00,Middle Aged,M01.060.116.630
20018308,2009-12-16T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20018308,2009-12-16T00:00:00,Prostatic Neoplasms,C12.294.260.750
20018308,2009-12-16T00:00:00,Prostatic Neoplasms,C12.294.565.625
20018308,2009-12-16T00:00:00,Prostatic Neoplasms,C12.758.409.750
20018457,2009-12-16T00:00:00,Adult,M01.060.116
20018457,2009-12-16T00:00:00,Aged,M01.060.116.100
20018457,2009-12-16T00:00:00,Head and Neck Neoplasms,C04.588.443
20018457,2009-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20018457,2009-12-16T00:00:00,Middle Aged,M01.060.116.630
20018457,2009-12-16T00:00:00,Spinal Cord,A08.186.854
20018457,2009-12-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20018457,2009-12-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20018457,2009-12-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20018457,2009-12-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20018457,2009-12-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20025709,2009-12-16T00:00:00,"Arrhythmias, Cardiac",C14.280.067
20025709,2009-12-16T00:00:00,"Arrhythmias, Cardiac",C23.550.073
20025709,2009-12-16T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20025709,2009-12-16T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20025709,2009-12-16T00:00:00,"Defibrillators, Implantable",E07.695.175
20025709,2009-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20025709,2009-12-16T00:00:00,Qualitative Research,H01.770.644.241.850
20025709,2009-12-16T00:00:00,Quality of Life,I01.800
20025709,2009-12-16T00:00:00,Quality of Life,K01.752.400.750
20053405,2009-12-16T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
20053405,2009-12-16T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
20053405,2009-12-16T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
20053405,2009-12-16T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
20053405,2009-12-16T00:00:00,Age Factors,N05.715.350.075
20053405,2009-12-16T00:00:00,Age Factors,N06.850.490.250
20053405,2009-12-16T00:00:00,Aged,M01.060.116.100
20053405,2009-12-16T00:00:00,Cardiovascular Diseases,C14
20053405,2009-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20053405,2009-12-16T00:00:00,Middle Aged,M01.060.116.630
20053405,2009-12-16T00:00:00,Neoplasm Proteins,D12.776.624
20053405,2009-12-16T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20053405,2009-12-16T00:00:00,Sex Factors,N05.715.350.675
20053405,2009-12-16T00:00:00,Sex Factors,N06.850.490.875
20019303,2009-12-17T00:00:00,Aged,M01.060.116.100
20019303,2009-12-17T00:00:00,Elder Abuse,I01.198.240.856.350.390
20019303,2009-12-17T00:00:00,Elder Abuse,I01.880.735.900.350.390
20019303,2009-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20019303,2009-12-17T00:00:00,Middle Aged,M01.060.116.630
20019303,2009-12-17T00:00:00,Risk Factors,E05.318.740.600.800.725
20019303,2009-12-17T00:00:00,Risk Factors,N05.715.350.200.700
20019303,2009-12-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20019303,2009-12-17T00:00:00,Risk Factors,N06.850.490.625.750
20019303,2009-12-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20019303,2009-12-17T00:00:00,Social Support,I01.880.656.600
20019303,2009-12-17T00:00:00,United States,Z01.107.567.875
20019324,2009-12-17T00:00:00,Heart Diseases,C14.280
20019324,2009-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20019324,2009-12-17T00:00:00,Risk Factors,E05.318.740.600.800.725
20019324,2009-12-17T00:00:00,Risk Factors,N05.715.350.200.700
20019324,2009-12-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20019324,2009-12-17T00:00:00,Risk Factors,N06.850.490.625.750
20019324,2009-12-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20019324,2009-12-17T00:00:00,Stroke,C10.228.140.300.775
20019324,2009-12-17T00:00:00,Stroke,C14.907.253.855
20019324,2009-12-17T00:00:00,United States,Z01.107.567.875
20028353,2009-12-17T00:00:00,Adolescent,M01.060.057
20028353,2009-12-17T00:00:00,Adult,M01.060.116
20028353,2009-12-17T00:00:00,Alcohol Drinking,F01.145.317.269
20028353,2009-12-17T00:00:00,Biological Markers,D23.101
20028353,2009-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20028353,2009-12-17T00:00:00,Pregnancy,G08.686.785.760.769
20028353,2009-12-17T00:00:00,Young Adult,M01.060.116.815
20221329,2009-12-17T00:00:00,Computer-Assisted Instruction,I02.903.573.208
20221329,2009-12-17T00:00:00,Diffusion of Innovation,L01.143.320
20221329,2009-12-17T00:00:00,"Education, Pharmacy",I02.358.525
20221329,2009-12-17T00:00:00,Educational Technology,J01.897.280
20221329,2009-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20221329,2009-12-17T00:00:00,Internet,L01.224.230.110.500
20221329,2009-12-17T00:00:00,"Models, Educational",E05.599.545
20221329,2009-12-17T00:00:00,"Models, Educational",I02.903.302
20221329,2009-12-17T00:00:00,"Schools, Pharmacy",I02.783.660.694
20221329,2009-12-17T00:00:00,Teaching,I02.903
20431708,2009-12-17T00:00:00,Aged,M01.060.116.100
20431708,2009-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20431708,2009-12-17T00:00:00,Middle Aged,M01.060.116.630
20431708,2009-12-17T00:00:00,Pilot Projects,E05.318.760.750
20431708,2009-12-17T00:00:00,Pilot Projects,E05.337.737
20431708,2009-12-17T00:00:00,Pilot Projects,N05.715.360.775.625
20431708,2009-12-17T00:00:00,Pilot Projects,N06.850.520.450.720
20431708,2009-12-17T00:00:00,Preoperative Care,E02.760.795
20431708,2009-12-17T00:00:00,Preoperative Care,E04.641
20431708,2009-12-17T00:00:00,Preoperative Care,N02.421.585.795
20431708,2009-12-17T00:00:00,Stroke,C10.228.140.300.775
20431708,2009-12-17T00:00:00,Stroke,C14.907.253.855
20431708,2009-12-17T00:00:00,Treatment Outcome,E01.789.800
20431708,2009-12-17T00:00:00,Treatment Outcome,N04.761.559.590.800
20431708,2009-12-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19858207,2009-12-18T00:00:00,Cell Line,A11.251.210
19858207,2009-12-18T00:00:00,Cell Membrane,A11.284.149
19858207,2009-12-18T00:00:00,"Endothelium, Vascular",A07.231.330
19858207,2009-12-18T00:00:00,"Endothelium, Vascular",A10.272.491.355
19858207,2009-12-18T00:00:00,Enzyme Inhibitors,D27.505.519.389
19858207,2009-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19858207,2009-12-18T00:00:00,Inflammation,C23.550.470
19858207,2009-12-18T00:00:00,Myocardium,A02.633.580
19858207,2009-12-18T00:00:00,Myocardium,A07.541.704
19858207,2009-12-18T00:00:00,Myocardium,A10.690.552.750
19858207,2009-12-18T00:00:00,NF-kappa B,D12.776.260.600
19858207,2009-12-18T00:00:00,NF-kappa B,D12.776.660.600
19858207,2009-12-18T00:00:00,NF-kappa B,D12.776.930.600
19858207,2009-12-18T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
19858207,2009-12-18T00:00:00,Serpins,D12.644.822.750
19858207,2009-12-18T00:00:00,Serpins,D12.644.861
19858207,2009-12-18T00:00:00,Serpins,D12.776.645.750
19858207,2009-12-18T00:00:00,Serpins,D12.776.872
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19858207,2009-12-18T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20023066,2009-12-18T00:00:00,"Brain Diseases, Metabolic",C10.228.140.163
20023066,2009-12-18T00:00:00,"Brain Diseases, Metabolic",C18.452.132
20023066,2009-12-18T00:00:00,Child,M01.060.406
20023066,2009-12-18T00:00:00,"Child, Preschool",M01.060.406.448
20023066,2009-12-18T00:00:00,Developmental Disabilities,F03.550.362
20023066,2009-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20023066,2009-12-18T00:00:00,Mass Screening,E01.370.500
20023066,2009-12-18T00:00:00,Mass Screening,E05.318.308.250.580
20023066,2009-12-18T00:00:00,Mass Screening,N02.421.143.827.233.443
20023066,2009-12-18T00:00:00,Mass Screening,N02.421.726.233.443
20023066,2009-12-18T00:00:00,Mass Screening,N05.715.360.300.375.500
20023066,2009-12-18T00:00:00,Mass Screening,N06.850.520.308.250.580
20023066,2009-12-18T00:00:00,Mass Screening,N06.850.780.500
20023066,2009-12-18T00:00:00,Metabolic Diseases,C18.452
20024610,2009-12-19T00:00:00,Adult,M01.060.116
20024610,2009-12-19T00:00:00,African Americans,M01.686.508.100.100
20024610,2009-12-19T00:00:00,African Americans,M01.686.754.100
20024610,2009-12-19T00:00:00,Age Factors,N05.715.350.075
20024610,2009-12-19T00:00:00,Age Factors,N06.850.490.250
20024610,2009-12-19T00:00:00,Aged,M01.060.116.100
20024610,2009-12-19T00:00:00,Breast Neoplasms,C04.588.180
20024610,2009-12-19T00:00:00,Breast Neoplasms,C17.800.090.500
20024610,2009-12-19T00:00:00,European Continental Ancestry Group,M01.686.508.400
20024610,2009-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20024610,2009-12-19T00:00:00,Incidence,E05.318.308.985.525.375
20024610,2009-12-19T00:00:00,Incidence,L01.280.975.525.375
20024610,2009-12-19T00:00:00,Incidence,N01.224.935.597.500
20024610,2009-12-19T00:00:00,Incidence,N06.850.505.400.975.525.375
20024610,2009-12-19T00:00:00,Incidence,N06.850.520.308.985.525.375
20024610,2009-12-19T00:00:00,Middle Aged,M01.060.116.630
20024610,2009-12-19T00:00:00,Neoplasm Staging,E01.370.550
20024610,2009-12-19T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
20024610,2009-12-19T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
20024610,2009-12-19T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
20024610,2009-12-19T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
20024610,2009-12-19T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
20024610,2009-12-19T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
20024610,2009-12-19T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
20024610,2009-12-19T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
20024610,2009-12-19T00:00:00,"Receptor, erbB-2",D23.101.840.642
20024610,2009-12-19T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
20024610,2009-12-19T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
20024610,2009-12-19T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
20024610,2009-12-19T00:00:00,SEER Program,E05.318.308.970.725
20024610,2009-12-19T00:00:00,SEER Program,L01.280.950.725
20024610,2009-12-19T00:00:00,SEER Program,N04.452.859.819.725
20024610,2009-12-19T00:00:00,SEER Program,N05.715.360.300.715.700.725
20024610,2009-12-19T00:00:00,SEER Program,N06.850.520.308.970.725
20024610,2009-12-19T00:00:00,South Carolina,Z01.107.567.875.075.662
20024610,2009-12-19T00:00:00,South Carolina,Z01.107.567.875.750.700
20024613,2009-12-19T00:00:00,Breast Neoplasms,C04.588.180
20024613,2009-12-19T00:00:00,Breast Neoplasms,C17.800.090.500
20024613,2009-12-19T00:00:00,Clinical Trials as Topic,E05.318.760.535
20024613,2009-12-19T00:00:00,Clinical Trials as Topic,E05.337.250
20024613,2009-12-19T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20024613,2009-12-19T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20024613,2009-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20024613,2009-12-19T00:00:00,Research,H01.770.644
20000644,2009-12-21T00:00:00,Luminescence,G01.201.875.770.578.665
20000644,2009-12-21T00:00:00,Luminescence,G01.590.540.665
20000644,2009-12-21T00:00:00,Metals,D01.552
20000644,2009-12-21T00:00:00,Molecular Structure,G02.111.570
20000644,2009-12-21T00:00:00,Molecular Structure,G02.575
20000644,2009-12-21T00:00:00,Molecular Structure,G02.842.575
20000644,2009-12-21T00:00:00,Organometallic Compounds,D01.632
20000644,2009-12-21T00:00:00,Organometallic Compounds,D02.691
20000644,2009-12-21T00:00:00,Phosphines,D01.695.525
20000644,2009-12-21T00:00:00,Phosphines,D02.705.621
20000644,2009-12-21T00:00:00,Photochemistry,H01.181.529.711
20000644,2009-12-21T00:00:00,Polymers,D05.750
20000644,2009-12-21T00:00:00,Polymers,D25.720
20000644,2009-12-21T00:00:00,Polymers,J01.637.051.720
20023330,2009-12-21T00:00:00,Adult,M01.060.116
20023330,2009-12-21T00:00:00,Head,A01.456
20023330,2009-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20023330,2009-12-21T00:00:00,"Models, Biological",E05.599.395
20023330,2009-12-21T00:00:00,"Phantoms, Imaging",E07.671
20023330,2009-12-21T00:00:00,Radiation Dosage,E05.799.513
20023330,2009-12-21T00:00:00,Radiation Dosage,G01.201.875.740
20023330,2009-12-21T00:00:00,Radiation Dosage,N06.850.810.250
20023330,2009-12-21T00:00:00,Radiometry,E05.799
20023330,2009-12-21T00:00:00,Time Factors,G01.910.857
20023330,2009-12-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20023330,2009-12-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20023330,2009-12-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20023330,2009-12-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20023330,2009-12-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20023330,2009-12-21T00:00:00,X-Rays,G01.201.875.750.918
20026781,2009-12-21T00:00:00,Adolescent,M01.060.057
20026781,2009-12-21T00:00:00,Cardiac Volume,G09.330.380.249
20026781,2009-12-21T00:00:00,Child,M01.060.406
20026781,2009-12-21T00:00:00,Echocardiography,E01.370.350.850.220
20026781,2009-12-21T00:00:00,Echocardiography,E01.370.370.380.220
20026781,2009-12-21T00:00:00,Fontan Procedure,E04.035.410.295
20026781,2009-12-21T00:00:00,Fontan Procedure,E04.100.376.410.295
20026781,2009-12-21T00:00:00,Fontan Procedure,E04.928.220.370.295
20026781,2009-12-21T00:00:00,Health Status,I01.240.425
20026781,2009-12-21T00:00:00,Health Status,N01.224.425
20026781,2009-12-21T00:00:00,Health Status,N06.850.505.400.425
20026781,2009-12-21T00:00:00,"Heart Defects, Congenital",C14.240.400
20026781,2009-12-21T00:00:00,"Heart Defects, Congenital",C14.280.400
20026781,2009-12-21T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20026781,2009-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20026781,2009-12-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20026781,2009-12-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20026781,2009-12-21T00:00:00,Postoperative Complications,C23.550.767
20026781,2009-12-21T00:00:00,Questionnaires,E05.318.308.750
20026781,2009-12-21T00:00:00,Questionnaires,L01.280.800
20026781,2009-12-21T00:00:00,Questionnaires,N05.715.360.300.695
20026781,2009-12-21T00:00:00,Questionnaires,N06.850.520.308.750
20026800,2009-12-21T00:00:00,Age Factors,N05.715.350.075
20026800,2009-12-21T00:00:00,Age Factors,N06.850.490.250
20026800,2009-12-21T00:00:00,Aged,M01.060.116.100
20026800,2009-12-21T00:00:00,Heart Diseases,C14.280
20026800,2009-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20026800,2009-12-21T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20026800,2009-12-21T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
20026800,2009-12-21T00:00:00,Liver Diseases,C06.552
20026800,2009-12-21T00:00:00,Lung Diseases,C08.381
20026800,2009-12-21T00:00:00,Middle Aged,M01.060.116.630
20026800,2009-12-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
20026800,2009-12-21T00:00:00,Risk Assessment,N04.452.871.715
20026800,2009-12-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20026800,2009-12-21T00:00:00,Risk Assessment,N06.850.505.715
20026800,2009-12-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20026800,2009-12-21T00:00:00,Risk Factors,E05.318.740.600.800.725
20026800,2009-12-21T00:00:00,Risk Factors,N05.715.350.200.700
20026800,2009-12-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20026800,2009-12-21T00:00:00,Risk Factors,N06.850.490.625.750
20026800,2009-12-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20026800,2009-12-21T00:00:00,Treatment Outcome,E01.789.800
20026800,2009-12-21T00:00:00,Treatment Outcome,N04.761.559.590.800
20026800,2009-12-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20026800,2009-12-21T00:00:00,United States,Z01.107.567.875
19911831,2009-12-22T00:00:00,Binding Sites,G02.111.570.120
19911831,2009-12-22T00:00:00,Carbohydrates,D09
19911831,2009-12-22T00:00:00,Crystallization,E05.196.300
19911831,2009-12-22T00:00:00,Crystallization,G02.149.767.505
19911831,2009-12-22T00:00:00,Crystallization,G02.842.750.505
19911831,2009-12-22T00:00:00,Materials Testing,E05.570
19911831,2009-12-22T00:00:00,Nanotechnology,H01.603
19911831,2009-12-22T00:00:00,Nanotechnology,J01.897.520.600
19911831,2009-12-22T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
19911831,2009-12-22T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
19911831,2009-12-22T00:00:00,"Spores, Bacterial",A11.870.700
19911831,2009-12-22T00:00:00,"Spores, Bacterial",B05.775.700
19911831,2009-12-22T00:00:00,Surface Properties,G02.842.850
20028548,2009-12-22T00:00:00,Adolescent,M01.060.057
20028548,2009-12-22T00:00:00,Adult,M01.060.116
20028548,2009-12-22T00:00:00,Animals,B01.050
20028548,2009-12-22T00:00:00,Child,M01.060.406
20028548,2009-12-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20028548,2009-12-22T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
20028548,2009-12-22T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
20028548,2009-12-22T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
20028548,2009-12-22T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
20028548,2009-12-22T00:00:00,Incidence,E05.318.308.985.525.375
20028548,2009-12-22T00:00:00,Incidence,L01.280.975.525.375
20028548,2009-12-22T00:00:00,Incidence,N01.224.935.597.500
20028548,2009-12-22T00:00:00,Incidence,N06.850.505.400.975.525.375
20028548,2009-12-22T00:00:00,Incidence,N06.850.520.308.985.525.375
20028548,2009-12-22T00:00:00,Young Adult,M01.060.116.815
20029091,2009-12-22T00:00:00,Bacterial Proteins,D12.776.097
20029091,2009-12-22T00:00:00,DNA Helicases,D08.811.277.040.025.159
20029091,2009-12-22T00:00:00,DNA Helicases,D08.811.399.340
20029091,2009-12-22T00:00:00,DNA Replication,G02.111.087.222
20029091,2009-12-22T00:00:00,DNA Replication,G02.149.115.222
20029091,2009-12-22T00:00:00,DNA Replication,G05.355.200
20029091,2009-12-22T00:00:00,DNA-Binding Proteins,D12.776.260
20029091,2009-12-22T00:00:00,Escherichia coli,B03.440.450.425.325.300
20029091,2009-12-22T00:00:00,Escherichia coli,B03.660.250.150.180.100
20029091,2009-12-22T00:00:00,Plasmids,G05.360.600
20029091,2009-12-22T00:00:00,Trans-Activators,D12.776.260.755
20029091,2009-12-22T00:00:00,Trans-Activators,D12.776.930.900
20029091,2009-12-22T00:00:00,Trans-Activators,D12.776.964.925.984
20032100,2009-12-23T00:00:00,Adult,M01.060.116
20032100,2009-12-23T00:00:00,African Americans,M01.686.508.100.100
20032100,2009-12-23T00:00:00,African Americans,M01.686.754.100
20032100,2009-12-23T00:00:00,Age Factors,N05.715.350.075
20032100,2009-12-23T00:00:00,Age Factors,N06.850.490.250
20032100,2009-12-23T00:00:00,Aged,M01.060.116.100
20032100,2009-12-23T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
20032100,2009-12-23T00:00:00,"Arthritis, Rheumatoid",C05.799.114
20032100,2009-12-23T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
20032100,2009-12-23T00:00:00,"Arthritis, Rheumatoid",C20.111.199
20032100,2009-12-23T00:00:00,Health Status,I01.240.425
20032100,2009-12-23T00:00:00,Health Status,N01.224.425
20032100,2009-12-23T00:00:00,Health Status,N06.850.505.400.425
20032100,2009-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20032100,2009-12-23T00:00:00,Middle Aged,M01.060.116.630
20032100,2009-12-23T00:00:00,Pain Measurement,E01.370.376.550.600
20032100,2009-12-23T00:00:00,United States,Z01.107.567.875
20032100,2009-12-23T00:00:00,Vitamin D,D04.808.812.768
20032100,2009-12-23T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
20032118,2009-12-23T00:00:00,Animals,B01.050
20032118,2009-12-23T00:00:00,Blood Urea Nitrogen,E01.370.390.400.100
20032118,2009-12-23T00:00:00,Blood Urea Nitrogen,E01.450.150.100.115
20032118,2009-12-23T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
20032118,2009-12-23T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
20032118,2009-12-23T00:00:00,Cell Adhesion Molecules,D23.050.301.350
20032118,2009-12-23T00:00:00,Creatinine,D03.383.129.308.207
20032118,2009-12-23T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
20032118,2009-12-23T00:00:00,Cytokines,D12.644.276.374
20032118,2009-12-23T00:00:00,Cytokines,D12.776.467.374
20032118,2009-12-23T00:00:00,Cytokines,D23.529.374
20032118,2009-12-23T00:00:00,Dinoprostone,D10.251.355.255.100.637.250.200
20032118,2009-12-23T00:00:00,Dinoprostone,D10.251.355.255.550.250.200
20032118,2009-12-23T00:00:00,Dinoprostone,D23.469.050.175.725.780.200
20032118,2009-12-23T00:00:00,"Disease Models, Animal",C22.232
20032118,2009-12-23T00:00:00,"Disease Models, Animal",E05.598.500
20032118,2009-12-23T00:00:00,"Disease Models, Animal",E05.599.395.080
20032118,2009-12-23T00:00:00,Endotoxemia,C01.539.757.100.275
20032118,2009-12-23T00:00:00,Endotoxemia,C01.539.861.375
20032118,2009-12-23T00:00:00,Endotoxemia,C23.550.470.790.500.100.275
20032118,2009-12-23T00:00:00,Heart Diseases,C14.280
20032118,2009-12-23T00:00:00,Kidney,A05.810.453
20032118,2009-12-23T00:00:00,Kidney Diseases,C12.777.419
20032118,2009-12-23T00:00:00,Kidney Diseases,C13.351.968.419
20032118,2009-12-23T00:00:00,Lipopolysaccharides,D09.400.500
20032118,2009-12-23T00:00:00,Lipopolysaccharides,D09.698.718.450
20032118,2009-12-23T00:00:00,Lipopolysaccharides,D10.494
20032118,2009-12-23T00:00:00,Lipopolysaccharides,D23.050.161.616.525
20032118,2009-12-23T00:00:00,Lipopolysaccharides,D23.946.123.329.500
20032118,2009-12-23T00:00:00,Liver,A03.620
20032118,2009-12-23T00:00:00,Liver Diseases,C06.552
20032118,2009-12-23T00:00:00,Myocardium,A02.633.580
20032118,2009-12-23T00:00:00,Myocardium,A07.541.704
20032118,2009-12-23T00:00:00,Myocardium,A10.690.552.750
20032118,2009-12-23T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
20032118,2009-12-23T00:00:00,Stroke Volume,E01.370.370.380.150.700
20032118,2009-12-23T00:00:00,Stroke Volume,G09.330.380.124.882
20032118,2009-12-23T00:00:00,Time Factors,G01.910.857
20035071,2009-12-24T00:00:00,Aged,M01.060.116.100
20035071,2009-12-24T00:00:00,Atrial Fibrillation,C14.280.067.198
20035071,2009-12-24T00:00:00,Atrial Fibrillation,C23.550.073.198
20035071,2009-12-24T00:00:00,Guidelines as Topic,N04.761.700.350
20035071,2009-12-24T00:00:00,Guidelines as Topic,N05.700.350
20035071,2009-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20035071,2009-12-24T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
20035071,2009-12-24T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
20035071,2009-12-24T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
20035071,2009-12-24T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
20035071,2009-12-24T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
20035071,2009-12-24T00:00:00,"Lipoproteins, LDL",D10.532.515
20035071,2009-12-24T00:00:00,"Lipoproteins, LDL",D12.776.521.550
20035071,2009-12-24T00:00:00,Middle Aged,M01.060.116.630
20035071,2009-12-24T00:00:00,Smoking,F01.145.466.753
20035071,2009-12-24T00:00:00,Stroke,C10.228.140.300.775
20035071,2009-12-24T00:00:00,Stroke,C14.907.253.855
20035724,2009-12-24T00:00:00,Animals,B01.050
20035724,2009-12-24T00:00:00,Biological Transport,G03.495.166
20035724,2009-12-24T00:00:00,Cocaine,D02.145.074.722.388
20035724,2009-12-24T00:00:00,Cocaine,D03.132.889.354
20035724,2009-12-24T00:00:00,Cocaine,D03.605.869.388
20035724,2009-12-24T00:00:00,Cocaine,D04.075.080.875.099.722.388
20035724,2009-12-24T00:00:00,Cocaine-Related Disorders,C21.739.300
20035724,2009-12-24T00:00:00,Cocaine-Related Disorders,F03.900.300
20035724,2009-12-24T00:00:00,Dopamine,D02.092.211.215.311.342
20035724,2009-12-24T00:00:00,Dopamine,D02.092.311.342
20035724,2009-12-24T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
20035724,2009-12-24T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
20035724,2009-12-24T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
20035724,2009-12-24T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
20035724,2009-12-24T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
20035724,2009-12-24T00:00:00,Phosphorylation,G02.111.087.677
20035724,2009-12-24T00:00:00,Phosphorylation,G02.149.115.677
20035724,2009-12-24T00:00:00,Phosphorylation,G02.149.465.700
20035724,2009-12-24T00:00:00,Phosphorylation,G02.607.750.700
20035724,2009-12-24T00:00:00,Phosphorylation,G03.495.790
20035724,2009-12-24T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
20035724,2009-12-24T00:00:00,Protein Phosphatase 2,D12.644.360.583
20035724,2009-12-24T00:00:00,Protein Phosphatase 2,D12.776.476.561
20035724,2009-12-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20035724,2009-12-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20035724,2009-12-24T00:00:00,Self Administration,E02.319.890
20035724,2009-12-24T00:00:00,Self Administration,E02.900.890
20035724,2009-12-24T00:00:00,Substance Withdrawal Syndrome,C21.739.835
20035724,2009-12-24T00:00:00,Substance Withdrawal Syndrome,F03.900.825
20038807,2009-12-28T00:00:00,"Antigens, CD",D23.050.301.264.035
20038807,2009-12-28T00:00:00,"Antigens, CD",D23.101.100.110
20038807,2009-12-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20038807,2009-12-28T00:00:00,Neoplasm Proteins,D12.776.624
20038807,2009-12-28T00:00:00,Neoplasms,C04
20038807,2009-12-28T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
20038807,2009-12-28T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
20038807,2009-12-28T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
20071001,2009-12-28T00:00:00,Adsorption,G02.149.047
20071001,2009-12-28T00:00:00,Adsorption,G02.149.767.029
20071001,2009-12-28T00:00:00,Adsorption,G02.842.750.029
20071001,2009-12-28T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
20071001,2009-12-28T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
20071001,2009-12-28T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
20071001,2009-12-28T00:00:00,Organic Chemicals,D02
20071001,2009-12-28T00:00:00,Temperature,G01.906.595
20071001,2009-12-28T00:00:00,Temperature,G16.500.275.063.725.710
20071001,2009-12-28T00:00:00,Temperature,G16.500.750.775.710
20071001,2009-12-28T00:00:00,Temperature,N06.230.150.450
20071001,2009-12-28T00:00:00,Temperature,N06.230.300.100.725.710
20004694,2009-12-29T00:00:00,Animals,B01.050
20004694,2009-12-29T00:00:00,Cell Membrane,A11.284.149
20004694,2009-12-29T00:00:00,Cytokines,D12.644.276.374
20004694,2009-12-29T00:00:00,Cytokines,D12.776.467.374
20004694,2009-12-29T00:00:00,Cytokines,D23.529.374
20004694,2009-12-29T00:00:00,Estradiol,D04.808.365.415.248
20004694,2009-12-29T00:00:00,Estradiol,D06.472.334.851.437.500
20004694,2009-12-29T00:00:00,Estrogens,D27.505.696.399.472.277
20004694,2009-12-29T00:00:00,Gene Expression,G05.355.310
20004694,2009-12-29T00:00:00,Gene Expression Regulation,G05.355.315
20004694,2009-12-29T00:00:00,Insulin,D06.472.699.587.740.625
20004694,2009-12-29T00:00:00,Insulin,D12.644.548.586.740.625
20004694,2009-12-29T00:00:00,Pregnancy,G08.686.785.760.769
20004694,2009-12-29T00:00:00,Progesterone,D04.808.745.745.654.829
20004694,2009-12-29T00:00:00,Progesterone,D06.472.334.734.623
20004694,2009-12-29T00:00:00,Progesterone,D06.472.334.851.687.750
20036586,2009-12-29T00:00:00,Breast Neoplasms,C04.588.180
20036586,2009-12-29T00:00:00,Breast Neoplasms,C17.800.090.500
20036586,2009-12-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20036586,2009-12-29T00:00:00,Mammography,E01.370.350.700.500
20036586,2009-12-29T00:00:00,Physical Stimulation,E05.723
20036586,2009-12-29T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20036586,2009-12-29T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20036586,2009-12-29T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20036586,2009-12-29T00:00:00,X-Ray Diffraction,E05.196.309.742
20036586,2009-12-29T00:00:00,X-Ray Diffraction,E05.196.822.950
20036586,2009-12-29T00:00:00,X-Ray Diffraction,G01.595.861.950
20036586,2009-12-29T00:00:00,X-Ray Diffraction,G02.149.767.915
20036586,2009-12-29T00:00:00,X-Ray Diffraction,G02.842.750.915
20040914,2009-12-29T00:00:00,Adult,M01.060.116
20040914,2009-12-29T00:00:00,Double-Blind Method,E05.318.780.300
20040914,2009-12-29T00:00:00,Double-Blind Method,E05.581.500.300
20040914,2009-12-29T00:00:00,Double-Blind Method,N05.715.360.780.320
20040914,2009-12-29T00:00:00,Double-Blind Method,N06.850.520.445.300
20040914,2009-12-29T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
20040914,2009-12-29T00:00:00,Heartburn,C23.888.821.525
20040914,2009-12-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20040914,2009-12-29T00:00:00,Manometry,E05.559
20040914,2009-12-29T00:00:00,Middle Aged,M01.060.116.630
20040914,2009-12-29T00:00:00,Young Adult,M01.060.116.815
20028148,2009-12-30T00:00:00,"Cells, Immobilized",A11.270
20028148,2009-12-30T00:00:00,Diffusion,G01.595.200
20028148,2009-12-30T00:00:00,Diffusion,G02.149.767.560
20028148,2009-12-30T00:00:00,Diffusion,G02.842.750.560
20028148,2009-12-30T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20028148,2009-12-30T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20028148,2009-12-30T00:00:00,Nanoparticles,J01.637.512.600
20028148,2009-12-30T00:00:00,Polymers,D05.750
20028148,2009-12-30T00:00:00,Polymers,D25.720
20028148,2009-12-30T00:00:00,Polymers,J01.637.051.720
20005917,2009-12-31T00:00:00,Computer Simulation,L01.224.160
20005917,2009-12-31T00:00:00,Epithelial Cells,A11.436
20005917,2009-12-31T00:00:00,Heart,A07.541
20005917,2009-12-31T00:00:00,Mesoderm,A16.504.660
20005917,2009-12-31T00:00:00,Monte Carlo Method,E05.318.740.525
20005917,2009-12-31T00:00:00,Monte Carlo Method,L01.906.575.422
20005917,2009-12-31T00:00:00,Monte Carlo Method,N05.715.360.750.540
20005917,2009-12-31T00:00:00,Monte Carlo Method,N06.850.520.830.525
19515534,2010-01-01T00:00:00,Adult,M01.060.116
19515534,2010-01-01T00:00:00,Aged,M01.060.116.100
19515534,2010-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
19515534,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19515534,2010-01-01T00:00:00,Insulin,D06.472.699.587.740.625
19515534,2010-01-01T00:00:00,Insulin,D12.644.548.586.740.625
19515534,2010-01-01T00:00:00,Insulin Resistance,C18.452.394.968.500
19515534,2010-01-01T00:00:00,Insulin Resistance,G07.690.320.617
19515534,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
19515534,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19515534,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19515534,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19515534,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19515534,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19515534,2010-01-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19515534,2010-01-01T00:00:00,Young Adult,M01.060.116.815
19535967,2010-01-01T00:00:00,African Americans,M01.686.508.100.100
19535967,2010-01-01T00:00:00,African Americans,M01.686.754.100
19535967,2010-01-01T00:00:00,Aged,M01.060.116.100
19535967,2010-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19535967,2010-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
19535967,2010-01-01T00:00:00,Blood Pressure,G09.330.380.076
19535967,2010-01-01T00:00:00,"Databases, Factual",L01.470.750.750
19535967,2010-01-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
19535967,2010-01-01T00:00:00,Dementia,C10.228.140.380
19535967,2010-01-01T00:00:00,Dementia,F03.087.400
19535967,2010-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19535967,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19535967,2010-01-01T00:00:00,Hypertension,C14.907.489
19535967,2010-01-01T00:00:00,Physician's Practice Patterns,N04.590.748
19535967,2010-01-01T00:00:00,Physician's Practice Patterns,N05.300.625
19535967,2010-01-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19535967,2010-01-01T00:00:00,Veterans,M01.930
19536771,2010-01-01T00:00:00,Aged,M01.060.116.100
19536771,2010-01-01T00:00:00,Head and Neck Neoplasms,C04.588.443
19536771,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19536771,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
19536771,2010-01-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
19536771,2010-01-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
19536771,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
19536771,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
19536771,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
19536771,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
19536771,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
19536771,2010-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19536771,2010-01-01T00:00:00,Risk Assessment,N04.452.871.715
19536771,2010-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19536771,2010-01-01T00:00:00,Risk Assessment,N06.850.505.715
19536771,2010-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19536771,2010-01-01T00:00:00,Skull Base,A01.456.830
19536771,2010-01-01T00:00:00,Skull Base,A02.835.232.781.750
19536771,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19536771,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19536771,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19536771,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19536771,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19679680,2010-01-01T00:00:00,Animals,B01.050
19679680,2010-01-01T00:00:00,Myocardium,A02.633.580
19679680,2010-01-01T00:00:00,Myocardium,A07.541.704
19679680,2010-01-01T00:00:00,Myocardium,A10.690.552.750
19679680,2010-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19679680,2010-01-01T00:00:00,Sinoatrial Node,A07.541.409.819
19679680,2010-01-01T00:00:00,Ventricular Remodeling,C23.300.985
19679680,2010-01-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
19693003,2010-01-01T00:00:00,Animals,B01.050
19693003,2010-01-01T00:00:00,Brain,A08.186.211
19693003,2010-01-01T00:00:00,Electric Stimulation Therapy,E02.342
19693003,2010-01-01T00:00:00,Electric Stimulation Therapy,E02.779.468
19693003,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19693003,2010-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19693003,2010-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19717140,2010-01-01T00:00:00,Animals,B01.050
19717140,2010-01-01T00:00:00,Antioxidants,D27.505.519.217
19717140,2010-01-01T00:00:00,Antioxidants,D27.505.696.706.125
19717140,2010-01-01T00:00:00,Antioxidants,D27.720.799.047
19717140,2010-01-01T00:00:00,Cocaine,D02.145.074.722.388
19717140,2010-01-01T00:00:00,Cocaine,D03.132.889.354
19717140,2010-01-01T00:00:00,Cocaine,D03.605.869.388
19717140,2010-01-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
19717140,2010-01-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19717140,2010-01-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19717140,2010-01-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
19717140,2010-01-01T00:00:00,Cystine,D01.248.497.158.874.390.369
19717140,2010-01-01T00:00:00,Cystine,D01.875.350.850.150.369
19717140,2010-01-01T00:00:00,Cystine,D02.886.030.230.369
19717140,2010-01-01T00:00:00,Cystine,D02.886.520.150.087
19717140,2010-01-01T00:00:00,Cystine,D12.125.095.369
19717140,2010-01-01T00:00:00,Cystine,D12.125.119.369
19717140,2010-01-01T00:00:00,Cystine,D12.125.166.230.369
19717140,2010-01-01T00:00:00,"Disease Models, Animal",C22.232
19717140,2010-01-01T00:00:00,"Disease Models, Animal",E05.598.500
19717140,2010-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19717140,2010-01-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
19717140,2010-01-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
19717140,2010-01-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
19717140,2010-01-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
19717140,2010-01-01T00:00:00,Glutamic Acid,D12.125.067.750
19717140,2010-01-01T00:00:00,Glutamic Acid,D12.125.119.450
19717140,2010-01-01T00:00:00,Glutamic Acid,D12.125.427.300
19717140,2010-01-01T00:00:00,Motor Activity,F01.145.632
19717140,2010-01-01T00:00:00,Motor Activity,G11.427.590.530.698
19717140,2010-01-01T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19717140,2010-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19717140,2010-01-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19717140,2010-01-01T00:00:00,Self Administration,E02.319.890
19717140,2010-01-01T00:00:00,Self Administration,E02.900.890
19717140,2010-01-01T00:00:00,Time Factors,G01.910.857
19770777,2010-01-01T00:00:00,Adult,M01.060.116
19770777,2010-01-01T00:00:00,Angiotensinogen,D12.644.456.073.070
19770777,2010-01-01T00:00:00,Angiotensinogen,D12.644.822.750.020
19770777,2010-01-01T00:00:00,Angiotensinogen,D12.644.861.020
19770777,2010-01-01T00:00:00,Angiotensinogen,D12.776.645.750.020
19770777,2010-01-01T00:00:00,Angiotensinogen,D12.776.811.070
19770777,2010-01-01T00:00:00,Angiotensinogen,D12.776.872.020
19770777,2010-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
19770777,2010-01-01T00:00:00,Blood Pressure,G09.330.380.076
19770777,2010-01-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19770777,2010-01-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
19770777,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19770777,2010-01-01T00:00:00,Hypertension,C14.907.489
19770777,2010-01-01T00:00:00,Kidney,A05.810.453
19770777,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
19770777,2010-01-01T00:00:00,Phenotype,G05.695
19770777,2010-01-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19770777,2010-01-01T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
19770777,2010-01-01T00:00:00,Renal Circulation,G08.852.796.700
19770777,2010-01-01T00:00:00,Renal Circulation,G09.330.190.163.812
19770777,2010-01-01T00:00:00,Sodium,D01.268.549.750
19770777,2010-01-01T00:00:00,Sodium,D01.552.528.850
19810110,2010-01-01T00:00:00,Animals,B01.050
19810110,2010-01-01T00:00:00,Bioprosthesis,E07.695.100
19810110,2010-01-01T00:00:00,Calcinosis,C18.452.174.130
19810110,2010-01-01T00:00:00,Collagen,D05.750.078.280
19810110,2010-01-01T00:00:00,Collagen,D12.776.860.300.250
19810110,2010-01-01T00:00:00,Ethanol,D02.033.375
19810110,2010-01-01T00:00:00,Glycosaminoglycans,D09.698.373
19810110,2010-01-01T00:00:00,Heart Valve Prosthesis,E07.695.310
19810110,2010-01-01T00:00:00,Neomycin,D09.408.051.623
19810110,2010-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19810110,2010-01-01T00:00:00,Swine,B01.050.150.900.649.077.880
19836015,2010-01-01T00:00:00,Adult,M01.060.116
19836015,2010-01-01T00:00:00,Aged,M01.060.116.100
19836015,2010-01-01T00:00:00,Biological Markers,D23.101
19836015,2010-01-01T00:00:00,C-Reactive Protein,D12.776.034.145
19836015,2010-01-01T00:00:00,C-Reactive Protein,D12.776.124.050.120
19836015,2010-01-01T00:00:00,C-Reactive Protein,D12.776.124.486.157
19836015,2010-01-01T00:00:00,Cardiovascular Diseases,C14
19836015,2010-01-01T00:00:00,Environmental Pollutants,D27.888.284
19836015,2010-01-01T00:00:00,Health Surveys,E05.318.308.250
19836015,2010-01-01T00:00:00,Health Surveys,N05.715.360.300.375
19836015,2010-01-01T00:00:00,Health Surveys,N06.850.520.308.250
19836015,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19836015,2010-01-01T00:00:00,Inflammation,C23.550.470
19836015,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
19836015,2010-01-01T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D02.455.426.559.847
19836015,2010-01-01T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D04.615
19836015,2010-01-01T00:00:00,United States,Z01.107.567.875
19836015,2010-01-01T00:00:00,Young Adult,M01.060.116.815
19877226,2010-01-01T00:00:00,Adult,M01.060.116
19877226,2010-01-01T00:00:00,Aged,M01.060.116.100
19877226,2010-01-01T00:00:00,Head and Neck Neoplasms,C04.588.443
19877226,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19877226,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
19877226,2010-01-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
19877226,2010-01-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
19890893,2010-01-01T00:00:00,Blood Transfusion,E02.095.135
19890893,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19890893,2010-01-01T00:00:00,Parents,F01.829.263.500.320
19890893,2010-01-01T00:00:00,Parents,I01.880.225.500.340
19890893,2010-01-01T00:00:00,Parents,M01.620
19890893,2010-01-01T00:00:00,Stroke,C10.228.140.300.775
19890893,2010-01-01T00:00:00,Stroke,C14.907.253.855
19890893,2010-01-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
19890893,2010-01-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
19890893,2010-01-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
19890893,2010-01-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
19894226,2010-01-01T00:00:00,Apoptosis,G04.299.139.160
19894226,2010-01-01T00:00:00,Astrocytes,A08.637.200
19894226,2010-01-01T00:00:00,Astrocytes,A11.650.200
19894226,2010-01-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
19894226,2010-01-01T00:00:00,Brain Neoplasms,C10.228.140.211
19894226,2010-01-01T00:00:00,Brain Neoplasms,C10.551.240.250
19894226,2010-01-01T00:00:00,Caspases,D08.811.277.656.262.500.126
19894226,2010-01-01T00:00:00,Caspases,D08.811.277.656.300.200.126
19894226,2010-01-01T00:00:00,Caspases,D12.644.360.075.405
19894226,2010-01-01T00:00:00,Caspases,D12.776.476.075.405
19894226,2010-01-01T00:00:00,Cell Line,A11.251.210
19894226,2010-01-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
19894226,2010-01-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
19894226,2010-01-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
19894226,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19894226,2010-01-01T00:00:00,Reactive Oxygen Species,D01.339.431
19894226,2010-01-01T00:00:00,Reactive Oxygen Species,D01.650.775
19913821,2010-01-01T00:00:00,Electric Stimulation Therapy,E02.342
19913821,2010-01-01T00:00:00,Electric Stimulation Therapy,E02.779.468
19913821,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19913821,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
19913821,2010-01-01T00:00:00,Time Factors,G01.910.857
19913821,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
19913821,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19913821,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19913821,2010-01-01T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
19913821,2010-01-01T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
19913821,2010-01-01T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
19918966,2010-01-01T00:00:00,Algorithms,G17.035
19918966,2010-01-01T00:00:00,Algorithms,L01.224.050
19918966,2010-01-01T00:00:00,Amino Acid Sequence,G02.111.570.060
19918966,2010-01-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19918966,2010-01-01T00:00:00,Animals,B01.050
19918966,2010-01-01T00:00:00,Brain Chemistry,G02.111.100
19918966,2010-01-01T00:00:00,Brain Chemistry,G03.200
19918966,2010-01-01T00:00:00,Cocaine,D02.145.074.722.388
19918966,2010-01-01T00:00:00,Cocaine,D03.132.889.354
19918966,2010-01-01T00:00:00,Cocaine,D03.605.869.388
19918966,2010-01-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
19918966,2010-01-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19918966,2010-01-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19918966,2010-01-01T00:00:00,Computational Biology,H01.158.273.180
19918966,2010-01-01T00:00:00,Molecular Sequence Data,L01.453.245.667
19918966,2010-01-01T00:00:00,Neuropeptides,D12.644.400
19918966,2010-01-01T00:00:00,Neuropeptides,D12.776.641.650
19918966,2010-01-01T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19918966,2010-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19918966,2010-01-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19918966,2010-01-01T00:00:00,Tissue Array Analysis,E05.196.630.570.850
19918966,2010-01-01T00:00:00,Tissue Array Analysis,E05.588.570.850
19952961,2010-01-01T00:00:00,Animals,B01.050
19952961,2010-01-01T00:00:00,Cell Separation,E05.200.500.363
19952961,2010-01-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
19952961,2010-01-01T00:00:00,Flow Cytometry,E05.200.500.386.350
19952961,2010-01-01T00:00:00,Neoplasms,C04
19952961,2010-01-01T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
19952961,2010-01-01T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
19952961,2010-01-01T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
19952961,2010-01-01T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
19952961,2010-01-01T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
19952961,2010-01-01T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
19952961,2010-01-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
19952961,2010-01-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
19952961,2010-01-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19959950,2010-01-01T00:00:00,Adolescent,M01.060.057
19959950,2010-01-01T00:00:00,Adult,M01.060.116
19959950,2010-01-01T00:00:00,Aged,M01.060.116.100
19959950,2010-01-01T00:00:00,"Air Pollutants, Radioactive",D20.693.101
19959950,2010-01-01T00:00:00,"Air Pollutants, Radioactive",D27.888.284.101.393
19959950,2010-01-01T00:00:00,Animals,B01.050
19959950,2010-01-01T00:00:00,"Disease Models, Animal",C22.232
19959950,2010-01-01T00:00:00,"Disease Models, Animal",E05.598.500
19959950,2010-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
19959950,2010-01-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
19959950,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959950,2010-01-01T00:00:00,Liver Neoplasms,C04.588.274.623
19959950,2010-01-01T00:00:00,Liver Neoplasms,C06.301.623
19959950,2010-01-01T00:00:00,Liver Neoplasms,C06.552.697
19959950,2010-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19959950,2010-01-01T00:00:00,Lung Neoplasms,C08.381.540
19959950,2010-01-01T00:00:00,Lung Neoplasms,C08.785.520
19959950,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
19959950,2010-01-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
19959950,2010-01-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
19959950,2010-01-01T00:00:00,Occupational Exposure,N06.850.460.350.600
19959950,2010-01-01T00:00:00,Plutonium,D01.268.033.700
19959950,2010-01-01T00:00:00,Plutonium,D01.268.271.100.700
19959950,2010-01-01T00:00:00,Plutonium,D01.268.556.700
19959950,2010-01-01T00:00:00,Plutonium,D01.552.020.734
19959950,2010-01-01T00:00:00,Plutonium,D01.552.544.700
19959950,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19959950,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19959950,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19959950,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19959950,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19959950,2010-01-01T00:00:00,Young Adult,M01.060.116.815
20010710,2010-01-01T00:00:00,Animals,B01.050
20010710,2010-01-01T00:00:00,Brain,A08.186.211
20010710,2010-01-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
20010710,2010-01-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
20010710,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20010710,2010-01-01T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
20010710,2010-01-01T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
20010710,2010-01-01T00:00:00,Substance-Related Disorders,C21.739
20010710,2010-01-01T00:00:00,Substance-Related Disorders,F03.900
20014119,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20014119,2010-01-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
20014119,2010-01-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
20014119,2010-01-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
20014119,2010-01-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
20014119,2010-01-01T00:00:00,Syndrome,C23.550.288.500
20027049,2010-01-01T00:00:00,Algorithms,G17.035
20027049,2010-01-01T00:00:00,Algorithms,L01.224.050
20027049,2010-01-01T00:00:00,C-Reactive Protein,D12.776.034.145
20027049,2010-01-01T00:00:00,C-Reactive Protein,D12.776.124.050.120
20027049,2010-01-01T00:00:00,C-Reactive Protein,D12.776.124.486.157
20027049,2010-01-01T00:00:00,Chest Pain,C23.888.646.215
20027049,2010-01-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20027049,2010-01-01T00:00:00,Coronary Angiography,E01.370.370.050.200
20027049,2010-01-01T00:00:00,Coronary Angiography,E01.370.370.380.200
20027049,2010-01-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
20027049,2010-01-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
20027049,2010-01-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
20027049,2010-01-01T00:00:00,Coronary Vessels,A07.231.114.269
20027049,2010-01-01T00:00:00,Coronary Vessels,A07.231.908.194
20027049,2010-01-01T00:00:00,Diagnostic Imaging,E01.370.350
20027049,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20027049,2010-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20027049,2010-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20027049,2010-01-01T00:00:00,Patient Selection,E05.581.500.653
20027049,2010-01-01T00:00:00,Patient Selection,N04.590.731
20027049,2010-01-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
20027049,2010-01-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
20027049,2010-01-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
20027049,2010-01-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
20027049,2010-01-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
20032143,2010-01-01T00:00:00,Breast Neoplasms,C04.588.180
20032143,2010-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
20032143,2010-01-01T00:00:00,Contrast Media,D27.720.259
20032143,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20032143,2010-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20032143,2010-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20032143,2010-01-01T00:00:00,Mammography,E01.370.350.700.500
20032143,2010-01-01T00:00:00,Mass Screening,E01.370.500
20032143,2010-01-01T00:00:00,Mass Screening,E05.318.308.250.580
20032143,2010-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20032143,2010-01-01T00:00:00,Mass Screening,N02.421.726.233.443
20032143,2010-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20032143,2010-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20032143,2010-01-01T00:00:00,Mass Screening,N06.850.780.500
20032143,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20032143,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20032143,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20032143,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20032143,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20032143,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20032143,2010-01-01T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
20032143,2010-01-01T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
20032143,2010-01-01T00:00:00,United States,Z01.107.567.875
20039413,2010-01-01T00:00:00,Adult,M01.060.116
20039413,2010-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
20039413,2010-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
20039413,2010-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
20039413,2010-01-01T00:00:00,B-Lymphocytes,A11.063.438
20039413,2010-01-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
20039413,2010-01-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
20039413,2010-01-01T00:00:00,B-Lymphocytes,A15.382.032.438
20039413,2010-01-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
20039413,2010-01-01T00:00:00,Double-Blind Method,E05.318.780.300
20039413,2010-01-01T00:00:00,Double-Blind Method,E05.581.500.300
20039413,2010-01-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20039413,2010-01-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20039413,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20039413,2010-01-01T00:00:00,Immunologic Factors,D27.505.696.477
20039413,2010-01-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20039413,2010-01-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20039413,2010-01-01T00:00:00,Quality of Life,I01.800
20039413,2010-01-01T00:00:00,Quality of Life,K01.752.400.750
20039413,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20039413,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20039413,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20042935,2010-01-01T00:00:00,Behavioral Medicine,F04.096.080
20042935,2010-01-01T00:00:00,Behavioral Medicine,H02.403.090
20042935,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20042935,2010-01-01T00:00:00,Internet,L01.224.230.110.500
20042935,2010-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20042935,2010-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20042935,2010-01-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
20042935,2010-01-01T00:00:00,"Quality Assurance, Health Care",N05.700
20042935,2010-01-01T00:00:00,Quality of Life,I01.800
20042935,2010-01-01T00:00:00,Quality of Life,K01.752.400.750
20042935,2010-01-01T00:00:00,United States,Z01.107.567.875
20043704,2010-01-01T00:00:00,Diffusion of Innovation,L01.143.320
20043704,2010-01-01T00:00:00,Health Services Research,N03.349.380
20043704,2010-01-01T00:00:00,Health Services Research,N05.425
20043704,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20043704,2010-01-01T00:00:00,Telemedicine,H02.403.840
20043704,2010-01-01T00:00:00,Telemedicine,L01.178.847.652
20043704,2010-01-01T00:00:00,Telemedicine,N04.590.374.800
20043704,2010-01-01T00:00:00,United States,Z01.107.567.875
20043704,2010-01-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
20043704,2010-01-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
20048335,2010-01-01T00:00:00,Adult,M01.060.116
20048335,2010-01-01T00:00:00,Aged,M01.060.116.100
20048335,2010-01-01T00:00:00,Cancer Vaccines,D20.215.894.200
20048335,2010-01-01T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
20048335,2010-01-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
20048335,2010-01-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
20048335,2010-01-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
20048335,2010-01-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.644.276.374.410.240.375
20048335,2010-01-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.395.240.300
20048335,2010-01-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.467.374.410.240.375
20048335,2010-01-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D23.529.374.410.240.375
20048335,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20048335,2010-01-01T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
20048335,2010-01-01T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
20048335,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20048335,2010-01-01T00:00:00,Pilot Projects,E05.318.760.750
20048335,2010-01-01T00:00:00,Pilot Projects,E05.337.737
20048335,2010-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
20048335,2010-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
20048335,2010-01-01T00:00:00,Piperazines,D03.383.606
20048335,2010-01-01T00:00:00,Pyrimidines,D03.383.742
20058735,2010-01-01T00:00:00,Action Potentials,G04.580.100
20058735,2010-01-01T00:00:00,Action Potentials,G07.265.750.100
20058735,2010-01-01T00:00:00,Action Potentials,G11.561.570.100
20058735,2010-01-01T00:00:00,"Adaptation, Physiological",G07.700.062
20058735,2010-01-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
20058735,2010-01-01T00:00:00,Adult,M01.060.116
20058735,2010-01-01T00:00:00,Bed Rest,E02.075
20058735,2010-01-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20058735,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20058735,2010-01-01T00:00:00,Leg,A01.378.610.500
20058735,2010-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20058735,2010-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20058735,2010-01-01T00:00:00,"Models, Statistical",E05.318.740.500
20058735,2010-01-01T00:00:00,"Models, Statistical",E05.599.835
20058735,2010-01-01T00:00:00,"Models, Statistical",N05.715.360.750.530
20058735,2010-01-01T00:00:00,"Models, Statistical",N06.850.520.830.500
20058735,2010-01-01T00:00:00,Neuronal Plasticity,G11.561.600.635
20058735,2010-01-01T00:00:00,Pilot Projects,E05.318.760.750
20058735,2010-01-01T00:00:00,Pilot Projects,E05.337.737
20058735,2010-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
20058735,2010-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
20058735,2010-01-01T00:00:00,Time Factors,G01.910.857
20058735,2010-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20058735,2010-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20063213,2010-01-01T00:00:00,Clinical Clerkship,I02.358.399.450.110
20063213,2010-01-01T00:00:00,Curriculum,I02.158
20063213,2010-01-01T00:00:00,Family Practice,H02.403.280
20063213,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20065127,2010-01-01T00:00:00,Aged,M01.060.116.100
20065127,2010-01-01T00:00:00,Cause of Death,E05.318.308.985.550.250
20065127,2010-01-01T00:00:00,Cause of Death,L01.280.975.550.250
20065127,2010-01-01T00:00:00,Cause of Death,N01.224.935.698.100
20065127,2010-01-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
20065127,2010-01-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
20065127,2010-01-01T00:00:00,Emergency Medical Services,N02.421.297
20065127,2010-01-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
20065127,2010-01-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
20065127,2010-01-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
20065127,2010-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
20065127,2010-01-01T00:00:00,Health Services Accessibility,N05.300.430
20065127,2010-01-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
20065127,2010-01-01T00:00:00,Hospital Mortality,L01.280.975.550.400
20065127,2010-01-01T00:00:00,Hospital Mortality,N01.224.935.698.400
20065127,2010-01-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
20065127,2010-01-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
20065127,2010-01-01T00:00:00,Hospitalization,E02.760.400
20065127,2010-01-01T00:00:00,Hospitalization,N02.421.585.400
20065127,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20065127,2010-01-01T00:00:00,"Hypoxia-Ischemia, Brain",C10.228.140.300.150.716
20065127,2010-01-01T00:00:00,"Hypoxia-Ischemia, Brain",C10.228.140.624.500
20065127,2010-01-01T00:00:00,"Hypoxia-Ischemia, Brain",C14.907.253.092.716
20065127,2010-01-01T00:00:00,Length of Stay,E02.760.400.480
20065127,2010-01-01T00:00:00,Length of Stay,N02.421.585.400.480
20065127,2010-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20065127,2010-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20065127,2010-01-01T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
20065127,2010-01-01T00:00:00,Quality of Health Care,N04.761
20065127,2010-01-01T00:00:00,Quality of Health Care,N05.715
20065127,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20065127,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20065127,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20065127,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20065127,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20065127,2010-01-01T00:00:00,Stroke,C10.228.140.300.775
20065127,2010-01-01T00:00:00,Stroke,C14.907.253.855
20065127,2010-01-01T00:00:00,Time Factors,G01.910.857
20065127,2010-01-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
20065127,2010-01-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
20065127,2010-01-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
20065127,2010-01-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
20065127,2010-01-01T00:00:00,United States,Z01.107.567.875
20065127,2010-01-01T00:00:00,Virginia,Z01.107.567.875.075.837
20065127,2010-01-01T00:00:00,Virginia,Z01.107.567.875.750.870
20065128,2010-01-01T00:00:00,Atrial Fibrillation,C14.280.067.198
20065128,2010-01-01T00:00:00,Atrial Fibrillation,C23.550.073.198
20065128,2010-01-01T00:00:00,Biological Markers,D23.101
20065128,2010-01-01T00:00:00,Brain,A08.186.211
20065128,2010-01-01T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
20065128,2010-01-01T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
20065128,2010-01-01T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
20065128,2010-01-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
20065128,2010-01-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
20065128,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20065128,2010-01-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
20065128,2010-01-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
20065128,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20065128,2010-01-01T00:00:00,Proteinuria,C12.777.934.734
20065128,2010-01-01T00:00:00,Proteinuria,C13.351.968.934.734
20065128,2010-01-01T00:00:00,Proteinuria,C23.888.942.750
20065128,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20065128,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20065128,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20065128,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20065128,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20065128,2010-01-01T00:00:00,Stroke,C10.228.140.300.775
20065128,2010-01-01T00:00:00,Stroke,C14.907.253.855
20068121,2010-01-01T00:00:00,Cognitive Therapy,F04.754.137.428
20068121,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20068121,2010-01-01T00:00:00,Implosive Therapy,F04.754.137.506.325
20068121,2010-01-01T00:00:00,Patient Education as Topic,I02.233.332.500
20068121,2010-01-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20068121,2010-01-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
20068121,2010-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20068121,2010-01-01T00:00:00,Substance-Related Disorders,C21.739
20068121,2010-01-01T00:00:00,Substance-Related Disorders,F03.900
20068121,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20068121,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20068121,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20073563,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20073563,2010-01-01T00:00:00,Military Personnel,M01.526.625
20073563,2010-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20073563,2010-01-01T00:00:00,United States,Z01.107.567.875
20073563,2010-01-01T00:00:00,Veterans,M01.930
20073563,2010-01-01T00:00:00,War,I01.880.735.944
20075691,2010-01-01T00:00:00,Adult,M01.060.116
20075691,2010-01-01T00:00:00,Age Factors,N05.715.350.075
20075691,2010-01-01T00:00:00,Age Factors,N06.850.490.250
20075691,2010-01-01T00:00:00,Cryotherapy,E02.258
20075691,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20075691,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20075691,2010-01-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
20075691,2010-01-01T00:00:00,Patient Selection,E05.581.500.653
20075691,2010-01-01T00:00:00,Patient Selection,N04.590.731
20075691,2010-01-01T00:00:00,Pilot Projects,E05.318.760.750
20075691,2010-01-01T00:00:00,Pilot Projects,E05.337.737
20075691,2010-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
20075691,2010-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
20075691,2010-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20075691,2010-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20075691,2010-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20075691,2010-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20075691,2010-01-01T00:00:00,Sex Factors,N05.715.350.675
20075691,2010-01-01T00:00:00,Sex Factors,N06.850.490.875
20075691,2010-01-01T00:00:00,Varicose Ulcer,C14.907.927.730
20075691,2010-01-01T00:00:00,Varicose Ulcer,C17.800.893.592.730
20081420,2010-01-01T00:00:00,Chromosome Aberrations,C23.550.210
20081420,2010-01-01T00:00:00,Chromosome Aberrations,G05.365.590.175
20081420,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20081420,2010-01-01T00:00:00,Incidence,E05.318.308.985.525.375
20081420,2010-01-01T00:00:00,Incidence,L01.280.975.525.375
20081420,2010-01-01T00:00:00,Incidence,N01.224.935.597.500
20081420,2010-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20081420,2010-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20081420,2010-01-01T00:00:00,Ovary,A05.360.319.114.630
20081420,2010-01-01T00:00:00,Ovary,A05.360.576.497
20081420,2010-01-01T00:00:00,Ovary,A06.407.312.497
20081420,2010-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20081420,2010-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20081420,2010-01-01T00:00:00,Pregnancy,G08.686.785.760.769
20081430,2010-01-01T00:00:00,Adolescent,M01.060.057
20081430,2010-01-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
20081430,2010-01-01T00:00:00,Attention Deficit and Disruptive Behavior Disorders,F03.550.150
20081430,2010-01-01T00:00:00,Child,M01.060.406
20081430,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20081430,2010-01-01T00:00:00,Mental Disorders,F03
20081430,2010-01-01T00:00:00,Psychological Tests,F04.711
20081430,2010-01-01T00:00:00,Questionnaires,E05.318.308.750
20081430,2010-01-01T00:00:00,Questionnaires,L01.280.800
20081430,2010-01-01T00:00:00,Questionnaires,N05.715.360.300.695
20081430,2010-01-01T00:00:00,Questionnaires,N06.850.520.308.750
20091715,2010-01-01T00:00:00,Adsorption,G02.149.047
20091715,2010-01-01T00:00:00,Adsorption,G02.149.767.029
20091715,2010-01-01T00:00:00,Adsorption,G02.842.750.029
20091715,2010-01-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
20091715,2010-01-01T00:00:00,"Models, Theoretical",E05.599
20091715,2010-01-01T00:00:00,Molecular Structure,G02.111.570
20091715,2010-01-01T00:00:00,Molecular Structure,G02.575
20091715,2010-01-01T00:00:00,Molecular Structure,G02.842.575
20091715,2010-01-01T00:00:00,Polyesters,D05.750.728
20091715,2010-01-01T00:00:00,Polyesters,D25.720.728
20091715,2010-01-01T00:00:00,Polyesters,J01.637.051.720.728
20091715,2010-01-01T00:00:00,Polymers,D05.750
20091715,2010-01-01T00:00:00,Polymers,D25.720
20091715,2010-01-01T00:00:00,Polymers,J01.637.051.720
20097999,2010-01-01T00:00:00,"Child, Preschool",M01.060.406.448
20097999,2010-01-01T00:00:00,Chronic Disease,C23.550.291.500
20097999,2010-01-01T00:00:00,"Diagnosis, Differential",E01.171
20097999,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20097999,2010-01-01T00:00:00,Infant,M01.060.703
20097999,2010-01-01T00:00:00,Postoperative Complications,C23.550.767
20097999,2010-01-01T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
20097999,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20097999,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20097999,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20103223,2010-01-01T00:00:00,Animals,B01.050
20103223,2010-01-01T00:00:00,"Cardiomyopathy, Dilated",C14.280.195.160
20103223,2010-01-01T00:00:00,"Cardiomyopathy, Dilated",C14.280.238.070
20103223,2010-01-01T00:00:00,Computer Simulation,L01.224.160
20103223,2010-01-01T00:00:00,"Disease Models, Animal",C22.232
20103223,2010-01-01T00:00:00,"Disease Models, Animal",E05.598.500
20103223,2010-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20103223,2010-01-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
20103223,2010-01-01T00:00:00,Finite Element Analysis,E05.355
20103223,2010-01-01T00:00:00,Heart Failure,C14.280.434
20103223,2010-01-01T00:00:00,Heart-Assist Devices,E04.050.430
20103223,2010-01-01T00:00:00,Heart-Assist Devices,E07.695.300.300
20103223,2010-01-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
20103223,2010-01-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20103223,2010-01-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20103223,2010-01-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
20103223,2010-01-01T00:00:00,Ventricular Pressure,G09.330.190.962.950
20103223,2010-01-01T00:00:00,Ventricular Pressure,G09.330.380.937
20103470,2010-01-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20103470,2010-01-01T00:00:00,Chronic Periodontitis,C07.465.714.533.324
20103470,2010-01-01T00:00:00,Dental Plaque,C07.793.208.377
20103470,2010-01-01T00:00:00,Gingivitis,C07.465.714.258.480
20103470,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20103470,2010-01-01T00:00:00,United States,Z01.107.567.875
20109314,2010-01-01T00:00:00,Chronic Disease,C23.550.291.500
20109314,2010-01-01T00:00:00,Complement System Proteins,D12.776.124.486.274
20109314,2010-01-01T00:00:00,Gene Expression Regulation,G05.355.315
20109314,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20109314,2010-01-01T00:00:00,Nasal Polyps,C08.460.572
20109314,2010-01-01T00:00:00,Nasal Polyps,C09.603.557
20109314,2010-01-01T00:00:00,Nasal Polyps,C23.300.825.557
20109314,2010-01-01T00:00:00,Sinusitis,C08.460.692.752
20109314,2010-01-01T00:00:00,Sinusitis,C08.730.749
20109314,2010-01-01T00:00:00,Sinusitis,C09.603.692.752
20109322,2010-01-01T00:00:00,Adult,M01.060.116
20109322,2010-01-01T00:00:00,Chronic Disease,C23.550.291.500
20109322,2010-01-01T00:00:00,Community-Based Participatory Research,N05.425.104
20109322,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20109322,2010-01-01T00:00:00,Questionnaires,E05.318.308.750
20109322,2010-01-01T00:00:00,Questionnaires,L01.280.800
20109322,2010-01-01T00:00:00,Questionnaires,N05.715.360.300.695
20109322,2010-01-01T00:00:00,Questionnaires,N06.850.520.308.750
20109322,2010-01-01T00:00:00,Research Design,E05.581.500
20109322,2010-01-01T00:00:00,Research Design,H01.770.644.728
20109322,2010-01-01T00:00:00,Rhinitis,C08.460.799
20109322,2010-01-01T00:00:00,Rhinitis,C08.730.674
20109322,2010-01-01T00:00:00,Rhinitis,C09.603.799
20109322,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20109322,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20109322,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20109322,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20109322,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20109322,2010-01-01T00:00:00,Sinusitis,C08.460.692.752
20109322,2010-01-01T00:00:00,Sinusitis,C08.730.749
20109322,2010-01-01T00:00:00,Sinusitis,C09.603.692.752
20109322,2010-01-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
20109322,2010-01-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
20116648,2010-01-01T00:00:00,Chronic Disease,C23.550.291.500
20116648,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20116648,2010-01-01T00:00:00,Kidney Diseases,C12.777.419
20116648,2010-01-01T00:00:00,Kidney Diseases,C13.351.968.419
20116648,2010-01-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
20116648,2010-01-01T00:00:00,Metabolic Syndrome X,C18.452.625
20116648,2010-01-01T00:00:00,Minority Groups,I01.880.371
20116648,2010-01-01T00:00:00,United States,Z01.107.567.875
20122316,2010-01-01T00:00:00,Anesthesia,E03.155
20122316,2010-01-01T00:00:00,"Anesthetics, Inhalation",D27.505.696.277.100.035.060
20122316,2010-01-01T00:00:00,"Anesthetics, Inhalation",D27.505.954.427.210.100.035.060
20122316,2010-01-01T00:00:00,Animals,B01.050
20122316,2010-01-01T00:00:00,Ketamine,D02.455.426.392.368.367.652
20122316,2010-01-01T00:00:00,Liver Transplantation,E04.210.650
20122316,2010-01-01T00:00:00,Liver Transplantation,E04.936.450.490
20122316,2010-01-01T00:00:00,Liver Transplantation,E04.936.580.490
20122316,2010-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20122316,2010-01-01T00:00:00,Time Factors,G01.910.857
20122490,2010-01-01T00:00:00,Echocardiography,E01.370.350.850.220
20122490,2010-01-01T00:00:00,Echocardiography,E01.370.370.380.220
20122490,2010-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20122490,2010-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20122490,2010-01-01T00:00:00,"Radiography, Interventional",E01.370.350.700.725
20122490,2010-01-01T00:00:00,"Radiography, Interventional",E02.148.694
20122490,2010-01-01T00:00:00,"Radiography, Interventional",E04.800.780
20122490,2010-01-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
20122490,2010-01-01T00:00:00,"Surgery, Computer-Assisted",E04.749
20122490,2010-01-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
20122490,2010-01-01T00:00:00,United States,Z01.107.567.875
20123246,2010-01-01T00:00:00,Adult,M01.060.116
20123246,2010-01-01T00:00:00,Aged,M01.060.116.100
20123246,2010-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
20123246,2010-01-01T00:00:00,Blood Pressure,G09.330.380.076
20123246,2010-01-01T00:00:00,Cardiac Output,E01.370.370.380.150
20123246,2010-01-01T00:00:00,Cardiac Output,G09.330.380.124
20123246,2010-01-01T00:00:00,Heart,A07.541
20123246,2010-01-01T00:00:00,Heart Failure,C14.280.434
20123246,2010-01-01T00:00:00,Heart-Assist Devices,E04.050.430
20123246,2010-01-01T00:00:00,Heart-Assist Devices,E07.695.300.300
20123246,2010-01-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
20123246,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20123246,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20123246,2010-01-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
20123246,2010-01-01T00:00:00,Stroke Volume,G09.330.380.124.882
20123246,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20123246,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20123246,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20124334,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20124334,2010-01-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C04.557.386.480.150.585
20124334,2010-01-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C15.604.515.569.480.150.585
20124334,2010-01-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C20.683.515.761.480.150.585
20124334,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20130695,2010-01-01T00:00:00,Animals,B01.050
20130695,2010-01-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20130695,2010-01-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
20130695,2010-01-01T00:00:00,Escherichia coli,B03.440.450.425.325.300
20130695,2010-01-01T00:00:00,Escherichia coli,B03.660.250.150.180.100
20130695,2010-01-01T00:00:00,Meat Products,J02.500.600.500
20130695,2010-01-01T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
20130695,2010-01-01T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
20130695,2010-01-01T00:00:00,Swine,B01.050.150.900.649.077.880
20130695,2010-01-01T00:00:00,United States,Z01.107.567.875
20130695,2010-01-01T00:00:00,Vancomycin,D09.400.420.925
20130695,2010-01-01T00:00:00,Vancomycin,D12.644.233.925
20130695,2010-01-01T00:00:00,Water,D01.455.900
20130695,2010-01-01T00:00:00,Water,D01.650.550.925
20135933,2010-01-01T00:00:00,Adult,M01.060.116
20135933,2010-01-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
20135933,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135933,2010-01-01T00:00:00,Infection Control,N06.850.780.200.450
20135933,2010-01-01T00:00:00,Skin,A17.815
20135951,2010-01-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
20135951,2010-01-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
20135951,2010-01-01T00:00:00,Colonoscopy,E04.210.240.250.160
20135951,2010-01-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
20135951,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135951,2010-01-01T00:00:00,Intestinal Perforation,C06.405.469.557
20135951,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20135952,2010-01-01T00:00:00,Abdominal Pain,C23.888.646.100
20135952,2010-01-01T00:00:00,Abdominal Pain,C23.888.821.030
20135952,2010-01-01T00:00:00,Appendicitis,C06.405.205.099
20135952,2010-01-01T00:00:00,Appendicitis,C06.405.469.110.207
20135952,2010-01-01T00:00:00,Child,M01.060.406
20135952,2010-01-01T00:00:00,"Child, Preschool",M01.060.406.448
20135952,2010-01-01T00:00:00,Colon,A03.556.124.526.356
20135952,2010-01-01T00:00:00,Colon,A03.556.249.249.356
20135952,2010-01-01T00:00:00,"Diagnosis, Differential",E01.171
20135952,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135952,2010-01-01T00:00:00,Intestinal Volvulus,C06.405.469.531.568
20135952,2010-01-01T00:00:00,Intestinal Volvulus,C23.300.970.500
20135952,2010-01-01T00:00:00,Laparoscopy,E01.370.388.250.520
20135952,2010-01-01T00:00:00,Laparoscopy,E04.800.250.520
20135952,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20135952,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20135952,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20135952,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20135952,2010-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20135955,2010-01-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
20135955,2010-01-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
20135955,2010-01-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
20135955,2010-01-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
20135955,2010-01-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
20135955,2010-01-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
20135955,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135955,2010-01-01T00:00:00,Liver Cirrhosis,C06.552.630
20135955,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20135955,2010-01-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20135955,2010-01-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20135955,2010-01-01T00:00:00,Pancreatic Neoplasms,C06.301.761
20135955,2010-01-01T00:00:00,Pancreatic Neoplasms,C06.689.667
20135955,2010-01-01T00:00:00,Pancreatic Neoplasms,C19.344.421
20135955,2010-01-01T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.035.760.795
20135955,2010-01-01T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.100.814.790.830
20135956,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135956,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20135956,2010-01-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
20135956,2010-01-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
20135958,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135958,2010-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
20135958,2010-01-01T00:00:00,Intestinal Volvulus,C06.405.469.531.568
20135958,2010-01-01T00:00:00,Intestinal Volvulus,C23.300.970.500
20143645,2010-01-01T00:00:00,"Angioedemas, Hereditary",C14.907.079.500
20143645,2010-01-01T00:00:00,"Angioedemas, Hereditary",C16.320.078
20143645,2010-01-01T00:00:00,"Angioedemas, Hereditary",C17.800.862.945.066.500
20143645,2010-01-01T00:00:00,"Angioedemas, Hereditary",C20.543.480.904.066.500
20143645,2010-01-01T00:00:00,Bradykinin,D12.644.276.812.169
20143645,2010-01-01T00:00:00,Bradykinin,D12.644.400.090
20143645,2010-01-01T00:00:00,Bradykinin,D12.644.456.193
20143645,2010-01-01T00:00:00,Bradykinin,D12.776.467.812.169
20143645,2010-01-01T00:00:00,Bradykinin,D12.776.641.650.090
20143645,2010-01-01T00:00:00,Bradykinin,D23.469.050.375.110
20143645,2010-01-01T00:00:00,Bradykinin,D23.529.812.169
20143645,2010-01-01T00:00:00,Complement Activation,G12.425.255
20143645,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20143645,2010-01-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20143645,2010-01-01T00:00:00,Kallikreins,D08.811.277.656.300.760.442
20143645,2010-01-01T00:00:00,Kallikreins,D08.811.277.656.959.350.442
20143645,2010-01-01T00:00:00,Kallikreins,D12.776.124.125.597
20143645,2010-01-01T00:00:00,Kallikreins,D23.119.597
20143645,2010-01-01T00:00:00,Mutation,G05.365.590
20145452,2010-01-01T00:00:00,Attention,F02.830.104.214
20145452,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20145452,2010-01-01T00:00:00,"Models, Educational",E05.599.545
20145452,2010-01-01T00:00:00,"Models, Educational",I02.903.302
20145452,2010-01-01T00:00:00,Needs Assessment,I02.594
20145452,2010-01-01T00:00:00,Needs Assessment,N03.349.380.565
20145452,2010-01-01T00:00:00,Needs Assessment,N05.300.537
20145452,2010-01-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
20145452,2010-01-01T00:00:00,Nurse's Role,N05.300.100.337
20145452,2010-01-01T00:00:00,Nursing Assessment,N04.590.233.508.480
20145452,2010-01-01T00:00:00,Patient Education as Topic,I02.233.332.500
20145452,2010-01-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20145452,2010-01-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
20151726,2010-01-01T00:00:00,Combined Modality Therapy,E02.186
20151726,2010-01-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
20151726,2010-01-01T00:00:00,Decision Support Techniques,E05.245
20151726,2010-01-01T00:00:00,Decision Support Techniques,L01.700.508.190
20151726,2010-01-01T00:00:00,Health Care Costs,N03.219.151.400
20151726,2010-01-01T00:00:00,Health Care Costs,N05.300.375
20151726,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20151726,2010-01-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20151726,2010-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20151726,2010-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20151726,2010-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20151726,2010-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20151726,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20151726,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20151726,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20151726,2010-01-01T00:00:00,United States,Z01.107.567.875
20158140,2010-01-01T00:00:00,Biomedical Research,H01.770.644.145
20158140,2010-01-01T00:00:00,Decision Making,F02.463.785.373
20158140,2010-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
20158140,2010-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
20158140,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20158140,2010-01-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
20158140,2010-01-01T00:00:00,Qualitative Research,H01.770.644.241.850
20199634,2010-01-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
20199634,2010-01-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
20199634,2010-01-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
20199634,2010-01-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
20199634,2010-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
20199634,2010-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
20199634,2010-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
20199634,2010-01-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
20199634,2010-01-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
20199634,2010-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
20199634,2010-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
20199634,2010-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20199634,2010-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20199634,2010-01-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
20199634,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20199634,2010-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20199634,2010-01-01T00:00:00,Lung Neoplasms,C08.381.540
20199634,2010-01-01T00:00:00,Lung Neoplasms,C08.785.520
20199634,2010-01-01T00:00:00,Mass Screening,E01.370.500
20199634,2010-01-01T00:00:00,Mass Screening,E05.318.308.250.580
20199634,2010-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20199634,2010-01-01T00:00:00,Mass Screening,N02.421.726.233.443
20199634,2010-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20199634,2010-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20199634,2010-01-01T00:00:00,Mass Screening,N06.850.780.500
20199634,2010-01-01T00:00:00,Neoplasm Staging,E01.370.550
20199634,2010-01-01T00:00:00,Neoplastic Stem Cells,A11.872.650
20217526,2010-01-01T00:00:00,Animals,B01.050
20217526,2010-01-01T00:00:00,Antineoplastic Agents,D27.505.954.248
20217526,2010-01-01T00:00:00,Drug Carriers,D26.255.260
20217526,2010-01-01T00:00:00,Drug Carriers,D27.720.280.260
20217526,2010-01-01T00:00:00,Drug Carriers,E02.319.300.380
20217526,2010-01-01T00:00:00,Drug Delivery Systems,E02.319.300
20217526,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20217526,2010-01-01T00:00:00,Liposomes,D25.479.517
20217526,2010-01-01T00:00:00,Liposomes,D26.255.260.517
20217526,2010-01-01T00:00:00,Liposomes,D27.720.280.260.517
20217526,2010-01-01T00:00:00,Liposomes,J01.637.051.479.517
20217526,2010-01-01T00:00:00,Liposomes,J01.637.087.500.517
20217526,2010-01-01T00:00:00,Nanoparticles,J01.637.512.600
20217526,2010-01-01T00:00:00,Neoplasms,C04
20217526,2010-01-01T00:00:00,Polymers,D05.750
20217526,2010-01-01T00:00:00,Polymers,D25.720
20217526,2010-01-01T00:00:00,Polymers,J01.637.051.720
20238012,2010-01-01T00:00:00,Aging,G07.700.320.124
20238012,2010-01-01T00:00:00,Animals,B01.050
20238012,2010-01-01T00:00:00,Eye Proteins,D12.776.306
20238012,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20238012,2010-01-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
20238012,2010-01-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
20238012,2010-01-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
20238012,2010-01-01T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
20238012,2010-01-01T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
20238012,2010-01-01T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
20238012,2010-01-01T00:00:00,Retinoids,D02.455.326.271.665.202.495
20238012,2010-01-01T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
20238012,2010-01-01T00:00:00,Retinoids,D02.455.849.131.495
20238012,2010-01-01T00:00:00,Retinoids,D23.767.261.700
20238012,2010-01-01T00:00:00,"Vision, Ocular",F02.830.816.964
20238012,2010-01-01T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
20238012,2010-01-01T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
20238012,2010-01-01T00:00:00,"Vision, Ocular",G04.299.880.480.900
20238012,2010-01-01T00:00:00,"Vision, Ocular",G11.561.600.810.964
20238012,2010-01-01T00:00:00,"Vision, Ocular",G14.640.816
20307862,2010-01-01T00:00:00,Drainage,E02.309
20307862,2010-01-01T00:00:00,Drainage,E04.237
20307862,2010-01-01T00:00:00,Fontan Procedure,E04.035.410.295
20307862,2010-01-01T00:00:00,Fontan Procedure,E04.100.376.410.295
20307862,2010-01-01T00:00:00,Fontan Procedure,E04.928.220.370.295
20307862,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20307862,2010-01-01T00:00:00,Length of Stay,E02.760.400.480
20307862,2010-01-01T00:00:00,Length of Stay,N02.421.585.400.480
20307862,2010-01-01T00:00:00,Oxygen,D01.268.185.550
20307862,2010-01-01T00:00:00,Oxygen,D01.362.670
20307862,2010-01-01T00:00:00,Pleural Effusion,C08.528.652
20307862,2010-01-01T00:00:00,Postoperative Complications,C23.550.767
20307862,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20307862,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20307862,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20308778,2010-01-01T00:00:00,Aged,M01.060.116.100
20308778,2010-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
20308778,2010-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
20308778,2010-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
20308778,2010-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
20308778,2010-01-01T00:00:00,Apolipoproteins E,D10.532.091.500
20308778,2010-01-01T00:00:00,Apolipoproteins E,D12.776.070.400.500
20308778,2010-01-01T00:00:00,Apolipoproteins E,D12.776.521.120.500
20308778,2010-01-01T00:00:00,Brain,A08.186.211
20308778,2010-01-01T00:00:00,Diet,E05.272
20308778,2010-01-01T00:00:00,Diet,G07.610.240
20308778,2010-01-01T00:00:00,Energy Intake,G07.610.240.340
20308778,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20308778,2010-01-01T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
20308778,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20308778,2010-01-01T00:00:00,Oxidative Stress,G03.495.710
20308778,2010-01-01T00:00:00,Oxidative Stress,G07.700.830.750
20308778,2010-01-01T00:00:00,Phosphorylation,G02.111.087.677
20308778,2010-01-01T00:00:00,Phosphorylation,G02.149.115.677
20308778,2010-01-01T00:00:00,Phosphorylation,G02.149.465.700
20308778,2010-01-01T00:00:00,Phosphorylation,G02.607.750.700
20308778,2010-01-01T00:00:00,Phosphorylation,G03.495.790
20308778,2010-01-01T00:00:00,Point Mutation,G05.365.590.675
20308787,2010-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
20308787,2010-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
20308787,2010-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
20308787,2010-01-01T00:00:00,Animals,B01.050
20308787,2010-01-01T00:00:00,Brain,A08.186.211
20308787,2010-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20308787,2010-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20308787,2010-01-01T00:00:00,"Disease Models, Animal",C22.232
20308787,2010-01-01T00:00:00,"Disease Models, Animal",E05.598.500
20308787,2010-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20308787,2010-01-01T00:00:00,Oxidative Stress,G03.495.710
20308787,2010-01-01T00:00:00,Oxidative Stress,G07.700.830.750
20308787,2010-01-01T00:00:00,tau Proteins,D12.776.220.600.450.510
20308787,2010-01-01T00:00:00,tau Proteins,D12.776.641.560.510
20364080,2010-01-01T00:00:00,African Americans,M01.686.508.100.100
20364080,2010-01-01T00:00:00,African Americans,M01.686.754.100
20364080,2010-01-01T00:00:00,Amputation,E04.555.080
20364080,2010-01-01T00:00:00,Chronic Disease,C23.550.291.500
20364080,2010-01-01T00:00:00,Community-Based Participatory Research,N05.425.104
20364080,2010-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
20364080,2010-01-01T00:00:00,Diabetes Mellitus,C19.246
20364080,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20364080,2010-01-01T00:00:00,Self Care,E02.900
20364080,2010-01-01T00:00:00,Self Care,N02.421.784.680
20364080,2010-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20364080,2010-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20364080,2010-01-01T00:00:00,Urban Population,N01.600.900
20374949,2010-01-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
20374949,2010-01-01T00:00:00,Aged,M01.060.116.100
20374949,2010-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20374949,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20374949,2010-01-01T00:00:00,Hypertension,C14.907.489
20374949,2010-01-01T00:00:00,Stroke,C10.228.140.300.775
20374949,2010-01-01T00:00:00,Stroke,C14.907.253.855
20374950,2010-01-01T00:00:00,Adrenergic alpha-Antagonists,D27.505.519.625.050.200.100
20374950,2010-01-01T00:00:00,Adrenergic alpha-Antagonists,D27.505.696.577.050.200.100
20374950,2010-01-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
20374950,2010-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20374950,2010-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
20374950,2010-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
20374950,2010-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20374950,2010-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20374950,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20374950,2010-01-01T00:00:00,Hypertension,C14.907.489
20374950,2010-01-01T00:00:00,Medication Adherence,F01.145.488.500.500
20374950,2010-01-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
20374950,2010-01-01T00:00:00,Patient Selection,E05.581.500.653
20374950,2010-01-01T00:00:00,Patient Selection,N04.590.731
20374950,2010-01-01T00:00:00,Renin,D08.811.277.656.074.500.780
20374950,2010-01-01T00:00:00,Renin,D08.811.277.656.300.048.780
20374950,2010-01-01T00:00:00,Renin,D08.811.277.656.837.750
20377363,2010-01-01T00:00:00,Antineoplastic Agents,D27.505.954.248
20377363,2010-01-01T00:00:00,Combined Modality Therapy,E02.186
20377363,2010-01-01T00:00:00,Computer Simulation,L01.224.160
20377363,2010-01-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
20377363,2010-01-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
20377363,2010-01-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
20377363,2010-01-01T00:00:00,Drug Delivery Systems,E02.319.300
20377363,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20377363,2010-01-01T00:00:00,"Hyperthermia, Induced",E02.565
20377363,2010-01-01T00:00:00,"Hyperthermia, Induced",E02.779.496
20377363,2010-01-01T00:00:00,Liposomes,D25.479.517
20377363,2010-01-01T00:00:00,Liposomes,D26.255.260.517
20377363,2010-01-01T00:00:00,Liposomes,D27.720.280.260.517
20377363,2010-01-01T00:00:00,Liposomes,J01.637.051.479.517
20377363,2010-01-01T00:00:00,Liposomes,J01.637.087.500.517
20377363,2010-01-01T00:00:00,Liver Neoplasms,C04.588.274.623
20377363,2010-01-01T00:00:00,Liver Neoplasms,C06.301.623
20377363,2010-01-01T00:00:00,Liver Neoplasms,C06.552.697
20377363,2010-01-01T00:00:00,"Models, Biological",E05.599.395
20386054,2010-01-01T00:00:00,Breast Neoplasms,C04.588.180
20386054,2010-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
20386054,2010-01-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
20386054,2010-01-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
20386054,2010-01-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
20386054,2010-01-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
20386054,2010-01-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
20386054,2010-01-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
20386054,2010-01-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
20386054,2010-01-01T00:00:00,Delivery of Health Care,N04.590.374
20386054,2010-01-01T00:00:00,Delivery of Health Care,N05.300
20386054,2010-01-01T00:00:00,Early Detection of Cancer,E01.390.500
20386054,2010-01-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
20386054,2010-01-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
20386054,2010-01-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
20386054,2010-01-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
20386054,2010-01-01T00:00:00,Health Policy,I01.880.604.825.608.400
20386054,2010-01-01T00:00:00,Health Policy,N03.706.825.608.428
20386054,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20386054,2010-01-01T00:00:00,Mammography,E01.370.350.700.500
20386054,2010-01-01T00:00:00,Mass Screening,E01.370.500
20386054,2010-01-01T00:00:00,Mass Screening,E05.318.308.250.580
20386054,2010-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20386054,2010-01-01T00:00:00,Mass Screening,N02.421.726.233.443
20386054,2010-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20386054,2010-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20386054,2010-01-01T00:00:00,Mass Screening,N06.850.780.500
20386054,2010-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20386054,2010-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20386054,2010-01-01T00:00:00,Primary Health Care,N04.590.233.727
20386054,2010-01-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
20386054,2010-01-01T00:00:00,"Quality Assurance, Health Care",N05.700
20386054,2010-01-01T00:00:00,Referral and Consultation,N04.452.758.849
20386054,2010-01-01T00:00:00,Social Support,I01.880.656.600
20386054,2010-01-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20386054,2010-01-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20386054,2010-01-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20386054,2010-01-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20390799,2010-01-01T00:00:00,Adolescent,M01.060.057
20390799,2010-01-01T00:00:00,Adolescent Behavior,F01.145.022
20390799,2010-01-01T00:00:00,Age Factors,N05.715.350.075
20390799,2010-01-01T00:00:00,Age Factors,N06.850.490.250
20390799,2010-01-01T00:00:00,Child,M01.060.406
20390799,2010-01-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20390799,2010-01-01T00:00:00,Health Surveys,E05.318.308.250
20390799,2010-01-01T00:00:00,Health Surveys,N05.715.360.300.375
20390799,2010-01-01T00:00:00,Health Surveys,N06.850.520.308.250
20390799,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20390799,2010-01-01T00:00:00,Interviews as Topic,E05.318.308.420
20390799,2010-01-01T00:00:00,Interviews as Topic,L01.280.520
20390799,2010-01-01T00:00:00,Interviews as Topic,N05.715.360.300.400
20390799,2010-01-01T00:00:00,Interviews as Topic,N06.850.520.308.420
20390799,2010-01-01T00:00:00,Questionnaires,E05.318.308.750
20390799,2010-01-01T00:00:00,Questionnaires,L01.280.800
20390799,2010-01-01T00:00:00,Questionnaires,N05.715.360.300.695
20390799,2010-01-01T00:00:00,Questionnaires,N06.850.520.308.750
20390799,2010-01-01T00:00:00,Regression Analysis,E05.318.740.750
20390799,2010-01-01T00:00:00,Regression Analysis,N05.715.360.750.695
20390799,2010-01-01T00:00:00,Regression Analysis,N06.850.520.830.750
20390799,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20390799,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20390799,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20390799,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20390799,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20390799,2010-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20390799,2010-01-01T00:00:00,Substance-Related Disorders,C21.739
20390799,2010-01-01T00:00:00,Substance-Related Disorders,F03.900
20390799,2010-01-01T00:00:00,United States,Z01.107.567.875
20390799,2010-01-01T00:00:00,Violence,I01.198.240.856
20390799,2010-01-01T00:00:00,Violence,I01.880.735.900
20390806,2010-01-01T00:00:00,Adolescent,M01.060.057
20390806,2010-01-01T00:00:00,African Americans,M01.686.508.100.100
20390806,2010-01-01T00:00:00,African Americans,M01.686.754.100
20390806,2010-01-01T00:00:00,Behavior Therapy,F04.754.137
20390806,2010-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20390806,2010-01-01T00:00:00,Body Mass Index,E05.041.124.125
20390806,2010-01-01T00:00:00,Body Mass Index,G07.100.100.125
20390806,2010-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20390806,2010-01-01T00:00:00,Community Health Services,N02.421.143
20390806,2010-01-01T00:00:00,Exercise,G11.427.590.237
20390806,2010-01-01T00:00:00,Exercise,I03.350
20390806,2010-01-01T00:00:00,Health Behavior,F01.145.488
20390806,2010-01-01T00:00:00,Health Promotion,N02.370
20390806,2010-01-01T00:00:00,Health Promotion,N02.421.726.507
20390806,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20390806,2010-01-01T00:00:00,Obesity,C18.654.726.500
20390806,2010-01-01T00:00:00,Obesity,C23.888.144.699.500
20390806,2010-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20390806,2010-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20390806,2010-01-01T00:00:00,Parenting,F01.829.263.370.310
20390806,2010-01-01T00:00:00,Social Environment,I01.880.656
20390812,2010-01-01T00:00:00,Child,M01.060.406
20390812,2010-01-01T00:00:00,Child Abuse,I01.198.240.856.350.250
20390812,2010-01-01T00:00:00,Child Abuse,I01.880.735.900.350.250
20390812,2010-01-01T00:00:00,Child Abuse,I01.880.787.293.292
20390812,2010-01-01T00:00:00,Child Behavior Disorders,F03.550.300
20390812,2010-01-01T00:00:00,"Child, Preschool",M01.060.406.448
20390812,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20390812,2010-01-01T00:00:00,"Models, Psychological",E05.599.695
20390812,2010-01-01T00:00:00,Parent-Child Relations,F01.829.263.370.290
20390812,2010-01-01T00:00:00,Parenting,F01.829.263.370.310
20390812,2010-01-01T00:00:00,Parents,F01.829.263.500.320
20390812,2010-01-01T00:00:00,Parents,I01.880.225.500.340
20390812,2010-01-01T00:00:00,Parents,M01.620
20390812,2010-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20390812,2010-01-01T00:00:00,Risk Assessment,N04.452.871.715
20390812,2010-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20390812,2010-01-01T00:00:00,Risk Assessment,N06.850.505.715
20390812,2010-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20390812,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20390812,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20390812,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20390812,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20390812,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20390812,2010-01-01T00:00:00,Social Isolation,F01.145.813.781
20390812,2010-01-01T00:00:00,Social Isolation,I01.880.683
20390812,2010-01-01T00:00:00,Social Support,I01.880.656.600
20391250,2010-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20391250,2010-01-01T00:00:00,Health Expenditures,N03.219.151.450
20391250,2010-01-01T00:00:00,Health Expenditures,N05.300.385
20391250,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20391250,2010-01-01T00:00:00,Income,N01.824.417
20391250,2010-01-01T00:00:00,Rural Population,N01.600.725
20391250,2010-01-01T00:00:00,Sex Factors,N05.715.350.675
20391250,2010-01-01T00:00:00,Sex Factors,N06.850.490.875
20391250,2010-01-01T00:00:00,United States,Z01.107.567.875
20391250,2010-01-01T00:00:00,Urban Population,N01.600.900
20397441,2010-01-01T00:00:00,Adult,M01.060.116
20397441,2010-01-01T00:00:00,Disability Evaluation,E01.370.400
20397441,2010-01-01T00:00:00,Health Status,I01.240.425
20397441,2010-01-01T00:00:00,Health Status,N01.224.425
20397441,2010-01-01T00:00:00,Health Status,N06.850.505.400.425
20397441,2010-01-01T00:00:00,Health Surveys,E05.318.308.250
20397441,2010-01-01T00:00:00,Health Surveys,N05.715.360.300.375
20397441,2010-01-01T00:00:00,Health Surveys,N06.850.520.308.250
20397441,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20397441,2010-01-01T00:00:00,"Models, Psychological",E05.599.695
20397441,2010-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20397441,2010-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20397441,2010-01-01T00:00:00,Questionnaires,E05.318.308.750
20397441,2010-01-01T00:00:00,Questionnaires,L01.280.800
20397441,2010-01-01T00:00:00,Questionnaires,N05.715.360.300.695
20397441,2010-01-01T00:00:00,Questionnaires,N06.850.520.308.750
20397441,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20397441,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20397441,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20397441,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20397441,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20397441,2010-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20397441,2010-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
20397441,2010-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
20397441,2010-01-01T00:00:00,United States,Z01.107.567.875
20399960,2010-01-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
20399960,2010-01-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
20399960,2010-01-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
20399960,2010-01-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
20399960,2010-01-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
20399960,2010-01-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
20399960,2010-01-01T00:00:00,Carrier Proteins,D12.776.157
20399960,2010-01-01T00:00:00,Cholesterol,D04.808.247.222.284
20399960,2010-01-01T00:00:00,Cholesterol,D04.808.247.808.197
20399960,2010-01-01T00:00:00,Cholesterol,D10.570.938.208
20399960,2010-01-01T00:00:00,Cholesterol,D10.851.208
20399960,2010-01-01T00:00:00,Estrone,D04.808.365.415.414
20399960,2010-01-01T00:00:00,Estrone,D04.808.578.502.497
20399960,2010-01-01T00:00:00,Estrone,D06.472.040.502.497
20399960,2010-01-01T00:00:00,Estrone,D06.472.334.851.437.996
20399960,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20399960,2010-01-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
20399960,2010-01-01T00:00:00,Kidney Neoplasms,C12.758.820.750
20399960,2010-01-01T00:00:00,Kidney Neoplasms,C12.777.419.473
20399960,2010-01-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
20399960,2010-01-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
20399960,2010-01-01T00:00:00,Lipids,D10
20399960,2010-01-01T00:00:00,Obesity,C18.654.726.500
20399960,2010-01-01T00:00:00,Obesity,C23.888.144.699.500
20399960,2010-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20399960,2010-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20413851,2010-01-01T00:00:00,Amino Acid Sequence,G02.111.570.060
20413851,2010-01-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20413851,2010-01-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
20413851,2010-01-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
20413851,2010-01-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
20413851,2010-01-01T00:00:00,Animals,B01.050
20413851,2010-01-01T00:00:00,Aqueous Humor,A09.371.060.067.070
20413851,2010-01-01T00:00:00,Aqueous Humor,A12.207.270.040
20413851,2010-01-01T00:00:00,Body Fluids,A12.207
20413851,2010-01-01T00:00:00,Brain Chemistry,G02.111.100
20413851,2010-01-01T00:00:00,Brain Chemistry,G03.200
20413851,2010-01-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20413851,2010-01-01T00:00:00,Central Nervous System,A08.186
20413851,2010-01-01T00:00:00,Eye,A01.456.505.420
20413851,2010-01-01T00:00:00,Eye,A09.371
20413851,2010-01-01T00:00:00,Molecular Sequence Data,L01.453.245.667
20413851,2010-01-01T00:00:00,Retina,A09.371.729
20413851,2010-01-01T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
20413851,2010-01-01T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
20421091,2010-01-01T00:00:00,Clinical Competence,I02.399.630.210
20421091,2010-01-01T00:00:00,Clinical Competence,N04.761.210
20421091,2010-01-01T00:00:00,Documentation,L01.453.245
20421091,2010-01-01T00:00:00,General Surgery,H02.403.810.300
20421091,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20421091,2010-01-01T00:00:00,Internship and Residency,I02.358.399.644
20421091,2010-01-01T00:00:00,Program Development,N04.452.760
20421091,2010-01-01T00:00:00,Program Evaluation,E05.337.820
20421091,2010-01-01T00:00:00,Program Evaluation,N04.761.685
20421091,2010-01-01T00:00:00,Program Evaluation,N05.715.360.650
20429157,2010-01-01T00:00:00,Air Pollution,N06.850.460.100
20429157,2010-01-01T00:00:00,Breast Neoplasms,C04.588.180
20429157,2010-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
20429157,2010-01-01T00:00:00,Disinfectants,D27.505.954.122.425
20429157,2010-01-01T00:00:00,Disinfectants,D27.720.274
20429157,2010-01-01T00:00:00,Environmental Exposure,N06.850.460.350
20429157,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20429157,2010-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20429157,2010-01-01T00:00:00,Lung Neoplasms,C08.381.540
20429157,2010-01-01T00:00:00,Lung Neoplasms,C08.785.520
20429157,2010-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20429157,2010-01-01T00:00:00,Risk Assessment,N04.452.871.715
20429157,2010-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20429157,2010-01-01T00:00:00,Risk Assessment,N06.850.505.715
20429157,2010-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20429157,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20429157,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20429157,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20429157,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20429157,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20429157,2010-01-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
20429157,2010-01-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
20429157,2010-01-01T00:00:00,United States,Z01.107.567.875
20429157,2010-01-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
20429157,2010-01-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
20429157,2010-01-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
20429157,2010-01-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
20429157,2010-01-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
20465074,2010-01-01T00:00:00,Confidentiality,F04.096.544.335.240
20465074,2010-01-01T00:00:00,Confidentiality,I01.880.604.473.650.500
20465074,2010-01-01T00:00:00,Confidentiality,I01.880.604.583.080
20465074,2010-01-01T00:00:00,Confidentiality,N03.706.437.650.124
20465074,2010-01-01T00:00:00,Confidentiality,N03.706.535.230
20465074,2010-01-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
20465074,2010-01-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
20465074,2010-01-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
20465074,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20465074,2010-01-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
20465074,2010-01-01T00:00:00,Physician-Patient Relations,N05.300.660.625
20465074,2010-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20465074,2010-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20465074,2010-01-01T00:00:00,Primary Prevention,N02.421.726.758
20465074,2010-01-01T00:00:00,Primary Prevention,N06.850.780.680
20465074,2010-01-01T00:00:00,United States,Z01.107.567.875
20500242,2010-01-01T00:00:00,Aged,M01.060.116.100
20500242,2010-01-01T00:00:00,Dementia,C10.228.140.380
20500242,2010-01-01T00:00:00,Dementia,F03.087.400
20500242,2010-01-01T00:00:00,Feeding Behavior,F01.145.113.547
20500242,2010-01-01T00:00:00,Feeding Behavior,F01.145.407
20500242,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20500242,2010-01-01T00:00:00,Malnutrition,C18.654.521
20515387,2010-01-01T00:00:00,Clinical Competence,I02.399.630.210
20515387,2010-01-01T00:00:00,Clinical Competence,N04.761.210
20515387,2010-01-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
20515387,2010-01-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
20515387,2010-01-01T00:00:00,Educational Measurement,I02.399
20515387,2010-01-01T00:00:00,Guidelines as Topic,N04.761.700.350
20515387,2010-01-01T00:00:00,Guidelines as Topic,N05.700.350
20515387,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20515387,2010-01-01T00:00:00,Workplace,N01.824.245.925
20515387,2010-01-01T00:00:00,Workplace,N04.452.677.975
20549881,2010-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
20549881,2010-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
20549881,2010-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
20549881,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20549881,2010-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20549881,2010-01-01T00:00:00,Lung Neoplasms,C08.381.540
20549881,2010-01-01T00:00:00,Lung Neoplasms,C08.785.520
20552423,2010-01-01T00:00:00,Animals,B01.050
20552423,2010-01-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20552423,2010-01-01T00:00:00,Cell Membrane,A11.284.149
20552423,2010-01-01T00:00:00,Cone Opsins,D12.776.306.466.249
20552423,2010-01-01T00:00:00,Cone Opsins,D23.767.930.750.249
20552423,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20552423,2010-01-01T00:00:00,Retinaldehyde,D02.047.850
20552423,2010-01-01T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
20552423,2010-01-01T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
20552423,2010-01-01T00:00:00,Retinaldehyde,D02.455.849.131.495.690
20552423,2010-01-01T00:00:00,Retinaldehyde,D23.767.261.700.690
20552423,2010-01-01T00:00:00,Transducin,D08.811.277.040.330.300.200.800
20552423,2010-01-01T00:00:00,Transducin,D12.644.360.375.940
20552423,2010-01-01T00:00:00,Transducin,D12.776.157.325.332.940
20552423,2010-01-01T00:00:00,Transducin,D12.776.476.375.940
20552423,2010-01-01T00:00:00,Transducin,D12.776.543.325.800
20711712,2010-01-01T00:00:00,Animals,B01.050
20711712,2010-01-01T00:00:00,Cell Line,A11.251.210
20711712,2010-01-01T00:00:00,Choroidal Neovascularization,C11.941.160.244
20711712,2010-01-01T00:00:00,Choroidal Neovascularization,C23.550.589.500.145
20711712,2010-01-01T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
20711712,2010-01-01T00:00:00,"Disease Models, Animal",C22.232
20711712,2010-01-01T00:00:00,"Disease Models, Animal",E05.598.500
20711712,2010-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20711712,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20711712,2010-01-01T00:00:00,Macular Degeneration,C11.768.585.439
20711712,2010-01-01T00:00:00,"Models, Biological",E05.599.395
20711712,2010-01-01T00:00:00,Oxidative Stress,G03.495.710
20711712,2010-01-01T00:00:00,Oxidative Stress,G07.700.830.750
20711712,2010-01-01T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
20711712,2010-01-01T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
20711712,2010-01-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
20711712,2010-01-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
20711712,2010-01-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20717777,2010-01-01T00:00:00,Biological Markers,D23.101
20717777,2010-01-01T00:00:00,Gene Expression Profiling,E05.393.332
20717777,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20717777,2010-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20717777,2010-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20717777,2010-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20717777,2010-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20717777,2010-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20717777,2010-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20717777,2010-01-01T00:00:00,RNA Stability,G02.111.780
20717777,2010-01-01T00:00:00,"RNA, Messenger",D13.444.735.544
20717777,2010-01-01T00:00:00,Saliva,A12.200.666
20737795,2010-01-01T00:00:00,Adolescent,M01.060.057
20737795,2010-01-01T00:00:00,Aged,M01.060.116.100
20737795,2010-01-01T00:00:00,Child,M01.060.406
20737795,2010-01-01T00:00:00,"Child, Preschool",M01.060.406.448
20737795,2010-01-01T00:00:00,Data Collection,E05.318.308
20737795,2010-01-01T00:00:00,Data Collection,L01.280
20737795,2010-01-01T00:00:00,Data Collection,N05.715.360.300
20737795,2010-01-01T00:00:00,Data Collection,N06.850.520.308
20737795,2010-01-01T00:00:00,Health Status,I01.240.425
20737795,2010-01-01T00:00:00,Health Status,N01.224.425
20737795,2010-01-01T00:00:00,Health Status,N06.850.505.400.425
20737795,2010-01-01T00:00:00,Hospitalization,E02.760.400
20737795,2010-01-01T00:00:00,Hospitalization,N02.421.585.400
20737795,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20737795,2010-01-01T00:00:00,Incidence,E05.318.308.985.525.375
20737795,2010-01-01T00:00:00,Incidence,L01.280.975.525.375
20737795,2010-01-01T00:00:00,Incidence,N01.224.935.597.500
20737795,2010-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20737795,2010-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20737795,2010-01-01T00:00:00,Infant,M01.060.703
20737795,2010-01-01T00:00:00,International Classification of Diseases,L01.453.245.945.400
20737795,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20737795,2010-01-01T00:00:00,Patient Discharge,E02.760.400.610
20737795,2010-01-01T00:00:00,Patient Discharge,N02.421.585.400.610
20737795,2010-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20737795,2010-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
20737795,2010-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
20737795,2010-01-01T00:00:00,Young Adult,M01.060.116.815
20811983,2010-01-01T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
20811983,2010-01-01T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
20811983,2010-01-01T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
20811983,2010-01-01T00:00:00,Amino Acid Sequence,G02.111.570.060
20811983,2010-01-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20811983,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20811983,2010-01-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
20811983,2010-01-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
20811983,2010-01-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
20811983,2010-01-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
20811983,2010-01-01T00:00:00,Mass Spectrometry,E05.196.566
20811983,2010-01-01T00:00:00,"Membranes, Artificial",D25.479
20811983,2010-01-01T00:00:00,"Membranes, Artificial",J01.637.051.479
20811983,2010-01-01T00:00:00,"Membranes, Artificial",J01.637.087.500
20811983,2010-01-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
20811983,2010-01-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
20811983,2010-01-01T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
20811983,2010-01-01T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
20811983,2010-01-01T00:00:00,Molecular Sequence Data,L01.453.245.667
20811983,2010-01-01T00:00:00,Mutation,G05.365.590
20811983,2010-01-01T00:00:00,Phosphorylation,G02.111.087.677
20811983,2010-01-01T00:00:00,Phosphorylation,G02.149.115.677
20811983,2010-01-01T00:00:00,Phosphorylation,G02.149.465.700
20811983,2010-01-01T00:00:00,Phosphorylation,G02.607.750.700
20811983,2010-01-01T00:00:00,Phosphorylation,G03.495.790
20811983,2010-01-01T00:00:00,Protein Engineering,E05.393.420.601
20813246,2010-01-01T00:00:00,Animals,B01.050
20813246,2010-01-01T00:00:00,Executive Function,F02.463.217
20813246,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20813246,2010-01-01T00:00:00,"Memory, Short-Term",F02.463.425.540.407
20813246,2010-01-01T00:00:00,Neurons,A08.663
20813246,2010-01-01T00:00:00,Neurons,A11.671
20813246,2010-01-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20818957,2010-01-01T00:00:00,Adult,M01.060.116
20818957,2010-01-01T00:00:00,Cesarean Section,E04.520.252.500
20818957,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20818957,2010-01-01T00:00:00,"Labor, Induced",E04.520.252.968
20818957,2010-01-01T00:00:00,Obesity,C18.654.726.500
20818957,2010-01-01T00:00:00,Obesity,C23.888.144.699.500
20818957,2010-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20818957,2010-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20818957,2010-01-01T00:00:00,Pre-Eclampsia,C13.703.395.249
20818957,2010-01-01T00:00:00,Pregnancy,G08.686.785.760.769
20818957,2010-01-01T00:00:00,Regression Analysis,E05.318.740.750
20818957,2010-01-01T00:00:00,Regression Analysis,N05.715.360.750.695
20818957,2010-01-01T00:00:00,Regression Analysis,N06.850.520.830.750
20818957,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20818957,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20818957,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20828092,2010-01-01T00:00:00,Adolescent,M01.060.057
20828092,2010-01-01T00:00:00,Adult,M01.060.116
20828092,2010-01-01T00:00:00,Aged,M01.060.116.100
20828092,2010-01-01T00:00:00,Hispanic Americans,M01.686.754.441
20828092,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20828092,2010-01-01T00:00:00,Hypertension,C14.907.489
20828092,2010-01-01T00:00:00,Mass Screening,E01.370.500
20828092,2010-01-01T00:00:00,Mass Screening,E05.318.308.250.580
20828092,2010-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20828092,2010-01-01T00:00:00,Mass Screening,N02.421.726.233.443
20828092,2010-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20828092,2010-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20828092,2010-01-01T00:00:00,Mass Screening,N06.850.780.500
20828092,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20828092,2010-01-01T00:00:00,Pilot Projects,E05.318.760.750
20828092,2010-01-01T00:00:00,Pilot Projects,E05.337.737
20828092,2010-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
20828092,2010-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
20828092,2010-01-01T00:00:00,Students,I02.233.748
20828092,2010-01-01T00:00:00,Students,I02.851
20828092,2010-01-01T00:00:00,Students,M01.848
20828092,2010-01-01T00:00:00,Urban Population,N01.600.900
20836938,2010-01-01T00:00:00,Adult,M01.060.116
20836938,2010-01-01T00:00:00,Algorithms,G17.035
20836938,2010-01-01T00:00:00,Algorithms,L01.224.050
20836938,2010-01-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
20836938,2010-01-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
20836938,2010-01-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
20836938,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20836938,2010-01-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
20836938,2010-01-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
20836938,2010-01-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
20836938,2010-01-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
20836938,2010-01-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
20836938,2010-01-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
20836938,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20836938,2010-01-01T00:00:00,Primary Health Care,N04.590.233.727
20836938,2010-01-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
20836938,2010-01-01T00:00:00,"Quality Assurance, Health Care",N05.700
20836938,2010-01-01T00:00:00,Rural Population,N01.600.725
20836938,2010-01-01T00:00:00,Urban Population,N01.600.900
20848872,2010-01-01T00:00:00,Aged,M01.060.116.100
20848872,2010-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
20848872,2010-01-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
20848872,2010-01-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
20848872,2010-01-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
20848872,2010-01-01T00:00:00,Energy Intake,G07.610.240.340
20848872,2010-01-01T00:00:00,Health Surveys,E05.318.308.250
20848872,2010-01-01T00:00:00,Health Surveys,N05.715.360.300.375
20848872,2010-01-01T00:00:00,Health Surveys,N06.850.520.308.250
20848872,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20848872,2010-01-01T00:00:00,Life Style,F01.829.458
20848872,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20848872,2010-01-01T00:00:00,"Models, Psychological",E05.599.695
20848872,2010-01-01T00:00:00,Motor Activity,F01.145.632
20848872,2010-01-01T00:00:00,Motor Activity,G11.427.590.530.698
20848872,2010-01-01T00:00:00,Obesity,C18.654.726.500
20848872,2010-01-01T00:00:00,Obesity,C23.888.144.699.500
20848872,2010-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20848872,2010-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20848872,2010-01-01T00:00:00,Smoking,F01.145.466.753
20848872,2010-01-01T00:00:00,"Stress, Psychological",F01.145.126.990
20848872,2010-01-01T00:00:00,"Stress, Psychological",F02.830.900
20919645,2010-01-01T00:00:00,Animals,B01.050
20919645,2010-01-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
20919645,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20919645,2010-01-01T00:00:00,Molecular Structure,G02.111.570
20919645,2010-01-01T00:00:00,Molecular Structure,G02.575
20919645,2010-01-01T00:00:00,Molecular Structure,G02.842.575
20919645,2010-01-01T00:00:00,Sphingolipids,D10.570.877
20919645,2010-01-01T00:00:00,Sphingolipids,D10.808
20919645,2010-01-01T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
20930300,2010-01-01T00:00:00,Aged,M01.060.116.100
20930300,2010-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
20930300,2010-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
20930300,2010-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
20930300,2010-01-01T00:00:00,Brain,A08.186.211
20930300,2010-01-01T00:00:00,Brain Mapping,E01.370.350.086
20930300,2010-01-01T00:00:00,Brain Mapping,E01.370.376.149
20930300,2010-01-01T00:00:00,Brain Mapping,E05.132
20930300,2010-01-01T00:00:00,Disease Progression,C23.550.291.656
20930300,2010-01-01T00:00:00,Double-Blind Method,E05.318.780.300
20930300,2010-01-01T00:00:00,Double-Blind Method,E05.581.500.300
20930300,2010-01-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20930300,2010-01-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20930300,2010-01-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
20930300,2010-01-01T00:00:00,Glucose,D09.546.359.448
20930300,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20930300,2010-01-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20930300,2010-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20930300,2010-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20930300,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20930300,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
20930300,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
20930300,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
20930300,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
20930300,2010-01-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
20930300,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20930300,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20930300,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20956819,2010-01-01T00:00:00,Adult,M01.060.116
20956819,2010-01-01T00:00:00,Aged,M01.060.116.100
20956819,2010-01-01T00:00:00,Breast Neoplasms,C04.588.180
20956819,2010-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
20956819,2010-01-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
20956819,2010-01-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
20956819,2010-01-01T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
20956819,2010-01-01T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
20956819,2010-01-01T00:00:00,"Carcinoma, Intraductal, Noninfiltrating",C04.557.470.200.025.275
20956819,2010-01-01T00:00:00,"Carcinoma, Intraductal, Noninfiltrating",C04.557.470.615.275
20956819,2010-01-01T00:00:00,Diagnostic Imaging,E01.370.350
20956819,2010-01-01T00:00:00,Disease Progression,C23.550.291.656
20956819,2010-01-01T00:00:00,Forecasting,I01.320
20956819,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20956819,2010-01-01T00:00:00,Incidence,E05.318.308.985.525.375
20956819,2010-01-01T00:00:00,Incidence,L01.280.975.525.375
20956819,2010-01-01T00:00:00,Incidence,N01.224.935.597.500
20956819,2010-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20956819,2010-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20956819,2010-01-01T00:00:00,Mammography,E01.370.350.700.500
20956819,2010-01-01T00:00:00,Mass Screening,E01.370.500
20956819,2010-01-01T00:00:00,Mass Screening,E05.318.308.250.580
20956819,2010-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20956819,2010-01-01T00:00:00,Mass Screening,N02.421.726.233.443
20956819,2010-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20956819,2010-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20956819,2010-01-01T00:00:00,Mass Screening,N06.850.780.500
20956819,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
20956819,2010-01-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
20956819,2010-01-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
20956819,2010-01-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
20956819,2010-01-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
20956819,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20956819,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20956819,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20956819,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20956819,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20956819,2010-01-01T00:00:00,Time Factors,G01.910.857
20956819,2010-01-01T00:00:00,"Tumor Markers, Biological",D23.101.840
20956819,2010-01-01T00:00:00,United States,Z01.107.567.875
20969555,2010-01-01T00:00:00,Biological Markers,D23.101
20969555,2010-01-01T00:00:00,Dietary Supplements,J02.500.456
20969555,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20969555,2010-01-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20969555,2010-01-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20969555,2010-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20969555,2010-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20969555,2010-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20969555,2010-01-01T00:00:00,Risk Assessment,N04.452.871.715
20969555,2010-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20969555,2010-01-01T00:00:00,Risk Assessment,N06.850.505.715
20969555,2010-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20969555,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20969555,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20969555,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20969555,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20969555,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20969555,2010-01-01T00:00:00,Treatment Outcome,E01.789.800
20969555,2010-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20969555,2010-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20969555,2010-01-01T00:00:00,Vitamin D,D04.808.812.768
20969555,2010-01-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
21050919,2010-01-01T00:00:00,Animals,B01.050
21050919,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21050919,2010-01-01T00:00:00,Transducin,D08.811.277.040.330.300.200.800
21050919,2010-01-01T00:00:00,Transducin,D12.644.360.375.940
21050919,2010-01-01T00:00:00,Transducin,D12.776.157.325.332.940
21050919,2010-01-01T00:00:00,Transducin,D12.776.476.375.940
21050919,2010-01-01T00:00:00,Transducin,D12.776.543.325.800
21061896,2010-01-01T00:00:00,Adolescent,M01.060.057
21061896,2010-01-01T00:00:00,Adult,M01.060.116
21061896,2010-01-01T00:00:00,Aged,M01.060.116.100
21061896,2010-01-01T00:00:00,H-Reflex,G11.561.600.765.643.474
21061896,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21061896,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
21061896,2010-01-01T00:00:00,"Muscle, Skeletal",A02.633.567
21061896,2010-01-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
21061896,2010-01-01T00:00:00,Posture,G11.427.695
21061896,2010-01-01T00:00:00,Psychomotor Performance,F02.808
21061896,2010-01-01T00:00:00,Psychomotor Performance,G11.427.700
21061896,2010-01-01T00:00:00,Psychomotor Performance,G11.561.623
21061896,2010-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
21061896,2010-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
21061896,2010-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
21061896,2010-01-01T00:00:00,Walking,G11.427.590.530.568.900
21061896,2010-01-01T00:00:00,Walking,G11.427.590.530.698.940
21061896,2010-01-01T00:00:00,Walking,I03.450.642.845.940
21061896,2010-01-01T00:00:00,Young Adult,M01.060.116.815
21061898,2010-01-01T00:00:00,Adult,M01.060.116
21061898,2010-01-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
21061898,2010-01-01T00:00:00,Aged,M01.060.116.100
21061898,2010-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
21061898,2010-01-01T00:00:00,Health Surveys,E05.318.308.250
21061898,2010-01-01T00:00:00,Health Surveys,N05.715.360.300.375
21061898,2010-01-01T00:00:00,Health Surveys,N06.850.520.308.250
21061898,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21061898,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
21061898,2010-01-01T00:00:00,Pressure Ulcer,C17.800.893.665
21061898,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21061898,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21061898,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21061898,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21061898,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21061898,2010-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
21061898,2010-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
21061898,2010-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
21061898,2010-01-01T00:00:00,Young Adult,M01.060.116.815
21096131,2010-01-01T00:00:00,Animals,B01.050
21096131,2010-01-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
21096131,2010-01-01T00:00:00,Catheter Ablation,E02.148.110
21096131,2010-01-01T00:00:00,Catheter Ablation,E02.148.442.110
21096131,2010-01-01T00:00:00,Catheter Ablation,E02.154.402.110
21096131,2010-01-01T00:00:00,Catheter Ablation,E04.014.170.402.110
21096131,2010-01-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
21096131,2010-01-01T00:00:00,Computer Simulation,L01.224.160
21096131,2010-01-01T00:00:00,Feedback,L01.143.283.425
21096131,2010-01-01T00:00:00,Hepatectomy,E04.210.556
21096131,2010-01-01T00:00:00,Liver,A03.620
21096131,2010-01-01T00:00:00,"Models, Biological",E05.599.395
21096131,2010-01-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
21096131,2010-01-01T00:00:00,"Surgery, Computer-Assisted",E04.749
21096131,2010-01-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
21096397,2010-01-01T00:00:00,Algorithms,G17.035
21096397,2010-01-01T00:00:00,Algorithms,L01.224.050
21096397,2010-01-01T00:00:00,Animals,B01.050
21096397,2010-01-01T00:00:00,Electroencephalography,E01.370.376.300
21096397,2010-01-01T00:00:00,Electroencephalography,E01.370.405.245
21096397,2010-01-01T00:00:00,Energy Transfer,G01.154.100.240
21096397,2010-01-01T00:00:00,Energy Transfer,G01.595.100.240
21096397,2010-01-01T00:00:00,Energy Transfer,G02.111.087.242
21096397,2010-01-01T00:00:00,Energy Transfer,G02.149.115.242
21096397,2010-01-01T00:00:00,Energy Transfer,G02.149.767.580
21096397,2010-01-01T00:00:00,Energy Transfer,G02.842.750.580
21096397,2010-01-01T00:00:00,Movement,G07.700.560
21096397,2010-01-01T00:00:00,Movement,G11.427.590.530
21096397,2010-01-01T00:00:00,Muscle Contraction,G11.427.590.540
21096397,2010-01-01T00:00:00,"Muscle, Skeletal",A02.633.567
21096397,2010-01-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
21096397,2010-01-01T00:00:00,"Pattern Recognition, Automated",L01.725
21105937,2010-01-01T00:00:00,Alcoholism,C21.739.100.250
21105937,2010-01-01T00:00:00,Alcoholism,F03.900.100.350
21105937,2010-01-01T00:00:00,Brain,A08.186.211
21105937,2010-01-01T00:00:00,Brain Mapping,E01.370.350.086
21105937,2010-01-01T00:00:00,Brain Mapping,E01.370.376.149
21105937,2010-01-01T00:00:00,Brain Mapping,E05.132
21105937,2010-01-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
21105937,2010-01-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
21105937,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21105937,2010-01-01T00:00:00,"Models, Theoretical",E05.599
21105937,2010-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21105937,2010-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21105937,2010-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21105937,2010-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21105937,2010-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21105937,2010-01-01T00:00:00,Substance-Related Disorders,C21.739
21105937,2010-01-01T00:00:00,Substance-Related Disorders,F03.900
21105937,2010-01-01T00:00:00,United States,Z01.107.567.875
21138698,2010-01-01T00:00:00,Clinical Competence,I02.399.630.210
21138698,2010-01-01T00:00:00,Clinical Competence,N04.761.210
21138698,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21138698,2010-01-01T00:00:00,Narration,E05.318.308.502
21138698,2010-01-01T00:00:00,Narration,F01.145.209.459
21138698,2010-01-01T00:00:00,Narration,L01.280.660
21138698,2010-01-01T00:00:00,Narration,N05.715.360.300.480
21138698,2010-01-01T00:00:00,Narration,N06.850.520.308.502
21138698,2010-01-01T00:00:00,Physician's Practice Patterns,N04.590.748
21138698,2010-01-01T00:00:00,Physician's Practice Patterns,N05.300.625
21140995,2010-01-01T00:00:00,Adult,M01.060.116
21140995,2010-01-01T00:00:00,Child,M01.060.406
21140995,2010-01-01T00:00:00,Forensic Psychiatry,F04.096.544.335
21140995,2010-01-01T00:00:00,Forensic Psychiatry,H02.403.690.208
21140995,2010-01-01T00:00:00,Forensic Psychiatry,I01.198.780.937.469
21140995,2010-01-01T00:00:00,Forensic Psychiatry,I01.880.604.583.310
21140995,2010-01-01T00:00:00,Forensic Psychiatry,N03.706.535.351
21140995,2010-01-01T00:00:00,Homicide,I01.198.240.470
21140995,2010-01-01T00:00:00,Homicide,I01.880.735.344
21140995,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21140995,2010-01-01T00:00:00,Mental Competency,F01.590
21140995,2010-01-01T00:00:00,Mental Competency,F02.410
21140995,2010-01-01T00:00:00,Mental Competency,I01.880.604.583.530
21140995,2010-01-01T00:00:00,Mental Competency,N03.706.535.625
21140995,2010-01-01T00:00:00,Mental Disorders,F03
21140995,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
21140995,2010-01-01T00:00:00,Schizophrenia,F03.700.750
21140995,2010-01-01T00:00:00,Substance-Related Disorders,C21.739
21140995,2010-01-01T00:00:00,Substance-Related Disorders,F03.900
21140995,2010-01-01T00:00:00,United States,Z01.107.567.875
21141049,2010-01-01T00:00:00,Curriculum,I02.158
21141049,2010-01-01T00:00:00,Data Collection,E05.318.308
21141049,2010-01-01T00:00:00,Data Collection,L01.280
21141049,2010-01-01T00:00:00,Data Collection,N05.715.360.300
21141049,2010-01-01T00:00:00,Data Collection,N06.850.520.308
21141049,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21141049,2010-01-01T00:00:00,Oral Health,N01.400.535
21141049,2010-01-01T00:00:00,Physician Assistants,M01.526.485.067.740
21141049,2010-01-01T00:00:00,Physician Assistants,N02.360.067.740
21141049,2010-01-01T00:00:00,Program Evaluation,E05.337.820
21141049,2010-01-01T00:00:00,Program Evaluation,N04.761.685
21141049,2010-01-01T00:00:00,Program Evaluation,N05.715.360.650
21141049,2010-01-01T00:00:00,Psychometrics,F04.711.780
21160122,2010-01-01T00:00:00,Age Factors,N05.715.350.075
21160122,2010-01-01T00:00:00,Age Factors,N06.850.490.250
21160122,2010-01-01T00:00:00,Aged,M01.060.116.100
21160122,2010-01-01T00:00:00,"Databases, Factual",L01.470.750.750
21160122,2010-01-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
21160122,2010-01-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
21160122,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21160122,2010-01-01T00:00:00,Middle Aged,M01.060.116.630
21160122,2010-01-01T00:00:00,Sex Factors,N05.715.350.675
21160122,2010-01-01T00:00:00,Sex Factors,N06.850.490.875
21160122,2010-01-01T00:00:00,United States,Z01.107.567.875
21175403,2010-01-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
21175403,2010-01-01T00:00:00,Catheter Ablation,E02.148.110
21175403,2010-01-01T00:00:00,Catheter Ablation,E02.148.442.110
21175403,2010-01-01T00:00:00,Catheter Ablation,E02.154.402.110
21175403,2010-01-01T00:00:00,Catheter Ablation,E04.014.170.402.110
21175403,2010-01-01T00:00:00,Computer Simulation,L01.224.160
21175403,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21175403,2010-01-01T00:00:00,"Models, Biological",E05.599.395
21188788,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21188788,2010-01-01T00:00:00,"Hyperthermia, Induced",E02.565
21188788,2010-01-01T00:00:00,"Hyperthermia, Induced",E02.779.496
21188788,2010-01-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
21188788,2010-01-01T00:00:00,"Surgery, Computer-Assisted",E04.749
21188788,2010-01-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
21225782,2010-01-01T00:00:00,Cadaver,C23.550.260.224
21225782,2010-01-01T00:00:00,Head and Neck Neoplasms,C04.588.443
21225782,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21225782,2010-01-01T00:00:00,Radiation Injuries,C21.866.733
21225782,2010-01-01T00:00:00,Radiation Injuries,N06.850.810.300.360
21225782,2010-01-01T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
22112489,2010-01-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
22112489,2010-01-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
22112489,2010-01-01T00:00:00,Early Detection of Cancer,E01.390.500
22112489,2010-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22112489,2010-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22112489,2010-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
22112489,2010-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
22112489,2010-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
22112489,2010-01-01T00:00:00,Proteomics,H01.158.201.843
22112489,2010-01-01T00:00:00,Proteomics,H01.158.273.180.350.700
22112489,2010-01-01T00:00:00,Proteomics,H01.158.273.343.350.700
22112489,2010-01-01T00:00:00,Proteomics,H01.181.122.738
22112489,2010-01-01T00:00:00,"Tumor Markers, Biological",D23.101.840
